0001288469-24-000128.txt : 20241023 0001288469-24-000128.hdr.sgml : 20241023 20241023160740 ACCESSION NUMBER: 0001288469-24-000128 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 102 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241023 DATE AS OF CHANGE: 20241023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAXLINEAR, INC CENTRAL INDEX KEY: 0001288469 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 141896129 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34666 FILM NUMBER: 241389288 BUSINESS ADDRESS: STREET 1: 5966 LA PLACE CT. CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 760-692-0711 MAIL ADDRESS: STREET 1: 5966 LA PLACE CT. CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: MAXLINEAR INC DATE OF NAME CHANGE: 20040423 10-Q 1 mxl-20240930.htm 10-Q mxl-20240930
0001288469December 312024Q3falseP3YP1YP1YP1Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesmxl:segmentmxl:business_activityxbrli:puremxl:claim00012884692024-01-012024-09-3000012884692024-10-1600012884692024-09-3000012884692023-12-3100012884692024-07-012024-09-3000012884692023-07-012023-09-3000012884692023-01-012023-09-300001288469us-gaap:CommonStockMember2023-12-310001288469us-gaap:AdditionalPaidInCapitalMember2023-12-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001288469us-gaap:RetainedEarningsMember2023-12-310001288469us-gaap:CommonStockMember2024-01-012024-03-310001288469us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-3100012884692024-01-012024-03-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001288469us-gaap:RetainedEarningsMember2024-01-012024-03-310001288469us-gaap:CommonStockMember2024-03-310001288469us-gaap:AdditionalPaidInCapitalMember2024-03-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001288469us-gaap:RetainedEarningsMember2024-03-3100012884692024-03-310001288469us-gaap:CommonStockMember2024-04-012024-06-300001288469us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-3000012884692024-04-012024-06-300001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001288469us-gaap:RetainedEarningsMember2024-04-012024-06-300001288469us-gaap:CommonStockMember2024-06-300001288469us-gaap:AdditionalPaidInCapitalMember2024-06-300001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001288469us-gaap:RetainedEarningsMember2024-06-3000012884692024-06-300001288469us-gaap:CommonStockMember2024-07-012024-09-300001288469us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001288469us-gaap:RetainedEarningsMember2024-07-012024-09-300001288469us-gaap:CommonStockMember2024-09-300001288469us-gaap:AdditionalPaidInCapitalMember2024-09-300001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001288469us-gaap:RetainedEarningsMember2024-09-300001288469us-gaap:CommonStockMember2022-12-310001288469us-gaap:AdditionalPaidInCapitalMember2022-12-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001288469us-gaap:RetainedEarningsMember2022-12-3100012884692022-12-310001288469us-gaap:CommonStockMember2023-01-012023-03-310001288469us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100012884692023-01-012023-03-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001288469us-gaap:RetainedEarningsMember2023-01-012023-03-310001288469us-gaap:CommonStockMember2023-03-310001288469us-gaap:AdditionalPaidInCapitalMember2023-03-310001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001288469us-gaap:RetainedEarningsMember2023-03-3100012884692023-03-310001288469us-gaap:CommonStockMember2023-04-012023-06-300001288469us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-3000012884692023-04-012023-06-300001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001288469us-gaap:RetainedEarningsMember2023-04-012023-06-300001288469us-gaap:CommonStockMember2023-06-300001288469us-gaap:AdditionalPaidInCapitalMember2023-06-300001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001288469us-gaap:RetainedEarningsMember2023-06-3000012884692023-06-300001288469us-gaap:CommonStockMember2023-07-012023-09-300001288469us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001288469us-gaap:RetainedEarningsMember2023-07-012023-09-300001288469us-gaap:CommonStockMember2023-09-300001288469us-gaap:AdditionalPaidInCapitalMember2023-09-300001288469us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001288469us-gaap:RetainedEarningsMember2023-09-3000012884692023-09-300001288469srt:MinimumMember2024-09-300001288469srt:MaximumMember2024-09-300001288469mxl:ProductionMasksMember2024-09-300001288469srt:MinimumMember2024-01-012024-09-300001288469srt:MaximumMember2024-01-012024-09-300001288469mxl:TerminatedSiliconMotionMergerMember2023-08-310001288469mxl:CompanyYMember2023-01-172023-01-170001288469mxl:CompanyYMember2023-01-170001288469mxl:CompanyYMember2024-09-300001288469mxl:A2024WorkforceReductionMember2024-01-012024-09-300001288469mxl:A2024WorkforceReductionMember2024-07-012024-09-300001288469us-gaap:ContractTerminationMembermxl:A2024WorkforceReductionMember2024-01-012024-09-300001288469us-gaap:ContractTerminationMembermxl:A2024WorkforceReductionMember2024-07-012024-09-300001288469us-gaap:EmployeeSeveranceMembermxl:A2024WorkforceReductionMember2024-07-012024-09-300001288469us-gaap:EmployeeSeveranceMembermxl:A2024WorkforceReductionMember2024-01-012024-09-300001288469us-gaap:FacilityClosingMembermxl:A2024WorkforceReductionMember2024-01-012024-09-300001288469us-gaap:FacilityClosingMembermxl:A2024WorkforceReductionMember2024-07-012024-09-300001288469us-gaap:OtherRestructuringMembermxl:A2023WorkforceReductionMember2024-01-012024-09-300001288469us-gaap:EmployeeSeveranceMembermxl:A2023WorkforceReductionMember2024-01-012024-09-300001288469mxl:A2023WorkforceReductionMember2024-01-012024-09-300001288469mxl:A2023And2024WorkforceReductionsMembersrt:MinimumMember2024-09-300001288469mxl:A2023And2024WorkforceReductionsMembersrt:MaximumMember2024-09-300001288469us-gaap:EmployeeSeveranceMember2024-07-012024-09-300001288469us-gaap:EmployeeSeveranceMember2023-07-012023-09-300001288469us-gaap:EmployeeSeveranceMember2024-01-012024-09-300001288469us-gaap:EmployeeSeveranceMember2023-01-012023-09-300001288469us-gaap:FacilityClosingMember2024-07-012024-09-300001288469us-gaap:FacilityClosingMember2023-07-012023-09-300001288469us-gaap:FacilityClosingMember2024-01-012024-09-300001288469us-gaap:FacilityClosingMember2023-01-012023-09-300001288469mxl:OtherRestructuringNettingMember2024-07-012024-09-300001288469mxl:OtherRestructuringNettingMember2023-07-012023-09-300001288469mxl:OtherRestructuringNettingMember2024-01-012024-09-300001288469mxl:OtherRestructuringNettingMember2023-01-012023-09-300001288469us-gaap:OneTimeTerminationBenefitsMember2023-12-310001288469mxl:FacilityClosingNettingMember2023-12-310001288469mxl:OtherRestructuringNettingMember2023-12-310001288469us-gaap:OneTimeTerminationBenefitsMember2024-01-012024-09-300001288469mxl:FacilityClosingNettingMember2024-01-012024-09-300001288469us-gaap:OneTimeTerminationBenefitsMember2024-09-300001288469mxl:FacilityClosingNettingMember2024-09-300001288469mxl:OtherRestructuringNettingMember2024-09-3000012884692023-10-312023-10-310001288469mxl:LicensedTechnologyMember2024-09-300001288469mxl:LicensedTechnologyMember2023-12-310001288469us-gaap:DevelopedTechnologyRightsMember2024-09-300001288469us-gaap:DevelopedTechnologyRightsMember2023-12-310001288469us-gaap:TrademarksAndTradeNamesMember2024-09-300001288469us-gaap:TrademarksAndTradeNamesMember2023-12-310001288469us-gaap:CustomerRelationshipsMember2024-09-300001288469us-gaap:CustomerRelationshipsMember2023-12-310001288469us-gaap:PatentsMember2024-09-300001288469us-gaap:PatentsMember2023-12-310001288469us-gaap:CostOfSalesMember2024-07-012024-09-300001288469us-gaap:CostOfSalesMember2023-07-012023-09-300001288469us-gaap:CostOfSalesMember2024-01-012024-09-300001288469us-gaap:CostOfSalesMember2023-01-012023-09-300001288469us-gaap:ResearchAndDevelopmentExpenseMember2024-07-012024-09-300001288469us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300001288469us-gaap:ResearchAndDevelopmentExpenseMember2024-01-012024-09-300001288469us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-09-300001288469us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-300001288469us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001288469us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-09-300001288469us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-300001288469us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001288469us-gaap:FairValueMeasurementsRecurringMember2024-09-300001288469us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001288469us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001288469us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001288469us-gaap:FairValueMeasurementsRecurringMember2023-12-310001288469us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001288469us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001288469mxl:ContingentConsiderationLiabilityMember2023-12-310001288469mxl:ContingentConsiderationLiabilityMember2022-12-310001288469mxl:ContingentConsiderationLiabilityMember2024-01-012024-09-300001288469mxl:ContingentConsiderationLiabilityMember2023-01-012023-09-300001288469mxl:ContingentConsiderationLiabilityMember2024-09-300001288469mxl:ContingentConsiderationLiabilityMember2023-09-300001288469us-gaap:FurnitureAndFixturesMember2024-09-300001288469us-gaap:FurnitureAndFixturesMember2023-12-310001288469srt:MinimumMemberus-gaap:MachineryAndEquipmentMember2024-09-300001288469srt:MaximumMemberus-gaap:MachineryAndEquipmentMember2024-09-300001288469us-gaap:MachineryAndEquipmentMember2024-09-300001288469us-gaap:MachineryAndEquipmentMember2023-12-310001288469mxl:MasksAndProductionEquipmentMember2024-09-300001288469mxl:MasksAndProductionEquipmentMember2023-12-310001288469us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-09-300001288469us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-12-310001288469srt:MinimumMemberus-gaap:LeaseholdImprovementsMember2024-09-300001288469srt:MaximumMemberus-gaap:LeaseholdImprovementsMember2024-09-300001288469us-gaap:LeaseholdImprovementsMember2024-09-300001288469us-gaap:LeaseholdImprovementsMember2023-12-310001288469us-gaap:ConstructionInProgressMember2024-09-300001288469us-gaap:ConstructionInProgressMember2023-12-3100012884692022-03-012022-03-3100012884692023-09-012023-09-3000012884692023-08-312023-08-310001288469mxl:ReductionInTransactionPriceMember2024-09-300001288469mxl:ReductionInTransactionPriceMember2023-12-310001288469us-gaap:SalesReturnsAndAllowancesMember2024-09-300001288469us-gaap:SalesReturnsAndAllowancesMember2023-12-310001288469us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001288469us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2023-12-310001288469us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300001288469us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-01-012024-09-300001288469us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300001288469us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember2024-09-300001288469mxl:InitialTermLoanTLBJune2021Member2024-09-300001288469mxl:InitialTermLoanTLBJune2021Member2023-12-310001288469us-gaap:MediumTermNotesMember2024-09-300001288469us-gaap:MediumTermNotesMember2023-12-310001288469mxl:WellsFargoBankNationalAssociationMembermxl:InitialTermLoanTLBJune2021Member2021-06-230001288469mxl:WellsFargoBankNationalAssociationMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-06-230001288469mxl:InitialTermLoanTLBJune2021Member2021-06-230001288469mxl:InitialTermLoanTLBJune2021Memberus-gaap:FederalFundsEffectiveSwapRateMember2024-01-012024-09-300001288469mxl:InitialTermLoanTLBJune2021Memberus-gaap:SecuredOvernightFinancingRateSofrMember2024-01-012024-09-300001288469mxl:InitialTermLoanTLBJune2021Member2024-01-012024-09-300001288469mxl:InitialTermLoanTLBJune2021Membermxl:SecuredOvernightFinancingRateSOFRSubjectToFloorMember2024-01-012024-09-300001288469us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:BaseRateMember2024-01-012024-09-300001288469us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-01-012024-09-300001288469us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:BaseRateMembersrt:MinimumMember2021-07-012024-09-300001288469us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:BaseRateMembersrt:MaximumMember2021-07-012024-09-300001288469us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMember2021-07-012024-09-300001288469us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MaximumMember2021-07-012024-09-300001288469us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MinimumMember2021-07-012024-09-300001288469us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MaximumMember2021-07-012024-09-300001288469us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300001288469us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-01-012024-09-300001288469mxl:InducementPlanMember2024-05-220001288469mxl:EquityIncentivePlanMember2024-09-300001288469mxl:EmployeeStockPurchasePlanMember2024-09-300001288469mxl:InducementPlanMember2024-09-3000012884692024-02-290001288469us-gaap:RestrictedStockUnitsRSUMember2024-09-300001288469us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300001288469us-gaap:PerformanceSharesMember2024-09-300001288469us-gaap:PerformanceSharesMember2024-01-012024-09-300001288469us-gaap:EmployeeStockOptionMember2024-09-300001288469us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001288469us-gaap:RestrictedStockUnitsRSUMember2023-12-310001288469us-gaap:RestrictedStockUnitsRSUMembermxl:InducementPlanMember2024-01-012024-09-300001288469us-gaap:ShareBasedCompensationAwardTrancheThreeMember2024-01-012024-09-300001288469us-gaap:ShareBasedCompensationAwardTrancheOneMember2024-01-012024-09-300001288469us-gaap:ShareBasedCompensationAwardTrancheTwoMember2024-01-012024-09-300001288469us-gaap:PerformanceSharesMember2023-12-310001288469us-gaap:EmployeeStockMember2024-01-012024-09-300001288469us-gaap:EmployeeStockMember2023-01-012023-09-300001288469us-gaap:EmployeeStockMember2024-09-300001288469us-gaap:EmployeeStockMember2023-09-300001288469us-gaap:EmployeeStockMembersrt:MinimumMember2024-09-300001288469us-gaap:EmployeeStockMembersrt:MaximumMember2024-09-300001288469us-gaap:EmployeeStockMembersrt:MinimumMember2023-09-300001288469us-gaap:EmployeeStockMembersrt:MaximumMember2023-09-300001288469us-gaap:EmployeeStockOptionMembersrt:MinimumMember2024-09-300001288469us-gaap:EmployeeStockOptionMembersrt:MaximumMember2024-09-300001288469mxl:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469mxl:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469mxl:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469mxl:CustomerAMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469mxl:CustomerBMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-09-300001288469mxl:CustomerBMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2023-01-012023-12-310001288469mxl:CustomerCMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2024-01-012024-09-300001288469mxl:CustomerCMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2023-01-012023-12-310001288469mxl:VendorAMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2024-07-012024-09-300001288469mxl:VendorAMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2023-07-012023-09-300001288469mxl:VendorAMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2024-01-012024-09-300001288469mxl:VendorAMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2023-01-012023-09-300001288469mxl:VendorBMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2024-07-012024-09-300001288469mxl:VendorBMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2023-07-012023-09-300001288469mxl:VendorBMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2024-01-012024-09-300001288469mxl:VendorBMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2023-01-012023-09-300001288469mxl:VendorCMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2024-07-012024-09-300001288469mxl:VendorCMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2023-07-012023-09-300001288469mxl:VendorCMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2024-01-012024-09-300001288469mxl:VendorCMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2023-01-012023-09-300001288469mxl:VendorDMemberus-gaap:SupplierConcentrationRiskMemberus-gaap:InventoriesMember2023-01-012023-09-300001288469srt:AsiaMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469srt:AsiaMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469srt:AsiaMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469srt:AsiaMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469srt:AsiaMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469srt:AsiaMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469srt:AsiaMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469srt:AsiaMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469srt:EuropeMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469srt:EuropeMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469srt:EuropeMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469srt:EuropeMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469country:USus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469country:USus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469country:USus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469country:USus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469mxl:RestOfWorldMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469mxl:RestOfWorldMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469mxl:RestOfWorldMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469mxl:RestOfWorldMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469mxl:RestOfWorldMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469mxl:RestOfWorldMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469mxl:RestOfWorldMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469mxl:RestOfWorldMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469us-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469us-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469us-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469us-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469country:HKus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469country:HKus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469country:HKus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469country:HKus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469country:CNus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469country:TWus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469country:THus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469country:USmxl:LongLivedAssetsMember2024-01-012024-09-300001288469country:USus-gaap:GeographicConcentrationRiskMembermxl:LongLivedAssetsMember2024-01-012024-09-300001288469country:USmxl:LongLivedAssetsMember2023-01-012023-12-310001288469country:USus-gaap:GeographicConcentrationRiskMembermxl:LongLivedAssetsMember2023-01-012023-12-310001288469country:SGmxl:LongLivedAssetsMember2024-01-012024-09-300001288469country:SGus-gaap:GeographicConcentrationRiskMembermxl:LongLivedAssetsMember2024-01-012024-09-300001288469country:SGmxl:LongLivedAssetsMember2023-01-012023-12-310001288469country:SGus-gaap:GeographicConcentrationRiskMembermxl:LongLivedAssetsMember2023-01-012023-12-310001288469mxl:RestOfWorldMembermxl:LongLivedAssetsMember2024-01-012024-09-300001288469mxl:RestOfWorldMemberus-gaap:GeographicConcentrationRiskMembermxl:LongLivedAssetsMember2024-01-012024-09-300001288469mxl:RestOfWorldMembermxl:LongLivedAssetsMember2023-01-012023-12-310001288469mxl:RestOfWorldMemberus-gaap:GeographicConcentrationRiskMembermxl:LongLivedAssetsMember2023-01-012023-12-310001288469mxl:LongLivedAssetsMember2024-01-012024-09-300001288469us-gaap:GeographicConcentrationRiskMembermxl:LongLivedAssetsMember2024-01-012024-09-300001288469mxl:LongLivedAssetsMember2023-01-012023-12-310001288469us-gaap:GeographicConcentrationRiskMembermxl:LongLivedAssetsMember2023-01-012023-12-310001288469mxl:BroadbandMember2024-07-012024-09-300001288469mxl:BroadbandMember2023-07-012023-09-300001288469mxl:BroadbandMember2024-01-012024-09-300001288469mxl:BroadbandMember2023-01-012023-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:BroadbandMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:BroadbandMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:BroadbandMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:BroadbandMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469mxl:ConnectivityMember2024-07-012024-09-300001288469mxl:ConnectivityMember2023-07-012023-09-300001288469mxl:ConnectivityMember2024-01-012024-09-300001288469mxl:ConnectivityMember2023-01-012023-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:ConnectivityMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:ConnectivityMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:ConnectivityMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:ConnectivityMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469mxl:InfrastructureMember2024-07-012024-09-300001288469mxl:InfrastructureMember2023-07-012023-09-300001288469mxl:InfrastructureMember2024-01-012024-09-300001288469mxl:InfrastructureMember2023-01-012023-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:InfrastructureMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:InfrastructureMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:InfrastructureMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:InfrastructureMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469mxl:IndustrialAndMultiMarketMember2024-07-012024-09-300001288469mxl:IndustrialAndMultiMarketMember2023-07-012023-09-300001288469mxl:IndustrialAndMultiMarketMember2024-01-012024-09-300001288469mxl:IndustrialAndMultiMarketMember2023-01-012023-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:IndustrialAndMultiMarketMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:IndustrialAndMultiMarketMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:IndustrialAndMultiMarketMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469us-gaap:ProductConcentrationRiskMembermxl:IndustrialAndMultiMarketMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001288469mxl:RevenueFromDistributorsMembermxl:DistributorsMemberus-gaap:SalesRevenueNetMember2024-07-012024-09-300001288469mxl:RevenueFromDistributorsMembermxl:DistributorsMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001288469mxl:RevenueFromDistributorsMembermxl:DistributorsMemberus-gaap:SalesRevenueNetMember2024-01-012024-09-300001288469mxl:RevenueFromDistributorsMembermxl:DistributorsMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-3000012884692023-01-012023-12-310001288469us-gaap:InventoriesMember2024-09-300001288469mxl:OtherObligationsMember2024-09-300001288469mxl:SiliconMotionStockholderLitigationMember2024-01-012024-09-300001288469mxl:WaterIslandEventDrivenFundVMaxLinearIncMember2023-08-310001288469mxl:WaterIslandEventDrivenFundVMaxLinearIncMember2024-09-180001288469mxl:DishLitigationMember2023-09-212023-09-210001288469mxl:DishLitigationMember2024-01-312024-01-310001288469mxl:CoxLitigationMember2023-02-102023-02-100001288469mxl:CoxLitigationMember2023-10-062023-10-0600012884692021-02-2300012884692021-02-232024-09-3000012884692024-02-16

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended September 30, 2024
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From              to
Commission file number: 001-34666
MaxLinear, Inc.
(Exact name of registrant as specified in its charter)
Delaware14-1896129
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
5966 La Place Court, Suite 100,CarlsbadCalifornia92008
(Address of principal executive offices)(Zip Code)
(760) 692-0711
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stockMXLThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes     No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filerEmerging growth company
Non-accelerated filerSmaller reporting company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No   
As of October 16, 2024, the registrant had 84,361,778 shares of common stock, par value $0.0001, outstanding.


MAXLINEAR, INC.
QUARTERLY REPORT ON FORM 10-Q
TABLE OF CONTENTS
Page
Part I
Item 1.
Item 2.
Item 3.
Item 4.
Part II
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
2

PART I — FINANCIAL INFORMATION

3

ITEM 1.    FINANCIAL STATEMENTS

MAXLINEAR, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except par value amounts)
September 30,
2024
December 31,
2023
Assets(unaudited)
Current assets:
Cash and cash equivalents$148,476 $187,288 
Short-term restricted cash993 1,051 
Accounts receivable, net47,930 170,619 
Inventory96,063 99,908 
Prepaid expenses and other current assets34,798 29,159 
Total current assets328,260 488,025 
Long-term restricted cash23 17 
Property and equipment, net63,493 66,431 
Leased right-of-use assets22,549 31,264 
Intangible assets, net58,031 73,630 
Goodwill318,588 318,588 
Deferred tax assets82,552 69,493 
Other long-term assets21,807 32,809 
Total assets$895,303 $1,080,257 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$30,628 $21,551 
Accrued price protection liability44,472 71,684 
Accrued expenses and other current liabilities71,197 98,468 
Accrued compensation22,300 30,426 
Total current liabilities168,597 222,129 
Long-term lease liabilities19,433 26,243 
Long-term debt122,840 122,375 
Other long-term liabilities27,561 23,245 
Total liabilities338,431 393,992 
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding
  
Common stock, $0.0001 par value; 550,000 shares authorized; 84,362 shares issued and outstanding at September 30, 2024 and 81,818 shares issued and outstanding December 31, 2023
8 8 
Additional paid-in capital866,603 808,575 
Accumulated other comprehensive loss(3,852)(3,791)
Accumulated deficit(305,887)(118,527)
Total stockholders’ equity556,872 686,265 
Total liabilities and stockholders’ equity$895,303 $1,080,257 

See accompanying notes.
4

MAXLINEAR, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited; in thousands, except per share data)
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net revenue$81,102 $135,530 $268,361 $567,910 
Cost of net revenue37,022 61,586 124,827 250,786 
Gross profit44,080 73,944 143,534 317,124 
Operating expenses:
Research and development52,604 66,306 173,911 204,254 
Selling, general and administrative30,154 25,402 100,242 97,772 
Impairment losses1,237  1,237 2,438 
Restructuring charges26,828 54 50,323 9,138 
Total operating expenses110,823 91,762 325,713 313,602 
Income (loss) from operations(66,743)(17,818)(182,179)3,522 
Interest income1,653 1,736 5,346 4,272 
Interest expense(2,655)(2,715)(8,072)(7,793)
Other income (expense), net(14,753)(22,721)(12,990)(21,180)
Total other income (expense), net(15,755)(23,700)(15,716)(24,701)
Loss before income taxes(82,498)(41,518)(197,895)(21,179)
Income tax provision (benefit)(6,713)(1,689)(10,535)13,468 
Net loss$(75,785)$(39,829)$(187,360)$(34,647)
Net loss per share:
Basic$(0.90)$(0.49)$(2.25)$(0.43)
Diluted$(0.90)$(0.49)$(2.25)$(0.43)
Shares used to compute net loss per share:
Basic84,074 81,249 83,303 80,395 
Diluted84,074 81,249 83,303 80,395 

See accompanying notes.
5

MAXLINEAR, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(unaudited; in thousands)

Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net loss$(75,785)$(39,829)$(187,360)$(34,647)
Foreign currency translation adjustments, net of tax benefit of $42 and $169 for the three and nine months ended September 30, 2024, respectively, and net of tax benefit of $64 and $229 for the three and nine months ended September 30, 2023, respectively
2,664 (1,855)(61)(3,125)
Reclassification adjustments of unrealized gain (loss) on pension and other defined benefit plans (3,792) (3,792)
Total comprehensive loss$(73,121)$(45,476)$(187,421)$(41,564)


See accompanying notes.
6

MAXLINEAR, INC.
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
FISCAL QUARTERS ENDED SEPTEMBER 30, 2024
(unaudited; in thousands)
Common StockAdditional
Paid-In
Capital
Accumulated
Other
Comprehensive
Income (Loss)
Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balance at December 31, 202381,818 $8 $808,575 $(3,791)$(118,527)$686,265 
Common stock issued pursuant to equity awards, net1,249 — 8,777 — — 8,777 
Stock-based compensation— — 17,032 — — 17,032 
Other comprehensive loss— — — (1,782)— (1,782)
Net loss— — — — (72,309)(72,309)
Balance at March 31, 202483,067 8 834,384 (5,573)(190,836)637,983 
Common stock issued pursuant to equity awards, net655 — (545)— — (545)
Employee stock purchase plan176 — 2,682 — — 2,682 
Stock-based compensation— — 17,344 — — 17,344 
Other comprehensive loss— — — (943)— (943)
Net loss— — — — (39,266)(39,266)
Balance at June 30, 202483,898 8 853,865 (6,516)(230,102)617,255 
Common stock issued pursuant to equity awards, net464 — (56)— — (56)
Stock-based compensation— — 12,794 — — 12,794 
Other comprehensive income— — — 2,664 — 2,664 
Net loss— — — — (75,785)(75,785)
Balance at September 30, 202484,362 $8 $866,603 $(3,852)$(305,887)$556,872 
7

MAXLINEAR, INC.
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
FISCAL QUARTERS ENDED SEPTEMBER 30, 2023
(unaudited; in thousands)
Common StockAdditional
Paid-In
Capital
Accumulated
Other
Comprehensive
Income (Loss)
Accumulated
Deficit
Total
Stockholders’
Equity
SharesAmount
Balance at December 31, 202278,745 $8 $722,778 $(1,021)$(45,380)$676,385 
Common stock issued pursuant to equity awards, net1,236 — 31,926 — — 31,926 
Stock-based compensation— — 16,460 — — 16,460 
Other comprehensive loss— — — (192)— (192)
Net income— — — — 9,533 9,533 
Balance at March 31, 202379,981 8 771,164 (1,213)(35,847)734,112 
Common stock issued pursuant to equity awards, net808 — (2,752)— — (2,752)
Employee stock purchase plan141 — 2,989 — — 2,989 
Stock-based compensation— — 17,127 — — 17,127 
Other comprehensive loss— — — (1,078)— (1,078)
Net loss— — — — (4,351)(4,351)
Balance at June 30, 202380,930 8 788,528 (2,291)(40,198)746,047 
Common stock issued pursuant to equity awards, net631 — (3,017)— — (3,017)
Stock-based compensation— — 5,123 — — 5,123 
Other comprehensive loss— — — (5,647)— (5,647)
Net loss— — — — (39,829)(39,829)
Balance at September 30, 202381,561 $8 $790,634 $(7,938)$(80,027)$702,677 
See accompanying notes.
8

MAXLINEAR, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited; in thousands)
Nine Months Ended September 30,
20242023
Operating Activities
Net loss$(187,360)$(34,647)
Adjustments to reconcile net loss to cash provided by operating activities:
Amortization and depreciation42,426 54,923 
Impairment of intangible assets1,237 2,438 
Impairment of investments and other assets14,000  
Amortization of debt issuance costs and accretion of discounts1,990 1,858 
Stock-based compensation47,208 38,763 
Deferred income taxes(13,058)6,502 
Loss on disposal of property and equipment1,068 2,057 
Unrealized holding loss on investments 3,917 
Impairment of leased right-of-use assets3,415  
Gain on extinguishment of lease liabilities(554) 
Gain on settlement of pension (1,008)
Loss on foreign currency973 140 
Excess tax (benefits) deficiencies on stock-based awards(2,988)(529)
Changes in operating assets and liabilities:
Accounts receivable122,689 13,769 
Inventory3,845 45,602 
Prepaid expenses and other assets(8,615)(10,215)
Accounts payable, accrued expenses and other current liabilities(16,041)(17,917)
Accrued compensation3,011 8,776 
Accrued price protection liability(27,212)(45,036)
Lease liabilities(7,806)(8,891)
Other long-term liabilities4,315 (557)
Net cash provided by (used in) operating activities(17,457)59,945 
Investing Activities
Purchases of property and equipment(15,487)(12,180)
Purchases of intangible assets(4,961)(6,198)
Cash used in acquisition, net of cash acquired (12,384)
Net cash used in investing activities(20,448)(30,762)
Financing Activities
Payment of debt commitment fees (18,325)
Net proceeds from issuance of common stock1,579 3,168 
Minimum tax withholding paid on behalf of employees for restricted stock units(1,714)(12,370)
Net cash used in financing activities(135)(27,527)
Effect of exchange rate changes on cash and cash equivalents (824)(1,861)
Decrease in cash, cash equivalents and restricted cash(38,864)(205)
Cash, cash equivalents and restricted cash at beginning of period188,356 188,357 
Cash, cash equivalents and restricted cash at end of period$149,492 $188,152 
Supplemental disclosures of cash flow information:
Cash paid for interest$7,444 $6,978 
Cash paid for income taxes$9,470 $25,336 
Supplemental disclosures of non-cash activities:
Issuance of shares for payment of bonuses$10,992 $38,348 
See accompanying notes.
9

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

1. Organization and Summary of Significant Accounting Policies
Description of Business
MaxLinear, Inc. was incorporated in Delaware in September 2003. MaxLinear, Inc., together with its directly and indirectly wholly-owned subsidiaries, collectively referred to as MaxLinear, or the Company, is a provider of communications systems-on-chip, or SoC, solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. MaxLinear is a fabless integrated circuit design company whose products integrate all or substantial portions of a high-speed communication system, including radio frequency, or RF, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management. MaxLinear’s customers primarily include electronics distributors, module makers, original equipment manufacturers, or OEMs, and original design manufacturers, or ODMs, who incorporate the Company’s products in a wide range of electronic devices. Examples of such devices include broadband modems compliant with Data Over Cable Service Interface Specifications, or DOCSIS, Passive Optical Network, or PON, and DSL; Wi-Fi and wireline routers for home networking; radio transceivers and modems for 4G/5G base-station and backhaul infrastructure; optical transceivers targeting hyperscale data centers; as well as power management and interface products used in these and many other markets.
Basis of Presentation and Principles of Consolidation
The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its directly and indirectly wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation.
In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive income, stockholders’ equity, and cash flows.
The consolidated balance sheet as of December 31, 2023 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on January 31, 2024, or the Annual Report. Interim results for the nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024.
The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these foreign subsidiaries are translated at the current exchange rate at the balance sheet date and historical rates for equity. Revenue and expense components are translated at weighted average exchange rates in effect during the period. Gains and losses resulting from foreign currency translation are included as a component of stockholders’ equity. Foreign currency transaction gains and losses are included in the results of operations, and to date, have not been material.
Use of Estimates and Significant Risks and Uncertainties
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes of the consolidated financial statements. Actual results could differ from those estimates.
The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of October 23, 2024, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates.
10

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Summary of Significant Accounting Policies

Business Combinations

The Company applies the provisions of ASC 805, Business Combinations, in accounting for its acquisitions. It requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed, at the acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the acquisition date fair values of the net assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations.

Costs to exit or restructure certain activities of an acquired company or the Company’s internal operations are accounted for as termination and exit costs pursuant to ASC 420, Exit or Disposal Cost Obligations, and are accounted for separately from the business combination. A liability for costs associated with an exit or disposal activity is recognized and measured at its fair value in the consolidated statements of operations in the period in which the liability is incurred.

For a given acquisition, the Company may identify certain pre-acquisition contingencies as of the acquisition date and may extend its review, evaluation, and adjustment of these pre-acquisition contingencies throughout the measurement period in order to obtain sufficient information to assess whether the Company includes these contingencies as a part of the fair value estimates of assets acquired and liabilities assumed and, if so, to determine their estimated amounts. A pre-acquisition contingency (non-income tax related) is only recognized as an asset or a liability if: (i) it is probable that an asset existed or a liability had been incurred at the acquisition date and (ii) the amount of the asset or liability can be reasonably estimated. Subsequent to the measurement period, changes in estimates of such contingencies will affect earnings and could have a material effect on the Company's results of operations and financial position.

In addition, uncertain tax positions and tax-related valuation allowances assumed, if any, in connection with a business combination are initially estimated as of the acquisition date. The Company re-evaluates these items quarterly based upon facts and circumstances that existed as of the acquisition date with any adjustments to the preliminary estimates being recorded to goodwill if identified within the measurement period. Subsequent to the end of the measurement period or final determination of the estimated value of the tax allowance or contingency, whichever comes first, changes to these uncertain tax positions and tax related valuation allowances will affect the income tax provision (benefit) in the consolidated statements of operations and could have a material impact on the results of operations and financial position.

Cash and Cash Equivalents

The Company considers all liquid investments with a maturity of three months or less when purchased to be cash equivalents. Cash equivalents are recorded at cost, which approximates market value.

Accounts Receivable

The Company performs ongoing credit evaluations of its customers and assesses each customer’s credit worthiness. The Company monitors collections and payments from its customers and maintains an allowance for doubtful accounts, which is based upon applying an expected credit loss rate to receivables based on the historical loss rate from similar high risk customers adjusted for current conditions, including any specific customer collection issues identified, and forecasts of economic conditions. Delinquent account balances are written off after management has determined that the likelihood of collection is remote.

Inventory

The Company assesses the recoverability of its inventory based on assumptions about demand and market conditions. Forecasted demand is determined based on historical sales and expected future sales. Inventory is stated at the lower of cost or
11

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
net realizable value. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis and net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company reduces its inventory to the lower of its cost or net realizable value on a part-by-part basis to account for obsolescence or lack of marketability. Reductions are calculated as the difference between the cost of inventory and its net realizable value based upon assumptions about future demand, market conditions and costs. Once established, these adjustments are considered permanent and are not revised until the related inventory is sold or disposed of.

Fair Value of Financial Instruments

The carrying amount of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses and compensation are considered to be representative of their respective fair values because of the short-term nature of these accounts.

Property and Equipment

Property and equipment is carried at cost and depreciated over the estimated useful lives of the assets, ranging from three to five years, using the straight-line method. Leasehold improvements are stated at cost and amortized over the shorter of the estimated useful lives of the assets or the lease term.

Production Masks

Production masks with alternative future uses or discernible future benefits are capitalized and amortized over their estimated useful lives of five years. To determine if a production mask has alternative future uses or benefits, the Company evaluates risks associated with developing new technologies and capabilities, and the related risks associated with entering new markets. Production masks that do not meet the criteria for capitalization are expensed as research and development costs.

Goodwill and Intangible Assets

Goodwill is the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations accounted for under the acquisition method. Intangible assets represent purchased intangible assets including developed technology, in-process research and development, or IPR&D, technologies acquired or licensed from other companies, customer relationships, non-compete covenants, backlog, and trademarks and tradenames. Purchased finite-lived intangible assets are capitalized and amortized over their estimated useful lives. Technologies acquired or licensed from other companies, customer relationships, non-compete covenants, backlog, and trademarks and tradenames are capitalized and amortized over the lesser of the terms of the agreement, or estimated useful life. The Company capitalizes IPR&D projects acquired as part of a business combination. On completion of each project, IPR&D assets are reclassified to developed technology and amortized over their estimated useful lives.

Impairment of Goodwill and Long-Lived Assets

Goodwill is not amortized but is tested for impairment using either a qualitative assessment, and/or quantitative assessment, which is based on comparing the fair value of a reporting unit with its carrying amount. If the carrying amount of a reporting unit exceeds its fair value, a goodwill impairment loss is recorded. The Company tests by reporting unit, goodwill and other indefinite-lived intangible assets for impairment as of October 31 each year or more frequently if it believes indicators of impairment exist.

The Company reviews indefinite-lived intangible assets for impairment using a qualitative assessment, followed by a quantitative assessment, as needed, each year as of October 31, the date of its annual goodwill impairment review, or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Recoverability of indefinite-lived intangible assets is measured by comparing the carrying amount of the asset to its fair value. In certain cases, the Company utilizes the relief-from-royalty method when appropriate, and a fair value will be obtained based on analysis over the costs saved by owning the right instead of leasing it.

12

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
During development, IPR&D is not subject to amortization and is tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Once an IPR&D project is complete, it becomes a finite-lived intangible asset and is evaluated for impairment both immediately prior to its change in classification and thereafter in accordance with the Company’s policy for long-lived assets.

The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the useful lives, to determine whether indicators of impairment may exist which warrant adjustments to carrying values or estimated useful lives. An impairment loss would be recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss would be measured based on the excess of the carrying amount of the asset over the asset’s fair value.

Revenue Recognition

The Company’s revenue is generated from sales of the Company’s integrated circuits and intellectual property, typically under individual customer purchase orders, some of which have underlying master sales agreements that specify terms governing the product or intellectual property sales. The Company recognizes such revenue at the point in time when control of the products or intellectual property is transferred to the customer at the estimated net consideration for which collection is probable, taking into account the customer’s rights to price protection, other pricing credits, unit rebates, and rights to return unsold product. Transfer of control occurs either when products are shipped to or received by the distributor or direct customer, based on the terms of the specific agreement with the customer, if the Company has a present right to payment and transfer of legal title and the risks and rewards of ownership to the customer has occurred. For most of the Company’s product sales, transfer of control occurs upon shipment to the distributor or direct customer. Under certain intellectual property sale agreements, we are entitled to fixed upfront consideration upon sale and variable consideration in the form of a portion of revenue generated by the recipient from the intellectual property. Fixed consideration is recognized when control of the functional intellectual property transfers; variable consideration may be constrained but is continuously monitored and recognized as revenue when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur and the uncertainty associated with the variable consideration is resolved. The Company recognized a material amount of variable consideration during the nine months ended September 30, 2024 as uncertainties related to such consideration were resolved. During the three months ended September 30, 2024, there was no variable consideration recognized related to resolution of uncertainties related to such consideration.

In assessing whether collection of consideration from a customer is probable, the Company considers the customer’s ability and intention to pay that amount of consideration when it is due. Payment of invoices is due as specified in the underlying customer agreement, typically 30 days from the invoice date, which occurs on the date of transfer of control of the products to the customer. Since payment terms are less than a year, the Company has elected the practical expedient and does not assess whether a customer contract has a significant financing component.

A five-step approach is applied in the recognition of revenue: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when the Company satisfies a performance obligation. Customer purchase orders plus the underlying master sales agreements are considered to be contracts with the customer for purposes of applying the five-step approach.

Pricing adjustments and estimates of returns under contractual stock rotation rights are treated as variable consideration for purposes of determining the transaction price, and are estimated at the time control transfers using the expected value method based on the Company’s analysis of actual price adjustment claims by distributors and historical product return rates, and then reassessed at the end of each reporting period. The Company also considers whether any variable consideration is constrained, since such amounts for which it is probable that a significant reversal will occur when the contingency is subsequently resolved are required to be excluded from revenues. Price adjustments are finalized at the time the products are sold through to the end customer and the distributor or end customer submits a claim to reduce the sale price to a pre-approved net price. Stock rotation allowances are capped at a fixed percentage of the Company’s sales to a distributor for a period of time, up to six months, as specified in the individual distributor contract. If the Company’s current estimates of such credits and rights are materially inaccurate, it may result in adjustments that affect future revenues and gross profits. Returns under the Company’s general assurance warranty of products for a period of one to three years have not been material and warranty-related services are not considered a separate performance obligation under the customer contracts. Most of the Company’s customers resell the Company’s product as part of their product and thus are tax-exempt; however, to the extent the Company
13

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
collects and remits taxes on product sales from customers, it has elected to exclude from the measurement of transaction price such taxes.

Each distinct promise to transfer products is considered to be an identified performance obligation for which revenue is recognized upon transfer of control of the products to the customer. Although customers may place orders for products to be delivered on multiple dates that may be in different quarterly reporting periods, all of the orders are scheduled within one year from the order date. The Company has elected to record sales commissions when incurred, as the period over which the sales commission asset that would have been recognized is less than one year.

Customer contract liabilities consist primarily of obligations to deliver rebates to customers in the form of units of products which are included in accrued expenses and other current liabilities in the consolidated balance sheets. Other obligations to customers, which are included in accrued price protection liability in the consolidated balance sheets, consist of estimates of price protection rights offered to the Company’s end customer on products sold by the Company to the end customer’s contract manufacturer at a standard price that are later incorporated into the end customers’ product. The Company’s price adjustments included in accrued expenses and other current liabilities are discounts and rebates expected to be claimed by the Company’s distributors upon sell-through of the products to their customers, which are initially sold by the Company to the distributors at a standard price. Also included in accrued expenses and other current liabilities are amounts expected to be returned by distributors under stock rotation rights. The Company also records a right of return asset, consisting of amounts representing the products the Company expects to receive from customers in returns, which is included in inventory in the consolidated balance sheets, and is typically settled within six months of transfer of control to the customer, or the period over which stock rotation rights are based. Upon lapse of the time period for stock rotations, or the contractual end to price protection and rebate programs, which is approximately one to two years, and when the Company believes unclaimed amounts are no longer subject to payment and will not be paid, any remaining asset or liability is derecognized by an offsetting entry to cost of net revenue and net revenue. For additional disclosures regarding contract liabilities and other obligations to customers, see Note 12.

The Company assesses customer accounts receivable and contract assets for impairment in accordance with ASC 310-10-35.

Warranty

The Company generally provides a warranty on its products for a period of one to three years. The Company makes estimates of product return rates and expected costs to replace the products under warranty at the time revenue is recognized based on historical warranty experience and any known product warranty issues. If actual return rates and/or replacement costs differ significantly from these estimates, adjustments to recognize additional warranty expenses in cost of net revenue may be required in future periods.

Segment Information

The Company operates under one segment as it has developed, marketed and sold primarily only one class of similar products, radio-frequency, high-performance analog and mixed-signal communications system-on-chip solutions for the connected home, wired and wireless infrastructure markets and industrial and multi-market applications.

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company’s Chief Executive Officer reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports under a single operating segment.

14

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Stock-based Compensation

The Company measures the cost of employee services received in exchange for equity incentive awards, including restricted stock units, employee stock purchase rights and stock options based on the grant date fair value of the award. The Company calculates the fair value of restricted stock units and performance-based restricted stock units based on the fair market value of the Company’s common stock on the grant date. Stock-based compensation expense is then determined based on the number of restricted stock units that are expected to vest; for performance-based restricted stock units, this is the number of units that are expected to vest during the performance period if it is probable that the Company will achieve the performance metrics specified in the underlying award agreement. The Company uses the Black-Scholes valuation model to calculate the fair value of stock options and employee stock purchase rights granted to employees. Stock-based compensation expense is recognized over the period during which the employee is required to provide services in exchange for the award, which is usually the vesting period. The Company recognizes compensation expense over the vesting period using the straight-line method and classifies these amounts in the consolidated statements of operations based on the department to which the related employee reports.

Research and Development

Costs incurred in connection with the development of the Company’s technology and future products are charged to research and development expense as incurred. From time to time, the Company enters into contracts for jointly funded research and development projects to develop technology that may be commercialized into a product in the future. The Company also obtains research and development funding grants from governments in certain jurisdictions in which it operates. Both of these types of income are reflected as a credit to research and development expense when such income has been earned and any contingencies associated with retaining such income have been resolved. In the three months ended September 30, 2024 and 2023, the Company recognized aggregate income from jointly funded R&D projects and government grants of approximately $0.6 million and $1.4 million, respectively. During the nine months ended September 30, 2024 and 2023, the Company recognized aggregate income from jointly funded R&D projects and government grants of approximately $3.1 million and $11.3 million, respectively. While the Company retains ownership and rights to the underlying technology developed under the joint development projects, the Company may be required to repay all or a portion of the funds provided by the other parties under certain conditions, and defers such funds as liabilities until the repayment conditions have been resolved (Note 15).

Leases

The Company’s leases primarily consist of facility leases which are classified as operating leases. The Company assesses whether an arrangement contains a lease at inception. The Company recognizes a lease liability to make contractual payments under all leases with terms greater than twelve months and a corresponding right-of-use asset, representing its right to use the underlying asset for the lease term. The lease liability is initially measured at the present value of the lease payments over the lease term using the collateralized incremental borrowing rate when the implicit rate is unknown. Options to extend or terminate a lease are included in the lease term when it is reasonably certain that the Company will exercise such an option. The right-of-use asset is initially measured as the contractual lease liability plus any initial direct costs and prepaid lease payments made, less any lease incentives. Upon adoption of ASC 842 on January 1, 2019, the carrying value of lease-related restructuring liabilities for certain restructured leases existing at that date was offset against the related right-of-use assets. Lease expense is recognized on a straight-line basis over the lease term.

Upon adoption of ASC 842, the Company elected certain practical expedients and accordingly has (1) carried forward its prior assessments of (a) whether existing contracts on the January 1, 2019 adoption date contain leases, (b) classification of leases as operating or financing and (c) initial direct costs for existing leases and (2) considered hindsight in determining the lease term and assessing impairment of the right-of-use-asset. In addition, the Company used a portfolio approach for its facility leases when making judgments and estimates, such as the discount rate.

Leased right-of-use assets are subject to impairment testing as a long-lived asset at the asset-group level. The Company monitors its long-lived assets for indicators of impairment. As the Company’s leased right-of-use assets primarily relate to facility leases, early abandonment of all or part of a facility as part of a restructuring plan is typically an indicator of impairment. If impairment indicators are present, the Company tests whether the carrying amount of the leased right-of-use
15

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
asset is recoverable including consideration of sublease income, and if not recoverable, measures impairment loss for the right-of-use asset or asset group.

Pension and Other Defined Benefit Retirement Obligations

The costs of pension and certain other defined benefit employee retirement benefits are required to be recognized based upon actuarial valuations. The related net retirement benefit obligation is recognized as the excess of the projected benefit obligation over the fair value of the plan assets. In measuring the retirement benefit obligation, the discount rate, expected long-term rate of return on plan assets, and long-term rate of salary increase are the most significant assumptions. Retirement benefit costs primarily represent the increase in the actuarial present value of the retirement benefit obligation.

Income Taxes

The Company provides for income taxes utilizing the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are presented net as noncurrent. The provision for income taxes generally represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from the differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when a judgment is made that is considered more likely than not that a tax benefit will not be realized. A decision to record a valuation allowance results in an increase in income tax expense or a decrease in income tax benefit. If the valuation allowance is released in a future period, income tax expense will be reduced accordingly.

The calculation of tax liabilities involves dealing with uncertainties in the application of complex global tax regulations. The impact of an uncertain income tax position is recognized at the largest amount that is “more likely than not” to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. If the estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to expense would result.

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company continually assesses the need for a valuation allowance on the deferred tax asset by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the consolidated statement of operations for the period that the adjustment is determined to be required.

On December 22, 2017, the Tax Cuts and Jobs Act, or the Tax Act, was enacted into U.S. tax law. In 2018, the Company made an accounting policy election to treat Global Intangible Low Taxed Income in accordance with the Tax Act as a period cost.

Comprehensive Income (Loss)

Comprehensive income (loss) is defined as the change in equity (net assets) of a business entity during a period from transactions and other events and circumstances from non-owner sources. Other comprehensive income (loss) includes certain changes in equity that are excluded from net income (loss), net of tax, such as foreign currency translation gains and losses and changes in fair value of projected benefit obligations for defined benefit plans.

Litigation and Settlement Costs

Legal costs are expensed as incurred. The Company is involved in disputes, litigation and other legal actions in the ordinary course of business. The Company continually evaluates uncertainties associated with litigation and records a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the loss or range of loss can be reasonably estimated.
16

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Recently Issued, Not Yet Adopted Accounting Pronouncements
In March 2024, the FASB issued ASU No. 2024-02, Codification Improvements - Amendments to Remove References to the Concepts Statements to remove various references to concepts statements from the FASB Accounting Standards Codification. This guidance is to clarify guidance, simplify wording or structure of guidance, and other minor improvements. These amendments are effective for the Company for annual periods in 2025, applied prospectively, with early adoption and retrospective application permitted. The Company intends to adopt the amendments in this update prospectively in 2025. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.
In March 2024, the FASB issued ASU No. 2024-01, Compensation - Stock Compensation (Topic 718) - Scope Application of Profits Interest and Similar Awards, to clarify whether profits interest and similar awards should be accounted for in accordance with Topic 718, Compensation - Stock Compensation. The guidance applies to all business entities that issue profits interest awards as compensation to employees or nonemployees in exchange for goods or services. These amendments are effective for the Company for annual and interim periods in 2025, applied prospectively, with early adoption and retrospective application permitted. As the Company does not issue profit interest awards, the impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures, to require enhanced income tax disclosures to provide information to assess how an entity’s operations and related tax risks, tax planning, and operational opportunities affect its tax rate and prospects for future cash flows. The amendments in this update provide that a business entity disclose (1) a tabular income tax rate reconciliation, using both percentages and amounts, (2) separate disclosure of any individual reconciling items that are equal to or greater than 5% of the amount computed by multiplying the income (loss) from continuing operations before income taxes by the applicable statutory income tax rate, and disaggregation of certain items that are significant and (3) amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign jurisdictions, including separate disclosure of any individual jurisdictions greater than 5% of total income taxes paid. These amendments are effective for the Company for annual periods in 2025, applied prospectively, with early adoption and retrospective application permitted. The Company intends to adopt the amendments in this update prospectively in 2025. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, since the amendments require only enhancement of existing income tax disclosures in the footnotes to the Company’s consolidated financial statements.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) – Improvements to Reportable Segment Disclosures, to require enhanced disclosures that include reportable segment expenses. The amendments in this update provide that a business entity disclose significant segment expenses, segment profit or loss (after significant segment expenses), and allows reporting of additional measures of a segments profit or loss if used in assessing segment performance. Such disclosures apply to entities with a single reportable segment. These amendments are effective for the Company for annual periods in 2024 and interim periods in 2025, retrospectively to all prior periods using the significant segment expense categories identified and disclosed in the period of adoption. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, since the requirements impact only segment reporting disclosures in the footnotes to the Company’s consolidated financial statements.
2. Net Income (Loss) Per Share
Basic earnings per share, or EPS, is calculated by dividing net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted EPS is computed by dividing net loss by the weighted-average number of common shares outstanding for the period and the weighted-average number of dilutive common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, stock options and restricted stock units are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive. In periods in which the Company has a net loss, dilutive common stock equivalents are excluded from the calculation of diluted EPS.
17

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The table below presents the computation of basic and diluted EPS:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands, except per share amounts)
Numerator:
Net loss$(75,785)$(39,829)$(187,360)$(34,647)
Denominator:
Weighted average common shares outstanding—basic84,074 81,249 83,303 80,395 
Dilutive common stock equivalents    
Weighted average common shares outstanding—diluted84,074 81,249 83,303 80,395 
Net loss per share:
Basic$(0.90)$(0.49)$(2.25)$(0.43)
Diluted$(0.90)$(0.49)$(2.25)$(0.43)
For the three months ended September 30, 2024 and 2023, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 6.0 million and 4.9 million, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature.
For the nine months ended September 30, 2024 and 2023, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 6.2 million and 4.8 million, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature.
3. Business Combinations
Terminated Silicon Motion Merger
On May 5, 2022, MaxLinear entered into an Agreement and Plan of Merger, or the Merger Agreement, with Silicon Motion Technology Corporation, or Silicon Motion, an exempted company with limited liability incorporated under the laws of the Cayman Islands, pursuant to which, among other things and subject to the terms and conditions thereof, MaxLinear agreed to acquire Silicon Motion pursuant to a statutory merger, under the laws of the Cayman Islands, of Shark Merger Sub, a wholly-owned subsidiary of MaxLinear, with and into Silicon Motion, with Silicon Motion surviving the merger as a wholly-owned subsidiary of MaxLinear. Silicon Motion is a provider of NAND flash controllers for solid state drives, or SSDs, and other solid state storage devices.
On July 26, 2023, MaxLinear terminated the Merger Agreement and notified Silicon Motion that MaxLinear was relieved of its obligations to close because, among other reasons, (i) certain conditions to closing set forth in the Merger Agreement were not satisfied and were incapable of being satisfied, (ii) Silicon Motion had suffered a Material Adverse Effect that was continuing, (iii) Silicon Motion was in material breach of representations, warranties, covenants, and agreements in the Merger Agreement that gave rise to the right of the Company to terminate, and (iv) in any event, the First Extended Outside Date had passed and was not automatically extended because certain conditions in Article 6 of the Merger Agreement were not satisfied or waived as of May 5, 2023. For these same reasons, under the terms of the Merger Agreement, MaxLinear was not required to pay a break-up fee or other fee to Silicon Motion as a result of the termination of the Merger Agreement. Undefined capitalized terms in this paragraph have the same meaning as in the Merger Agreement. On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration to seek damages from MaxLinear arising from MaxLinear's alleged breaches of the Merger Agreement.
On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. See Note 15 for more information on legal matters related to the termination of the Merger Agreement.
The second amended and restated commitment letter dated October 24, 2022 with Wells Fargo Bank, N.A., or Wells Fargo Bank, and other lenders, and related financing commitments for the previously pending (now terminated) merger were also terminated upon termination of the Merger Agreement. As a result of the termination of the financing, in August 2023, the Company was required to pay to Wells Fargo Bank a ticking fee of $18.3 million.
18

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Acquisition of Company Y
On January 17, 2023, the Company completed its acquisition of a business, or Company Y, pursuant to a Purchase and Sale Agreement, or the Purchase Agreement. The transaction consideration included $9.8 million in cash. In addition, Company Y stockholders are eligible to receive up to $2.6 million in consideration due to the acquired business satisfying certain personnel objectives by June 17, 2024.
Company Y is headquartered in Bangalore, India and operates as a provider of engineering design services.
Acquisition Consideration
The following table summarizes the fair value of purchase price consideration to acquire Company Y (in thousands):
DescriptionAmount
Fair value of purchase consideration:
Cash$9,824 
Contingent consideration(1)
2,600 
Total purchase price$12,424 
_________________
(1) The fair value of contingent consideration is based on applying the Monte Carlo simulation method to forecast achievement under various contingent consideration events which may result in up to $2.6 million in payments due to the acquired business’s satisfying certain financial and personnel objectives by June 17, 2024 under the Purchase Agreement. Key inputs in the valuation include forecasted revenue, revenue volatility and discount rate. Underlying forecast mathematics were based on Geometric Brownian Motion in a risk-neutral framework and discounted back to the applicable period in which the accumulative thresholds were achieved at discount rates commensurate with the risk and expected payout term of the contingent consideration.
Purchase Price Allocation
The final allocation of purchase price as of the January 17, 2023 acquisition closing date based upon an estimate of the fair value of the assets acquired and the liabilities assumed by the Company in the acquisition primarily includes $2.0 million in net operating liabilities, with $11.8 million in goodwill.
Assumptions in the Allocations of Purchase Price
Management prepared the purchase price allocations for Company Y and in doing so considered or relied in part upon reports of a third party valuation expert to calculate the fair value of certain acquired assets, which primarily included an acquired workforce and contingent consideration. Certain stockholders that are employees of Company Y were not required to remain employed in order to receive the contingent consideration; accordingly, the fair value of the contingent consideration was accounted for as a portion of the purchase consideration.
Estimates of fair value require management to make significant estimates and assumptions. The goodwill recognized is attributable primarily to the acquired workforce. Certain liabilities included in the purchase price allocations are based on management’s best estimates of the amounts to be paid or settled and based on information available at the time the purchase price allocations were prepared.
Goodwill recorded in connection with Company Y was $11.8 million as of September 30, 2024. The Company does not expect to deduct any of the acquired goodwill for tax purposes.
19

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
4. Restructuring Activity
From time to time, the Company approves and implements restructuring plans as a result of internal resource alignment and cost saving measures. Such restructuring plans may include terminating employees, vacating certain leased facilities, and cancellation of contracts.
Restructuring costs in the nine months ended September 30, 2024 included costs pertaining to restructuring plans initiated in 2023 and 2024 as described below.
In July 2024, the Company initiated a reduction of its workforce, or the 2024 Workforce Reduction. In the three and nine months ended September 30, 2024, the Company incurred $26.8 million in restructuring costs pertaining to the 2024 Workforce Reduction, which included $17.0 million in charges under contracts associated with cancelled projects and related impairment of assets, $9.1 million in severance costs and related expenses, and $0.7 million from exiting facilities.
During the year ended December 31, 2023, the Company entered into restructuring plans to reduce its workforce, or the 2023 Workforce Reductions. In the nine months ended September 30, 2024, the Company completed notification to remaining affected employees of the 2023 Workforce Reductions, and incurred $23.5 million in restructuring costs, including $19.8 million in severance and related costs, or a cumulative total of $43.3 million pertaining to the 2023 Workforce Reductions. Substantially all of the severance and related costs incurred in the nine months ended September 30, 2024 related to the 2023 Workforce Reductions pertained to statutory severance benefits in the jurisdictions in which the terminated employees were employed.
The Company expects to incur additional restructuring costs associated with the 2023 Workforce Reductions and 2024 Workforce Reduction of approximately $3.0 million to $5.0 million, which is expected to pertain to severance due to statutory requirements in the jurisdictions in which the terminated employees were employed, as well as exiting facilities. The Company expects to complete notifications to employees regarding the 2024 Workforce Reduction and finalize its plans to exit facilities by the end of 2024. The estimate of costs that the Company expects to incur, and the timing thereof, are subject to a number of assumptions and actual results may differ. The Company may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the 2023 Workforce Reductions and 2024 Workforce Reduction.
All statements other than statements of historical facts contained in the paragraphs above are forward-looking statements including statements relating to the Company’s plans, expectations, forecasts and future events. Such forward-looking statements include, but are not limited to, the potential of, and expectations regarding the Company’s statements relating to the expected impacts, charges and costs associated with the 2023 Workforce Reductions and 2024 Workforce Reduction that the Company expects to incur.
The following table presents the activity related to the restructuring plans, which is included in restructuring charges in the consolidated statements of operations:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands)
Employee separation expenses$9,109 $(13)$28,902 $8,863 
Lease related charges674  3,628 42 
Other17,045 67 17,793 233 
$26,828 $54 $50,323 $9,138 
20

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The following table presents a roll-forward of the Company’s restructuring liability for the nine months ended September 30, 2024. The restructuring liability is included in accrued expenses and other current liabilities and other long-term liabilities in the consolidated balance sheets.
Employee Separation ExpensesLease Related ChargesOtherTotal
(in thousands)
Liability as of December 31, 2023$7,383 $(2)$920 $8,301 
Restructuring charges28,902 3,628 17,793 50,323 
Cash payments(30,452)(172)(915)(31,539)
Non-cash charges and adjustments967 (3,419)(3,406)(5,858)
Liability as of September 30, 20246,800 35 14,392 21,227 
Less: current portion as of September 30, 2024(6,800)(35)(8,775)(15,610)
Long-term portion as of September 30, 2024$ $ $5,617 $5,617 

21

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
5. Goodwill and Intangible Assets
Goodwill
Goodwill arises from the acquisition method of accounting for business combinations and represents the excess of the purchase price over the fair value of the net assets and other identifiable intangible assets acquired. The fair values of net tangible assets and intangible assets acquired are based upon preliminary valuations and the Company’s estimates and assumptions are subject to change within the measurement period (potentially up to one year from the acquisition date).
The following table presents the changes in the carrying amount of goodwill for the periods indicated:
Nine Months Ended September 30,
20242023
(in thousands)
Beginning balance$318,588 $306,739 
Acquisitions (Note 3)
 11,717 
Ending balance$318,588 $318,456 
The Company performs an annual goodwill impairment assessment on October 31st each year, using a quantitative assessment comparing the fair value of each reporting unit, which the Company has determined to be the entity itself, with its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recorded. As a result of the Company’s impairment assessment, no goodwill impairment was recognized as of October 31, 2023.
In addition to its annual review, the Company performs a test of impairment when indicators of impairment are present. During the nine months ended September 30, 2024 and 2023, there were no indications of impairment of the Company’s goodwill balances.
Acquired Intangibles
Finite-lived Intangible Assets
The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which are amortized over their estimated useful lives:
September 30, 2024December 31, 2023
Weighted
Average
Useful Life
(in Years)
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
(in thousands)
Licensed technology7.0$23,857 $(2,172)$21,685 $20,133 $(1,431)$18,702 
Developed technology6.9311,261 (280,443)30,818 311,261 (263,635)47,626 
Trademarks and trade names6.214,800 (14,383)417 14,800 (14,276)524 
Customer relationships5.0128,800 (127,502)1,298 128,800 (126,347)2,453 
Patents7.04,780 (967)3,813 4,780 (455)4,325 
6.1$483,498 $(425,467)$58,031 $479,774 $(406,144)$73,630 

22

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands)(in thousands)
Cost of net revenue$3,745 $8,581 $17,549 $27,372 
Research and development   2 
Selling, general and administrative591 653 1,774 2,290 
$4,336 $9,234 $19,323 $29,664 
Amortization of finite-lived intangible assets in cost of net revenue in the consolidated statements of operations results primarily from acquired developed technology.
The following table sets forth the activity related to finite-lived intangible assets:
Nine Months Ended September 30,
20242023
(in thousands)
Beginning balance$73,630 $109,316 
Additions4,961 6,198 
Other disposals (769)
Amortization(19,323)(29,664)
Impairment losses(1,237)(2,438)
Ending balance$58,031 $82,643 
The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the related useful lives, to determine whether indicators of impairment may exist that warrant adjustments to carrying values or estimated useful lives. An impairment loss is recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss is measured based on the excess of the carrying amount of the asset over the asset’s fair value. During each of the three and nine months ended September 30, 2024, impairment losses related to finite-lived intangible assets of $1.2 million were recognized. During the three and nine months ended September 30, 2023, impairment losses related to finite-lived intangible assets of $0 and $2.4 million were recognized, respectively. The impairment losses were attributable to abandonment of certain purchased licensed technology.
The following table presents future amortization of the Company’s finite-lived intangible assets at September 30, 2024:
Amount
(in thousands)
2024 (3 months)$3,992 
202514,619 
202613,916 
202710,437 
20285,099 
Thereafter9,968 
Total$58,031 
23

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
6. Financial Instruments
The composition of financial instruments is as follows:
Fair Value
September 30, 2024December 31, 2023
(in thousands)
Liabilities
Contingent consideration (Note 3)
$2,600 $2,462 
The fair value of the Company’s financial instruments is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants and is recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The levels are described below:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.
Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
Level 3: Unobservable inputs are used when little or no market data is available.
The Company classifies its financial instruments that are categorized within Level 1 or Level 2 of the fair value hierarchy on the basis of valuations using quoted market prices or alternate pricing sources and models utilizing market observable inputs, respectively.
The contingent consideration liability as of September 30, 2024 and December 31, 2023 is associated with the Company’s acquisition of Company Y in January 2023 (Note 3). The contingent consideration liability is classified as a Level 3 financial instrument. The contingent consideration as it relates to Company Y was subject to the acquired business’s satisfaction of certain personnel objectives by June 17, 2024. The fair value of contingent consideration is based on (1) applying the Monte Carlo simulation method, with underlying forecast mathematics based on Geometric Brownian motion in a risk-neutral framework, to forecast achievement of the acquired business’ financial objectives, if applicable, under various possible contingent consideration events and (2) a probability based methodology using management’s inputs and assumptions to forecast achievement of the acquired business’ personnel objectives which included an assumption of total payments up to $2.6 million to Company Y. Key inputs in the valuation include forecasted revenue, revenue volatility, discount rate and discount term as it relates to the financial objectives and probability of achievement, discount term and discount rate as it relates to the personnel objectives.
Fair Value Measurements at September 30, 2024
Balance at
September 30, 2024
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
(in thousands)
Liabilities
Contingent consideration$2,600 $ $ $2,600 
Fair Value Measurements at December 31, 2023
Balance at December 31, 2023Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
(in thousands)
Liabilities
Contingent consideration$2,462 $ $ $2,462 
24

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The following summarizes the activity in Level 3 financial instruments:
Nine Months Ended September 30,
20242023
(in thousands)
Contingent consideration
Beginning balance
$2,462 $2,941 
Acquisitions(1)(Note 3)
 2,200 
Payments (2,700)
Accretion of discount(1)
138 249 
Ending balance
$2,600 $2,690 
_____________________
(1) These changes to the balance associated with the estimated fair value of contingent consideration for the nine months ended September 30, 2024 and 2023 were due to the addition of contingent consideration associated with the acquisition of Company Y in January 2023 and accretion of discounts on contingent consideration.
There were no transfers between Level 1, Level 2, or Level 3 fair value hierarchy categories of financial instruments. for the nine months ended September 30, 2024.
Financial Instruments Not Recorded at Fair Value on a Recurring Basis
Some of the Company’s financial instruments are recorded at amounts that approximate fair value due to their liquid or short-term nature or by election on investments in privately-held entities as described below. Such financial assets and financial liabilities include: cash and cash equivalents, restricted cash, net receivables, investments in privately-held entities, certain other assets, accounts payable, accrued price protection liability, accrued expenses, accrued compensation costs, and other current liabilities.
The Company’s long-term debt is not recorded at fair value on a recurring basis but is measured at fair value for disclosure purposes (Note 8).
Included in other long-term assets as of December 31, 2023 were investments in a privately held entity of $11.8 million, which were impaired in the three months ended September 30, 2024. The Company does not have the ability to exercise significant influence or control over such entity and had accounted for the investments as financial instruments. Given that fair values for such investments were not readily determinable, the Company had elected to measure these investments at cost, less any impairment, and adjust the carrying value to fair value if any observable price changes for similar investments in the same entity are identified. The impairment loss of $11.8 million is included in other expense in the consolidated statement of operations for the three and nine months ended September 30, 2024.
7. Balance Sheet Details
Cash, cash equivalents and restricted cash consist of the following:
September 30, 2024December 31, 2023
(in thousands)
Cash and cash equivalents$148,476 $187,288 
Short-term restricted cash993 1,051 
Long-term restricted cash23 17 
Total cash, cash equivalents and restricted cash$149,492 $188,356 
As of September 30, 2024 and December 31, 2023, cash and cash equivalents included money market funds of approximately $103.3 million and $78.1 million, respectively. As of September 30, 2024 and December 31, 2023, the Company had restricted cash of approximately $1.0 million and $1.1 million, respectively. The cash is restricted in connection with guarantees for certain import duties and office leases.
25

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Inventory consists of the following:
September 30, 2024December 31, 2023
(in thousands)
Work-in-process$54,909 $60,368 
Finished goods41,154 39,540 
$96,063 $99,908 
Property and equipment, net consists of the following:
Useful Life
(in Years)
September 30, 2024December 31, 2023
(in thousands)
Furniture and fixtures5$3,944 $3,995 
Machinery and equipment
3-5
80,641 76,732 
Masks and production equipment562,676 54,240 
Software311,194 11,427 
Leasehold improvements
1-5
35,401 35,867 
Construction in progressN/A686 348 
194,542 182,609 
Less: accumulated depreciation and amortization(131,049)(116,178)
$63,493 $66,431 
Depreciation expense for the three months ended September 30, 2024 and 2023 was $5.8 million and $5.6 million, respectively. Depreciation expense for the nine months ended September 30, 2024 and 2023 was $17.0 million and $18.5 million, respectively.
In March 2022, the Company entered into a note receivable with a supplier for $10.0 million. In September 2023, the terms of this note receivable were renegotiated, and the first initial repayment of $1.5 million is due by March 31, 2025, and annual repayments of $1.7 million per year are due annually thereafter by March 31, from 2026 through 2030, provided that certain production utilization targets for the prior year are met. During the three months ended September 30, 2024, a portion of the note receivable, or $0.5 million, was written off to other expense in the consolidated statement of operations. The amount written off represents the portion of the payment associated with production utilization that is anticipated to be less than target. The balance of the note receivable has been classified as a long-term asset based on expected timing of receipt of repayment. The long-term portion of the note receivable is included in other long-term assets as of September 30, 2024 and December 31, 2023, respectively. Previously, repayments of $2.0 million per year were due annually by March 31, in years 2024 through 2027.
Accrued price protection liability consists of the following activity:
Nine Months Ended September 30,
20242023
(in thousands)
Beginning balance$71,684 $113,274 
Charged as a reduction of revenue42,042 50,092 
Reversal of unclaimed rebates(15,272) 
Payments(53,982)(91,723)
Ending balance$44,472 $71,643 
26

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The decrease in price protection liability from approximately $71.7 million as of December 31, 2023 to approximately $44.5 million as of September 30, 2024 was driven by payments of rebates as well as reversal of unclaimed rebates due to expiration of rebate pricing.
Accrued expenses and other current liabilities consist of the following:
September 30, 2024December 31, 2023
(in thousands)
Accrued technology license payments$3,627 $3,843 
Accrued professional fees4,196 3,736 
Accrued engineering and production costs5,461 2,861 
Accrued restructuring15,610 8,301 
Accrued royalty403 603 
Short-term lease liabilities9,799 9,132 
Accrued customer credits3,705 3,984 
Income tax liability421 521 
Customer contract liabilities164 1,597 
Accrued obligations to customers for price adjustments20,558 54,837 
Accrued obligations to customers for stock rotation rights167 349 
Contingent consideration - current portion2,600 2,462 
Other4,486 6,242 
$71,197 $98,468 
The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:
Cumulative Translation AdjustmentsPension and Other Defined Benefit Plan ObligationTotal
(in thousands)
Balance at December 31, 2023$(5,059)$1,268 $(3,791)
Other comprehensive loss before reclassifications, net of tax(61) (61)
Balance at September 30, 2024$(5,120)$1,268 $(3,852)
8. Debt
Debt
The carrying amount of the Company’s long-term debt consists of the following:
September 30, 2024December 31, 2023
(in thousands)
Principal balance:
Initial term loan under the June 23, 2021 credit agreement$125,000 $125,000 
Total principal balance125,000 125,000 
Less:
     Unamortized debt discount(477)(571)
     Unamortized debt issuance costs(1,683)(2,054)
Net carrying amount of long-term debt122,840 122,375 
Less: current portion of long-term debt  
Long-term debt, non-current portion$122,840 $122,375 
27

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
As of September 30, 2024 and December 31, 2023, the weighted average effective interest rate on aggregate debt was approximately 7.9% and 7.6%, respectively.
During the three months ended September 30, 2024 and 2023, the Company recognized total amortization of debt discount and debt issuance costs of $0.2 million and $0.2 million, respectively, to interest expense. During the nine months ended September 30, 2024 and 2023, the Company recognized total amortization of debt discount and debt issuance costs of $0.5 million and $0.5 million.
The approximate aggregate fair value of the term loans outstanding as of September 30, 2024 and December 31, 2023 was $115.7 million and $114.5 million, respectively, which was estimated on the basis of inputs that are observable in the market and which is considered a Level 2 measurement method in the fair value hierarchy (Note 6).
As of September 30, 2024, the outstanding principal balance of $125.0 million is due in full on June 23, 2028, upon maturity of the loan.
Initial Term Loan and Revolving Facility under the June 23, 2021 Credit Agreement
On June 23, 2021, the Company entered into a Credit Agreement, or the June 23, 2021 Credit Agreement, by and among the Company, the lenders from time to time party thereto, and Wells Fargo Bank, National Association, as administrative agent and collateral agent, that provides for a senior secured term B loan facility, or the “Initial Term Loan under the June 23, 2021 Credit Agreement,” in an aggregate principal amount of $350.0 million and a senior secured revolving credit facility, or the “Revolving Facility,” in an aggregate principal amount of up to $100.0 million. The proceeds of the Initial Term Loan under the June 23, 2021 Credit Agreement were used (i) to repay in full all outstanding indebtedness under that certain Credit Agreement dated May 12, 2017, by and among the Company, MUFG Bank Ltd., as administrative agent and MUFG Union Bank, N.A., as collateral agent and the lenders from time to time party thereto (as amended by Amendment No. 1, dated July 31, 2020) and (ii) to pay fees and expenses incurred in connection therewith. The remaining proceeds of the Initial Term Loan under the June 23, 2021 Credit Agreement are available for general corporate purposes and the proceeds of the Revolving Facility may be used to finance the working capital needs and other general corporate purposes of the Company and its subsidiaries. As of September 30, 2024, the Revolving Facility was undrawn. Under the terminated amended and restated commitment letter with Wells Fargo Bank and other lenders entered into in connection with the previously pending (now terminated) merger with Silicon Motion (Note 3), the Company had expected to repay the remaining outstanding term loans under this agreement upon closing of the merger.
The June 23, 2021 Credit Agreement permits the Company to request incremental loans in an aggregate principal amount not to exceed the sum of an amount equal to the greater of (x) $175.0 million and (y) 100% of consolidated EBITDA, plus the amount of certain voluntary prepayments, plus an unlimited amount that is subject to pro forma compliance with certain first lien net leverage ratio, secured net leverage ratio and total net leverage ratio tests. Incremental loans are subject to certain additional conditions, including obtaining additional commitments from the lenders then party to the June 23, 2021 Credit Agreement or new lenders.
Under the June 23, 2021 Credit Agreement, the Initial Term Loan bears interest, at the Company’s option, at a per annum rate equal to either (i) a base rate equal to the highest of (x) the federal funds rate, plus 0.50%, (y) the prime rate then in effect and (z) an adjusted Term SOFR rate determined on the basis of a one-month interest period plus 1.00%, in each case, plus an applicable margin of 1.25% or (ii) an adjusted Term SOFR rate, subject to a floor of 0.50%, plus an applicable margin of 2.25%. Loans under the Revolving Facility initially bear interest, at a per annum rate equal to either (i) a base rate (as calculated above) plus an applicable margin of 0.00%, or (ii) an adjusted Term SOFR rate (as calculated above) plus an applicable margin of 1.00%. Following delivery of financial statements for the Company’s fiscal quarter ending June 30, 2021, the applicable margin for loans under the Revolving Facility will range from 0.00% to 0.75% in the case of base rate loans and 1.00% to 1.75% in the case of Term SOFR rate loans, in each case, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. The Company is required to pay commitment fees ranging from 0.175% to 0.25% per annum on the daily undrawn commitments under the Revolving Facility, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. Commencing on September 30, 2021, the Initial Term Loan under the June 23, 2021 Credit Agreement will amortize in equal quarterly installments equal to 0.25% of the original principal amount of the Initial Term Loan under the June 23, 2021 Credit Agreement, with the balance payable on the maturity date. The June 23, 2021 Credit Agreement was amended on June 29, 2023 to implement a benchmark replacement.
The Company is required to make mandatory prepayments of the outstanding principal amount of term loans under the June 23, 2021 Credit Agreement with the net cash proceeds from the disposition of certain assets and the receipt of insurance
28

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
proceeds upon certain casualty and condemnation events, in each case, to the extent not reinvested within a specified time period, from excess cash flow beyond stated threshold amounts, and from the incurrence of certain indebtedness. The Company has the right to prepay its term loans under the June 23, 2021 Credit Agreement, in whole or in part, at any time without premium or penalty, subject to certain limitations and a 1.0% soft call premium applicable during the first six months following the closing date of the June 23, 2021 Credit Agreement. The Initial Term Loan under the June 23, 2021 Credit Agreement will mature on June 23, 2028, at which time all outstanding principal and accrued and unpaid interest on the Initial Term Loan under the June 23, 2021 Credit Agreement must be repaid. The Revolving Facility will mature on June 23, 2026, at which time all outstanding principal and accrued and unpaid interest under the Revolving Facility must be repaid. The Company is also obligated to pay fees customary for a credit facility of this size and type.
The Company’s obligations under the June 23, 2021 Credit Agreement are required to be guaranteed by certain of its domestic subsidiaries meeting materiality thresholds set forth in the June 23, 2021 Credit Agreement. Such obligations, including the guaranties, are secured by substantially all of the assets of the Company and the subsidiary guarantors pursuant to a Security Agreement, dated as of June 23, 2021, by and among the Company, the subsidiary guarantors from time to time party thereto, and Wells Fargo Bank, National Association, as collateral agent.
The June 23, 2021 Credit Agreement contains customary affirmative and negative covenants, including covenants limiting the ability of the Company and its restricted subsidiaries to, among other things, incur debt, grant liens, undergo certain fundamental changes, make investments, make certain restricted payments, and sell assets, in each case, subject to limitations and exceptions set forth in the June 23, 2021 Credit Agreement. The Revolving Facility also prohibits the Company from having a secured net leverage ratio in excess of 3.50:1.00 (subject to a temporary increase to 3.75:1.00 following the consummation of certain material permitted acquisitions) as of the last day of any fiscal quarter of the Company (commencing with the fiscal quarter ending September 30, 2021) if the aggregate borrowings under the Revolving Facility exceed 1% of the aggregate commitments thereunder (subject to certain exceptions set forth in the June 23, 2021 Credit Agreement) as of such date. As of September 30, 2024, the Company was in compliance with such covenants. The June 23, 2021 Credit Agreement also contains customary events of default that include, among other things, certain payment defaults, cross defaults to other indebtedness, covenant defaults, change in control defaults, judgment defaults, and bankruptcy and insolvency defaults. If an event of default exists, the lenders may require immediate payment of all obligations under the June 23, 2021 Credit Agreement and may exercise certain other rights and remedies provided for under the June 23, 2021 Credit Agreement, the other loan documents and applicable law.
The debt is carried at its principal amount, net of unamortized debt discount and issuance costs, and is not adjusted to fair value each period. The issuance date fair value of the liability component of the debt in the amount of $350.2 million was determined using a discounted cash flow analysis, in which the projected interest and principal payments were discounted back to the issuance date of the term loan at a market interest rate for nonconvertible debt of 3.4%, which represents a Level 2 fair value measurement. The debt discount of $0.9 million and debt issuance costs of $2.9 million associated with the Initial Term Loan under the June 23, 2021 Credit Agreement are being amortized to interest expense using the effective interest method over its seven-year term. Debt issuance costs of $0.4 million associated with the Revolving Facility are being amortized to interest expense over its five-year term.
9. Stock-Based Compensation
Employee Stock-Based Compensation Plans
At September 30, 2024, the Company had stock-based compensation awards outstanding under the following plans: the 2010 Equity Incentive Plan, as amended, or 2010 Plan, and the 2010 Employee Stock Purchase Plan, or ESPP, and the 2024 Inducement Equity Incentive Plan, or the Inducement Plan. Refer to the Company’s Annual Report for a summary of the 2010 Plan and the ESPP.
On May 22, 2024, the Board of Directors adopted the Inducement Plan pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules, and, subject to the adjustment provisions of the Inducement Plan, reserved 4,000,000 shares of the Company's common stock for issuance under equity awards granted under the Inducement Plan. The Inducement Plan provides for the grant of equity-based awards, including non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares, and its terms are substantially similar to the 2010 Plan, including with respect to treatment of equity awards in the event of a merger or “change in control” as defined under the Inducement Plan, but with such other terms and conditions intended to comply with the Nasdaq inducement award exception. Awards under the Inducement Plan may only be made to individuals not previously employees or non-employee directors of the Company as an inducement material to the individuals’ entry into employment with the Company.
29

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
As of September 30, 2024, the number of shares of common stock available for future issuance under the 2010 Plan was 15,417,601 shares. As of September 30, 2024, the number of shares of common stock available for future issuance under the ESPP was 6,451,538 shares. As of September 30, 2024, the number of shares of common stock available for future issuance under the Inducement Plan was 4,000,000 shares.
Employee Incentive Bonus
The Company’s Executive Incentive Bonus Plan permits the settlement of awards under the plan in any combination of cash or shares of its common stock. The Company settles a majority of bonus awards for its employees, including executives, in shares of common stock under the 2010 Equity Incentive Plan. When bonus awards are settled in common stock issued under the 2010 Equity Incentive Plan, the number of shares issuable to plan participants is determined based on the closing price of the Company’s common stock as determined in trading on the applicable stock exchange, on a date approved by the Board of Directors. In connection with the Company’s bonus programs, in February 2024, the Company issued 0.4 million freely-tradable (subject to certain restrictions for affiliates) shares of the Company’s common stock in settlement of bonus awards to employees, including executives, for the 2023 performance period. At September 30, 2024, the Company has an accrual of $3.5 million for bonus awards for employees for year-to-date achievement in the 2024 performance period, which the Company intends to settle primarily in shares of its common stock, unless otherwise required to be settled in cash due to local laws or agreements. The Company’s compensation committee retains discretion to effect payment in cash, stock, or a combination of cash and stock.
Stock-Based Compensation
The Company recognizes stock-based compensation in the consolidated statements of operations, based on the department to which the related employee reports, as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands)(in thousands)
Cost of net revenue$81 $170 $436 $626 
Research and development7,423 9,436 27,952 33,128 
Selling, general and administrative5,284 (4,488)18,820 5,009 
$12,788 $5,118 $47,208 $38,763 
The total unrecognized compensation cost related to unvested restricted stock units as of September 30, 2024 was $112.0 million, and the weighted average period over which these equity awards are expected to vest is 2.39 years.
The total unrecognized compensation cost related to unvested performance-based restricted stock units as of September 30, 2024 was $1.4 million, and the weighted average period over which these equity awards are expected to vest is 1.40 years. Actual levels of future performance for the unvested periods may differ from current estimates.
The total unrecognized compensation cost related to unvested stock options as of September 30, 2024 was $28.0 million, and the weighted average period over which these equity awards are expected to vest is 3.39 years.
30

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Restricted Stock Units
A summary of the Company’s restricted stock unit activity for all equity plans is as follows:
Number of Shares
(in thousands)
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 20235,632 $36.72 
  Granted1
2,945 18.24 
  Vested(2,461)29.44 
  Canceled2
(1,007)38.32 
Outstanding at September 30, 20245,109 $29.25 
____________
(1) Includes approximately 227 thousand shares granted under the Inducement Plan at a weighted-average grant-date fair value per share of $13.64.
(2) Includes approximately 24 thousand shares canceled under the Inducement Plan at a weighted-average grant-date fair value per share of $12.46.
Performance-Based Restricted Stock Units
Performance-based restricted stock units are eligible to vest at the end of each year-long performance period, as defined in the underlying agreement, in a three-year performance period based on the Company’s annual growth rate in net sales and non-GAAP diluted earnings per share (subject to certain adjustments) over baseline results relative to the growth rates for a peer group of companies for the same metrics and periods.
For the performance-based restricted stock units granted to date, 60% of each performance-based award is subject to the net sales metric for the performance period and 40% is subject to the non-GAAP diluted earnings per share metric for the performance period. The maximum percentage for a particular metric is 250% of the target number of units subject to the award related to that metric, however, vesting of the performance stock units is capped at 30% and 100%, respectively, of the target number of units subject to the award in years one and two, respectively, of the three-year performance period.
As of September 30, 2024, achievement to date under the performance metrics specified in the respective award agreements are based on its expected revenue and non-GAAP diluted EPS results over the performance periods and calculated growth rates relative to its peers’ expected results based on data available, as defined in the respective award agreements. To the extent any prior achievement levels are no longer probable, any compensation expense recorded is adjusted to the revised achievement levels.
A summary of the Company’s performance-based restricted stock unit activity is as follows:
Number of Shares
(in thousands)
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 20232,653 $34.38 
  Granted1
1,472 17.78 
  Vested(58)24.43 
  Canceled(665)41.74 
Outstanding at September 30, 20243,402 $25.93 
________________
(1) Number of shares granted is based on the maximum percentage achievable in the performance-based restricted stock unit award.
Employee Stock Purchase Rights and Stock Options
Employee Stock Purchase Rights
During the nine months ended September 30, 2024 and 2023, there were 175,764 and 140,631 shares of common stock purchased under the ESPP at a weighted average price of $15.26 and $21.25, respectively.
31

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:
Nine Months Ended September 30,
20242023
Weighted-average grant date fair value per share
$5.78 - $6.35
$7.56 - $11.97
Risk-free interest rate
5.40% - 5.41%
4.54% - 5.24%
Dividend yield % %
Expected life (in years)0.500.50
Volatility
49.76% - 70.46%
51.73% - 59.78%
The risk-free interest rate assumption was based on rates for United States (U.S.) Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The assumed dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. The expected term is the duration of the offering period for each grant date. In addition, the estimated volatility incorporates the historical volatility over the expected term based on the Company’s daily closing stock prices.
Stock Options
A summary of the Company’s stock options activity is as follows:
Number of Options
(in thousands)
Weighted-Average Exercise PriceWeighted-Average Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2023375 $17.29 
Granted2,688 19.45 
Exercised(39)7.68 
Canceled(1)23.75 
Outstanding at September 30, 20243,023 $19.33 8.45$ 
Vested and expected to vest at September 30, 20242,807 $19.32 8.38$ 
Exercisable at September 30, 2024335 $18.40 0.86$ 
The fair values of stock options were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:
Nine Months Ended September 30,
20242023(1)
Weighted-average grant date fair value per share
$10.84 - $11.24
N/A
Risk-free interest rate4.33 %N/A
Dividend yield %N/A
Expected life (in years)6.50N/A
Volatility57.50 %N/A
__________________
(1) No options were granted during the nine months ended September 30, 2023.
The risk-free interest rate assumption was based on the United States Treasury’s rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The assumed dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. The expected term of the options was calculated using the simplified method as prescribed by guidance provided by the SEC. This decision was based on the lack of historical data due to the Company’s limited number of stock option exercises under the 2010 Equity Incentive Plan. Estimated volatility incorporates historical volatility of the Company over the expected term based on the Company's daily closing stock prices.
32

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The intrinsic value of stock options exercised was $0 and $47.0 thousand in the three months ended September 30, 2024 and 2023, respectively. The intrinsic value of stock options exercised was $0.5 million and $0.2 million in the nine months ended September 30, 2024 and 2023, respectively.
Cash received from exercise of stock options was negligible during the three and nine months ended September 30, 2024. Cash received from exercise of stock options was $0.1 million and $0.2 million during the three and nine months ended September 30, 2023, respectively.
The tax benefit from stock options exercised was $0 and $0.1 million during the three months ended September 30, 2024 and 2023, respectively. The tax benefit from stock options exercised was $0.8 million and $0.4 million during the nine months ended September 30, 2024 and 2023, respectively.
10. Income Taxes
The provision for income taxes primarily relates to projected federal, state, and foreign income taxes. To determine the quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is generally based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates. In addition, the tax effects of certain significant or unusual items are recognized discretely in the quarter during which they occur and can be a source of variability in the effective tax rates from quarter to quarter.
The Company utilizes the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the temporary differences reverse. The Company records a valuation allowance to reduce its deferred taxes to the amount it believes is more likely than not to be realized. In making such determination, the Company considers all available positive and negative evidence quarterly, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. Forming a conclusion that a valuation allowance is not required is difficult when there is negative evidence such as cumulative losses in recent years. Based upon the Company’s review of all positive and negative evidence, the Company continues to have a valuation allowance on its state deferred tax assets, certain of its federal deferred tax assets, and certain foreign deferred tax assets in jurisdictions where the Company has cumulative losses or otherwise is not expected to utilize certain tax attributes. The Company does not incur expense or benefit in certain tax-free jurisdictions in which it operates.
The Company recorded an income tax benefit of $6.7 million in the three months ended September 30, 2024 and an income tax benefit of $1.7 million in the three months ended September 30, 2023. The Company recorded an income tax benefit of $10.5 million in the nine months ended September 30, 2024 and an income tax provision of $13.5 million in the nine months ended September 30, 2023.
The difference between the Company’s effective tax rate and the 21.0% United States federal statutory rate for the nine months ended September 30, 2024 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items, and stock based compensation.
The difference between the Company’s effective tax rate and the 21.0% U.S. federal statutory rate for the nine months ended September 30, 2023 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items including the tax on global intangible low-taxed income, stock based compensation, excess tax benefits related to stock-based compensation, and the release of uncertain tax positions under ASC 740-10. The permanent tax item related to global intangible low-taxed income also reflected the then recent legislative changes requiring the capitalization of research and experimentation costs, as well as limitations on the creditability of certain foreign income taxes.
Income tax positions must meet a more-likely-than-not threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are de-recognized in the first financial reporting period in which that threshold is no longer met. The Company records potential penalties and interest accrued related to unrecognized tax benefits within the consolidated statements of operations as income tax expense.
During the nine months ended September 30, 2024, the Company’s unrecognized tax benefits increased by $0.2 million. The Company does not expect its unrecognized tax benefits to change significantly over the next 12 months. Accrued interest and penalties associated with uncertain tax positions as of September 30, 2024 were approximately $0.1 million and $4 thousand, respectively.
33

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
The Company is subject to federal and state income tax in the United States and is also subject to income tax in certain other foreign tax jurisdictions. At September 30, 2024, the statutes of limitations for the assessment of federal, state, and foreign income taxes are closed for the years before 2020, 2019, and 2017, respectively.
The Company’s subsidiary in Singapore operates under certain tax incentives in Singapore, which are generally effective through March 2027, and are conditional upon meeting certain employment and investment thresholds in Singapore. Under the incentives, qualifying income derived from certain sales of the Company’s integrated circuits is taxed at a concessionary rate over the incentive period, and there are reduced Singapore withholding taxes on certain intercompany royalties during the incentive period. The Company recorded a tax benefit in the nine months ended September 30, 2024 and 2023 at the incentive rate.
11. Concentration of Credit Risk, Significant Customers and Geographic Information
Concentration of Credit Risk
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents and accounts receivable. Collateral is generally not required for customer receivables. The Company limits its exposure to credit loss by placing its cash with high credit quality financial institutions. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.
Significant Customers
The Company markets its products and services to manufacturers of a wide range of electronic devices (Note 1). The Company sells its products both directly to end-customers and through third-party distributors, both of which are referred to as the Company’s customers (Note 12). Revenue is also generated from sales of intellectual property, and the recipients of such intellectual property are also referred to as the Company’s customers. The Company makes periodic evaluations of the credit worthiness of its customers.
One customer comprised 10% or greater of net revenues for each of the periods presented,
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Percentage of total net revenue
Customer A25 %11 %13 %11 %

The following table presents balances that are 10% or greater of accounts receivable, based on the Company’s billings to its customers.
September 30, 2024December 31, 2023
Percentage of gross accounts receivable
Customer B12 %33 %
Customer C18 %24 %

Significant Suppliers

Suppliers comprising greater than 10% or greater of total inventory purchases are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Vendor A27 %28 %18 %21 %
Vendor B26 %17 %35 %24 %
Vendor C12 %14 %11 %10 %
Vendor D***10 %
____________________________
*    Represents less than 10% of total inventory purchases for the period presented.
34

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Geographic Information
The Company’s consolidated net revenues by geographic area based on ship-to location are as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Amount% of total net revenueAmount% of total net revenueAmount% of total net revenueAmount% of total net revenue
Asia $65,293 80 %$98,647 73 %$193,555 72 %$419,478 74 %
Europe10,208 13 %24,886 18 %29,034 11 %110,058 19 %
United States3,955 5 %8,757 6 %41,586 15 %29,847 5 %
Rest of world1,646 2 %3,240 2 %4,186 2 %8,527 2 %
Total$81,102 100 %$135,530 100 %$268,361 100 %$567,910 100 %
The products shipped to individual countries or territories representing greater than 10% of net revenue for each of the periods presented are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Percentage of total net revenue
Hong Kong49 %41 %37 %34 %
China***12 %
Taiwan, ROC*10 %**
Thailand11 %***
____________________________
*    Represents less than 10% of total net revenue for the respective period.
The determination of which country a particular sale is allocated to is based on the destination of the product shipment. No other individual country accounted for more than 10% of net revenue during these periods. Although a large percentage of the Company’s products is shipped to Asia, and in particular, Hong Kong and Thailand, the Company believes that a significant number of the systems designed by customers and incorporating the Company’s semiconductor products are subsequently sold outside Asia to Europe, Middle East, and Africa markets and North American markets.
Long-lived assets, which consists of property and equipment, net, leased right-of-use assets, intangible assets, net, and goodwill by geographic area are as follows (in thousands):
September 30, 2024December 31, 2023
Amount% of totalAmount% of total
United States$326,442 71 %$337,696 69 %
Singapore106,444 23 %113,248 23 %
Rest of world29,775 6 %38,969 8 %
Total$462,661 100 %$489,913 100 %


35

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
12. Revenue from Contracts with Customers
Revenue by Market
The table below presents disaggregated net revenues by market (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Broadband$32,275 $34,416 $87,157 $169,646 
% of net revenue40 %25 %32 %30 %
Connectivity12,726 15,025 35,700 119,232 
% of net revenue16 %11 %13 %21 %
Infrastructure23,046 49,985 87,436 145,549 
% of net revenue28 %37 %33 %26 %
Industrial and multi-market13,055 36,104 58,068 133,483 
% of net revenue16 %27 %22 %23 %
Total net revenue$81,102 $135,530 $268,361 $567,910 
Revenues from sales through the Company’s distributors accounted for 35% and 46% of net revenue for the three months ended September 30, 2024 and 2023, respectively. Revenues from sales through the Company’s distributors accounted for 42% and 47% of net revenue for the nine months ended September 30, 2024 and 2023, respectively. Revenue related to the sales of intellectual property recognized during the nine months ended September 30, 2024 has been allocated by market based upon the usage of such intellectual property.
Contract Liabilities
As of September 30, 2024 and December 31, 2023, customer contract liabilities were approximately $0.2 million and $1.6 million, respectively, and consisted primarily of advanced payments received for which performance obligations have not been completed. Revenue recognized in each of the nine months ended September 30, 2024 and 2023 that was included in the contract liability balance as of the beginning of each of those respective periods was immaterial.
There were no material changes in the contract liabilities balance during the nine months ended September 30, 2024 and 2023.
Obligations to Customers for Price Adjustments and Returns and Assets for Right-of-Returns
As of September 30, 2024 and December 31, 2023, obligations to customers consisting of estimates of price protection rights offered to the Company’s end customers totaled $44.5 million and $71.7 million, respectively, and are included in accrued price protection liability in the consolidated balance sheets. For activity in this account, including amounts included in net revenue, refer to Note 7.
Other obligations to customers representing estimates of price adjustments to be claimed by distributors upon sell-through of their inventory to their end customer and estimates of stock rotation returns to be claimed by distributors on products sold as of September 30, 2024 were $20.6 million and $0.2 million, respectively, and as of December 31, 2023 were $54.8 million and $0.3 million, respectively, and are included in accrued expenses and other current liabilities in the consolidated balance sheets (Note 7). The reason for the significant decrease in accrued obligations to customers for price adjustments from approximately $54.8 million as of December 31, 2023 to approximately $20.6 million as of September 30, 2024, was due to a significant decrease in sales to distributors which decreased the corresponding accrued obligations to such customers. The increase or decrease in revenue for the three and nine months ended September 30, 2024 and 2023 from net changes in transaction prices for amounts included in obligations to customers for price adjustments and estimates of stock rotation returns to be claimed by distributors as of the beginning of those respective periods was not material.
36

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
As of September 30, 2024 and December 31, 2023, right of return assets under customer contracts representing the estimates of product inventory the Company expects to receive from customers in stock rotation returns were approximately $58 thousand and $0.1 million, respectively. Right of return assets are included in inventory in the consolidated balance sheets.
As of September 30, 2024 and December 31, 2023, there were no impairment losses recorded on customer accounts receivable.
13. Leases
Operating Leases
Operating lease arrangements primarily consist of office leases expiring in various years through 2029. These leases have original terms of approximately 2 to 8 years and some contain options to extend the lease up to 5 years or terminate the lease, which are included in right-of-use assets and lease liabilities when the Company is reasonably certain it will renew the underlying leases. Since the implicit rate of such leases is unknown and the Company is not reasonably certain to renew its leases, the Company has elected to apply a collateralized incremental borrowing rate to facility leases on the original lease term in calculating the present value of future lease payments. As of September 30, 2024 and December 31, 2023, the weighted average discount rate for operating leases was 4.9% and 4.6%, respectively, and the weighted average remaining lease term for operating leases was 3.4 years and 3.9 years, respectively, as of the end of each of these periods.
The table below presents aggregate future minimum payments due under leases, reconciled to total lease liabilities included in the consolidated balance sheet as of September 30, 2024:
Operating Leases
(in thousands)
2024 (3 months)$2,864 
202510,791 
20268,391 
20276,031 
20282,467 
Thereafter1,596 
Total minimum payments32,140 
Less: imputed interest(2,906)
Less: unrealized translation loss(2)
Total lease liabilities29,232 
Less: short-term lease liabilities(9,799)
Long-term lease liabilities$19,433 
Operating lease cost was $2.4 million and $2.7 million for the three months ended September 30, 2024 and 2023, respectively. Operating lease cost was $7.5 million and $8.0 million for the nine months ended September 30, 2024 and 2023, respectively.
Short-term lease costs for the nine months ended September 30, 2024 and 2023 were not material.
There were $0 and $0 of right-of-use assets obtained in exchange for new lease liabilities for the three months ended September 30, 2024 and 2023, respectively. There were $1.2 million and $12.2 million of right-of-use assets obtained in exchange for new lease liabilities for the nine months ended September 30, 2024 and 2023, respectively.
14. Employee Retirement Plans
Defined Contribution Plan
The Company has a 401(k) defined contribution retirement plan (the 401(k) Plan) covering all eligible employees. Participants may voluntarily contribute on a pre-tax basis an amount not to exceed a maximum contribution amount pursuant to Section 401(k) of the Internal Revenue Code. The Company is not required to contribute, nor has it contributed, to the 401(k) Plan for any of the periods presented.
37

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Pension and Other Defined Benefit Retirement Obligations
The Company maintains defined benefit retirement plans, including a pension plan, in certain foreign jurisdictions. As of September 30, 2024, the net defined benefit obligation, primarily related to other defined benefit plans, was $0.4 million. As of December 31, 2023, the net defined benefit obligation was $1.4 million. The benefit is based on a formula applied to eligible employee earnings.
Net periodic benefit costs were $45 thousand and $0.1 million for the three months ended September 30, 2024 and 2023, respectively, and were recorded to research and development expenses in the consolidated statements of operations. Net periodic benefit costs were $0.2 million and $0.2 million for the nine months ended September 30, 2024 and 2023, respectively, and were recorded to research and development expenses in the consolidated statements of operations.
15. Commitments and Contingencies
Inventory Purchase and Other Contractual Obligations
As of September 30, 2024, future minimum payments under inventory purchase and other obligations are as follows:
Inventory Purchase ObligationsOther ObligationsTotal
2024 (3 months)$3,004 $7,708 $10,712 
202513,419 32,131 45,550 
2026 19,482 19,482 
2027 3,673 3,673 
Total minimum payments$16,423 $62,994 $79,417 
Other obligations consist primarily of contractual payments due for software licenses.
Jointly Funded Research and Development
From time to time, the Company enters into contracts for jointly funded research and development projects to develop technology that may be commercialized into a product in the future and receives payments as milestones under the contracts are met. If the Company is required to repay all or a portion of the funds provided by the other parties under certain conditions, the Company defers such funds in other-long term liabilities. As of September 30, 2024, funds of $15.0 million received from the other parties have been deferred in other long-term liabilities. The Company de-recognizes the liabilities when the contingencies associated with the repayment conditions have been resolved. During the three and nine months ended September 30, 2024 and 2023, the Company did not recognize income from any previously deferred amounts from other parties upon resolution of such repayment conditions.
Dispute with Silicon Motion
As previously disclosed, on July 26, 2023, MaxLinear terminated the Merger Agreement on multiple grounds (Note 3). On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration before the Singapore International Arbitration Centre to seek damages from MaxLinear arising from MaxLinear’s alleged breaches of the Merger Agreement. Silicon Motion’s position is that MaxLinear’s Willful and Material Breaches (as such term is defined in the Merger Agreement) of the Merger Agreement prevented the Merger from being completed by August 7, 2023, and that MaxLinear is consequently liable for substantial monetary damages in excess of the termination fee as provided in the Merger Agreement.
On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. Silicon Motion seeks payment of the termination fee, additional damages, fees, and costs. The arbitration will be confidential.
MaxLinear believes that it properly terminated the Merger Agreement. MaxLinear remains confident in its decision and will vigorously defend its right to terminate the Silicon Motion transaction without penalty.
38

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
Silicon Motion Stockholder Litigation
MaxLinear and certain of its officers have been named as defendants in two lawsuits brought by stockholders of Silicon Motion.
On August 31, 2023, a Silicon Motion stockholder filed a putative class action complaint in the United States District Court for the Southern District of California captioned Water Island Event-Driven Fund v. MaxLinear, Inc., No. 23-cv-01607 (S.D. Cal.), against MaxLinear and certain of its current officers, alleging two claims: (1) an alleged violation of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder; and (2) an alleged violation of Section 20(a) of the Exchange Act. On December 20, 2023, the court appointed the lead plaintiffs, who filed the Consolidated Complaint on February 15, 2024. The Consolidated Complaint alleged that the defendants made false and misleading statements and/or omitted material facts that MaxLinear had a duty to disclose, concerning the Company’s intention to close the merger with Silicon Motion. On August 28, 2024, the court granted the defendants a motion to dismiss, holding that the plaintiffs lacked standing to sue MaxLinear and its officers. The case was dismissed without prejudice.
On September 18, 2024, the plaintiffs filed an Amended Consolidated Complaint (the "Amended Complaint"). The Amended Complaint includes the same two claims as alleged in the Consolidated Complaint and makes similar factual allegations against the MaxLinear defendants, but adds Silicon Motion and certain of its officers as additional defendants. The Amended Complaint seeks compensatory damages, including interest, costs and expenses and such other relief that the court deems appropriate. MaxLinear intends to continue to vigorously defend its position.
On June 13, 2024, HBK Master Fund L.P. and HBK Merger Strategies Master Fund L.P., stockholders of Silicon Motion, filed an additional complaint in the United States District Court for the Southern District of California captioned HBK Master Fund L.P. v. MaxLinear, Inc., No. 24-cv-01033 (S.D. Cal.), against MaxLinear and certain of its current officers, which also alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act, and other violations. The complaint alleges that the defendants concealed their intention to terminate the merger with Silicon Motion from Silicon Motion’s shareholders. The complaint seeks compensatory damages, including interest, costs and expenses, punitive damages, and such other equitable or injunctive relief that the court deems appropriate. On July 12, 2024, the defendants filed a motion to dismiss this complaint, which is pending. MaxLinear intends to continue to vigorously defend its position.
Comcast Litigation
On December 1, 2023, MaxLinear filed claims against Comcast Management, LLC and Comcast Cable Communications, LLC, or together, Comcast, in the United States District Court for the Southern District of New York. MaxLinear alleges that in 2020, MaxLinear shared its proprietary design and know-how for a full-duplex, or FDX, amplifier with Comcast in the hope of securing future business with Comcast. MaxLinear shared its design and know-how on several occasions, all pursuant to a non-disclosure agreement between MaxLinear and Comcast, with the expectation that Comcast would keep the information confidential. MaxLinear alleges that Comcast needed this technology in order to effectively compete with fiber-optic internet providers. Instead of engaging MaxLinear to develop the FDX amplifier, Comcast allegedly shared MaxLinear’s proprietary designs with MaxLinear’s direct competitor. Comcast allegedly then worked with MaxLinear’s competitor to develop the FDX-amplifier technology. MaxLinear brought claims for trade secret misappropriation, unfair competition, and breach of the parties’ non-disclosure agreement, and it sought an unspecified amount of compensatory damages, punitive damages, pre-judgment and post-judgment interest, costs, expenses, and attorney fees as well as an injunction against Comcast’s use or disclosure of MaxLinear’s trade secrets.
On March 19, 2024, Comcast amended its claims for declaratory judgments, indemnification, and breach of the implied covenant of good faith and fair dealing, and on April 3, 2024, MaxLinear moved to dismiss all claims against it. On September 19, 2024, the court granted the motion to dismiss with respect to certain claims for declaratory judgment claim and denied the motion to dismiss with respect to the remaining claims. On September 23, 2024, Comcast filed amended claims for declaratory judgment, indemnification, and breach of the implied covenant of good faith and fair dealing, and on October 14, 2024, MaxLinear amended and refiled its trade secret and related claims. MaxLinear intends to continue to vigorously defend its position.
Dish Litigation
On February 10, 2023, Entropic Communications, LLC, or Entropic, filed claims for patent infringement against Dish Network Corporation, Dish Network LLC, Dish Network Service, LLC, and Dish Network California Service Corporation in the United States District Court for the Central District of California. At that time, MaxLinear was not a party to the action. On September 21, 2023, Dish Network California Service Corporation, or Dish California, filed four counterclaims against
39

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
MaxLinear. The four claims are declaratory judgment, breach of contract, fraud and negligent misrepresentation, and civil conspiracy.
On January 31, 2024, the Dish defendants, together with DISH Technologies L.L.C., or collectively, Dish, filed eight counterclaims (amended counterclaims for Dish California) against MaxLinear. The eight counterclaims are (1) breach of contract, (2) fraud and negligent misrepresentation, (3) fraud arising from a civil conspiracy, (4) quasi-contract for restitution/unjust enrichment, (5) combination in restraint of trade, (6) violation of the Cartwright Act (by Dish California only), (7) patent misuse, and (8) violation of Cal. Bus. & Prof. Code § 17200 et seq. Dish’s eight counterclaims revolve around a core allegation that MaxLinear is a member of the Multimedia over Coax Alliance (MoCA) and that MaxLinear violated its obligation under MoCA’s Intellectual Property Rights Policy, or IPR Policy, by acting with Entropic to rid the asserted patents of the RAND encumbrances. Dish seeks an unspecified amount of compensatory damages, disgorgement, attorneys’ fees, experts’ fees, and costs. On February 21, 2024, MaxLinear moved to dismiss the Dish defendants’ counterclaim.
On April 22, 2024, a Special Master issued a report and recommendation, or the R&R, which recommended granting the motion to dismiss with prejudice as to the following counterclaims: (1) quasi-contract for restitution/unjust enrichment, (2) combination in restraint of trade, (3) violation of the Cartwright Act, (4) patent misuse, and (5) violation of Cal. Bus. & Prof. Code § 17200. MaxLinear submitted objections to the R&R as to the remaining claims that were not dismissed. Dish submitted objections to the R&R’s recommended dismissal of the quasi-contract for restitution/unjust enrichment counterclaim. The court has not yet issued any ruling regarding the R&R or MaxLinear’s pending motion to dismiss.
On July 30, 2024, this case was stayed until September 17, 2024. There was a motion to stay this case pending resolution of Inter Partes Review (“IPR”). MaxLinear intends to continue to vigorously defend its position.
Cox Litigations
On February 10, 2023, Entropic sued Cox Communications, Inc., CoxCom, LLC, and Cox Communications California, LLC, or together, Cox, in two separate actions in the United States District Court for the Central District of California. On October 6, 2023, Cox filed counterclaims against MaxLinear in each of the two actions.
In the first action, Cox alleges that when MaxLinear assigned certain patents to Entropic, MaxLinear violated its obligations under MoCA’s IPR Policy by assigning these patents and by allegedly failing to ensure that Cox would be offered a FRAND license for these patents. Cox amended its counterclaims on January 9, 2024 and is asserting claims of breach of contract, unjust enrichment, and declaratory judgment against MaxLinear. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.
On April 22, 2024, a Special Master issued the R&R, which recommended granting the motion to dismiss with prejudice as to the unjust enrichment counterclaim but denying the motion as to the breach of contract and declaratory judgment counterclaims. MaxLinear submitted objections to the R&R’s denial-in-part. Cox submitted objections to the R&R as to the unjust enrichment counterclaim and as to certain findings related to the breach of contract counterclaim. The court has not yet issued any ruling regarding the R&R or MaxLinear’s pending motion to dismiss.
In the second action, in response to Entropic suing Cox for patent infringement, Cox filed counterclaims against MaxLinear. Cox alleges that MaxLinear granted CableLabs a non-exclusive, royalty-free license to all patents essential for compliance with DOCSIS specifications. It further alleges that MaxLinear breached this agreement when MaxLinear assigned certain patents to Entropic. Cox amended its counterclaims on January 9, 2024 and is asserting claims for breach of contract, unjust enrichment, and declaratory judgment. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.
On April 22, 2024, a Special Master issued the R&R, which recommended dismissing all Cox counterclaims with prejudice. Cox submitted objections to the R&R as to the unjust enrichment counterclaim. The court has not yet issued any ruling regarding the R&R or MaxLinear’s pending motion to dismiss.
On July 30, 2024, these cases were stayed until September 17, 2024. There was a motion to stay pending resolution of IPR. MaxLinear intends to continue to vigorously defend its position.
*    *    *
The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. As of September 30, 2024, no material loss contingencies have been accrued for litigation and other legal claims in the consolidated financial statements, since the Company’s management currently does
40

MAXLINEAR, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
not believe that the ultimate outcome of any of the matters described above is probable. An unfavorable outcome of these matters may be reasonably possible in excess of recorded amounts; however, a reasonable estimate of the amount or range of such loss cannot be made at this time.
Other Matters
From time to time, the Company is subject to threats of litigation or actual litigation in the ordinary course of business as described above and in “Part II. — Other Information, Item 1. — Legal Proceedings,” some of which may be material. The results of any litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have a material adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors.
16. Stock Repurchases
On February 23, 2021, the Company’s board of directors authorized a plan to repurchase up to $100 million of the Company’s common stock over a period which ended February 16, 2024. The amount and timing of repurchases were subject to a variety of factors including liquidity, share price, market conditions, and legal requirements. Any purchases were funded from available working capital and were effected through open market purchases, block transactions, and privately negotiated transactions. The share repurchase program did not obligate the Company to make any repurchases and was able to be modified, suspended, or terminated by the Company at any time without prior notice.
The share repurchase program was suspended from July 2022 until its expiration due to the Company’s previously pending (now terminated) merger with Silicon Motion (Note 3). As a result, during the nine months ended September 30, 2024, the Company did not repurchase any shares of its common stock under the repurchase program.
At September 30, 2024, the aggregate value of common stock repurchased under the program was approximately $55.0 million and no shares remained available for repurchase under the program, as the plan expired on February 16, 2024.
41

ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking Statements
The following discussion and analysis of the financial condition and results of our operations should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this report. This discussion contains forward-looking statements that involve a number of risks, uncertainties, and assumptions that could cause our actual results to differ materially from those discussed below. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section titled “Risk Factors” included in Part II, Item 1A in this report.
Overview
We are a provider of communications systems-on-chips, or SoCs, used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. We are a fabless integrated circuit design company whose products integrate all or substantial portions of a high-speed communication system, including radio frequency, or RF, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management. In most cases, these products are designed on a single silicon-die, using standard digital complementary metal oxide semiconductor, or CMOS, manufacturing processes and conventional packaging technologies. Importantly, our ability to design analog and mixed-signal circuits in CMOS allows us to efficiently combine analog functionality and complex digital signal processing logic in the same integrated circuit. As a result, we believe our solutions have exceptional levels of functional integration and performance, low manufacturing cost, and reduced power consumption versus competition. These solutions also enable shorter design cycles, significant design flexibility and low system-level cost across a range of markets.
Our customers primarily include electronics distributors, module makers, original equipment manufacturers, or OEMs and original design manufacturers, or ODMs, which incorporate our products in a wide range of electronic devices. Examples of such devices include radio transceivers and modems for 4G/5G base-station and backhaul infrastructure; optical transceivers targeting hyperscale data centers; Wi-Fi and wireline routers for home networking; broadband modems compliant with Data Over Cable Service Interface Specifications, or DOCSIS, passive optical fiber standards, or PON, and digital subscriber line, or DSL; as well as power management and interface products used in these and many other markets. In addition, we generate revenue from certain intellectual property sale agreements.
In the nine months ended September 30, 2024, net revenue was $268.4 million, which was derived in part from sales of RF receivers and RF receiver SOC and connectivity solutions and intellectual property into broadband operator voice and data modems and gateways and connectivity adapters, global analog and digital RF receiver products, radio and modem solutions into wireless carrier access and backhaul infrastructure platforms, high-speed optical interconnect solutions sold into optical modules for data-center, metro and long-haul networks, and high-performance interface and power management solutions into a broad range of communications, industrial, automotive and multi-market applications. We have experienced slower than expected recovery in sales and our ability to achieve revenue growth in the future will depend, among other factors, on our ability to improve revenue in key markets such as the broadband market which has experienced slower than expected recovery; our ability to further penetrate existing markets; our ability to expand our target addressable markets by developing new and innovative products such as researching, developing and designing capabilities for new solutions in advanced semiconductor process nodes such as 16nm and 5nm and beyond, and addressing challenges of capturing and processing high quality broadband communications and high-speed optical interconnect signals; changes in government trade policies; changes in export control regulations; our ability to carry on licensed activities with entities on the Entity List, which have been paused, delayed or halted by the U.S. Department of Commerce Bureau of Industry and Security, or BIS at certain times; and our ability to obtain design wins with device manufacturers, in particular manufacturers of data modems, and gateways for the broadband service provider, storage networking market, cable infrastructure market, industrial and automotive markets, and optical module and telecommunications infrastructure markets.
Products shipped to Asia accounted for 72% and 74% of net revenue during the nine months ended September 30, 2024 and 2023, respectively, including 37% from products shipped to Hong Kong during the nine months ended September 30, 2024 and 34% from products shipped to Hong Kong and 12% from products shipped to mainland China during nine months ended September 30, 2023. Although a large percentage of our products is shipped to Asia, we believe that a significant number of the systems designed by these customers and incorporating our semiconductor products are then sold outside Asia. For example, revenue generated from sales of our products during the nine months ended September 30, 2024 and 2023 related principally to
42

sales to Asian ODMs and contract manufacturers delivering products into European and North American markets. To date, all of our sales have been denominated in United States dollars.
A significant portion of our net revenue has historically been generated by a limited number of customers through sales of our products, as well as consideration under intellectual property sale agreements. Sales of products to customers comprise both direct sales to customers and indirect sales through distributors. In the three months ended September 30, 2024, one customer accounted for 25% of our net revenue, and our ten largest customers collectively accounted for 71% of our net revenue, of which distributor customers accounted for 8% of our net revenue. In the nine months ended September 30, 2024, one customer accounted for 13% of our net revenue, and our ten largest customers collectively accounted for 64% of our net revenue, of which distributor customers accounted for 15% of our net revenue. For certain customers, we sell multiple products into disparate end user applications such as PON outdoor units, or PON ODUs, Wi-Fi routers, broadband gateways, and cable modems.
Our business depends on winning competitive bid selection processes, known as design wins, to develop integrated circuits for use in our customers’ products. These selection processes are typically lengthy, and as a result, our sales cycles will vary based on the specific market served, whether the design win is with an existing or a new customer and whether our product being designed in our customer’s device is a first generation or subsequent generation product. Our customers’ products can be complex and, if our engagement results in a design win, can require significant time to define, design and result in volume production. Because the sales cycle for our products is long, we can incur significant design and development expenditures in circumstances where we do not ultimately recognize any revenue. We do not have any long-term purchase commitments with any of our customers, all of whom purchase our products on a purchase order basis. Once one of our products is incorporated into a customer’s design, however, we believe that our product is likely to remain a component of the customer’s product for its life cycle because of the time and expense associated with redesigning the product or substituting an alternative chip. Product life cycles in our target markets will vary by application. For example, in the broadband data modem and gateway sectors, a design-in can have a product life cycle of 24 to 60 months. In the industrial and wired and wireless infrastructure markets, a design-in can have a product life cycle of 24 to 84 months and beyond.
Impact of Global Economic Uncertainty and Inventory Build
Inflation and uncertainty in customer demand and the worldwide economy has continued, and we could experience continued volatility in our sales and revenues. Inventory oversupply could potentially lead to more inventory write-downs, including charges for any excess or obsolete inventory which could negatively impact our gross margins. However, the magnitude of such volatility on our business and its duration is uncertain and cannot be reasonably estimated at this time. As supplier lead times continue to stabilize, we have seen and expect to continue to see a more normalized demand-planning horizon.
Terminated Silicon Motion Merger
On May 5, 2022, we entered into an agreement and plan of merger, or the Merger Agreement, with Silicon Motion Technology Corporation, or Silicon Motion, an exempted company with limited liability incorporated under the Law of the Cayman Islands, pursuant to which, subject to the terms and conditions thereof, we agreed to acquire Silicon Motion pursuant to a statutory merger of Shark Merger Sub, a wholly-owned subsidiary of MaxLinear, with and into Silicon Motion, with Silicon Motion surviving the merger as a wholly-owned subsidiary of MaxLinear. Silicon Motion is a provider of NAND flash controllers for solid state drives and other solid state storage devices.
On July 26, 2023, we terminated the Merger Agreement and notified Silicon Motion that we were relieved of our obligations to close because, among other reasons, (i) certain conditions to closing set forth in the Merger Agreement were not satisfied and were incapable of being satisfied, (ii) Silicon Motion had suffered a Material Adverse Effect that was continuing, (iii) Silicon Motion was in material breach of representations, warranties, covenants, and agreements in the Merger Agreement that gave rise to the right of the Company to terminate, and (iv) in any event, the First Extended Outside Date had passed and was not automatically extended because certain conditions in Article 6 of the Merger Agreement were not satisfied or waived as of May 5, 2023. Under the terms of the Merger Agreement, MaxLinear was not required to pay a break-up fee or other fee as a result of the termination of the Merger Agreement on these grounds. On August 16, 2023, Silicon Motion delivered a notice to us, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration to seek damages from us arising from our alleged breaches of the Merger Agreement. Undefined capitalized terms in this paragraph have the same meaning as in the Merger Agreement.
43

On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that we breached the Merger Agreement. See Part II, Item 1 (Legal Proceedings) of this report for more information on legal proceedings related to the termination of the Merger Agreement.
The second amended and restated commitment letter dated October 24, 2022 with Wells Fargo Bank, N.A., or Wells Fargo Bank, and other lenders, and related financing commitments for the previously pending (now terminated) merger were also terminated upon termination of the Merger Agreement. As a result of the termination of the financing, in August 2023, the Company was required to pay to Wells Fargo Bank a ticking fee of $18.3 million.
Workforce Reductions
We initiated a reduction in our workforce in July 2024, or the 2024 Workforce Reduction, following slower than expected recovery in our sales as a result of macroeconomic conditions and the demand environment. Previously, during the year ended December 31, 2023, we entered into two plans of restructuring to reduce our workforce, or the 2023 Workforce Reductions, which together with the 2024 Workforce Reduction, are referred to collectively as the Workforce Reductions. The Workforce Reductions are intended to align our operational needs with the changes in macroeconomic conditions and the demand environment while continuing to support the long-term business strategy by reducing our operating expenses.
In the three months ended September 30, 2024, the Company incurred $26.8 million in restructuring costs pertaining to the 2024 Workforce Reduction, which included $17.0 million charges under contracts associated with cancelled projects and related impairment of assets, $9.1 million in severance costs and related expenses, and $0.7 million from exiting facilities.
During the nine months ended September 30, 2024, we completed notification to the remaining affected employees of the 2023 Workforce Reductions, and incurred $23.5 million in restructuring costs, including $19.8 million in severance costs and related expenses, or a cumulative total of $43.3 million in restructuring costs under the 2023 Workforce Reductions. Substantially all of the severance and related costs incurred in the nine months ended September 30, 2024 that related to the 2023 Workforce Reductions pertained to statutory severance benefits in the jurisdictions in which the terminated employees were employed.
We expect to incur additional restructuring costs associated with the 2023 Workforce Reductions and 2024 Workforce Reduction of approximately $3.0 million to $5.0 million, which is expected to pertain to severance due to statutory requirements in the jurisdictions in which the terminated employees were employed, as well as exiting facilities. We expect to complete notifications to employees regarding the 2024 Workforce Reduction and finalize our plans to exit facilities by the end of 2024.
The estimate of costs that we expect to incur, and the timing thereof, are subject to a number of assumptions and actual results may differ. We may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the Workforce Reductions.
Inducement Equity Incentive Plan for New Employees
On May 22, 2024, the Board of Directors adopted the Inducement Plan pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules, and, subject to the adjustment provisions of the Inducement Plan, reserved 4,000,000 shares of the Company’s common stock for issuance under equity awards granted under the Inducement Plan. The Inducement Plan provides for the grant of equity-based awards, including non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares, and its terms are substantially similar to the 2010 Equity Incentive Plan, including with respect to treatment of equity awards in the event of a merger or “change in control” as defined under the Inducement Plan, but with such other terms and conditions intended to comply with the Nasdaq inducement award exception. Awards under the Inducement Plan may only be made to individuals not previously employees or non-employee directors of the Company as an inducement material to the individuals’ entry into employment with the Company.

Critical Accounting Policies and Estimates
Management’s discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements which are prepared in accordance with accounting principles that are generally accepted in the United States of America. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, related disclosure of contingent assets and liabilities at the date of the
44

consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. We continually evaluate our estimates and judgments, the most critical of which are those related to business combinations, revenue recognition, inventory valuation, production masks, goodwill and other intangible assets valuation, and income taxes. We base our estimates and judgments on historical experience and other factors that we believe to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known.
We believe that accounting policies we have identified as critical involve a greater degree of judgment and complexity than our other accounting policies. Accordingly, those are the policies we believe are the most critical to understanding and evaluating our consolidated financial condition and results of operations.
For a summary of our critical accounting policies and estimates, refer to Management’s Discussion and Analysis section of our Annual Report on Form 10-K for the year ended December 31, 2023, which we filed with the Securities and Exchange Commission, or SEC, on January 31, 2024, or our Annual Report. There have been no material changes to our critical accounting policies and estimates during the nine months ended September 30, 2024.

Recently Issued Accounting Pronouncements
See Note 1 to our consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for recently issued accounting pronouncements not yet adopted as of the date of this report.
Results of Operations
The following describes the line items set forth in our unaudited consolidated statements of operations.
Net Revenue. Net revenue is generated from sales of radio-frequency, analog, digital, and mixed-signal integrated circuits and intellectual property for access and connectivity, wired and wireless infrastructure, and industrial and multi-market applications. A significant portion of our sales are to distributors, who then resell our products.
Cost of Net Revenue. Cost of net revenue includes the cost of finished silicon wafers processed by third-party foundries; costs associated with our outsourced packaging and assembly, test and shipping; costs of personnel, including salaries, benefits, and stock-based compensation; equipment associated with manufacturing support, logistics and quality assurance; amortization of acquired developed technology and purchased licensed technology intangible assets; inventory fair value adjustments, if any; amortization of certain production mask costs and computer-aided design software license costs; cost of production load boards and sockets; and an allocated portion of our occupancy costs.
Research and Development. Research and development, or R&D, expense includes personnel-related expenses, including salaries and benefits and stock-based compensation, new product engineering mask costs, prototype integrated circuit packaging and test costs, computer-aided design software license costs, intellectual property license costs, reference design development costs, development testing and evaluation costs, depreciation expense and allocated occupancy costs, partially offset by income from joint R&D projects and/or governmental R&D grants, if any. Research and development activities include the design of new products, refinement of existing products and design of test methodologies to ensure compliance with required specifications. All research and development costs are expensed as incurred.
Selling, General and Administrative. Selling, general and administrative expense includes personnel-related expenses, including salaries and benefits and stock-based compensation, amortization of certain acquired intangible assets, merger, acquisition and integration costs, if any, third-party sales commissions, field application engineering support, travel costs, professional and consulting fees, legal fees, depreciation expense and allocated occupancy costs.
Impairment Losses. Impairment losses consist of charges resulting from the impairment of intangible assets.
Restructuring Charges. Restructuring charges consist of severance, lease and leasehold impairment charges, and other charges related to restructuring plans.
45

Interest and Other Income (Expense), Net. Interest and other income (expense), net includes interest income, interest expense and other income (expense). Interest income consists of interest earned on our cash, cash equivalents and restricted cash balances. Interest expense consists of interest accrued on debt and amortization of discounts on debt and other liabilities. Other income (expense) consists of income (expense) generated from non-operating transactions, including a ticking fee paid to lenders following the termination of the Silicon Motion merger, net gains (losses) from sales or impairment of investments and/or income or losses from investments, if any, including unrealized holding gains (losses) from certain investments required to be marked to market value, if any, and a gain from partial curtailment of employee defined benefit obligations.
Income Tax Provision (Benefit). We make certain estimates and judgments in determining income taxes for financial statement purposes. These estimates and judgments occur in the calculation of certain tax assets and liabilities, which arise from differences in the timing of recognition of revenue and expenses for tax and financial statement purposes and the realizability of assets in future years.
The following table sets forth our consolidated statement of operations data as a percentage of net revenue for the periods indicated:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net revenue100 %100 %100 %100 %
Cost of net revenue46 45 47 44 
Gross profit54 55 53 56 
Operating expenses:
Research and development65 49 65 36 
Selling, general and administrative37 19 37 17 
Impairment losses— — — 
Restructuring charges33 — 19 
Total operating expenses137 68 121 55 
Income (loss) from operations(82)(13)(68)
Interest income
Interest expense(3)(2)(3)(1)
Other income (expense), net(18)(17)(5)— 
Total other income (expense), net(19)(17)(6)(4)
Loss before income taxes(102)(31)(74)(4)
Income tax provision (benefit)(8)(1)(4)
Net loss(93)%(29)%(70)%(6)%
Net Revenue
Three Months Ended September 30,Nine Months Ended September 30,
20242023$ Change% Change20242023$ Change% Change
(dollars in thousands) (dollars in thousands)
Broadband$32,275 $34,416 $(2,141)(6)%$87,157 $169,646 $(82,489)(49)%
% of net revenue40 %25 %32 %30 %
Connectivity12,726 15,025 (2,299)(15)%35,700 119,232 (83,532)(70)%
% of net revenue16 %11 %13 %21 %
Infrastructure23,046 49,985 (26,939)(54)%87,436 145,549 (58,113)(40)%
% of net revenue28 %37 %33 %26 %
Industrial and multi-market13,055 36,104 (23,049)(64)%58,068 133,483 (75,415)(56)%
% of net revenue16 %27 %22 %23 %
Total net revenue$81,102 $135,530 $(54,428)(40 %)$268,361 $567,910 $(299,549)(53)%
46

Net revenue decreased $54.4 million to $81.1 million for the three months ended September 30, 2024, as compared to $135.5 million for the three months ended September 30, 2023, primarily as a result of macroeconomic conditions impacting customer demand, including excess inventory in the channel built up following the supply shortages in 2022. The decrease in broadband net revenue of $2.1 million was driven by decreases in the volume of broadband SOC, satellite ODU, and tuner shipments in this category, partially offset by increases from reversals of unclaimed rebates due to expiration of rebate pricing and improvements in shipments of cable data shipments. The decrease in connectivity net revenue of $2.3 million was driven by decreased volume of shipments of certain products associated with residential broadband market decline, while ethernet product shipments improved. The decrease in net infrastructure revenues of $26.9 million was driven by a decrease in the volume of wireless backhaul and high performance analog product shipments. The decrease in industrial and multi-market net revenue of $23.0 million was driven by decreased volume of shipments of component and high-performance analog products, while high speed interconnect product shipments improved. Price changes did not have a material impact to revenues period over period.
Net revenue decreased $299.5 million to $268.4 million for the nine months ended September 30, 2024, as compared to $567.9 million for the nine months ended September 30, 2023, primarily as a result of macroeconomic conditions impacting customer demand, including excess inventory in the channel built up following the supply shortages in 2022. The decrease in broadband net revenue of $82.5 million was driven by decreases in the volume of broadband SOC shipments in this category, partially offset by revenue from certain intellectual property sale agreements and increases from reversals of unclaimed rebates due to expiration of rebate pricing. The decrease in connectivity net revenue of $83.5 million was driven by decreased volume of shipments of certain products associated with residential broadband market decline, partially offset by revenue from certain intellectual property sale agreements. The decrease in net infrastructure revenues of $58.1 million was driven by decreases in the volume of wireless backhaul products, and to a lesser extent, high performance analog shipments, partially offset by improvement in shipments of from high speed interconnect products, and revenues from certain intellectual property sale agreements. The decrease in industrial and multi-market net revenue of $75.4 million was driven by decreased volume of shipments of component and high-performance analog products. Price changes did not have a material impact to revenues period over period.
We currently expect that revenue will fluctuate in the future, from period-to-period, consistent with the cyclical nature of our industry.
Cost of Net Revenue and Gross Profit
Three Months Ended September 30,Nine Months Ended September 30,
20242023$ Change% Change20242023$ Change% Change
(dollars in thousands) (dollars in thousands)
Cost of net revenue$37,022 $61,586 $(24,564)(40)%$124,827 $250,786 $(125,959)(50)%
% of net revenue46 %45 %47 %44 %
Gross profit 44,080 73,944 (29,864)(40)%143,534 317,124 (173,590)(55)%
% of net revenue54 %55 %53 %56 %
Cost of net revenue decreased $24.6 million to $37.0 million for the three months ended September 30, 2024, as compared to $61.6 million for the three months ended September 30, 2023. The decrease was driven by a decreased volume of shipments as a result of macroeconomic conditions impacting customer demand for our products as described above under “Net Revenue.” Gross profit percentage declined for the three months ended September 30, 2024, as compared to the three months ended September 30, 2023, due to reduced absorption of intangible amortization and fixed costs.
Cost of net revenue decreased $126.0 million to $124.8 million for the nine months ended September 30, 2024, as compared to $250.8 million for the nine months ended September 30, 2023. The decrease was driven by a decreased volume of shipments as a result of macroeconomic conditions impacting customer demand for our products as described above under “Net Revenue.” Gross profit percentage declined for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, due to reduced absorption of intangible amortization and fixed costs.
We currently expect that gross profit percentage will fluctuate in the future, from period-to-period, based on changes in product mix, average selling prices, and average manufacturing costs.
47

Research and Development
Three Months Ended September 30,Nine Months Ended September 30,
20242023$ Change% Change20242023$ Change% Change
(dollars in thousands) (dollars in thousands)
Research and development$52,604 $66,306 $(13,702)(21)%$173,911 $204,254 $(30,343)(15)%
% of net revenue65 %49 %65 %36 %
Research and development expense decreased $13.7 million to $52.6 million for the three months ended September 30, 2024, as compared to $66.3 million for the three months ended September 30, 2023. The decrease was driven by decreases in payroll and benefits expense of $5.6 million, bonuses of $3.1 million, stock based compensation of $2.0 million, CAD design tools expense of $1.7 million, consulting expense of $0.9 million and prototype expense of $0.7 million. These decreases were partially offset by the impact of a decrease to income from joint R&D projects and government grants of $0.7 million offset against R&D expense. The decrease in payroll and benefits, bonuses, and stock-based compensation are attributable to the 2023 Workforce Reductions. The decrease in CAD design tool, consulting and prototype expenses are due to timing of project completion. The decrease in research and development funded by others is due to timing of governmental R&D grants and termination of certain programs during the third quarter of 2024 as a result of the 2024 Workforce Reduction. The amount of income from research and development funded by others also varies from period to period depending on availability of such funding, including governmental grants.
Research and development expense decreased $30.3 million to $173.9 million for the nine months ended September 30, 2024, as compared to $204.3 million for the nine months ended September 30, 2023. The decrease was driven by decreases in payroll and benefits expense of $15.8 million, CAD design tools expense of $5.9 million, stock based compensation of $5.2 million, bonuses of $3.3 million, consulting expense of $3.0 million, prototype expense of $2.3 million, depreciation expense of $1.7 million and occupancy expenses of $0.6 million. These decreases were partially offset by a decrease in income from joint R&D and governmental grants of $8.1 million offset against R&D expense. The decrease in payroll and benefits expense, stock-based compensation, and bonuses are attributable to the 2023 Workforce Reductions and cost reduction measures. The decrease in CAD design tool, consulting and prototype expenses are due to timing of project completion. The decrease in depreciation expense is from acquired assets becoming fully amortized as they reached the end of their useful lives. The decrease in income from joint R&D projects and governmental grants is due to timing of governmental R&D grants and termination of certain programs during the first and third quarters of 2024 as a result of the 2023 Workforce Reductions and 2024 Workforce Reduction. The amount of income from research and development funded by others also varies from period to period depending on availability of such funding, including governmental grants.
We are reducing our research and development spending, including via our Workforce Reductions, to meet evolving demand; however, we expect our research and development expenses to increase in future years as we develop products to drive future growth.
Selling, General and Administrative
Three Months Ended September 30,
Nine Months Ended September 30,
20242023$ Change% Change20242023$ Change% Change
(dollars in thousands) (dollars in thousands)
Selling, general and administrative$30,154 $25,402 $4,752 19 %$100,242 $97,772 $2,470 %
% of net revenue37 %19 %37 %17 %
Selling, general and administrative expense increased $4.8 million to $30.2 million for the three months ended September 30, 2024, as compared to $25.4 million for the three months ended September 30, 2023. The increase was a result of increase in stock based compensation of $9.8 million, partially offset by decreases in payroll and other benefits expense of $1.8 million, professional fees of $1.8 million, and bonuses of $1.4 million. The increase in stock-based compensation expense is a result of incremental grants made to executives for retention purposes in the first quarter of 2024. The decrease in professional fees is mainly due to a decrease in merger and acquisition related fees following the termination of our merger with Silicon Motion. The decreases in payroll and other benefits and bonuses are attributable to the 2023 Workforce Reductions and other cost reduction measures.
48

Selling, general and administrative expense increased $2.5 million to $100.2 million for the nine months ended September 30, 2024, as compared to $97.8 million for the nine months ended September 30, 2023. The increase was a result of increase in stock based compensation of $13.8 million, partially offset by decreases in professional fees of $4.1 million, payroll and other benefits expense of $3.9 million, bonuses of $1.6 million, commissions of $1.0 million, and depreciation and amortization of $1.0 million. The increase in stock-based compensation expense is a result of incremental grants made to executives for retention purposes in the first quarter of 2024. The decrease in professional fees is mainly due to a decrease in merger and acquisition related fees following the termination of our merger with Silicon Motion. The decreases in payroll and other benefits and bonuses are attributable to the 2023 Workforce Reductions and other cost reduction measures. The decrease in commissions expense is due to decreased revenues. The decrease in depreciation and amortization is from assets becoming fully amortized as they reached the end of their useful lives.
We are reducing our selling, general and administrative expenses, including via our Workforce Reductions; however, we expect selling, general and administrative expenses to increase in future years when we return to growing our sales and marketing organization to expand into existing and new markets.
Impairment Losses
Three Months Ended September 30,Nine Months Ended September 30,
20242023$ Change% Change20242023$ Change% Change
(dollars in thousands) (dollars in thousands)
Impairment losses$1,237 $— $1,237 N/A$1,237 $2,438 $(1,201)(49)%
% of net revenue%— %— %— %
Impairment losses in the three and nine months ended September 30, 2024 and the nine months ended September 30, 2023 related to abandonment of certain intellectual property licenses.
Restructuring Charges
Three Months Ended September 30,Nine Months Ended September 30,
20242023$ Change% Change20242023$ Change% Change
(dollars in thousands) (dollars in thousands)
Restructuring charges$26,828 $54 $26,774 49,581 %$50,323 $9,138 $41,185451 %
% of net revenue33 %— %19 %%
Restructuring charges increased $26.8 million to $26.8 million for the three months ended September 30, 2024, compared to $0.1 million for the three months ended September 30, 2023. Restructuring charges for the three months ended September 30, 2024 included $17.0 million charges under contracts associated with cancelled projects and related impairment of assets, $9.1 million in severance and related charges related to the 2024 Workforce Reduction, and $0.7 million in charges related to the reduction of space leased for office facilities. A significant portion of the employee severance-related changes from the 2024 Workforce Reduction are estimated statutory severance benefits payable in the jurisdictions in which the terminated employees were employed.
49

Restructuring charges increased $41.2 million to $50.3 million for the nine months ended September 30, 2024, compared to $9.1 million for the nine months ended September 30, 2023. Restructuring charges for the nine months ended September 30, 2024 included $28.9 million in employee severance and related charges, $19.8 million of which related to the 2023 Workforce Reductions and $9.1 million which related to the 2024 Workforce Reduction, $17.8 million in charges under contracts associated with cancelled projects and related impairment of assets, and $3.6 million in charges related to reduction of space leased for office facilities. Substantially all of the employee severance-related charges from the 2023 Workforce Reductions and a significant portion of the employee severance-related charges from the 2024 Workforce Reduction are estimated statutory severance benefits payable in the jurisdictions in which the terminated employees were employed.
    Interest and Other Income (Expense)
Three Months Ended September 30,Nine Months Ended September 30,
20242023$ Change% Change20242023$ Change% Change
(dollars in thousands)(dollars in thousands)
Interest and other income (expense), net$(15,755)$(23,700)$7,945 (34)%$(15,716)$(24,701)$8,985 (36)%
% of net revenue(19)%(17)%(6)%(4)%
Interest and other income (expense), net changed by $7.9 million from expense of $23.7 million in the three months ended September 30, 2023 to expense of $15.8 million for the three months ended September 30, 2024. Interest and other income (expense), net for the three months ended September 30, 2023 included a loan ticking fee of approximately $18.3 million paid to lenders following the termination of the Silicon Motion merger and investment losses of $5.3 million, partially offset by a $1.0 million gain related to partial curtailment of defined benefit pension obligations which did not recur in the three months ended September 30, 2024. The positive impacts pertaining to these items were partially offset by negative impacts from the impairment of privately held investments and notes receivable of $12.3 million and currency exchange losses of $2.3 million.
Interest and other income (expense), net changed by $9.0 million from expense of $24.7 million in the nine months ended September 30, 2023 to expense of $15.7 million for the nine months ended September 30, 2024. Interest and other income (expense), net for the three months ended September 30, 2023 included a loan ticking fee of approximately $18.3 million paid to lenders following the termination of the Silicon Motion merger and investment losses of $3.3 million, partially offset by $1.0 million gain related to partial curtailment of defined benefit pension obligations which did not recur in the three months ended September 30, 2024. Interest income increased by $1.1 million due to higher interest rates on interest-bearing cash equivalents. The positive impacts pertaining to these items were partially offset by negative impacts from the impairment of privately held investments and notes receivable of $12.3 million, and currency exchange losses of $0.8 million.
Income Tax Provision (Benefit)
 Three Months Ended September 30,Nine Months Ended September 30,
 20242023$ Change% Change20242023$ Change% Change
(dollars in thousands)(dollars in thousands)
Income tax benefit$(6,713)$(1,689)$(5,024)297 %$(10,535)$13,468 $(24,003)(178)%
The income tax benefit for the three months ended September 30, 2024 was $6.7 million compared to an income tax benefit of $1.7 million for the three months ended September 30, 2023.
The income tax benefit for the nine months ended September 30, 2024 was $10.5 million compared to an income tax provision of $13.5 million for the nine months ended September 30, 2023.
The difference between our effective tax rate and the 21.0% U.S. federal statutory rate for the nine months ended September 30, 2024 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items, and stock based compensation.
50

The difference between our effective tax rate and the 21.0% U.S. federal statutory rate for the nine months ended September 30, 2023 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items including a tax on global intangible low-taxed income, stock based compensation, excess tax benefits related to stock-based compensation, and release of certain reserves for uncertain tax positions under ASC 740-10. The permanent tax item related to global intangible low-taxed income also reflected the then recent legislative changes requiring the capitalization of research and experimentation costs, as well as limitations on the creditability of certain foreign income taxes.
We continue to maintain a valuation allowance to offset state and certain federal and foreign deferred tax assets, as realization of such assets does not meet the more-likely-than-not threshold required under accounting guidelines. In making such determination, we consider all available positive and negative evidence quarterly, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. Based upon our review of all positive and negative evidence, we continue to have a valuation allowance on state deferred tax assets, certain federal deferred tax assets, and certain foreign deferred tax assets in jurisdictions where we have cumulative losses or otherwise are not expected to utilize certain tax attributes. We do not incur income tax expense or benefit in certain tax-free jurisdictions in which we operate.
Our subsidiary in Singapore operates under certain tax incentives in Singapore, which are effective through March 2027. Under these incentives, qualifying income derived from certain sales of our integrated circuits is taxed at a concessionary rate over the incentive period. We also receive a reduced withholding tax rate on certain intercompany royalty payments made by our Singapore subsidiary during the incentive period. We recorded income taxes in the nine months ended September 30, 2024 and 2023 at the incentive rate. The incentives are conditional upon our meeting certain minimum employment and investment thresholds within Singapore over time, and we may be required to return certain tax benefits in the event we do not achieve compliance related to that incentive period. We currently believe that we will be able to satisfy these conditions without material risk.
Liquidity and Capital Resources
As of September 30, 2024, we had cash and cash equivalents of $148.5 million, restricted cash of $1.0 million and net accounts receivable of $47.9 million. Additionally, as of September 30, 2024, our working capital, which we define as current assets less current liabilities, was $159.7 million. Financial instruments, which potentially subject us to concentrations of credit risk, consist primarily of cash and cash equivalents and accounts receivable. Collateral is generally not required for customer receivables. We limit our exposure to credit loss by placing our cash with high credit quality financial institutions. At times, such deposits may be in excess of insured limits. We have not experienced any losses on our deposits of cash and cash equivalents.
Our primary uses of cash are to fund operating expenses and purchases of inventory, property and equipment, and from time to time, the acquisition of businesses. In May 2022, we entered into the Merger Agreement to acquire Silicon Motion. However, on July 26, 2023, we terminated the Merger Agreement and were relieved of our obligations to close.
From time to time, we may also use cash to pay down outstanding debt and/or make investments. As of September 30, 2024, $125.0 million of principal was outstanding under a senior secured term B loan facility or the “Initial Term Loan under the June 23, 2021 Credit Agreement.” The Company also has available, subject to the terms and conditions of the agreement, a senior secured revolving credit facility, in an aggregate principal amount of up to $100.0 million which remained undrawn as of September 30, 2024. The proceeds of the revolving facility may be used to finance the working capital needs and other general corporate purposes of the Company and its subsidiaries.
51

Commencing on September 30, 2021, the Initial Term Loan under the June 23, 2021 Credit Agreement has amortized in equal quarterly installments equal to 0.25% of the original principal amount of the Initial Term Loan under the June 23, 2021 Credit Agreement, with the balance payable on June 23, 2028. We could be subject to substantial variable interest rate risk because our interest rate under term loans typically vary based on a fixed margin over an indexed rate or an adjusted base rate. While we had been mitigating the impact of high interest rates with large amounts of prepayments on our outstanding debt, if interest rates were to further increase substantially, it could have a material adverse effect on our operating results and could affect our ability to service the indebtedness. Please refer to the Risk Factor entitled “As of September 30, 2024, our aggregate indebtedness was $125.0 million, and we are subject to a variable amount of interest on the principal balance of our credit agreements and could continue to be adversely impacted by high interest rates in the future. Such indebtedness adversely affects our operating results and cash-flows as we satisfy our underlying interest and principal payment obligations and contains financial and operational covenants that could adversely affect our operational freedom or ability to pursue strategic transactions that we would otherwise consider to be in the best interest of stockholders, including obtaining additional indebtedness to finance such transactions. In addition, high interest rates may make it more difficult for us, our customers, and our distributors to obtain financing and service their interest and debt obligations, which in turn has an impact on customer demand for our products and our distributors' business” for a discussion of how our indebtedness could have a material adverse effect on our liquidity and capital resources.
Our future capital requirements will depend on many factors, including changes in revenue, the expansion or contraction of our engineering, sales and marketing activities, the timing and extent of our expansion into new territories, the timing of introductions of new products and enhancements to existing products, the continuing market acceptance of our products, any damages from legal proceedings related to the termination of the Merger Agreement with Silicon Motion or any alleged breaches of the Merger Agreement that we are required to pay, or any amounts we agree to pay in any settlement and any other potential material investments in, or acquisitions of, complementary businesses, services or technologies. Additional funds may not be available on terms favorable to us or at all. If we are unable to raise additional funds when needed, we may not be able to sustain our operations or execute our strategic plans.
Our cash and cash equivalents are impacted by the timing of when we pay expenses as reflected in the change in our outstanding accounts payable and accrued expenses. Cash used to fund operating expenses in our consolidated statements of cash flows excludes the impact of non-cash items such as, but not limited to, amortization and depreciation of acquired intangible assets and leased right-of-use assets and property and equipment, stock-based compensation, impairment of assets, and gain on extinguishment of lease liabilities. Cash used to fund capital purchases and acquisitions of businesses and investments are included in investing activities in our consolidated statements of cash flows. Cash paid to satisfy minimum tax withholdings on behalf of employees for restricted stock units are included in financing activities in our consolidated statements of cash flows.
As of September 30, 2024, our material cash requirements include long-term debt, non-cancelable operating leases, inventory purchase obligations and other obligations, which primarily consist of contractual payments due for computer-aided design software, as follows:
Payments due
TotalLess than 1 year1-3 years3-5 yearsMore than 5 years
(in thousands)
Long-term debt obligations$125,000 $— $— $125,000 $— 
Operating lease obligations32,140 2,864 19,182 8,498 1,596 
Purchase obligations16,423 3,004 13,419 — — 
Other obligations62,994 7,708 51,613 3,673 — 
Total$236,557 $13,576 $84,214 $137,171 $1,596 
Our planned capital expenditures as of September 30, 2024 were not material. Our consolidated balance sheet at September 30, 2024 included $4.4 million in other long-term liabilities for uncertain tax positions, some of which may result in cash payment and $15.0 million received from other parties for jointly funded research and development projects which will be recognized into income when the contingencies associated with the repayment conditions have been resolved. The future payments related to uncertain tax positions recorded as other long-term liabilities have not been presented in the table above due to the uncertainty of the amounts and timing of cash settlement with the taxing authorities.
52

Our primary sources of cash are cash receipts on accounts receivable from our shipment of products to distributors and direct customers, as well as proceeds that we receive under certain intellectual property sale agreements. Aside from the amounts billed to our customers, net cash collections of accounts receivable are impacted by the efficiency of our cash collections process, which can vary from period to period depending on the payment cycles of our major distributor customers, and relative linearity of shipments period-to-period.
The June 23, 2021 Credit Agreement, under which we entered into a senior secured term B loan facility and a revolving credit facility, permits us to request incremental loans in an aggregate principal amount not to exceed the sum of an amount equal to the greater of (x) $175.0 million and (y) 100% of “Consolidated EBITDA” (as defined in such agreement), plus the amount of certain voluntary prepayments, plus an unlimited amount that is subject to pro forma compliance with certain first lien net leverage ratio, secured net leverage ratio and total net leverage ratio tests.
The following is a summary of our working capital, cash and cash equivalents, and restricted cash for the periods indicated:
September 30, 2024December 31, 2023
(in thousands)
Working capital$159,663 $265,896 
Cash and cash equivalents$148,476 $187,288 
Short-term restricted cash993 1,051 
Long-term restricted cash23 17 
Total cash, cash equivalents, and restricted cash$149,492 $188,356 

We believe that our $148.5 million of cash and cash equivalents at September 30, 2024 will be sufficient to fund our projected operating requirements for at least the next twelve months. As of September 30, 2024, our indebtedness totaled $125.0 million, which consists of outstanding principal under the Initial Term Loan under the June 23, 2021 Credit Agreement. The June 23, 2021 Credit Agreement also provides the Company with the Revolving Facility in an aggregate principal amount of up to $100.0 million, which remained undrawn as of September 30, 2024. The Initial Term Loan under the June 23, 2021 Credit Agreement has a seven-year term expiring in June 2028 and bears interest, at the Company’s option, at a per annum rate equal to either (i) a base rate equal to the highest of (x) the federal funds rate, plus 0.50%, (y) the prime rate then in effect and (z) an adjusted SOFR rate determined on the basis of a one-month interest period plus 1.00%, in each case, plus an applicable margin of 1.25% or (ii) an adjusted SOFR rate, subject to a floor of 0.50%, plus an applicable margin of 2.25%. Loans under the Revolving Facility initially bear interest, at a per annum rate equal to either (i) a base rate (as calculated above) plus an applicable margin of 0.00%, or (ii) an adjusted SOFR rate (as calculated above) plus an applicable margin of 1.00%. Following delivery of financial statements for the Company’s fiscal quarter ending June 30, 2021, the applicable margin for loans under the Revolving Facility will range from 0.00% to 0.75% in the case of base rate loans and 1.00% to 1.75% in the case of SOFR rate loans, in each case, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. The Company is required to pay commitment fees ranging from 0.175% to 0.25% per annum on the daily undrawn commitments under the Revolving Facility, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. Commencing on September 30, 2021, the Initial Term Loan under the June 23, 2021 Credit Agreement amortizes in equal quarterly installments equal to 0.25% of the original principal amount, with the balance payable at maturity on June 23, 2028. The June 23, 2021 Credit Agreement was amended on June 29, 2023 to implement a benchmark replacement.
53

The following is a summary of our cash flows provided by (used in) operating activities, investing activities and financing activities for the periods indicated:
Nine Months Ended September 30,
20242023
(in thousands)
Net cash provided by (used in) operating activities$(17,457)$59,945 
Net cash used in investing activities(20,448)(30,762)
Net cash used in financing activities(135)(27,527)
Effect of exchange rate changes on cash, cash equivalents and restricted cash(824)(1,861)
Decrease in cash, cash equivalents and restricted cash$(38,864)$(205)
Cash Flows from Operating Activities
Net cash used in operating activities was $17.5 million for the nine months ended September 30, 2024, compared to net cash provided by operating activities of $59.9 million nine months ended September 30, 2023. The decline in operating cash flows was driven by a decline in revenue from decreased volume of shipments of our products as a result of macroeconomic conditions impacting customer demand for our products (as discussed under the heading, “Results of Operations,” above). Operating cash flows were also impacted by changes in our working capital, which increased $88.7 million, in particular, in the first nine months of 2024, we collected accounts receivable of $177.6 million, which was partially offset by payments against our price protection liability of $54.0 million and severance and other payments from the Workforce Reductions of $31.5 million.
Cash Flows from Investing Activities
Our use of cash in investing activities declined by $10.3 million driven by a reduction our acquisition investments, offset by increased capital purchases. In the nine months ended September 30, 2023, we used $12.4 million in acquiring a small business. We did not make any acquisition-related payments in the 2024 period. Our capital purchases of property and equipment and intangible assets increased $2.1 million for the nine months ended September 30, 2024 due to the timing of purchases of production masks and other property and equipment.
Net cash used in investing activities was $20.4 million for the nine months ended September 30, 2024 and consisted of purchases of property and equipment of $15.5 million, and purchases of intangible assets of $5.0 million.
Net cash used in investing activities was $30.8 million for the nine months ended September 30, 2023 and consisted of cash used in acquisitions of Company X and Y of $12.4 million (including $2.7 million contingent consideration paid to shareholders of Company X), purchases of property and equipment of $12.2 million, and purchases of intangible assets of $6.2 million.
Cash Flows from Financing Activities
Our use of cash in financing activities for the 2023 period included payment of debt commitment, or ticking fees, of $18.3 million in connection with the termination of the merger with Silicon Motion. Both the 2024 and 2023 periods included minimum tax withholding paid on behalf of employees for restricted stock, partially offset by net proceeds from issuance of common stock for stock-related awards to employee. The employee stock-related amounts declined due to a smaller amount of restricted stock units released for bonuses and a decline in value of other stock-related awards released during the periods.
Warranties and Indemnifications
In connection with the sale of products in the ordinary course of business, we often make representations affirming, among other things, that our products do not infringe on the intellectual property rights of others, and agree to indemnify customers against third-party claims for such infringement. Further, our certificate of incorporation and bylaws require us to indemnify our officers and directors against any action that may arise out of their services in that capacity, and we have also entered into indemnification agreements with respect to all of our directors and certain controlling persons.
ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
54

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates and interest rates.
Foreign Currency Risk
To date, our international customer and vendor agreements have been denominated mostly in United States dollars. Accordingly, we have limited exposure to foreign currency exchange rates and do not enter into foreign currency hedging transactions. The functional currency of certain foreign subsidiaries is the local currency. Accordingly, the effects of exchange rate fluctuations on the net assets of these foreign subsidiaries’ operations are accounted for as translation gains or losses in accumulated other comprehensive income (loss) within stockholders’ equity. A hypothetical change of 100 basis points in such foreign currency exchange rates during the nine months ended September 30, 2024 would result in a change to translation gain in accumulated other comprehensive income (loss) of approximately $1.1 million.
Interest Rate Risk
We are subject to a variable amount of interest on the principal balance of our credit agreements described above and could be adversely impacted by high interest rates in the future. If SOFR interest rates had increased by 10% during the nine months ended September 30, 2024, the rate increase would have resulted in an immaterial increase to interest expense. We currently believe our operating cash held primarily for working capital purpose is sufficient to cover our interest obligations, but we are monitoring the impact of high interest rates on our ability to service our interest and debt obligations, obtain financing, and on our business in general.
ITEM 4.    CONTROLS AND PROCEDURES
Evaluation of Disclosure and Procedures
We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports filed with the SEC is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and no evaluation of controls and procedures can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
As required by Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, prior to filing this Quarterly Report, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this Quarterly Report. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Quarterly Report to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control over Financial Reporting
An evaluation was performed under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, to determine whether any change in our internal control over financial reporting occurred during the fiscal quarter ended September 30, 2024 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. There were no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15 of the Securities Exchange Act of 1934, as amended, that occurred during the fiscal quarter ended September 30, 2024 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

55

PART II — OTHER INFORMATION

ITEM 1.    LEGAL PROCEEDINGS
Dispute with Silicon Motion
As previously disclosed, on July 26, 2023, MaxLinear terminated the Merger Agreement on multiple grounds. On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration before the Singapore International Arbitration Centre to seek damages from MaxLinear arising from MaxLinear’s alleged breaches of the Merger Agreement. Silicon Motion’s position is that MaxLinear’s Willful and Material Breaches (as such term is defined in the Merger Agreement) of the Merger Agreement prevented the Merger from being completed by August 7, 2023, and that MaxLinear is consequently liable for substantial monetary damages in excess of the termination fee as provided in the Merger Agreement.
On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. Silicon Motion seeks payment of the termination fee, additional damages, fees, and costs. The arbitration will be confidential.
MaxLinear believes that it properly terminated the Merger Agreement. MaxLinear remains confident in its decision and will vigorously defend its right to terminate the Silicon Motion transaction without penalty.
Silicon Motion Stockholder Litigation
MaxLinear and certain of its officers have been named as defendants in two lawsuits brought by stockholders of Silicon Motion.
On August 31, 2023, a Silicon Motion stockholder filed a putative class action complaint in the United States District Court for the Southern District of California captioned Water Island Event-Driven Fund v. MaxLinear, Inc., No. 23-cv-01607 (S.D. Cal.), against MaxLinear and certain of its current officers. The complaint included two claims: (1) an alleged violation of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder; and (2) an alleged violation of Section 20(a) of the Exchange Act. On December 20, 2023, the court appointed the lead plaintiffs, who filed the Consolidated Complaint on February 15, 2024. The Consolidated Complaint alleged that the defendants made false and misleading statements and/or omitted material facts that MaxLinear had a duty to disclose, concerning the Company’s intention to close the merger with Silicon Motion. On August 28, 2024, the court granted the defendants a motion to dismiss holding that the plaintiffs lacked standing to sue MaxLinear and its officers. The case was dismissed without prejudice.
On September 18, 2024, the plaintiffs filed an Amended Consolidated Complaint (the "Amended Complaint"). The Amended Complaint includes the same two claims as alleged in the Consolidated Complaint and makes similar factual allegations against the MaxLinear defendants, but adds Silicon Motion and certain of its officers as additional defendants. The Amended Complaint seeks compensatory damages, including interest, costs and expenses and such other relief that the court deems appropriate. MaxLinear intends to continue to vigorously defend its position.

On June 13, 2024, HBK Master Fund L.P. and HBK Merger Strategies Master Fund L.P., stockholders of Silicon Motion, filed an additional complaint in the United States District Court for the Southern District of California captioned HBK Master Fund L.P. v. MaxLinear, Inc., No. 24-cv-01033 (S.D. Cal.), against MaxLinear and certain of its current officers, which also alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act, and other violations. The complaint alleges that the defendants concealed their intention to terminate the merger with Silicon Motion from Silicon Motion’s shareholders. The complaint seeks compensatory damages, including interest, costs and expenses, punitive damages, and such other equitable or injunctive relief that the court deems appropriate. On July 12, 2024, the defendants filed a motion to dismiss this complaint, which is pending. MaxLinear intends to continue to vigorously defend its position.
56

Comcast Litigation
On December 1, 2023, MaxLinear filed claims against Comcast Management, LLC and Comcast Cable Communications, LLC, or together, Comcast, in the United States District Court for the Southern District of New York. MaxLinear alleges that in 2020, MaxLinear shared its proprietary design and know-how for a full-duplex, or FDX, amplifier with Comcast in the hope of securing future business with Comcast. MaxLinear shared its design and know-how on several occasions, all pursuant to a non-disclosure agreement between MaxLinear and Comcast, with the expectation that Comcast would keep the information confidential. MaxLinear alleges that Comcast needed this technology in order to effectively compete with fiber-optic internet providers. Instead of engaging MaxLinear to develop the FDX amplifier, Comcast allegedly shared MaxLinear’s proprietary designs with MaxLinear’s direct competitor. Comcast allegedly then worked with MaxLinear’s competitor to develop the FDX-amplifier technology. MaxLinear brought claims for trade secret misappropriation, unfair competition, and breach of the parties’ non-disclosure agreement, and it sought an unspecified amount of compensatory damages, punitive damages, pre-judgment and post-judgment interest, costs, expenses, and attorney fees as well as an injunction against Comcast’s use or disclosure of MaxLinear’s trade secrets.

On March 19, 2024, Comcast amended its claims for declaratory judgments, indemnification, and breach of the implied covenant of good faith and fair dealing, and on April 3, 2024, MaxLinear moved to dismiss all claims against it. On September 19, 2024, the court granted the motion to dismiss with respect to certain claims for declaratory judgment claim and denied the motion to dismiss with respect to the remaining claims. On September 23, 2024, Comcast filed amended claims for declaratory judgment, indemnification, and breach of the implied covenant of good faith and fair dealing, and on October 14, 2024, MaxLinear amended and refiled its trade secret and related claims. MaxLinear intends to continue to vigorously defend its position.
Dish Litigation
On February 10, 2023, Entropic Communications, LLC, or Entropic, filed claims for patent infringement against Dish Network Corporation, Dish Network LLC, Dish Network Service, LLC, and Dish Network California Service Corporation in the United States District Court for the Central District of California. At that time, MaxLinear was not a party to the action. On September 21, 2023, Dish Network California Service Corporation, or Dish California, filed four counterclaims against MaxLinear. The four claims are declaratory judgment, breach of contract, fraud and negligent misrepresentation, and civil conspiracy.
On January 31, 2024, the Dish defendants, together with DISH Technologies L.L.C., or collectively, Dish, filed eight counterclaims (amended counterclaims for Dish California) against MaxLinear. The eight counterclaims are (1) breach of contract, (2) fraud and negligent misrepresentation, (3) fraud arising from a civil conspiracy, (4) quasi-contract for restitution/unjust enrichment, (5) combination in restraint of trade, (6) violation of the Cartwright Act (by Dish California only), (7) patent misuse, and (8) violation of Cal. Bus. & Prof. Code § 17200 et seq. Dish’s eight counterclaims revolve around a core allegation that MaxLinear is a member of the Multimedia over Coax Alliance (MoCA) and that MaxLinear violated its obligation under MoCA’s Intellectual Property Rights Policy, or IPR Policy, by acting with Entropic to rid the asserted patents of the RAND encumbrances. Dish seeks an unspecified amount of compensatory damages, disgorgement, attorneys’ fees, experts’ fees, and costs. On February 21, 2024, MaxLinear moved to dismiss the Dish defendants’ counterclaim.
On April 22, 2024, a Special Master issued a report and recommendation, or the R&R, which recommended granting the motion to dismiss with prejudice as to the following counterclaims: (1) quasi-contract for restitution/unjust enrichment, (2) combination in restraint of trade, (3) violation of the Cartwright Act, (4) patent misuse, and (5) violation of Cal. Bus. & Prof. Code § 17200. MaxLinear submitted objections to the R&R as to the remaining claims that were not dismissed. Dish submitted objections to the R&R’s recommended dismissal of the quasi-contract for restitution/unjust enrichment counterclaim. The court has not yet issued any ruling regarding the R&R or MaxLinear’s pending motion to dismiss.
On July 30, 2024, this case was stayed until September 17, 2024. There was a motion to stay this case pending resolution of Inter Partes Review (“IPR”). MaxLinear intends to continue to vigorously defend its position.
Cox Litigations
On February 10, 2023, Entropic sued Cox Communications, Inc., CoxCom, LLC, and Cox Communications California, LLC, or together, Cox, in two separate actions in the United States District Court for the Central District of California. On October 6, 2023, Cox filed counterclaims against MaxLinear in each of the two actions.
In the first action, Cox alleges that when MaxLinear assigned certain patents to Entropic, MaxLinear violated its obligations under MoCA’s IPR Policy by assigning these patents and by allegedly failing to ensure that Cox would be offered a FRAND license for these patents. Cox amended its counterclaims on January 9, 2024 and is asserting claims of breach of
57

contract, unjust enrichment, and declaratory judgment against MaxLinear. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.
On April 22, 2024, a Special Master issued the R&R, which recommended granting the motion to dismiss with prejudice as to the unjust enrichment counterclaim but denying the motion as to the breach of contract and declaratory judgment counterclaims. MaxLinear submitted objections to the R&R’s denial-in-part. Cox submitted objections to the R&R as to the unjust enrichment counterclaim and as to certain findings related to the breach of contract counterclaim. The court has not yet issued any ruling regarding the R&R or MaxLinear’s pending motion to dismiss.
In the second action, in response to Entropic suing Cox for patent infringement, Cox filed counterclaims against MaxLinear. Cox alleges that MaxLinear granted CableLabs a non-exclusive, royalty-free license to all patents essential for compliance with DOCSIS specifications. It further alleges that MaxLinear breached this agreement when MaxLinear assigned certain patents to Entropic. Cox amended its counterclaims on January 9, 2024 and is asserting claims for breach of contract, unjust enrichment, and declaratory judgment. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.
On April 22, 2024, a Special Master issued the R&R, which recommended dismissing all Cox counterclaims with prejudice. Cox submitted objections to the R&R as to the unjust enrichment counterclaim. The court has not yet issued any ruling regarding the R&R or MaxLinear’s pending motion to dismiss.
On July 30, 2024, these cases were stayed until September 17, 2024. There was a motion to stay pending resolution of IPR. MaxLinear intends to continue to vigorously defend its position.
*    *    *
The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. As of September 30, 2024, no material loss contingencies have been accrued for litigation and other legal claims in our consolidated financial statements, since our management currently does not believe that the ultimate outcome of any of the matters described above is probable. An unfavorable outcome of these matters may be reasonably possible in excess of recorded amounts; however, a reasonable estimate of the amount or range of such loss cannot be made at this time.
Other Matters
From time to time, we are subject to threats of litigation or actual litigation in the ordinary course of business as described above, some of which may be material. Results of litigation and claims are inherently unpredictable. Regardless of the outcome, litigation and claims can have an adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors.
58

ITEM 1A.    RISK FACTORS
This Quarterly Report on Form 10-Q, or Form 10-Q, including any information that may be incorporated by reference herein, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, referred to as the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “intend,” “forecast,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue” or the negative of these terms or other comparable terminology. The forward-looking statements contained in this Form 10-Q involve known and unknown risks, uncertainties and situations that may cause our or our industry’s actual results, level of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these statements. These factors include those listed below in this Part II, Item 1A and those discussed elsewhere in this Form 10-Q. We encourage investors to review these factors carefully. We may from time to time make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission or SEC. However, we do not undertake to update any forward-looking statement that may be made from time to time by or on behalf of us, whether as a result of new information, future events, or otherwise, except as required by law.
The following discussion provides information concerning the material risks and uncertainties that we have identified and believe may adversely affect our business, our financial condition and our results of operations. Before you decide whether to invest in our securities, you should carefully consider these risk factors together with all of the other information included in this Quarterly Report on Form 10-Q, and in our other public filings, which could materially affect our business, financial condition or future results. Our risk factors are not guarantees that no such conditions exist as of the date of this report and should not be interpreted as an affirmative statement that such risks or conditions have not materialized, in whole or in part.
For the risks relating to our terminated merger with Silicon Motion, please refer to the section of these risk factors captioned “Risks Relating to the Terminated Merger with Silicon Motion.”
Risk Factor Summary
Risks Relating to the Terminated Merger with Silicon Motion
The termination of the Merger Agreement and the related legal proceedings have caused us to incur substantial costs, may divert management’s attention from our business and could otherwise adversely affect our business, financial results and operations.
If we are required to pay any damages in connection with legal proceedings related to the termination of the Merger Agreement with Silicon Motion, including for any alleged breaches of the Merger Agreement, or if we agree to make any payments in any settlement of legal proceedings related to the termination of the Merger Agreement, the amount of such damages or payments could be significant and require us to draw down on all our existing lines of credit and use our cash resources, which may not be sufficient to satisfy any damages or payments and could have a material adverse effect on our business, operating results, and financial condition. We expect that we may not be able to obtain financing on favorable terms if at all or raise additional capital for any such payments.
Risks Relating to Our Business
We face intense competition and expect competition to increase in the future, which could have a material adverse effect on our revenue, revenue growth rate, if any, and market share.
Global economic conditions, including factors such as high inflation or a potential recession, could continue to adversely affect our business, financial condition, and results of operations.
We are subject to the cyclical nature of the semiconductor industry.
A significant variance in our operating results or rates of growth, if any, could continue to lead to substantial volatility in our stock price. Our revenue has declined, and we may not sustain our current level of revenue, which has declined, and/or manage future growth effectively. The impact of excess inventory in the channel has continued to influence our customers’ expected demand for certain of our products and negatively impact our revenue.
Our business, financial condition and results of operations could continue to be adversely affected by military conflicts, geopolitical and economic tensions among or with countries in which we conduct business, including between the United States and China, Israel (and its conflicts with Iran and Lebanon), and among other countries. For example, as more entities are added to restricted export control lists, or as semiconductor technology exports to other countries are further controlled, our need to seek authorization from the U.S. government may impact our ability to do business and/or the speed with which we can deliver, if at all.
We also are subject to risks associated with international geopolitical and military conflicts.
59

Changes in trade policies among the United States and other countries, in particular the imposition of new or higher tariffs, could place pressure on our average selling prices as our customers seek to offset the impact of increased tariffs on their own products. Increased tariffs or the imposition of other barriers to international trade could decrease demand and have a material adverse effect on our revenues and operating results.
We will lose sales if we are unable to obtain or retain government authorization to export certain of our products or technology or if such authorizations are revoked. In addition, we will be subject to legal and regulatory consequences if we do not comply with applicable export control laws and regulations.
We depend on a limited number of customers for a substantial portion of our revenue, and the loss of, or a significant reduction in orders from major customers has had and could continue to have a material adverse effect on our revenue and operating results.
Any legal proceedings or claims against us or potential violations of applicable regulations could be costly and time-consuming to defend and could harm our reputation regardless of the outcome.
We have been and may in the future be subject to information technology failures, including security breaches, cyber-attacks, design defects or system failures, that could disrupt our operations, damage our reputation and adversely affect our business, operations, and financial results.
Average selling prices of our products have previously decreased and could decrease in the future, which could have a material adverse effect on our revenue and gross margins.
If we fail to penetrate new applications and markets, our revenue, revenue growth rate, if any, and financial condition could be materially and adversely affected.
A significant portion of our revenue is attributable to demand for our products in markets for broadband solutions, and development delays and consolidation trends among cable and satellite Pay-TV and broadband operators could adversely affect our future revenues and operating results.
We may be unable to make the substantial productive research and development investments that are required to remain competitive in our business.
The complexity of our products could result in unforeseen delays or expenses caused by undetected defects or bugs, which could reduce the market acceptance of our new products, damage our reputation with current or prospective customers and adversely affect our operating costs.
Our revenue and operating results are subject to substantial quarterly and annual fluctuations and have fluctuated in the past and may fluctuate significantly due to a number of factors that could adversely affect our business and our stock price.
If we fail to develop and introduce new or enhanced products on a timely basis, our ability to attract and retain customers could be impaired and our competitive position could be harmed.
We are subject to order and shipment uncertainties, and differences between our estimates of customer demand and product mix and our actual results could continue to negatively affect our inventory levels, sales and operating results.
We may have difficulty accurately predicting our future revenue and appropriately budgeting our expenses particularly as we seek to enter new markets where we may not have prior experience.
Our customers require our products and our third-party contractors to undergo a lengthy and expensive qualification process which does not assure product sales.
We incur significant expenditures to win business and customer product plan cancellations may adversely affect our results of operations.
A failure to maintain compliance with governmental regulations could have a material adverse effect on our business.
If we are unable to attract, train and retain qualified personnel and senior management, our business, financial condition, results of operations and prospects could suffer.
We are subject to a variable amount of interest on the principal balance of our credit agreements and could continue to be adversely impacted by high interest rates in the future. Such indebtedness adversely affects our operating results and cash-flows, as we satisfy our underlying interest and principal payment obligations and contains financial and operational covenants that could adversely affect our operational freedom or ability to pursue strategic transactions that we would otherwise consider to be in the best interests of stockholders, including obtaining additional indebtedness to finance such transactions. In addition, high interest rates may make it more difficult for us, our customers, and our distributors to obtain financing and service our respective interest and debt obligations, which in turn has an impact on customer demand for our products and our distributors’ business.
We are subject to governmental laws, regulations and other legal obligations related to privacy, data protection, and cybersecurity. Our inability to comply with such obligations may negatively impact our business.
Our products must conform to industry standards in order to be accepted by end users in our markets.
We may, from time to time, make additional business acquisitions or investments, which involve significant risks.
60

Risks Relating to Intellectual Property
We have settled in the past intellectual property litigation and may in the future face additional claims of intellectual property infringement, including indemnification claims based on intellectual property allegations. Any current or future litigation could be time-consuming, costly to prosecute, defend or settle and result in damages and/or the loss of significant rights.
If we are unable to protect our intellectual property, our business could be adversely affected.
We face risks related to security vulnerabilities in our products.
The use of open source software in our products, processes and technology may expose us to additional risks and harm our intellectual property.
Risks Relating to Reliance on Third Parties
A lack of long-term supply contracts, and any supply disruption could have a material adverse effect on our business.
Failure to manage our relationships with our third-party contractors successfully, or impacts from volatility in global supply, natural disasters, public health crises, or other labor stoppages in the regions where such contractors operate, could adversely affect our ability to market and sell our products.
Should any of our distributors cease or be forced to stop distributing our products, our business would suffer.
Any failure of third parties to provide services and technology could have a material adverse effect on our business.
Risks Relating to Our Common Stock
Our share price may be volatile as a result of various factors.
Our management team may use our available cash and cash equivalents in ways with which you may not agree or in ways which may not yield a return.
Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.
Risks Relating to our Terminated Merger with Silicon Motion

The termination of the Merger Agreement and the related legal proceedings have caused us to incur substantial costs, may divert management’s attention from our business and could otherwise adversely affect our business, financial results and operations.
We terminated the Merger Agreement on July 26, 2023 and notified Silicon Motion that we are relieved of our obligation to close the merger. Silicon Motion has challenged the validity of that termination. On August 16, 2023, Silicon Motion delivered to us a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration before the Singapore International Arbitration Centre to seek damages from us arising from our alleged breaches of the Merger Agreement. On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that we breached the Merger Agreement. Additionally, on August 31, 2023, a Silicon Motion stockholder filed a class action complaint against us and certain of our current officers alleging that we materially misrepresented the likelihood the merger would close, and a similar individual action was filed by a different Silicon Motion stockholder on June 13, 2024. Other potential plaintiffs may file additional lawsuits related to the previously contemplated merger. See Part II, Item 1 (Legal Proceedings) of this report for more information on the Silicon Motion arbitration and the class action lawsuit. We intend to vigorously defend against these legal proceedings and any alleged breaches of the Merger Agreement, but due to the uncertainties inherent in any legal proceedings, we cannot predict the outcome of any legal proceedings. Legal proceedings are time-consuming, and may divert management’s attention from our business. Legal proceedings are also expensive and could result in substantial costs to us, including any damages we are required to pay and costs associated with the indemnification of directors and officers. Please refer to the Risk Factor entitled “If we are required to pay any damages in connection with legal proceedings related to the termination of the Merger Agreement with Silicon Motion, including for any alleged breaches of the Merger Agreement, or if we agree to make any payments in any settlement of legal proceedings related to the termination of the Merger Agreement, the amount of such damages or payments could be significant and require us to draw down on all our existing lines of credit and use our cash resources, which may not be sufficient to satisfy any damages or payments and could have a material adverse effect on our business, operating results, and financial condition. We expect that we may not be able to obtain financing on favorable terms if at all or raise additional capital for any such payments. Even if we are able to finance such payments through the incurrence of additional indebtedness, any material increase in our indebtedness would adversely affect our operating results and cash-
61

flows as we satisfy our underlying interest and principal payment obligations. Issuing additional shares of our common stock, if material, will result in dilution of existing shares outstanding. Any loan agreement is also expected to contain financial and operational covenants that would adversely affect our operational freedom or ability to pursue strategic transactions that we would otherwise consider to be in the best interests of stockholders, including obtaining additional indebtedness to finance such transactions.
We have already incurred, and expect to continue to incur, substantial costs in connection with the previously pending merger, the termination of the Merger Agreement, and the related legal proceedings. Aside from any damages or settlement amounts we may be required to pay, these costs are primarily associated with the fees of our financial advisors, accountants, lenders, and legal counsel. Since the merger has been terminated, we will have received little or no benefit in respect of such costs incurred. We may also experience negative reactions from the financial markets and our suppliers, customers, customer prospects, and employees with regard to legal proceedings related to the termination of the Merger Agreement. Any of these factors could have a material adverse effect on our business, operating results, and financial condition or on the trading price of our common stock.
If we are required to pay any damages in connection with legal proceedings related to the termination of the Merger Agreement with Silicon Motion, including for any alleged breaches of the Merger Agreement, or if we agree to make any payments in any settlement of legal proceedings related to the termination of the Merger Agreement, the amount of such damages or payments could be significant and require us to draw down on all our existing lines of credit and use our cash resources, which may not be sufficient to satisfy any damages or payments and could have a material adverse effect on our business, operating results, and financial condition. We expect that we may not be able to obtain financing on favorable terms if at all or raise additional capital for any such payments. Even if we are able to finance such payments through the incurrence of additional indebtedness, any material increase in our indebtedness would adversely affect our operating results and cash-flows as we satisfy our underlying interest and principal payment obligations. Issuing additional shares of our common stock, if material, will result in dilution of existing shares outstanding. Any loan agreement is also expected to contain financial and operational covenants that would adversely affect our operational freedom or ability to pursue strategic transactions that we would otherwise consider to be in the best interests of stockholders, including obtaining additional indebtedness to finance such transactions.
If we are required to pay any damages in connection with legal proceedings related to the termination of the Merger Agreement, including for any alleged breaches of the Merger Agreement, or if we agree to make any payments in any settlement of legal proceedings related to the termination of the Merger Agreement, the amount of such damages or payments could be significant and require us to draw down on all our existing lines of credit and use our cash resources, which may not be sufficient to satisfy any damages or payments and could have a material adverse effect on our business, operating results, and financial condition. We expect that we may not be able to obtain financing on favorable terms if at all or raise additional capital for any such payments. However, if we finance all or a portion of the payment of damages or settlement amounts through the incurrence of additional indebtedness, any material payment and increase in our indebtedness would adversely affect our ability to use cash generated from operations as we repay interest and principal under the term loans and revolving credit facility, as applicable. Issuing additional shares of common stock, if material, would result in dilution of existing shares outstanding. In addition, our current credit agreement, and any new loan agreements, contain and would likely contain financial and operational covenants that may adversely affect our ability to engage in certain activities, including certain financing and acquisition transactions, any future stock repurchases, guarantees, and similar transactions, without obtaining the consent of the lenders, which may or may not be forthcoming. Such financial and operational covenants include compliance with a secured net leverage ratio test. Accordingly, outstanding indebtedness could adversely affect our operational freedom or ability to pursue strategic transactions that we would otherwise consider to be in the best interests of stockholders.
Specifically, if we are required to pay damages in connection with legal proceedings related to the termination of the Merger Agreement, including for alleged breaches of the Merger Agreement, or if we agree to make any payments in any settlement of legal proceedings related to the termination of the Merger Agreement, and we finance all or a portion of the payment of damages through the incurrence of additional indebtedness, any materially increased indebtedness could have important consequences to investors in our common stock, including the following:
our ability to obtain any necessary financing in the future for working capital, capital expenditures, debt service requirements, or other purposes may be limited or financing may be unavailable;
high interest rates may make it more difficult for us, our customers, and our distributors to obtain financing and service our respective interest and debt obligations, which in turn has an impact on customer demand for our products as well as the business of our distributors;
62

we could be subject to substantial variable interest rate risk because our interest rate under term loans typically varies based on a fixed margin over an indexed rate (such as for the Initial Term Loan under the June 23, 2021 Credit Agreement) or an adjusted base rate. If interest rates were to continue to increase substantially, and we incur additional indebtedness, it would adversely affect our operating results and could affect our ability to service the indebtedness;
a portion of our cash flows is dedicated to the payment of interest and when applicable, principal, on our indebtedness and other obligations and will not be available for use in our business;
our level of indebtedness, combined with high interest rates, could limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we operate, including limiting our future investments or ability to enter into acquisitions and strategic partnerships, and obtain financing for such transactions; and
our high degree of indebtedness may make us more vulnerable to changes in general economic conditions and/or a downturn in our business, thereby making it more difficult for us to satisfy our obligations.
If we fail to make required debt payments, or if we fail to comply with other covenants in our debt service agreements, we would be in default under the terms of these agreements. Subject to customary cure rights, any default would permit the holders of the indebtedness to accelerate repayment of this debt and could cause defaults under other indebtedness that we have, any of which could have a material adverse effect on the trading price of our common stock.
Risks Related to Our Business
We face intense competition and expect competition to increase in the future, which could have a material adverse effect on our revenue, revenue growth rate, if any, and market share.
The global semiconductor market in general, and the broadband, wired and wireless infrastructure, and broader industrial and communications analog and mixed-signal markets in particular, are highly competitive. We compete in different target markets to various degrees on the basis of a number of principal competitive factors, including our products’ performance, features and functionality, energy efficiency, size, ease of system design, customer support, product roadmap, reputation, reliability and price. We expect competition to increase and intensify as a result of industry consolidation and the resulting creation of larger semiconductor companies. Large semiconductor companies resulting from industry consolidation could enjoy substantial market power, which they could exert through, among other things, aggressive pricing that could adversely affect our customer relationships, revenues, margins and profitability. In addition, we expect the internal resources of large, integrated OEMs may continue to enter our markets. Increased competition has resulted in price pressure, decreased demand, reduced revenue and profitability, and loss of market share, any of which could in the future materially and adversely affect our business, revenue, revenue growth rates, if any, and operating results.
As our products are integrated into a variety of communications and industrial platforms, our competitors range from large, international merchant semiconductor companies offering a wide range of semiconductor products to smaller companies specializing in narrow markets, to internal or vertically integrated engineering groups within certain of our customers. Our primary merchant semiconductor competitors include Broadcom Inc., Qualcomm Incorporated, Realtek Semiconductor Corp., Skyworks Solutions, Inc., Credo Semiconductor Inc., MediaTek, Inc., Marvell Technology Group Ltd., MACOM Technology Solutions Holdings, Inc., Texas Instruments Incorporated, Analog Devices, Inc., Renesas Electronics Corporation, Microchip Technology Inc. and Semtech Corporation. It is quite likely that competition in the markets in which we participate will increase in the future as existing competitors improve or expand their product offerings. In addition, other companies are in the process of developing competing products for our current and target markets. Because our products often are building block semiconductors which provide functions that in some cases can be integrated into more complex integrated circuits, we also face competition from manufacturers of integrated circuits, some of which may be existing customers or platform partners that develop their own integrated circuit products. If we cannot offer an attractive solution for applications where our competitors offer more fully integrated products, we may lose significant market share to our competitors. Some of our targeted customers for our optical interconnect solutions are module makers who are vertically integrated, where we compete with internally supplied components, and we compete with much larger analog and mixed-signal catalog competitors in the multi-market high-performance analog markets.
Our ability to compete successfully depends on factors both within and outside of our control, including industry and general economic trends. During past periods of downturns in our industry, competition in the markets in which we operate intensified as manufacturers of semiconductors reduced prices in order to combat production overcapacity and high inventory levels. Many of our competitors have substantially greater financial and other resources with which to withstand similar adverse economic or market conditions in the future. Moreover, the competitive landscape is changing as a result of intense
63

consolidation within our industry as some of our competitors have merged with or been acquired by other competitors, and other competitors have begun to collaborate with each other, which could result in significant changes to the competitive landscape. In addition, changes in government trade policies, including the imposition of tariffs and export restrictions, as well as actions by government agencies, could limit our ability to sell our products to certain customers and adversely affect our ability to compete successfully. These developments may materially and adversely affect our current and future target markets and our ability to compete successfully in those markets. See the risk factors “We also are subject to risks associated with international geopolitical and military conflicts” and “We will lose sales if we are unable to obtain or retain government authorization to export certain of our products or technology or if such authorizations are revoked. In addition, we will be subject to legal and regulatory consequences if we do not comply with applicable export control laws and regulations” below.
Global economic conditions, including factors such as high inflation or a potential recession, could continue to adversely affect our business, financial condition, and results of operations.
Inflation and uncertainty in customer demand and the worldwide economy has continued, and we have experienced and could continue to experience volatility in our sales and revenues in the future. Inventory oversupply could potentially lead to more inventory write-downs, including charges for any excess or obsolete inventory which could negatively impact our gross margins. Our products are incorporated in numerous consumer devices, and demand for such products is ultimately driven by consumer demand for products such as televisions, personal computers, automobiles, and cable modems. Many of these purchases are discretionary. Global economic volatility and economic volatility in the specific markets in which the devices that incorporate our products are ultimately sold, including the impacts of current high rates of inflation and a potential recession, can cause extreme difficulties for our customers and third-party vendors in accurately forecasting and planning future business activities. If banks and financial institutions with whom we have banking relationships enter receivership or become insolvent in the future, we may be unable to access, and we may lose, some or all of our existing cash, cash equivalents and investments to the extent those funds are not insured or otherwise protected by the FDIC. This unpredictability has and could continue to cause our customers to delay or reduce their capital expenditures and spending on our products, which delays and lengthens sales cycles and negatively affects the overall demand for our products. Worsening economic instability could continue to result in a cancellation of such orders or otherwise adversely affect spending for information technology and limit our ability to forecast future demand for our products, which could reduce expected revenues or result in a write-down of any excess or obsolete inventory. Furthermore, during inflationary economic times, our customers may face challenges in gaining timely access to sufficient credit, which could impact their ability to make timely payments to us. These events, together with economic volatility that may face the broader economy and, in particular, the semiconductor and communications industries, may adversely affect, our business, particularly to the extent that consumers decrease their discretionary spending for devices deploying our products. However, the magnitude of such volatility on our business and its duration is uncertain and cannot be reasonably estimated at this time.
Other areas of our business which could be disrupted or subject to negative impacts of negative global economic conditions may include, but may not be limited to, the following:
Reduced ability to accurately predict our future revenue and budget future expenses;
Inefficiencies, delays and additional costs in design win, product development, production and fulfillment;
Accounts receivable collection issues should any of our limited and significant customers experience liquidity concerns;
Material impacts to the value of our common stock, which may result in impairment of our goodwill;
Material impairment of our assets, if recoverability thereof becomes a concern; and
Decreased availability of capital or access thereto in the United States and from other jurisdictions in which we operate.
We are subject to the cyclical nature of the semiconductor industry.
The semiconductor industry is highly cyclical and is characterized by constant and rapid technological change, rapid product obsolescence and price erosion, evolving standards, short product life cycles and wide fluctuations in product supply and demand. The current downturn, which was aggravated by certain factors such as high interest rates and excess channel inventory, has resulted in, or any future downturns may result in, diminished product demand, production overcapacity, high inventory levels and accelerated erosion of our average selling prices. Furthermore, any future upturn in the semiconductor
64

industry could result in increased competition for access to third-party foundry and assembly capacity. We are dependent on the availability of this capacity to manufacture and assemble all of our products. None of our third-party foundry or assembly contractors has provided assurances that adequate capacity will be available to us in the future. A significant downturn or upturn could have a material adverse effect on our business and operating results.
A significant variance in our operating results or rates of growth, if any, could continue to lead to substantial volatility in our stock price. Our revenue has declined, and we may not sustain our current level of revenue, which has declined, and/or manage future growth effectively. The impact of excess inventory in the channel has continued to influence our customers’ expected demand for certain of our products and negatively impact our revenue.
Our net revenue decreased from $567.9 million in the nine months ended September 30, 2023, to $268.4 million in the nine months ended September 30, 2024, and the decline in net revenue could continue in future periods. Among other factors, the decrease is as a result of macroeconomic conditions impacting customer demand; for example, the broadband market which has experienced slower than expected recovery. Prior to 2023, our net revenues grew to $1.1 billion for the year ended December 31, 2022. We currently expect that revenue will fluctuate in the future, from period-to-period, consistent with the cyclical nature of our industry, and we could experience further decline in revenue in the future due to current macroeconomic conditions impacting customer demand for various products. Further, the impact of excess inventory in the channel has continued to influence our customers’ expected demand for some of our products and negatively affected our revenue.
In addition, in July 2024, we initiated the 2024 Workforce Reduction and in the first half of 2024, we completed notifications to remaining affected employees regarding the 2023 Workforce Reductions. We may not realize, in full or in part, the anticipated benefits, savings and improvements from the reductions of our workforce if our revenue continues to decline. If we are unable to realize the expected operational efficiencies and cost savings from reductions of our workforce, our operating results and financial condition would be adversely affected.
You should not rely on our operating results for any prior quarterly or annual periods as an indication of our future operating performance. Please refer to the Risk Factor entitled “Our revenue and operating results are subject to substantial quarterly and annual fluctuations and have fluctuated in the past and may fluctuate significantly due to a number of factors that could adversely affect our business and our stock price” for a discussion of factors contributing to variances in our operating results or rates of growth, if any. If we are unable to resume adequate revenue growth and manage our operating expenses, our financial results could suffer and our stock price could decline.
To manage any future growth successfully, we believe we must effectively, among other things:
successfully develop new products and penetrate new applications and markets;
recruit, hire, train and manage additional qualified engineers for our research and development activities, especially in the positions of design engineering, product and test engineering and applications engineering;
implement and improve our administrative, financial and operational systems, procedures and controls; and
enhance our information technology support for enterprise resource planning and design engineering by adapting and expanding our systems and tool capabilities, and properly training new hires as to their use.
If we are unable to resume and manage our growth effectively, we may not be able to take advantage of market opportunities or develop new products and we may fail to satisfy customer requirements, maintain product quality, execute our business plan, or respond to competitive pressures.
Our business, financial condition and results of operations could continue to be adversely affected by military conflicts, geopolitical and economic tensions among or with countries in which we conduct business, including between the United States and China, Israel (and its conflicts with Iran and Lebanon), and among other countries. For example, as more entities are added to restricted export control lists, or as semiconductor technology exports to other countries are further controlled, our need to seek authorization from the U.S. government may impact our ability to do business.
We sell our products throughout the world. Products shipped to Asia accounted for 72% of our net revenue in the nine months ended September 30, 2024. In addition, as of September 30, 2024, approximately 77% of our employees are located outside of the United States. The majority of our products are manufactured, assembled and tested in Asia, and our major distributors are located in Asia. Multiple factors relating to our international operations and to particular countries in which we
65

operate could have a material adverse effect on our business, financial condition and results of operations. These factors include:
changes in political, regulatory, legal or economic conditions, including as a result of the upcoming U.S. presidential election;
geopolitical conflicts and tensions, especially between the United States and China, that could destabilize trading relationships and economic activity;
restrictive governmental actions, such as restrictions on the transfer or repatriation of funds and foreign investments and trade protection measures, including export controls and restrictions, duties and quotas and customs duties and tariffs;
disruptions of capital and trading markets;
changes in import and/or export control restrictions and regulations by governments, such as changes to licensing requirements or other anti-diversion enforcement measures, as a result of ongoing armed conflict and geopolitical tensions among the United States, China, Russia, Ukraine, Iran, Israel, Lebanon, and other countries or due to a change in administration from the upcoming U.S. presidential election;
transportation delays;
civil disturbances or political instability;
other unpredictable geopolitical turmoil, including terrorism, war or political or military coups, including the current conflict in Israel and continued escalation of Israel’s conflicts with Iran and Lebanon;
differing employment practices and labor standards;
limitations on our ability under local laws to protect our intellectual property;
local business and cultural factors that differ from our customary standards and practices;
nationalization and expropriation;
changes in tax laws;
public health emergencies, such as another outbreak of COVID-19 or other communicable disease;
currency fluctuations relating to our international operating activities; and
difficulty in obtaining distribution and support.
In addition to a significant portion of our wafer supply coming from Taiwan, Singapore, China and South Korea, substantially all of our products undergo packaging and final testing in Taiwan, Singapore, China, South Korea, Malaysia, and Thailand. Any conflict or uncertainty in these countries, including due to geopolitical conditions, natural disasters, public health or safety concerns, could have a material adverse effect on our business, financial condition and results of operations. In addition, if the government of any country in which our products are manufactured or sold sets technical standards for products manufactured in or imported into their country that are not widely shared, it may lead some of our customers to suspend imports of their products into that country, require manufacturers in that country to manufacture products with different technical standards and disrupt cross-border manufacturing relationships which, in each case, could have a material adverse effect on our business, financial condition and results of operations.
We also are subject to risks associated with international geopolitical and military conflicts.
Our business has been impacted and may continue to be impacted by geopolitical conditions such as international trade wars (including between the United States and China), the military conflict in Israel, including the escalation in its conflicts with Iran and Lebanon, the Russia-Ukraine conflict, and increased political tensions in Russia, Europe, the Middle East and Asia. Currently, significant uncertainty surrounds the future trade relationships among the United States, China, and Russia. The U.S. government continues to make significant changes in U.S. trade policies that could negatively affect our business, and there may be further changes in U.S. trade policy if there is a change in administration as a result of the upcoming U.S.
66

presidential election. Additionally, policies made by other countries, such as China and Russia or their allies, could also negatively impact our business. In a number of cases, compliance with these policies has required us to take actions adverse to our business.
Beginning in May 2019, we ceased normal business operations with entities affiliated with Huawei Technologies Co., Ltd., and certain other entities following an amendment to the EAR which added these entities to the Entity List for acting contrary to the national security or foreign policy of the United States. We obtained export licenses for certain transactions with these entities. As noted above, such export licenses can be revoked or BIS could choose not to renew such licenses and we have been required by BIS to pause, delay or halt licensed activities under such licenses at certain times and could continue to do so in the future, which negatively impacts our revenue. Also, as described in more detail in the risk factor, “We will lose sales if we are unable to obtain or retain government authorization to export certain of our products or technology related to the development or production of our products or if such authorizations are revoked, and we will be subject to legal and regulatory consequences if we do not comply with applicable export control laws and regulations”, Semiconductor Manufacturing International Corporation, or SMIC, was added to the BIS Entity list in December 2020.
In September 2020, we further restricted business operations with additional entities affiliated with Huawei when the BIS again amended the EAR to add such entities to the Entity List.
Since October 2022, the United States government has taken steps to restrict the export of certain advanced semiconductor products and technology to the People’s Republic of China and/or certain companies located in China due to national security and human rights concerns. In October 2022, BIS announced additional restrictions on products and/or technology destined for use in the People’s Republic of China, including additional export controls and/or requirements on (1) certain advanced computing integrated circuits, computer commodities that contain such integrated circuits and certain semiconductor manufacturing items; (2) products and/or technologies that may be destined for facilities capable of producing certain advanced node integrated circuits; and (3) transactions involving items for supercomputer and semiconductor manufacturing end uses. In October 2023, BIS announced additional restrictions on the export of certain advanced semiconductors and semiconductor manufacturing technology to China, primarily focused on integrated circuits with military, data center, or artificial intelligence applications. Pursuant to those October 2023 export control amendments, various categories of integrated circuits are now subject to export licensing and export control restrictions for export or reexport to China and certain other countries. We have confirmed that some of our products are subject to these new controls. BIS also announced restrictions on exports to (1) companies headquartered in China or whose ultimate parent company is headquartered in China or Macau, and (2) end users in certain countries of concern, in order to prevent diversion of controlled products or technology to China. The United States government has also continued to add Chinese entities to the Entity List. We regularly monitor changes to applicable export control regulations to assess the impact to our business, if any. To date, none of our material customers located in China has been added to the Entity List or other restricted party list.
The BIS continues to add many new entities to the Entity List and Unverified List. As noted above and in the risk factor,
Changes in trade policies among the United States and other countries, in particular the imposition of new or higher tariffs
could place pressure on our average selling prices as our customers seek to offset the impact of increased tariffs on their own
products. Increased tariffs or the imposition of other barriers to international trade could decrease demand and have a
material adverse effect on our revenues and operating results” below, our ability to manufacture, sell or distribute products or technology will be limited if BIS further amends the EAR to add restrictions against parties who are or may be our customers.
We are required to obtain special licenses to conduct business with entities on the Entity List and to conduct additional diligence and recordkeeping, including obtaining user statements from entities on the Unverified List. Failure to obtain any required license would likely result in a loss of business and a corresponding negative impact on our financial position and results of operations.
We cannot predict what actions may ultimately be taken with respect to trade relations between the United States and China or other countries, which products may be subject to such actions or what actions may be taken by other countries in retaliation. In addition, there may be further changes in U.S. trade policy if there is a change in administration as a result of the upcoming U.S. presidential election. In response to the United States tightening export controls on China, China has instituted restrictions of its own that affect U.S. companies and may impact us and related entities. We have experienced weakening demand in China, and such future developments related to U.S.-China relations may also have an impact on our supply chain. Additionally, the geopolitical developments in relations between Taiwan and China could affect the supply of our products from Taiwan, including from Taiwan Semiconductor Manufacturing Company, Limited, or TSMC. Such developments could
67

include restriction on the export of products from Taiwan to China and/or restriction on the import of Taiwanese-origin products into China.
We believe direct impacts of the U.S. and European economic sanctions against Russia and the military conflict in Ukraine are currently limited to volatility in the prices of metals used by our outsourced semiconductor assembly and test, or OSAT, supply chain, in particular around the supply of palladium, for which Russia is the top producer in the world, as well as increased fuel costs, which has global impact on transportation costs, including the shipping and delivery of our products. However, the magnitude of such price volatility on our business and its duration is uncertain and cannot be reasonably estimated at this time. We currently do not sell product in Russia, or sell product to distributors for resale in Russia.
The ongoing military conflict in Israel, and the recent escalation in Israel’s conflicts with Iran and Lebanon, have resulted in our employees located in Israel having to perform military service and/or being negatively impacted by violence or political instability, which could interrupt business and increase costs associated with relocating employees, engaging with alternative third-party contractors or hiring additional employees outside of Israel. The United States has also imposed additional sanctions on Iran in response to attacks on Israel by Iran. As the conflict and its escalation continues, we cannot provide assurances that our business will not be impacted in the future.
We cannot provide assurances that we will not face disruptions of distribution arrangements in the future, including through the imposition of governmental prohibitions on selling our products to particular customers, further sanctions on Russia or other countries, and/or increases in costs of certain raw materials and transportation that will also adversely affect our revenues and operating results. Loss of a key distributor or customer under similar circumstances could have a material adverse effect on our business, revenues and operating results.
Changes in trade policies among the United States and other countries, in particular the imposition of new or higher tariffs, could place pressure on our average selling prices as our customers seek to offset the impact of increased tariffs on their own products. Increased tariffs or the imposition of other barriers to international trade could decrease demand and have a material adverse effect on our revenues and operating results.
The United States has imposed or proposed new or higher tariffs on certain products exported by a number of U.S. trading partners, including China, Europe, Canada, and Mexico. In response, many of those trading partners, including China, have imposed or proposed new or higher tariffs on American products. We have experienced weakening demand in China, and continuing changes in government trade policies (including as a result of any change in administration due to the upcoming U.S. presidential election) create a heightened risk of further increased tariffs that impose barriers to international trade and could further decrease international demand. Our business and operating results are substantially dependent on international trade. Many of our manufacturers sell products incorporating our integrated circuits into international markets.
Tariffs on our customers’ products may adversely affect our gross profit margins in the future due to the potential for increased pressure on our selling prices by customers seeking to offset the impact of tariffs on their own products. In addition, tariffs could make our OEM and ODM customers’ products less attractive relative to products offered by their competitors, which may not be subject to similar tariffs. Some OEM and ODMs in our industry have already implemented short-term price adjustments to offset such tariffs and transitioned their production and supply chain to locations outside of China. We believe that increases in tariffs on imported goods or the failure to resolve current international trade disputes could further decrease demand and have a material adverse effect on our business and operating results.
Furthermore, compliance with export controls and implementation of additional tariffs may increase compliance costs and further affect our business and operating results.
We will lose sales if we are unable to obtain or retain government authorization to export certain of our products or technology related to the development or production of our products or if such authorizations are revoked, and we will be subject to legal and regulatory consequences if we do not comply with applicable export control laws and regulations.
Certain of our products and technologies are subject to export and/or import controls imposed by countries in which we do business, including the United States Export Administration Regulations, or EAR, administered by BIS. Certain of our products and technologies are subject to the EAR, which may require a license authorization from BIS prior to the shipment or sharing of certain products and technologies with certain end users or destinations. Such approval may be delayed, denied, or even revoked after initially being granted by BIS, depending on one or more factors including the type of product or technology at issue, the intended end use, the identity of the end user, the identity of other companies involved in the production process, and whether a license exception might apply, among others. We are subject to similar export controls regulations in other jurisdictions where we operate, including the European Union, Singapore, and Taiwan, among others.
68

Export control laws, regulations, and orders are complex, change frequently and with limited or no notice, have generally become more stringent over time and have intensified as U.S.-China geopolitical tensions worsen. Since October 2022, the United States has announced export control restrictions on a number of entities based in China due to national security and human rights concerns and additional more severe restrictions may be possible. The addition of new entities to restricted party lists can further increase the scope of export restrictions applicable to our business. The United States has also announced measures intended to further restrict the export of certain advanced semiconductor products and technology, as well as products that incorporate those advanced semiconductor products, to the People’s Republic of China, or China, and/or certain companies located in China due to national security and human rights concerns, including the imposition of new license requirements for certain semiconductor technologies. Failure to obtain required export licenses for our products or the placement of one or more of our customers on any restricted parties lists could significantly reduce our revenue and harm our business.
Obtaining export licenses can be difficult, costly and time-consuming and we may not always be successful in obtaining necessary export licenses due to reasons beyond our control. Our inability to obtain required import or export approval for our products may adversely affect our business, and other limitations imposed on our ability to export or sell our products may also harm our international and domestic revenue. In addition, it is possible that BIS can revoke licenses that have been granted or decline to re-issue such licenses upon their expiration or in the event modifications are required to a previously-issued license. Although our policies, procedures, and controls are designed to detect and prevent potential violations and maintain ongoing compliance with applicable export controls laws, we cannot assure you that we have been or will be at all times in complete compliance with such laws and regulations. For example, our products could be diverted to bad actors by third parties. In addition, if our customers or business partners fail to comply with applicable regulations and laws or to timely notify us of material changes to the licenses, we may be subject to liability and may be required to suspend sales or take other action which could damage our reputation and negatively impact our results of operations. If we violate or fail to comply with any of these requirements, a range of consequences could result, including fines, import/export restrictions, sales limitations, criminal and civil liabilities or other sanctions. The absence of comparable restrictions imposed on competitors based in other countries may adversely affect our competitive position.
To the extent that we do business with parties on the Entity List under approved export licenses, our business could be affected if the government delays, denies, or otherwise does not grant, amend, or renew required licenses. We currently have licenses from BIS that permit certain of our transactions with two restricted parties, but those licenses may be revoked at any time or denied for renewal when the license expires. One of our third-party foundry partners, Semiconductor Manufacturing International Corporation, or SMIC, was added to the BIS Entity list in December 2020. As a result of that Entity List listing, we have been required to obtain export licenses from BIS for the export or reexport to SMIC of any technology for the development or production (fabrication) of our products. Although we have obtained export licenses in order to have SMIC manufacture certain products for us, those export licenses could be revoked at any time. Revocation of any of those export licenses could significantly disrupt our ability to obtain the products in question and fulfill customer requirements. Moreover, the issuance of export licenses for other technology transfers to SMIC is a matter of discretion with the U.S. government, and it is uncertain whether we will be able to obtain export licenses, in a timely manner, for the transfer of technology required by SMIC to produce semiconductor wafers for us. If we are unable to obtain those export licenses, it may be necessary to have the products fabricated by other semiconductor foundries, which may be more costly alternatives to SMIC, and which may have limited capacity to fabricate sufficient products to meet our requirements.
Additionally, current and future business with parties subject to significant export restrictions, including those named on the Entity List may be limited in scope or suspended entirely in order to comply with the EAR or other applicable laws or regulations and, as a result, our revenue could be adversely impacted until a license is granted or renewed. It is possible that the U.S. government may not grant licenses or renew licenses to transact business with entities on the Entity List.
In September 2022, we self-identified a potential violation of the EAR related to certain transactions with one of our foundry partners in China on the Entity List in which limited technology was furnished to our Specific Foundry Partner without authorization under the EAR. Upon discovery, we took immediate action to remediate, including by implementing additional measures to prevent recurrence. Our Audit Committee engaged outside counsel to conduct a privileged investigation. On March 3, 2023, we submitted a comprehensive voluntary self-disclosure to BIS regarding the potential EAR violation described above and other potential export control violations. On June 8, 2023, BIS closed out its review of our voluntary self-disclosure without monetary or other penalties and with the issuance of a “warning letter.”
69

We depend on a limited number of customers for a substantial portion of our revenue, and the loss of, or a significant reduction in orders from, one or more of our major customers has had and could continue to have a material adverse effect on our revenue and operating results.
Our customers include electronics distributors, module makers, OEMs and ODMs, which incorporate our products in a wide range of electronic devices. Revenue is also generated from sales of intellectual property and consideration under intellectual property agreements. The recipients of such intellectual property are also referred to as the Company’s customers. In the nine months ended September 30, 2024, one customer accounted for 13% of our net revenue, and our ten largest customers collectively accounted for 64% of our net revenue, of which distributor customers accounted for 15% of our net revenue. In the nine months ended September 30, 2024, we have continued to experience a decrease in customer demand, and consequently a reduction in orders, primarily due to macroeconomic factors, including slower than expected recovery in sales, and excess inventory in the channel following the industry-wide supply shortage in 2021 and 2022. We expect that our operating results for the foreseeable future will continue to show a substantial percentage of sales dependent on a relatively small number of customers. In the future, these customers may decide, as they have at times before, not to purchase our products at all, may purchase fewer products than they did in the past, or may defer or cancel purchases or otherwise alter their purchasing patterns. While we are entitled to consideration under intellectual property sales agreements, which consideration has been and could be material, we may not receive such consideration in the future. Factors that could affect our revenue from these large customers include the following:
macroeconomic and business factors influencing such customers’ demand for our products, including excess inventory in the channel;
substantially all of our sales to date have been made on a purchase order basis, and we do not have long-term product purchase commitments with our customers;
some of our customers have sought or are seeking relationships with current or potential competitors which may affect their purchasing decisions;
service provider and OEM consolidation across cable, satellite, and fiber markets could result in significant changes to our customers’ technology development and deployment priorities and roadmaps, which could affect our ability to forecast demand accurately and could lead to increased volatility in our business;
technological changes in our markets could lead to substantial volatility in our revenues based on product transitions, and particularly in our broadband markets, we face risks based on changes in the way consumers are accessing and using broadband and cable services, which would affect operator demand for our products; and
any decrease in revenue generated by the recipient of intellectual property under certain intellectual property sale agreements, including due to any inability to enforce our intellectual property rights as described in the section “Risks Relating to Intellectual Property” under the risk factor “We utilize a significant amount of intellectual property in our business. If we are unable to protect our intellectual property, our business could be adversely affected.”
In addition, delays in development could impair our relationships with our strategic customers and negatively impact sales of the products under development. Moreover, it is possible that our customers may develop their own products or adopt a competitor’s solution for products that they currently buy from us. When this occurs, our sales could decline and/or our market share could be reduced.
Our relationship with customers has been and could continue to be impaired by our sale of patents. For example, our customers are and could be subject to patent infringement based on patents we divested to the extent that our customers also source components from our competitors, such as those referenced in Part II, Item 1 (Legal Proceedings) of this report.
Our relationships with some customers may deter other potential customers who compete with these customers from buying our products. To attract new customers or retain existing customers, we sometimes offer customers favorable prices on our products which results in a decline in our average selling prices and, if material, a decline in our gross margins. The loss of a key customer, a reduction in sales to any key customer or our inability to attract new significant customers could seriously impact our revenue and materially and adversely affect our results of operations.
70

A significant portion of our revenues are from sales of product to distributors, who then resell our product. Our agreements with certain of these distributors provide protection against price reduction on their inventories of our products. The loss of certain distributors could have a material adverse effect on our business and results of operations, and price reductions associated with their inventories of our products could have a material adverse effect on our operating results in the event of a dramatic decline in selling prices for these products.
In addition, the current situation relating to trade with China and governmental and regulatory concerns relating to specific Chinese companies continue to remain fluid and unpredictable and may further change as a result of any change in administration from the upcoming U.S. presidential election. Products shipped to mainland China accounted for less than 10% of our net revenue during the nine months ended September 30, 2024, compared to 12% during the nine months ended September 30, 2023. Our current and future operating results could be materially and adversely affected by limitations on our ability to sell to one or more Chinese customers, as described in the section “Risks Related to Our Business” under the risk factors “We are also subject to risks associated with international geopolitical and military conflict” and “We will lose sales if we are unable to obtain or retain government authorization to export certain of our products or technology related to the development or production of our products or if such authorization are revoked, and we will be subject to legal and regulatory consequences if we do not comply with applicable export control laws and regulations”, and by tariffs and other trade barriers that have or may be implemented by governmental authorities.
Any legal proceedings or claims against us or potential violations of applicable regulations could be costly and time-consuming to defend and could harm our reputation regardless of the outcome.
In addition to the legal proceedings referenced in Part II, Item 1 (Legal Proceedings) of this report, we are subject to legal proceedings, claims, and/or inquiries that arise in the ordinary course of business, including intellectual property, product liability, employment, class action, customer claims, whistleblower and other litigation claims, and governmental and other regulatory investigations and proceedings regarding potential violations of applicable law, and we may not be successful in resolving such proceedings or inquiries. In addition, we have implemented a reduction in force and the attendant layoffs has resulted and could result in the risk of claims being made by or on behalf of affected employees. Such matters can be time-consuming, divert management’s attention and resources, cause us to incur significant expenses or liability, or require us to change our business practices. In addition, the expense of litigation or responding to inquiries and the timing of such expenses from period to period are difficult to estimate, subject to change, and could adversely affect our financial condition and results of operations. Because of the potential risks, expenses, and uncertainties of litigation or government proceedings, we may, from time to time, resolve disputes, even where we have meritorious claims or defenses, by agreeing to settlement agreements. Any of the foregoing could adversely affect our business, financial condition, and results of operations.

We have been and may in the future be subject to information technology failures, including security breaches, cyber-attacks, design defects or system failures, that could disrupt our operations, damage our reputation and adversely affect our business, operations, and financial results.
We rely on our information technology systems for the effective operation of our business and for the secure maintenance and storage of confidential data relating to our business and third-party businesses. In June 2020, we announced a security incident resulting from a Maze ransomware attack affecting certain but not all operational systems within our information technology infrastructure. Because we did not satisfy the attacker’s monetary demands, on June 15, 2020, the attacker released online certain proprietary information obtained from our network. In response, our internal information technology team, supplemented by a leading cyber defense firm, took steps aimed at containing and assessing this incident, including implementing enhanced security controls aimed at protecting our information technology systems. Since that event, security breaches and incidents, computer malware and computer hacking attacks have continued to become more prevalent and sophisticated. These threats are constantly evolving, making it increasingly difficult to successfully defend against or implement adequate preventive measures. We experience cyber-attacks of varying degrees on our technology infrastructure and systems and notwithstanding our defensive measures, experienced programmers, hackers, state actors, or others may be able to penetrate our security controls through attacks such as phishing, impersonating authorized users, ransomware, viruses, worms and other malicious software programs, software supply chain attacks, exploitation of design flaws, bugs and other security weaknesses and vulnerabilities, covert introduction of malware to computers and networks, including those using techniques that change frequently or may be disguised or difficult to detect, or designed to remain dormant until a triggering event or that may continue undetected for an extended period of time. Geopolitical tensions or conflicts may create heightened risk of cyber-attacks and attackers have used artificial intelligence and machine learning to launch more automated, targeted and coordinated attacks against targets. Businesses we acquire may increase the scope and complexity of our information technology systems, and this may increase our risk exposure to cyber-attack when there are difficulties integrating diverse legacy systems that support operations for the acquired businesses. Our information technology infrastructure also includes products and services provided
71

by third parties, and these providers can experience breaches of their systems and products, or provide inadequate updates or support, which can impact the security of our systems and our proprietary or confidential information.
A cybersecurity incident or other compromise of our information technology systems could result in unauthorized publication or misuse of confidential business or proprietary information belonging to us, a customer, supplier, employee or other third party, including personal data, result in violations of privacy or other laws, expose us to a risk of litigation, cause us to incur direct losses if attackers initiate wire transfers or access our bank or investment accounts, or damage our reputation. More generally, any theft, loss, misuse, or other unauthorized processing of any confidential business or proprietary information, including personal data, collected, used, stored, transferred, or otherwise processed by us or on our behalf could result in significantly increased costs, expenses, damage to our reputation, and claims, litigation, demands, and regulatory investigations or other proceedings. The cost and operational consequences of implementing further data protection measures either as a response to specific breaches or incidents or as a result of evolving risks could be significant. In addition, our inability to use or access our information systems at critical points in time could adversely affect the timely and efficient operation of our business. Any delayed sales, significant costs or lost customers resulting from these technology failures could adversely affect our business, operations and financial results. We also may face difficulties or delays in identifying and remediating and otherwise responding to any security breach or incident.
From time-to-time, we upgrade software that we use in our business, including our enterprise resource planning, or ERP, system. Our business may be disrupted if our software does not work as planned or if we experience issues relating to any implementation, or accessing our software as has happened in a previous cybersecurity attack, in which case we may be unable to timely or accurately prepare financial reports, make payments to our suppliers and employees, or ship to, invoice and collect from our customers.
We may be subject to supply chain attacks where threat actors attempt to inject malicious code into our products thus infecting our products and the systems of our customers. Any such supply chain attack could have magnified damages to our business as a direct result of the attack as well as due to a loss of credibility or reputation with our customers. Such attempts are increasing in number and in technical sophistication, and if successful, expose us and the affected parties to risk of loss or misuse of proprietary or confidential information or disruptions of our business operations, including our manufacturing operations.
Third parties with which we conduct business, such as foundries, assembly and test contractors, and distributors, have access to certain portions of our sensitive data, and we rely on third parties to store and otherwise process data for us. We are dependent on the information security systems of these third parties and they face substantial security risks similar to those outlined above. Any security breaches or incidents or other unauthorized access by third parties to the systems of our suppliers, service providers, or other third parties with access to our sensitive data, or the existence of computer viruses, ransomware or other malicious code in their data, software, or hardware, could result in disruptions or failures of systems used in our business, payments to fraudulent bank accounts, and expose us to a risk of loss, misappropriation, unavailability and other unauthorized processing of information. Any of the foregoing, or the perception any of them has occurred, could have a material adverse impact on our business, operations and financial results.
Additionally, we cannot be certain that our insurance coverage will be adequate or otherwise protect us with respect to claims, expenses, fines, penalties, business loss, data loss, litigation, regulatory actions, or other impacts arising from any of the security breaches or incidents outlined above, or that such coverage will continue to be available on acceptable terms or at all. Any of these results could adversely affect our business, operations and financial results, potentially in a material manner.
Average selling prices of our products have previously decreased and could decrease in the future, which could have a material adverse effect on our revenue and gross margins.
We have and may in the future experience substantial period-to-period fluctuations in our operating results due to erosion of our average selling prices. From time to time, we have reduced the average unit price of our products due to competitive pricing pressures, new product introductions by us or our competitors, and for other reasons, and we expect that we will have to do so again in the future. In particular, we believe that industry consolidation has provided a number of larger semiconductor companies with substantial market power, which has had a material adverse impact on selling prices in some of our markets. If we are unable to offset any reductions in our average selling prices by increasing our sales volumes or introducing new products with higher margins, our revenue and gross margins will suffer. To support our gross margins, we must develop and introduce new products and product enhancements on a timely basis and continually reduce our and our customers’ costs. Our inability to do so would cause our revenue and gross margins to decline. In addition, under certain of our agreements with key distributors,
72

we provide protection for reductions in selling prices of the distributors’ inventory, which could have a material adverse effect on our operating results if the selling prices for those products fell dramatically.
If we fail to penetrate new applications and markets, our revenue, revenue growth rate, if any, and financial condition could be materially and adversely affected.
We sell a significant portion of our products to manufacturers of cable broadband voice and data modems and gateways, satellite outdoor units, optical modules for long-haul and metro telecommunications markets, and RF transceivers and modem solutions for wireless infrastructure markets. Our product offerings also include broadband data access, power management and interface technologies which are ubiquitous functions in new and existing markets such as wireless and wireline communications infrastructure, broadband access, industrial, enterprise network, and automotive applications. We have further expanded our product offerings to include Wi-Fi, ethernet and broadband gateway processor SoCs and intellectual property that utilizes patented machine learning techniques to improve signal integrity and power efficiency in SoCs, ASICs, and field-programmable gate arrays, or FPGAs, used in next-generation communication and artificial intelligence systems. Our future revenue growth, if any, will depend in part on our ability to further penetrate into, and expand beyond, these markets with analog, digital and mixed-signal solutions targeting the markets for Wi-Fi and broadband, high-speed optical interconnects for data center, metro, and long-haul optical modules, telecommunications wireless infrastructure, and cable DOCSIS 3.1 network infrastructure products. Each of these markets presents distinct and substantial risks. If any of these markets do not develop as we currently anticipate, or if we are unable to penetrate them successfully, it could materially and adversely affect our revenue and revenue growth rate, if any.
Broadband data modems and gateways and video gateways continue to represent a significant North American and European revenue generator. The North American and European Pay-TV market is dominated by a few OEMs, including Vantiva SA, Commscope Holding Company, Inc., Hitron Technologies Inc., Compal Broadband Networks, Inc., Humax Co., Ltd., and Samsung Electronics Co., Ltd. These OEMs are large multinational corporations with negotiating power relative to us and are undergoing significant consolidation. Securing design wins with any of these companies requires a substantial investment of our time and resources. Even if we succeed, additional testing and operational certifications will be required by the OEMs’ customers, which include large Pay-TV television companies such as Comcast Corporation, Liberty Global plc, Charter Communications, Inc., Sky UK Limited, AT&T Inc. and EchoStar Corporation. In addition, our products will need to be compatible with other components in our customers’ designs, including components produced by our competitors or potential competitors. There can be no assurance that these other companies will support or continue to support our products.
If we fail to penetrate these or other new markets upon which we target our resources, our revenue and revenue growth rate, if any, likely will decrease over time and our financial condition could suffer.
A significant portion of our revenue is attributable to demand for our products in markets for broadband solutions, and development delays and consolidation trends among cable and satellite Pay-TV and broadband operators could adversely affect our future revenues and operating results.
For the nine months ended September 30, 2024 and 2023, revenue directly attributable to broadband applications accounted for approximately 32% and 30% of our net revenue, respectively. We have experienced a decrease in broadband net revenue of $82.5 million for the nine months ended September 30, 2024, as compared to the nine months ended September 30, 2023, and negative impact to our revenues is expected to continue in the fourth quarter of 2024 and possibly beyond due to slower than expected recovery in this market. Delays in the development of, or unexpected developments in, the broadband markets, including international macroeconomic headwinds, has had and is expected to continue to have an adverse effect on order activity by OEMs in these markets for the fourth quarter of 2024 and possibly thereafter and, as a result, on our business, revenue, operating results and financial condition. In addition, consolidation trends among Pay-TV and broadband operators may continue, which could delay or lead to cancellations of major spending programs and have a material adverse effect on our future operating results and financial condition.
73

We may be unable to make the substantial and productive research and development investments that are required to remain competitive in our business.
The semiconductor industry requires substantial investment in research and development in order to develop and bring to market new and enhanced technologies and products. Many of our products originated with our research and development efforts, which we believe have provided us with a significant competitive advantage. For nine months ended September 30, 2024, and 2023, our research and development expense was $173.9 million and $204.3 million, respectively. While we have decreased our research and development spending to meet evolving demand, we expect our research and development expenses to increase in future years when we return to expanding our product portfolio and enhancing existing products. We monitor such expenditures as part of our strategy of devoting focused research and development efforts on the development of innovative and sustainable product platforms. We are committed to investing in new product development internally in order to stay competitive in our markets and plan to maintain research and development and design capabilities for new solutions in advanced semiconductor process nodes such as 16nm and 5nm and beyond, as well as to address challenges of capturing and processing high quality broadband communications and high-speed optical interconnect signals. However, we do not know whether we will have sufficient resources to maintain the level of investment in research and development required to remain competitive as semiconductor process nodes continue to shrink and become increasingly complex. In addition, we cannot assure you that the technologies that are the focus of our research and development expenditures will become commercially successful. Furthermore, we currently receive grants from certain non-U.S. governments, but those grants and any future grants may not be available to us in the future.
The complexity of our products could result in unforeseen delays or expenses caused by undetected defects or bugs, which could reduce the market acceptance of our new products, damage our reputation with current or prospective customers and adversely affect our operating costs.
Highly complex products like our Wi-Fi and broadband RF receivers and RF receiver SoCs, physical medium devices for optical modules, RF transceiver and modem solutions for wireless infrastructure markets, and high-performance analog solutions may contain defects and bugs when they are first introduced or as new versions are released. Where any of our products, including legacy acquired products, contain defects or bugs, or have reliability, quality or compatibility problems, we may not be able to successfully correct these problems. Consequently, our reputation may be damaged and customers may be reluctant to buy our products, which could materially and adversely affect our ability to retain existing customers and attract new customers, and our financial results. In addition, these defects or bugs could interrupt or delay sales to our customers. If any of these problems are not found until after we have commenced commercial production of a new product, we may be required to incur additional development costs and product recall, repair or replacement costs, and our operating costs could be adversely affected. These problems may also result in warranty or product liability claims against us by our customers or others that may require us to make significant expenditures to defend these claims or pay damage awards. In the event of a warranty claim, we may also incur costs if we compensate the affected customer. We maintain product liability insurance, but this insurance is limited in amount and subject to significant deductibles. There is no guarantee that our insurance will be available or adequate to protect against all claims. We also may incur costs and expenses relating to a recall of one of our customers’ products containing one of our devices. The process of identifying a recalled product in devices that have been widely distributed may be lengthy and require significant resources, and we may incur significant replacement costs, contract damage claims from our customers and reputational harm. Costs or payments made in connection with warranty and product liability claims and product recalls could materially affect our financial condition and results of operations, and ability to obtain future coverage. Although we purchase insurance to mitigate certain losses, any uninsured losses could negatively affect our operating results. Although we maintain reserves for reasonably estimable liabilities and purchase product liability insurance, if a catastrophic product liability claim were to occur, our reserves may be inadequate to cover the uninsured portion of such claims. Further, our business liability insurance may be inadequate, may not cover the claims, and future coverage may be unavailable on acceptable terms, which could adversely impact our financial results.
Our revenue and operating results are subject to substantial quarterly and annual fluctuations and have fluctuated in the past and may fluctuate significantly due to a number of factors that could adversely affect our business and our stock price.
Our revenue and operating results have fluctuated in the past and are likely to fluctuate in the future. For example, our revenue declined from $567.9 million for the nine months ended September 30, 2023, to $268.4 million for the nine months ended September 30, 2024 and revenue could continue to decline. These fluctuations may occur on a quarterly and on an annual basis and are due to a number of factors, many of which are beyond our control. These factors include, among others:
seasonality or cyclical fluctuations in our markets;
74

overall demand volatility for semiconductor solutions across a diverse range of communications, industrial and multi-market applications;
changes in end-user demand for the products manufactured and sold by our customers;
the receipt, reduction or cancellation of significant orders by customers;
fluctuations in the levels of component inventories held by our customers;
the gain or loss of significant customers;
market acceptance of our products and our customers’ products;
our ability to develop, introduce, and market new products and technologies on a timely basis;
size and timing of any consideration received under our intellectual property sale agreements;
the availability and cost of products from our suppliers;
the timing and extent of operating expenses, including costs related to product development and personnel compensation and benefits;
new product announcements and introductions by us or our competitors;
incurrence of research and development and related new product expenditures;
government actions, by the United States, China or other countries, that impose barriers or restrictions that would impact our ability to sell or ship products to customers;
currency fluctuations;
fluctuations in manufacturing yields of integrated circuits;
significant warranty claims, including those not covered by our suppliers;
changes in our product mix or customer mix;
potential indemnification claims, including those arising as a result of our contractual arrangements or intellectual property disputes;
intellectual property disputes;
timing and extent of product development costs;
loss of key personnel or inability to attract, retain and motivate qualified skilled workers;
impairment of long-lived assets, including masks and production equipment; and
the effects of competitive pricing pressures, including decreases in average selling prices of our products.

75

If our growth rate continues to slow, seasonal or cyclical variations in our operations may become more pronounced over time and may materially affect our business, financial condition, results of operations and prospects. These factors are difficult to forecast, and these, as well as other factors, could materially adversely affect our quarterly or annual operating results. We typically are required to incur substantial development costs in advance of a prospective sale with no certainty that we will ever recover these costs. A substantial amount of time may pass between a design win and the generation of revenue related to the expenses previously incurred, which can potentially cause our operating results to fluctuate significantly from period to period. In addition, a significant amount of our operating expenses are relatively fixed in nature due to our significant sales, research and development costs. Any failure to adjust spending or our operations quickly enough to compensate for a revenue shortfall could magnify its adverse impact on our results of operations.
If we fail to develop and introduce new or enhanced products on a timely basis, our ability to attract and retain customers could be impaired and our competitive position could be harmed.
We operate in a dynamic environment characterized by rapidly changing technologies and industry standards and technological obsolescence. To compete successfully, we must design, develop, market and sell new or enhanced products that provide increasingly higher levels of performance and reliability and meet the cost expectations of our customers. The introduction of new products by our competitors, the market acceptance of products based on new or alternative technologies, or the emergence of new industry standards could render our existing or future products obsolete. Our failure to anticipate or timely develop new or enhanced products or technologies in response to technological shifts has resulted, and could in the future, result in decreased revenue and our competitors winning more competitive bid processes, known as “design wins.” In particular, we may experience difficulties with product design, manufacturing, marketing or certification that could delay or prevent our development, introduction or marketing of new or enhanced products. If we fail or are slow to introduce new or enhanced products that meet the needs of our customers or penetrate new markets in a timely fashion, as has happened previously or in the future, we will lose market share and our operating results will be adversely affected.
In particular, we believe that we will need to develop new products in part to respond to changing dynamics and trends in our end user markets, including (among other trends) consolidation among cable and satellite operators, potential industry shifts away from the hardware devices and other technologies that incorporate certain of our products, advances in artificial intelligence, and changes in consumer television viewing habits and how consumers access and receive broadcast content and digital broadband services. We cannot predict how these trends will continue to develop or how or to what extent they may affect our future revenues and operating results. We believe that we will need to continue to make substantial investments in research and development in an attempt to ensure a product roadmap that anticipates these types of changes; however, we cannot provide any assurances that we will accurately predict the direction in which our markets will evolve or that we will be able to develop, market, or sell new products that respond to such changes successfully or in a timely manner, if at all.
76

We are subject to order and shipment uncertainties, and differences between our estimates of customer demand and product mix and our actual results could continue to negatively affect our inventory levels, sales and operating results.
Our revenue is generated on the basis of shipments of products under purchase orders with our customers rather than long-term purchase commitments. In addition, our customers can and have requested to cancel purchase orders or defer the shipments of our products under certain circumstances. Our products are manufactured using a silicon foundry according to our estimates of customer demand, which requires us to make separate demand forecast assumptions for every customer, each of which may introduce significant variability into our aggregate estimate. We have limited visibility into future customer demand and the product mix that our customers will require, which has in the past affected and could in the future adversely affect our revenue forecasts and operating margins. Also, as customer lead times continue to improve, we have seen and expect to continue to see a more normalized demand-planning horizon. Moreover, because our target markets are relatively new, many of our customers have difficulty accurately forecasting their product requirements and estimating the timing of their new product introductions, which ultimately affects their demand for our products. Historically, because of this limited visibility, actual results have been different from our forecasts of customer demand. Some of these differences have been material which has led to and could continue to lead to excess inventory or product shortages and revenue and margin forecasts above those we were actually able to achieve. These differences may occur in the future, and the adverse impact of these differences between forecasts and actual results could grow if we are not successful in expanding the customer base for our products. In addition, the rapid pace of innovation in our industry could render significant portions of our inventory obsolete. Excess or obsolete inventory levels has resulted and continue to result in unexpected expenses or increases in our reserves that could adversely affect our business, operating results and financial condition. Conversely, if we were to underestimate customer demand or if sufficient manufacturing capacity were unavailable, we could forego revenue opportunities, potentially lose market share and damage our customer relationships. In addition, any significant future cancellations or deferrals of product orders or the return of previously sold products due to manufacturing defects could materially and adversely impact our profit margins, increase our write-offs due to product obsolescence and restrict our ability to fund our operations.
We may have difficulty accurately predicting our future revenue and appropriately budgeting our expenses particularly as we seek to enter new markets where we may not have prior experience.
Our operating history had historically focused on developing integrated circuits for specific applications and more recently, the wired whole-home broadband connectivity market and markets for wireless telecommunications infrastructure and power management and interface technologies which are ubiquitous functions in wireless and wireline communications infrastructure, broadband access, industrial, enterprise network, and automotive applications. As part of our growth strategy, we seek to expand our addressable market into new product categories. For example, we expanded into the markets for Wi-Fi, ethernet and broadband gateway processor SoCs and intellectual property that utilizes patented machine learning techniques to improve signal integrity and power efficiency in SoCs, ASICs, and FPGAs used in next-generation communication and artificial intelligence systems. Our limited operating experience in new markets or potential markets we may enter, combined with the rapidly evolving nature of our markets in general, substantial uncertainty concerning how these markets may develop and other factors beyond our control reduces our ability to accurately forecast quarterly or annual revenue. If our revenue does not increase particularly in new markets, we could continue to incur significant losses due to our higher expense levels if we are not able to decrease our expenses in a timely manner to offset any shortfall in current or future revenue.
Our customers require our products and our third-party contractors to undergo a lengthy and expensive qualification process which does not assure product sales.
Prior to purchasing our products, our customers require that both our products and our third-party contractors undergo extensive qualification processes, which involve testing of the products in the customer’s system and rigorous reliability testing. This qualification process may continue for six months or more. However, qualification of a product by a customer does not assure any sales of the product to that customer. Even after successful qualification and sales of a product to a customer, a subsequent revision to our solutions, or changes in our customer’s manufacturing process or our selection of a new supplier may require a new qualification process, which may result in delays and in us holding excess or obsolete inventory. After our products are qualified, it can take six months or more before the customer commences volume production of components or devices that incorporate our products. Despite these uncertainties, we devote substantial resources, including design, engineering, sales, marketing and management efforts, to qualifying our products with customers in anticipation of sales. If we are unsuccessful or delayed in qualifying any of our products with a customer, sales of this product to the customer may be precluded or delayed, which may result in a decrease in our revenue and cause our business to suffer.
77

Winning business is subject to lengthy competitive selection processes that require us to incur significant expenditures. Even if we begin a product design, customers may decide to cancel or change their product plans, which could cause us to generate no revenue from a product and adversely affect our results of operations.
We are focused on securing design wins to develop RF receivers and RF receiver SoCs, MoCA and G.hn SoCs, DBS-ODU SoCs, physical medium devices for optical modules, interface and power management devices, and SoC solutions targeting infrastructure opportunities within the telecommunications, wireless, industrial and multi-market and Wi-Fi and broadband operator markets for use in our customers’ products. These selection processes typically are lengthy and can require us to incur significant design and development expenditures and dedicate scarce engineering resources in pursuit of a single customer opportunity. We may not win the competitive selection process and may never generate any revenue despite incurring significant design and development expenditures. These risks are exacerbated by the fact that some of our customers’ products likely will have short life cycles. Although this has not occurred to date, failure to obtain a design win could prevent us from offering an entire generation of a product. This could cause us to lose revenue and require us to write off obsolete inventory, and could weaken our position in future competitive selection processes. After securing a design win, we may experience delays in generating revenue from our products as a result of the lengthy development cycle typically required. Our customers generally take a considerable amount of time to evaluate our products. The typical time from early engagement by our sales force to actual product introduction runs from nine to twelve months for the broadband and communications market, and 36 months or longer for industrial, wired and wireless infrastructure markets. The delays inherent in these lengthy sales cycles increase the risk that a customer will decide to cancel, curtail, reduce or delay its product plans, causing us to lose anticipated sales. In addition, any delay or cancellation of a customer’s plans could materially and adversely affect our financial results, as we may have incurred significant expense and generated no revenue. Finally, our customers’ failure to successfully market and sell their products could reduce demand for our products and materially and adversely affect our business, financial condition and results of operations. If we were unable to generate revenue after incurring substantial expenses to develop any of our products, our business would suffer.
Our business is subject to various international and U.S. laws and governmental regulations, and compliance with these laws and regulations may cause us to incur significant expenses. A failure to maintain compliance with applicable laws and regulations could result in a material adverse effect on our business and operating results, and we could be subject to civil or criminal penalties.
Our business is subject to various laws and regulations in the United States and other jurisdictions where we do business, including but not limited to laws, regulations and other legal requirements related to packaging; product content; labor and employment; import and customs; export controls; anti-corruption; personal and data privacy; cybersecurity; human rights; conflict minerals; environment, health and safety; competition and antitrust; and intellectual property ownership and infringement. These laws and regulations are complex, change frequently and with little or no notice, occasionally are conflicting or ambiguous, and have generally become more stringent over time. Complying with these laws and regulations can be costly and we may be required to incur significant costs to remedy any potential gaps or violations that are identified. In addition, because many of our products are regulated or sold into regulated industries, we must comply with additional regulations in marketing our products. Although our policies, procedures, and controls are designed to detect and prevent potential violations and maintain ongoing compliance with applicable laws, we cannot assure you that we have been or will be at all times in compliance with such laws and regulations. If we violate or fail to comply with any of them, a range of consequences could result, including fines, import/export restrictions, sales limitations, criminal and civil liabilities or other penalties or sanctions. The costs of complying with these laws (including the costs of any investigations, remediation, auditing and monitoring) could adversely affect our current or future business.
78

As indicated elsewhere in this report, we do a substantial portion of our business in Asia, including in Hong Kong, a special administrative region of the People’s Republic of China, or China. Since October 2022, the United States has taken steps to restrict the export of certain advanced semiconductor products and technology to China as well as a number of specific Chinese companies, due to national security and human rights concerns. There has also been a substantial focus by regulators in the United States and Europe on the business practices of certain major Chinese technology companies. Complying with changing export control laws may require us to develop additional policies, procedures, and controls, or incur additional costs, including in connection with the development or performance of additional due diligence in order to prevent diversion of restricted products or technology to China, Russia, or other destinations. Compliance with these laws and regulations may also result in the loss of revenue. Since October 2022, we have restricted shipments and exports to certain major Chinese technology companies, including a semiconductor foundry and OSAT providers. While we intend to continue to conduct our businesses in compliance with all applicable laws, including laws relating to export controls and anti-corruption, it is possible that the nature of our business and customers could result in a review of our relationships and practices by regulatory authorities. At times, we may discover issues that we bring to the attention of the relevant government agencies, as we did on March 3, 2023, when we submitted a comprehensive voluntary self-disclosure to BIS regarding the potential EAR violation described above and other potential export control violations. Although the March 2023 voluntary self-disclosure to BIS resulted in a warning letter, we could incur increased administrative and legal costs in order to remediate any potential compliance gaps or violations, to respond to any inquiries, or in connection with the preparation and submission of any voluntary self-disclosures to the government agencies, as appropriate. Any failure to comply with applicable laws or regulatory approvals could adversely affect our business and operating results. We have implemented policies and procedures, including adoption of an anti-corruption policy and procedures with respect to applicable export control laws, but there can be no assurance that our policies and procedures will prove effective.
Our products and operations are also subject to the rules of industrial standards bodies, like the International Standards Organization, as well as regulation by other agencies, such as the U.S. Federal Communications Commission. If we fail to adequately address any of these rules or regulations, our business could be harmed.
In addition, climate change and new or revised rules and regulations related thereto, including regulations with respect to greenhouse gas emissions and regulations enacted by the SEC and recent legislation enacted in California, may impact our business in numerous ways. Climate change and its effects could lead to further increases in raw material prices or their reduced availability due to, for example, increased frequency and severity of extreme weather events and any supply chain disruptions resulting therefrom, and could cause increased incidence of disruption to the production and distribution of our products and an adverse impact on consumer demand and spending. For example, as a fabless semiconductor company, we outsource our manufacturing to countries outside of the United States, and our manufacturers’ suppliers reside in areas that are more susceptible to extreme weather impacts. If our suppliers have difficulty obtaining raw materials and natural resources due to extreme weather impacts, this could increase the cost associated with extraction of raw materials or limit the supply available for our key suppliers to manufacture our products, driving the cost up for us and/or threaten our upstream supply chain. In recent months, there have been substantial legislative and regulatory developments on climate-related issues, including proposed, issued and implemented legislation and rulemakings that would require companies to assess and/or disclose climate metrics, risks, opportunities, policies and practices. For example, on March 6, 2024, the SEC adopted rules mandating climate-related disclosures that would require increased climate change-related disclosure in our periodic reports and other filings with the SEC for fiscal year 2025 and beyond, which were stayed on April 4, 2024. The potential impact to us of these legislative and regulatory developments is uncertain at this time, although we expect that the emerging legal and regulatory requirements on climate-related issues will result in additional compliance and may require us to spend or add significant resources and divert management attention. We cannot be sure that we will be able to successfully adapt our operations in response to any climate-related changes or comply with any increased reporting obligations in a cost-effective manner, and our business, financial condition and results of operations could be materially and adversely affected.
We must also conform the manufacture and distribution of our semiconductors to various laws and adapt to regulatory requirements in all countries as these requirements change. If we fail to comply with these requirements in the manufacture or distribution of our products, we could be required to pay civil penalties, face criminal prosecution and, in some cases, be prohibited from distributing our products in commerce until the products or component substances are brought into compliance.
If we are unable to attract, train and retain qualified personnel and senior management, our business, financial condition, results of operations and prospects could suffer.
Our future success depends on our ability to retain, attract and motivate qualified personnel, including our management, sales and marketing and finance teams, and especially our design and technical staff. In July 2024, we initiated the 2024 Workforce Reduction, and previously, in March and October 2023, we initiated the 2023 Workforce Reductions, to align our
79

operational needs with the changes in macroeconomic conditions and the demand environment. These workforce reductions may yield unintended consequences, such as attrition beyond our intended reduction in workforce and reduced employee morale, which may cause our employees who were not affected by the reduction in workforce to seek alternate employment. Employees whose positions were eliminated or those who determine to seek alternate employment may seek employment with our competitors. In addition, our reductions in workforce may adversely impact our ability to implement our business strategy and respond rapidly to any new product, growth or revenue opportunities. Additionally, reductions in workforce may make it more difficult to recruit and retain new employees. If we need to increase the size of our workforce in the future, we may encounter a competitive hiring market due to labor shortages, increased employee turnover, changes in the availability of workers and increased wage costs. Employee litigation related to the reduction of our workforce could be costly and time-consuming.
We do not know whether we will be able to attract and retain the required and desirable personnel as we continue to pursue our business strategy. Historically, we have encountered difficulties in hiring and retaining qualified engineers because there is a limited pool of engineers with the expertise required in our field, and expect to continue facing such difficulties in seeking talent. Competition for these personnel is intense in the semiconductor industry. As the source of our technological and product innovations, our design and technical personnel represent a significant asset. In addition, in making employment decisions, particularly in the high-technology industry, job candidates often consider the value of the stock-based compensation they are to receive in connection with their employment. We have experienced declines in the market price of our stock and reductions in force which could adversely affect our ability to attract, motivate or retain key employees. In addition, our future performance also depends on the ability of our senior management to execute our business plan and to identify and pursue new opportunities and product innovations. Our employment arrangements with our employees do not generally require that they continue to work for us for any specified period, and therefore, they could terminate their employment with us at any time. The loss of the services of one or more of our key employees, especially our management and key design and technical personnel, or our inability to retain, attract and motivate our management and qualified design and technical and other personnel, could have a material adverse effect on our business, financial condition and results of operations.
Our future success also depends on the continued contributions of our senior management team and other key personnel. None of our senior management team or other key personnel is bound by written employment contracts to remain with us for a specified period. In addition, we have not entered into non-compete agreements with members of our senior management team or other key personnel, except in limited circumstances (e.g., in connection with the acquisition of other companies). We are fortunate that certain members of our senior management team have long tenures with us, but recently we also have been required to recruit new members of senior management. With respect to recruitment and retention of senior management, we need to ensure that our compensation programs provide sufficient recruitment and retention incentives as well as incentives to achieve our long-term strategic business and financial objectives. We expect competition for individuals with our required skill sets, particularly technical and engineering skills, to remain intense even in weak global macroeconomic environments. The loss of any member of our senior management team or other key personnel could harm our ability to implement our business strategy and respond to the rapidly changing market conditions in which we operate.
As of September 30, 2024, our aggregate indebtedness was $125.0 million, and we are subject to a variable amount of interest on the principal balance of our credit agreements and could continue to be adversely impacted by high interest rates in the future. Such indebtedness adversely affects our operating results and cash-flows as we satisfy our underlying interest and principal payment obligations and contains financial and operational covenants that could adversely affect our operational freedom or ability to pursue strategic transactions that we would otherwise consider to be in the best interests of stockholders, including obtaining additional indebtedness to finance such transactions. In addition, high interest rates may make it more difficult for us, our customers, and our distributors to obtain financing and service our respective interest and debt obligations, which in turn has an impact on customer demand for our products and our distributors business.
As of September 30, 2024, our aggregate indebtedness was $125.0 million from an initial secured term B loan facility, or the Initial Term Loan under the June 23, 2021 Credit Agreement. The June 23, 2021 Credit Agreement also provides for a revolving credit facility of up to $100.0 million, or the Revolving Facility, which remains undrawn as of September 30, 2024. The credit agreement also permits us to request incremental loans in an aggregate principal amount not to exceed the sum of an amount equal to the greater of (x) $175.0 million and (y) 100% of “Consolidated EBITDA” (as defined in such agreement), plus the amount of certain voluntary prepayments, plus an unlimited amount that is subject to pro forma compliance with certain first lien net leverage ratio, secured net leverage ratio and total net leverage ratio tests. The June 23, 2021 Credit Agreement was amended on June 29, 2023 to implement a benchmark replacement.
80

The Initial Term Loan under the June 23, 2021 Credit Agreement has a seven-year term expiring in June 2028 and bears interest at either an Adjusted Term SOFR plus a fixed applicable margin of 2.25% or an Adjusted Base Rate plus a fixed applicable margin of 1.25%, at our option. Commencing on September 30, 2021, the Initial Term Loan under the June 23, 2021 Credit Agreement amortizes in equal quarterly installments equal to 0.25% of the original principal amount, with the balance payable on June 23, 2028. We are subject to commitment fees ranging from 0.175% to 0.25% on the undrawn portion of the Revolving Facility, and any outstanding loans under the Revolving Facility will bear interest at either an Adjusted Term SOFR plus a margin of 1.00% to 1.75% or an Adjusted Base Rate plus a margin of 0% to 0.75%. Our obligations under the June 23, 2021 Credit Agreement are required to be guaranteed by certain of our domestic subsidiaries meeting materiality thresholds set forth in the credit agreement. Such obligations, including the guaranties, are secured by substantially all of our assets and those of the subsidiary guarantors.
Our material indebtedness adversely affects our operating expenses through increased interest payment obligations and adversely affects our ability to use cash generated from operations as we repay interest at a variable rate, and principal under the term loans. In addition, the Revolving Facility provisions under the June 23, 2021 Credit Agreement include financial covenants such as an initial maximum secured net leverage ratio of 3.50 to 1.00, which temporarily increases to 3.75 to 1.00 following the consummation of certain material permitted acquisitions, and operational covenants that may adversely affect our ability to engage in certain activities, including obtaining additional financing, granting liens, undergoing certain fundamental changes, or making investments or certain restricted payments, and selling assets, and similar transactions, without obtaining the consent of the lenders, which may or may not be forthcoming. The Initial Term Loan under the June 23, 2021 Credit Agreement is only subject to operational covenants. Lastly, our borrowing costs can be affected by periodic credit ratings from independent rating agencies. Such ratings are largely based on our performance, which may be measured by credit metrics such as leverage and interest coverage ratios. Accordingly, outstanding indebtedness could adversely affect our operational freedom or ability to pursue strategic transactions that we would otherwise consider to be in the best interests of stockholders, including obtaining additional indebtedness to finance such transactions.
Specifically, our indebtedness and high interest rates have important consequences to investors in our common stock, including the following:
high interest rates may make it more difficult for us, our customers, and our distributors to obtain financing and service our respective interest and debt obligations, which in turn has an impact on customer demand for our products as well as the business of our distributors;
we are subject to variable interest rate risk because our interest rate under the Initial Term Loan under the June 23, 2021 Credit Agreement varies based on a fixed margin of 2.25% per annum over an adjusted Term SOFR rate or 1.25% per annum over an adjusted base rate and our interest rate for any outstanding principal under the revolving credit facility varies based a margin of 0% to 0.75% over adjusted base rate or a margin of 1.00% to 1.75% over an adjusted Term SOFR rate, and we are also subject to commitment fees ranging from 0.175% to 0.25% on the undrawn portion of the Revolving Facility. If interest rates were to continue to increase substantially, it would adversely affect our operating results and could affect our ability to service our indebtedness;
a portion of our cash flows is dedicated to the payment of interest and when applicable, principal, on our indebtedness and other obligations and will not be available for use in our business;
our level of indebtedness, combined with high interest rates, could limit our flexibility in planning for, or reacting to, changes in our business and the markets in which we operate, including limiting our future investments or ability to enter into acquisitions and strategic partnerships, and obtain financing for such transactions; and
our high degree of indebtedness may make us more vulnerable to changes in general economic conditions and/or a downturn in our business, thereby making it more difficult for us to satisfy our obligations.
If we fail to make required debt payments, or if we fail to comply with financial or other covenants in our debt service agreements, which include a maximum leverage ratio, we would be in default under the terms of these agreements. Subject to customary cure rights, any default would permit the holders of the indebtedness to accelerate repayment of this debt and could cause defaults under other indebtedness that we have, any of which could have a material adverse effect on the trading price of our common stock.
81

We and our subsidiaries may, subject to any limitations in the terms of our existing loan facilities, incur additional debt, secure existing or future debt, recapitalize our debt or take a number of other actions that are not limited by the terms of our term loans that could have the effect of diminishing our ability to make payments under the indebtedness when due. If we incur any additional debt, the related risks that we and our subsidiaries face could intensify. Please refer to the Risk Factor entitled “If we are required to pay any damages in connection with legal proceedings related to the termination of the Merger Agreement with Silicon Motion, including for any alleged breaches of the Merger Agreement, or if we agree to make any payments in any settlement of legal proceedings related to the termination of the Merger Agreement, the amount of such damages or payments could be significant and require us to draw down on all our existing lines of credit and use our cash resources, which may not be sufficient to satisfy any damages or payments and could have a material adverse effect on our business, operating results, and financial condition. We expect that we may not be able to obtain financing on favorable terms if at all or raise additional capital for any such payments. Even if we are able to finance such payments through the incurrence of additional indebtedness, any material increase in our indebtedness would adversely affect our operating results and cash-flows as we satisfy our underlying interest and principal payment obligations. Issuing additional shares of our common stock, if material, will result in dilution of existing shares outstanding. Any loan agreement is also expected to contain financial and operational covenants that would adversely affect our operational freedom or ability to pursue strategic transactions that we would otherwise consider to be in the best interests of stockholders, including obtaining additional indebtedness to finance such transactions”.
We are subject to governmental laws, regulations and other legal obligations related to privacy, data protection, and cybersecurity, and any inability of us to comply with such obligations may negatively impact our business.
The legislative, enforcement policy and regulatory framework for privacy, data protection and cybersecurity issues worldwide is rapidly evolving and complex and is likely to remain uncertain for the foreseeable future. We collect and otherwise process data, including personal data and other regulated or sensitive data, as part of our business processes and activities. This data is subject to a variety of U.S. and international laws and regulations, including oversight by various regulatory or other governmental bodies. Many foreign countries and governmental bodies, including China, the European Union and other relevant jurisdictions where we conduct business, have laws and regulations concerning the collection and use of personal data, and other data obtained from their residents or by businesses operating within their jurisdictions that are currently more restrictive than those in the U.S. These laws may require that our overall information technology security environment meet certain standards and/or be certified. For example, effective May 2018, the European Union adopted the General Data Protection Regulation, or GDPR, that imposed stringent data protection requirements and provided for greater penalties for noncompliance. The United Kingdom has adopted legislation that substantially implements the GDPR and provides for a similar penalty structure. Similarly, California has adopted the California Consumer Privacy Act of 2018, or CCPA, which took effect in 2020. The CCPA gives California residents the right to access, delete and opt out of certain sharing of their information, and imposes penalties for failure to comply. California has adopted a new law, the California Privacy Rights Act of 2020 that substantially expands the CCPA and was effective as of January 1, 2023. Additionally, other U.S. states continue to propose and enact privacy and security-focused legislation. In addition, governments around the world continue to enact laws relating to privacy and data security. For example, in 2021, the National People’s Congress passed the Data Security Law of the People’s Republic of China, or the Data Security Law and the Personal Information Protection Law of the People’s Republic of China, or PIPL. The Data Security Law is the first comprehensive data security legislation in the People’s Republic of China, or China, and aims to regulate a wide range of issues in relation to the collection, storage, processing, use, provision, transaction and publication of any kind of data. In March 2024, the Cyberspace Administration of China published the Provisions on Promoting and Standardizing Cross-Border Data Flows to implement the mechanisms for the cross-border data transfers, including the security assessment. These regulations contain provisions that allow substantial government oversight and include fines for failure to obtain required approval from China’s cyber and data protection regulators for cross-border personal data-related data transfers. However, there is still some uncertainty in how regulators will interpret and enforce these laws.
The laws outlined above are only a sample of the governmental laws, regulations and other legal obligations related to privacy, data protection, and cybersecurity to which we are subject. Various aspects of these laws, including their interpretation and enforcement, remain unclear, resulting in further uncertainty and potentially requiring us to modify our data practices and policies and to incur substantial additional costs and expenses in an effort to comply. Because the interpretation and application of many such laws and regulations, remain uncertain and continue to evolve, it is possible that these laws and regulations may be interpreted and applied in a manner that is inconsistent with our data management practices or the features of our products or solutions, and we could face fines, lawsuits, regulatory investigations, and other claims and penalties, and we could be required to fundamentally change our products or our business practices, all of which could have a material adverse effect on our business. Any inability, or perceived inability, to adequately address privacy and data protection concerns, or to comply with applicable laws, regulations, policies, industry standards, contractual obligations or other legal obligations, even if unfounded,
82

could result in additional cost and liability to us, damage our reputation, inhibit sales and have a material adverse effect on our business, results of operations, and financial condition.
Our products must conform to industry standards in order to be accepted by end users in our markets.
Generally, our products comprise only a part or parts of a communications device. All components of these devices must uniformly comply with industry standards in order to operate efficiently together. We depend on companies that provide other components of the devices to support prevailing industry standards. Many of these companies are significantly larger and more influential in driving industry standards than we are. Some industry standards may not be widely adopted or implemented uniformly, and competing standards may emerge that may be preferred by our customers or end users. If larger companies do not support the same industry standards that we do, or if competing standards emerge, market acceptance of our products could be adversely affected, which would harm our business.
Products for communications applications are based on industry standards that are continually evolving. Our ability to compete in the future will depend on our ability to identify and ensure compliance with these evolving industry standards. The emergence of new industry standards could render our products incompatible with products developed by other suppliers. As a result, we could be required to invest significant time and effort and to incur significant expense to redesign our products to ensure compliance with relevant standards. If our products are not in compliance with prevailing industry standards for a significant period of time, we could miss opportunities to achieve crucial design wins. We may not be successful in developing or using new technologies or in developing new products or product enhancements that achieve market acceptance. Our pursuit of necessary technological advances may require substantial time and expense.
We may, from time to time, make additional business acquisitions or investments, which involve significant risks.
We have completed multiple acquisitions in the past nine years. We may also enter into alliances or make investments in other businesses to complement our existing product offerings, augment our market coverage or enhance our technological capabilities. Any such transactions has resulted and could result in:
issuances of equity securities dilutive to our existing stockholders;
substantial cash payments;
the incurrence of substantial debt and assumption of unknown liabilities;
large one-time write-offs;
amortization expenses related to intangible assets;
a limitation on our ability to use our net operating loss carryforwards;
the diversion of management’s time and attention from operating our business to acquisition integration challenges;
stockholder or other litigation relating to the transaction;
adverse tax consequences;
costs and expenses associated with any undisclosed or potential liabilities; and
the potential loss of, or ability to attract, key personnel, customers and suppliers of the acquired businesses.
To the extent we pay the purchase price of any acquisition or investment in cash or through borrowings under our Revolving Facility, it would reduce our cash balances and/or result in indebtedness we must service, which may have a material adverse effect on our business and financial condition. If the purchase price is paid with our stock, it would be dilutive to our stockholders. In addition, we may assume liabilities associated with a business acquisition or investment, including unrecorded liabilities that are not discovered at the time of the transaction, and the repayment of those liabilities may have a material adverse effect on our financial condition.
Integrating acquired organizations and their products and services, including the integration of completed acquisitions, may be expensive, time-consuming and a strain on our resources and our relationships with employees, customers, distributors and suppliers, and ultimately may not be successful. The benefits or synergies we may expect from the acquisition of
83

complementary or supplementary businesses may not be realized to the extent or in the time frame we initially anticipate. Some of the risks that may affect our ability to successfully integrate acquired businesses include those associated with:
failure to successfully further develop the acquired products or technology;
conforming the acquired company’s standards, policies, processes, procedures and controls with our operations;
coordinating new product and process development, especially with respect to highly complex technologies;
loss of key employees or customers of the acquired business;
hiring additional management and other key personnel;
in the case of foreign acquisitions, the need to integrate operations across different cultures and languages and to address the particular economic, currency, political and regulatory risks associated with specific countries;
increasing the scope, geographic diversity and complexity of our operations;
consolidation of facilities, integration of the acquired businesses’ accounting, human resource and other administrative functions and coordination of product, engineering and sales and marketing functions;
the geographic distance between the businesses;
liability for activities of the acquired businesses before the acquisition, including patent and trademark infringement claims, violations of laws, commercial disputes, tax liabilities and other known and unknown liabilities; and
litigation or other claims in connection with the acquired businesses, including claims for terminated employees, customers, former stockholders or other third parties.
We may not be able to identify suitable acquisition or investment candidates, or even if we do identify suitable candidates, they may be difficult to finance, expensive to fund and there is no guarantee that we can obtain any necessary antitrust approvals or complete such transactions on terms that are favorable to us.
We have in the past been, are currently, and may in the future be party to litigation related to acquisitions. Any adverse determination in litigation resulting from acquisitions could have a material adverse effect on our business and operating results.
Risks Relating to Intellectual Property
We have settled in the past intellectual property litigation and may in the future face additional claims of intellectual property infringement, including indemnification claims based on intellectual property allegations. Any current or future litigation could be time-consuming, costly to prosecute, defend or settle and result in damages and/or the loss of significant rights.
The semiconductor industry is characterized by companies that hold large numbers of patents and other intellectual property rights and that vigorously pursue, protect and enforce intellectual property rights. Third parties have in the past and may in the future assert against us and our customers and distributors their patent and other intellectual property rights to technologies that are important to our business. For example, we were involved in a litigation with Bell Semiconductor, which has since been settled pursuant to a Settlement and Patent License Agreement. In addition, from time to time, we receive correspondence from competitors and other third parties seeking to engage us in discussions concerning potential claims against us, and we receive correspondence from customers seeking indemnification for potential claims related to infringement claims asserted against down-stream users of our products. We investigate these requests and claims as received and could be required to enter license agreements with respect to third-party intellectual property rights or indemnify third parties, either of which could have a material adverse effect on our future operating results.
Claims that our products, processes or technology infringe third-party intellectual property rights, regardless of their merit or resolution are costly to defend or settle and could divert the efforts and attention of our management and technical personnel. In addition, many of our customer and distributor agreements require us to indemnify and defend our customers or distributors from third-party infringement claims and pay damages and attorneys’ fees in the case of adverse rulings. Claims of this sort also could harm our relationships with our customers or distributors and might deter future customers from doing business with us. In order to maintain our relationships with existing customers and secure business from new customers, we
84

have been required from time to time to provide additional assurances beyond our standard terms. If any of our current or future proceedings result in an adverse outcome, we could be required to:
cease the manufacture, use or sale of the infringing products, processes or technology;
pay substantial damages, indemnification expenses and attorneys’ fees;
expend significant resources to develop non-infringing products, processes or technology;
license technology from the third-party claiming infringement, which license may not be available on commercially reasonable terms, or at all;
cross-license our technology to a competitor to resolve an infringement claim, which could weaken our ability to compete with that competitor; or
pay substantial damages to our customers or end users to discontinue their use of or to replace infringing technology sold to them with non-infringing technology.
Any of the foregoing results could have a material adverse effect on our business, financial condition, and results of operations.
We utilize a significant amount of intellectual property in our business. If we are unable to protect our intellectual property, our business could be adversely affected.
Our success depends in part upon our ability to protect our intellectual property. To accomplish this, we rely on a combination of intellectual property rights, including patents, copyrights, trademarks and trade secrets in the United States and in selected foreign countries where we believe filing for such protection is appropriate. Effective patent, copyright, trademark and trade secret protection may be unavailable, limited or not applied for in some countries. Some of our products and technologies are not covered by any patent or patent application. We cannot guarantee that:
any of our present or future patents or patent claims will not lapse or be invalidated, circumvented, challenged or abandoned;
our intellectual property rights will provide competitive advantages to us;
our ability to assert our intellectual property rights against potential competitors or to settle current or future disputes will not be limited by our agreements with third parties or obligations, if any, to standards organizations;
any of our pending or future patent applications will be issued or have the coverage originally sought;
our intellectual property rights will be enforced in jurisdictions where competition may be intense or where legal protection may be weak;
any of the trademarks, copyrights, trade secrets or other intellectual property rights that we presently employ in our business will not lapse or be invalidated, circumvented, challenged or abandoned;
we will not lose the ability to assert our intellectual property rights against or to license our technology to others and collect consideration that we are entitled to under certain intellectual property sale agreements; or
our ability to monetize our portfolio through divestiture and/or exclusive licensing transactions will not be impacted by conduct of counterparties to any such transactions, and we will not face liability arising from our monetization efforts.
In addition, our competitors or others may design around our protected patents or technologies. Effective intellectual property protection may be unavailable or more limited in one or more relevant jurisdictions relative to those protections available in the United States, or may not be applied for in one or more relevant jurisdictions. If we pursue litigation to assert our intellectual property rights, an adverse decision in any of these legal actions could limit our ability to assert our intellectual property rights, limit the value of our technology or otherwise negatively impact our business, financial condition and results of operations.
85

Monitoring unauthorized use of our intellectual property is difficult and costly. Unauthorized use of our intellectual property may have occurred or may occur in the future. Although we have taken steps to minimize the risk of this occurring, any such failure to identify unauthorized use and otherwise adequately protect our intellectual property would adversely affect our business. Moreover, if we are required to commence litigation, whether as a plaintiff or defendant as has occurred in the past, not only will this be time-consuming, but we will also be forced to incur significant costs and divert our attention and efforts of our employees, which could, in turn, result in lower revenue and higher expenses.
We also rely on customary contractual protections with our customers, suppliers, distributors, employees and consultants, and we implement security measures to protect our trade secrets. We cannot assure you that these contractual protections and security measures will not be breached, that we will have adequate remedies for any such breach or that our suppliers, employees or consultants will not assert rights to intellectual property arising out of such contracts. For example, as described in Part II, Item 1 (Legal Proceedings), Comcast shared our proprietary designs with our direct competitor. Comcast then worked with our competitor to develop the FDX-amplifier technology. We have brought claims for trade secret misappropriation, unfair competition, and breach of the parties’ non-disclosure agreement, and sought an unspecified amount of compensatory damages, punitive damages, pre-judgment and post-judgment interest, costs, expenses, and attorney fees as well as an injunction against Comcast’s use or disclosure of our trade secrets. However, our claims may not be successful.
In addition, we have a number of third-party patent and intellectual property license agreements. Some of these license agreements require us to make one-time payments or ongoing royalty payments. Also, a few of our license agreements contain most-favored nation clauses or other price restriction clauses which may affect the amount we may charge for our products, processes or technology. We cannot guarantee that the third-party patents and technology we license will not be licensed to our competitors or others in the semiconductor industry. In the future, we may need to obtain additional licenses, renew existing license agreements or otherwise replace existing technology. We are unable to predict whether these license agreements can be obtained or renewed or the technology can be replaced on acceptable terms, or at all.
When we originally settled a trademark dispute with Analog Devices International Unlimited Company (ADIUC) and its predecessor, Linear Technology Corporation, we agreed not to register the “MAXLINEAR” mark or any other marks containing the term “LINEAR”. Pursuant to the original settlement agreement, we agreed not to use the “MAXLINEAR” mark on our products. We have since entered into another settlement agreement with ADIUC that now allows us to use and register the “MAXLINEAR” mark on our products, in addition to continuing to use “MAXLINEAR” as a corporate identifier, including to advertise our products and services. We have filed trademark applications to register the “MAXLINEAR” mark, but prior to approval of the applications and registration of the mark in the relevant jurisdictions, our ability to effectively prevent third parties from using the “MAXLINEAR” mark in connection with similar products or technology will be based on our common law rights in the mark, which may make enforcement challenging. If we are unable to protect our trademarks in certain jurisdictions, we may experience difficulties in achieving and maintaining brand recognition and customer loyalty in such jurisdictions.
We face risks related to security vulnerabilities in our products.
We regularly become aware of security vulnerabilities with respect to our products as well as intellectual property that we purchase or license from third parties for use in our products. Our products are used in application areas that create new or increased cybersecurity and privacy risks, including applications that gather and process large amounts of data, such as the cloud, Internet of Things, or artificial intelligence, and critical infrastructure, payment card applications, and automotive applications. Security features in our products cannot make our products entirely secure, and security vulnerabilities identified in our products have resulted in, and are expected to continue to result in, attempts by third parties to identify and exploit additional vulnerabilities. Vulnerabilities are not always mitigated before they become known. We, our customers, and the users of our products do not always promptly learn of or have the ability to fully assess the magnitude or effects of a vulnerability, including the extent, if any, to which a vulnerability has been exploited.
Mitigation techniques designed to address security vulnerabilities, including software and firmware updates or other preventative measures, are not always available on a timely basis, or at all, and at times do not operate as intended or effectively resolve vulnerabilities for all applications. In addition, we are often required to rely on third parties, including hardware, software, and services vendors, as well as our customers and end users, to develop and/or deploy mitigation techniques, and the availability, effectiveness, and performance impact of mitigation techniques can depend solely or in part on the actions of these third parties in determining whether, when, and how to develop and deploy mitigations. We and such third parties make prioritization decisions about which vulnerabilities to address, which can delay, limit, or prevent development or deployment of a mitigation and harm our reputation. Subsequent events or new information can develop that changes our assessment of the
86

impact of a security vulnerability, which can cause certain claims or customer satisfaction considerations, as well as result in litigation or regulatory inquiries or actions over these matters.
Security vulnerabilities and/or mitigation techniques can result in adverse performance or power effects, reboots, system instability or unavailability, loss of functionality, non-compliance with standards, data loss or corruption, unpredictable system behavior, decisions by customers, regulators and end users to limit or change the applications in which they use our products or product features, and/or the misappropriation of data by third parties. Security vulnerabilities and any limitations or adverse effects of mitigation techniques can adversely affect our results of operations, financial condition, customer relationships, prospects, and reputation in a number of ways, any of which may be material.
The use of open source software in our products, processes and technology may expose us to additional risks and harm our intellectual property.
Our products, processes and technology sometimes utilize and incorporate software that is subject to an open source license. Open source software is typically freely accessible, usable and modifiable. Certain open source software licenses require a user who intends to distribute the open source software as a component of the user’s software to disclose publicly part or all of the source code to the user’s software. In addition, certain open source software licenses require the user of such software to make any derivative works of the open source code available to others on unfavorable terms or at no cost. This can subject previously proprietary software to open source license terms.
While we monitor the use of all open source software in our products, processes and technology and try to ensure that no open source software is used in such a way as to require us to disclose the source code to the related product, processes or technology when we do not wish to do so, such use could inadvertently occur. Additionally, if a third-party software provider has incorporated certain types of open source software into software we license from such third party for our products, processes or technology, we could, under certain circumstances, be required to disclose the source code to our products, processes or technology. This could harm our intellectual property position and have a material adverse effect on our business, results of operations and financial condition.
Risks Relating to Reliance on Third-Parties
We do not have long-term supply contracts with most of our contract manufacturers or suppliers, and any disruption in our supply of products or materials could have a material adverse effect on our business, revenue and operating results.
Currently we do not have long-term supply contracts with most of our other third-party vendors, including but, not limited to Advanced Semiconductor Engineering, or ASE, TSMC, and United Microelectronics Corporation, or UMC. Certain products are supplied to us by Intel on a turnkey basis at agreed upon prices under terms of a supply agreement with an initial term of five years, which will expire in July 2025. Intel can also terminate its supply agreement with us under certain circumstances. If Intel does not continue to supply us with such products, we would need to seek alternative sources of supply for those products in a short timeframe, which would cause us to incur additional costs, could delay the sale of such products, and could increase our supply costs with a new vendor, which in turn, could negatively impact our revenue and our gross margins. Alternatively, if Intel does continue to supply us with such products, the costs of such products would likely increase and reduce our margins on such products, and their minimum purchase requirements may exceed our current customer demand.
We make substantially all of our purchases on a purchase order basis, and our contract manufacturers are not required to supply us products for any specific period or in any specific quantity. Foundry capacity may not be available when we need it or at reasonable prices. Availability of foundry capacity has in the past been reduced from time to time due to strong demand. Foundries can allocate capacity to the production of other companies’ products and reduce deliveries to us on short notice. It is possible that foundry customers that are larger and better financed than we are, or that have long-term agreements with our foundry, may induce our foundry to reallocate capacity to them. This reallocation could impair our ability to secure the supply of components that we need. We generally place orders for products with some of our suppliers approximately four to five months prior to the anticipated delivery date, with order volumes based on our forecasts of demand from our customers. Accordingly, if we inaccurately forecast demand for our products or if orders are placed with a short lead-time, we may be unable to obtain adequate and cost-effective foundry or assembly capacity from our third-party contractors to meet our customers’ delivery requirements, which could harm our reputation and customer relationships, or we may accumulate excess inventories. On occasion, we have been unable to adequately respond to unexpected increases in customer purchase orders and therefore were unable to benefit from this incremental demand. None of our third-party contractors has provided any assurance to us that adequate capacity will be available to us within the time required to meet additional demand for our products.
87

We do not have our own manufacturing facilities and rely on a limited number of third parties to manufacture, assemble, and test our products. The failure to manage our relationships with our third-party contractors successfully, or impacts from volatility in global supply, natural disasters, public health crises, or other labor stoppages in the regions where such contractors operate, could adversely affect our ability to market and sell our products.
We operate an outsourced manufacturing business model that utilizes third-party foundry and assembly and test capabilities. As a result, we rely on third-party foundry wafer fabrication, including sole sourcing for many components or products. Currently, a large portion of our products are manufactured by ASE, TSMC, and UMC, at foundries located in Taiwan, Singapore, and China. We also use third-party contractors for all of our assembly and test operations. We also rely on Intel Corporation, or Intel, for certain products on a turnkey basis at agreed upon prices under terms of a supply agreement with an initial term of five years, which will expire in July 2025 and may be terminated by Intel under certain circumstances.
Relying on third-party manufacturing, assembly and testing presents significant risks to us, including the following:
capacity shortages during periods of high demand or from events beyond our control or inventory oversupply during periods of decreased demand. For example, we have experienced and could continue to experience inventory oversupply in certain of our products due to changes in customer demand which has added to volatility in managing the business. Inventory oversupply has also led and could continue to lead to inventory write-downs, including charges for any excess or obsolete inventory, which could negatively impact our gross margins;
failure by us, our customers, or their end customers to qualify a selected supplier;
reduced control over delivery schedules and quality;
shortages of materials;
misappropriation of our intellectual property;
limited warranties on wafers or products supplied to us;
potential increases in costs of our products;
costs to switch to alternate sources of supply for certain products and/or delays in sales of such products, if a supplier does not continue to supply certain products; and
our use of foundry partners who are currently subject to BIS restrictions, such as SMIC, to manufacture certain of our products may be impaired if one or more of the following were to occur: (1) we are unable to obtain U.S. export licenses authorizing its interactions and technology exchanges with these foundry partners or if there are delays in obtaining such licenses, or (2) if BIS increases export control restrictions to Chinese foundries without the ability for us to obtain a U.S. export license, or (3) U.S. providers of semiconductor manufacturer equipment are unable to export such equipment or related spare or replacement parts used in the manufacture of our products, or obtain a license to export such equipment and parts, to current or future Chinese foundry partners.
The ability and willingness of our third-party contractors to perform is largely outside our control. If one or more of our contract manufacturers or other outsourcers fails to perform its obligations in a timely manner or at satisfactory quality levels, our ability to bring products to market and our reputation could suffer. For example, in the event that manufacturing capacity is reduced or eliminated at one or more facilities, manufacturing could be disrupted, we could have difficulties fulfilling our customer orders and our net revenue could decline. In addition, if these third parties fail to deliver quality products and components on time and at reasonable prices, we could have difficulties fulfilling our customer orders, our net revenue could decline and our business, financial condition and results of operations would be adversely affected.
88

Additionally, our product shipment and manufacturing capacity may be similarly reduced or eliminated at one or more facilities due to the fact that the majority of our fabrication and assembly and test contractors are all located in the Pacific Rim region, principally in China, Taiwan, and Singapore. The risk of earthquakes in these geographies is significant due to the proximity of major earthquake fault lines, and Taiwan in particular is also subject to typhoons and other Pacific storms, and more recently, a drought impacting the water supply which chip manufacturers rely upon to fabricate chip products. Earthquakes, fire, flooding, drought, or other natural disasters in Taiwan or the Pacific Rim region, or political unrest, war, labor strikes, work stoppages or public health crises, such as the outbreak of COVID-19, in countries where our contractors’ facilities are located could result in the disruption of our product shipments, foundry, assembly, or test capacity. If such disruption were to recur over a prolonged period, it could have a material impact on our revenues and our business. Any disruption resulting from similar events on a larger scale or over a prolonged period could cause significant delays in shipments of our products until we are able to resume such shipments, or shift our manufacturing, assembly, or test from the affected contractor to another third-party vendor, if needed. If such disruption were to recur over a prolonged period, it could have a material impact on our revenue and business. There can be no assurance that alternative capacity could be obtained on favorable terms, if at all.
We are subject to risks associated with our distributors’ product inventories and product sell-through. Should any of our distributors cease or be forced to stop distributing our products, our business would suffer.
We currently sell a significant portion of our products to customers through our distributors, who maintain their own inventories of our products. Sales to distributors accounted for approximately 42%, and 47% of our net revenue in the nine months ended September 30, 2024, and 2023, respectively. Upon shipment of product to these distributors, title to the inventory transfers to the distributor and the distributor is invoiced, generally with 30 to 60 day terms. Distributor sales are also recognized upon shipment to the distributor and estimates of future pricing credits and/or stock rotation rights reduce revenue recognized to the net amount before the actual amounts are known. If our estimates of such credits and rights are materially understated it could cause subsequent adjustments that negatively impact our revenues and gross profits in a future period.
If our distributors are unable to sell an adequate amount of their inventories of our products in a given quarter to manufacturers and end users or if they decide to decrease their inventories of our products for any reason, our sales through these distributors and our revenue may decline. In addition, if some distributors decide to purchase more of our products than are required to satisfy end customer demand in any particular quarter, inventories at these distributors would grow in that quarter. These distributors could then reduce future orders until inventory levels realign with end customer demand, which has in the past and could in the future adversely affect our product revenue.
Our reserve estimates with respect to the products stocked by our distributors are based principally on reports provided to us by our distributors, typically on a weekly basis. To the extent that this resale and channel inventory data is inaccurate or not received in a timely manner, we may not be able to make reserve estimates accurately or at all.
We rely on third parties to provide services and technology necessary for the operation of our business. Any failure of one or more of our partners, vendors, suppliers or licensors to provide these services or technology could have a material adverse effect on our business.
We rely on third-party vendors to provide critical services, including, among other things, services related to accounting, billing, compliance, internal audit, human resources, information technology, network development, network monitoring, in-licensing and intellectual property that we cannot or do not create or provide ourselves. We depend on these vendors to ensure that our corporate infrastructure will consistently meet our business requirements and legal obligations. The ability of these third-party vendors to successfully provide reliable and high quality services is subject to technical and operational uncertainties that are beyond our control. While we may be entitled to damages if our vendors fail to perform under their agreements with us, our agreements with these vendors limit the amount of damages we may receive. In addition, we do not know whether we will be able to collect on any award of damages or that these damages would be sufficient to cover the actual costs we would incur as a result of any vendor’s failure to perform under its agreement with us. Any failure of our corporate infrastructure could have a material adverse effect on our business, financial condition and results of operations. Upon expiration or termination of any of our agreements with third-party vendors, we may not be able to replace the services provided to us in a timely manner or on terms and conditions, including service levels and cost, that are favorable to us and a transition from one vendor to another vendor could subject us to operational delays and inefficiencies until the transition is complete.
Additionally, we incorporate third-party technology into and with some of our products, and we may do so in future products. The operation of our products could be impaired if errors occur in the third-party technology we use, including as a result of information technology failures from cyber-attacks on or security breaches of third parties. It may be more difficult for
89

us to correct any errors in a timely manner if at all because the development and maintenance of the technology is not within our control. There can be no assurance that these third parties will continue to make their technology, or improvements to the technology, available to us, or that they will continue to support and maintain their technology. Further, due to the limited number of vendors of some types of technology, it may be difficult to obtain new licenses or replace existing technology. Any impairment of the technology or our relationship with these third parties could have a material adverse effect on our business.
Risks Relating to Our Common Stock
Our share price may be volatile as a result of various factors.
The trading price of our common stock is highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. For example, in the nine months ended September 30, 2024, the trading price of our common stock ranged from a low of $11.08 to a high of $26.59. These factors include those discussed in this “Risk Factors” section of this report and others such as:
any developments related to our terminated merger with Silicon Motion;
actual or anticipated fluctuations in our financial condition and operating results;
overall conditions in the semiconductor market;
addition or loss of significant customers;
changes in laws or regulations applicable to our products, including export controls;
geopolitical changes impacting our business and markets, including with respect to China and Taiwan and the upcoming U.S. presidential election;
actual or anticipated changes in our growth rate relative to our competitors;
announcements of technological innovations by us or our competitors;
announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, or capital commitments;
departures of, and inability to attract, qualified key personnel;
competition from existing products or new products that may emerge;
issuance of new or updated research or reports by securities analysts;
fluctuations in the valuation of companies perceived by investors to be comparable to us;
disputes or other developments related to proprietary rights, including patents, litigation matters, and our ability to obtain intellectual property protection for our technologies;
actions by institutional or activist stockholders;
acquisitions may not be accretive and may cause dilution to our earnings per share;
announcement or expectation of additional financing efforts;
sales of our common stock by us or our stockholders; and
general economic and market conditions, including the impacts from sanctions against Russia and the military conflicts in Ukraine and among Israel, Iran and Lebanon, increased inflationary pressures, and interest rate changes.
Furthermore, the stock markets have experienced extreme price and volume fluctuations that have affected the market prices of equity securities of many companies, including us. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political, and market conditions such as recessions, interest rate changes or international currency fluctuations, may negatively impact the market price of our common stock.
90

In the past, companies that have experienced volatility in the market price of their stock are attractive to momentum, hedge, day-trading, or activist investors who often shift funds into and out of stocks rapidly, exacerbating price fluctuations in either direction, and have also been subject to securities class action litigation. We may be the target of momentum, hedge, day-trading, or activist investors, and have been and may continue to be the target of securities class action litigation in the future. Stockholder activism or securities litigation against us could result in substantial costs and divert our management’s attention from other business concerns, which could seriously harm our business. A proxy contest or other activist behaviors could have an adverse effect on us.
Even if a proxy contest or other activist efforts are not successful, the increased costs that we would bear and the distraction of our Board of Directors and senior management could negatively impact our business, although we cannot predict with certainty the extent of such negative impacts.
Our management team may use our available cash and cash equivalents in ways with which you may not agree or in ways which may not yield a return.
We use our cash and cash equivalents for general corporate purposes, including working capital and for repayment of outstanding long-term debt. We may also, in the future, use a portion of our assets to acquire other complementary businesses, products, services or technologies. Our management has considerable discretion in the application of our cash and cash equivalents, and resources, and you will not have the opportunity to assess whether these liquid assets are being used in a manner that you deem best to maximize your return. We may use our available cash and cash equivalents and resources for corporate purposes that do not increase our operating results or market value. In addition, in the future our cash and cash equivalents, and resources may be placed in investments that do not produce significant income or that may lose value.
Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of us more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our common stock.
Provisions in our certificate of incorporation and bylaws, as amended and restated, may have the effect of delaying or preventing a change of control or changes in our management. These provisions provide for the following:
authorize our Board of Directors to issue, without further action by the stockholders, up to 25,000,000 shares of undesignated preferred stock;
require that any action to be taken by our stockholders be effected at a duly called annual or special meeting and not by written consent;
specify that special meetings of our stockholders can be called only by our Board of Directors, our Chairman of the Board of Directors, or our President;
establish an advance notice procedure for stockholder approvals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to our Board of Directors;
establish that our Board of Directors is divided into three classes, Class I, Class II and Class III, with each class serving staggered terms;
provide that our directors may be removed only for cause;
provide that vacancies on our Board of Directors may be filled only by a majority of directors then in office, even though less than a quorum;
specify that no stockholder is permitted to cumulate votes at any election of directors; and
require supermajority votes of the holders of our common stock to amend specified provisions of our charter documents.
91

These provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our Board of Directors, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law, which generally restricts a Delaware corporation from engaging in any of a broad range of business combinations with any “interested” stockholder for a period of three years following the date on which the stockholder became an “interested” stockholder.
If securities or industry analysts do not publish research or reports about our business, or publish negative reports about our business, our share price and trading volume could decline.
The trading market for our common stock depends in part on the research and reports that securities or industry analysts publish about us or our business. We do not have any control over these analysts. If one or more of the analysts who cover us downgrade our shares or change their opinion of our shares, our share price would likely decline. If one or more of these analysts cease coverage of us or fails to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline.
Future sales of our common stock in the public market could cause our share price to decline.
Sales of a substantial number of shares of our common stock in the public market, or the perception that these sales might occur, could depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. As of September 30, 2024, we had approximately 84.4 million shares of common stock outstanding.
All shares of our common stock are freely tradable without restrictions or further registration under the Securities Act unless held by our “affiliates,” as that term is defined under Rule 144 of the Securities Act.
Our Executive Incentive Bonus Plan permits the settlement of awards under the plan in the form of shares of our common stock. We have issued shares of our common stock to settle such bonus awards for our employees, including executives, for the 2014 to 2023 performance periods, and we intend to continue this practice in the foreseeable future, subject to availability of such shares under our stock plans. We issued 0.4 million shares of our common stock for the 2023 performance period in February 2024. If we issue additional shares of our common stock to settle bonus awards in the future, such shares may be freely sold in the public market immediately following the issuance of such shares, subject to the applicable conditions of Rule 144 and our insider trading policy, and the issuance of such shares may have a material adverse effect on our share price once they are issued.
We do not intend to pay dividends for the foreseeable future.
We have never declared or paid any cash dividends on our common stock and do not intend to pay any cash dividends in the foreseeable future. We anticipate that we will retain all of our future earnings for use in the development of our business and for general corporate purposes. Any determination to pay dividends in the future will be at the discretion of our Board of Directors. Accordingly, investors must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investments.
General Risk Factors
If we suffer losses to our facilities or distribution system due to catastrophe, our operations could be seriously harmed.
Our facilities and distribution system, and those of our third-party contractors, are subject to risk of catastrophic loss due to fire, flood, drought or other natural or man-made disasters. A number of our facilities and those of our contract manufacturers are located in areas with above average seismic activity and/or which have experienced more frequent, more extreme and less predictable weather conditions. For example, the risk of an earthquake in the Pacific Rim region, including Taiwan, or Southern California is significant due to the proximity of major earthquake fault lines, and Taiwan in particular is also subject to typhoons and other Pacific storms, and more recently, a drought impacting the water supply which chip manufacturers rely upon to fabricate chip products. We have experienced higher insurance costs and may experience a decrease in available coverage in such areas and an increased likelihood of damage, power outages and catastrophic loss to these facilities, which would likely disrupt our operations, delay production, shipments and revenue and result in significant expenses to repair or replace the facility. The majority of the factories we use for foundry, assembly and test, and warehousing services, are located in Asia, principally in China, Taiwan, South Korea, Malaysia, Singapore and Thailand. Our corporate headquarters is located in Southern California. Our operations and financial condition could be seriously harmed in the event of a major
92

earthquake, fire, flooding, drought, or other natural disasters in Taiwan or the Pacific Rim region, or political unrest, war, labor strikes, work stoppages or public health crises, such as the outbreak of COVID-19, or other natural or man-made disaster in countries where our contractors’ facilities are located. Such catastrophes could result in the disruption of our product shipments, foundry, assembly, or test capacity.
We have recorded goodwill and other intangible assets in connection with business acquisitions. Goodwill and other acquired intangible assets could become impaired and adversely affect our future operating results.
We account for business acquisitions as business combinations under the acquisition method of accounting in accordance with accounting principles generally accepted in the United States. Under the acquisition method of accounting, the total purchase price is allocated to net tangible assets and identifiable intangible assets of acquired businesses based on their fair values as of the date of completion of the acquisition. The excess of the purchase price over those fair values is recorded as goodwill. Our acquisitions have resulted in the creation of goodwill and recording of a large amount of intangible assets based upon the application of the acquisition method of accounting. To the extent the value of goodwill or other intangible assets become impaired, we may be required to incur material charges relating to such impairment. We conduct our annual goodwill and indefinite-lived intangible asset impairment analysis on October 31 each year, or more frequently if we believe indicators of impairment exist. Our reported financial condition and results of operations reflect the balances and results of the acquired businesses but are not restated retroactively to reflect the historical financial position or results of operations of acquired businesses for periods prior to the acquisitions. As a result, comparisons of future results against prior period results will be more difficult for investors. In addition, there can be no guarantee that acquired intangible assets, particularly in-process research and development, will generate revenues or profits that we include in our forecast that is the basis for their fair values as of the acquisition date. Any such impairment charges relating to goodwill or other intangible assets could have a material impact on our operating results in future periods, and the announcement of a material impairment could have a material adverse effect on the trading price and trading volume of our common stock. As of September 30, 2024, our balance sheet reflected goodwill of $318.6 million and other intangible assets of $58.0 million. Consequently, we could recognize material impairment charges in the future.
Unanticipated changes in our tax rates or unanticipated tax obligations could affect our future results.
We are subject to income taxes in the United States, Singapore and various other foreign jurisdictions. The amount of income taxes we pay is subject to our interpretation and application of tax laws in jurisdictions in which we file. Changes in current or future laws or regulations, the imposition of new or changed tax laws or regulations or new interpretations by taxing authorities or courts could affect our results of operations and lead to volatility with respect to tax expenses and liabilities from period to period. For example, beginning in 2022, the Tax Cuts and Jobs Act, or the Tax Act, eliminated the option to deduct research and development expenditures currently and requires taxpayers to capitalize and amortize them over five or fifteen years pursuant to Internal Revenue Code Section 174. This has increased our effective tax rate and our cash tax payable since 2022. Further, following the enactment of the Tax Act, most of our income is now subject to U.S. taxation, with a large portion taxed under the Global Intangible Low-Taxed Income, or GILTI, regime. Starting in 2026, the GILTI deduction will decrease from 50% to 37.5%, leading to a higher effective tax rate on our income. The application of tax laws and related regulations is subject to legal and factual interpretation, judgment and uncertainty. We cannot determine whether any legislative proposals may be enacted into law or what, if any, changes may be made to such proposals prior to their being enacted into law. If U.S. or international tax laws change in a manner that increases our tax obligation, it could result in a material adverse impact on our results of operations and our financial position. In addition, many countries are implementing legislation and other guidance to align their international tax rules with the Organisation for Economic Co-operation and Development’s, or OECD, Base Erosion and Profit Shifting recommendations and action plan that aim to standardize and modernize global corporate tax policy, including changes to cross-border tax, transfer pricing documentation rules, and nexus-based tax incentive practices. The OECD is also continuing discussions surrounding fundamental changes in allocation of profits among tax jurisdictions in which companies do business, as well as the implementation of a global minimum tax (namely the “Pillar One” and “Pillar Two” proposals). The European Union and other countries (including those in which we operate) have enacted or committed to enact global minimum taxes, which may adversely impact our provision for income taxes, existing tax incentives, net income and cash flows. As a result of this heightened scrutiny, prior decisions by tax authorities regarding treatments and positions of corporate income taxes could be subject to enforcement activities, and legislative investigation and inquiry, which could also result in changes in tax policies or prior tax rulings. Any such changes may also result in the taxes we previously paid being subject to change.
93

Our income tax provision is subject to volatility and our ability to use our deferred tax assets to offset future taxable income may be limited since we are subject to tax examinations, which may adversely impact our future effective tax rate and operating results.
Excess tax benefits associated with employee stock-based compensation are included in income tax expense. However, since the amount of such excess tax benefits and deficiencies depend on the fair market value of our common stock, our income tax provision is subject to volatility in our stock price and in the future, could unfavorably affect our future effective tax rate.
Our future effective tax rate could be unfavorably affected by unanticipated changes in the valuation of our deferred tax assets and liabilities, and the ultimate use and depletion of these various tax credits and net operating loss carryforwards. Changes in our effective tax rate could have a material adverse impact on our results of operations. We record a valuation allowance to reduce our net deferred tax assets to the amount that we believe is more likely than not to be realized. In making such determination, we consider all available positive and negative evidence quarterly, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. To the extent we believe it is more likely than not that some portion of our deferred tax assets will not be realized, we record a valuation allowance against the deferred tax asset. Realization of our deferred tax assets is dependent primarily upon future taxable income in the applicable jurisdiction. On a periodic basis we evaluate our deferred tax assets for realizability. Based upon our review of all positive and negative evidence, as of September 30, 2024, we continue to have a valuation allowance on state deferred tax assets, certain federal deferred tax assets, and certain foreign deferred tax assets in jurisdictions where we have cumulative losses or otherwise are not expected to utilize certain tax attributes. The impact of releasing some or all of such valuation allowance in a future period could be material in the period in which such release occurs. Additionally, the amount of the deferred tax asset considered realizable, however, could be adjusted in the subsequent periods if estimates of future taxable income are reduced or if objective negative evidence in the form of cumulative losses is present. Any future changes in the deferred tax asset realizability assertion may require a valuation allowance to reduce our deferred tax assets, which would increase our tax expense in the period the allowance is recognized and affect our results of operations.
Our corporate income tax liability could materially increase if tax incentives we have negotiated in Singapore cease to be effective or applicable or if we are challenged on our use of such incentives.
We operate under certain favorable tax incentives in Singapore which are effective through March 2027, and generally are dependent on our meeting certain headcount and investment thresholds. Such incentives allow certain qualifying income earned in Singapore to be taxed at reduced rates and are conditional upon our meeting certain employment and investment thresholds over time. If we fail to satisfy the conditions for receipt of these tax incentives, or to the extent U.S. or other tax authorities challenge our operation under these favorable tax incentive programs or our intercompany transfer pricing agreements, our taxable income could be taxed at higher federal or foreign statutory rates and our income tax liability and expense could materially increase beyond our projections. Each of our Singapore tax incentives is separate and distinct from the others, and may be granted, withheld, extended, modified, truncated, complied with or terminated independently without any effect on the other incentives. Absent these tax incentives, our corporate income tax rate in Singapore would generally be the 17% statutory tax rate. We are also subject to operating and other compliance requirements to maintain our favorable tax incentives. If we fail to comply with such requirements, we could lose the tax benefits and could possibly be required to refund previously realized material tax benefits. Additionally, in the future, we may fail to qualify for renewal of our favorable tax incentives or such incentives may not be available to us, which could also cause our future taxable income to increase and be taxed at higher statutory rates. Loss of one more of our tax incentives could cause us to modify our tax strategies and our operational structure, which could cause disruption in our business and have a material adverse impact on our results of operations. Further, there can be no guarantee that such modification in our tax strategy will yield tax incentives as favorable as those we have negotiated with Singapore. Our interpretations and conclusions regarding the tax incentives are not binding on any taxing authority, and if our assumptions about tax and other laws are incorrect or if these tax incentives are substantially modified or rescinded we could suffer material adverse tax and other financial consequences, which would increase our expenses, reduce our profitability and adversely affect our cash flows.
Investor confidence may be adversely impacted if we are unable to comply with Section 404 of the Sarbanes-Oxley Act of 2002, and as a result, our stock price could decline.
We are subject to rules adopted by the SEC pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, or Sarbanes-Oxley Act, which require us to include in our Annual Report on Form 10-K our management’s report on, and assessment of the effectiveness of, our internal controls over financial reporting.
94

If we fail to maintain the adequacy of our internal controls, there is a risk that we will not comply with all of the requirements imposed by Section 404. Moreover, effective internal controls, particularly those related to revenue recognition, are necessary for us to produce reliable financial reports and are important to helping prevent financial fraud. Any of these possible outcomes could result in an adverse reaction in the financial marketplace due to a loss of investor confidence in the reliability of our consolidated financial statements and could result in investigations or sanctions by the SEC, the Nasdaq Stock Market LLC, or Nasdaq, or other regulatory authorities or in stockholder litigation. Any of these factors ultimately could harm our business and could negatively impact the market price of our securities. Ineffective control over financial reporting could also cause investors to lose confidence in our reported financial information, which could adversely affect the trading price of our common stock.
Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives. However, our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected.
ITEM 2.    UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Recent Sales of Unregistered Securities
None.
Recent Repurchases of Equity Securities
None.
ITEM 3.    DEFAULTS UPON SENIOR SECURITIES
None.

ITEM 4.    MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.    OTHER INFORMATION
Securities Trading Plans of Directors and Executive Officers
During our last fiscal quarter, no director or officer, as defined in Rule 16a-1(f), adopted or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Regulation S-K Item 408.
95

ITEM 6.    EXHIBITS
Exhibit NumberExhibit Title
31.1
31.2
32.1(*)
10.1+
101.INSInline XBRL Instance Document - the instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
+Indicates a management contract or compensatory plan.
(*)In accordance with Item 601(b)(32)(ii) of Regulation S-K and SEC Release No. 33-8238 and 34-47986, Final Rule: Management’s Reports on Internal Control Over Financial Reporting and Certification of Disclosure in Exchange Act Periodic Reports, the certifications furnished pursuant to this item will not be deemed “filed” for purposes of Section 18 of the Exchange Act (15 U.S.C. 78r), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

96


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
  MAXLINEAR, INC.
  (Registrant)
Date:October 23, 2024  By: /s/ Steven G. Litchfield
   Steven G. Litchfield
   
Chief Financial Officer and Chief Corporate Strategy Officer
(Principal Financial Officer and Duly Authorized Officer)


97
EX-10.1 2 a9302024ex101separationagr.htm EX-10.1 Document

Exhibit 10.1

Employer SEPARATION AGREEMENT AND RELEASE

This Separation Agreement and Release (“Agreement”) is made by and Michelle Sayer (“Employee”) and MaxLinear, Inc. (“MaxLinear” or the “Company”) (collectively referred to as the “Parties” or individually referred to as a “Party”).

RECITALS
WHEREAS, Employee was employed by the Company;

WHEREAS, Employee signed an Offer of Employment letter agreement dated April 26, 2022 as well as a Change In Control and Severance Agreement dated June 2, 2022 (collectively the “Severance Agreement”);

WHEREAS, Employee also signed an Indemnity Agreement dated May 5, 2022 (the “Indemnity Agreement”).

WHEREAS, the Company and Employee have entered into certain restricted stock unit agreements granting Employee the right to purchase Company’s restricted stock units (the “RSUs”) subject to the terms and conditions of the Company’s 2007 or 2010 Stock Plan (as applicable) and the applicable restricted stock unit agreements (collectively the “Restricted Stock Agreements”) (together with the Assumed Stock Option Agreements, the “Stock Agreements”) and Employee acknowledges receipt of the Memorandum dated August 28, 2024 setting forth your Securities Laws Obligations as a Departing Executive Officer .

WHEREAS, the Employer has elected to exercise its right to terminate the at will employment as an Involuntary Termination Not in Connection with a Change of Control as permitted by and per the terms of the Severance Agreement and as stated in the Company Form 8-K dated August of 2024 relating to the same with an effective date of October 1, 2024 (the “Separation Date”);

WHEREAS, the Parties wish to resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions, and demands that the Employee may have against the Company and any of the Releasees as defined below, including, but not limited to, any and all claims arising out of or in any way related to Employee’s employment with or separation from the Company;

NOW, THEREFORE, in consideration of the mutual promises made herein, the Company and Employee hereby agree as follows:

COVENANTS

1.Consideration. In consideration of Employee’s execution of this Agreement and Employee’s fulfillment of all of its terms and conditions, and provided that Employee does not revoke the Agreement under Section 5(c) below, the Company agrees to the following:
1


(a)Severance Pay. The Company agrees to pay Employee 10 months’ salary in a lump sum total THREE HUNDRED EIGHT THOUSAND THREE HUNDRED AND THIRTY-THREE DOLLARS ($308,333), less applicable withholding. This payment will be made within fifteen (15) business days after the Effective Date (as defined below).

(b)COBRA. If Employee was enrolled and participating in the Company’s health benefit plans at the time of termination, the Company shall reimburse Employee for the payments Employee makes for COBRA coverage for a period 9 months commencing on November 1. 2024, provided Employee timely elects and pays for continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), within the time period prescribed pursuant to COBRA. COBRA reimbursements shall be made by the Company to Employee consistent with the Company’s normal expense reimbursement policy, provided that Employee submits documentation to the Company substantiating Employee’s payments for COBRA coverage. Reimbursement of actual COBRA costs shall be submitted no later than 6 months from the effective date of COBRA coverage. Notwithstanding the foregoing, if the Company determines at any time that its payments pursuant to this paragraph may be taxable income to Employee, it may convert such payments to payroll payments directly to Employee, which shall be subject to tax-related deductions and withholdings.

(c)Bonus. The Company agrees to pay employee a 2024 Bonus based on 275 days of the calendar year or 75% of the year at a 60% target resulting in a payment of $166,500 within 15 business days after the Effective Date (as defined below).

(d)Stock Vesting. The Company and Employee agree the following Table reflects the Vesting of Shares in the 2010 Equity Incentive Plan as of the Termination Date for 2024 and through June 1, 2025, which is also a vesting of shares to which the Employee is otherwise not entitled absent this Separation Agreement subject to exercise within 6 months after the Separation Date as set forth in the Severance Agreement. Shares can be accelerated in the first open trading window post termination, which we anticipate to be on or about October 25, 2024. Once started this process may take up to 10 business days to complete:

2


Sum of Vested SharesCY of VESTING
VESTED IN 2024VESTING IN 2025GRAND
Grant Type2/20/20245/20/20241/31/20252/20/20255/20/2025TOTAL
NQ
  000241256,4626,462
PSU
  P600008
  P700007
RSU
  000178978,3938,39316,786
  000186431,1481,1482,296
  000224223,3773,377
  000238622,4502,450
  000241059,5739,573
Grand Total3,5988,39320,5608,39340,944
*Please note that Vest Shares for PSUs are based on current Goal Status and is subject to change.

(e)Acknowledgement. Employee acknowledges that without this Agreement, Employee is otherwise not entitled the full consideration listed in this Section 1.

2.Benefits. If Employee was enrolled and participating in the Company’s health benefit plans at the time of termination, Employee’s health insurance benefits shall cease on October 31, 2024, subject to Employee’s right to continue Employee’s health insurance under COBRA. Employee’s participation in all other benefits and incidents of employment, including, but not limited to, vesting in any stock options and/or restricted stock units; participation in other group insurance programs; and the accrual of bonuses, vacation, or paid time off, ceased as of the Separation Date other than as set forth in this Agreement. Under the terms of the Severance Agreement, Employee would be entitled to 6 months of Cobra reimbursement, but in exchange for the execution of this Separation Agreement, the Company has agreed to extend the Cobra reimbursement period up to 9 months commencing on November 1, 2024.

3.Payment of Salary and Receipt of All Benefits. Employee acknowledges and represents that, other than the consideration set forth in this Agreement, the Company has timely paid or provided all applicable salary, wages, bonuses, commissions, accrued vacation/paid time off, premiums, leaves, housing allowances, relocation costs, interest, severance, outplacement costs, fees, reimbursable expenses, commissions, stock, stock options, restricted stock units, vesting, and any and all other benefits and compensation due to Employee. No other benefits or payments of any kind are owed to Employee other than as expressly set forth in this Agreement. Employee shall submit proper documentation to seek reimbursement for any reimbursable expenses on or before September 13 such that all such proper and lawful reimbursable expenses shall be paid on or before the Separation Date. The Company agrees to reimburse Employee for any reasonable and
3


necessary expenses incurred through the Termination Date such as Employee’s phone bill which can be submitted and processed post termination.

4.Release of Claims by Employee. Employee agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Employee by the Company, its subsidiaries, parent companies, predecessors, successors or any direct or indirect related corporation or any current or former officers, directors, employees, agents, investors, attorneys, shareholders, administrators, affiliates, benefit plans, plan administrators, professional employer organization or co-employer, insurers, trustees, divisions or assigns of any of the foregoing (collectively, the “Releasees”). Employee, on Employee’s own behalf and on behalf of Employee’s respective heirs, family members, executors, agents, and assigns, hereby and forever releases the Releasees from, and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, demand, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Employee may possess against any of the Releasees arising from any omissions, acts, facts, or damages that have occurred up until and including the Effective Date of this Agreement (the “Employee Released Claims”). The Employee Released Claims include without limitation:

(a)any and all claims relating to or arising from Employee’s employment relationship with the Company and the termination of that relationship;

(b)any and all claims relating to, or arising from, Employee’s right to purchase, or actual purchase of shares of stock of the Company, or restricted stock units, including, without limitation, any claims for fraud, misrepresentation, breach of fiduciary duty, breach of duty under applicable state corporate law, and securities fraud under any state or federal law;

(c)any and all claims for wrongful discharge of employment; termination in violation of public policy; discrimination; harassment; retaliation; breach of contract, both express and implied; breach of covenant of good faith and fair dealing, both express and implied; promissory estoppel; negligent or intentional infliction of emotional distress; fraud; negligent or intentional misrepresentation; negligent or intentional interference with contract or prospective economic advantage; unfair business practices; defamation; libel; slander; negligence; personal injury; assault; battery; invasion of privacy; false imprisonment; conversion; and disability benefits;

(d)any and all claims for violation of any federal, state, or municipal statute, including, but not limited to, Title VII of the Civil Rights Act of 1964; the Civil Rights Act of 1991; the Rehabilitation Act of 1973; the Americans with Disabilities Act of 1990; the Equal Pay Act; the Fair Labor Standards Act; the Fair Credit Reporting Act; the Age Discrimination in Employment Act of 1967; the Older Workers Benefit Protection Act; the Employee Retirement Income Security Act of 1974; the federal Worker Adjustment and Retraining Notification Act; the Family and Medical Leave Act; the Sarbanes-Oxley Act of 2002; the California Family Rights Act; the California Labor Code; California Labor Code
4


sections 132a and 4553; the California Worker Adjustment and Retraining Notification Act; the California Fair Employment and Housing Act; the Massachusetts Payment of Wages Law (the “Wage Act”), and any and all claims for violation of any other federal, state, or local law, rule, regulation, or ordinance that can be waived under applicable law;

(e)any and all claims for violation of the federal or any state constitution;

(f)any and all claims arising out of any other laws and regulations relating to employment or employment discrimination, whether under state, local or federal law, or the common law;

(g)any claim for any loss, cost, damage, or expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Employee as a result of this Agreement; and

(h)any and all claims for attorneys’ fees and costs.

Employee agrees that the release set forth in this section shall be and remain in effect in all respects as a complete general release as to the matters released. This release does not extend to any obligations incurred under this Agreement. This release does not release claims that cannot be released as a matter of law or waive the right to engage in any Protected Activity (as defined below). This release does not extend to any right Employee may have to unemployment or workers’ compensation benefits. This release does not release any rights Employee may have to seek coverage or indemnity for any claims made against Employee arising out of or relating to her employment and/or her right to seek coverage, defense or indemnity for any such claims under the Indemnity Agreement or pursuant to any Company policy of insurance including its Officers and Directors policy.

5.Acknowledgment of Waiver of Claims under ADEA. Employee understands and acknowledges that Employee is waiving and releasing any rights Employee may have under the Age Discrimination in Employment Act of 1967 (“ADEA”), and that this waiver and release is knowing and voluntary. Employee understands and agrees that this waiver and release does not apply to any rights or claims that may arise under the ADEA after the Effective Date of this Agreement. Employee understands and acknowledges that some of the consideration given for this waiver and release is in addition to anything of value to which Employee was already entitled. Employee further understands and acknowledges that Employee has been advised by this writing that: (a) Employee should consult with an attorney prior to executing this Agreement; (b) Employee has twenty-one (21) days within which to consider this Agreement; (c) Employee has seven (7) days following Employee’s execution of this Agreement to revoke this Agreement; (d) this Agreement shall not be effective until after the revocation period has expired; and (e) nothing in this Agreement prevents or precludes Employee from challenging or seeking a determination in good faith of the validity of this waiver under the ADEA, nor does it impose any condition precedent, penalties, or costs for doing so, unless specifically authorized by federal law. In the event Employee signs this Agreement and returns it to the Company in less than the 21-day period identified above, Employee hereby acknowledges that Employee has freely and voluntarily chosen to waive the time period
5


allotted for considering this Agreement. Employee acknowledges and understands that revocation must be accomplished by a written notification to the person executing this Agreement on the Company’s behalf that is received prior to the eighth day after Employee signs this Agreement. The Parties agree that changes, whether material or immaterial, do not restart the running of the 21-day period.

6.Release of Unknown Claims. The Company and Employee waive and relinquishes all of their rights and benefits afforded under the provisions of California Civil Code Section 1542 and any other state statutes that otherwise prohibit the release of unknown claims. California Civil Code Section 1542 provides as follows:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.

The Company and Employee have had the opportunity to have the consequences of the above Section 1542 waiver explained to them by counsel of their choosing. Being aware of said code section, the Company and Employee agree to expressly waive any rights they may have thereunder, as well as under any other statute or common law principles of similar effect. The Company and Employee acknowledges that they may in the future discover facts different from, or in addition to, those which they now know or believes to be true regarding the Employee and The Company Released Claims and agree that the releases contained in this Agreement will remain effective in all respects notwithstanding the discovery of such facts.

7.Release of Claims by the Company. The Company herby releases any claims against Employee arising out of or related to her employment and agrees not to sue concerning, or in any manner to institute, prosecute, or pursue, any claim, complaint, charge, duty, obligation, demand, or cause of action relating to any matters of any kind, whether presently known or unknown, suspected or unsuspected, that Employer may possess against Employee arising from any omissions, acts, facts, or damages that have occurred up until and including the Effective Date of this Agreement (the “Company Released Claims”).

8.No Pending or Future Lawsuits. Employee represents that Employee has no lawsuits, claims, or actions pending in Employee’s name, or on behalf of any other person or entity, against the Company or any of the other Releasees. The Company likewise represents that it has no lawsuits, claims or actions pending in the Company’s name against Employee. Employee acknowledges and agrees that Employee has not suffered any injury or illness in connection with Employee’s employment with the Company that would be compensable under the California Workers’ Compensation Act. Employee also represents that Employee does not intend to bring any claims on Employee’s own behalf or on behalf of any other person or entity against the Company or any of the other Releasees.

9.Confidentiality. Subject to Section 12 below governing Protected Activity, Employee agrees to maintain in complete confidence the contents and terms of this Agreement
6


(hereinafter referred to as “Separation Information”). Except as required by law, Employee may disclose Separation Information only to Employee’s immediate family members, the Court in any proceedings to enforce the terms of this Agreement, and Employee’s attorney(s), financial advisors or retained consultants and must take reasonable steps to prevent disclosure of any Separation Information to all other third parties other than the facts previously communicated in the Company Form 8-K dated August, 2024 relating to Employee’s separation from the Company. Employee agrees that Employee will not publicize, directly or indirectly, any Separation Information other than the facts previously communicated in the Company Form 8-K dated August, 2024 relating to Employee’s separation from the Company. This Section 9 does not prevent Employee from disclosing the existence of or the consideration provided for this Agreement.

10.Trade Secrets and Confidential Information/Company Property. Employee reaffirms and agrees to observe and abide by the terms of the Confidentiality Agreement, specifically including the provisions therein regarding nondisclosure of the Company’s trade secrets and confidential and proprietary information. Employee acknowledges that, in connection with Employee’s employment with the Company, Employee sent, received, generated, or otherwise had access to, communications and information subject to a claim of attorney-client privilege belonging to the Company. Employee hereby affirms that on or before the Separation Date of Oct 1, 2024, the Employee has returned all Company property in Employee’s possession, custody, and control, including but not limited to documents, correspondence, notes and any other hard copy and/or electronic documents and other items provided to Employee by the Company, developed or obtained by Employee in connection with Employee’s employment with the Company, or otherwise belonging to the Company. Employee further affirms that Employee has not retained any copies, duplicates, or backups of any aforementioned Company property. Employee further affirms and agrees to maintain the confidentiality of any privileged information in Employee’s possession and understands that nothing in this Agreement shall be construed as a waiver of the Company’s attorney-client or other applicable privilege.

11.No Cooperation. Subject to Section 12 below governing Protected Activity, Employee agrees that Employee will not knowingly encourage, counsel, or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against any of the Releasees, unless under a subpoena or other court order to do so or as related directly to the ADEA waiver in this Agreement. Employee agrees both to immediately notify the Company upon receipt of any such subpoena or court order, and to furnish, within three (3) business days of its receipt, a copy of such subpoena or other court order. If approached by anyone for counsel or assistance in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints against any of the Releasees, Employee shall state no more than that Employee cannot provide counsel or assistance.

12.Protected Activity Not Prohibited. Employee understands that nothing in this Agreement shall in any way limit or prohibit Employee from engaging in any Protected Activity. For purposes of this Agreement, “Protected Activity” shall mean (i) filing a charge, complaint, or report with, or otherwise communicating, cooperating, or participating in any investigation or proceeding that may be conducted by, any federal,
7


state or local government agency or commission, including the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (each, a “Government Agency”), (ii) exercising any rights Employee may have under Section 7 of the National Labor Relations Act to engage in protected, concerted activity with other employees (such as discussing wages, benefits, or other terms and conditions of employment or raising complaints about working conditions for Employee’s own and other employees’ mutual aid or protection), or (iii) discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Employee has reason to believe is unlawful, including but not limited to retaliation, a wage-and-hour violation, or sexual assault, or other conduct that is recognized as unlawful under state, federal or common law, or that is recognized as against a clear mandate of public policy, whether occurring in the workplace, at work-related events coordinated by or through the Company, or between employees, or between the Company and an employee, whether on or off the employment premises. Employee understands that in connection with such Protected Activity, Employee is permitted to disclose documents or other information as permitted by law, and without giving notice to, or receiving authorization from, the Company. Notwithstanding the foregoing, Employee agrees to take all reasonable precautions to prevent any unauthorized use or disclosure of any information that may constitute Company confidential information under the Confidentiality Agreement to any parties other than a Government Agency. Employee further understands that “Protected Activity” does not include the disclosure of any Company documents or communications subject to a claim of attorney-client privilege. Any language in the Confidentiality Agreement regarding Employee’s right to engage in Protected Activity that conflicts with, or is contrary to, this paragraph is superseded by this Agreement. If Employee files any charge or complaint with any Government Agency and if the Government Agency pursues any claim on Employee’s behalf, or if any other third party pursues any claim on Employee’s behalf, Employee waives any right to monetary or other individualized relief (either individually, or as part of any collective or class action); provided that nothing in this Agreement limits any right Employee may have to receive a whistleblower award or bounty for information provided to the Securities and Exchange Commission. Pursuant to the Defend Trade Secrets Act of 2016, Employee is notified that an individual will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to court order.

13.Non-Disparagement. Subject to Section 12 above governing Protected Activity, Employee agrees to refrain from any defamation, libel, or slander of any of the Releasees, and agrees to refrain from any tortious interference with the contracts and relationships of any of the Releasees. Employee shall direct any inquiries by potential future employers
8


to the Company’s human resources department, which shall use its best efforts to provide only the Employee’s last position and dates of employment. In addition, the Company Officers, Directors and Vice Presidents agree to refrain from any defamation, libel, or slander of Employee, and agree to refrain from any tortious interference with the contracts and relationships of Employee.

14.No Admission of Liability. Employee understands and acknowledges that this Agreement constitutes a compromise and settlement of any and all actual or potential disputed claims by Employee. No action taken by the Company hereto, either previously or in connection with this Agreement, shall be deemed or construed to be (a) an admission of the truth or falsity of any actual or potential claims or (b) an acknowledgment or admission by the Company of any fault or liability whatsoever to Employee or to any third party.

15.Costs. The Parties shall each bear their own costs, attorneys’ fees, and other fees incurred in connection with the preparation of this Agreement.

16.Breach. In addition to the rights provided in the “Attorneys’ Fees” section below, Employee acknowledges and agrees that any material breach of this Agreement, unless such breach constitutes a legal action by Employee challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, or of any provision of the Confidentiality Agreement, shall entitle the Company immediately seek to recover and/or cease providing the consideration provided to Employee under this Agreement and to obtain damages, except as provided by law.

17.ARBITRATION. THE PARTIES AGREE THAT ANY AND ALL DISPUTES ARISING OUT OF THE TERMS OF THIS AGREEMENT, THEIR INTERPRETATION, AND ANY OF THE MATTERS HEREIN RELEASED, SHALL BE SUBJECT TO ARBITRATION BEFORE JUDICIAL ARBITRATION & MEDIATION SERVICES, INC. (“JAMS”), PURSUANT TO ITS EMPLOYMENT ARBITRATION RULES & PROCEDURES (“JAMS RULES”). THE ARBITRATOR MAY GRANT INJUNCTIONS AND OTHER RELIEF IN SUCH DISPUTES. THE ARBITRATOR SHALL ADMINISTER AND CONDUCT ANY ARBITRATION IN ACCORDANCE WITH THE LAW OF THE STATE IN WHICH EMPLOYEE WAS LAST EMPLOYED BY THE COMPANY, INCLUDING THE RULES OF CIVIL PROCEDURE OF SUCH STATE, AND THE ARBITRATOR SHALL APPLY THE SUBSTANTIVE AND PROCEDURAL LAW OF SUCH TO ANY DISPUTE OR CLAIM, WITHOUT REFERENCE TO ANY CONFLICT-OF-LAW PROVISIONS OF ANY JURISDICTION. TO THE EXTENT THAT THE JAMS RULES CONFLICT WITH APPLICABLE STATE LAW, STATE LAW SHALL TAKE PRECEDENCE. THE DECISION OF THE ARBITRATOR SHALL BE FINAL, CONCLUSIVE, AND BINDING ON THE PARTIES TO THE ARBITRATION. THE PARTIES AGREE THAT THE PREVAILING PARTY IN ANY ARBITRATION SHALL BE ENTITLED TO INJUNCTIVE RELIEF IN ANY COURT OF COMPETENT JURISDICTION TO ENFORCE THE ARBITRATION AWARD. THE PARTIES TO THE ARBITRATION SHALL EACH PAY AN EQUAL SHARE OF THE COSTS AND EXPENSES OF SUCH ARBITRATION, AND EACH PARTY SHALL SEPARATELY PAY FOR ITS RESPECTIVE COUNSEL FEES AND EXPENSES; PROVIDED, HOWEVER, THAT
9


THE ARBITRATOR SHALL AWARD ATTORNEYS’ FEES AND COSTS TO THE PREVAILING PARTY, EXCEPT AS PROHIBITED BY LAW. THE PARTIES HEREBY AGREE TO WAIVE THEIR RIGHT TO HAVE ANY DISPUTE BETWEEN THEM RESOLVED IN A COURT OF LAW BY A JUDGE OR JURY. NOTWITHSTANDING THE FOREGOING, THIS SECTION WILL NOT PREVENT EITHER PARTY FROM SEEKING INJUNCTIVE RELIEF (OR ANY OTHER PROVISIONAL REMEDY) FROM ANY COURT HAVING JURISDICTION OVER THE PARTIES AND THE SUBJECT MATTER OF THEIR DISPUTE RELATING TO THIS AGREEMENT AND THE AGREEMENTS INCORPORATED HEREIN BY REFERENCE. SHOULD ANY PART OF THE ARBITRATION AGREEMENT CONTAINED IN THIS PARAGRAPH CONFLICT WITH ANY OTHER ARBITRATION AGREEMENT BETWEEN THE PARTIES, THE PARTIES AGREE THAT THIS ARBITRATION AGREEMENT SHALL GOVERN.

18.Tax Consequences. The Company makes no representations or warranties with respect to the tax consequences of the payments and any other consideration provided to Employee or made on Employee’s behalf under the terms of this Agreement. Employee agrees and understands that Employee is responsible for payment, if any, of local, state, and/or federal taxes on the payments and any other consideration provided hereunder by the Company and any penalties or assessments thereon. Employee further agrees to indemnify and hold the Releasees harmless from any claims, demands, deficiencies, penalties, interest, assessments, executions, judgments, or recoveries by any government agency against the Company for any amounts claimed due on account of (a) Employee’s failure to pay or delayed payment of, federal or state taxes, or (b) damages sustained by the Company by reason of any such claims, including attorneys’ fees and costs.

19.Section 409A. It is intended that this Agreement comply with, or be exempt from, Code Section 409A and the final regulations and official guidance thereunder (“Section 409A”) and any ambiguities herein will be interpreted to so comply and/or be exempt from Section 409A. Each payment and benefit to be paid or provided under this Agreement is intended to constitute a series of separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations. The Company and Employee will work together in good faith to consider either (i) amendments to this Agreement; or (ii) revisions to this Agreement with respect to the payment of any awards, which are necessary or appropriate to avoid imposition of any additional tax or income recognition prior to the actual payment to Employee under Section 409A. In no event will the Releasees reimburse Employee for any taxes that may be imposed on Employee as a result of Section 409A.

20.Authority. The Company represents and warrants that the undersigned has the authority to act on behalf of the Company and to bind the Company and all who may claim through it to the terms and conditions of this Agreement. Employee represents and warrants that Employee has the capacity to act on Employee’s own behalf and on behalf of all who might claim through Employee to bind them to the terms and conditions of this Agreement. Each Party warrants and represents that there are no liens or claims of lien or assignments in law or equity or otherwise of or against any of the claims or causes of action released herein.

10


21.No Representations. Employee represents that Employee has had an opportunity to consult with an attorney and has carefully read and understands the scope and effect of the provisions of this Agreement. Employee has not relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement.

22.Severability. In the event that any provision or any portion of any provision hereof or any surviving agreement made a part hereof becomes or is declared by a court of competent jurisdiction or arbitrator to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision or portion of provision.

23.Attorneys’ Fees. Except with regard to a legal action challenging or seeking a determination in good faith of the validity of the waiver herein under the ADEA, in the event that either Party brings an action to enforce or effect its rights under this Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys’ fees incurred in connection with such an action.

24.Entire Agreement. This Agreement represents the entire agreement and understanding between the Company and Employee concerning the subject matter of this Agreement and Employee’s employment with and separation from the Company and the events leading thereto and associated therewith, and supersedes and replaces any and all prior agreements and understandings concerning the subject matter of this Agreement and Employee’s relationship with the Company, with the exception of the Confidentiality Agreement, the Indemnity Agreement and the Stock Agreements.

25.No Oral Modification. This Agreement may only be amended in a writing signed by Employee and the Company’s Chief Executive Officer.

26.Governing Law. This Agreement shall be governed by the laws of the state in which Employee last worked for the Company, without regard for choice-of-law provisions. Employee agrees to submit to the personal jurisdiction of the State of California and agrees that any dispute relating to this Agreement must be brought in the State of California or in the state in which Employee last worked for the Company.

27.Effective Date. Employee understands that this Agreement shall be null and void if not executed by Employee within the twenty-one (21) day period set forth under Section 5 above. Each Party has seven (7) days after that Party signs this Agreement to revoke it. This Agreement will become effective on the eighth (8th) day after Employee signed this Agreement, so long as it has been signed by the Parties and has not been revoked by either Party before that date (the “Effective Date”).

28.Counterparts. This Agreement may be executed in counterparts and by facsimile, and each counterpart and facsimile shall have the same force and effect as an original and shall constitute an effective, binding agreement on the part of each of the undersigned.

29.Voluntary Execution of Agreement. Employee understands and agrees that Employee executed this Agreement voluntarily, without any duress or undue influence on the part or behalf of the Company or any third party, with the full intent of releasing all of
11


Employee’s claims against the Company and any of the other Releasees. Employee acknowledges that:

(a)Employee has read this Agreement;

(b)Employee has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of Employee’s own choice or has elected not to retain legal counsel;

(c)Employee understands the terms and consequences of this Agreement and of the releases it contains;

(d)Employee is fully aware of the legal and binding effect of this Agreement; and

(e)Employee has not relied upon any representations or statements made by the Company that are not specifically set forth in this Agreement.

IN WITNESS WHEREOF, the Parties have executed this Agreement on the respective dates set forth below.


Michelle Sayer, an individual
Dated:
 Michelle Sayer
MAXLINEAR, INC.
Dated:By: 
 Connie Kwong
 
Principal Accounting Officer
12
EX-31.1 3 a9302024exhibit311.htm EX-31.1 Document

EXHIBIT 31.1
Certification of Principal Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Kishore Seendripu, Ph.D., certify that:
 
1.I have reviewed this Form 10-Q of MaxLinear, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: October 23, 2024  /s/ Kishore Seendripu, Ph.D.
  Kishore Seendripu, Ph.D.
  President and Chief Executive Officer
  (Principal Executive Officer)


EX-31.2 4 a9302024exhibit312.htm EX-31.2 Document

EXHIBIT 31.2
Certification of Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Steven G. Litchfield, certify that:
 
1.I have reviewed this Form 10-Q of MaxLinear, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: October 23, 2024/s/ Steven G. Litchfield
Steven G. Litchfield
  Chief Financial Officer and Chief Corporate Strategy Officer
  (Principal Financial Officer)


EX-32.1 5 a9302024exhibit321.htm EX-32.1 Document

EXHIBIT 32.1



CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002

I, Kishore Seendripu, Ph.D., certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of MaxLinear, Inc. on Form 10-Q for the fiscal nine months ended September 30, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of MaxLinear, Inc.
Date: October 23, 2024 By:  /s/ Kishore Seendripu, Ph.D.
 Name:Kishore Seendripu, Ph.D.
 Title:President and Chief Executive Officer
I, Steven G. Litchfield, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of MaxLinear, Inc. on Form 10-Q for the fiscal nine months ended September 30, 2024 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of MaxLinear, Inc.
Date: October 23, 2024 By:   /s/ Steven G. Litchfield
 Name:Steven G. Litchfield
 Title:
Chief Financial Officer and Chief Corporate Strategy Officer



EX-101.SCH 6 mxl-20240930.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - Consolidated Statement of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 9952157 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Organization and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - Net Income (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Business Combinations link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Restructuring Activity link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Goodwill and Intangible Assets link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Balance Sheet Details link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information link:presentationLink link:calculationLink link:definitionLink 9952169 - Disclosure - Revenue from Contracts with Customers link:presentationLink link:calculationLink link:definitionLink 9952170 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 9952171 - Disclosure - Employee Retirement Plans link:presentationLink link:calculationLink link:definitionLink 9952172 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 9952173 - Disclosure - Stock Repurchases link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Net Income (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Business Combinations (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Restructuring Activity (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Goodwill and Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Balance Sheet Details (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Revenue from Contracts with Customers (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Organization and Summary of Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Net Income (Loss) Per Share - Summary of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Net Income (Loss) Per Share - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Business Combinations - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Business Combinations - Summary of Business Acquisitions, by Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Restructuring Activity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Restructuring Activity - Restructuring and Related Costs (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Restructuring Activity - Schedule of Restructuring Reserve by Type of Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Goodwill and Intangible Assets - Summary of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Goodwill and Intangible Assets - Schedule of Acquired Finite-Lived Intangible Assets by Major Class (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Goodwill and Intangible Assets - Finite-lived Intangible Assets Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Financial Instruments - Composition of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Financial Instruments - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Financial Instruments - Fair Value, Liabilities Measured on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Financial Instruments - Summary of Level 3 Financial Instrument Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Balance Sheet Details - Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Balance Sheet Details - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Balance Sheet Details - Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Balance Sheet Details - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Balance Sheet Details - Accrued Price Protection Liability (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Balance Sheet Details - Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Balance Sheet Details - Schedule of Accumulated Other Comprehensive Income (Loss) by Component (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Stock-Based Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Unit and Performance-Based Restricted Stock Unit Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Stock-Based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - Stock-Based Compensation - Schedule of Stock Options, Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information - Concentration of Risk, by Risk Factor (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information - Revenue from External Customers by Geographic Areas (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information - Long-Lived Assets by Geographic Areas (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - Revenue from Contracts with Customers - Revenues from External Customers by Products and Services (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - Revenue from Contracts with Customers - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - Leases - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - Leases - Aggregate Future Minimum Payments Due (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - Leases - Aggregate Future Minimum Payments Due (Details) link:presentationLink link:calculationLink link:definitionLink 9954525 - Disclosure - Employee Retirement Plans (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - Commitments and Contingencies - Future Minimum Inventory Purchase and Other Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - Commitments and Contingencies - Future Minimum Inventory Purchase and Other Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954527 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 9954528 - Disclosure - Stock Repurchases (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 mxl-20240930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 mxl-20240930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 mxl-20240930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Less: current portion as of September 30, 2024 Accrued restructuring Restructuring Reserve, Current Federal funds rate Fed Funds Effective Rate Overnight Index Swap Rate [Member] Dish Litigation Dish Litigation [Member] Dish Litigation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Weighted Average Contractual Term, Vested and expected to vest (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Accrued obligations to customers for price adjustments Accrued obligations to customers for price adjustments Customer Refund Liability, Current Adjustments to reconcile net loss to cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Acquisitions (Note 3) Goodwill, Acquired During Period Work-in-process Inventory, Work in Process, Gross Statistical Measurement [Domain] Statistical Measurement [Domain] Cover page. Cover [Abstract] Silicon Motion Stockholder Litigation Silicon Motion Stockholder Litigation [Member] Silicon Motion Stockholder Litigation Decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Summary of Aggregate Future Minimum Payments Due Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Litigation and Settlement Costs Legal Costs, Policy [Policy Text Block] Trading Symbol Trading Symbol All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Non-NEOs Non-NEOs [Member] Summary of Basic and Diluted Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Excess tax (benefits) deficiencies on stock-based awards Share-Based Payment Arrangement, Expense, Tax Benefit Employee Stock Purchase Plan Employee Stock Purchase Plan [Member] Employee stock purchase plan. Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Accounts receivable Increase (Decrease) in Accounts Receivable Organization and Summary of Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Lease liabilities Increase (Decrease) in Operating Lease Liability SOFR subject to floor Secured Overnight Financing Rate (SOFR) Subject To Floor [Member] Secured Overnight Financing Rate (SOFR) Subject to Floor [Member] Inventory Inventory, Policy [Policy Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] 2026 Other Commitment, to be Paid, Year Two Cash received from exercise of stock options Proceeds from Stock Options Exercised Financial Instruments Fair Value Disclosures [Text Block] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Award Timing Disclosures [Line Items] Other Performance Measure, Amount Other Performance Measure, Amount 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Shares issued upon settlement of employee bonus plan (in shares) Shares Issued Upon Settlement Of Executive Bonus Plan Shares issued upon settlement of executive bonus plan Leases Lessee, Operating Leases [Text Block] Common stock, shares outstanding (in shares) Balance at beginning of period (in shares) Balance at end of period (in shares) Common Stock, Shares, Outstanding Operating lease cost Operating Lease, Cost 2024 Workforce Reduction 2024 Workforce Reduction [Member] 2024 Workforce Reduction 2024 (3 months) Recorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Long-term lease liabilities Long-term lease liabilities Operating Lease, Liability, Noncurrent Loss contingency, number of pending claims Loss Contingency, Pending Claims, Number Segment Information Segment Reporting, Policy [Policy Text Block] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Plan Name [Domain] Plan Name [Domain] United States United States UNITED STATES Dilutive common stock equivalents (in shares) Weighted Average Number of Shares Outstanding, Diluted, Adjustment Other long-term assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Accrued engineering and production costs Accrued Engineering And Production Costs Accrued Engineering And Production Costs Leases [Abstract] Leases [Abstract] Industrial and multi-market Industrial And multi-market [Member] Industrial and multi-market [Member] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Production Masks Production Masks [Member] Production Masks Broadband Broadband [Member] Broadband Selling, general and administrative Selling, general and administrative Selling, General and Administrative Expenses [Member] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Patents Patents [Member] Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Thailand THAILAND Accrued technology license payments Accrued Technology License Payments Current Accrued technology license payments current. Capitalized Contract Cost [Line Items] Capitalized Contract Cost [Line Items] Summary of Performance-Based Restricted Stock Unit Activity Share-Based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block] Summary of Accumulated Other Comprehensive Income (Loss) by Component Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Plan Name [Axis] Plan Name [Axis] Equity Components [Axis] Equity Components [Axis] Award Timing Method Award Timing Method [Text Block] Net periodic benefit cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Rest of world Rest of world Rest Of World [Member] Rest of World [Member] Lease related charges Facility Closing [Member] Research and Development Research and Development Expense, Policy [Policy Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Non-cash charges and adjustments Restructuring Reserve, Non-Cash Charges and Adjustments Restructuring Reserve, Non-Cash Charges and Adjustments Restructuring Type [Axis] Restructuring Type [Axis] Accounts Receivable Accounts Receivable [Policy Text Block] Pension and Other Defined Benefit Retirement Obligations Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block] Taiwan, ROC TAIWAN Measurement Frequency [Axis] Measurement Frequency [Axis] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Vendor A Vendor A [Member] Vendor A [Member] Use of Estimates and Significant Risks and Uncertainties Use of Estimates, Policy [Policy Text Block] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Adjustment to Compensation, Amount Adjustment to Compensation Amount Aggregate Intrinsic Value, Outstanding (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Additional paid-in capital Additional Paid in Capital, Common Stock Compensation Amount Outstanding Recovery Compensation Amount Supplemental disclosures of non-cash activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Developed technology Developed Technology Rights [Member] Company Selected Measure Amount Company Selected Measure Amount Geographical [Axis] Geographical [Axis] Summary of Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] Payment of debt commitment fees Payments of Debt Issuance Costs Tabular List, Table Tabular List [Table Text Block] Vendor C Vendor C [Member] Vendor C [Member] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Fair value of purchase consideration: Business Combination, Consideration Transferred [Abstract] Additions Finite-Lived Intangible Assets Acquired Stock repurchased during period Stock Repurchased During Period, Value Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Contingent consideration - current portion Business Combination, Contingent Consideration, Liability, Current Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Accrued expenses and other current liabilities Total Accrued Liabilities, Current Common stock equivalents excluded from the calculation of diluted net income (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 2023 Workforce Reduction 2023 Workforce Reduction [Member] 2023 Workforce Reduction Share-based payment arrangement, tranche one Share-Based Payment Arrangement, Tranche One [Member] Cash payments Payments for Restructuring Credit Facility [Domain] Credit Facility [Domain] Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Reclassification adjustments of unrealized gain (loss) on pension and other defined benefit plans Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax Total Contractual Obligation, Fiscal Year Maturity [Abstract] Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Current assets: Assets, Current [Abstract] Goodwill Goodwill Beginning balance Ending balance Goodwill Net operating liabilities Net Operating Liabilities Net Operating Liabilities Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Minimum tax withholding paid on behalf of employees for restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Stock repurchase program, authorized amount Share Repurchase Program, Authorized, Amount Unrecognized tax benefits, accrued interest Unrecognized Tax Benefits, Interest on Income Taxes Accrued Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount 2026 Recorded Unconditional Purchase Obligation, to be Paid, Year Two Product and Service [Domain] Product and Service [Domain] Stock Options Share-Based Payment Arrangement, Option [Member] Vested (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Depreciation expense Depreciation Goodwill [Roll Forward] Goodwill [Roll Forward] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Capitalized Contract Cost [Table] Capitalized Contract Cost [Table] Total comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Income tax liability Accrued Income Taxes, Current Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Recorded Unconditional Purchase Obligation, Category [Domain] Recorded Unconditional Purchase Obligation, Category [Domain] Security Exchange Name Security Exchange Name Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Award Type [Axis] Award Type [Axis] Net loss per share: Earnings Per Share, Basic [Abstract] Exercised (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Repayments of notes receivable due to the company annually Repayments Of Notes Receivable Due To The Company Annually Repayments Of Notes Receivable Due To The Company Annually Number of Shares (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Accrued Price Protection Rebate Activity [Roll Forward] Accrued Price Protection Rebate Activity [Roll Forward] Accrued price protection rebate activity Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Proceeds received from other party, deferred in other long-term liabilities Research And Development Arrangement, Contract For A Jointly Funded Project, Cumulative Proceeds Received From Other Party, Deferred In Liabilities Research And Development Arrangement, Contract For A Jointly Funded Project, Cumulative Proceeds Received From Other Party, Deferred In Liabilities Total liabilities Liabilities Summary of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Exercisable (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Total minimum payments Other Commitment Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Revolving Credit Facility Revolving Credit Facility [Member] Expiration Date Trading Arrangement Expiration Date Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Product warranty, period Standard Product Warranty, Period Standard Product Warranty, Period Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Short-term lease liabilities Less: short-term lease liabilities Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Common stock, shares issued (in shares) Common Stock, Shares, Issued Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Concentration risk percentage Concentration Risk, Percentage Credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Less: accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property and equipment, gross Property, Plant and Equipment, Gross Employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Ownership Plan Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Asia Asia [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Weighted-Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Research and development Research and development Research and Development Expense [Member] Goodwill and Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Europe Europe [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Cash used in acquisition, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Total cash, cash equivalents and restricted cash Cash, Cash Equivalents And Restricted Cash Cash, Cash Equivalents And Restricted Cash Diluted (in shares) Weighted average common shares outstanding—diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Restructuring and related cost, expected cost Restructuring and Related Cost, Expected Cost MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Proceeds loaned under notes receivable Proceeds Loaned Under Notes Receivable Proceeds Loaned Under Notes Receivable 2024 (3 months) Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Stock rotation allowance, term (up to) Contract with Customer, Stock Rotation Allowance, Term Contract with Customer, Stock Rotation Allowance, Term Total stockholders’ equity Balance at beginning of period Balance at end of period Equity, Attributable to Parent Operating lease renewal term Lessee, Operating Lease, Renewal Term Long-term portion as of September 30, 2024 Restructuring Reserve, Noncurrent Litigation Case [Axis] Litigation Case [Axis] Interest expense Interest Expense, Nonoperating Deferred income taxes Deferred Income Tax Expense (Benefit) Summary of Goodwill Schedule of Goodwill [Table Text Block] Software Software and Software Development Costs [Member] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Licensed technology Licensed Technology [Member] Licensed technology. Significant Accounting Policies Accounting Standards Update and Change in Accounting Principle [Table] Gain on settlement of pension Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement Selling, general and administrative Selling, General and Administrative Expense Tax benefit from stock options exercised Share-Based Payment Arrangement, Exercise of Option, Tax Benefit Other comprehensive (loss) income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Fair Value, Recurring Fair Value, Recurring [Member] Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Cost of net revenue Cost of net revenue Cost of Sales [Member] Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Impairment losses Asset Impairment Charges Foreign currency translation adjustments, net of tax benefit of $42 and $169 for the three and nine months ended September 30, 2024, respectively, and net of tax benefit of $64 and $229 for the three and nine months ended September 30, 2023, respectively Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Net carrying amount of long-term debt Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus All Executive Categories All Executive Categories [Member] Accrued obligations to customers for stock rotation rights Sales Returns and Allowances Sales Returns and Allowances [Member] Summary of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Weighted Average Contractual Term, Outstanding (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Expected tax deductible amount of acquired goodwill Business Acquisition, Goodwill, Expected Tax Deductible Amount Assets Assets [Abstract] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Outstanding beginning balance (in shares) Outstanding ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Document Type Document Type Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Weighted Average Contractual Term, Exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis] Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Inducement Plan Inducement Plan [Member] Inducement Plan Revenue from Distributors Revenue From Distributors [Member] Revenue from Distributors [Member] Summary of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Maximum Maximum Maximum [Member] Amortization Amortization Amortization of Intangible Assets Customer contract liabilities Contract with Customer, Liability Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Furniture and fixtures Furniture and Fixtures [Member] Net Carrying Amount Beginning balance Ending balance Finite-Lived Intangible Assets, Net Accounts payable Accounts Payable, Current Unamortized debt discount Unamortized debt discount Debt Instrument, Unamortized Discount Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Leasehold improvements Leasehold Improvements [Member] Schedule of Stock Options, Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Accrued obligations to customers for stock rotation rights Accrued Obligations To Customers For Stock Rotation Rights Accrued Obligations To Customers For Stock Rotation Rights Business Combinations Business Combination Disclosure [Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Debt instrument, quarterly amortization rate Debt Instrument, Quarterly Amortization Rate Debt Instrument, Quarterly Amortization Rate Statistical Measurement [Axis] Statistical Measurement [Axis] PEO Name PEO Name Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Vesting [Axis] Vesting [Axis] Award Type [Domain] Award Type [Domain] Issuance of shares for payment of bonuses Other Significant Noncash Transaction, Value of Consideration Given Name Outstanding Recovery, Individual Name Common stock issued pursuant to equity awards, net (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Goodwill impairment Goodwill, Impairment Loss Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Supplier Concentration Risk Supplier Concentration Risk [Member] Money market funds Money Market Funds, at Carrying Value Deferred tax assets Deferred Income Tax Assets, Net Non-PEO NEO Non-PEO NEO [Member] Weighted Average Useful Life (in Years) Finite-Lived Intangible Asset, Useful Life Right of return assets Contract with Customer, Right to Recover Product Other comprehensive loss before reclassifications, net of tax OCI, before Reclassifications, Net of Tax, Attributable to Parent Additional Paid-In Capital Additional Paid-in Capital [Member] Award Timing Predetermined Award Timing Predetermined [Flag] Employee Retirement Plans Retirement Benefits [Text Block] Concentration of Credit Risk, Significant Customers and Geographic Information Concentration Risk Disclosure [Text Block] Customer relationships Customer Relationships [Member] Recently Issued, Not Yet Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Warranty Standard Product Warranty, Policy [Policy Text Block] Diluted (in usd per share) Earnings Per Share, Diluted Accrued price protection liability Increase (Decrease) in Accrued Price Protection Liability The increase (decrease) during the reporting period in accrued price protection liability. Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Less: unrealized translation loss Unrealized Gain (Loss) On Translation To Reporting Currency Unrealized Gain (Loss) On Translation To Reporting Currency Summary of Finite-lived Intangible Assets Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Type of Restructuring [Domain] Type of Restructuring [Domain] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Vesting percentage relative to net sales Vesting Percentage Relative To Net Sales Vesting Percentage Relative To Net Sales Number of operating segments Number of Operating Segments Retirement Benefits [Abstract] Cash paid for income taxes Income Taxes Paid Loss on foreign currency Gain (Loss), Foreign Currency Transaction, before Tax Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Stock available for purchase (in shares) Share Repurchase Program, Remaining Authorized, Number of Shares Customer [Axis] Customer [Axis] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Accrued obligations to customers for price adjustments Reduction in Transaction Price Reduction In Transaction Price [Member] Reduction in Transaction Price [Member] Employee separation expenses Employee Severance [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] China CHINA Interest period Debt Instrument, Interest Period Debt Instrument, Interest Period Restructuring Activity Restructuring and Related Activities Disclosure [Text Block] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Unrecognized tax benefits, period increase (decrease) Unrecognized Tax Benefits, Period Increase (Decrease) Share-based payment arrangement, tranche two Share-Based Payment Arrangement, Tranche Two [Member] Income tax provision (benefit) Income tax provision (benefit) Income Tax Expense (Benefit) Acquisitions (Note 3) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Supplemental disclosures of cash flow information: Supplemental Cash Flow Information [Abstract] Total minimum payments Recorded Unconditional Purchase Obligation Contingent Consideration, Liability Contingent Consideration, Liability [Member] Contingent Consideration, Liability Unrecognized compensation costs, period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Net revenue Revenue from Contract with Customer, Excluding Assessed Tax Purchases of intangible assets Payments to Acquire Intangible Assets Total other income (expense), net Nonoperating Income (Expense) Other long-term liabilities Increase (Decrease) in Other Noncurrent Liabilities Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Debt instrument, basis spread on variable rate, additional applicable margin Debt Instrument, Basis Spread On Variable Rate, Additional Applicable Margin Debt Instrument, Basis Spread On Variable Rate, Additional Applicable Margin Long lived assets Long Lived Assets Long Lived Assets Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Income (loss) from operations Operating Income (Loss) Inventory Purchase Obligations Inventories [Member] Call premium, percentage Call Premium, Percentage Call Premium, Percentage Variable Rate [Domain] Variable Rate [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Research and development Research and Development Expense (Excluding Acquired in Process Cost) Total liabilities and stockholders’ equity Liabilities and Equity Payments Price Protection Payments Price Protection Payments Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Accrued compensation Employee-related Liabilities, Current Customer A Customer A [Member] Customer A Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Impairment of leased right-of-use assets Operating Lease, Impairment Loss Restructuring charges Restructuring charges Restructuring Charges Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Interest income Investment Income, Interest Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Summary of Restricted Stock Unit Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Other Obligations Other Commitments [Abstract] Right-of-use asset obtained in exchange for operating lease liability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Underlying Security Market Price Change Underlying Security Market Price Change, Percent Research and development arrangement, recognized income Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Individual: Individual [Axis] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Customer B Customer B [Member] Customer B Contingent consideration Business Combination, Consideration Transferred, Liabilities Incurred Expected life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Balance Sheet Related Disclosures [Abstract] Balance Sheet Related Disclosures [Abstract] Inventory Inventory Inventory, Net Product and Service [Axis] Product and Service [Axis] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity Address, State or Province Entity Address, State or Province Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Statement [Line Items] Statement [Line Items] Weighted average price of stock purchased under the ESPP (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Per Share Weighted Average Price of Shares Purchased Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] 2026 Contractual Obligation, to be Paid, Year Two Summary of Future Minimum Payments Under Inventory Purchase Obligations Recorded Unconditional Purchase Obligations [Table Text Block] 2025 Recorded Unconditional Purchase Obligation, to be Paid, Year One Operating expenses: Operating Expenses [Abstract] Call premium, period Call Premium, Period Call Premium, Period Summary of Property and Equipment Property, Plant and Equipment [Table Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Vesting [Domain] Vesting [Domain] Total purchase price Business Combination, Consideration Transferred Water Island Event-Driven Fund v. MaxLinear, Inc. Water Island Event-Driven Fund v. MaxLinear, Inc. [Member] Water Island Event-Driven Fund v. MaxLinear, Inc. Revenue Stream [Domain] Revenue Stream [Domain] Revenue Stream [Domain] Outstanding beginning balance (in usd per share) Outstanding ending balance (in usd per share) Weighted-average grant date fair value per share (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Terminated Silicon Motion Merger Terminated Silicon Motion Merger [Member] Terminated Silicon Motion Merger Loss contingency, number of claims filed Loss Contingency, New Claims Filed, Number Risks and Uncertainties [Abstract] Risks and Uncertainties [Abstract] Significant Supplier [Axis] Significant Supplier [Axis] Significant Supplier [Axis] Customer C Customer C [Member] Customer C [Member] Minimum Minimum Minimum [Member] Restatement Determination Date Restatement Determination Date Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Accrued bonuses Accrued Bonuses Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Outstanding beginning balance (in usd per share) Outstanding ending balance (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Concentration Risk [Table] Concentration Risk [Table] Leased right-of-use assets Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Lease Related Charges Facility Closing, Netting [Member] Facility Closing, Netting Distributors Distributors [Member] Distributors Outstanding beginning balance (in shares) Outstanding ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Foreign currency translation adjustment, tax benefit Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Summary of Fair Value, Liabilities Measured on Recurring Basis Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] 2024 (3 months) Contractual Obligation, to be Paid, Remainder of Fiscal Year Aggregate principal amount of long-term debt Long-Term Debt, Gross Exercise Price Award Exercise Price 2025 Other Commitment, to be Paid, Year One Vendor B Vendor B [Member] Vendor B [Member] Net Income (Loss) Per Share Earnings Per Share [Text Block] Long lived assets Long Lived Assets [Member] Long lived assets [Member] Accrued compensation Increase (Decrease) in Employee Related Liabilities Arrangement Duration Trading Arrangement Duration Payment term Contract with Customer, Payment Term Contract with Customer, Payment Term Employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Summary of Employee Stock Purchase Plan, Valuation Assumptions Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block] Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Short-term restricted cash Short-term restricted cash Restricted Cash and Cash Equivalents, Current Stockholders’ equity: Equity, Attributable to Parent [Abstract] Granted (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Income Taxes Income Tax, Policy [Policy Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Initial term loan under the June 23, 2021 credit agreement Initial Term Loan - TLB June 2021 [Member] Initial Term Loan - TLB June 2021 Restructuring Plan [Axis] Restructuring Plan [Axis] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Debt instrument, term Debt Instrument, Term 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four All Individuals All Individuals [Member] Trademarks and trade names Trademarks and Trade Names [Member] PEO PEO [Member] Variable Rate [Axis] Variable Rate [Axis] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Name Trading Arrangement, Individual Name Other income (expense), net Other Nonoperating Income (Expense) Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Summary of Future Minimum Payments Under Other Obligations Other Commitments [Table Text Block] Employee Separation Expenses One-time Termination Benefits [Member] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Summary of Concentration of Risk, by Risk Factor Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Accrued customer credits Accrued Customer Credits Accrued Customer Credits Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Share-based payment arrangement, tranche three Share-Based Payment Arrangement, Tranche Three [Member] Lender Name [Axis] Lender Name [Axis] Transaction costs Business Acquisition, Transaction Costs Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Charged as a reduction of revenue Price Protection Rebate Charges Price protection rebate charges as a reduction of revenue Long-term Purchase Commitment [Line Items] Long-Term Purchase Commitment [Line Items] Local Phone Number Local Phone Number Liability Class [Axis] Liability Class [Axis] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Total operating expenses Operating Expenses Other Other Restructuring [Member] Unrealized holding loss on investments Unrealized Gain (Loss) on Investments Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Repurchase of common stock (in shares) Stock Repurchased During Period, Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Other Obligations Other Obligations [Member] Other Obligations SOFR Secured Overnight Financing Rate (SOFR) [Member] PEO Total Compensation Amount PEO Total Compensation Amount Contingent consideration Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Debt instrument, covenant, leverage ratio, maximum Debt Instrument, Covenant, Leverage Ratio, Maximum Debt Instrument, Covenant, Leverage Ratio, Maximum Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Summary of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Vested and expected to vest (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Summary of Long-lived Assets by Geographic Areas Long-Lived Assets by Geographic Areas [Table Text Block] Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Impairment losses related to finite-lived intangible assets Impairment losses Impairment of Intangible Assets, Finite-Lived Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Common Stock Common Stock [Member] Measure: Measure [Axis] Impairment of Goodwill and Long-Lived Assets Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Common stock issued pursuant to equity awards, net Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture 2027 Contractual Obligation, to be Paid, Year Three Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Summary of Level 3 Financial Instrument Activity Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Accrued price protection liability Beginning balance Ending balance Accrued Price Protection Liability Accrued price protection liability. Credit facility, incremental borrowing capacity, percent of consolidated EBITDA Line Of Credit Facility, Incremental Borrowing Capacity, Percent Of Consolidated EBITDA Line Of Credit Facility, Incremental Borrowing Capacity, Percent Of Consolidated EBITDA Line of credit Line of Credit [Member] Unrecognized tax benefits, accrued penalties Unrecognized Tax Benefits, Income Tax Penalties Accrued Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Summary of Inventory Schedule of Inventory, Current [Table Text Block] Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Cumulative Translation Adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Stock Repurchases Equity [Text Block] Accounts payable, accrued expenses and other current liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Defined benefit obligation Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position Less: current portion of long-term debt Long-Term Debt, Current Maturities Thereafter Lessee, Operating Lease, Liability, To Be Paid, After Year Four Lessee, Operating Lease, Liability, To Be Paid, After Year Four Pension and Other Defined Benefit Plan Obligation Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member] Accretion of discount Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Entity Shell Company Entity Shell Company 2027 Recorded Unconditional Purchase Obligation, to be Paid, Year Three Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Comprehensive Income (Loss) Comprehensive Income, Policy [Policy Text Block] Title Trading Arrangement, Individual Title Statement [Table] Statement [Table] Summary of Price Protection Liability Price Protection Liability [Table Text Block] Tabular disclosure of price protection liability Measurement Frequency [Domain] Measurement Frequency [Domain] Geographic Concentration Risk Geographic Concentration Risk [Member] City Area Code City Area Code Current liabilities: Liabilities, Current [Abstract] Contract Termination Contract Termination [Member] Finite-lived Intangible Assets [Roll Forward] Finite-Lived Intangible Assets [Roll Forward] Contingent consideration (up to) Contingent consideration (Note 3) Contingent consideration Business Combination, Contingent Consideration, Liability Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Revenue Recognition Revenue [Policy Text Block] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Total current assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Portion of note receivable written off Note Receivable, Write-Off Note Receivable, Write-Off Company Y Company Y [Member] Company Y Reversal of unclaimed rebates Reversal Of Unclaimed Rebates Reversal Of Unclaimed Rebates Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Rebate and price protection program, term Contract with Customer, Rebate and Price Protection Program Term Contract with Customer, Rebate and Price Protection Program Term Long-term debt Long-term debt, non-current portion Long-Term Debt, Excluding Current Maturities Weighted-Average Grant-Date Fair Value per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Hong Kong HONG KONG Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Investments in privately held entities Equity Securities without Readily Determinable Fair Value, Amount Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Vendor D Vendor D [Member] Vendor D Income Taxes Income Tax Disclosure [Text Block] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Net loss per share: Earnings Per Share [Abstract] Numerator: Net Income (Loss) Attributable to Parent [Abstract] Summary of Revenue from External Customers by Products and Services Revenue from External Customers by Products and Services [Table Text Block] Production Masks Production Masks, Policy [Policy Text Block] Production Masks, Policy Equity [Abstract] Accumulated deficit Retained Earnings (Accumulated Deficit) Canceled (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 2024 (3 months) Other Commitment, to be Paid, Remainder of Fiscal Year Delivery term Revenue, Performance Obligation, Delivery Term Revenue, Performance Obligation, Delivery Term Inventory Increase (Decrease) in Inventories Gain on extinguishment of lease liabilities Gain (Loss) On Extinguishment Of Lease Liabilities Gain (Loss) On Extinguishment Of Lease Liabilities Debt issuance costs Debt Issuance Costs, Gross Schedule of Debt Schedule of Debt [Table Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Operating lease, weighted average discount rate, percent Operating Lease, Weighted Average Discount Rate, Percent Total lease liabilities Operating Lease, Liability Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Underlying Securities Award Underlying Securities Amount Performance-based restricted stock units (PRSUs) Performance Shares [Member] Credit Facility [Axis] Credit Facility [Axis] Amendment Flag Amendment Flag Fair value of term loans outstanding Long-Term Debt, Fair Value Entity Registrant Name Entity Registrant Name Cash consideration Cash Payments to Acquire Businesses, Gross Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Impairment of investments and other assets Other Asset Impairment Charges Amortization and depreciation Depreciation, Depletion and Amortization Gross profit Gross Profit Summary of Restriction Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Machinery and equipment Machinery and Equipment [Member] Fair Value as of Grant Date Award Grant Date Fair Value Connectivity Connectivity [Member] Connectivity Customer Concentration Risk Customer Concentration Risk [Member] Aggregate Intrinsic Value, Vested and expected to vest (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Unamortized debt issuance costs Debt Issuance Costs, Net Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Debt Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Shares awarded as a percentage of grants, peer group based Performance Based Compensation, Shares Awarded As A Percentage Of Grants, Peer Group Based Performance Based Compensation, Shares Awarded As A Percentage Of Grants, Peer Group Based Geographical [Domain] Geographical [Domain] Inventory Purchase Obligations Other Commitment, Fiscal Year Maturity [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Entity Address, Postal Zip Code Entity Address, Postal Zip Code Summary of Stock-Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Basis of Presentation and Principles of Consolidation Consolidation, Policy [Policy Text Block] Impairment losses Equity Securities, FV-NI, Unrealized Loss Schedule of Restructuring and Related Costs [Table] Restructuring Cost [Table] Restatement Determination Date: Restatement Determination Date [Axis] Title of 12(b) Security Title of 12(b) Security Long-term Purchase Commitment [Table] Long-Term Purchase Commitment [Table] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock, $0.0001 par value; 550,000 shares authorized; 84,362 shares issued and outstanding at September 30, 2024 and 81,818 shares issued and outstanding December 31, 2023 Common Stock, Value, Issued Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Sales commission assets recognized, term (less than) Sales Commission Assets Recognized, Term Sales Commission Assets Recognized, Term Canceled (in usd per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Impairment losses Impairment of intangible assets Impairment of Intangible Assets (Excluding Goodwill) Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding Preferred Stock, Value, Issued Performance period Share-based Compensation Arrangement By Share-based Payment Award, Performance Period Share-based Compensation Arrangement By Share-based Payment Award, Performance Period Finished goods Inventory, Finished Goods, Gross Property, plant and equipment, useful life Useful Life (in Years) Property, Plant and Equipment, Useful Life Number of Options (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Employee Stock Employee Stock [Member] Basic (in usd per share) Earnings Per Share, Basic Net proceeds from issuance of common stock Proceeds from Issuance of Common Stock Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Total minimum payments Contractual Obligation Debt instrument, covenant, leverage ratio, maximum, potential temporary increase Debt Instrument, Covenant, Leverage Ratio, Maximum, Potential Temporary Increase Debt Instrument, Covenant, Leverage Ratio, Maximum, Potential Temporary Increase Vesting percentage relative to earnings per share Vesting Percentage Relative To EPS Vesting Percentage Relative To EPS 2025 Contractual Obligation, to be Paid, Year One Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Revenue Stream [Axis] Revenue Stream [Axis] Revenue Stream Property and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Right of return, term Contract with Customer, Right of Return, Term Contract with Customer, Right of Return, Term Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Shares used to compute net loss per share: Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Total assets Assets 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Contingent consideration (up to) Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Equity Incentive Plan Equity Incentive Plan [Member] Equity incentive plan. Summary of Acquired Finite-Lived Intangible Assets by Major Class Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Other long-term liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Commitments and contingencies Commitments and Contingencies Stock-based Compensation Share-Based Payment Arrangement [Policy Text Block] Accrued royalty Accrued Royalties, Current Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Business Combinations Business Combinations Policy [Policy Text Block] Termination Date Trading Arrangement Termination Date Volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Aggregate commitments percentage Aggregate Commitments, Percentage Aggregate Commitments, Percentage Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two Singapore SINGAPORE Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Summary of Revenue from External Customers by Geographic Areas Revenue from External Customers by Geographic Areas [Table Text Block] Entity Address, City or Town Entity Address, City or Town Leases Lessee, Leases [Policy Text Block] Summary of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Intrinsic value of stock options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Stock-based compensation expense Share-Based Payment Arrangement, Expense Net loss Net loss Net income (loss) Net loss Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Summary of Composition of Financial Instruments Fair Value, by Balance Sheet Grouping [Table Text Block] Granted (in usd per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Other Other Restructuring, Netting [Member] Other Restructuring, Netting Loss Contingencies [Table] Loss Contingencies [Table] Canceled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Business Acquisition [Axis] Business Acquisition [Axis] Summary of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Common stock purchased under the ESPP (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Purchased for Award Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Entity File Number Entity File Number Operating Leases Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Right of return under the general assurance warranty, term Contract with Customer, Right of Return Under General Assurance Warranty, Term Contract with Customer, Right of Return Under General Assurance Warranty, Term Liabilities Liabilities, Fair Value Disclosure [Abstract] Revenue from Contracts with Customers Revenue from Contract with Customer [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Product Concentration Risk Product Concentration Risk [Member] Infrastructure Infrastructure [Member] Infrastructure [Member] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Other Other Accrued Liabilities, Current Restructuring Plan [Domain] Restructuring Plan [Domain] Operating lease, term (greater than) Original operating lease terms Lessee, Operating Lease, Term of Contract Name Forgone Recovery, Individual Name 2024 (3 months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Aggregate Intrinsic Value, Exercisable (in thousands) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Document Period End Date Document Period End Date Number of business activities Number of Business Activities Number of Business Activities Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Base rate Base Rate [Member] Total minimum payments Lessee, Operating Lease, Liability, to be Paid 2023 And 2024 Workforce Reductions 2023 And 2024 Workforce Reductions [Member] 2023 And 2024 Workforce Reductions Wells Fargo Bank, National Association Wells Fargo Bank, National Association [Member] Wells Fargo Bank, National Association Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Insider Trading Arrangements [Line Items] Balance Sheet Details Supplemental Balance Sheet Disclosures [Text Block] Amortization of debt issuance costs and accretion of discounts Amortization Of Debt Issuance Cost And Accretion Of Discounts Amortization of Debt Issuance Costs and Discount on Debt and Leases Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cost of net revenue Cost of Revenue Credit facility, incremental borrowing capacity Line Of Credit Facility, Incremental Borrowing Capacity Line Of Credit Facility, Incremental Borrowing Capacity Summary of Business Acquisitions, by Acquisition Schedule of Business Acquisitions, by Acquisition [Table Text Block] Adjustment to Compensation: Adjustment to Compensation [Axis] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Accounts Receivable Accounts Receivable [Member] Long-term restricted cash Long-term restricted cash Restricted Cash and Cash Equivalents, Noncurrent Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Cox Litigation Cox Litigation [Member] Cox Litigation Litigation Case [Domain] Litigation Case [Domain] Customer [Domain] Customer [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Accumulated Deficit Retained Earnings [Member] Restricted cash Restricted Cash and Cash Equivalents Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Basic (in shares) Weighted average common shares outstanding—basic (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Amortization of debt issuance costs and accretion of discount on debt and leases Amortization of Debt Issuance Costs and Discounts 2027 Other Commitment, to be Paid, Year Three Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Accrued professional fees Accrued Professional Fees, Current Executive Category: Executive Category [Axis] Term Debt Medium-Term Note [Member] Name Awards Close in Time to MNPI Disclosures, Individual Name Construction in progress Construction in Progress [Member] Revenue Benchmark Revenue Benchmark [Member] First initial repayments of notes receivable due to the company annually First Initial Repayments Of Notes Receivable Due To The Company Annually First Initial Repayments Of Notes Receivable Due To The Company Annually Masks and production equipment Masks And Production Equipment [Member] Masks and production equipment. Entity Filer Category Entity Filer Category Liability beginning balance Liability ending balance Restructuring Reserve Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Other disposals Finite-Lived Intangible Assets Disposals Finite-Lived Intangible Assets Disposals Company Selected Measure Name Company Selected Measure Name Significant Supplier [Domain] Significant Supplier [Domain] [Domain] for Significant Supplier [Axis] EX-101.PRE 10 mxl-20240930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.24.3
Cover - shares
9 Months Ended
Sep. 30, 2024
Oct. 16, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2024  
Document Transition Report false  
Entity File Number 001-34666  
Entity Registrant Name MaxLinear, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 14-1896129  
Entity Address, Address Line One 5966 La Place Court, Suite 100,  
Entity Address, City or Town Carlsbad  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92008  
City Area Code 760  
Local Phone Number 692-0711  
Title of 12(b) Security Common stock  
Trading Symbol MXL  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   84,361,778
Entity Central Index Key 0001288469  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 148,476 $ 187,288
Short-term restricted cash 993 1,051
Accounts receivable, net 47,930 170,619
Inventory 96,063 99,908
Prepaid expenses and other current assets 34,798 29,159
Total current assets 328,260 488,025
Long-term restricted cash 23 17
Property and equipment, net 63,493 66,431
Leased right-of-use assets 22,549 31,264
Intangible assets, net 58,031 73,630
Goodwill 318,588 318,588
Deferred tax assets 82,552 69,493
Other long-term assets 21,807 32,809
Total assets 895,303 1,080,257
Current liabilities:    
Accounts payable 30,628 21,551
Accrued price protection liability 44,472 71,684
Accrued expenses and other current liabilities 71,197 98,468
Accrued compensation 22,300 30,426
Total current liabilities 168,597 222,129
Long-term lease liabilities 19,433 26,243
Long-term debt 122,840 122,375
Other long-term liabilities 27,561 23,245
Total liabilities 338,431 393,992
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 84,362 shares issued and outstanding at September 30, 2024 and 81,818 shares issued and outstanding December 31, 2023 8 8
Additional paid-in capital 866,603 808,575
Accumulated other comprehensive loss (3,852) (3,791)
Accumulated deficit (305,887) (118,527)
Total stockholders’ equity 556,872 686,265
Total liabilities and stockholders’ equity $ 895,303 $ 1,080,257
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Balance Sheets (Parenthetical) - $ / shares
Sep. 30, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Preferred stock, par value (in usd per share) $ 0.0001 $ 0.0001
Preferred stock, shares authorized (in shares) 25,000,000 25,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in usd per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 550,000,000 550,000,000
Common stock, shares issued (in shares) 84,362,000 81,818,000
Common stock, shares outstanding (in shares) 84,362,000 81,818,000
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Net revenue $ 81,102 $ 135,530 $ 268,361 $ 567,910
Cost of net revenue 37,022 61,586 124,827 250,786
Gross profit 44,080 73,944 143,534 317,124
Operating expenses:        
Research and development 52,604 66,306 173,911 204,254
Selling, general and administrative 30,154 25,402 100,242 97,772
Impairment losses 1,237 0 1,237 2,438
Restructuring charges 26,828 54 50,323 9,138
Total operating expenses 110,823 91,762 325,713 313,602
Income (loss) from operations (66,743) (17,818) (182,179) 3,522
Interest income 1,653 1,736 5,346 4,272
Interest expense (2,655) (2,715) (8,072) (7,793)
Other income (expense), net (14,753) (22,721) (12,990) (21,180)
Total other income (expense), net (15,755) (23,700) (15,716) (24,701)
Loss before income taxes (82,498) (41,518) (197,895) (21,179)
Income tax provision (benefit) (6,713) (1,689) (10,535) 13,468
Net loss $ (75,785) $ (39,829) $ (187,360) $ (34,647)
Net loss per share:        
Basic (in usd per share) $ (0.90) $ (0.49) $ (2.25) $ (0.43)
Diluted (in usd per share) $ (0.90) $ (0.49) $ (2.25) $ (0.43)
Shares used to compute net loss per share:        
Basic (in shares) 84,074 81,249 83,303 80,395
Diluted (in shares) 84,074 81,249 83,303 80,395
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Statement of Comprehensive Income [Abstract]        
Net loss $ (75,785) $ (39,829) $ (187,360) $ (34,647)
Foreign currency translation adjustments, net of tax benefit of $42 and $169 for the three and nine months ended September 30, 2024, respectively, and net of tax benefit of $64 and $229 for the three and nine months ended September 30, 2023, respectively 2,664 (1,855) (61) (3,125)
Reclassification adjustments of unrealized gain (loss) on pension and other defined benefit plans 0 (3,792) 0 (3,792)
Total comprehensive loss $ (73,121) $ (45,476) $ (187,421) $ (41,564)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Statement of Comprehensive Income [Abstract]        
Foreign currency translation adjustment, tax benefit $ 42 $ 64 $ 169 $ 229
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2022   78,745      
Balance at beginning of period at Dec. 31, 2022 $ 676,385 $ 8 $ 722,778 $ (1,021) $ (45,380)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,236      
Common stock issued pursuant to equity awards, net 31,926   31,926    
Stock-based compensation 16,460   16,460    
Other comprehensive (loss) income (192)     (192)  
Net income (loss) 9,533       9,533
Balance at end of period (in shares) at Mar. 31, 2023   79,981      
Balance at end of period at Mar. 31, 2023 734,112 $ 8 771,164 (1,213) (35,847)
Balance at beginning of period (in shares) at Dec. 31, 2022   78,745      
Balance at beginning of period at Dec. 31, 2022 676,385 $ 8 722,778 (1,021) (45,380)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (34,647)        
Balance at end of period (in shares) at Sep. 30, 2023   81,561      
Balance at end of period at Sep. 30, 2023 702,677 $ 8 790,634 (7,938) (80,027)
Balance at beginning of period (in shares) at Mar. 31, 2023   79,981      
Balance at beginning of period at Mar. 31, 2023 734,112 $ 8 771,164 (1,213) (35,847)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   808      
Common stock issued pursuant to equity awards, net (2,752)   (2,752)    
Employee stock purchase plan (in shares)   141      
Employee stock purchase plan 2,989   2,989    
Stock-based compensation 17,127   17,127    
Other comprehensive (loss) income (1,078)     (1,078)  
Net income (loss) (4,351)       (4,351)
Balance at end of period (in shares) at Jun. 30, 2023   80,930      
Balance at end of period at Jun. 30, 2023 746,047 $ 8 788,528 (2,291) (40,198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   631      
Common stock issued pursuant to equity awards, net (3,017)   (3,017)    
Stock-based compensation 5,123   5,123    
Other comprehensive (loss) income (5,647)     (5,647)  
Net income (loss) (39,829)       (39,829)
Balance at end of period (in shares) at Sep. 30, 2023   81,561      
Balance at end of period at Sep. 30, 2023 $ 702,677 $ 8 790,634 (7,938) (80,027)
Balance at beginning of period (in shares) at Dec. 31, 2023 81,818 81,818      
Balance at beginning of period at Dec. 31, 2023 $ 686,265 $ 8 808,575 (3,791) (118,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,249      
Common stock issued pursuant to equity awards, net 8,777   8,777    
Stock-based compensation 17,032   17,032    
Other comprehensive (loss) income (1,782)     (1,782)  
Net income (loss) (72,309)       (72,309)
Balance at end of period (in shares) at Mar. 31, 2024   83,067      
Balance at end of period at Mar. 31, 2024 $ 637,983 $ 8 834,384 (5,573) (190,836)
Balance at beginning of period (in shares) at Dec. 31, 2023 81,818 81,818      
Balance at beginning of period at Dec. 31, 2023 $ 686,265 $ 8 808,575 (3,791) (118,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ (187,360)        
Balance at end of period (in shares) at Sep. 30, 2024 84,362 84,362      
Balance at end of period at Sep. 30, 2024 $ 556,872 $ 8 866,603 (3,852) (305,887)
Balance at beginning of period (in shares) at Mar. 31, 2024   83,067      
Balance at beginning of period at Mar. 31, 2024 637,983 $ 8 834,384 (5,573) (190,836)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   655      
Common stock issued pursuant to equity awards, net (545)   (545)    
Employee stock purchase plan (in shares)   176      
Employee stock purchase plan 2,682   2,682    
Stock-based compensation 17,344   17,344    
Other comprehensive (loss) income (943)     (943)  
Net income (loss) (39,266)       (39,266)
Balance at end of period (in shares) at Jun. 30, 2024   83,898      
Balance at end of period at Jun. 30, 2024 617,255 $ 8 853,865 (6,516) (230,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   464      
Common stock issued pursuant to equity awards, net (56)   (56)    
Stock-based compensation 12,794   12,794    
Other comprehensive (loss) income 2,664     2,664  
Net income (loss) $ (75,785)       (75,785)
Balance at end of period (in shares) at Sep. 30, 2024 84,362 84,362      
Balance at end of period at Sep. 30, 2024 $ 556,872 $ 8 $ 866,603 $ (3,852) $ (305,887)
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Operating Activities    
Net loss $ (187,360) $ (34,647)
Adjustments to reconcile net loss to cash provided by operating activities:    
Amortization and depreciation 42,426 54,923
Impairment of intangible assets 1,237 2,438
Impairment of investments and other assets 14,000 0
Amortization of debt issuance costs and accretion of discounts 1,990 1,858
Stock-based compensation 47,208 38,763
Deferred income taxes (13,058) 6,502
Loss on disposal of property and equipment 1,068 2,057
Unrealized holding loss on investments 0 3,917
Impairment of leased right-of-use assets 3,415 0
Gain on extinguishment of lease liabilities (554) 0
Gain on settlement of pension 0 (1,008)
Loss on foreign currency 973 140
Excess tax (benefits) deficiencies on stock-based awards (2,988) (529)
Changes in operating assets and liabilities:    
Accounts receivable 122,689 13,769
Inventory 3,845 45,602
Prepaid expenses and other assets (8,615) (10,215)
Accounts payable, accrued expenses and other current liabilities (16,041) (17,917)
Accrued compensation 3,011 8,776
Accrued price protection liability (27,212) (45,036)
Lease liabilities (7,806) (8,891)
Other long-term liabilities 4,315 (557)
Net cash provided by (used in) operating activities (17,457) 59,945
Investing Activities    
Purchases of property and equipment (15,487) (12,180)
Purchases of intangible assets (4,961) (6,198)
Cash used in acquisition, net of cash acquired 0 (12,384)
Net cash used in investing activities (20,448) (30,762)
Financing Activities    
Payment of debt commitment fees 0 (18,325)
Net proceeds from issuance of common stock 1,579 3,168
Minimum tax withholding paid on behalf of employees for restricted stock units (1,714) (12,370)
Net cash used in financing activities (135) (27,527)
Effect of exchange rate changes on cash and cash equivalents (824) (1,861)
Decrease in cash, cash equivalents and restricted cash (38,864) (205)
Cash, cash equivalents and restricted cash at beginning of period 188,356 188,357
Cash, cash equivalents and restricted cash at end of period 149,492 188,152
Supplemental disclosures of cash flow information:    
Cash paid for interest 7,444 6,978
Cash paid for income taxes 9,470 25,336
Supplemental disclosures of non-cash activities:    
Issuance of shares for payment of bonuses $ 10,992 $ 38,348
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Organization and Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Summary of Significant Accounting Policies Organization and Summary of Significant Accounting Policies
Description of Business
MaxLinear, Inc. was incorporated in Delaware in September 2003. MaxLinear, Inc., together with its directly and indirectly wholly-owned subsidiaries, collectively referred to as MaxLinear, or the Company, is a provider of communications systems-on-chip, or SoC, solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. MaxLinear is a fabless integrated circuit design company whose products integrate all or substantial portions of a high-speed communication system, including radio frequency, or RF, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management. MaxLinear’s customers primarily include electronics distributors, module makers, original equipment manufacturers, or OEMs, and original design manufacturers, or ODMs, who incorporate the Company’s products in a wide range of electronic devices. Examples of such devices include broadband modems compliant with Data Over Cable Service Interface Specifications, or DOCSIS, Passive Optical Network, or PON, and DSL; Wi-Fi and wireline routers for home networking; radio transceivers and modems for 4G/5G base-station and backhaul infrastructure; optical transceivers targeting hyperscale data centers; as well as power management and interface products used in these and many other markets.
Basis of Presentation and Principles of Consolidation
The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its directly and indirectly wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation.
In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive income, stockholders’ equity, and cash flows.
The consolidated balance sheet as of December 31, 2023 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on January 31, 2024, or the Annual Report. Interim results for the nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024.
The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these foreign subsidiaries are translated at the current exchange rate at the balance sheet date and historical rates for equity. Revenue and expense components are translated at weighted average exchange rates in effect during the period. Gains and losses resulting from foreign currency translation are included as a component of stockholders’ equity. Foreign currency transaction gains and losses are included in the results of operations, and to date, have not been material.
Use of Estimates and Significant Risks and Uncertainties
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes of the consolidated financial statements. Actual results could differ from those estimates.
The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of October 23, 2024, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates.
Summary of Significant Accounting Policies

Business Combinations

The Company applies the provisions of ASC 805, Business Combinations, in accounting for its acquisitions. It requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed, at the acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the acquisition date fair values of the net assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations.

Costs to exit or restructure certain activities of an acquired company or the Company’s internal operations are accounted for as termination and exit costs pursuant to ASC 420, Exit or Disposal Cost Obligations, and are accounted for separately from the business combination. A liability for costs associated with an exit or disposal activity is recognized and measured at its fair value in the consolidated statements of operations in the period in which the liability is incurred.

For a given acquisition, the Company may identify certain pre-acquisition contingencies as of the acquisition date and may extend its review, evaluation, and adjustment of these pre-acquisition contingencies throughout the measurement period in order to obtain sufficient information to assess whether the Company includes these contingencies as a part of the fair value estimates of assets acquired and liabilities assumed and, if so, to determine their estimated amounts. A pre-acquisition contingency (non-income tax related) is only recognized as an asset or a liability if: (i) it is probable that an asset existed or a liability had been incurred at the acquisition date and (ii) the amount of the asset or liability can be reasonably estimated. Subsequent to the measurement period, changes in estimates of such contingencies will affect earnings and could have a material effect on the Company's results of operations and financial position.

In addition, uncertain tax positions and tax-related valuation allowances assumed, if any, in connection with a business combination are initially estimated as of the acquisition date. The Company re-evaluates these items quarterly based upon facts and circumstances that existed as of the acquisition date with any adjustments to the preliminary estimates being recorded to goodwill if identified within the measurement period. Subsequent to the end of the measurement period or final determination of the estimated value of the tax allowance or contingency, whichever comes first, changes to these uncertain tax positions and tax related valuation allowances will affect the income tax provision (benefit) in the consolidated statements of operations and could have a material impact on the results of operations and financial position.

Cash and Cash Equivalents

The Company considers all liquid investments with a maturity of three months or less when purchased to be cash equivalents. Cash equivalents are recorded at cost, which approximates market value.

Accounts Receivable

The Company performs ongoing credit evaluations of its customers and assesses each customer’s credit worthiness. The Company monitors collections and payments from its customers and maintains an allowance for doubtful accounts, which is based upon applying an expected credit loss rate to receivables based on the historical loss rate from similar high risk customers adjusted for current conditions, including any specific customer collection issues identified, and forecasts of economic conditions. Delinquent account balances are written off after management has determined that the likelihood of collection is remote.

Inventory

The Company assesses the recoverability of its inventory based on assumptions about demand and market conditions. Forecasted demand is determined based on historical sales and expected future sales. Inventory is stated at the lower of cost or
net realizable value. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis and net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company reduces its inventory to the lower of its cost or net realizable value on a part-by-part basis to account for obsolescence or lack of marketability. Reductions are calculated as the difference between the cost of inventory and its net realizable value based upon assumptions about future demand, market conditions and costs. Once established, these adjustments are considered permanent and are not revised until the related inventory is sold or disposed of.

Fair Value of Financial Instruments

The carrying amount of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses and compensation are considered to be representative of their respective fair values because of the short-term nature of these accounts.

Property and Equipment

Property and equipment is carried at cost and depreciated over the estimated useful lives of the assets, ranging from three to five years, using the straight-line method. Leasehold improvements are stated at cost and amortized over the shorter of the estimated useful lives of the assets or the lease term.

Production Masks

Production masks with alternative future uses or discernible future benefits are capitalized and amortized over their estimated useful lives of five years. To determine if a production mask has alternative future uses or benefits, the Company evaluates risks associated with developing new technologies and capabilities, and the related risks associated with entering new markets. Production masks that do not meet the criteria for capitalization are expensed as research and development costs.

Goodwill and Intangible Assets

Goodwill is the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations accounted for under the acquisition method. Intangible assets represent purchased intangible assets including developed technology, in-process research and development, or IPR&D, technologies acquired or licensed from other companies, customer relationships, non-compete covenants, backlog, and trademarks and tradenames. Purchased finite-lived intangible assets are capitalized and amortized over their estimated useful lives. Technologies acquired or licensed from other companies, customer relationships, non-compete covenants, backlog, and trademarks and tradenames are capitalized and amortized over the lesser of the terms of the agreement, or estimated useful life. The Company capitalizes IPR&D projects acquired as part of a business combination. On completion of each project, IPR&D assets are reclassified to developed technology and amortized over their estimated useful lives.

Impairment of Goodwill and Long-Lived Assets

Goodwill is not amortized but is tested for impairment using either a qualitative assessment, and/or quantitative assessment, which is based on comparing the fair value of a reporting unit with its carrying amount. If the carrying amount of a reporting unit exceeds its fair value, a goodwill impairment loss is recorded. The Company tests by reporting unit, goodwill and other indefinite-lived intangible assets for impairment as of October 31 each year or more frequently if it believes indicators of impairment exist.

The Company reviews indefinite-lived intangible assets for impairment using a qualitative assessment, followed by a quantitative assessment, as needed, each year as of October 31, the date of its annual goodwill impairment review, or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Recoverability of indefinite-lived intangible assets is measured by comparing the carrying amount of the asset to its fair value. In certain cases, the Company utilizes the relief-from-royalty method when appropriate, and a fair value will be obtained based on analysis over the costs saved by owning the right instead of leasing it.
During development, IPR&D is not subject to amortization and is tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Once an IPR&D project is complete, it becomes a finite-lived intangible asset and is evaluated for impairment both immediately prior to its change in classification and thereafter in accordance with the Company’s policy for long-lived assets.

The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the useful lives, to determine whether indicators of impairment may exist which warrant adjustments to carrying values or estimated useful lives. An impairment loss would be recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss would be measured based on the excess of the carrying amount of the asset over the asset’s fair value.

Revenue Recognition

The Company’s revenue is generated from sales of the Company’s integrated circuits and intellectual property, typically under individual customer purchase orders, some of which have underlying master sales agreements that specify terms governing the product or intellectual property sales. The Company recognizes such revenue at the point in time when control of the products or intellectual property is transferred to the customer at the estimated net consideration for which collection is probable, taking into account the customer’s rights to price protection, other pricing credits, unit rebates, and rights to return unsold product. Transfer of control occurs either when products are shipped to or received by the distributor or direct customer, based on the terms of the specific agreement with the customer, if the Company has a present right to payment and transfer of legal title and the risks and rewards of ownership to the customer has occurred. For most of the Company’s product sales, transfer of control occurs upon shipment to the distributor or direct customer. Under certain intellectual property sale agreements, we are entitled to fixed upfront consideration upon sale and variable consideration in the form of a portion of revenue generated by the recipient from the intellectual property. Fixed consideration is recognized when control of the functional intellectual property transfers; variable consideration may be constrained but is continuously monitored and recognized as revenue when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur and the uncertainty associated with the variable consideration is resolved. The Company recognized a material amount of variable consideration during the nine months ended September 30, 2024 as uncertainties related to such consideration were resolved. During the three months ended September 30, 2024, there was no variable consideration recognized related to resolution of uncertainties related to such consideration.

In assessing whether collection of consideration from a customer is probable, the Company considers the customer’s ability and intention to pay that amount of consideration when it is due. Payment of invoices is due as specified in the underlying customer agreement, typically 30 days from the invoice date, which occurs on the date of transfer of control of the products to the customer. Since payment terms are less than a year, the Company has elected the practical expedient and does not assess whether a customer contract has a significant financing component.

A five-step approach is applied in the recognition of revenue: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when the Company satisfies a performance obligation. Customer purchase orders plus the underlying master sales agreements are considered to be contracts with the customer for purposes of applying the five-step approach.

Pricing adjustments and estimates of returns under contractual stock rotation rights are treated as variable consideration for purposes of determining the transaction price, and are estimated at the time control transfers using the expected value method based on the Company’s analysis of actual price adjustment claims by distributors and historical product return rates, and then reassessed at the end of each reporting period. The Company also considers whether any variable consideration is constrained, since such amounts for which it is probable that a significant reversal will occur when the contingency is subsequently resolved are required to be excluded from revenues. Price adjustments are finalized at the time the products are sold through to the end customer and the distributor or end customer submits a claim to reduce the sale price to a pre-approved net price. Stock rotation allowances are capped at a fixed percentage of the Company’s sales to a distributor for a period of time, up to six months, as specified in the individual distributor contract. If the Company’s current estimates of such credits and rights are materially inaccurate, it may result in adjustments that affect future revenues and gross profits. Returns under the Company’s general assurance warranty of products for a period of one to three years have not been material and warranty-related services are not considered a separate performance obligation under the customer contracts. Most of the Company’s customers resell the Company’s product as part of their product and thus are tax-exempt; however, to the extent the Company
collects and remits taxes on product sales from customers, it has elected to exclude from the measurement of transaction price such taxes.

Each distinct promise to transfer products is considered to be an identified performance obligation for which revenue is recognized upon transfer of control of the products to the customer. Although customers may place orders for products to be delivered on multiple dates that may be in different quarterly reporting periods, all of the orders are scheduled within one year from the order date. The Company has elected to record sales commissions when incurred, as the period over which the sales commission asset that would have been recognized is less than one year.

Customer contract liabilities consist primarily of obligations to deliver rebates to customers in the form of units of products which are included in accrued expenses and other current liabilities in the consolidated balance sheets. Other obligations to customers, which are included in accrued price protection liability in the consolidated balance sheets, consist of estimates of price protection rights offered to the Company’s end customer on products sold by the Company to the end customer’s contract manufacturer at a standard price that are later incorporated into the end customers’ product. The Company’s price adjustments included in accrued expenses and other current liabilities are discounts and rebates expected to be claimed by the Company’s distributors upon sell-through of the products to their customers, which are initially sold by the Company to the distributors at a standard price. Also included in accrued expenses and other current liabilities are amounts expected to be returned by distributors under stock rotation rights. The Company also records a right of return asset, consisting of amounts representing the products the Company expects to receive from customers in returns, which is included in inventory in the consolidated balance sheets, and is typically settled within six months of transfer of control to the customer, or the period over which stock rotation rights are based. Upon lapse of the time period for stock rotations, or the contractual end to price protection and rebate programs, which is approximately one to two years, and when the Company believes unclaimed amounts are no longer subject to payment and will not be paid, any remaining asset or liability is derecognized by an offsetting entry to cost of net revenue and net revenue. For additional disclosures regarding contract liabilities and other obligations to customers, see Note 12.

The Company assesses customer accounts receivable and contract assets for impairment in accordance with ASC 310-10-35.

Warranty

The Company generally provides a warranty on its products for a period of one to three years. The Company makes estimates of product return rates and expected costs to replace the products under warranty at the time revenue is recognized based on historical warranty experience and any known product warranty issues. If actual return rates and/or replacement costs differ significantly from these estimates, adjustments to recognize additional warranty expenses in cost of net revenue may be required in future periods.

Segment Information

The Company operates under one segment as it has developed, marketed and sold primarily only one class of similar products, radio-frequency, high-performance analog and mixed-signal communications system-on-chip solutions for the connected home, wired and wireless infrastructure markets and industrial and multi-market applications.

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company’s Chief Executive Officer reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports under a single operating segment.
Stock-based Compensation

The Company measures the cost of employee services received in exchange for equity incentive awards, including restricted stock units, employee stock purchase rights and stock options based on the grant date fair value of the award. The Company calculates the fair value of restricted stock units and performance-based restricted stock units based on the fair market value of the Company’s common stock on the grant date. Stock-based compensation expense is then determined based on the number of restricted stock units that are expected to vest; for performance-based restricted stock units, this is the number of units that are expected to vest during the performance period if it is probable that the Company will achieve the performance metrics specified in the underlying award agreement. The Company uses the Black-Scholes valuation model to calculate the fair value of stock options and employee stock purchase rights granted to employees. Stock-based compensation expense is recognized over the period during which the employee is required to provide services in exchange for the award, which is usually the vesting period. The Company recognizes compensation expense over the vesting period using the straight-line method and classifies these amounts in the consolidated statements of operations based on the department to which the related employee reports.

Research and Development

Costs incurred in connection with the development of the Company’s technology and future products are charged to research and development expense as incurred. From time to time, the Company enters into contracts for jointly funded research and development projects to develop technology that may be commercialized into a product in the future. The Company also obtains research and development funding grants from governments in certain jurisdictions in which it operates. Both of these types of income are reflected as a credit to research and development expense when such income has been earned and any contingencies associated with retaining such income have been resolved. In the three months ended September 30, 2024 and 2023, the Company recognized aggregate income from jointly funded R&D projects and government grants of approximately $0.6 million and $1.4 million, respectively. During the nine months ended September 30, 2024 and 2023, the Company recognized aggregate income from jointly funded R&D projects and government grants of approximately $3.1 million and $11.3 million, respectively. While the Company retains ownership and rights to the underlying technology developed under the joint development projects, the Company may be required to repay all or a portion of the funds provided by the other parties under certain conditions, and defers such funds as liabilities until the repayment conditions have been resolved (Note 15).

Leases

The Company’s leases primarily consist of facility leases which are classified as operating leases. The Company assesses whether an arrangement contains a lease at inception. The Company recognizes a lease liability to make contractual payments under all leases with terms greater than twelve months and a corresponding right-of-use asset, representing its right to use the underlying asset for the lease term. The lease liability is initially measured at the present value of the lease payments over the lease term using the collateralized incremental borrowing rate when the implicit rate is unknown. Options to extend or terminate a lease are included in the lease term when it is reasonably certain that the Company will exercise such an option. The right-of-use asset is initially measured as the contractual lease liability plus any initial direct costs and prepaid lease payments made, less any lease incentives. Upon adoption of ASC 842 on January 1, 2019, the carrying value of lease-related restructuring liabilities for certain restructured leases existing at that date was offset against the related right-of-use assets. Lease expense is recognized on a straight-line basis over the lease term.

Upon adoption of ASC 842, the Company elected certain practical expedients and accordingly has (1) carried forward its prior assessments of (a) whether existing contracts on the January 1, 2019 adoption date contain leases, (b) classification of leases as operating or financing and (c) initial direct costs for existing leases and (2) considered hindsight in determining the lease term and assessing impairment of the right-of-use-asset. In addition, the Company used a portfolio approach for its facility leases when making judgments and estimates, such as the discount rate.

Leased right-of-use assets are subject to impairment testing as a long-lived asset at the asset-group level. The Company monitors its long-lived assets for indicators of impairment. As the Company’s leased right-of-use assets primarily relate to facility leases, early abandonment of all or part of a facility as part of a restructuring plan is typically an indicator of impairment. If impairment indicators are present, the Company tests whether the carrying amount of the leased right-of-use
asset is recoverable including consideration of sublease income, and if not recoverable, measures impairment loss for the right-of-use asset or asset group.

Pension and Other Defined Benefit Retirement Obligations

The costs of pension and certain other defined benefit employee retirement benefits are required to be recognized based upon actuarial valuations. The related net retirement benefit obligation is recognized as the excess of the projected benefit obligation over the fair value of the plan assets. In measuring the retirement benefit obligation, the discount rate, expected long-term rate of return on plan assets, and long-term rate of salary increase are the most significant assumptions. Retirement benefit costs primarily represent the increase in the actuarial present value of the retirement benefit obligation.

Income Taxes

The Company provides for income taxes utilizing the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are presented net as noncurrent. The provision for income taxes generally represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from the differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when a judgment is made that is considered more likely than not that a tax benefit will not be realized. A decision to record a valuation allowance results in an increase in income tax expense or a decrease in income tax benefit. If the valuation allowance is released in a future period, income tax expense will be reduced accordingly.

The calculation of tax liabilities involves dealing with uncertainties in the application of complex global tax regulations. The impact of an uncertain income tax position is recognized at the largest amount that is “more likely than not” to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. If the estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to expense would result.

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company continually assesses the need for a valuation allowance on the deferred tax asset by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the consolidated statement of operations for the period that the adjustment is determined to be required.

On December 22, 2017, the Tax Cuts and Jobs Act, or the Tax Act, was enacted into U.S. tax law. In 2018, the Company made an accounting policy election to treat Global Intangible Low Taxed Income in accordance with the Tax Act as a period cost.

Comprehensive Income (Loss)

Comprehensive income (loss) is defined as the change in equity (net assets) of a business entity during a period from transactions and other events and circumstances from non-owner sources. Other comprehensive income (loss) includes certain changes in equity that are excluded from net income (loss), net of tax, such as foreign currency translation gains and losses and changes in fair value of projected benefit obligations for defined benefit plans.

Litigation and Settlement Costs

Legal costs are expensed as incurred. The Company is involved in disputes, litigation and other legal actions in the ordinary course of business. The Company continually evaluates uncertainties associated with litigation and records a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the loss or range of loss can be reasonably estimated.
Recently Issued, Not Yet Adopted Accounting Pronouncements
In March 2024, the FASB issued ASU No. 2024-02, Codification Improvements - Amendments to Remove References to the Concepts Statements to remove various references to concepts statements from the FASB Accounting Standards Codification. This guidance is to clarify guidance, simplify wording or structure of guidance, and other minor improvements. These amendments are effective for the Company for annual periods in 2025, applied prospectively, with early adoption and retrospective application permitted. The Company intends to adopt the amendments in this update prospectively in 2025. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.
In March 2024, the FASB issued ASU No. 2024-01, Compensation - Stock Compensation (Topic 718) - Scope Application of Profits Interest and Similar Awards, to clarify whether profits interest and similar awards should be accounted for in accordance with Topic 718, Compensation - Stock Compensation. The guidance applies to all business entities that issue profits interest awards as compensation to employees or nonemployees in exchange for goods or services. These amendments are effective for the Company for annual and interim periods in 2025, applied prospectively, with early adoption and retrospective application permitted. As the Company does not issue profit interest awards, the impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures, to require enhanced income tax disclosures to provide information to assess how an entity’s operations and related tax risks, tax planning, and operational opportunities affect its tax rate and prospects for future cash flows. The amendments in this update provide that a business entity disclose (1) a tabular income tax rate reconciliation, using both percentages and amounts, (2) separate disclosure of any individual reconciling items that are equal to or greater than 5% of the amount computed by multiplying the income (loss) from continuing operations before income taxes by the applicable statutory income tax rate, and disaggregation of certain items that are significant and (3) amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign jurisdictions, including separate disclosure of any individual jurisdictions greater than 5% of total income taxes paid. These amendments are effective for the Company for annual periods in 2025, applied prospectively, with early adoption and retrospective application permitted. The Company intends to adopt the amendments in this update prospectively in 2025. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, since the amendments require only enhancement of existing income tax disclosures in the footnotes to the Company’s consolidated financial statements.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) – Improvements to Reportable Segment Disclosures, to require enhanced disclosures that include reportable segment expenses. The amendments in this update provide that a business entity disclose significant segment expenses, segment profit or loss (after significant segment expenses), and allows reporting of additional measures of a segments profit or loss if used in assessing segment performance. Such disclosures apply to entities with a single reportable segment. These amendments are effective for the Company for annual periods in 2024 and interim periods in 2025, retrospectively to all prior periods using the significant segment expense categories identified and disclosed in the period of adoption. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, since the requirements impact only segment reporting disclosures in the footnotes to the Company’s consolidated financial statements.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.24.3
Net Income (Loss) Per Share
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Net Income (Loss) Per Share Net Income (Loss) Per Share
Basic earnings per share, or EPS, is calculated by dividing net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted EPS is computed by dividing net loss by the weighted-average number of common shares outstanding for the period and the weighted-average number of dilutive common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, stock options and restricted stock units are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive. In periods in which the Company has a net loss, dilutive common stock equivalents are excluded from the calculation of diluted EPS.
The table below presents the computation of basic and diluted EPS:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands, except per share amounts)
Numerator:
Net loss$(75,785)$(39,829)$(187,360)$(34,647)
Denominator:
Weighted average common shares outstanding—basic84,074 81,249 83,303 80,395 
Dilutive common stock equivalents— — — — 
Weighted average common shares outstanding—diluted84,074 81,249 83,303 80,395 
Net loss per share:
Basic$(0.90)$(0.49)$(2.25)$(0.43)
Diluted$(0.90)$(0.49)$(2.25)$(0.43)
For the three months ended September 30, 2024 and 2023, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 6.0 million and 4.9 million, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature.
For the nine months ended September 30, 2024 and 2023, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 6.2 million and 4.8 million, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.24.3
Business Combinations
9 Months Ended
Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Business Combinations Business Combinations
Terminated Silicon Motion Merger
On May 5, 2022, MaxLinear entered into an Agreement and Plan of Merger, or the Merger Agreement, with Silicon Motion Technology Corporation, or Silicon Motion, an exempted company with limited liability incorporated under the laws of the Cayman Islands, pursuant to which, among other things and subject to the terms and conditions thereof, MaxLinear agreed to acquire Silicon Motion pursuant to a statutory merger, under the laws of the Cayman Islands, of Shark Merger Sub, a wholly-owned subsidiary of MaxLinear, with and into Silicon Motion, with Silicon Motion surviving the merger as a wholly-owned subsidiary of MaxLinear. Silicon Motion is a provider of NAND flash controllers for solid state drives, or SSDs, and other solid state storage devices.
On July 26, 2023, MaxLinear terminated the Merger Agreement and notified Silicon Motion that MaxLinear was relieved of its obligations to close because, among other reasons, (i) certain conditions to closing set forth in the Merger Agreement were not satisfied and were incapable of being satisfied, (ii) Silicon Motion had suffered a Material Adverse Effect that was continuing, (iii) Silicon Motion was in material breach of representations, warranties, covenants, and agreements in the Merger Agreement that gave rise to the right of the Company to terminate, and (iv) in any event, the First Extended Outside Date had passed and was not automatically extended because certain conditions in Article 6 of the Merger Agreement were not satisfied or waived as of May 5, 2023. For these same reasons, under the terms of the Merger Agreement, MaxLinear was not required to pay a break-up fee or other fee to Silicon Motion as a result of the termination of the Merger Agreement. Undefined capitalized terms in this paragraph have the same meaning as in the Merger Agreement. On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration to seek damages from MaxLinear arising from MaxLinear's alleged breaches of the Merger Agreement.
On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. See Note 15 for more information on legal matters related to the termination of the Merger Agreement.
The second amended and restated commitment letter dated October 24, 2022 with Wells Fargo Bank, N.A., or Wells Fargo Bank, and other lenders, and related financing commitments for the previously pending (now terminated) merger were also terminated upon termination of the Merger Agreement. As a result of the termination of the financing, in August 2023, the Company was required to pay to Wells Fargo Bank a ticking fee of $18.3 million.
Acquisition of Company Y
On January 17, 2023, the Company completed its acquisition of a business, or Company Y, pursuant to a Purchase and Sale Agreement, or the Purchase Agreement. The transaction consideration included $9.8 million in cash. In addition, Company Y stockholders are eligible to receive up to $2.6 million in consideration due to the acquired business satisfying certain personnel objectives by June 17, 2024.
Company Y is headquartered in Bangalore, India and operates as a provider of engineering design services.
Acquisition Consideration
The following table summarizes the fair value of purchase price consideration to acquire Company Y (in thousands):
DescriptionAmount
Fair value of purchase consideration:
Cash$9,824 
Contingent consideration(1)
2,600 
Total purchase price$12,424 
_________________
(1) The fair value of contingent consideration is based on applying the Monte Carlo simulation method to forecast achievement under various contingent consideration events which may result in up to $2.6 million in payments due to the acquired business’s satisfying certain financial and personnel objectives by June 17, 2024 under the Purchase Agreement. Key inputs in the valuation include forecasted revenue, revenue volatility and discount rate. Underlying forecast mathematics were based on Geometric Brownian Motion in a risk-neutral framework and discounted back to the applicable period in which the accumulative thresholds were achieved at discount rates commensurate with the risk and expected payout term of the contingent consideration.
Purchase Price Allocation
The final allocation of purchase price as of the January 17, 2023 acquisition closing date based upon an estimate of the fair value of the assets acquired and the liabilities assumed by the Company in the acquisition primarily includes $2.0 million in net operating liabilities, with $11.8 million in goodwill.
Assumptions in the Allocations of Purchase Price
Management prepared the purchase price allocations for Company Y and in doing so considered or relied in part upon reports of a third party valuation expert to calculate the fair value of certain acquired assets, which primarily included an acquired workforce and contingent consideration. Certain stockholders that are employees of Company Y were not required to remain employed in order to receive the contingent consideration; accordingly, the fair value of the contingent consideration was accounted for as a portion of the purchase consideration.
Estimates of fair value require management to make significant estimates and assumptions. The goodwill recognized is attributable primarily to the acquired workforce. Certain liabilities included in the purchase price allocations are based on management’s best estimates of the amounts to be paid or settled and based on information available at the time the purchase price allocations were prepared.
Goodwill recorded in connection with Company Y was $11.8 million as of September 30, 2024. The Company does not expect to deduct any of the acquired goodwill for tax purposes.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring Activity
9 Months Ended
Sep. 30, 2024
Restructuring and Related Activities [Abstract]  
Restructuring Activity Restructuring Activity
From time to time, the Company approves and implements restructuring plans as a result of internal resource alignment and cost saving measures. Such restructuring plans may include terminating employees, vacating certain leased facilities, and cancellation of contracts.
Restructuring costs in the nine months ended September 30, 2024 included costs pertaining to restructuring plans initiated in 2023 and 2024 as described below.
In July 2024, the Company initiated a reduction of its workforce, or the 2024 Workforce Reduction. In the three and nine months ended September 30, 2024, the Company incurred $26.8 million in restructuring costs pertaining to the 2024 Workforce Reduction, which included $17.0 million in charges under contracts associated with cancelled projects and related impairment of assets, $9.1 million in severance costs and related expenses, and $0.7 million from exiting facilities.
During the year ended December 31, 2023, the Company entered into restructuring plans to reduce its workforce, or the 2023 Workforce Reductions. In the nine months ended September 30, 2024, the Company completed notification to remaining affected employees of the 2023 Workforce Reductions, and incurred $23.5 million in restructuring costs, including $19.8 million in severance and related costs, or a cumulative total of $43.3 million pertaining to the 2023 Workforce Reductions. Substantially all of the severance and related costs incurred in the nine months ended September 30, 2024 related to the 2023 Workforce Reductions pertained to statutory severance benefits in the jurisdictions in which the terminated employees were employed.
The Company expects to incur additional restructuring costs associated with the 2023 Workforce Reductions and 2024 Workforce Reduction of approximately $3.0 million to $5.0 million, which is expected to pertain to severance due to statutory requirements in the jurisdictions in which the terminated employees were employed, as well as exiting facilities. The Company expects to complete notifications to employees regarding the 2024 Workforce Reduction and finalize its plans to exit facilities by the end of 2024. The estimate of costs that the Company expects to incur, and the timing thereof, are subject to a number of assumptions and actual results may differ. The Company may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the 2023 Workforce Reductions and 2024 Workforce Reduction.
All statements other than statements of historical facts contained in the paragraphs above are forward-looking statements including statements relating to the Company’s plans, expectations, forecasts and future events. Such forward-looking statements include, but are not limited to, the potential of, and expectations regarding the Company’s statements relating to the expected impacts, charges and costs associated with the 2023 Workforce Reductions and 2024 Workforce Reduction that the Company expects to incur.
The following table presents the activity related to the restructuring plans, which is included in restructuring charges in the consolidated statements of operations:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands)
Employee separation expenses$9,109 $(13)$28,902 $8,863 
Lease related charges674 — 3,628 42 
Other17,045 67 17,793 233 
$26,828 $54 $50,323 $9,138 
The following table presents a roll-forward of the Company’s restructuring liability for the nine months ended September 30, 2024. The restructuring liability is included in accrued expenses and other current liabilities and other long-term liabilities in the consolidated balance sheets.
Employee Separation ExpensesLease Related ChargesOtherTotal
(in thousands)
Liability as of December 31, 2023$7,383 $(2)$920 $8,301 
Restructuring charges28,902 3,628 17,793 50,323 
Cash payments(30,452)(172)(915)(31,539)
Non-cash charges and adjustments967 (3,419)(3,406)(5,858)
Liability as of September 30, 20246,800 35 14,392 21,227 
Less: current portion as of September 30, 2024(6,800)(35)(8,775)(15,610)
Long-term portion as of September 30, 2024$— $— $5,617 $5,617 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets
9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill
Goodwill arises from the acquisition method of accounting for business combinations and represents the excess of the purchase price over the fair value of the net assets and other identifiable intangible assets acquired. The fair values of net tangible assets and intangible assets acquired are based upon preliminary valuations and the Company’s estimates and assumptions are subject to change within the measurement period (potentially up to one year from the acquisition date).
The following table presents the changes in the carrying amount of goodwill for the periods indicated:
Nine Months Ended September 30,
20242023
(in thousands)
Beginning balance$318,588 $306,739 
Acquisitions (Note 3)
— 11,717 
Ending balance$318,588 $318,456 
The Company performs an annual goodwill impairment assessment on October 31st each year, using a quantitative assessment comparing the fair value of each reporting unit, which the Company has determined to be the entity itself, with its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recorded. As a result of the Company’s impairment assessment, no goodwill impairment was recognized as of October 31, 2023.
In addition to its annual review, the Company performs a test of impairment when indicators of impairment are present. During the nine months ended September 30, 2024 and 2023, there were no indications of impairment of the Company’s goodwill balances.
Acquired Intangibles
Finite-lived Intangible Assets
The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which are amortized over their estimated useful lives:
September 30, 2024December 31, 2023
Weighted
Average
Useful Life
(in Years)
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
(in thousands)
Licensed technology7.0$23,857 $(2,172)$21,685 $20,133 $(1,431)$18,702 
Developed technology6.9311,261 (280,443)30,818 311,261 (263,635)47,626 
Trademarks and trade names6.214,800 (14,383)417 14,800 (14,276)524 
Customer relationships5.0128,800 (127,502)1,298 128,800 (126,347)2,453 
Patents7.04,780 (967)3,813 4,780 (455)4,325 
6.1$483,498 $(425,467)$58,031 $479,774 $(406,144)$73,630 
The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands)(in thousands)
Cost of net revenue$3,745 $8,581 $17,549 $27,372 
Research and development— — — 
Selling, general and administrative591 653 1,774 2,290 
$4,336 $9,234 $19,323 $29,664 
Amortization of finite-lived intangible assets in cost of net revenue in the consolidated statements of operations results primarily from acquired developed technology.
The following table sets forth the activity related to finite-lived intangible assets:
Nine Months Ended September 30,
20242023
(in thousands)
Beginning balance$73,630 $109,316 
Additions4,961 6,198 
Other disposals— (769)
Amortization(19,323)(29,664)
Impairment losses(1,237)(2,438)
Ending balance$58,031 $82,643 
The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the related useful lives, to determine whether indicators of impairment may exist that warrant adjustments to carrying values or estimated useful lives. An impairment loss is recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss is measured based on the excess of the carrying amount of the asset over the asset’s fair value. During each of the three and nine months ended September 30, 2024, impairment losses related to finite-lived intangible assets of $1.2 million were recognized. During the three and nine months ended September 30, 2023, impairment losses related to finite-lived intangible assets of $0 and $2.4 million were recognized, respectively. The impairment losses were attributable to abandonment of certain purchased licensed technology.
The following table presents future amortization of the Company’s finite-lived intangible assets at September 30, 2024:
Amount
(in thousands)
2024 (3 months)$3,992 
202514,619 
202613,916 
202710,437 
20285,099 
Thereafter9,968 
Total$58,031 
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments
9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Financial Instruments Financial Instruments
The composition of financial instruments is as follows:
Fair Value
September 30, 2024December 31, 2023
(in thousands)
Liabilities
Contingent consideration (Note 3)
$2,600 $2,462 
The fair value of the Company’s financial instruments is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants and is recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The levels are described below:
Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.
Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.
Level 3: Unobservable inputs are used when little or no market data is available.
The Company classifies its financial instruments that are categorized within Level 1 or Level 2 of the fair value hierarchy on the basis of valuations using quoted market prices or alternate pricing sources and models utilizing market observable inputs, respectively.
The contingent consideration liability as of September 30, 2024 and December 31, 2023 is associated with the Company’s acquisition of Company Y in January 2023 (Note 3). The contingent consideration liability is classified as a Level 3 financial instrument. The contingent consideration as it relates to Company Y was subject to the acquired business’s satisfaction of certain personnel objectives by June 17, 2024. The fair value of contingent consideration is based on (1) applying the Monte Carlo simulation method, with underlying forecast mathematics based on Geometric Brownian motion in a risk-neutral framework, to forecast achievement of the acquired business’ financial objectives, if applicable, under various possible contingent consideration events and (2) a probability based methodology using management’s inputs and assumptions to forecast achievement of the acquired business’ personnel objectives which included an assumption of total payments up to $2.6 million to Company Y. Key inputs in the valuation include forecasted revenue, revenue volatility, discount rate and discount term as it relates to the financial objectives and probability of achievement, discount term and discount rate as it relates to the personnel objectives.
Fair Value Measurements at September 30, 2024
Balance at
September 30, 2024
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
(in thousands)
Liabilities
Contingent consideration$2,600 $— $— $2,600 
Fair Value Measurements at December 31, 2023
Balance at December 31, 2023Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
(in thousands)
Liabilities
Contingent consideration$2,462 $— $— $2,462 
The following summarizes the activity in Level 3 financial instruments:
Nine Months Ended September 30,
20242023
(in thousands)
Contingent consideration
Beginning balance
$2,462 $2,941 
Acquisitions(1)(Note 3)
— 2,200 
Payments— (2,700)
Accretion of discount(1)
138 249 
Ending balance
$2,600 $2,690 
_____________________
(1) These changes to the balance associated with the estimated fair value of contingent consideration for the nine months ended September 30, 2024 and 2023 were due to the addition of contingent consideration associated with the acquisition of Company Y in January 2023 and accretion of discounts on contingent consideration.
There were no transfers between Level 1, Level 2, or Level 3 fair value hierarchy categories of financial instruments. for the nine months ended September 30, 2024.
Financial Instruments Not Recorded at Fair Value on a Recurring Basis
Some of the Company’s financial instruments are recorded at amounts that approximate fair value due to their liquid or short-term nature or by election on investments in privately-held entities as described below. Such financial assets and financial liabilities include: cash and cash equivalents, restricted cash, net receivables, investments in privately-held entities, certain other assets, accounts payable, accrued price protection liability, accrued expenses, accrued compensation costs, and other current liabilities.
The Company’s long-term debt is not recorded at fair value on a recurring basis but is measured at fair value for disclosure purposes (Note 8).
Included in other long-term assets as of December 31, 2023 were investments in a privately held entity of $11.8 million, which were impaired in the three months ended September 30, 2024. The Company does not have the ability to exercise significant influence or control over such entity and had accounted for the investments as financial instruments. Given that fair values for such investments were not readily determinable, the Company had elected to measure these investments at cost, less any impairment, and adjust the carrying value to fair value if any observable price changes for similar investments in the same entity are identified. The impairment loss of $11.8 million is included in other expense in the consolidated statement of operations for the three and nine months ended September 30, 2024.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheet Details
9 Months Ended
Sep. 30, 2024
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Details Balance Sheet Details
Cash, cash equivalents and restricted cash consist of the following:
September 30, 2024December 31, 2023
(in thousands)
Cash and cash equivalents$148,476 $187,288 
Short-term restricted cash993 1,051 
Long-term restricted cash23 17 
Total cash, cash equivalents and restricted cash$149,492 $188,356 
As of September 30, 2024 and December 31, 2023, cash and cash equivalents included money market funds of approximately $103.3 million and $78.1 million, respectively. As of September 30, 2024 and December 31, 2023, the Company had restricted cash of approximately $1.0 million and $1.1 million, respectively. The cash is restricted in connection with guarantees for certain import duties and office leases.
Inventory consists of the following:
September 30, 2024December 31, 2023
(in thousands)
Work-in-process$54,909 $60,368 
Finished goods41,154 39,540 
$96,063 $99,908 
Property and equipment, net consists of the following:
Useful Life
(in Years)
September 30, 2024December 31, 2023
(in thousands)
Furniture and fixtures5$3,944 $3,995 
Machinery and equipment
3-5
80,641 76,732 
Masks and production equipment562,676 54,240 
Software311,194 11,427 
Leasehold improvements
1-5
35,401 35,867 
Construction in progressN/A686 348 
194,542 182,609 
Less: accumulated depreciation and amortization(131,049)(116,178)
$63,493 $66,431 
Depreciation expense for the three months ended September 30, 2024 and 2023 was $5.8 million and $5.6 million, respectively. Depreciation expense for the nine months ended September 30, 2024 and 2023 was $17.0 million and $18.5 million, respectively.
In March 2022, the Company entered into a note receivable with a supplier for $10.0 million. In September 2023, the terms of this note receivable were renegotiated, and the first initial repayment of $1.5 million is due by March 31, 2025, and annual repayments of $1.7 million per year are due annually thereafter by March 31, from 2026 through 2030, provided that certain production utilization targets for the prior year are met. During the three months ended September 30, 2024, a portion of the note receivable, or $0.5 million, was written off to other expense in the consolidated statement of operations. The amount written off represents the portion of the payment associated with production utilization that is anticipated to be less than target. The balance of the note receivable has been classified as a long-term asset based on expected timing of receipt of repayment. The long-term portion of the note receivable is included in other long-term assets as of September 30, 2024 and December 31, 2023, respectively. Previously, repayments of $2.0 million per year were due annually by March 31, in years 2024 through 2027.
Accrued price protection liability consists of the following activity:
Nine Months Ended September 30,
20242023
(in thousands)
Beginning balance$71,684 $113,274 
Charged as a reduction of revenue42,042 50,092 
Reversal of unclaimed rebates(15,272)— 
Payments(53,982)(91,723)
Ending balance$44,472 $71,643 
The decrease in price protection liability from approximately $71.7 million as of December 31, 2023 to approximately $44.5 million as of September 30, 2024 was driven by payments of rebates as well as reversal of unclaimed rebates due to expiration of rebate pricing.
Accrued expenses and other current liabilities consist of the following:
September 30, 2024December 31, 2023
(in thousands)
Accrued technology license payments$3,627 $3,843 
Accrued professional fees4,196 3,736 
Accrued engineering and production costs5,461 2,861 
Accrued restructuring15,610 8,301 
Accrued royalty403 603 
Short-term lease liabilities9,799 9,132 
Accrued customer credits3,705 3,984 
Income tax liability421 521 
Customer contract liabilities164 1,597 
Accrued obligations to customers for price adjustments20,558 54,837 
Accrued obligations to customers for stock rotation rights167 349 
Contingent consideration - current portion2,600 2,462 
Other4,486 6,242 
$71,197 $98,468 
The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:
Cumulative Translation AdjustmentsPension and Other Defined Benefit Plan ObligationTotal
(in thousands)
Balance at December 31, 2023$(5,059)$1,268 $(3,791)
Other comprehensive loss before reclassifications, net of tax(61)— (61)
Balance at September 30, 2024$(5,120)$1,268 $(3,852)
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.24.3
Debt
9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
Debt Debt
Debt
The carrying amount of the Company’s long-term debt consists of the following:
September 30, 2024December 31, 2023
(in thousands)
Principal balance:
Initial term loan under the June 23, 2021 credit agreement$125,000 $125,000 
Total principal balance125,000 125,000 
Less:
     Unamortized debt discount(477)(571)
     Unamortized debt issuance costs(1,683)(2,054)
Net carrying amount of long-term debt122,840 122,375 
Less: current portion of long-term debt— — 
Long-term debt, non-current portion$122,840 $122,375 
As of September 30, 2024 and December 31, 2023, the weighted average effective interest rate on aggregate debt was approximately 7.9% and 7.6%, respectively.
During the three months ended September 30, 2024 and 2023, the Company recognized total amortization of debt discount and debt issuance costs of $0.2 million and $0.2 million, respectively, to interest expense. During the nine months ended September 30, 2024 and 2023, the Company recognized total amortization of debt discount and debt issuance costs of $0.5 million and $0.5 million.
The approximate aggregate fair value of the term loans outstanding as of September 30, 2024 and December 31, 2023 was $115.7 million and $114.5 million, respectively, which was estimated on the basis of inputs that are observable in the market and which is considered a Level 2 measurement method in the fair value hierarchy (Note 6).
As of September 30, 2024, the outstanding principal balance of $125.0 million is due in full on June 23, 2028, upon maturity of the loan.
Initial Term Loan and Revolving Facility under the June 23, 2021 Credit Agreement
On June 23, 2021, the Company entered into a Credit Agreement, or the June 23, 2021 Credit Agreement, by and among the Company, the lenders from time to time party thereto, and Wells Fargo Bank, National Association, as administrative agent and collateral agent, that provides for a senior secured term B loan facility, or the “Initial Term Loan under the June 23, 2021 Credit Agreement,” in an aggregate principal amount of $350.0 million and a senior secured revolving credit facility, or the “Revolving Facility,” in an aggregate principal amount of up to $100.0 million. The proceeds of the Initial Term Loan under the June 23, 2021 Credit Agreement were used (i) to repay in full all outstanding indebtedness under that certain Credit Agreement dated May 12, 2017, by and among the Company, MUFG Bank Ltd., as administrative agent and MUFG Union Bank, N.A., as collateral agent and the lenders from time to time party thereto (as amended by Amendment No. 1, dated July 31, 2020) and (ii) to pay fees and expenses incurred in connection therewith. The remaining proceeds of the Initial Term Loan under the June 23, 2021 Credit Agreement are available for general corporate purposes and the proceeds of the Revolving Facility may be used to finance the working capital needs and other general corporate purposes of the Company and its subsidiaries. As of September 30, 2024, the Revolving Facility was undrawn. Under the terminated amended and restated commitment letter with Wells Fargo Bank and other lenders entered into in connection with the previously pending (now terminated) merger with Silicon Motion (Note 3), the Company had expected to repay the remaining outstanding term loans under this agreement upon closing of the merger.
The June 23, 2021 Credit Agreement permits the Company to request incremental loans in an aggregate principal amount not to exceed the sum of an amount equal to the greater of (x) $175.0 million and (y) 100% of consolidated EBITDA, plus the amount of certain voluntary prepayments, plus an unlimited amount that is subject to pro forma compliance with certain first lien net leverage ratio, secured net leverage ratio and total net leverage ratio tests. Incremental loans are subject to certain additional conditions, including obtaining additional commitments from the lenders then party to the June 23, 2021 Credit Agreement or new lenders.
Under the June 23, 2021 Credit Agreement, the Initial Term Loan bears interest, at the Company’s option, at a per annum rate equal to either (i) a base rate equal to the highest of (x) the federal funds rate, plus 0.50%, (y) the prime rate then in effect and (z) an adjusted Term SOFR rate determined on the basis of a one-month interest period plus 1.00%, in each case, plus an applicable margin of 1.25% or (ii) an adjusted Term SOFR rate, subject to a floor of 0.50%, plus an applicable margin of 2.25%. Loans under the Revolving Facility initially bear interest, at a per annum rate equal to either (i) a base rate (as calculated above) plus an applicable margin of 0.00%, or (ii) an adjusted Term SOFR rate (as calculated above) plus an applicable margin of 1.00%. Following delivery of financial statements for the Company’s fiscal quarter ending June 30, 2021, the applicable margin for loans under the Revolving Facility will range from 0.00% to 0.75% in the case of base rate loans and 1.00% to 1.75% in the case of Term SOFR rate loans, in each case, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. The Company is required to pay commitment fees ranging from 0.175% to 0.25% per annum on the daily undrawn commitments under the Revolving Facility, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. Commencing on September 30, 2021, the Initial Term Loan under the June 23, 2021 Credit Agreement will amortize in equal quarterly installments equal to 0.25% of the original principal amount of the Initial Term Loan under the June 23, 2021 Credit Agreement, with the balance payable on the maturity date. The June 23, 2021 Credit Agreement was amended on June 29, 2023 to implement a benchmark replacement.
The Company is required to make mandatory prepayments of the outstanding principal amount of term loans under the June 23, 2021 Credit Agreement with the net cash proceeds from the disposition of certain assets and the receipt of insurance
proceeds upon certain casualty and condemnation events, in each case, to the extent not reinvested within a specified time period, from excess cash flow beyond stated threshold amounts, and from the incurrence of certain indebtedness. The Company has the right to prepay its term loans under the June 23, 2021 Credit Agreement, in whole or in part, at any time without premium or penalty, subject to certain limitations and a 1.0% soft call premium applicable during the first six months following the closing date of the June 23, 2021 Credit Agreement. The Initial Term Loan under the June 23, 2021 Credit Agreement will mature on June 23, 2028, at which time all outstanding principal and accrued and unpaid interest on the Initial Term Loan under the June 23, 2021 Credit Agreement must be repaid. The Revolving Facility will mature on June 23, 2026, at which time all outstanding principal and accrued and unpaid interest under the Revolving Facility must be repaid. The Company is also obligated to pay fees customary for a credit facility of this size and type.
The Company’s obligations under the June 23, 2021 Credit Agreement are required to be guaranteed by certain of its domestic subsidiaries meeting materiality thresholds set forth in the June 23, 2021 Credit Agreement. Such obligations, including the guaranties, are secured by substantially all of the assets of the Company and the subsidiary guarantors pursuant to a Security Agreement, dated as of June 23, 2021, by and among the Company, the subsidiary guarantors from time to time party thereto, and Wells Fargo Bank, National Association, as collateral agent.
The June 23, 2021 Credit Agreement contains customary affirmative and negative covenants, including covenants limiting the ability of the Company and its restricted subsidiaries to, among other things, incur debt, grant liens, undergo certain fundamental changes, make investments, make certain restricted payments, and sell assets, in each case, subject to limitations and exceptions set forth in the June 23, 2021 Credit Agreement. The Revolving Facility also prohibits the Company from having a secured net leverage ratio in excess of 3.50:1.00 (subject to a temporary increase to 3.75:1.00 following the consummation of certain material permitted acquisitions) as of the last day of any fiscal quarter of the Company (commencing with the fiscal quarter ending September 30, 2021) if the aggregate borrowings under the Revolving Facility exceed 1% of the aggregate commitments thereunder (subject to certain exceptions set forth in the June 23, 2021 Credit Agreement) as of such date. As of September 30, 2024, the Company was in compliance with such covenants. The June 23, 2021 Credit Agreement also contains customary events of default that include, among other things, certain payment defaults, cross defaults to other indebtedness, covenant defaults, change in control defaults, judgment defaults, and bankruptcy and insolvency defaults. If an event of default exists, the lenders may require immediate payment of all obligations under the June 23, 2021 Credit Agreement and may exercise certain other rights and remedies provided for under the June 23, 2021 Credit Agreement, the other loan documents and applicable law.
The debt is carried at its principal amount, net of unamortized debt discount and issuance costs, and is not adjusted to fair value each period. The issuance date fair value of the liability component of the debt in the amount of $350.2 million was determined using a discounted cash flow analysis, in which the projected interest and principal payments were discounted back to the issuance date of the term loan at a market interest rate for nonconvertible debt of 3.4%, which represents a Level 2 fair value measurement. The debt discount of $0.9 million and debt issuance costs of $2.9 million associated with the Initial Term Loan under the June 23, 2021 Credit Agreement are being amortized to interest expense using the effective interest method over its seven-year term. Debt issuance costs of $0.4 million associated with the Revolving Facility are being amortized to interest expense over its five-year term.
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Employee Stock-Based Compensation Plans
At September 30, 2024, the Company had stock-based compensation awards outstanding under the following plans: the 2010 Equity Incentive Plan, as amended, or 2010 Plan, and the 2010 Employee Stock Purchase Plan, or ESPP, and the 2024 Inducement Equity Incentive Plan, or the Inducement Plan. Refer to the Company’s Annual Report for a summary of the 2010 Plan and the ESPP.
On May 22, 2024, the Board of Directors adopted the Inducement Plan pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules, and, subject to the adjustment provisions of the Inducement Plan, reserved 4,000,000 shares of the Company's common stock for issuance under equity awards granted under the Inducement Plan. The Inducement Plan provides for the grant of equity-based awards, including non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares, and its terms are substantially similar to the 2010 Plan, including with respect to treatment of equity awards in the event of a merger or “change in control” as defined under the Inducement Plan, but with such other terms and conditions intended to comply with the Nasdaq inducement award exception. Awards under the Inducement Plan may only be made to individuals not previously employees or non-employee directors of the Company as an inducement material to the individuals’ entry into employment with the Company.
As of September 30, 2024, the number of shares of common stock available for future issuance under the 2010 Plan was 15,417,601 shares. As of September 30, 2024, the number of shares of common stock available for future issuance under the ESPP was 6,451,538 shares. As of September 30, 2024, the number of shares of common stock available for future issuance under the Inducement Plan was 4,000,000 shares.
Employee Incentive Bonus
The Company’s Executive Incentive Bonus Plan permits the settlement of awards under the plan in any combination of cash or shares of its common stock. The Company settles a majority of bonus awards for its employees, including executives, in shares of common stock under the 2010 Equity Incentive Plan. When bonus awards are settled in common stock issued under the 2010 Equity Incentive Plan, the number of shares issuable to plan participants is determined based on the closing price of the Company’s common stock as determined in trading on the applicable stock exchange, on a date approved by the Board of Directors. In connection with the Company’s bonus programs, in February 2024, the Company issued 0.4 million freely-tradable (subject to certain restrictions for affiliates) shares of the Company’s common stock in settlement of bonus awards to employees, including executives, for the 2023 performance period. At September 30, 2024, the Company has an accrual of $3.5 million for bonus awards for employees for year-to-date achievement in the 2024 performance period, which the Company intends to settle primarily in shares of its common stock, unless otherwise required to be settled in cash due to local laws or agreements. The Company’s compensation committee retains discretion to effect payment in cash, stock, or a combination of cash and stock.
Stock-Based Compensation
The Company recognizes stock-based compensation in the consolidated statements of operations, based on the department to which the related employee reports, as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands)(in thousands)
Cost of net revenue$81 $170 $436 $626 
Research and development7,423 9,436 27,952 33,128 
Selling, general and administrative5,284 (4,488)18,820 5,009 
$12,788 $5,118 $47,208 $38,763 
The total unrecognized compensation cost related to unvested restricted stock units as of September 30, 2024 was $112.0 million, and the weighted average period over which these equity awards are expected to vest is 2.39 years.
The total unrecognized compensation cost related to unvested performance-based restricted stock units as of September 30, 2024 was $1.4 million, and the weighted average period over which these equity awards are expected to vest is 1.40 years. Actual levels of future performance for the unvested periods may differ from current estimates.
The total unrecognized compensation cost related to unvested stock options as of September 30, 2024 was $28.0 million, and the weighted average period over which these equity awards are expected to vest is 3.39 years.
Restricted Stock Units
A summary of the Company’s restricted stock unit activity for all equity plans is as follows:
Number of Shares
(in thousands)
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 20235,632 $36.72 
  Granted1
2,945 18.24 
  Vested(2,461)29.44 
  Canceled2
(1,007)38.32 
Outstanding at September 30, 20245,109 $29.25 
____________
(1) Includes approximately 227 thousand shares granted under the Inducement Plan at a weighted-average grant-date fair value per share of $13.64.
(2) Includes approximately 24 thousand shares canceled under the Inducement Plan at a weighted-average grant-date fair value per share of $12.46.
Performance-Based Restricted Stock Units
Performance-based restricted stock units are eligible to vest at the end of each year-long performance period, as defined in the underlying agreement, in a three-year performance period based on the Company’s annual growth rate in net sales and non-GAAP diluted earnings per share (subject to certain adjustments) over baseline results relative to the growth rates for a peer group of companies for the same metrics and periods.
For the performance-based restricted stock units granted to date, 60% of each performance-based award is subject to the net sales metric for the performance period and 40% is subject to the non-GAAP diluted earnings per share metric for the performance period. The maximum percentage for a particular metric is 250% of the target number of units subject to the award related to that metric, however, vesting of the performance stock units is capped at 30% and 100%, respectively, of the target number of units subject to the award in years one and two, respectively, of the three-year performance period.
As of September 30, 2024, achievement to date under the performance metrics specified in the respective award agreements are based on its expected revenue and non-GAAP diluted EPS results over the performance periods and calculated growth rates relative to its peers’ expected results based on data available, as defined in the respective award agreements. To the extent any prior achievement levels are no longer probable, any compensation expense recorded is adjusted to the revised achievement levels.
A summary of the Company’s performance-based restricted stock unit activity is as follows:
Number of Shares
(in thousands)
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 20232,653 $34.38 
  Granted1
1,472 17.78 
  Vested(58)24.43 
  Canceled(665)41.74 
Outstanding at September 30, 20243,402 $25.93 
________________
(1) Number of shares granted is based on the maximum percentage achievable in the performance-based restricted stock unit award.
Employee Stock Purchase Rights and Stock Options
Employee Stock Purchase Rights
During the nine months ended September 30, 2024 and 2023, there were 175,764 and 140,631 shares of common stock purchased under the ESPP at a weighted average price of $15.26 and $21.25, respectively.
The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:
Nine Months Ended September 30,
20242023
Weighted-average grant date fair value per share
$5.78 - $6.35
$7.56 - $11.97
Risk-free interest rate
5.40% - 5.41%
4.54% - 5.24%
Dividend yield— %— %
Expected life (in years)0.500.50
Volatility
49.76% - 70.46%
51.73% - 59.78%
The risk-free interest rate assumption was based on rates for United States (U.S.) Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The assumed dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. The expected term is the duration of the offering period for each grant date. In addition, the estimated volatility incorporates the historical volatility over the expected term based on the Company’s daily closing stock prices.
Stock Options
A summary of the Company’s stock options activity is as follows:
Number of Options
(in thousands)
Weighted-Average Exercise PriceWeighted-Average Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2023375 $17.29 
Granted2,688 19.45 
Exercised(39)7.68 
Canceled(1)23.75 
Outstanding at September 30, 20243,023 $19.33 8.45$— 
Vested and expected to vest at September 30, 20242,807 $19.32 8.38$— 
Exercisable at September 30, 2024335 $18.40 0.86$— 
The fair values of stock options were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:
Nine Months Ended September 30,
20242023(1)
Weighted-average grant date fair value per share
$10.84 - $11.24
N/A
Risk-free interest rate4.33 %N/A
Dividend yield— %N/A
Expected life (in years)6.50N/A
Volatility57.50 %N/A
__________________
(1) No options were granted during the nine months ended September 30, 2023.
The risk-free interest rate assumption was based on the United States Treasury’s rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The assumed dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. The expected term of the options was calculated using the simplified method as prescribed by guidance provided by the SEC. This decision was based on the lack of historical data due to the Company’s limited number of stock option exercises under the 2010 Equity Incentive Plan. Estimated volatility incorporates historical volatility of the Company over the expected term based on the Company's daily closing stock prices.
The intrinsic value of stock options exercised was $0 and $47.0 thousand in the three months ended September 30, 2024 and 2023, respectively. The intrinsic value of stock options exercised was $0.5 million and $0.2 million in the nine months ended September 30, 2024 and 2023, respectively.
Cash received from exercise of stock options was negligible during the three and nine months ended September 30, 2024. Cash received from exercise of stock options was $0.1 million and $0.2 million during the three and nine months ended September 30, 2023, respectively.
The tax benefit from stock options exercised was $0 and $0.1 million during the three months ended September 30, 2024 and 2023, respectively. The tax benefit from stock options exercised was $0.8 million and $0.4 million during the nine months ended September 30, 2024 and 2023, respectively.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.3
Income Taxes
9 Months Ended
Sep. 30, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The provision for income taxes primarily relates to projected federal, state, and foreign income taxes. To determine the quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is generally based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates. In addition, the tax effects of certain significant or unusual items are recognized discretely in the quarter during which they occur and can be a source of variability in the effective tax rates from quarter to quarter.
The Company utilizes the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the temporary differences reverse. The Company records a valuation allowance to reduce its deferred taxes to the amount it believes is more likely than not to be realized. In making such determination, the Company considers all available positive and negative evidence quarterly, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. Forming a conclusion that a valuation allowance is not required is difficult when there is negative evidence such as cumulative losses in recent years. Based upon the Company’s review of all positive and negative evidence, the Company continues to have a valuation allowance on its state deferred tax assets, certain of its federal deferred tax assets, and certain foreign deferred tax assets in jurisdictions where the Company has cumulative losses or otherwise is not expected to utilize certain tax attributes. The Company does not incur expense or benefit in certain tax-free jurisdictions in which it operates.
The Company recorded an income tax benefit of $6.7 million in the three months ended September 30, 2024 and an income tax benefit of $1.7 million in the three months ended September 30, 2023. The Company recorded an income tax benefit of $10.5 million in the nine months ended September 30, 2024 and an income tax provision of $13.5 million in the nine months ended September 30, 2023.
The difference between the Company’s effective tax rate and the 21.0% United States federal statutory rate for the nine months ended September 30, 2024 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items, and stock based compensation.
The difference between the Company’s effective tax rate and the 21.0% U.S. federal statutory rate for the nine months ended September 30, 2023 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items including the tax on global intangible low-taxed income, stock based compensation, excess tax benefits related to stock-based compensation, and the release of uncertain tax positions under ASC 740-10. The permanent tax item related to global intangible low-taxed income also reflected the then recent legislative changes requiring the capitalization of research and experimentation costs, as well as limitations on the creditability of certain foreign income taxes.
Income tax positions must meet a more-likely-than-not threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are de-recognized in the first financial reporting period in which that threshold is no longer met. The Company records potential penalties and interest accrued related to unrecognized tax benefits within the consolidated statements of operations as income tax expense.
During the nine months ended September 30, 2024, the Company’s unrecognized tax benefits increased by $0.2 million. The Company does not expect its unrecognized tax benefits to change significantly over the next 12 months. Accrued interest and penalties associated with uncertain tax positions as of September 30, 2024 were approximately $0.1 million and $4 thousand, respectively.
The Company is subject to federal and state income tax in the United States and is also subject to income tax in certain other foreign tax jurisdictions. At September 30, 2024, the statutes of limitations for the assessment of federal, state, and foreign income taxes are closed for the years before 2020, 2019, and 2017, respectively.
The Company’s subsidiary in Singapore operates under certain tax incentives in Singapore, which are generally effective through March 2027, and are conditional upon meeting certain employment and investment thresholds in Singapore. Under the incentives, qualifying income derived from certain sales of the Company’s integrated circuits is taxed at a concessionary rate over the incentive period, and there are reduced Singapore withholding taxes on certain intercompany royalties during the incentive period. The Company recorded a tax benefit in the nine months ended September 30, 2024 and 2023 at the incentive rate.
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.3
Concentration of Credit Risk, Significant Customers and Geographic Information
9 Months Ended
Sep. 30, 2024
Risks and Uncertainties [Abstract]  
Concentration of Credit Risk, Significant Customers and Geographic Information Concentration of Credit Risk, Significant Customers and Geographic Information
Concentration of Credit Risk
Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents and accounts receivable. Collateral is generally not required for customer receivables. The Company limits its exposure to credit loss by placing its cash with high credit quality financial institutions. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.
Significant Customers
The Company markets its products and services to manufacturers of a wide range of electronic devices (Note 1). The Company sells its products both directly to end-customers and through third-party distributors, both of which are referred to as the Company’s customers (Note 12). Revenue is also generated from sales of intellectual property, and the recipients of such intellectual property are also referred to as the Company’s customers. The Company makes periodic evaluations of the credit worthiness of its customers.
One customer comprised 10% or greater of net revenues for each of the periods presented,
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Percentage of total net revenue
Customer A25 %11 %13 %11 %

The following table presents balances that are 10% or greater of accounts receivable, based on the Company’s billings to its customers.
September 30, 2024December 31, 2023
Percentage of gross accounts receivable
Customer B12 %33 %
Customer C18 %24 %

Significant Suppliers

Suppliers comprising greater than 10% or greater of total inventory purchases are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Vendor A27 %28 %18 %21 %
Vendor B26 %17 %35 %24 %
Vendor C12 %14 %11 %10 %
Vendor D***10 %
____________________________
*    Represents less than 10% of total inventory purchases for the period presented.
Geographic Information
The Company’s consolidated net revenues by geographic area based on ship-to location are as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Amount% of total net revenueAmount% of total net revenueAmount% of total net revenueAmount% of total net revenue
Asia $65,293 80 %$98,647 73 %$193,555 72 %$419,478 74 %
Europe10,208 13 %24,886 18 %29,034 11 %110,058 19 %
United States3,955 %8,757 %41,586 15 %29,847 %
Rest of world1,646 %3,240 %4,186 %8,527 %
Total$81,102 100 %$135,530 100 %$268,361 100 %$567,910 100 %
The products shipped to individual countries or territories representing greater than 10% of net revenue for each of the periods presented are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Percentage of total net revenue
Hong Kong49 %41 %37 %34 %
China***12 %
Taiwan, ROC*10 %**
Thailand11 %***
____________________________
*    Represents less than 10% of total net revenue for the respective period.
The determination of which country a particular sale is allocated to is based on the destination of the product shipment. No other individual country accounted for more than 10% of net revenue during these periods. Although a large percentage of the Company’s products is shipped to Asia, and in particular, Hong Kong and Thailand, the Company believes that a significant number of the systems designed by customers and incorporating the Company’s semiconductor products are subsequently sold outside Asia to Europe, Middle East, and Africa markets and North American markets.
Long-lived assets, which consists of property and equipment, net, leased right-of-use assets, intangible assets, net, and goodwill by geographic area are as follows (in thousands):
September 30, 2024December 31, 2023
Amount% of totalAmount% of total
United States$326,442 71 %$337,696 69 %
Singapore106,444 23 %113,248 23 %
Rest of world29,775 %38,969 %
Total$462,661 100 %$489,913 100 %
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue from Contracts with Customers
9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers Revenue from Contracts with Customers
Revenue by Market
The table below presents disaggregated net revenues by market (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Broadband$32,275 $34,416 $87,157 $169,646 
% of net revenue40 %25 %32 %30 %
Connectivity12,726 15,025 35,700 119,232 
% of net revenue16 %11 %13 %21 %
Infrastructure23,046 49,985 87,436 145,549 
% of net revenue28 %37 %33 %26 %
Industrial and multi-market13,055 36,104 58,068 133,483 
% of net revenue16 %27 %22 %23 %
Total net revenue$81,102 $135,530 $268,361 $567,910 
Revenues from sales through the Company’s distributors accounted for 35% and 46% of net revenue for the three months ended September 30, 2024 and 2023, respectively. Revenues from sales through the Company’s distributors accounted for 42% and 47% of net revenue for the nine months ended September 30, 2024 and 2023, respectively. Revenue related to the sales of intellectual property recognized during the nine months ended September 30, 2024 has been allocated by market based upon the usage of such intellectual property.
Contract Liabilities
As of September 30, 2024 and December 31, 2023, customer contract liabilities were approximately $0.2 million and $1.6 million, respectively, and consisted primarily of advanced payments received for which performance obligations have not been completed. Revenue recognized in each of the nine months ended September 30, 2024 and 2023 that was included in the contract liability balance as of the beginning of each of those respective periods was immaterial.
There were no material changes in the contract liabilities balance during the nine months ended September 30, 2024 and 2023.
Obligations to Customers for Price Adjustments and Returns and Assets for Right-of-Returns
As of September 30, 2024 and December 31, 2023, obligations to customers consisting of estimates of price protection rights offered to the Company’s end customers totaled $44.5 million and $71.7 million, respectively, and are included in accrued price protection liability in the consolidated balance sheets. For activity in this account, including amounts included in net revenue, refer to Note 7.
Other obligations to customers representing estimates of price adjustments to be claimed by distributors upon sell-through of their inventory to their end customer and estimates of stock rotation returns to be claimed by distributors on products sold as of September 30, 2024 were $20.6 million and $0.2 million, respectively, and as of December 31, 2023 were $54.8 million and $0.3 million, respectively, and are included in accrued expenses and other current liabilities in the consolidated balance sheets (Note 7). The reason for the significant decrease in accrued obligations to customers for price adjustments from approximately $54.8 million as of December 31, 2023 to approximately $20.6 million as of September 30, 2024, was due to a significant decrease in sales to distributors which decreased the corresponding accrued obligations to such customers. The increase or decrease in revenue for the three and nine months ended September 30, 2024 and 2023 from net changes in transaction prices for amounts included in obligations to customers for price adjustments and estimates of stock rotation returns to be claimed by distributors as of the beginning of those respective periods was not material.
As of September 30, 2024 and December 31, 2023, right of return assets under customer contracts representing the estimates of product inventory the Company expects to receive from customers in stock rotation returns were approximately $58 thousand and $0.1 million, respectively. Right of return assets are included in inventory in the consolidated balance sheets.
As of September 30, 2024 and December 31, 2023, there were no impairment losses recorded on customer accounts receivable.
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.24.3
Leases
9 Months Ended
Sep. 30, 2024
Leases [Abstract]  
Leases Leases
Operating Leases
Operating lease arrangements primarily consist of office leases expiring in various years through 2029. These leases have original terms of approximately 2 to 8 years and some contain options to extend the lease up to 5 years or terminate the lease, which are included in right-of-use assets and lease liabilities when the Company is reasonably certain it will renew the underlying leases. Since the implicit rate of such leases is unknown and the Company is not reasonably certain to renew its leases, the Company has elected to apply a collateralized incremental borrowing rate to facility leases on the original lease term in calculating the present value of future lease payments. As of September 30, 2024 and December 31, 2023, the weighted average discount rate for operating leases was 4.9% and 4.6%, respectively, and the weighted average remaining lease term for operating leases was 3.4 years and 3.9 years, respectively, as of the end of each of these periods.
The table below presents aggregate future minimum payments due under leases, reconciled to total lease liabilities included in the consolidated balance sheet as of September 30, 2024:
Operating Leases
(in thousands)
2024 (3 months)$2,864 
202510,791 
20268,391 
20276,031 
20282,467 
Thereafter1,596 
Total minimum payments32,140 
Less: imputed interest(2,906)
Less: unrealized translation loss(2)
Total lease liabilities29,232 
Less: short-term lease liabilities(9,799)
Long-term lease liabilities$19,433 
Operating lease cost was $2.4 million and $2.7 million for the three months ended September 30, 2024 and 2023, respectively. Operating lease cost was $7.5 million and $8.0 million for the nine months ended September 30, 2024 and 2023, respectively.
Short-term lease costs for the nine months ended September 30, 2024 and 2023 were not material.
There were $0 and $0 of right-of-use assets obtained in exchange for new lease liabilities for the three months ended September 30, 2024 and 2023, respectively. There were $1.2 million and $12.2 million of right-of-use assets obtained in exchange for new lease liabilities for the nine months ended September 30, 2024 and 2023, respectively.
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.24.3
Employee Retirement Plans
9 Months Ended
Sep. 30, 2024
Retirement Benefits [Abstract]  
Employee Retirement Plans Employee Retirement Plans
Defined Contribution Plan
The Company has a 401(k) defined contribution retirement plan (the 401(k) Plan) covering all eligible employees. Participants may voluntarily contribute on a pre-tax basis an amount not to exceed a maximum contribution amount pursuant to Section 401(k) of the Internal Revenue Code. The Company is not required to contribute, nor has it contributed, to the 401(k) Plan for any of the periods presented.
Pension and Other Defined Benefit Retirement Obligations
The Company maintains defined benefit retirement plans, including a pension plan, in certain foreign jurisdictions. As of September 30, 2024, the net defined benefit obligation, primarily related to other defined benefit plans, was $0.4 million. As of December 31, 2023, the net defined benefit obligation was $1.4 million. The benefit is based on a formula applied to eligible employee earnings.
Net periodic benefit costs were $45 thousand and $0.1 million for the three months ended September 30, 2024 and 2023, respectively, and were recorded to research and development expenses in the consolidated statements of operations. Net periodic benefit costs were $0.2 million and $0.2 million for the nine months ended September 30, 2024 and 2023, respectively, and were recorded to research and development expenses in the consolidated statements of operations.
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Inventory Purchase and Other Contractual Obligations
As of September 30, 2024, future minimum payments under inventory purchase and other obligations are as follows:
Inventory Purchase ObligationsOther ObligationsTotal
2024 (3 months)$3,004 $7,708 $10,712 
202513,419 32,131 45,550 
2026— 19,482 19,482 
2027— 3,673 3,673 
Total minimum payments$16,423 $62,994 $79,417 
Other obligations consist primarily of contractual payments due for software licenses.
Jointly Funded Research and Development
From time to time, the Company enters into contracts for jointly funded research and development projects to develop technology that may be commercialized into a product in the future and receives payments as milestones under the contracts are met. If the Company is required to repay all or a portion of the funds provided by the other parties under certain conditions, the Company defers such funds in other-long term liabilities. As of September 30, 2024, funds of $15.0 million received from the other parties have been deferred in other long-term liabilities. The Company de-recognizes the liabilities when the contingencies associated with the repayment conditions have been resolved. During the three and nine months ended September 30, 2024 and 2023, the Company did not recognize income from any previously deferred amounts from other parties upon resolution of such repayment conditions.
Dispute with Silicon Motion
As previously disclosed, on July 26, 2023, MaxLinear terminated the Merger Agreement on multiple grounds (Note 3). On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration before the Singapore International Arbitration Centre to seek damages from MaxLinear arising from MaxLinear’s alleged breaches of the Merger Agreement. Silicon Motion’s position is that MaxLinear’s Willful and Material Breaches (as such term is defined in the Merger Agreement) of the Merger Agreement prevented the Merger from being completed by August 7, 2023, and that MaxLinear is consequently liable for substantial monetary damages in excess of the termination fee as provided in the Merger Agreement.
On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. Silicon Motion seeks payment of the termination fee, additional damages, fees, and costs. The arbitration will be confidential.
MaxLinear believes that it properly terminated the Merger Agreement. MaxLinear remains confident in its decision and will vigorously defend its right to terminate the Silicon Motion transaction without penalty.
Silicon Motion Stockholder Litigation
MaxLinear and certain of its officers have been named as defendants in two lawsuits brought by stockholders of Silicon Motion.
On August 31, 2023, a Silicon Motion stockholder filed a putative class action complaint in the United States District Court for the Southern District of California captioned Water Island Event-Driven Fund v. MaxLinear, Inc., No. 23-cv-01607 (S.D. Cal.), against MaxLinear and certain of its current officers, alleging two claims: (1) an alleged violation of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder; and (2) an alleged violation of Section 20(a) of the Exchange Act. On December 20, 2023, the court appointed the lead plaintiffs, who filed the Consolidated Complaint on February 15, 2024. The Consolidated Complaint alleged that the defendants made false and misleading statements and/or omitted material facts that MaxLinear had a duty to disclose, concerning the Company’s intention to close the merger with Silicon Motion. On August 28, 2024, the court granted the defendants a motion to dismiss, holding that the plaintiffs lacked standing to sue MaxLinear and its officers. The case was dismissed without prejudice.
On September 18, 2024, the plaintiffs filed an Amended Consolidated Complaint (the "Amended Complaint"). The Amended Complaint includes the same two claims as alleged in the Consolidated Complaint and makes similar factual allegations against the MaxLinear defendants, but adds Silicon Motion and certain of its officers as additional defendants. The Amended Complaint seeks compensatory damages, including interest, costs and expenses and such other relief that the court deems appropriate. MaxLinear intends to continue to vigorously defend its position.
On June 13, 2024, HBK Master Fund L.P. and HBK Merger Strategies Master Fund L.P., stockholders of Silicon Motion, filed an additional complaint in the United States District Court for the Southern District of California captioned HBK Master Fund L.P. v. MaxLinear, Inc., No. 24-cv-01033 (S.D. Cal.), against MaxLinear and certain of its current officers, which also alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act, and other violations. The complaint alleges that the defendants concealed their intention to terminate the merger with Silicon Motion from Silicon Motion’s shareholders. The complaint seeks compensatory damages, including interest, costs and expenses, punitive damages, and such other equitable or injunctive relief that the court deems appropriate. On July 12, 2024, the defendants filed a motion to dismiss this complaint, which is pending. MaxLinear intends to continue to vigorously defend its position.
Comcast Litigation
On December 1, 2023, MaxLinear filed claims against Comcast Management, LLC and Comcast Cable Communications, LLC, or together, Comcast, in the United States District Court for the Southern District of New York. MaxLinear alleges that in 2020, MaxLinear shared its proprietary design and know-how for a full-duplex, or FDX, amplifier with Comcast in the hope of securing future business with Comcast. MaxLinear shared its design and know-how on several occasions, all pursuant to a non-disclosure agreement between MaxLinear and Comcast, with the expectation that Comcast would keep the information confidential. MaxLinear alleges that Comcast needed this technology in order to effectively compete with fiber-optic internet providers. Instead of engaging MaxLinear to develop the FDX amplifier, Comcast allegedly shared MaxLinear’s proprietary designs with MaxLinear’s direct competitor. Comcast allegedly then worked with MaxLinear’s competitor to develop the FDX-amplifier technology. MaxLinear brought claims for trade secret misappropriation, unfair competition, and breach of the parties’ non-disclosure agreement, and it sought an unspecified amount of compensatory damages, punitive damages, pre-judgment and post-judgment interest, costs, expenses, and attorney fees as well as an injunction against Comcast’s use or disclosure of MaxLinear’s trade secrets.
On March 19, 2024, Comcast amended its claims for declaratory judgments, indemnification, and breach of the implied covenant of good faith and fair dealing, and on April 3, 2024, MaxLinear moved to dismiss all claims against it. On September 19, 2024, the court granted the motion to dismiss with respect to certain claims for declaratory judgment claim and denied the motion to dismiss with respect to the remaining claims. On September 23, 2024, Comcast filed amended claims for declaratory judgment, indemnification, and breach of the implied covenant of good faith and fair dealing, and on October 14, 2024, MaxLinear amended and refiled its trade secret and related claims. MaxLinear intends to continue to vigorously defend its position.
Dish Litigation
On February 10, 2023, Entropic Communications, LLC, or Entropic, filed claims for patent infringement against Dish Network Corporation, Dish Network LLC, Dish Network Service, LLC, and Dish Network California Service Corporation in the United States District Court for the Central District of California. At that time, MaxLinear was not a party to the action. On September 21, 2023, Dish Network California Service Corporation, or Dish California, filed four counterclaims against
MaxLinear. The four claims are declaratory judgment, breach of contract, fraud and negligent misrepresentation, and civil conspiracy.
On January 31, 2024, the Dish defendants, together with DISH Technologies L.L.C., or collectively, Dish, filed eight counterclaims (amended counterclaims for Dish California) against MaxLinear. The eight counterclaims are (1) breach of contract, (2) fraud and negligent misrepresentation, (3) fraud arising from a civil conspiracy, (4) quasi-contract for restitution/unjust enrichment, (5) combination in restraint of trade, (6) violation of the Cartwright Act (by Dish California only), (7) patent misuse, and (8) violation of Cal. Bus. & Prof. Code § 17200 et seq. Dish’s eight counterclaims revolve around a core allegation that MaxLinear is a member of the Multimedia over Coax Alliance (MoCA) and that MaxLinear violated its obligation under MoCA’s Intellectual Property Rights Policy, or IPR Policy, by acting with Entropic to rid the asserted patents of the RAND encumbrances. Dish seeks an unspecified amount of compensatory damages, disgorgement, attorneys’ fees, experts’ fees, and costs. On February 21, 2024, MaxLinear moved to dismiss the Dish defendants’ counterclaim.
On April 22, 2024, a Special Master issued a report and recommendation, or the R&R, which recommended granting the motion to dismiss with prejudice as to the following counterclaims: (1) quasi-contract for restitution/unjust enrichment, (2) combination in restraint of trade, (3) violation of the Cartwright Act, (4) patent misuse, and (5) violation of Cal. Bus. & Prof. Code § 17200. MaxLinear submitted objections to the R&R as to the remaining claims that were not dismissed. Dish submitted objections to the R&R’s recommended dismissal of the quasi-contract for restitution/unjust enrichment counterclaim. The court has not yet issued any ruling regarding the R&R or MaxLinear’s pending motion to dismiss.
On July 30, 2024, this case was stayed until September 17, 2024. There was a motion to stay this case pending resolution of Inter Partes Review (“IPR”). MaxLinear intends to continue to vigorously defend its position.
Cox Litigations
On February 10, 2023, Entropic sued Cox Communications, Inc., CoxCom, LLC, and Cox Communications California, LLC, or together, Cox, in two separate actions in the United States District Court for the Central District of California. On October 6, 2023, Cox filed counterclaims against MaxLinear in each of the two actions.
In the first action, Cox alleges that when MaxLinear assigned certain patents to Entropic, MaxLinear violated its obligations under MoCA’s IPR Policy by assigning these patents and by allegedly failing to ensure that Cox would be offered a FRAND license for these patents. Cox amended its counterclaims on January 9, 2024 and is asserting claims of breach of contract, unjust enrichment, and declaratory judgment against MaxLinear. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.
On April 22, 2024, a Special Master issued the R&R, which recommended granting the motion to dismiss with prejudice as to the unjust enrichment counterclaim but denying the motion as to the breach of contract and declaratory judgment counterclaims. MaxLinear submitted objections to the R&R’s denial-in-part. Cox submitted objections to the R&R as to the unjust enrichment counterclaim and as to certain findings related to the breach of contract counterclaim. The court has not yet issued any ruling regarding the R&R or MaxLinear’s pending motion to dismiss.
In the second action, in response to Entropic suing Cox for patent infringement, Cox filed counterclaims against MaxLinear. Cox alleges that MaxLinear granted CableLabs a non-exclusive, royalty-free license to all patents essential for compliance with DOCSIS specifications. It further alleges that MaxLinear breached this agreement when MaxLinear assigned certain patents to Entropic. Cox amended its counterclaims on January 9, 2024 and is asserting claims for breach of contract, unjust enrichment, and declaratory judgment. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.
On April 22, 2024, a Special Master issued the R&R, which recommended dismissing all Cox counterclaims with prejudice. Cox submitted objections to the R&R as to the unjust enrichment counterclaim. The court has not yet issued any ruling regarding the R&R or MaxLinear’s pending motion to dismiss.
On July 30, 2024, these cases were stayed until September 17, 2024. There was a motion to stay pending resolution of IPR. MaxLinear intends to continue to vigorously defend its position.
*    *    *
The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. As of September 30, 2024, no material loss contingencies have been accrued for litigation and other legal claims in the consolidated financial statements, since the Company’s management currently does
not believe that the ultimate outcome of any of the matters described above is probable. An unfavorable outcome of these matters may be reasonably possible in excess of recorded amounts; however, a reasonable estimate of the amount or range of such loss cannot be made at this time.
Other Matters
From time to time, the Company is subject to threats of litigation or actual litigation in the ordinary course of business as described above and in “Part II. — Other Information, Item 1. — Legal Proceedings,” some of which may be material. The results of any litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have a material adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors.
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.3
Stock Repurchases
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Stock Repurchases Stock Repurchases
On February 23, 2021, the Company’s board of directors authorized a plan to repurchase up to $100 million of the Company’s common stock over a period which ended February 16, 2024. The amount and timing of repurchases were subject to a variety of factors including liquidity, share price, market conditions, and legal requirements. Any purchases were funded from available working capital and were effected through open market purchases, block transactions, and privately negotiated transactions. The share repurchase program did not obligate the Company to make any repurchases and was able to be modified, suspended, or terminated by the Company at any time without prior notice.
The share repurchase program was suspended from July 2022 until its expiration due to the Company’s previously pending (now terminated) merger with Silicon Motion (Note 3). As a result, during the nine months ended September 30, 2024, the Company did not repurchase any shares of its common stock under the repurchase program.
At September 30, 2024, the aggregate value of common stock repurchased under the program was approximately $55.0 million and no shares remained available for repurchase under the program, as the plan expired on February 16, 2024.
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Pay vs Performance Disclosure                
Net loss $ (75,785) $ (39,266) $ (72,309) $ (39,829) $ (4,351) $ 9,533 $ (187,360) $ (34,647)
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.24.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.24.3
Organization and Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation and Principles of Consolidation
Basis of Presentation and Principles of Consolidation
The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its directly and indirectly wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation.
In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive income, stockholders’ equity, and cash flows.
The consolidated balance sheet as of December 31, 2023 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on January 31, 2024, or the Annual Report. Interim results for the nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024.
The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these foreign subsidiaries are translated at the current exchange rate at the balance sheet date and historical rates for equity. Revenue and expense components are translated at weighted average exchange rates in effect during the period. Gains and losses resulting from foreign currency translation are included as a component of stockholders’ equity. Foreign currency transaction gains and losses are included in the results of operations, and to date, have not been material.
Use of Estimates and Significant Risks and Uncertainties
Use of Estimates and Significant Risks and Uncertainties
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes of the consolidated financial statements. Actual results could differ from those estimates.
The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of October 23, 2024, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates.
Business Combinations
Business Combinations

The Company applies the provisions of ASC 805, Business Combinations, in accounting for its acquisitions. It requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed, at the acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the acquisition date fair values of the net assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations.

Costs to exit or restructure certain activities of an acquired company or the Company’s internal operations are accounted for as termination and exit costs pursuant to ASC 420, Exit or Disposal Cost Obligations, and are accounted for separately from the business combination. A liability for costs associated with an exit or disposal activity is recognized and measured at its fair value in the consolidated statements of operations in the period in which the liability is incurred.

For a given acquisition, the Company may identify certain pre-acquisition contingencies as of the acquisition date and may extend its review, evaluation, and adjustment of these pre-acquisition contingencies throughout the measurement period in order to obtain sufficient information to assess whether the Company includes these contingencies as a part of the fair value estimates of assets acquired and liabilities assumed and, if so, to determine their estimated amounts. A pre-acquisition contingency (non-income tax related) is only recognized as an asset or a liability if: (i) it is probable that an asset existed or a liability had been incurred at the acquisition date and (ii) the amount of the asset or liability can be reasonably estimated. Subsequent to the measurement period, changes in estimates of such contingencies will affect earnings and could have a material effect on the Company's results of operations and financial position.

In addition, uncertain tax positions and tax-related valuation allowances assumed, if any, in connection with a business combination are initially estimated as of the acquisition date. The Company re-evaluates these items quarterly based upon facts and circumstances that existed as of the acquisition date with any adjustments to the preliminary estimates being recorded to goodwill if identified within the measurement period. Subsequent to the end of the measurement period or final determination of the estimated value of the tax allowance or contingency, whichever comes first, changes to these uncertain tax positions and tax related valuation allowances will affect the income tax provision (benefit) in the consolidated statements of operations and could have a material impact on the results of operations and financial position.
Cash and Cash Equivalents
Cash and Cash Equivalents

The Company considers all liquid investments with a maturity of three months or less when purchased to be cash equivalents. Cash equivalents are recorded at cost, which approximates market value.
Accounts Receivable
Accounts Receivable

The Company performs ongoing credit evaluations of its customers and assesses each customer’s credit worthiness. The Company monitors collections and payments from its customers and maintains an allowance for doubtful accounts, which is based upon applying an expected credit loss rate to receivables based on the historical loss rate from similar high risk customers adjusted for current conditions, including any specific customer collection issues identified, and forecasts of economic conditions. Delinquent account balances are written off after management has determined that the likelihood of collection is remote.
Inventory
Inventory

The Company assesses the recoverability of its inventory based on assumptions about demand and market conditions. Forecasted demand is determined based on historical sales and expected future sales. Inventory is stated at the lower of cost or
net realizable value. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis and net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company reduces its inventory to the lower of its cost or net realizable value on a part-by-part basis to account for obsolescence or lack of marketability. Reductions are calculated as the difference between the cost of inventory and its net realizable value based upon assumptions about future demand, market conditions and costs. Once established, these adjustments are considered permanent and are not revised until the related inventory is sold or disposed of.
Fair Value of Financial Instruments
Fair Value of Financial Instruments

The carrying amount of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses and compensation are considered to be representative of their respective fair values because of the short-term nature of these accounts.
Property and Equipment
Property and Equipment
Property and equipment is carried at cost and depreciated over the estimated useful lives of the assets, ranging from three to five years, using the straight-line method. Leasehold improvements are stated at cost and amortized over the shorter of the estimated useful lives of the assets or the lease term.
Production Masks
Production Masks

Production masks with alternative future uses or discernible future benefits are capitalized and amortized over their estimated useful lives of five years. To determine if a production mask has alternative future uses or benefits, the Company evaluates risks associated with developing new technologies and capabilities, and the related risks associated with entering new markets. Production masks that do not meet the criteria for capitalization are expensed as research and development costs.
Goodwill and Intangible Assets
Goodwill and Intangible Assets

Goodwill is the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations accounted for under the acquisition method. Intangible assets represent purchased intangible assets including developed technology, in-process research and development, or IPR&D, technologies acquired or licensed from other companies, customer relationships, non-compete covenants, backlog, and trademarks and tradenames. Purchased finite-lived intangible assets are capitalized and amortized over their estimated useful lives. Technologies acquired or licensed from other companies, customer relationships, non-compete covenants, backlog, and trademarks and tradenames are capitalized and amortized over the lesser of the terms of the agreement, or estimated useful life. The Company capitalizes IPR&D projects acquired as part of a business combination. On completion of each project, IPR&D assets are reclassified to developed technology and amortized over their estimated useful lives.
Impairment of Goodwill and Long-Lived Assets
Impairment of Goodwill and Long-Lived Assets

Goodwill is not amortized but is tested for impairment using either a qualitative assessment, and/or quantitative assessment, which is based on comparing the fair value of a reporting unit with its carrying amount. If the carrying amount of a reporting unit exceeds its fair value, a goodwill impairment loss is recorded. The Company tests by reporting unit, goodwill and other indefinite-lived intangible assets for impairment as of October 31 each year or more frequently if it believes indicators of impairment exist.

The Company reviews indefinite-lived intangible assets for impairment using a qualitative assessment, followed by a quantitative assessment, as needed, each year as of October 31, the date of its annual goodwill impairment review, or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Recoverability of indefinite-lived intangible assets is measured by comparing the carrying amount of the asset to its fair value. In certain cases, the Company utilizes the relief-from-royalty method when appropriate, and a fair value will be obtained based on analysis over the costs saved by owning the right instead of leasing it.
During development, IPR&D is not subject to amortization and is tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Once an IPR&D project is complete, it becomes a finite-lived intangible asset and is evaluated for impairment both immediately prior to its change in classification and thereafter in accordance with the Company’s policy for long-lived assets.

The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the useful lives, to determine whether indicators of impairment may exist which warrant adjustments to carrying values or estimated useful lives. An impairment loss would be recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss would be measured based on the excess of the carrying amount of the asset over the asset’s fair value.
Revenue Recognition
Revenue Recognition

The Company’s revenue is generated from sales of the Company’s integrated circuits and intellectual property, typically under individual customer purchase orders, some of which have underlying master sales agreements that specify terms governing the product or intellectual property sales. The Company recognizes such revenue at the point in time when control of the products or intellectual property is transferred to the customer at the estimated net consideration for which collection is probable, taking into account the customer’s rights to price protection, other pricing credits, unit rebates, and rights to return unsold product. Transfer of control occurs either when products are shipped to or received by the distributor or direct customer, based on the terms of the specific agreement with the customer, if the Company has a present right to payment and transfer of legal title and the risks and rewards of ownership to the customer has occurred. For most of the Company’s product sales, transfer of control occurs upon shipment to the distributor or direct customer. Under certain intellectual property sale agreements, we are entitled to fixed upfront consideration upon sale and variable consideration in the form of a portion of revenue generated by the recipient from the intellectual property. Fixed consideration is recognized when control of the functional intellectual property transfers; variable consideration may be constrained but is continuously monitored and recognized as revenue when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur and the uncertainty associated with the variable consideration is resolved. The Company recognized a material amount of variable consideration during the nine months ended September 30, 2024 as uncertainties related to such consideration were resolved. During the three months ended September 30, 2024, there was no variable consideration recognized related to resolution of uncertainties related to such consideration.

In assessing whether collection of consideration from a customer is probable, the Company considers the customer’s ability and intention to pay that amount of consideration when it is due. Payment of invoices is due as specified in the underlying customer agreement, typically 30 days from the invoice date, which occurs on the date of transfer of control of the products to the customer. Since payment terms are less than a year, the Company has elected the practical expedient and does not assess whether a customer contract has a significant financing component.

A five-step approach is applied in the recognition of revenue: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when the Company satisfies a performance obligation. Customer purchase orders plus the underlying master sales agreements are considered to be contracts with the customer for purposes of applying the five-step approach.

Pricing adjustments and estimates of returns under contractual stock rotation rights are treated as variable consideration for purposes of determining the transaction price, and are estimated at the time control transfers using the expected value method based on the Company’s analysis of actual price adjustment claims by distributors and historical product return rates, and then reassessed at the end of each reporting period. The Company also considers whether any variable consideration is constrained, since such amounts for which it is probable that a significant reversal will occur when the contingency is subsequently resolved are required to be excluded from revenues. Price adjustments are finalized at the time the products are sold through to the end customer and the distributor or end customer submits a claim to reduce the sale price to a pre-approved net price. Stock rotation allowances are capped at a fixed percentage of the Company’s sales to a distributor for a period of time, up to six months, as specified in the individual distributor contract. If the Company’s current estimates of such credits and rights are materially inaccurate, it may result in adjustments that affect future revenues and gross profits. Returns under the Company’s general assurance warranty of products for a period of one to three years have not been material and warranty-related services are not considered a separate performance obligation under the customer contracts. Most of the Company’s customers resell the Company’s product as part of their product and thus are tax-exempt; however, to the extent the Company
collects and remits taxes on product sales from customers, it has elected to exclude from the measurement of transaction price such taxes.

Each distinct promise to transfer products is considered to be an identified performance obligation for which revenue is recognized upon transfer of control of the products to the customer. Although customers may place orders for products to be delivered on multiple dates that may be in different quarterly reporting periods, all of the orders are scheduled within one year from the order date. The Company has elected to record sales commissions when incurred, as the period over which the sales commission asset that would have been recognized is less than one year.

Customer contract liabilities consist primarily of obligations to deliver rebates to customers in the form of units of products which are included in accrued expenses and other current liabilities in the consolidated balance sheets. Other obligations to customers, which are included in accrued price protection liability in the consolidated balance sheets, consist of estimates of price protection rights offered to the Company’s end customer on products sold by the Company to the end customer’s contract manufacturer at a standard price that are later incorporated into the end customers’ product. The Company’s price adjustments included in accrued expenses and other current liabilities are discounts and rebates expected to be claimed by the Company’s distributors upon sell-through of the products to their customers, which are initially sold by the Company to the distributors at a standard price. Also included in accrued expenses and other current liabilities are amounts expected to be returned by distributors under stock rotation rights. The Company also records a right of return asset, consisting of amounts representing the products the Company expects to receive from customers in returns, which is included in inventory in the consolidated balance sheets, and is typically settled within six months of transfer of control to the customer, or the period over which stock rotation rights are based. Upon lapse of the time period for stock rotations, or the contractual end to price protection and rebate programs, which is approximately one to two years, and when the Company believes unclaimed amounts are no longer subject to payment and will not be paid, any remaining asset or liability is derecognized by an offsetting entry to cost of net revenue and net revenue. For additional disclosures regarding contract liabilities and other obligations to customers, see Note 12.

The Company assesses customer accounts receivable and contract assets for impairment in accordance with ASC 310-10-35.
Warranty
Warranty

The Company generally provides a warranty on its products for a period of one to three years. The Company makes estimates of product return rates and expected costs to replace the products under warranty at the time revenue is recognized based on historical warranty experience and any known product warranty issues. If actual return rates and/or replacement costs differ significantly from these estimates, adjustments to recognize additional warranty expenses in cost of net revenue may be required in future periods.
Segment Information
Segment Information

The Company operates under one segment as it has developed, marketed and sold primarily only one class of similar products, radio-frequency, high-performance analog and mixed-signal communications system-on-chip solutions for the connected home, wired and wireless infrastructure markets and industrial and multi-market applications.

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company’s Chief Executive Officer reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports under a single operating segment.
Stock-based Compensation
Stock-based Compensation

The Company measures the cost of employee services received in exchange for equity incentive awards, including restricted stock units, employee stock purchase rights and stock options based on the grant date fair value of the award. The Company calculates the fair value of restricted stock units and performance-based restricted stock units based on the fair market value of the Company’s common stock on the grant date. Stock-based compensation expense is then determined based on the number of restricted stock units that are expected to vest; for performance-based restricted stock units, this is the number of units that are expected to vest during the performance period if it is probable that the Company will achieve the performance metrics specified in the underlying award agreement. The Company uses the Black-Scholes valuation model to calculate the fair value of stock options and employee stock purchase rights granted to employees. Stock-based compensation expense is recognized over the period during which the employee is required to provide services in exchange for the award, which is usually the vesting period. The Company recognizes compensation expense over the vesting period using the straight-line method and classifies these amounts in the consolidated statements of operations based on the department to which the related employee reports.
Research and Development
Research and Development

Costs incurred in connection with the development of the Company’s technology and future products are charged to research and development expense as incurred. From time to time, the Company enters into contracts for jointly funded research and development projects to develop technology that may be commercialized into a product in the future. The Company also obtains research and development funding grants from governments in certain jurisdictions in which it operates. Both of these types of income are reflected as a credit to research and development expense when such income has been earned and any contingencies associated with retaining such income have been resolved. In the three months ended September 30, 2024 and 2023, the Company recognized aggregate income from jointly funded R&D projects and government grants of approximately $0.6 million and $1.4 million, respectively. During the nine months ended September 30, 2024 and 2023, the Company recognized aggregate income from jointly funded R&D projects and government grants of approximately $3.1 million and $11.3 million, respectively. While the Company retains ownership and rights to the underlying technology developed under the joint development projects, the Company may be required to repay all or a portion of the funds provided by the other parties under certain conditions, and defers such funds as liabilities until the repayment conditions have been resolved (Note 15).
Leases
Leases

The Company’s leases primarily consist of facility leases which are classified as operating leases. The Company assesses whether an arrangement contains a lease at inception. The Company recognizes a lease liability to make contractual payments under all leases with terms greater than twelve months and a corresponding right-of-use asset, representing its right to use the underlying asset for the lease term. The lease liability is initially measured at the present value of the lease payments over the lease term using the collateralized incremental borrowing rate when the implicit rate is unknown. Options to extend or terminate a lease are included in the lease term when it is reasonably certain that the Company will exercise such an option. The right-of-use asset is initially measured as the contractual lease liability plus any initial direct costs and prepaid lease payments made, less any lease incentives. Upon adoption of ASC 842 on January 1, 2019, the carrying value of lease-related restructuring liabilities for certain restructured leases existing at that date was offset against the related right-of-use assets. Lease expense is recognized on a straight-line basis over the lease term.

Upon adoption of ASC 842, the Company elected certain practical expedients and accordingly has (1) carried forward its prior assessments of (a) whether existing contracts on the January 1, 2019 adoption date contain leases, (b) classification of leases as operating or financing and (c) initial direct costs for existing leases and (2) considered hindsight in determining the lease term and assessing impairment of the right-of-use-asset. In addition, the Company used a portfolio approach for its facility leases when making judgments and estimates, such as the discount rate.

Leased right-of-use assets are subject to impairment testing as a long-lived asset at the asset-group level. The Company monitors its long-lived assets for indicators of impairment. As the Company’s leased right-of-use assets primarily relate to facility leases, early abandonment of all or part of a facility as part of a restructuring plan is typically an indicator of impairment. If impairment indicators are present, the Company tests whether the carrying amount of the leased right-of-use
asset is recoverable including consideration of sublease income, and if not recoverable, measures impairment loss for the right-of-use asset or asset group.
Pension and Other Defined Benefit Retirement Obligations
Pension and Other Defined Benefit Retirement Obligations
The costs of pension and certain other defined benefit employee retirement benefits are required to be recognized based upon actuarial valuations. The related net retirement benefit obligation is recognized as the excess of the projected benefit obligation over the fair value of the plan assets. In measuring the retirement benefit obligation, the discount rate, expected long-term rate of return on plan assets, and long-term rate of salary increase are the most significant assumptions. Retirement benefit costs primarily represent the increase in the actuarial present value of the retirement benefit obligation.
Income Taxes
Income Taxes

The Company provides for income taxes utilizing the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are presented net as noncurrent. The provision for income taxes generally represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from the differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when a judgment is made that is considered more likely than not that a tax benefit will not be realized. A decision to record a valuation allowance results in an increase in income tax expense or a decrease in income tax benefit. If the valuation allowance is released in a future period, income tax expense will be reduced accordingly.

The calculation of tax liabilities involves dealing with uncertainties in the application of complex global tax regulations. The impact of an uncertain income tax position is recognized at the largest amount that is “more likely than not” to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. If the estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to expense would result.

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company continually assesses the need for a valuation allowance on the deferred tax asset by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the consolidated statement of operations for the period that the adjustment is determined to be required.

On December 22, 2017, the Tax Cuts and Jobs Act, or the Tax Act, was enacted into U.S. tax law. In 2018, the Company made an accounting policy election to treat Global Intangible Low Taxed Income in accordance with the Tax Act as a period cost.
Comprehensive Income (Loss)
Comprehensive Income (Loss)
Comprehensive income (loss) is defined as the change in equity (net assets) of a business entity during a period from transactions and other events and circumstances from non-owner sources. Other comprehensive income (loss) includes certain changes in equity that are excluded from net income (loss), net of tax, such as foreign currency translation gains and losses and changes in fair value of projected benefit obligations for defined benefit plans.
Litigation and Settlement Costs
Litigation and Settlement Costs

Legal costs are expensed as incurred. The Company is involved in disputes, litigation and other legal actions in the ordinary course of business. The Company continually evaluates uncertainties associated with litigation and records a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the loss or range of loss can be reasonably estimated.
Recently Issued, Not Yet Adopted Accounting Pronouncements
Recently Issued, Not Yet Adopted Accounting Pronouncements
In March 2024, the FASB issued ASU No. 2024-02, Codification Improvements - Amendments to Remove References to the Concepts Statements to remove various references to concepts statements from the FASB Accounting Standards Codification. This guidance is to clarify guidance, simplify wording or structure of guidance, and other minor improvements. These amendments are effective for the Company for annual periods in 2025, applied prospectively, with early adoption and retrospective application permitted. The Company intends to adopt the amendments in this update prospectively in 2025. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.
In March 2024, the FASB issued ASU No. 2024-01, Compensation - Stock Compensation (Topic 718) - Scope Application of Profits Interest and Similar Awards, to clarify whether profits interest and similar awards should be accounted for in accordance with Topic 718, Compensation - Stock Compensation. The guidance applies to all business entities that issue profits interest awards as compensation to employees or nonemployees in exchange for goods or services. These amendments are effective for the Company for annual and interim periods in 2025, applied prospectively, with early adoption and retrospective application permitted. As the Company does not issue profit interest awards, the impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures, to require enhanced income tax disclosures to provide information to assess how an entity’s operations and related tax risks, tax planning, and operational opportunities affect its tax rate and prospects for future cash flows. The amendments in this update provide that a business entity disclose (1) a tabular income tax rate reconciliation, using both percentages and amounts, (2) separate disclosure of any individual reconciling items that are equal to or greater than 5% of the amount computed by multiplying the income (loss) from continuing operations before income taxes by the applicable statutory income tax rate, and disaggregation of certain items that are significant and (3) amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign jurisdictions, including separate disclosure of any individual jurisdictions greater than 5% of total income taxes paid. These amendments are effective for the Company for annual periods in 2025, applied prospectively, with early adoption and retrospective application permitted. The Company intends to adopt the amendments in this update prospectively in 2025. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, since the amendments require only enhancement of existing income tax disclosures in the footnotes to the Company’s consolidated financial statements.
In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280) – Improvements to Reportable Segment Disclosures, to require enhanced disclosures that include reportable segment expenses. The amendments in this update provide that a business entity disclose significant segment expenses, segment profit or loss (after significant segment expenses), and allows reporting of additional measures of a segments profit or loss if used in assessing segment performance. Such disclosures apply to entities with a single reportable segment. These amendments are effective for the Company for annual periods in 2024 and interim periods in 2025, retrospectively to all prior periods using the significant segment expense categories identified and disclosed in the period of adoption. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, since the requirements impact only segment reporting disclosures in the footnotes to the Company’s consolidated financial statements.
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Net Income (Loss) Per Share (Tables)
9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Summary of Basic and Diluted Earnings Per Share
The table below presents the computation of basic and diluted EPS:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands, except per share amounts)
Numerator:
Net loss$(75,785)$(39,829)$(187,360)$(34,647)
Denominator:
Weighted average common shares outstanding—basic84,074 81,249 83,303 80,395 
Dilutive common stock equivalents— — — — 
Weighted average common shares outstanding—diluted84,074 81,249 83,303 80,395 
Net loss per share:
Basic$(0.90)$(0.49)$(2.25)$(0.43)
Diluted$(0.90)$(0.49)$(2.25)$(0.43)
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Business Combinations (Tables)
9 Months Ended
Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Summary of Business Acquisitions, by Acquisition
The following table summarizes the fair value of purchase price consideration to acquire Company Y (in thousands):
DescriptionAmount
Fair value of purchase consideration:
Cash$9,824 
Contingent consideration(1)
2,600 
Total purchase price$12,424 
_________________
(1) The fair value of contingent consideration is based on applying the Monte Carlo simulation method to forecast achievement under various contingent consideration events which may result in up to $2.6 million in payments due to the acquired business’s satisfying certain financial and personnel objectives by June 17, 2024 under the Purchase Agreement. Key inputs in the valuation include forecasted revenue, revenue volatility and discount rate. Underlying forecast mathematics were based on Geometric Brownian Motion in a risk-neutral framework and discounted back to the applicable period in which the accumulative thresholds were achieved at discount rates commensurate with the risk and expected payout term of the contingent consideration.
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring Activity (Tables)
9 Months Ended
Sep. 30, 2024
Restructuring and Related Activities [Abstract]  
Summary of Restructuring and Related Costs
The following table presents the activity related to the restructuring plans, which is included in restructuring charges in the consolidated statements of operations:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands)
Employee separation expenses$9,109 $(13)$28,902 $8,863 
Lease related charges674 — 3,628 42 
Other17,045 67 17,793 233 
$26,828 $54 $50,323 $9,138 
Summary of Restructuring Reserve by Type of Cost
The following table presents a roll-forward of the Company’s restructuring liability for the nine months ended September 30, 2024. The restructuring liability is included in accrued expenses and other current liabilities and other long-term liabilities in the consolidated balance sheets.
Employee Separation ExpensesLease Related ChargesOtherTotal
(in thousands)
Liability as of December 31, 2023$7,383 $(2)$920 $8,301 
Restructuring charges28,902 3,628 17,793 50,323 
Cash payments(30,452)(172)(915)(31,539)
Non-cash charges and adjustments967 (3,419)(3,406)(5,858)
Liability as of September 30, 20246,800 35 14,392 21,227 
Less: current portion as of September 30, 2024(6,800)(35)(8,775)(15,610)
Long-term portion as of September 30, 2024$— $— $5,617 $5,617 
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets (Tables)
9 Months Ended
Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Goodwill
The following table presents the changes in the carrying amount of goodwill for the periods indicated:
Nine Months Ended September 30,
20242023
(in thousands)
Beginning balance$318,588 $306,739 
Acquisitions (Note 3)
— 11,717 
Ending balance$318,588 $318,456 
Summary of Acquired Finite-Lived Intangible Assets by Major Class
The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which are amortized over their estimated useful lives:
September 30, 2024December 31, 2023
Weighted
Average
Useful Life
(in Years)
Gross Carrying AmountAccumulated AmortizationNet Carrying AmountGross Carrying AmountAccumulated AmortizationNet Carrying Amount
(in thousands)
Licensed technology7.0$23,857 $(2,172)$21,685 $20,133 $(1,431)$18,702 
Developed technology6.9311,261 (280,443)30,818 311,261 (263,635)47,626 
Trademarks and trade names6.214,800 (14,383)417 14,800 (14,276)524 
Customer relationships5.0128,800 (127,502)1,298 128,800 (126,347)2,453 
Patents7.04,780 (967)3,813 4,780 (455)4,325 
6.1$483,498 $(425,467)$58,031 $479,774 $(406,144)$73,630 
Summary of Finite-lived Intangible Assets Amortization Expense
The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands)(in thousands)
Cost of net revenue$3,745 $8,581 $17,549 $27,372 
Research and development— — — 
Selling, general and administrative591 653 1,774 2,290 
$4,336 $9,234 $19,323 $29,664 
Summary of Finite-Lived Intangible Assets
The following table sets forth the activity related to finite-lived intangible assets:
Nine Months Ended September 30,
20242023
(in thousands)
Beginning balance$73,630 $109,316 
Additions4,961 6,198 
Other disposals— (769)
Amortization(19,323)(29,664)
Impairment losses(1,237)(2,438)
Ending balance$58,031 $82,643 
Summary of Finite-Lived Intangible Assets, Future Amortization Expense The following table presents future amortization of the Company’s finite-lived intangible assets at September 30, 2024:
Amount
(in thousands)
2024 (3 months)$3,992 
202514,619 
202613,916 
202710,437 
20285,099 
Thereafter9,968 
Total$58,031 
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2024
Fair Value Disclosures [Abstract]  
Summary of Composition of Financial Instruments
The composition of financial instruments is as follows:
Fair Value
September 30, 2024December 31, 2023
(in thousands)
Liabilities
Contingent consideration (Note 3)
$2,600 $2,462 
Summary of Fair Value, Liabilities Measured on Recurring Basis
Fair Value Measurements at September 30, 2024
Balance at
September 30, 2024
Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
(in thousands)
Liabilities
Contingent consideration$2,600 $— $— $2,600 
Fair Value Measurements at December 31, 2023
Balance at December 31, 2023Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
(in thousands)
Liabilities
Contingent consideration$2,462 $— $— $2,462 
Summary of Level 3 Financial Instrument Activity
The following summarizes the activity in Level 3 financial instruments:
Nine Months Ended September 30,
20242023
(in thousands)
Contingent consideration
Beginning balance
$2,462 $2,941 
Acquisitions(1)(Note 3)
— 2,200 
Payments— (2,700)
Accretion of discount(1)
138 249 
Ending balance
$2,600 $2,690 
_____________________
(1) These changes to the balance associated with the estimated fair value of contingent consideration for the nine months ended September 30, 2024 and 2023 were due to the addition of contingent consideration associated with the acquisition of Company Y in January 2023 and accretion of discounts on contingent consideration.
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheet Details (Tables)
9 Months Ended
Sep. 30, 2024
Balance Sheet Related Disclosures [Abstract]  
Summary of Cash and Cash Equivalents
Cash, cash equivalents and restricted cash consist of the following:
September 30, 2024December 31, 2023
(in thousands)
Cash and cash equivalents$148,476 $187,288 
Short-term restricted cash993 1,051 
Long-term restricted cash23 17 
Total cash, cash equivalents and restricted cash$149,492 $188,356 
Summary of Restriction Cash
Cash, cash equivalents and restricted cash consist of the following:
September 30, 2024December 31, 2023
(in thousands)
Cash and cash equivalents$148,476 $187,288 
Short-term restricted cash993 1,051 
Long-term restricted cash23 17 
Total cash, cash equivalents and restricted cash$149,492 $188,356 
Summary of Inventory Inventory consists of the following:
September 30, 2024December 31, 2023
(in thousands)
Work-in-process$54,909 $60,368 
Finished goods41,154 39,540 
$96,063 $99,908 
Summary of Property and Equipment
Property and equipment, net consists of the following:
Useful Life
(in Years)
September 30, 2024December 31, 2023
(in thousands)
Furniture and fixtures5$3,944 $3,995 
Machinery and equipment
3-5
80,641 76,732 
Masks and production equipment562,676 54,240 
Software311,194 11,427 
Leasehold improvements
1-5
35,401 35,867 
Construction in progressN/A686 348 
194,542 182,609 
Less: accumulated depreciation and amortization(131,049)(116,178)
$63,493 $66,431 
Summary of Price Protection Liability
Accrued price protection liability consists of the following activity:
Nine Months Ended September 30,
20242023
(in thousands)
Beginning balance$71,684 $113,274 
Charged as a reduction of revenue42,042 50,092 
Reversal of unclaimed rebates(15,272)— 
Payments(53,982)(91,723)
Ending balance$44,472 $71,643 
Summary of Accrued Expenses
Accrued expenses and other current liabilities consist of the following:
September 30, 2024December 31, 2023
(in thousands)
Accrued technology license payments$3,627 $3,843 
Accrued professional fees4,196 3,736 
Accrued engineering and production costs5,461 2,861 
Accrued restructuring15,610 8,301 
Accrued royalty403 603 
Short-term lease liabilities9,799 9,132 
Accrued customer credits3,705 3,984 
Income tax liability421 521 
Customer contract liabilities164 1,597 
Accrued obligations to customers for price adjustments20,558 54,837 
Accrued obligations to customers for stock rotation rights167 349 
Contingent consideration - current portion2,600 2,462 
Other4,486 6,242 
$71,197 $98,468 
Summary of Accumulated Other Comprehensive Income (Loss) by Component
The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:
Cumulative Translation AdjustmentsPension and Other Defined Benefit Plan ObligationTotal
(in thousands)
Balance at December 31, 2023$(5,059)$1,268 $(3,791)
Other comprehensive loss before reclassifications, net of tax(61)— (61)
Balance at September 30, 2024$(5,120)$1,268 $(3,852)
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.3
Debt (Tables)
9 Months Ended
Sep. 30, 2024
Debt Disclosure [Abstract]  
Schedule of Debt
The carrying amount of the Company’s long-term debt consists of the following:
September 30, 2024December 31, 2023
(in thousands)
Principal balance:
Initial term loan under the June 23, 2021 credit agreement$125,000 $125,000 
Total principal balance125,000 125,000 
Less:
     Unamortized debt discount(477)(571)
     Unamortized debt issuance costs(1,683)(2,054)
Net carrying amount of long-term debt122,840 122,375 
Less: current portion of long-term debt— — 
Long-term debt, non-current portion$122,840 $122,375 
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-Based Compensation Expense
The Company recognizes stock-based compensation in the consolidated statements of operations, based on the department to which the related employee reports, as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
(in thousands)(in thousands)
Cost of net revenue$81 $170 $436 $626 
Research and development7,423 9,436 27,952 33,128 
Selling, general and administrative5,284 (4,488)18,820 5,009 
$12,788 $5,118 $47,208 $38,763 
Summary of Restricted Stock Unit Activity
A summary of the Company’s restricted stock unit activity for all equity plans is as follows:
Number of Shares
(in thousands)
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 20235,632 $36.72 
  Granted1
2,945 18.24 
  Vested(2,461)29.44 
  Canceled2
(1,007)38.32 
Outstanding at September 30, 20245,109 $29.25 
____________
(1) Includes approximately 227 thousand shares granted under the Inducement Plan at a weighted-average grant-date fair value per share of $13.64.
(2) Includes approximately 24 thousand shares canceled under the Inducement Plan at a weighted-average grant-date fair value per share of $12.46.
Summary of Performance-Based Restricted Stock Unit Activity
A summary of the Company’s performance-based restricted stock unit activity is as follows:
Number of Shares
(in thousands)
Weighted-Average Grant-Date Fair Value per Share
Outstanding at December 31, 20232,653 $34.38 
  Granted1
1,472 17.78 
  Vested(58)24.43 
  Canceled(665)41.74 
Outstanding at September 30, 20243,402 $25.93 
________________
(1) Number of shares granted is based on the maximum percentage achievable in the performance-based restricted stock unit award.
Summary of Employee Stock Purchase Plan, Valuation Assumptions
The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:
Nine Months Ended September 30,
20242023
Weighted-average grant date fair value per share
$5.78 - $6.35
$7.56 - $11.97
Risk-free interest rate
5.40% - 5.41%
4.54% - 5.24%
Dividend yield— %— %
Expected life (in years)0.500.50
Volatility
49.76% - 70.46%
51.73% - 59.78%
Summary of Stock Option Activity
A summary of the Company’s stock options activity is as follows:
Number of Options
(in thousands)
Weighted-Average Exercise PriceWeighted-Average Contractual Term (in years)Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2023375 $17.29 
Granted2,688 19.45 
Exercised(39)7.68 
Canceled(1)23.75 
Outstanding at September 30, 20243,023 $19.33 8.45$— 
Vested and expected to vest at September 30, 20242,807 $19.32 8.38$— 
Exercisable at September 30, 2024335 $18.40 0.86$— 
Schedule of Stock Options, Valuation Assumptions
The fair values of stock options were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:
Nine Months Ended September 30,
20242023(1)
Weighted-average grant date fair value per share
$10.84 - $11.24
N/A
Risk-free interest rate4.33 %N/A
Dividend yield— %N/A
Expected life (in years)6.50N/A
Volatility57.50 %N/A
__________________
(1) No options were granted during the nine months ended September 30, 2023.
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.24.3
Concentration of Credit Risk, Significant Customers and Geographic Information (Tables)
9 Months Ended
Sep. 30, 2024
Risks and Uncertainties [Abstract]  
Summary of Concentration of Risk, by Risk Factor
One customer comprised 10% or greater of net revenues for each of the periods presented,
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Percentage of total net revenue
Customer A25 %11 %13 %11 %

The following table presents balances that are 10% or greater of accounts receivable, based on the Company’s billings to its customers.
September 30, 2024December 31, 2023
Percentage of gross accounts receivable
Customer B12 %33 %
Customer C18 %24 %

Significant Suppliers

Suppliers comprising greater than 10% or greater of total inventory purchases are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Vendor A27 %28 %18 %21 %
Vendor B26 %17 %35 %24 %
Vendor C12 %14 %11 %10 %
Vendor D***10 %
____________________________
*    Represents less than 10% of total inventory purchases for the period presented.
Summary of Revenue from External Customers by Geographic Areas
The Company’s consolidated net revenues by geographic area based on ship-to location are as follows (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Amount% of total net revenueAmount% of total net revenueAmount% of total net revenueAmount% of total net revenue
Asia $65,293 80 %$98,647 73 %$193,555 72 %$419,478 74 %
Europe10,208 13 %24,886 18 %29,034 11 %110,058 19 %
United States3,955 %8,757 %41,586 15 %29,847 %
Rest of world1,646 %3,240 %4,186 %8,527 %
Total$81,102 100 %$135,530 100 %$268,361 100 %$567,910 100 %
The products shipped to individual countries or territories representing greater than 10% of net revenue for each of the periods presented are as follows:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Percentage of total net revenue
Hong Kong49 %41 %37 %34 %
China***12 %
Taiwan, ROC*10 %**
Thailand11 %***
____________________________
*    Represents less than 10% of total net revenue for the respective period.
Summary of Long-lived Assets by Geographic Areas
Long-lived assets, which consists of property and equipment, net, leased right-of-use assets, intangible assets, net, and goodwill by geographic area are as follows (in thousands):
September 30, 2024December 31, 2023
Amount% of totalAmount% of total
United States$326,442 71 %$337,696 69 %
Singapore106,444 23 %113,248 23 %
Rest of world29,775 %38,969 %
Total$462,661 100 %$489,913 100 %
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue from Contracts with Customers (Tables)
9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Summary of Revenue from External Customers by Products and Services
The table below presents disaggregated net revenues by market (in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Broadband$32,275 $34,416 $87,157 $169,646 
% of net revenue40 %25 %32 %30 %
Connectivity12,726 15,025 35,700 119,232 
% of net revenue16 %11 %13 %21 %
Infrastructure23,046 49,985 87,436 145,549 
% of net revenue28 %37 %33 %26 %
Industrial and multi-market13,055 36,104 58,068 133,483 
% of net revenue16 %27 %22 %23 %
Total net revenue$81,102 $135,530 $268,361 $567,910 
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Leases (Tables)
9 Months Ended
Sep. 30, 2024
Leases [Abstract]  
Summary of Aggregate Future Minimum Payments Due
The table below presents aggregate future minimum payments due under leases, reconciled to total lease liabilities included in the consolidated balance sheet as of September 30, 2024:
Operating Leases
(in thousands)
2024 (3 months)$2,864 
202510,791 
20268,391 
20276,031 
20282,467 
Thereafter1,596 
Total minimum payments32,140 
Less: imputed interest(2,906)
Less: unrealized translation loss(2)
Total lease liabilities29,232 
Less: short-term lease liabilities(9,799)
Long-term lease liabilities$19,433 
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Summary of Future Minimum Payments Under Inventory Purchase Obligations
As of September 30, 2024, future minimum payments under inventory purchase and other obligations are as follows:
Inventory Purchase ObligationsOther ObligationsTotal
2024 (3 months)$3,004 $7,708 $10,712 
202513,419 32,131 45,550 
2026— 19,482 19,482 
2027— 3,673 3,673 
Total minimum payments$16,423 $62,994 $79,417 
Summary of Future Minimum Payments Under Other Obligations
As of September 30, 2024, future minimum payments under inventory purchase and other obligations are as follows:
Inventory Purchase ObligationsOther ObligationsTotal
2024 (3 months)$3,004 $7,708 $10,712 
202513,419 32,131 45,550 
2026— 19,482 19,482 
2027— 3,673 3,673 
Total minimum payments$16,423 $62,994 $79,417 
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.24.3
Organization and Summary of Significant Accounting Policies (Details)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
segment
business_activity
Sep. 30, 2023
USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Payment term     30 days  
Stock rotation allowance, term (up to)     6 months  
Delivery term     1 year  
Sales commission assets recognized, term (less than)     1 year  
Right of return, term     6 months  
Number of operating segments | segment     1  
Number of business activities | business_activity     1  
Research and development arrangement, recognized income | $ $ 0.6 $ 1.4 $ 3.1 $ 11.3
Operating lease, term (greater than) 12 months   12 months  
Production Masks        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Property, plant and equipment, useful life 5 years   5 years  
Minimum        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Property, plant and equipment, useful life 3 years   3 years  
Right of return under the general assurance warranty, term     1 year  
Rebate and price protection program, term     1 year  
Product warranty, period 1 year   1 year  
Operating lease, term (greater than) 2 years   2 years  
Maximum        
New Accounting Pronouncements or Change in Accounting Principle [Line Items]        
Property, plant and equipment, useful life 5 years   5 years  
Right of return under the general assurance warranty, term     3 years  
Rebate and price protection program, term     2 years  
Product warranty, period 3 years   3 years  
Operating lease, term (greater than) 8 years   8 years  
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Net Income (Loss) Per Share - Summary of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Numerator:                
Net loss $ (75,785) $ (39,266) $ (72,309) $ (39,829) $ (4,351) $ 9,533 $ (187,360) $ (34,647)
Denominator:                
Weighted average common shares outstanding—basic (in shares) 84,074     81,249     83,303 80,395
Dilutive common stock equivalents (in shares) 0     0     0 0
Weighted average common shares outstanding—diluted (in shares) 84,074     81,249     83,303 80,395
Net loss per share:                
Basic (in usd per share) $ (0.90)     $ (0.49)     $ (2.25) $ (0.43)
Diluted (in usd per share) $ (0.90)     $ (0.49)     $ (2.25) $ (0.43)
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.3
Net Income (Loss) Per Share - Additional Information (Details) - shares
shares in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Earnings Per Share [Abstract]        
Common stock equivalents excluded from the calculation of diluted net income (in shares) 6.0 4.9 6.2 4.8
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.24.3
Business Combinations - Additional Information (Details) - USD ($)
Jan. 17, 2023
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Aug. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]            
Contingent consideration (up to)   $ 2,600,000        
Goodwill   318,588,000 $ 318,588,000 $ 318,456,000   $ 306,739,000
Terminated Silicon Motion Merger            
Business Acquisition [Line Items]            
Transaction costs         $ 18,300,000  
Company Y            
Business Acquisition [Line Items]            
Cash consideration $ 9,824,000          
Contingent consideration (up to) 2,600,000          
Net operating liabilities 2,000,000          
Goodwill $ 11,800,000 11,800,000        
Expected tax deductible amount of acquired goodwill   $ 0        
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.24.3
Business Combinations - Summary of Business Acquisitions, by Acquisition (Details) - Company Y - USD ($)
$ in Thousands
Jan. 17, 2023
Sep. 30, 2024
Fair value of purchase consideration:    
Cash $ 9,824  
Contingent consideration 2,600  
Total purchase price 12,424  
Contingent consideration (up to) $ 2,600 $ 2,600
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring Activity - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 26,828 $ 54 $ 50,323 $ 9,138
Employee separation expenses        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 9,109 (13) 28,902 8,863
Lease related charges        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 674 $ 0 3,628 $ 42
2023 And 2024 Workforce Reductions | Minimum        
Restructuring Cost and Reserve [Line Items]        
Restructuring and related cost, expected cost 3,000   3,000  
2023 And 2024 Workforce Reductions | Maximum        
Restructuring Cost and Reserve [Line Items]        
Restructuring and related cost, expected cost 5,000   5,000  
2024 Workforce Reduction        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 26,800   26,800  
2024 Workforce Reduction | Contract Termination        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 17,000   17,000  
2024 Workforce Reduction | Employee separation expenses        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 9,100   9,100  
2024 Workforce Reduction | Lease related charges        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 700   700  
2023 Workforce Reduction        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges     43,300  
2023 Workforce Reduction | Employee separation expenses        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges     19,800  
2023 Workforce Reduction | Other        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges     $ 23,500  
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring Activity - Restructuring and Related Costs (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 26,828 $ 54 $ 50,323 $ 9,138
Employee separation expenses        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 9,109 (13) 28,902 8,863
Lease related charges        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges 674 0 3,628 42
Other        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges $ 17,045 $ 67 $ 17,793 $ 233
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.24.3
Restructuring Activity - Schedule of Restructuring Reserve by Type of Cost (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Restructuring Reserve [Roll Forward]          
Liability beginning balance     $ 8,301    
Restructuring charges $ 26,828 $ 54 50,323 $ 9,138  
Cash payments     (31,539)    
Non-cash charges and adjustments     (5,858)    
Liability ending balance 21,227   21,227    
Less: current portion as of September 30, 2024 (15,610)   (15,610)   $ (8,301)
Long-term portion as of September 30, 2024 5,617   5,617    
Employee Separation Expenses          
Restructuring Reserve [Roll Forward]          
Liability beginning balance     7,383    
Restructuring charges     28,902    
Cash payments     (30,452)    
Non-cash charges and adjustments     967    
Liability ending balance 6,800   6,800    
Less: current portion as of September 30, 2024 (6,800)   (6,800)    
Long-term portion as of September 30, 2024 0   0    
Lease Related Charges          
Restructuring Reserve [Roll Forward]          
Liability beginning balance     (2)    
Restructuring charges     3,628    
Cash payments     (172)    
Non-cash charges and adjustments     (3,419)    
Liability ending balance 35   35    
Less: current portion as of September 30, 2024 (35)   (35)    
Long-term portion as of September 30, 2024 0   0    
Other          
Restructuring Reserve [Roll Forward]          
Liability beginning balance     920    
Restructuring charges 17,045 $ 67 17,793 $ 233  
Cash payments     (915)    
Non-cash charges and adjustments     (3,406)    
Liability ending balance 14,392   14,392    
Less: current portion as of September 30, 2024 (8,775)   (8,775)    
Long-term portion as of September 30, 2024 $ 5,617   $ 5,617    
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Summary of Goodwill (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Goodwill [Roll Forward]    
Beginning balance $ 318,588 $ 306,739
Acquisitions (Note 3) 0 11,717
Ending balance $ 318,588 $ 318,456
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Oct. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]          
Goodwill impairment $ 0     $ 0 $ 0
Impairment losses related to finite-lived intangible assets   $ 1,200,000 $ 0 $ 1,237,000 $ 2,438,000
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Schedule of Acquired Finite-Lived Intangible Assets by Major Class (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]        
Weighted Average Useful Life (in Years) 6 years 1 month 6 days      
Gross Carrying Amount $ 483,498 $ 479,774    
Accumulated Amortization (425,467) (406,144)    
Net Carrying Amount $ 58,031 73,630 $ 82,643 $ 109,316
Licensed technology        
Finite-Lived Intangible Assets [Line Items]        
Weighted Average Useful Life (in Years) 7 years      
Gross Carrying Amount $ 23,857 20,133    
Accumulated Amortization (2,172) (1,431)    
Net Carrying Amount $ 21,685 18,702    
Developed technology        
Finite-Lived Intangible Assets [Line Items]        
Weighted Average Useful Life (in Years) 6 years 10 months 24 days      
Gross Carrying Amount $ 311,261 311,261    
Accumulated Amortization (280,443) (263,635)    
Net Carrying Amount $ 30,818 47,626    
Trademarks and trade names        
Finite-Lived Intangible Assets [Line Items]        
Weighted Average Useful Life (in Years) 6 years 2 months 12 days      
Gross Carrying Amount $ 14,800 14,800    
Accumulated Amortization (14,383) (14,276)    
Net Carrying Amount $ 417 524    
Customer relationships        
Finite-Lived Intangible Assets [Line Items]        
Weighted Average Useful Life (in Years) 5 years      
Gross Carrying Amount $ 128,800 128,800    
Accumulated Amortization (127,502) (126,347)    
Net Carrying Amount $ 1,298 2,453    
Patents        
Finite-Lived Intangible Assets [Line Items]        
Weighted Average Useful Life (in Years) 7 years      
Gross Carrying Amount $ 4,780 4,780    
Accumulated Amortization (967) (455)    
Net Carrying Amount $ 3,813 $ 4,325    
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Finite-lived Intangible Assets Amortization Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Finite-Lived Intangible Assets [Line Items]        
Amortization $ 4,336 $ 9,234 $ 19,323 $ 29,664
Cost of net revenue        
Finite-Lived Intangible Assets [Line Items]        
Amortization 3,745 8,581 17,549 27,372
Research and development        
Finite-Lived Intangible Assets [Line Items]        
Amortization 0 0 0 2
Selling, general and administrative        
Finite-Lived Intangible Assets [Line Items]        
Amortization $ 591 $ 653 $ 1,774 $ 2,290
XML 63 R52.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Finite-lived Intangible Assets [Roll Forward]        
Beginning balance     $ 73,630 $ 109,316
Additions     4,961 6,198
Other disposals     0 (769)
Amortization $ (4,336) $ (9,234) (19,323) (29,664)
Impairment losses (1,200) 0 (1,237) (2,438)
Ending balance $ 58,031 $ 82,643 $ 58,031 $ 82,643
XML 64 R53.htm IDEA: XBRL DOCUMENT v3.24.3
Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]        
2024 (3 months) $ 3,992      
2025 14,619      
2026 13,916      
2027 10,437      
2028 5,099      
Thereafter 9,968      
Net Carrying Amount $ 58,031 $ 73,630 $ 82,643 $ 109,316
XML 65 R54.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments - Composition of Financial Instruments (Details)
$ in Thousands
Sep. 30, 2024
USD ($)
Fair Value Disclosures [Abstract]  
Contingent consideration (Note 3) $ 2,600
XML 66 R55.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Dec. 31, 2023
Jan. 17, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Investments in privately held entities     $ 11.8  
Impairment losses $ 11.8 $ 11.8    
Company Y        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Contingent consideration (up to) $ 2.6 $ 2.6   $ 2.6
XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments - Fair Value, Liabilities Measured on Recurring Basis (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Liabilities    
Contingent consideration $ 2,600  
Fair Value, Recurring    
Liabilities    
Contingent consideration 2,600 $ 2,462
Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Liabilities    
Contingent consideration 0 0
Fair Value, Recurring | Significant Other Observable Inputs (Level 2)    
Liabilities    
Contingent consideration 0 0
Fair Value, Recurring | Significant Unobservable Inputs (Level 3)    
Liabilities    
Contingent consideration $ 2,600 $ 2,462
XML 68 R57.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Instruments - Summary of Level 3 Financial Instrument Activity (Details) - Contingent Consideration, Liability - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Contingent consideration    
Beginning balance $ 2,462 $ 2,941
Acquisitions (Note 3) 0 2,200
Payments 0 (2,700)
Accretion of discount 138 249
Ending balance $ 2,600 $ 2,690
XML 69 R58.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheet Details - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]    
Cash and cash equivalents $ 148,476 $ 187,288
Short-term restricted cash 993 1,051
Long-term restricted cash 23 17
Total cash, cash equivalents and restricted cash 149,492 188,356
Money market funds 103,300 78,100
Restricted cash $ 1,000 $ 1,100
XML 70 R59.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheet Details - Inventory (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]    
Work-in-process $ 54,909 $ 60,368
Finished goods 41,154 39,540
Inventory $ 96,063 $ 99,908
XML 71 R60.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheet Details - Property and Equipment, Net (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Property, Plant and Equipment [Line Items]          
Property and equipment, gross $ 194,542   $ 194,542   $ 182,609
Less: accumulated depreciation and amortization (131,049)   (131,049)   (116,178)
Property and equipment, net 63,493   63,493   66,431
Depreciation expense $ 5,800 $ 5,600 $ 17,000 $ 18,500  
Minimum          
Property, Plant and Equipment [Line Items]          
Useful Life (in Years) 3 years   3 years    
Maximum          
Property, Plant and Equipment [Line Items]          
Useful Life (in Years) 5 years   5 years    
Furniture and fixtures          
Property, Plant and Equipment [Line Items]          
Useful Life (in Years) 5 years   5 years    
Property and equipment, gross $ 3,944   $ 3,944   3,995
Machinery and equipment          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross $ 80,641   $ 80,641   76,732
Machinery and equipment | Minimum          
Property, Plant and Equipment [Line Items]          
Useful Life (in Years) 3 years   3 years    
Machinery and equipment | Maximum          
Property, Plant and Equipment [Line Items]          
Useful Life (in Years) 5 years   5 years    
Masks and production equipment          
Property, Plant and Equipment [Line Items]          
Useful Life (in Years) 5 years   5 years    
Property and equipment, gross $ 62,676   $ 62,676   54,240
Software          
Property, Plant and Equipment [Line Items]          
Useful Life (in Years) 3 years   3 years    
Property and equipment, gross $ 11,194   $ 11,194   11,427
Leasehold improvements          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross $ 35,401   $ 35,401   35,867
Leasehold improvements | Minimum          
Property, Plant and Equipment [Line Items]          
Useful Life (in Years) 1 year   1 year    
Leasehold improvements | Maximum          
Property, Plant and Equipment [Line Items]          
Useful Life (in Years) 5 years   5 years    
Construction in progress          
Property, Plant and Equipment [Line Items]          
Property and equipment, gross $ 686   $ 686   $ 348
XML 72 R61.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheet Details - Additional Information (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended
Aug. 31, 2023
Sep. 30, 2023
Mar. 31, 2022
Sep. 30, 2024
Balance Sheet Related Disclosures [Abstract]        
Proceeds loaned under notes receivable     $ 10.0  
First initial repayments of notes receivable due to the company annually   $ 1.5    
Repayments of notes receivable due to the company annually $ 2.0 $ 1.7    
Portion of note receivable written off       $ 0.5
XML 73 R62.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheet Details - Accrued Price Protection Liability (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Accrued Price Protection Rebate Activity [Roll Forward]    
Beginning balance $ 71,684 $ 113,274
Charged as a reduction of revenue 42,042 50,092
Reversal of unclaimed rebates (15,272) 0
Payments (53,982) (91,723)
Ending balance 44,472 71,643
Accrued price protection liability $ 44,472 $ 71,643
XML 74 R63.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheet Details - Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Capitalized Contract Cost [Line Items]    
Accrued technology license payments $ 3,627 $ 3,843
Accrued professional fees 4,196 3,736
Accrued engineering and production costs 5,461 2,861
Accrued restructuring 15,610 8,301
Accrued royalty 403 603
Short-term lease liabilities 9,799 9,132
Accrued customer credits 3,705 3,984
Income tax liability 421 521
Customer contract liabilities 164 1,597
Contingent consideration - current portion 2,600 2,462
Other 4,486 6,242
Total 71,197 98,468
Accrued obligations to customers for price adjustments    
Capitalized Contract Cost [Line Items]    
Accrued obligations to customers for price adjustments 20,558 54,837
Accrued obligations to customers for stock rotation rights    
Capitalized Contract Cost [Line Items]    
Accrued obligations to customers for stock rotation rights $ 167 $ 349
XML 75 R64.htm IDEA: XBRL DOCUMENT v3.24.3
Balance Sheet Details - Schedule of Accumulated Other Comprehensive Income (Loss) by Component (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2024
USD ($)
AOCI Attributable to Parent, Net of Tax [Roll Forward]  
Balance at beginning of period $ 686,265
Other comprehensive loss before reclassifications, net of tax (61)
Balance at end of period 556,872
Accumulated Other Comprehensive Income (Loss)  
AOCI Attributable to Parent, Net of Tax [Roll Forward]  
Balance at beginning of period (3,791)
Balance at end of period (3,852)
Cumulative Translation Adjustments  
AOCI Attributable to Parent, Net of Tax [Roll Forward]  
Balance at beginning of period (5,059)
Other comprehensive loss before reclassifications, net of tax (61)
Balance at end of period (5,120)
Pension and Other Defined Benefit Plan Obligation  
AOCI Attributable to Parent, Net of Tax [Roll Forward]  
Balance at beginning of period 1,268
Other comprehensive loss before reclassifications, net of tax 0
Balance at end of period $ 1,268
XML 76 R65.htm IDEA: XBRL DOCUMENT v3.24.3
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Aggregate principal amount of long-term debt $ 125,000  
Long-term debt, non-current portion 122,840 $ 122,375
Term Debt    
Debt Instrument [Line Items]    
Aggregate principal amount of long-term debt 125,000 125,000
Unamortized debt discount (477) (571)
Unamortized debt issuance costs (1,683) (2,054)
Net carrying amount of long-term debt 122,840 122,375
Less: current portion of long-term debt 0 0
Long-term debt, non-current portion 122,840 122,375
Initial term loan under the June 23, 2021 credit agreement    
Debt Instrument [Line Items]    
Aggregate principal amount of long-term debt 125,000 $ 125,000
Unamortized debt discount $ (900)  
XML 77 R66.htm IDEA: XBRL DOCUMENT v3.24.3
Debt - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended 39 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Dec. 31, 2023
Jun. 23, 2021
Debt Instrument [Line Items]              
Effective interest rate 7.90%   7.90%   7.90% 7.60%  
Amortization of debt issuance costs and accretion of discount on debt and leases $ 200,000 $ 200,000 $ 500,000 $ 500,000      
Aggregate principal amount of long-term debt $ 125,000,000.0   $ 125,000,000.0   $ 125,000,000.0    
Aggregate commitments percentage 1.00%   1.00%   1.00%    
Initial term loan under the June 23, 2021 credit agreement              
Debt Instrument [Line Items]              
Effective interest rate 3.40%   3.40%   3.40%    
Fair value of term loans outstanding $ 115,700,000   $ 115,700,000   $ 115,700,000 $ 114,500,000 $ 350,200,000
Aggregate principal amount of long-term debt $ 125,000,000   $ 125,000,000   $ 125,000,000 $ 125,000,000  
Credit facility, incremental borrowing capacity             $ 175,000,000
Credit facility, incremental borrowing capacity, percent of consolidated EBITDA             100.00%
Interest period 1 month   1 month   1 month    
Debt instrument, basis spread on variable rate, additional applicable margin     1.25%        
Debt instrument, quarterly amortization rate 0.25%   0.25%   0.25%    
Call premium, percentage     1.00%        
Call premium, period     6 months        
Unamortized debt discount $ 900,000   $ 900,000   $ 900,000    
Debt issuance costs $ 2,900,000   $ 2,900,000   $ 2,900,000    
Debt instrument, term     7 years        
Initial term loan under the June 23, 2021 credit agreement | Federal funds rate              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate     0.50%        
Initial term loan under the June 23, 2021 credit agreement | SOFR              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate     1.00%        
Initial term loan under the June 23, 2021 credit agreement | SOFR subject to floor              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate     0.50%        
Debt instrument, basis spread on variable rate, additional applicable margin     2.25%        
Initial term loan under the June 23, 2021 credit agreement | Wells Fargo Bank, National Association              
Debt Instrument [Line Items]              
Aggregate principal amount of long-term debt             $ 350,000,000.0
Line of credit | Revolving Credit Facility              
Debt Instrument [Line Items]              
Debt instrument, covenant, leverage ratio, maximum 3.50   3.50   3.50    
Debt instrument, covenant, leverage ratio, maximum, potential temporary increase 3.75   3.75   3.75    
Debt issuance costs $ 400,000   $ 400,000   $ 400,000    
Debt instrument, term     5 years        
Line of credit | Revolving Credit Facility | Minimum              
Debt Instrument [Line Items]              
Commitment fee percentage         0.175%    
Line of credit | Revolving Credit Facility | Maximum              
Debt Instrument [Line Items]              
Commitment fee percentage         0.25%    
Line of credit | Revolving Credit Facility | SOFR              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate, additional applicable margin     1.00%        
Line of credit | Revolving Credit Facility | SOFR | Minimum              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate         1.00%    
Line of credit | Revolving Credit Facility | SOFR | Maximum              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate         1.75%    
Line of credit | Revolving Credit Facility | Base rate              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate, additional applicable margin     0.00%        
Line of credit | Revolving Credit Facility | Base rate | Minimum              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate         0.00%    
Line of credit | Revolving Credit Facility | Base rate | Maximum              
Debt Instrument [Line Items]              
Debt instrument, basis spread on variable rate         0.75%    
Line of credit | Wells Fargo Bank, National Association | Revolving Credit Facility              
Debt Instrument [Line Items]              
Credit facility, maximum borrowing capacity             $ 100,000,000
XML 78 R67.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
May 22, 2024
Feb. 29, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares issued upon settlement of employee bonus plan (in shares)           400,000
Accrued bonuses $ 3,500,000   $ 3,500,000      
Vesting percentage relative to net sales     60.00%      
Vesting percentage relative to earnings per share     40.00%      
Intrinsic value of stock options exercised 0 $ 47,000.0 $ 500,000 $ 200,000    
Cash received from exercise of stock options   100,000   200,000    
Tax benefit from stock options exercised 0 $ 100,000 $ 800,000 $ 400,000    
Share-based payment arrangement, tranche three            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares awarded as a percentage of grants, peer group based     250.00%      
Share-based payment arrangement, tranche one            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares awarded as a percentage of grants, peer group based     30.00%      
Share-based payment arrangement, tranche two            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Shares awarded as a percentage of grants, peer group based     100.00%      
Restricted Stock Units (RSUs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized compensation cost 112,000,000.0   $ 112,000,000.0      
Unrecognized compensation costs, period for recognition     2 years 4 months 20 days      
Performance-based restricted stock units (PRSUs)            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized compensation cost 1,400,000   $ 1,400,000      
Unrecognized compensation costs, period for recognition     1 year 4 months 24 days      
Performance period     3 years      
Stock Options            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Unrecognized compensation cost $ 28,000,000.0   $ 28,000,000.0      
Unrecognized compensation costs, period for recognition     3 years 4 months 20 days      
Employee Stock            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Common stock purchased under the ESPP (in shares)     175,764 140,631    
Weighted average price of stock purchased under the ESPP (in usd per share) $ 15.26 $ 21.25 $ 15.26 $ 21.25    
Inducement Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares available for grant (in shares) 4,000,000   4,000,000   4,000,000  
Equity Incentive Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares available for grant (in shares) 15,417,601   15,417,601      
Employee Stock Purchase Plan            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares available for grant (in shares) 6,451,538   6,451,538      
XML 79 R68.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense $ 12,788 $ 5,118 $ 47,208 $ 38,763
Cost of net revenue        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 81 170 436 626
Research and development        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense 7,423 9,436 27,952 33,128
Selling, general and administrative        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Stock-based compensation expense $ 5,284 $ (4,488) $ 18,820 $ 5,009
XML 80 R69.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation - Summary of Restricted Stock Unit and Performance-Based Restricted Stock Unit Activity (Details)
shares in Thousands
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Restricted Stock Units (RSUs)  
Number of Shares (in thousands)  
Outstanding beginning balance (in shares) | shares 5,632
Granted (in shares) | shares 2,945
Vested (in shares) | shares (2,461)
Canceled (in shares) | shares (1,007)
Outstanding ending balance (in shares) | shares 5,109
Weighted-Average Grant-Date Fair Value per Share  
Outstanding beginning balance (in usd per share) | $ / shares $ 36.72
Granted (in usd per share) | $ / shares 18.24
Vested (in usd per share) | $ / shares 29.44
Canceled (in usd per share) | $ / shares 38.32
Outstanding ending balance (in usd per share) | $ / shares $ 29.25
Restricted Stock Units (RSUs) | Inducement Plan  
Number of Shares (in thousands)  
Granted (in shares) | shares 227
Canceled (in shares) | shares (24)
Weighted-Average Grant-Date Fair Value per Share  
Granted (in usd per share) | $ / shares $ 13.64
Canceled (in usd per share) | $ / shares $ 12.46
Performance-based restricted stock units (PRSUs)  
Number of Shares (in thousands)  
Outstanding beginning balance (in shares) | shares 2,653
Granted (in shares) | shares 1,472
Vested (in shares) | shares (58)
Canceled (in shares) | shares (665)
Outstanding ending balance (in shares) | shares 3,402
Weighted-Average Grant-Date Fair Value per Share  
Outstanding beginning balance (in usd per share) | $ / shares $ 34.38
Granted (in usd per share) | $ / shares 17.78
Vested (in usd per share) | $ / shares 24.43
Canceled (in usd per share) | $ / shares 41.74
Outstanding ending balance (in usd per share) | $ / shares $ 25.93
XML 81 R70.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details) - Employee Stock - $ / shares
9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Risk-free interest rate, minimum 5.40% 4.54%
Risk-free interest rate, maximum 5.41% 5.24%
Dividend yield 0.00% 0.00%
Expected life (in years) 6 months 6 months
Volatility, minimum 49.76% 51.73%
Volatility, maximum 70.46% 59.78%
Minimum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Weighted-average grant date fair value per share (in usd per share) $ 5.78 $ 7.56
Maximum    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Weighted-average grant date fair value per share (in usd per share) $ 6.35 $ 11.97
XML 82 R71.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation - Summary of Stock Option Activity (Details)
$ / shares in Units, shares in Thousands, $ in Thousands
9 Months Ended
Sep. 30, 2024
USD ($)
$ / shares
shares
Number of Options (in thousands)  
Outstanding beginning balance (in shares) | shares 375
Granted (in shares) | shares 2,688
Exercised (in shares) | shares (39)
Canceled (in shares) | shares (1)
Outstanding ending balance (in shares) | shares 3,023
Vested and expected to vest (in shares) | shares 2,807
Exercisable (in shares) | shares 335
Weighted-Average Exercise Price  
Outstanding beginning balance (in usd per share) | $ / shares $ 17.29
Granted (in usd per share) | $ / shares 19.45
Exercised (in usd per share) | $ / shares 7.68
Canceled (in usd per share) | $ / shares 23.75
Outstanding ending balance (in usd per share) | $ / shares 19.33
Vested and expected to vest (in usd per share) | $ / shares 19.32
Exercisable (in usd per share) | $ / shares $ 18.40
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]  
Weighted Average Contractual Term, Outstanding (in years) 8 years 5 months 12 days
Weighted Average Contractual Term, Vested and expected to vest (in years) 8 years 4 months 17 days
Weighted Average Contractual Term, Exercisable (in years) 10 months 9 days
Aggregate Intrinsic Value, Outstanding (in thousands) | $ $ 0
Aggregate Intrinsic Value, Vested and expected to vest (in thousands) | $ 0
Aggregate Intrinsic Value, Exercisable (in thousands) | $ $ 0
XML 83 R72.htm IDEA: XBRL DOCUMENT v3.24.3
Stock-Based Compensation - Schedule of Stock Options, Valuation Assumptions (Details) - Stock Options
9 Months Ended
Sep. 30, 2024
$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Risk-free interest rate 4.33%
Dividend yield 0.00%
Expected life (in years) 6 years 6 months
Volatility 57.50%
Minimum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted-average grant date fair value per share (in usd per share) $ 10.84
Maximum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted-average grant date fair value per share (in usd per share) $ 11.24
XML 84 R73.htm IDEA: XBRL DOCUMENT v3.24.3
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Tax Disclosure [Abstract]        
Income tax provision (benefit) $ (6,713) $ (1,689) $ (10,535) $ 13,468
Unrecognized tax benefits, period increase (decrease)     200  
Unrecognized tax benefits, accrued interest 100   100  
Unrecognized tax benefits, accrued penalties $ 4   $ 4  
XML 85 R74.htm IDEA: XBRL DOCUMENT v3.24.3
Concentration of Credit Risk, Significant Customers and Geographic Information - Concentration of Risk, by Risk Factor (Details)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Inventory Purchase Obligations | Supplier Concentration Risk | Vendor A          
Concentration Risk [Line Items]          
Concentration risk percentage 27.00% 28.00% 18.00% 21.00%  
Inventory Purchase Obligations | Supplier Concentration Risk | Vendor B          
Concentration Risk [Line Items]          
Concentration risk percentage 26.00% 17.00% 35.00% 24.00%  
Inventory Purchase Obligations | Supplier Concentration Risk | Vendor C          
Concentration Risk [Line Items]          
Concentration risk percentage 12.00% 14.00% 11.00% 10.00%  
Inventory Purchase Obligations | Supplier Concentration Risk | Vendor D          
Concentration Risk [Line Items]          
Concentration risk percentage       10.00%  
Customer A | Revenue Benchmark | Customer Concentration Risk          
Concentration Risk [Line Items]          
Concentration risk percentage 25.00% 11.00% 13.00% 11.00%  
Customer B | Accounts Receivable | Customer Concentration Risk          
Concentration Risk [Line Items]          
Concentration risk percentage     12.00%   33.00%
Customer C | Accounts Receivable | Customer Concentration Risk          
Concentration Risk [Line Items]          
Concentration risk percentage     18.00%   24.00%
XML 86 R75.htm IDEA: XBRL DOCUMENT v3.24.3
Concentration of Credit Risk, Significant Customers and Geographic Information - Revenue from External Customers by Geographic Areas (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Concentration Risk [Line Items]        
Net revenue $ 81,102 $ 135,530 $ 268,361 $ 567,910
Revenue Benchmark        
Concentration Risk [Line Items]        
Net revenue $ 81,102 $ 135,530 $ 268,361 $ 567,910
Revenue Benchmark | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk percentage 100.00% 100.00% 100.00% 100.00%
Asia | Revenue Benchmark        
Concentration Risk [Line Items]        
Net revenue $ 65,293 $ 98,647 $ 193,555 $ 419,478
Asia | Revenue Benchmark | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk percentage 80.00% 73.00% 72.00% 74.00%
Europe | Revenue Benchmark        
Concentration Risk [Line Items]        
Net revenue $ 10,208 $ 24,886 $ 29,034 $ 110,058
Europe | Revenue Benchmark | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk percentage 13.00% 18.00% 11.00% 19.00%
United States | Revenue Benchmark        
Concentration Risk [Line Items]        
Net revenue $ 3,955 $ 8,757 $ 41,586 $ 29,847
United States | Revenue Benchmark | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk percentage 5.00% 6.00% 15.00% 5.00%
Rest of world | Revenue Benchmark        
Concentration Risk [Line Items]        
Net revenue $ 1,646 $ 3,240 $ 4,186 $ 8,527
Rest of world | Revenue Benchmark | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk percentage 2.00% 2.00% 2.00% 2.00%
Hong Kong | Revenue Benchmark | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk percentage 49.00% 41.00% 37.00% 34.00%
China | Revenue Benchmark | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk percentage       12.00%
Taiwan, ROC | Revenue Benchmark | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk percentage   10.00%    
Thailand | Revenue Benchmark | Geographic Concentration Risk        
Concentration Risk [Line Items]        
Concentration risk percentage 11.00%      
XML 87 R76.htm IDEA: XBRL DOCUMENT v3.24.3
Concentration of Credit Risk, Significant Customers and Geographic Information - Long-Lived Assets by Geographic Areas (Details) - Long lived assets - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Concentration Risk [Line Items]    
Long lived assets $ 462,661 $ 489,913
Geographic Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk percentage 100.00% 100.00%
United States    
Concentration Risk [Line Items]    
Long lived assets $ 326,442 $ 337,696
United States | Geographic Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk percentage 71.00% 69.00%
Singapore    
Concentration Risk [Line Items]    
Long lived assets $ 106,444 $ 113,248
Singapore | Geographic Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk percentage 23.00% 23.00%
Rest of world    
Concentration Risk [Line Items]    
Long lived assets $ 29,775 $ 38,969
Rest of world | Geographic Concentration Risk    
Concentration Risk [Line Items]    
Concentration risk percentage 6.00% 8.00%
XML 88 R77.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue from Contracts with Customers - Revenues from External Customers by Products and Services (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net revenue $ 81,102 $ 135,530 $ 268,361 $ 567,910
Revenue Benchmark        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net revenue 81,102 135,530 268,361 567,910
Broadband        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net revenue $ 32,275 $ 34,416 $ 87,157 $ 169,646
Broadband | Revenue Benchmark | Product Concentration Risk        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Concentration risk percentage 40.00% 25.00% 32.00% 30.00%
Connectivity        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net revenue $ 12,726 $ 15,025 $ 35,700 $ 119,232
Connectivity | Revenue Benchmark | Product Concentration Risk        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Concentration risk percentage 16.00% 11.00% 13.00% 21.00%
Infrastructure        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net revenue $ 23,046 $ 49,985 $ 87,436 $ 145,549
Infrastructure | Revenue Benchmark | Product Concentration Risk        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Concentration risk percentage 28.00% 37.00% 33.00% 26.00%
Industrial and multi-market        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Net revenue $ 13,055 $ 36,104 $ 58,068 $ 133,483
Industrial and multi-market | Revenue Benchmark | Product Concentration Risk        
Revenues from External Customers and Long-Lived Assets [Line Items]        
Concentration risk percentage 16.00% 27.00% 22.00% 23.00%
XML 89 R78.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue from Contracts with Customers - Additional Information (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]            
Customer contract liabilities $ 164,000   $ 164,000   $ 1,597,000  
Accrued price protection liability 44,472,000 $ 71,643,000 44,472,000 $ 71,643,000 71,684,000 $ 113,274,000
Right of return assets 58,000   58,000   100,000  
Impairment losses     0   0  
Reduction in Transaction Price            
Revenues from External Customers and Long-Lived Assets [Line Items]            
Accrued obligations to customers for price adjustments 20,558,000   20,558,000   54,837,000  
Sales Returns and Allowances            
Revenues from External Customers and Long-Lived Assets [Line Items]            
Accrued obligations to customers for stock rotation rights $ 167,000   $ 167,000   $ 349,000  
Distributors | Revenue from Distributors | Revenue Benchmark            
Revenues from External Customers and Long-Lived Assets [Line Items]            
Concentration risk percentage 35.00% 46.00% 42.00% 47.00%    
XML 90 R79.htm IDEA: XBRL DOCUMENT v3.24.3
Leases - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Lessee, Lease, Description [Line Items]          
Original operating lease terms 12 months   12 months    
Operating lease renewal term 5 years   5 years    
Operating lease, weighted average discount rate, percent 4.90%   4.90%   4.60%
Operating lease, weighted average remaining lease term 3 years 4 months 24 days   3 years 4 months 24 days   3 years 10 months 24 days
Operating lease cost $ 2.4 $ 2.7 $ 7.5 $ 8.0  
Right-of-use asset obtained in exchange for operating lease liability $ 0.0 $ 0.0 $ 1.2 $ 12.2  
Minimum          
Lessee, Lease, Description [Line Items]          
Original operating lease terms 2 years   2 years    
Maximum          
Lessee, Lease, Description [Line Items]          
Original operating lease terms 8 years   8 years    
XML 91 R80.htm IDEA: XBRL DOCUMENT v3.24.3
Leases - Aggregate Future Minimum Payments Due (Details) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Operating Leases    
2024 (3 months) $ 2,864  
2025 10,791  
2026 8,391  
2027 6,031  
2028 2,467  
Thereafter 1,596  
Total minimum payments 32,140  
Less: imputed interest (2,906)  
Less: unrealized translation loss (2)  
Total lease liabilities 29,232  
Less: short-term lease liabilities (9,799) $ (9,132)
Long-term lease liabilities $ 19,433 $ 26,243
XML 92 R81.htm IDEA: XBRL DOCUMENT v3.24.3
Employee Retirement Plans (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Retirement Benefits [Abstract]          
Defined benefit obligation $ 400   $ 400   $ 1,400
Net periodic benefit cost $ 45 $ 100 $ 200 $ 200  
XML 93 R82.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies - Future Minimum Inventory Purchase and Other Obligations (Details)
$ in Thousands
Sep. 30, 2024
USD ($)
Total  
2024 (3 months) $ 10,712
2025 45,550
2026 19,482
2027 3,673
Total minimum payments 79,417
Inventory Purchase Obligations  
Inventory Purchase Obligations  
2024 (3 months) 3,004
2025 13,419
2026 0
2027 0
Total minimum payments 16,423
Other Obligations  
Other Obligations  
2024 (3 months) 7,708
2025 32,131
2026 19,482
2027 3,673
Total minimum payments $ 62,994
XML 94 R83.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies - Additional Information (Details)
$ in Millions
9 Months Ended
Jan. 31, 2024
claim
Oct. 06, 2023
claim
Sep. 21, 2023
claim
Feb. 10, 2023
claim
Sep. 30, 2024
USD ($)
claim
Sep. 18, 2024
claim
Aug. 31, 2023
claim
Loss Contingencies [Line Items]              
Proceeds received from other party, deferred in other long-term liabilities | $         $ 15.0    
Silicon Motion Stockholder Litigation              
Loss Contingencies [Line Items]              
Loss contingency, number of claims filed         2    
Water Island Event-Driven Fund v. MaxLinear, Inc.              
Loss Contingencies [Line Items]              
Loss contingency, number of pending claims           2 2
Dish Litigation              
Loss Contingencies [Line Items]              
Loss contingency, number of claims filed 8   4        
Cox Litigation              
Loss Contingencies [Line Items]              
Loss contingency, number of claims filed   2   2      
XML 95 R84.htm IDEA: XBRL DOCUMENT v3.24.3
Stock Repurchases (Details) - USD ($)
9 Months Ended 43 Months Ended
Sep. 30, 2024
Sep. 30, 2024
Feb. 16, 2024
Feb. 23, 2021
Equity [Abstract]        
Stock repurchase program, authorized amount       $ 100,000,000
Repurchase of common stock (in shares) 0      
Stock repurchased during period   $ 55,000,000.0    
Stock available for purchase (in shares)     0  
EXCEL 96 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( /* 5UD'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #R@%=92](&.^X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R''*!B;-I:.G#@8K;.QF;+4UBQUC:R1]^R5>FS*V!]C1TN]/ MGT"-#E+W$9]C'S"2Q70WNLXGJ<.:G8B"!$CZA$ZE,1@M(? MZH@@.+\'AZ2,(@4SL @+D;6-T5)'5-3'"][H!1\^8Y=A1@-VZ-!3@JJL@+7S MQ' >NP9N@!E&&%WZ+J!9B+GZ)S9W@%V28[)+:AB&GW4M>M[ ^ MD?(:IU_)2CH'7+/KY-=Z\[C?LE9PL2HJ7HAZ+[CD#U*LWF?7'WXW8=<;>[#_ MV/@JV#;PZR[:+U!+ P04 " #R@%=9F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M /* 5UDH^WZ;P@4 +(> 8 >&PO=V]R:W-H965T&UL MM9EK<^(V%(;_BH;.=-J9$"R9&-@FS! GV6::[+(AO6P[_2!L 9ZU+2K+(?GW M/;+!SJ;R@7J6+XEOYT6/="2]DLXW4GW)5D)H\IS$:7;166F]?M?K9<%*)#P[ ME6N1PIN%5 G7<*N6O6RM! ^+H"3N,@F/TL[XO'@V5>-SF>LX2L54D2Q/ M$JY>+D4L-Q<=VMD]>(B6*VT>],;G:[X4,Z%_74\5W/4JE3!*1)I%,B5*+"XZ M$_K.=YD)*+[X+1*;[-4U,2AS*;^8F]OPHN.8$HE8!-I(!M!G![[\DDHTB79BBN1G?UL)'BX=3I M?K(AH5$MD+J55;JL4'XUJB>=5>-YA>%.A M(AF:7DA@'+ V'JY4];O&CH?&M^0<5)R# S-3<9A"BAF@N1UQK06/,VM#HF$M M 8<5X! MU'6J(_U";J)8D ]Y,A?*!H9K. [MNGW/\VQP:&A+N%$%-SH$[D$L M(S.,0C-^X(DU1W&=>_Y\!X^X.B&W:7!JPT0%6F)2IYY,G4- H7!207)RDZH7UW;B/&@MLBO_ ,]!/F1/Y/;$'IHM(B"@AM) MXSV2M-^EPY%'V!R/E=Q M-N>AE?08AHC6CHCBGN8M:=67ITH^16E@;V]4S^C-;-PQ6N.(*EY-!*>@S'1&O+1'&G4R3K!-:\S6"XP,!SK%C',$BT=D@4 MMS5W,H#VFJYDBCF(/2+>B'6= :56OF/X(UH;)(J[F\=(@S>2"T+9#_,?R4P$ MN8*6M$+B2KY,$IB?8&T=?+&"'L,KT=HL4=SE@,4-HW1)9B_)7,96OCTVZ8\[ M*]8QO!&KO1'#W.*\CV21 ($ *9L)2T$A_#[;#: M[;"#W,YU(M32).Y[4- KF">3-4_MZ+A@XUH;CVL+6KL==I#;F24\CLEEGL'K MS-Y!<9UFOF-X'%9['(9;E!W?2@ ?UGRX3#/>,;P.J[T.PVW*;J0M)_*9FSK8=2[:Q0,TU&E@\LB6H6QL@=\_VS6X/\S7I#3RT#CQ[Q)HV:?&PMHRU M!7)QP_*6<;LMW4R)RWURK8S'L#]N;7]V[\0$9BL8!0YW0 YXJ M#TC+&RW7Q1GC7&HMD^)R)7@HE/D WB^DU+L;\P/5,?7X7U!+ P04 " #R M@%=9MS=38ID& @' & 'AL+W=OGYX[D/0^IBP)[I"U:5U331<7 M4CP ::U--'O1UJ;U-MGPQ@[C4DOS*S=^>G$E&B4J7E+-2O"15K0I&%C:< J< M@J_+:_#3VY_!6\ ;\&4E-HHVI;J8:_-FZS\ONK=\W+T%3;QER=9G $N.#]WG)M]]TFB?-&KCX:FD-U*R1@.JE,GSO2^?78#8'\"N MK?=J30MV.3.+1S&Y9;/%NSYXGVN.!1]<475"IA1 X6]8-\W M?$LKD[QW%'>ATC:4;0#;!8Q)G*47\^TP'X\9R1 A>[,#I/$>:1Q$NEP)J4\U MD[7I#TI+7M@Y:6'[H.YB)0,,>8Y'.%T;&"70CS+9HTR"*#\4A=B8\AF,!3.U MO*W8"6B8]F%,G/?'68ZC$4K7"F91"G,_SG2/,PWB_-1LS2@+^>0#EKK%2Z-T M7#Z/59Y'$Z.<[7%E05PWDJTI+P%[-$RDF&KGIM K)DV[&RY+'^[,081-19!D+^+YO[% M*RAWRS2> :X)S/P(8=033G1D A@-(O53._"V'ZV-*M"3:ZB+-L20XMA9ZCZS M-,83BQT.Z!&&*\J,1BB!M&K@5-R=;A0+#'X7[*"F*(GS,5C7#$.4QA-@>UJ# M028Q:U[3YIZ;EM1AG*XJZ86>4ET/0Q--8NNQ"4)&@,TS5+\^'\/439 MTQ ,\]"?;*PI_5+3#I'LZ@V$^V^N8 M-7VR(L:;L(?,HA0Y*]$U0S"9$EJP)S,89C,#46[,.EP;(F/FK]#=WN]YH+S: M!KJD%<=QYJQ+URR#*9GHP:BG-Q2FMV?0 7TSF&?>K8=+91F$^7B]>LQR$J<3 M[0_UC(?"C/><0"%JFP&U%??"]'$=CL9"QV.&HQBE$S '6[@PUQWJL6,E=7G, MC'7BUM2U0PA!--$$44]X*$QXO3"KK* XBM?E-IC'>-P2/68H1?$$MZ"> 5&8 M 7NT);OUZ@?DV5HA1&)G]+UV.)O0N:BG/_0Z^CM64 \'9DDZUCL^,XSB*;0] M!Z*7<. QC"[!84QB1Y3Y['*-<44 MXO] 8P\[NT,ZE_C'BBQHD"[M MDS1-'57OLXM(,D40N-<'.*P/C(S9U)NJ/=?NY)<1-)*M[">(K6%@H?Q'H*X$ M.,7$V=9YS;)\0O/BP6EM6"@,89?LCA?IR?[IA>W*@21)B2/./78I25$Z-2MZV8##LL$AXG8=OC*)Q#G^ M]FY8/7;^#>M\\/G&?CO[@\I[WB@C%>^,9W26F4!R]SEJ=Z/%NOVBX[/N;XF M'F^X>)09@$)/.65RXF1*%3>N*Y,,:DH83 32)9YCL7O.Z!\,W%\YWG@@:PR90;<>%S@%-73>HT:QK@=ON9_:,UK\TLL(0II]])JK*),W)0"DM< M4O7 -Y^@-A09OH13:7_1IHJ-A@Y*2JEX7H.U@IRPZHF?ZD1L ?S^'D!0 X)3 M 6$-"*W12IFU=8\5CL>";Y PT9K--&QN+%J[(BAT+O"@5>T.^ 3P_#[R'1<-_"PS;;Q"!19HC6D)Z((P5,H4%2"J3;_L MRD1%/[3TYC]C'7L]S_/\L;O>]G@TK*6^WZCOGZ>^*DZ$2Y5Q0?[H">.B&NV4 M7_%'6[J"R+.?%P9."&Q9B!H+T:LL$"G+X_*C'54O=1^*: D>-(('KQ*LWQ%2 M8982MCJF>G!4]:&(ENIAHWIX4/64Y[D^U:\L\N%I17XTK"5]U$@?G2'][ H? M[:0RJ@OW9=)/B6PYN&X<7)_OX+0"O][1-.J'@V!7?$>@K[][M?O>OS>D=[[Z M,ZJ]IC_!0U=DMPEWZXUOKEM?L%@1)A&%I89ZO:'F$-4-INHH7MA+P((K?:6P MS4S?^D"8 #V_Y%P]=\R]HKE'QG\!4$L#!!0 ( /* 5UEG\'W)A@8 .<> M 8 >&PO=V]R:W-H965T&ULK5E=<^(V%/TK&KK326:2 MH _;LM.$F0W0-C/=;F:SVSYT^N" ,]BBUHB2?]])6-LD*[=;,L+8'-TK'-U M=75DW;S(\JM:":'1:[XNU.U@I?7F>CA4LY7(4W4E-Z(P_RQDF:?:7);+H=J4 M(IU7C?+UD&(<#?,T*P:CF^K>0SFZD5N]S@KQ4"*US?.T_/M.K.7+[8 ,]C<^ M9&HYM-NA2/0G_9/)3F:MBPS+-<%"J3!2K%XG;PGEQ/:60;5(C?,O&B M#GXC*^5)RJ_VXGY^.\"V1V(M9MI2I.;K68S%>FV93#_^JDD'S3-MP\/?>_8? M*_%&S%.JQ%BN?\_F>G4[B =H+A;I=JT_R9>?12THM'PSN5;5)WJIL7B 9ENE M95XW-CW(LV+WG;[6@3AH8'C@!K1N0-T&04<#5C=@;WU"4#<(WOJ$L&Y021_N MM%>!FZ0Z'=V4\@65%FW8[(\J^E5K$Z^LL(GRJ$OS;V;:Z=%8%DJNLWFJQ1P] M:O-ELD K)!?HXT:4J1U-A2[1E\<).GMWCM0J+85"68$^K^16I<5<7:!W1]G23/$_H:'>D04PF:U[UVJ3SL3MP!0V)H6.IM"U%1;_@'4EX\'#&,74%^ZB( MA''DZ/51A 8QY8Y>'T9#S _8CO1&C=ZH5^]/I50*;4JYR#0D-/*>&@0X=H9L M[*,X2X+ $>JC2,!"YL"F/HP13F@ "^6-4-Y;4^JUI5@B\6H\CQ+J&M++3UE+ M3DDV.279]$1D1R,1-R,1]Z;<)\.8EK,5,DNW<5C/QCIN;)6'AB/VE M+3Y*3"!,)A9-W:LV(\#8?8Q8 "8UY/+*.*!%P 1WA,8C<"$"ZFA"=N"'P@"VE7 %IK2/J]X7VA MA5DEM-F2V4B D@-_S*/0$PR@.'/+.( R'B)RM?JH@'96L=8=DGY[V&BM,QP4 MZSNU2QJ%H:L6@G$2NG(!6(RY6[4A&.<)ZQ#[27@2"UF*?11T^MI1WWT# M=1G3(/%6-0 7D- O;P".)#Q.0E<] #0Y<% &C]6WUHWT>[?[1K'=*#UGU2O+ MLR=CY,RFZ1R,@6^B+B-O31I#,!+%B1L!"(9#Y@4 <'BF,G:L[K2U;K3?NMG- MOUW=(*5UT^BH[H0\=E,=PK$DIJY6"$=BLPJX,QXD#** =ZAMW1LEO1O%O5ID M%O'=RT=PHTA[/>"W[A1/RC8Y*=OT5&S'X]%Z2]KO+>]2E2V2*[\9$HGHE]Y:)V>M6OWEBGI)M MI]<*TWPNW$W-W1 /GI>]+XP!S]PT&!"/43TP QAAV]WH0#+,# MPW"LN#7#M-\,'T[)/LV^&04U S!(,P"#- ,P0//PX. N%^6R.C%59HYM"[T[ MH&GN-J>R[ZNS2.?^';D>$^#^A%Q/=V>N+?WN"/A#6BZS0J&U6)A'X2MN^EKN M3E5W%UINJF/#)ZFUS*N?*Y'.16D!YO^%E'I_81_0G&V/_@%02P,$% @ M\H!76;@4,"NT P W L !@ !X;"]W;W)KYS9!A+;Q0JL0Q"WVX=A'VCI;&F52(VD[62_?D=* MUFR9<8,N'VR)U#W/Z9X['6^TX^*KS $4>:I*)L=.KE1]Z[HRS:&B\IK7P/#) MBHN**ER*M2MK 30SH*IT_<$@=BM:,&L]]X+-:YTAON9%33-2Q ?:D?!*[_8/ M)G:,94DE3'GY>Y&I?.S<."2#%=V4ZI'O?H8VGDCSI;R4YI_L6MN!0]*-5+QJ MP?@&5<&:*WUJ=3@ ((\=X+< OP\(7P $+2!XK8>P!82O]1"U !.ZV\1NA)M1 M12VS\2(^BJ(C!\P4M\^T(XK8./+.45D#_NEE()_,S_M.6^80_M M[+KUW"5<=D29MC)OL+6Z3I6)>$@2E719_( M$ABL"K.\"'V"+8I<>/&0X+E*5 [X$P!FFZ$[4C6M!'0K(?@M8>TO073?XR4> MB+(&A4PLUC% M7B^M%IO \R-[5N,NJ_'9K#Y"6E(IBU61GF12"[EA./24Q3\HT1J''?).E_I[ M@H9U.Z-H/3G**_18@.Q9EX>ZQ *Q"1>?1-(KX>FIQ560#/V>:M_DF7^+YTBS MI-,L.:O99ZYH2=*C;OQ2!T@L'0"SULOMU&(61F$2]P*VF&$'"/MTS"N5"#69DZ4&-F&J>:,ZG:[4?3.3&"]_7OO=NI9]FN6[ @ !P@ !@ !X;"]W;W)KVV\.]W[*2AI:%"&R_Q[7S?N>:<:"WDORH!J/W;)%I<^'&44D7, 5]5TXDGMR&)64%<,4$)Q+F?>>RTQN' M1MX*?&>P5EM[8CR9"7%O#M=IW_&,09!#H@T#Q64%0\AS0X1F_*DYG4:E 6[O M-^Q7UG?T9485#$7^@Z4ZZSN?')+"G"YS?2O67Z#VY]SP)2)7]DO6M:SGD&2I MM"AJ,%I0,%ZM]*&.PQ8 >=H!?@WPGP/"%P!!#0A>JR&L >%K-9S7 .NZ6_EN M S>BFL:1%&LBC32RF8V-OD5CO!@W=3+5$E\9XG0\%%R)G*540TJF&A$(E/F>@64+S$_*!W$U'Y/CHA!P1QLFW3"P5Y:F* M7(VV&0UN4MLQJ.SP7[ C(#<"B149\Q32%OSH,/[B -[%F#2!\3>!&?@'":=0 MGI' .R6^YX-_UKX3C*"IDL#R!2_Q;0ICORZN>2(*(#\O M9TI+_.U_M>6^8@_;V4TK[*F2)M!WD%B!7($3OW_7Z7J?VP+_EF2CMR0;OQ'9 M3HK")D7A(?88VR8V18X]0^(OFCP2S 97.:W:R/_P)02P,$% @ M\H!760,P7;(H# +'L !@ !X;"]W;W)K43+-X_5]K=Z411-],=JN:YO!XNFV;P= MC>K9HECE]9MJ4ZS;O]Q7VU7>M"^W#Z-ZLRWR^;[1:CFB<2Q&J[Q<#^YN]K_[ ML+V[J7;-LEP7'[91O5NM\NW7=\6R>KP=D,&W7WPL'Q9-]XO1WO__Z/$0&P^BV:YNJM6A M<7L$JW+]]&_^QZ$C3AH0=J8!/32@H0W8H0&S&M#T3(/DT""Q&B3B3 -^:,#M M#.?>M#@T$/N^?^JL?4]/\R:_N]E6C]&VBV[5NA_V=NU;MQUT_[;!IHNJ^?5'-?EM4RWFQK?\2R=]W9?,U&D:_ M?II&KWYX'=6+?%O44;F.?EE4NSI?S^L?HQ^,US>CICW"+L]H=CB:=T]'0\\< MS2]5DR^!9A-_LTFU6K6C='_$0.NIO_5/\WG9C?)\&7W(R_GP_3J:Y)L2/A)Y M06LVVZUVRWUO_JM9%-NH/;9VRB^ZN?BEB-ZO9]6JB%[]HZKKUX"\"I>?%O?E MK&Q,D5%K_W$,T.,8H'O5Y(SJNWR9KV=%E#?1Y^*A7*_+]4,W C;%MJSFT:O6 MTR>W7WY-U9\JW]2:?%;>#ME_J8ONE&-S]^4]$Q'^% MC'\2XWNQ[BSYY2[-TH3?C+Z<&HR94F***20QPU=V])5]CZ\A7CXE$"?=+U+! M,JO_)VY89CGD1J24IJD5)MVP(8DI,:,4$)5PEL7',*.[DF-W)?MV[$QWM7.S MO3;7[>QLNV7_T^ON= :>!__[L5HNH_;:]IAOY_^#>B[!G 688E-,,8DIII#$ M#/?YT7WNG2R':TC=N1V5=;UK3[&;W;;>Y>WEL*FBXLGXO#.\O=*MVT7?R8D1 M&@'>?'U' '?.@X0R84TRS(P24TPAB1G.BJ.S ME9R$WA&,#(F%H.3+Q'TG>B M!J64F"D5DICA4WKT*?7ZM#_1#KLR81ZUJZ2V=JKS;ET&N9&ZTT$D(K;<\.;K MZT902HF94B&)&6YD1S9L7I]M>R6K>U%L5O$0K9D3A\-VQ%KN>+- MV]<53#$9C"NEC/SY=*/^?;X_*:@=6P-T_?-<)!S2B6QN/,6CU/ M49-*5#6%I68:>P)#R/.,#3*3N-W/$D+L\]\ASE :9BT^1563J&H*2\UT39,"XD<%H0N[3\6F/>W%GK4 9E4^ M(2X)R @7SL(.,ZE$55-8:J:Q&BT0/UOP+>PNF^F6_FE,1>I,T_3R-0R0&L>" M.0L[-VZ8CEEF7\. L"R.Z;F%G2[^B;_Z[[>PN[PTQBS3)\2MT\$Z!Y4-H*HI M+#737HT1B)\C7%[87;;4+:WA:F=\>5( 4F"UX\:!U0X0YJEVJ"[[:7S%A1U% MK?U1U::H:A)536&IF8- (P+J1P3X]XG\"7L/!+?6SV)[QJ&FE*AJ"DO-]/=D M+X0?:>#<+:(N>QC2E-LG1_^Q])ZU04DE:E*%I6;:I1$%]2,*N=HLJZ]%<3"L M=6JVZ$[1F_8"=W'B>:5[3SR7)Y#$7I.@II2H:@I+S7128Q/JK3/V-N3H*02-:G" M4C--T9R"^CG%LV[.4I,$]L-U#T,J&H254U=[!#3#8TR:##*\#*]O^_6?@SDS]-[N>!"C"P>L]A> M,*!"#%0UA:5F&JLA!@V&& [3NVPFP!P2$3OHG5[&%Y!4EG%JWY<"XH:4CNW[ M4E!8$I-Q!D\$IO$%NR:^8*CX E5MBJHF4=44EIHY"#2^8-?&%_Z$O0>"BR\$ MLZLHU)0254UAJ9G^:GS!KH$O&$ 26$SLDZ/_6'K/VJ"D$C6IPE(S[3KYA(8? M7_2IKI@+&#BA]L8^?\+>GH3DE*@Y%9:::8GF$,S/(9Y56S$7# RY>R/?G[JW M.:C;+\+>@L)*:KJC<01#V%?!H'T5XXS:<,B?J[<=J/LJ4-74Y1XQ_= D@EUI MQX0_3^]E1-B."=2D$E5-8:F9QFJ(P5YPQP1S=T* .R: ..>#@X$[)H X:,<$ M%.;9,<$T9F"8.R9.]TW"/0C@ =+^9W=@4-C4?^R]QSDJ1""Y,(#2Q5H%3U)P254UAJ9D&:YJ0 M7(,F)&YAGZ7.6L!_*+UG;4A.B9I38:F99FF6D."QA 38K)#&S-Z?XL_8VY.@ MI!(UJ<)2,TTY>:;$"]"$!"C%29HY[J#2!%0U&?86%%92TQU-$Q($FI M7-* M66S3!'^NWG:@T@14-76Y1TP_-$U(<&C"Z>[D!/0,E28D $U@L4CMA00J34!5 M4UAJIK&:)B3/IPF7S70I@6B+G QT5)V"IF;YIG)"\.$Y( G$"$.<8 M%8@3@#@()T!A/IS -4[@U\0)'!4GH*I-4=4DJIK"4C,'@<8)W(\3@E9CW'UZ MPI!D*7,>_N-/UMLV5$B JJ:PU$S;-"3@P0^!"+X%!%[G.5"S)TS894]8V-1_ MU+T=0R4%6&JF8YH4\.#G.GCO[< NN4]JX%QDJ6/3Y2T\> M_>C' /T^#@M;ZI;$8(URB//."E<*K%& .*A&@<)\-0K7U3H7UURTH9;LJ&I3 M5#6)JJ:PU,Q!H"M[[J_L7^"YJ9@?*YAPMT07W'X&%&I*B:JFL-1,?S6(X'X0 M@7,+B ./5N3VH[@F_D/I/6E#>B I(Z MSRM&?7 DJIK"4C,?6:R!B/ _8K+OIV&%^^Q'*IP[1OZD?2=84$Z)FE-AJ9FV M:$0A_(BBSSU6 >P^2%F2V)Z@ MKOLS]S8'%4D$O0.%E=/T1J,&X4<-04Q/0(7[F KGZ>JHVQ%0U22JFKK<(Z8? MFF2(8)(1_&E8L.#UY^F[7! 0P\C&=FF,FE2BJBDL-=-8S3!$,,/P?AH6-A.@ M%R2E=ITT$9?I!2"5<9;9=Z\D$#<4G C[] 6$41:3F)Z9"2??"G%->B%0Z06J MVA153:*J*2PUB&N32_\"7L/!)=>)/9S\::H*26JFL)2,_W5]$)<@UX( MB"0XBQ-4>!&24J*F5%AJIE6:70@_N^A56@%T@:9CI[1"_9:+L*02-:G"4C._ MD4=CB-2/(9Y56J40%[#/6A-_YK[FH*K)H'>@L'*:WF@6D2)LETB![1(I3YWG M[_MS]78#=;<$JII*@2_#,'O$]$-CB/1*^R#2L'T086%3_U'W]@)U'P26FNF8 MAA/I"^Z#2 /W00!Q=LT$A4#[(( X:!\$& ;M@QB=?&]P]SW2/^?;AW)=1\OB MOFT9OTG;L;5]^FKFIQ=-M=E_E?#GJFFJU?['19&WI5(7T/[]OJJ:;R^Z;R<^ M?D'VW?\!4$L#!!0 ( /* 5UES!"6QOP@ '0F 8 >&PO=V]R:W-H M965T&ULK5IK<]NZ$?TK'/5.)YF)(N+!EVMKQG&2-C,WO9[K MIOT,49"%AB1T"T)N(CW]%&_;+A;4VD^MK>+\2NI61M%M75 L9QNJ@):V;+ M2W/MMEU>\KVL6$-OVTCLZYJTSY]HQ1^O9F!VN/ [N]]*?6&QO-R1>WI'Y8_= M;:N^+08M:U;31C#>1"W=7,VNP<4-SO0"(_%O1A_%T>=(F[+B_*?^\FU]-8LU M(EK14FH51/U[H#>TJK0FA>./7NELN*=>>/SYH/VK,5X9LR*"WO#J/VPMMU>S M?!:MZ8;L*_D[?_P'[0U*M+Z25\+\C1X[V:R81>5>2%[WBQ6"FC7=?_+4;\31 M J7'O0#V"^!T ?8L0/T"9 SMD!FS/A-)EI MR5;]RM0ZN;SAC> 56Q-)U]&=5/_4&4D1\4UT0\0V^JK.643SZ,?=Y^C=+^^C M7R+61/_:\KT@S5I<+J3"H#4MROY^G[K[0<_]BN@[;^161%^:-5V?KE\H[(,! M\&# )QA4>$=W'R,4?XA@#+$#S\WKEZ, '#3L)S+ZD$??;SO:$LF:^^A:.RB3 MC#IWJ=."W5IT[%Z('2GIU4P%IZ#M YTM__H7D,9_LCZ:JF=?-?R!Z;<,5H]1WPX0#(-N9.\_#G7++]6T&M5 M^@BO4_>J3KPZ@W$^ >H00WF6>MP:'-$P"$+]3#>T;15.UBBD-)+DR4TF<[Z9[T4H\?6J3R!AD$R!VU*>% )& MX@5!OEK^7;4/>EOIDR;2/1/;$PNBBI$5J[RU4:_]Q,63!$^!VU(^X",3@C 5 M'H"K+945/8#>=5V+$ZK-^Y#8R(0A3X2$252NG>I5&-0LJ?S3E MLQ.FS6]%AJ9 '4R)?5LZDB (L^"7IY+J4HL\1>]6M*$;)L5[W6BQDBFXR@7, MAA]E:O)(6D]K8=/='!:YE3\<8@DL/):,S B*8#UYLU7%AH*K760L$DWXFM%>.YM)TV72.UPC"U7I<=X^NRFK('HFHPE\W0IDL 89H7DR-S MR:$L]9P9'&D5AFGUFTKLC>2M,RJ@39$HQ],$Z9#"2>IC4C@R*0PSZ6U+56Y7 MA/FD\PM]754(;6J@1PZ%80X=CGU'GO69?S"%X)XZS>@R MDGPIW4.;.N?*3S&8&N62R[PD"T>2A6&2O>Y->*E$A Y"C8$%TY;*LRSU@!PY M%88Y]0!RUS)5B*N22_:#L,/NNEW<0:4P@P!.03OD%# M!T5F>3SM*%UB>5X #\:126&827\SWEKQYGXN:5N_B-;F28SL$+2E5!'C\]61 M3F&83O6XQ9I9O-L+TSF\=TXOG#8X*!)D.)GVQ0ZYI"BP+X^,7 K#7/K-%-PO MC\G@63GS7-I.)X,C9Z(P9][NVW)+=(Y\4].$;&Z<@P3GT[-RRD&0>THX-)(H M"I/H">Y7S5R0HTG%13I-E2ZQ%!2>TAB-U(K"U&HFUWU,J$!0FRN8SI4?S.A/ M&6$BR/S03H?0O0$V@4[K>H>(VFY50'C0'TV0PQP[A/C! C8$2SBHD8,@88SQ MM#YVR:$X2STE#1J)%.%@5']E#5$E_3U. M]W1@*/"'=LR)W*9@D&33:MXAA4#J"^N1IU&8I[^SAM7[VO22CTQN#U,<4T8K MU"NZ)=5&FT'K7<6?U>[K[EBU*$*JJDD_X3*&1?N&>?*6@[1!!J:C!Z<81)DO MTX[LCE[)[H?0WPP1]4+HN_@<36L2EQ3,$NBI2M!(YR@\-?ZRV:AJU.S\4VG: MY$B5(30J^Y99'4Z7/,^A=0P.*9"GGGH0CSR-PSS] MF9:M*5M9!_N#A=D86N.1@[(EU/!(W#A/WS:O!1T2J M\+EG3:-]SZ3\S@;'MD=O\SNK[>*ZG8T:(]C)HT+ M7$Q;))=8A M)#Q2/PY3_Q1F^,D-MBF]P)GU+-R6@@GR->)XY'V<_M]>UO!FWI?$P4?>.%A: MO-G'SJ3M=$/&:@*_\"CYJ.P16]+VQ<)N+.=6O%$\[#[+S'IE <2%G3-L,90C M/'6\Q='[.S5M[\UK32(RH[;N39CAZO#JU+5Y86AR_1.XN.E>@!K5=.]C?2>M MRNXBJNA&J8P_9LK!VNX5I^Z+Y#OSEM"*2\EK\W%+R9JV6D#]ON%<'K[H&PPO MFBW_!U!+ P04 " #R@%=9UP:\X%PI &A@ & 'AL+W=O6R[SW[G M7)]]V=>-__YBU_>'[YX\\<7.[7._:@^N@6\V;;?/>_BSVS[QA\[E);VTKY]< M7U[^]LD^KYJ+5R_ILT_=JY?MT-=5XSYUF1_V^[P[O79U>_S^XNI"/_BIVNYZ M_.#)JY>'?.MN7?_SX5,'?ST)JY35WC6^:INLE_LZ,\>WF1 M%8/OV[V\#!#LJX;_FW\1/#SDA6MYX9K@YHT(RK=YG[]ZV;7'K,.G837\!QV5 MW@;@J@8OY;;OX-L*WNM??>RV>5/]/6<4-65VR[>3M9OLMMHVU:8J\J;/;HJB M'9J^:K;9I[:NBLKYET]Z "7>5+(9J]YL^LSF_UK]H>VZ7<^>]>4KDS??P* M!^BO%?K7U_.L.J^SIY2*[OKQ^=L]Z3P,VGM)Z3Q^ C47VIFT\G+6,R/G4 M.>^:GC\ #/U0-7E35'F=W<*'#HBU]]G_N5G[O@-R^[]S&&( GLT#@"SXG3_D MA?O^XH![=7?NXM5O_NGJMYLW"\9_>M_M]]V?_/-LO>.E]TU4'1_'KP ML+CWV1_R+Q_@7WFWR-XWQ2H[YCZKFJ+M#FT'^"_A#WBWSH]YY_#?0!]P*VO7 M 8%)%MF_75>T(^B/ CK<"3VRZ'&AR*/JA M1%JUA,OZ#%HA/QQJA"=>D/#M>V&!($+9 "ZJ%$ NKR MLFJS3>?^-KBF.!'*?OIAP4L<7$=*K"D0/7G=;@%;U1=7+A'0O :\5-NJA_WY M;P2V@,/!PH!S5PQ=U9\RUVR1%A6)<+H.GQ$:;UR/6@AAJ?.3ZSSC]] >X8IA M:]!S*"0,'G_S3[^_OOK="R_"'EZ!?2O ?07$Q"=S&2FQKH63(X'B3:V'OL75 M]X!/N.Y]_IDV:SLX L(.&*@.N!7N.FQRNGE^(OOX[@\"5WA<+FOFV;?X+%R> MY3-+QP%^<[5P::#%'%Q'LW5XB1%^V.FN JRNLG=?\OT!B >_]T.QTV_"H0-1 MXR&!$0C9=84R@[@5]5WV\0X0^P:I$)B]PP6 LX&NX13PR<$5)&:(FN@\;S^^ MN7U_N\@^Y7!I=R[["$*F 3\D2^.GOGT\8^,GK>W'UYD?ZV6/U0I/W5@W>!% M 3EE.[@S<^TOA 9! 32^<+ %/&?.@*\\^_')\Q_)EECZ/LK'=5Y\WH$U,6+7 M%UDK,"9K]GD'H@L);7<"RO;P@+.,[5^@^#F"N8/_'1.@<+TB*MR="A2X8,]" M9(_,VY*,9($ 5_EEDP ]AB[%&H'/]&C%.#^YR((FU\H(K.?&SHDF0@$] VP.=PH$=N/-S>?%D06=!W5 MWIP?"($L3\4N[8XK5@V3!PE)4#1HH&97E\L_T6,W(#T+H(:K2]SL)[<=:E[C M=OF?*]*W'4K+&N0C+';*RC9KVCZ@F 3R1O9) 0#94]2M!ZKT&0K9"C&T/M$A MZ S$H@XDQ-PEPMYUS<=4K4 DGGI%9O=3,L)@>=@5X.W:_>RI'L[I>0\+P/_@(ZL'"XU[[\[OVJ&&XX#D M!K]52.B7H6'','#5-\ (F -=0 \ ZP WH(!T<,$;L?).:"(Y='-F,":<%@3$ M&%DW30.D YR+AE &("I__P> 4S/+F??B"6[92E%Q]NY+L2,5# _N*[)2@AEZ M^PXL25CZWT'E(W$*<,_" PD0*]:J@&"E/CUH@PIQSVX=GS<:W>J996B.HXA1 M7F#;IB3-?.=4VNC2=/W[_(07YKZ #J=[D/TV%:JZ@%\DB3&"GS'9;.2"X6ED M2C0(R4BV*+F+],N:^D;U!'@?W7=F00=*10$#/,TBNXK3O7#/P@ MHJ[QC@1#VS#=3J X4M@"_PU6!0C-%!0RYMQF U>0E0/)-80,I$[5EJOL1\"C M(*(%I'BY07R,!(%B(J!?]R9]0BZ:,$*.SD0 E$S"LX)KA>PPLRZKD6P[!BK9 M2#CNC S%MX")$=<+5C](M:2"0 LZ=)!6V<^>*/:=[ZL]X8B<6^/1_E3YS_SI MSXU0&U$($B7;%2& \!##!Q]"-8S>!W$Z:5M1O]X:=0 Z.@*92T #>AWV![$5 MD+5ROE 2>7NVI#KB\HB?;S'-: \KHEDB"E-_]7WDKGX@WW;[+?7SY?G%EDH?:T[$EV+R*L@&M@ P=@?=]'\K9Z#E /!E8+T/\=Q"(S M$L9\"C32^7H#I1UT^ M#Z0]>0'N;>]R-(])HN$S($X1"<+J&.EAWB>))9&B%GW8KT&@FS9DB3WX=*OL MKSN,!UDT#B@5$>MKH(_[A$6+5S4(DIG.Y[:>V?8L3HU/BA8UT R:((;##+/\0NAP2 M,?H<8)!4G>\7+(C!!J)@7)]@ B^0,<2!THFB,.HE4=$K0+!G5+HO%4EV0(V& M2H)M1[F>8);E33R#.IYI,#98WN1&(&KBE@2LB"RQ0Y&W#>+8V*J0C!&VP]"A M1*YXP(L"3BSR">ZJ$#.T?*_?]]^U[7#%ES1_AQC NC( M$AT)G#4=Q0^;#6KEID^",91<\$@!("LI.&>1(M:N%[ FQ\\S("F%V]ZH,7JF M[']6U&/:H0*+O5V0\2Q"A70.K*QKEFIL(J&>Q]0I>]2TS9+C%UF??U%'^S%2 M1]O4IX1"/7$W0DIVFJ6ES7?9HPK>ZO%%L%+6%"5F"UC? 4[P/8LV^^XN+]GJ M5VH\K\\ *8\JV"9:TX&Z%*JX+IA<$H7PX)>NX2P!.VBA!5DI(G%.-[%WQHZ9 MO2T*H:8*&_N@NL!3W[*29W.1_)L\.#;JY[5)3.)_^7E?B=:91J7 MI7!JU,QXD?H0OPR?+#6&$G@+@X_M$Z2.B.73 MG+%PZ"3VV9W,?:\=9;N,!@W6+R!+Y&$E$E\D[Y28YD@.Q=ZOM1PBGH-/A!_C MU8=K)5\L,OM9XT')G,'R[FNDE-U+2I83.*X=I$MP7[)':]> P=@__C;%=IZA M*B"FR%#?QD9O,"Z+7](_W@'%P,%H=TNG:C=["MK7%3R6AM"%20 DSE[2E70N M1.Q0.HD6:=!P ;1[)JBUX]BPBUL+5.:3U)#+V0)2^QGL]Z[](A0KR60BC)5Z MG1Z<6\QGD6"VYY)4+E;!7CSNF3<5]<13T<3F*0_DNQM9Y MF2,XU#N2&BG; U(J3*N&C+[>T"$_,3[) IMNB]5/O<2=#*VC$5:VP[K?#'7( M6BEZ0"D9&8+.#H43R#R3F*> BW$LC@RR RP8T_>%ODQ<,+Y \'H0(#6X+I@% MS[K*?[;0D\@14U/#D06Z&A(2BRF.)+"B*QA4420#-5,0/VPI81002(E)'VBE M:?>X0-ACA24;52-> F-)@Y],84>@73#(T/4!+N[33.:.T@]B!"=55X,=R!]9SS-5IY MI=L331*!$/G;0_\@:(&WY<$J.4A8V%PLV.KBI\>X^$">#WUC#P2+D<@*IDM- M*6!"A2>S!",)8(G4U=^)_X0UR2^I.-D^X.NH7[>X5E/F77F>PW,.2?'J6 ) MDAP,N87\"U&RILRQ5$I,=M?P>U0DWM6UY%F+X'!0*!X5(I!*Q\%8M0(6+,Z, M@75 'BIZVH0=(JZTP30EV2C1"4)-@F$9C+>)2Y4:!>502.0DWK_HS8!=$@[W M8)AQ@_;W@4PC!$C[O!A=2-HJQ/?X5+5J#$U;0G3N$ HR01JLH)'+@@K0D@K@& M>3/X8)?Y'=#Y$N5-UN1T@\&152!7V:<.C96>R>-=*"I*/HZU1B@W &=5- :X M; #AE!A$"'9&)@>84$'6 *]/G"=$:H[U5EL-?:#I\HF+51 K?\@QTV(^V-,' M;/74%,IA+#"%4N"3B0&,R:9"],M78OLI%QVP#BS$0.#ZNY[^4N@3OW8,_P:W MQ& AFA?6(49'1FMM%%K27_? JH"E88_HG72<;!H%>4JPJ&NLB-@"/Q^SWA6[ MIJW;K6:&X83!D5^$^+%RT/R:5%:D*X9:H GR.7G/)25[S%R2N $-CD8QFQF* MWDC:0O@DM9"D\Z[8">G00?9LEI (B9%X^/X]$#]0"-[D#<?A2[&YIR)K2_=_T.O2\#NZP?&-K8XM7D MJ6B2"790(.@-DY^\E-+%L[BD+/_[3S_])M\?7KQ=C @D"?@6?#'$@%P'QC%4 M+GU5,Y!(!S&PJP[P.89P2'[U*+9 'NHN1=>BRN@D5TI_-OD>S9A/ MX?0;=./=LJ;JDBDJ_D%N!?[\GW3P!QZ';!RV-LB_=N0IB=S<@H@,-SQSZLTH MU!&W\Y$@4$AA$L5&_WP(&LX'75"W&\.*C'UTPF2IA5G=7![HA1I+,2E:0='# M*45_^ZV^A[-5G09G$X'Q 5S*Y0SZ!%_^&&8&Y[T?.8"L5TR$_E0JF7#+U7 E5];%N?62K M XV:9XZVC"315!$NM*/XOL+C+X'W,2#DW,8E18@X>A(MS6OV-B4&,A6'Y1EVY.PJ94L41.O@H MX^.J%*,;&_L8]O>_ D2FB_,$L6DQ/L!%7/EYNLC1$G,88Y>2C4BZ%(;6>"$8XVYD/@W@,Y#$$ZNG+%"$P]6 "?RR KI\R]GJ1'U'82I2RZ2]18#%Y.19&<;44I_.,,^W M48>F2.A*]G0@P OOAE+B(S=>3+6,AANP<'C!',NQX/Q^]:]G4V-X*U1QS#,3-MC MV8(5V5T=I*+=L1#;U/.Z58+$$"/\,-&4E MFI9V_L2X"2T58SKLY+E*6Q)Z-6(Y>BC[SE4^I!U<6I /G(.ATX$[HLCM!W2< M#AB1I.J;4@CGKBHI JBF$I'G4F/103:#4XFO*@4)CGS*EB3838H:THXYX![3JF0>VY!J+CCI^<%%V*,X>(7;!IV;HUA!E9\<9'. >,U\ C%UP07 M@&$YK]2[,;ZPA,RKH@#H.!T8/U3-0PU.H<3==+MQY ;[>,+Q%BG# M)9Y02%4$4C(55>']*N$&#L:$+@W6RH@SSO_$$+&HGCL2K7ZM_. M@90L.>-W!$[$DT[( '5C) Z4?0B@66$;XK5XHY:&?QU;*ZR MGXF7U7 ZSTR&/<&#<1S":0@/=)$;;*L$$$#LC*O[!+!<,'8')I[$YNU#$NG' M)"![+-(2BG\HJT;I)K2"JO! I3*A4&KV"(!F@F^TI9^HG1'+FX:">=3H=?@7 MY\XE-87X(3S,]N(@!A FQ8=V\'5(1$H$(*UWT>,3A+/%+=2_J@6^^'CG">11 MC0I8<=08=N?"FA8!:->B84GT%*@[I.'[TR1 V%/UX/Q]4BBJK>_&[J(]6\R< M1R#/K&<*.!_6@.(-Y!5U*G"H$XA5*V?,\D='H0D%^&W<+G]MNP>8C=48U M[;DSF*,;:&C706G]&X#FTAOR(!%8M>B,YI@4(1.;Y%$6I:IEMLY@5KFHGZ?V M0J,U:B WA28CU:6(CD1F[_ *1:0[TZ80K(>H5V,$+!HI M3R_!2SYY*QAH=:G<924KDE.422C'GY.Q(QM@)-3!C*S05U"UP7H)A60T17/R MZ!<3[4.MTJZ4];$P$Q._:/&6E:J@LG42JDIK '.;EF]H!H5H-"L1I-P$<:8- M-UB2AUF+)5A@!W9XQS),J9WA_:4")6K<1]>C M1VU??FL*8F,5#JT$;SY]G%87)GT_9-? 0\\>4P5&"%E,G@FE50_=EVK\GC\V MO0>)#+8WB-DZOZ%8\IGU5]F;,_9Q=J@'/R;K/B1VV!Y/,+&;[;-4AVX%>G #=?Z &G[;XG(&5*<*.34=N0'.: MH#XC&<>PZJ4'(3R]=DT-FUH_MH3)@%>^#0I:HG2),RDA+8[\)';EI)DU1'8V M6O; E&6*@HLZK_84"+4#&\8=?&K/B3W=15N[1]+".@:J10G'D?H\"@G&"*O6 M\R55++5OC> .,J(YW:.DC6$"[AH),=(TVB<6/9)OL#S(E& S(C",+?BMO.D3 MH*@(*UY)$$@"@DD(/XR;D &GGM3CP_^@X41\HVMAR6 M!3'T.HZ]P09A;2[.*K+V+B+&;5KG'V M[9+*_B'W,&EMUW;7:>$R.YW6R\3SJD%([<+:BT0A0C2DN:(R2YOR,]OB*/$A M)1-:?MMAZ 8PCUEU#*M8"38'M0QVH,*7CF. '/RBP'8@I#%"L6-(C"]U!XD^ M^OR+(R,C\>68GD-='ITQ,0=:)?UHP]@"7354$D5'J*7]5MD[E!AX6\#42&WM MOO*L"M6^B0-<_%2U@,5BRHKG59N1#B8(9MHMQ8\>TU'QTR9Q4$YHH0MN^5.AJ.\)"0[I*;G>N,PTUX[3J M8]3))XPEM8:C+N[9DBE)TXN8L6#.E70G#?98FT9OCV W+'D_(..XFFU%^>KF MBX!'5.Y6/$Z6%?'8$KF&L.)8:"6JJ34A-])UH_D1,RK/CB/A2[>SH5@#A9I0 MT6LD>-')R3EMDLQEF]DC]/7'^.%LR&NLV?\!,D#P-%>@4IEI,IB!8DJC#G=C M3 6@$IN.(UJNKI=J0\S+LZH[1TW:J7+/Y:16Y!3]*"-]^X_B1NV\$3;8/&5T MI$KGO2ER5*0#N,X/ ML;R33%U9B?I(DR5\V,PZ;8[G7TQD3F04_'3;Y7N+0E,&CN*_I]R KWAY!>=3:HN"%#9I@;0$=R6!$I1G(RBDG#39Q]*] MH2 N>,+D#L/S(3#;';"I Z8-',E-Y$V&I8#.YHF=0R-H#0+CR<_ MVF%U6A[:(SE@&I9"!W?H"J=H,F%;T%/OOKABH #_ M1^PB1D-Z;LDS#X?JA'E4BDR66I>QJ,3HR"3DQ.?GUD6+ 6WKPCKOV MW!A.< M,6M,$WSH7@^%&](E$-B0VX4H"M+2=SM7ERJ'B!:HY<), HH(UKX]Z@,##3!R M-&3HG=#F&J=<3U4'I5)KE #3^7LF%8+>ADH1C*7 ,\Y (J>1(,&20U1O;)> M19-XASY4'I%IN3_4[P8T+6G,KH3BR334(G%MQU??X)M:M1/V M*=%2Z+4Z(J).DZP!A2*7,51HFBG>FL84GDD39D7,S"G@#>,;9V3&J.9=PI=) MK!KNJMN&5/%\HXPB/$_&J5 DBN+?K41[$_>)A@:SHQ[S2$@2OV M%$Z?&2C= M?7;7T#,0R_CM@6R\#66CZU#-<^"ID9@X!T0U(D2GGW$CN=3VGD8AA)1-L3PT M;7/)6)RI)S4NOP#G>&P0U=1?R&ZH5;_*7F,9:>B- W^/S1D9(L!)BHV$\'B0 M(?=M/^2***Q'<5I9#JT;GGF;D\?-'<2GR1"7M/0"_-J<\V/I6C'*I[4,,BWW M074,M#E.+)W.MM*:C2T(URW-/N,M"=GKN;-,1;GS?WM25 MI?5Y(T5HV# VV,2,!QUJEI>GPY;6:4H.QUF>=(9_4J;%+-R47I5.B&Q)O2%( MWRHXS:%8WXP>8)ZA="U1-:\&_&&C5K;_5^LM3.OQE 6R1W]LX5*OGC]>91\< M]@;,.D4U?Q4]0%!W;EH1C*,\U,Z*4$TYT?7,T'1F)J-J.PA PVD(G3 M*%#H=9K U>!H\9G6]*!Y]>$8?=:IH#;0$P9:B+.!TT/D+*2NN,J6$O4=YP/Z MHP/L*5MQ&T0ZF(ZH;]ENEH-W&M!+0G,((5=P)A8ZKQ".;MKI="=CBF#J#D\?5%3!F39 WAJ.W1[Y]R9Z M4P12X<\3%%@T*\,@A^9S QRZHE\9D'R"C!;#0\H$'1&92K0'.%$N9 0=A M+,ZL^>R^H)[UFL9OQ%1EE$YO[!Q6U8N,%#2^#BI>X>%C]'HH+N4A=.AO(8-6 MY?@:]GGI9&P#OL[?!J_32V@S+]OP38.?K_Z5Q=5T-"LM&J9- MQ8F!Q)I&F%!WLN#3S!4LE3FH%X!(U0PIIS(_FM*D7DG]DD7%H$G;.J@?4;Y(GNT?CQNT-$;]:F0E>E47-M& M15O%XWERI/B&PJ=+X0O7CVWJ>U>!PI'.K$D1DF',.'F(Q%S2?-J/^&PIC2;) MG#1[4_03'*Q)-^#2M+$<3X?E3M4/S:>FZ.,O0ZD!5%NKM1#^UYD@G $C026T M.$NGG-R._4;F:+WX<&3PCIN4,ML+MJ2(J(:_DA"5SEN:;W3B'\68;TBB@:YS M+E1]_C!1ES-K4J5ZBDMLML3P;XZ_.],V>HEBW\0&Z/!:TA:="A8,%J8)(OQ; MSS,^SOM-FNL(Q\Z[H,Y20N%.6SO_\4R+T5F4J-R1ODT3V4L+PZA*9QTD,Z4" M*'*]D5$L88E%##N.FZ54K\^ (8*DY]CY*OLD/_J'>W!2_JUD E[S- RLVJFD M\L7.4/WSS@SY.9A55.RQZ:EY!9FM85W]L&PR$&14A&9DM1V,@XJ1LAUQ2IGH M6?VI"!JM,]["5M",YJ_.3K!@T]R ;]X_,\^"WJMUZB7-B9*+"@VH]X&UF$J- M18SW$>.2'.RD9%J2NI@DB)LRR4P?]GF=4\:UZ((1A-M1&XRM)S2#AU:6 !1> MF;YKF%RM0#+.='WM@PBW-6LKWHL/Q!^YA'^F6BXKTD*.D867CAE$1X5ZCA7? ML8$UFE!!T%-9:3HCW:RD;3H4E=5W%NPI$8W2=NGI)9*$ P^1M3ES.*IZ&%5H MAI\$T%!;&T?"CB?!=J'_VY4L*"MLFT@A,H),>(':(QJI15C)[R/H.,8) F,B M-YS-IT^0>4G;GT)2AQ/L7.U %5FARCKV_XY09P+77 'U=HQ:JCL,I5UQQ)9/ M9FS%7)8.J5SG_GP'YCGD2F5S.JDO]F/3\,LPOQW_JO.C& 7Z&/=GY07-F?W+ M[+#5T41N*5VUF%$ N2D^6!K4MY^7,9UJ#"CJ*:=!?"?V(E%=2*DPX4-8*S0; M\7!<MH= MI((M9M;CJ+LOV;9NU]BK2*-2]1?!1#_IH%)*K,=!JW9*J@PF'2LH&2V((6D? MNGR4$)"RKR]?S!$!?77U0O2I!\+F9CA6I/C3([&I#PQ'FJ:>?R'39NAW;4>S M[VZ^!FQ*5K'.<:-%&;8=Y_GEOXQF1O*4W0!VX!6"ES;@4:@7G H"U.4M%?-9!.3WDOZC(U M6A'*R<\3F6@^_QA*#V9>VZ&MD0IL?IWG*-+TDB2YS&V9;+[;N: XG$6JA>9D M1$@RC<^(=&WJ'6A$!1/LG9/!F%MNRG1H2(2?JPD#&)#N[:AH#?>B0IW9;@ZX M9,Y"9X)-\VFT419-M:ID[^+@CPA2.LE4C6:VH6E.5/C)KNMK"@+\CDU,L*>R M-X,HP7]OUQY_Z"94JN&W]#<&7$2=<>[HY]7M2E4?<0HL^?MQ[+JD*G;[XXT\ ML2/\0C@5PSLXS8\L*\U\M@_MD8R]4BV_,T-!!$09LL\(0KMT17#$G^>351Y] M ,_H\>@[(>A'-7U'J QE4*G=(B4:C^*$NL>C^5S4E'U2Y@@@L>DR_NU%=HYD MZ,MTG#F]A//-*.F020&/EDT7]YU!?X\@1/G-$'L^@RDCL T^>+)DK05]Q((W M!C7N_:&QZ0^"X=$B!*FK=)][Q;0_]AZI*&B5?0 6WII?NZ9B4),>_D"S B0< M.AIY&+.T5O940>^7W*'@<2(OSKA-M^)[XUD$>T8-_ M4B+^[-<9,"@PJ3\Q0;C!.1GZT\J,K/M^5P)GK%/.\CW.YP;[](^@WO\WP'R# M<5< Q/X&6-1ZQB^CK^7-D/-[>O>=(WO'C[,RRVHF^7ER#)W[1E MC-*^WY,QQ"LM\4=OFS(,"OK)[>$[^$]0Q*&1@5)&<$L#GBK93-^P1:Y :>"C(]OO M]-/EH?H5[B,^&ED32)Y+F0,^B/FHC"4@A60"M:U1Z7KZ T7,&3S;S9@W@/CG MB]"C#%_"OC_KCW"_U*[ /Y6^:N7>P=B\8VK:_K%OJ;__N+JPGR* M5/W]Q^>7W T5?_HVP,NB:*R M;_?TSYT#NZ?#!^#[3=OV^@=N@+]93N"]^B]02P,$% @ \H!761\(4J1T M! D@L !D !X;"]W;W)K&ULO59M;]LX#/XK MA'<86L!-7-MI7I8$Z,N&#;@5Q7IW^W"X#XK-Q$)MRY/DIOGW1\HO37%-NGVY M+XDDDH\>4B3-^5;I!Y,A6G@J\M(LO,S::C87-ZX5V>SZYBUG<*?TG $3PAP3RPB"_A[Q&O.<@8C&CQ;3ZZ]DP_UUA_[)^4Z^K(3!:Y5_ MEZG-%M[$@Q37HL[M-[7]C*T_(\9+5&[<+VP;W2CP(*F-545K3 P*63;_XJF- MPY[!Y)!!V!J$CG=SD6-Y(ZQ8SK7:@F9M0N.%<]59$SE9\J/<6TU2279V>4OO M_J5,5(%P\KLRYA3N4,-])C3.AY8N8+5ATH)=-6#A ; I?%6ES0Q\+%-,7]H/ MB5C/+NS8785' >^Q&D 4^! &87P$+^J]C1Q>= #OH]"E+#?FV4GX^W)EK*;D M^.P"5I' L, 'I>'CW;T/TD B\J3.A<445CM(Y:-,21M*PLT)CP]M MAK!UM8'IF7A$3:4.95VL"%"M@2XOJ#@=M 'J&L:*TH%0PW'&=+-4J4]U83.2 MDP5UA)1P7%6S5H=A5?( ^*.6CR+'DGH5W,B\9G+$U]%5157_#V2!3M_"2ID: M-:2#[(_AIVA14S<@5VK#4-6Z4H8YKTEU[^$H MA'Y[M:IX9QQW=&%GT16P>H(?P9B"U7F.Y!EDM?4%&CA MR.X1Z*/1/M0V0Z!Z3=V;GZX+UX 2MHV"8:QM)I/,(5[3XXIR!YF@J_M7 M]7\BT$P2GUI^:ZV*-Q@.X \.MUCE2 &@SQJXDF(H9^BRK#=1E-_4DX=?FAB,HG]8!S#Y-P/XRE,(C\*(I@$?C0=-95[]-5: MJ(/_OTRJ>YYCM/I@]3&=M9V28A,,IDV0@D'<1"X<#IQ1G@ORB%/JD/!I'[RGZ?<1IG/.90W+9"AJ4DK6F-O':!WBX-R=1_F_<-,B?!2J*9F3J3_N!\[*9LY[5 MFVGUJ] ;2=TRQS69!H/QR /=3(#-QJK*35TK96F&<\N,AF;4K$#RM:(@MAN^ MH!_#E_\"4$L#!!0 ( /* 5UDE!3GES H $P< 9 >&PO=V]R:W-H M965T;'OG:D<]E4%L?CDY.+XU*; M:G#Y1NY]=9=O;!,*4]%7IWQ3EMJMKZBPJ[>#TT%[XUJXDY*;DBIO;*4OK\YYO2SXW=#*]WXKMF1J[2U??,S?#DY8 M(2HH"RQ!X\^2KJDH6!#4^)YD#KHC>6/_=RO]@]@.6Z;:T[4M_C!Y6+P=O!RH MG&:Z*<*O=O5G2O8\9WF9+;S\7ZW2VI.!RAH?;)DV0X/25/&OODM^>,R&<=HP M%KWC0:+E.QWTY1MG5\KQ:DCC'V*J[(9RIN*@W 2'IP;[PN55XW''>W5MRZFI M-+O*OSD.$,T+CK,DYBJ*&1\0\TI]LE58>/6^RBG?WG\,E3J]QJU>5^,'!=Y0 M/5)G)T,U/AF?/R#OK+/S3.2=_0]V#M7$>^!^DGUOC#?QEJYR]8LU55"_4Q4: M1RI&GR'T]\G4!P<@_6.?AZ("Y_L5X.1Z[6N=T=L!LL>36]+@\LLH6B6 MA.%V S!'E0J]\JPI_[[6ZQ(2/WIHG_NAJAOG&PV38.)J8;(%#BQM-5<6JWF[ MJ>9>[/7-]%]@(U[(@N":,CZ LKF)SN8]9&=])VIV1,Z[-",5D-QQ15\#K7S0 MH0G6K569_/HX.W#[9J'=;>O_FV8*2V"2+8KU,[NJ2"SP)C>@;XE;JV**$)LB MD=X-P+[X^<8MS1*^$66BJDK[1YXXVA5G>&?M[-*PK5CZ>?+YG9H5VB_8O<%! M)CFO4,>4MX7)Q4^DJX"-L;M[Y2 Q 11X6A)9;"*A,0OVEAYBDWX>RL ML)[4E#+=>-K&'LJTQZJA>F*>JHQ<0)7> EO HW8.Z6(X[IE= M4H6+%'G=FNL/^D%4FNLE*6>@:$IFQ^6_2ZU$,ORLQ4*4_\0LG[)D?HJ8,KGQ MA@_&^:#>WP7B^JF^- &@)_6.H<>>JC4J5?(W[.0H:.0XUZ5,(UG ;VEKPL&^ M:.-JXK !4;IH-7U,E"W#T# M8])V'+]V8BK(PO"B5Z7M$'G M3CO*V%$]1Z(O*5G>XW\ABPP(DO)RG_W!!QDPD!LO7) /(T9-S!Q4!Q2T($S; MP^-A:I+-N]EEFX+!Q?43"S.Q%LYV4Q-BY67AGNA6Y;H$4X)IG2W[5B!;>-?V M[3\A6B#F.2-7$I8.0D5<^"4+=HJ[SP^X<&8*X9//XC$6->FI*'6(9=] $PVO MD/K('4K$!K-/;_$USL0"42^6J2UF3NKNIWB4)X 32I Z?2XUI[1"D[.NF<0_ M",:9N Y>S9HF?^P'#DU0?MYE9=Z>IVJ#Z/)B.IC?IDP0>[1*"M%4@E'6&RT2%6 M7[8$A+PTMO% +<;+G)<]J=#R;BKGT[8E$$+2A;?]LMK4#+C'>&CR*#KHM!T* M2\8\C0#K\WFLQMOLA#^[SL&)0-^MH)T$A$>G+T=GF-^* H>.^A,'/VW%_TVZ M"ETUW.VQY$:N.,RE?(%/4#1, */7HU>MK:R.S/T8",DFM)YGJ:L MC<5HK+);-'R,(' $*7#@W' G 54=901&1+CYZF@\NMB2NW5\WG2U.+7)>>>. M5,S6 L=4&&L<:*N*"O13W)5S&ZBF:W1U%;7./Q_U- 7_+TCGWQ&==JCA:".% MD=I#V([ M$AZ2/BN^14&-\A' VCBUU$4C<*O;X-6.67#;4;TY8F/<$ZE;R$B>!9Z^5N_( M9\[4LF%2V@;0^;#_B"WAKS%5H.$^4J^&+\?G; ;7'::?;1V>G#Y5X^'%R8GZ M9E%J=Q4^4J?CX3D$_'/W/]GY[9[!V:&#$#1^:9,SW>JZ+M;MP,'O*W@&<@7* MEBF;(JXO"5Z0W 95H94"#8#EN?T6$HU=S1*.AZL.GRJ=G4_EN@1)) *"D_=# M&402"?(A%/_XP\OQZ8N?]J(Y$1AJ= MCXAY'S8WR(/T0RTMNU2&:E:)FQ.!$:=&[+9"#K\8+AOD5O;MY/?]VU5+NU9:N M),@=PC) M]5)F^>V)#X8'JZY<;B6?>(S?I/D-9F,?2=V;%2-T"-+B0*RW2EI"5U\5Z,WD M5JQ;I'G.F)-^QE285R/1LLZ]8]+;AJ/3T^TJ-+WZN2=DUJ^_Z<6(RJT,QK:+TG(:')2T3$"9HQ6VA.Q:XJM_<8KW:C9;ZD<\:>$=HMXQ3KAJ4T[ M\%"^_,3)BQUX5JR'!]!ZD+BYP>/]D3$XB+&&\_RTZ1;WU[Z1>I_21.SLG9KL M \%U.((UI;Y%&4+8#9#1:[>#SEMUX!Q#AM8E>P M">=N$>DBN0E6/S>[Z*>$> #:NL_,&Y.ZZC2%'3U;6H*0)D)>.6&*K+41Z .* MH4ATTUHWM/'HHBDCD;Z+8[I' M([CO<\!Q[PN/S$77,G((4./'GNYN]ZEL$K\0;9;'[VR?,*88.*F@&;:>C%X\ M'\275^U%L+5\+YK:$&PI/[GO)<<+\'QF,=:F"SZ@^X!X^1]02P,$% @ M\H!761F>>*"O!P EA4 !D !X;"]W;W)K&UL MK5CO;]LX$OU7"*^Q2 '5MB0[MMLD0)IV<7OH[A7-WNV'PWV@)3IF5Q*U)!7' M]]??&Y*29==Q6MP"AB7QQW#FS9M'2E=;I?\P&R$L>RJ+REP/-M;6;\9CDVU$ MRQJ;7@N9M4%N-D,KD36F\&_ O*;:F=\\HDI52?]##S_GU8$(.B4)DEBQP7![%G2@*,@0W M_@PV!]V2-+%_WUK_R<6.6%;+ 8L%VO>%/:SVOY-A'AF9"]3 MA7'_;.O'3C$X:XQ599@,#TI9^2M_"CCT)BPFSTQ(PH3$^>T7Y><-7@OZA%+)Q%+)LGTC+VT M"S1U]M)O"I17.?LL"FY%W@8MA6'_OEUA%)CRGU,(^ 6FIQ>@ZGEC:IZ)ZP'* MPPC]* 8W/_X07T[>GG%_VKD_/6?]._)TULYI+T\;9S]I53*+$F16N6O$[$:P M.U76O-HQ7M=:/0(U E.6=2%0K-:@5/O6ZH)7&((?=:!6F%HS65FA*UY0DVIT M)A@OY$-%\YVU3!G+#'\D Z7@IL&X$;MOLLU)ZR7?P616-#E<%1IEPBWU"CBE M=D*8B#WRS+=E0EMH%2M@%LE?\TP6+OF17YE7&22".\F IQE8383 \H]N,N,,,MP0-L!LMA'/F6P(_]B5K-)Q@P^1RM("D%04Y(ZLC"$Z!=,ZYB&TW M$OSH4![&\]&D;S_;%R%/<7,^)1:#(4 NE;$$_84DW+N.%D-.]FKJGDQ)-T5-US M<\3>>U0(@9W@.H#]7F0!Z]AAG1YB+:C,''V>89AK!H#B>2:DI\ V'16^GP"9 M(JD@'"IEY5IFOM:<*V7(-5^O@3M!U58P87W6(P]FCUWI:/8"NZ) %FH8QLM# M-NX3V$]=F =X.';GLB&A>"1]M! SN#BM]@[^$5"K5 $>.O M#?F,)_MXOT>(6A,O^=3Z[X?".=M8I7<]AU:B$FNYU\$O0-?D,DQ'HZ])IQE! MEP^2N@4]V\=\Q'[KY)+M^U_A**8ZK^'QDG9">Z'5E37O; MD\2I3R 9P[2G)'!H.-L_=[IC@LL>K0"= ZZ#*V_$(9):_-E('?;-OP+#B':& M+=2+KJ=TY!F(VZ(\J$G7LU](BP>N\U:%GD6/H%W#RT+^U\M*)S7D3\\9MMHY M2^ I04X&O7_(KD/>[[^47+OA]E#9CMCAJ]]A),O@HA9JC7:@8YH5Z3B-YJQJ M7#5X[6[*>D\([ :-9Q>.*?Y4D4LHD3Z$C=IY85I>*EJJVUR@#!DW&Z_Q("R= M7 A4YNJTLL7.[3R$JLMCH 0H4K5QDGV5.#YBM^ )D3$0 MT$<"'ZJ#UC7;2+R':+"BH/2AC4+PPA!(6W/-'S2O(3M\A4.A@QWK;<&8UP7> MR2@G/:-[X>TU.EWJB64 _,_!45D<^WPFO$XNZ$21T;;2DJ@] M O^EJO9B#7F6KU6!TZ1SDZ\*1$]O"9Z;PK]#TZO!T19RXFS1T\7N2/;U-AP" M#BP"K8PJ9.Y,'U)005 ]X&_@)AT_^^^;1[O+:'&9LH_T;K'?J4.0 ME_,I<[Q(WK(TNDP6;)JP?[B:B^?19#K#"+J;+^%7FI+9RVB!84,VF]+?)$J3 MU"^>+LXG"[*!KM>!^NU)XIB]!:J>GA-V]]!_RG:K'CA]EKW2002T"7R?I_(#^WR/E'MAX"[ MD"B?D]_Z(%A^[R+BCY5<'<*1G'J4+NEXD1(UE,G&\2"?Q\1MD6"Z0QU,B MY#_D^HZVDIKO?!E< //I#%8OXCG]+^,9_K'R+%V^8K^JZK7;>OHJPO,OC;%^ M^A+TNDBC:;Q\Y:Z32UQGT6*V^#JN$_4"+DXF+)VQ>!JERX0E<90D_(SKR[GOKN,NY] M*RL%@*(O@K2C-97UG\VZUNZCXZW_UK8?[K]8_@*<)62W$&M,Q6O<;,"T_PKH M'ZRJW9>WE;)6E>YV(SC>/FD ^M<*6TMXH 6Z3[$W_P-02P,$% @ \H!7 M64B:WW>A" ^!8 !D !X;"]W;W)K&ULK5AK MC]LV%OTKA!L48T"U];(>DYD!G,FV#;!-@R2[_;#8#[1$VVPET2&I<69_?<^E M)+_&GJ39 H.QQ,?E?9Y[J)NMTG^8M1"6?:ZKQMR.UM9NKJ=34ZQ%SIKJ:A[R?3FLMF='?CQM[INQO5VDHVXIUFIJUKKA]? MB4IM;T?!:!AX+U=K2P/3NYL-7XD/POYK\T[C;;J34LI:-$:JAFFQO!W-@^M7 M,:UW"_XMQ=8PWA$[O[B"GY6MN^=V-5ENF:36D MT8,SU>V&]-8WJSDHA)L;HRPYF9J<0:M MG!:]O%>=O/""O)S]HAJ[-NP?32G*X_U3Z+93,!P4?!4^*_"#V$Q8Y'LL],/X M&7G1SN#(R8N^R6#V6IJB4J;5@OUGOC!6(VW^>\X-W2GQ^5.HE*[-AA?B=H1: M,4(_B-'=]]\%B?_R&1OBG0WQ<]*_(6C/RCNO[1<K]/2",.66M7,K@4* M[E,KC73%5PN[5B532XP6JFVL;%8,D,(6K8$RQK!"U0O9<%IMW)%:.%T:G$72 MQ.>"ED$"O6U:7:Q1C&RC92&8>A#:C2^YU.R!5ZT85C8 -MZI3%(5QC23)>3* MI>1DD-S;-BPDS;4H)^SCD4QW/ E\L@&2+XN!9X2#CI*U&S@#=E42M0P0='(/ MC":-[U6]X5]4CU*%]JA'L47!]/G0ECA[WGE 50)Q" M9YWGC@+4G6Y8?W3!M7ZDI;RF>)/G5D.F4.!=%)U*M*64!8XIK]E;9,,1A# M@!7U E$;4(#^1>S*':1: Z^8,7LE5K)IZ, %KWB#I'C!HB#S9EE&3W[BI5'. MYGO##+MZ"U>P:,R-/DYD!35'"@_^FI97>TLE MEDCM_$])88Q[A%=_+:QR-@7&,L&+M8N QZ@4(DN74LPZW%G2H=B%X MDNY.#,I&:5=>;2.MQ[9KB=&#O&*H&_0M*S12$/Y% BQ$5V)TXB.3%DUSZ;D\ MHI?34'J(5U&USD>#H1/V9GDI[/Q$)U?*@L(.V7L+//+?@;^ PEABL+E0NJ1B MG!LGRZ#A#M5]6BMG_>VQ1IT-R99WXE>-_!^5J:OO?61(!4 ;L6PK1AJ8ZW->?BV*?J3/#_:;8W[8^Y.FE+T?*F#>5<"\*-JZ MK9ST>7>X"P9[BT9RNOAO$'&"B_]$?VRH]5A1K!M5J=4C2R<^L R9DLU2/%R% M7I"&8QH*O"2;T8/O!5%$0ET6S,XM1+0H"HYB6N&+A^=+V/7EG#:Z16,@E9$'N9[T.# MV(LRB(L!S0=C89J,V0P1N778X MGGA1G(Y9"%B/V#MN73\C!\5>FF%%GF 6G@JB822>D0E>%,Z@9@#/Q%GDQ3FU MAZLXG'DQ[7C!9IGG1VXZS;TTC=TTVE 0QS2=DB_\+Q4)/XRV^+RA4%(UJ$*Z M;' 8_7S5#,DO38_;;E$'UO"5JF3I1!DT&\<4'$H@PGK@):;7$ 7Q<:W%L_WY MZ_OWQ4Y^\GJO.A EW@6\%4WK6K*7QI2HU)C)R0'B&^>4N:D7I2%[#Q#EFFH> MF55V.>LP;^CUI[\A%*U C%<>6XD&QG?$EY?HDI+N :X3S_* )4B4P$4T1#)1 M)2$9H@2_N1=&%.<@1W90]82YER3Q<GK^9U/6% R_[<'.0L'G?FPWBD -G M4&(HQE]="RBEV2C#*[.+\U6:Y./CB%QU\4+F=?$:LS?'- 2 !!P,HY26 ^S M\5..N"OW+/22.#IBB%JL@-ZZ>NP)@[E$E8A:5*I9]:[L\^& XI=T*:+:=U\T M*#\/#/&H5+>"KF+="4.(#IN:UXGIZ1_QD>Y&=(F2U/P1P(,*@$1.E$EK3DRE M_!VPVV4>73T&6X9[TJ6>"BIQD>7U-,Q1)%(?%YV!HA#T%21KV5JZF[=0U[B+ M),:H2 IN (0$4B2M(E8 ?2]>15PFDW[$_675O>ZYSXX)[ZB?(_3]7NN0ET+^-630.]54CC,V)129#3<\("C -$\0QV!>(6I?2[#Y&YT]UEWWGW-W"_OO@G_PC4: M -7S$EO]23H;,=U]9^U>K-JX;YL+9<$!W>-:@$9J6H#YI<(5OW^A W8?N^_^ M!%!+ P04 " #R@%=9EN7P&@X) 6&0 &0 'AL+W=O[Z9H<\WUGWRI5)!?*DKXR\F M90C-V6SF\U+5TD]MHPR^K*VK9<"KNYGYQBE9\*&ZFBWG\Y-9+;697)[SV@=W M>6[;4&FC/CCAV[J6;GNE*KNYF"PFW<)'?5,&6IA=GC?R1EVK\$OSP>%MUE,I M=*V,U]8(I]87D]>+LZMCVL\;?M5JXT?/@C196?N)7MX5%Y,Y":0JE0>B(/%S MJ]ZHJB)"$.-SHCGI6=+!\7-'_7O6';JLI%=O;/4/783R8G(Z$85:R[8*'^WF MSRKI\QW1RVWE^5^QB7N/CB[( MB*5\*X.\/'=V(QSM!C5Z8%7Y-(33AIQR'1R^:IP+E]]K(TVN927>&1]<"WL' M?SX+($T;9GDB0>2G>6Q-*+_YD"E7,;VC?7I*[<2OLFJ5>*M]7EG?.N7%OUZOH#5"X]^[=(XD MCW>3I'0Y\XW,U<4$^>"5NU63RV^_69S,7STB\'$O\/%CU)_NF*\@(_Y>*I'; MNK%>K&V%9+7GXF1%>&@H.J58&7" )7.HRJU;;S%H21'OH(T50;0L*F#; 4[_3QW3^@<4RQ+MO.$A5M9TF.-J#!T.Z M219V!_ 0\X?@P]CE;1Z3CRRU$S!D_KG5 PYV/ODGQ>^/TK1H51*8)6!ZLKP0 MH/=L0=+++HYVNOA_T)44'#!UVT5S]0*]:+(HKM:P\A*1P '*I<^(*8"]:5 T!'U M'Y3%082DN$*9-1JH7-LH PPGG/:?GAO5 J&K 4$SLE5/5P)KX1P&H)0[^VPX M\MY@JDSH-6L(Q$:D9U%X6,EIU#^!4AOQ;J^UP+PK" =+& LI9E==*$5-HW%L M96^V*5%K:= ZD]"]?SM0,A1RZ+6;F-A?J^O.L-B@+I7@E%Q>G7?:< MCANK]T,E]%0==^#=E:P@+=?.5'\_1(B^UC<&:).CM;CS_#5]V-!^<2@L7]UY MBM\>$?LA'H^D?OCQ_ZL'M8_[].A;2VYRN:;Q@(KZFIK&KIGJ"^UN_$9__#-2 MY\XDM,M[NSKCO=)?J1MM#$FU2N8;]%EF+X\7XO50OSS#;-] =UHN,XSHXD.7 MC=WRP3)[,9\?@D#N5)>Y?003I<71J5@>OR15[DO0->8G+^?B/[O^, '8U0/R M2@G5^@SHR.PJSLH'7?/2$VL,M8ETT)#EZVAYM<_RE*)L_8VBIA:DNVI9%'T# M\$@!?BCODYL'AN-=AO94O_;QY'(+45E>,TPAOA\P4N>7=7U?-O2 1[N;OZY] M5'[OV#?]0V8%>NT<,A&&XF,WUR#I1V!!UJ1OK>,IY(H;T6O4\#\VU5$W[$8< MXGC7M$Y SGZ6YJTL(CNI[\^XDH$K YI MH#34 M^">+5]7BI,DEB.2 38OS,N7O(\? M%,2%&B0!]]#4\E \TL=,&!72,$L="'4D3Q(XZUM "ZMT4U=&X1K-B3H>6QH* MX+:;]J@TAF2^6&%+ARP%),IMYYY0+/(E6*!XO_!&'H_%"IK M;J*C"K4*U&32;#<.@S%T&C:PT\:.>\?H= ?#=Q-Z]"[T6S+L'J* M]O]=U_?T)AMDZCS+R?6PS'$BWW.+'!PC!L=PN_%LL9B>=CU3EMJN2 -&X7XM M]4NA=.H)F3J>.@NKHNU*>:LBFJ5&!_FAOBB7:X"W'Y5?;=:P$&$W;$28Y2S: MF%M%E[P0+,E-/BUET<4/87E"D['BEC(.<[#J:> M2^=X0(G!0UWV$$HT$>"XO7=-T1=$5DG#O=+=#PJB[3&H]$8EGQ?T0L-D=.0@ M%@+0^PZJ:^5N^$8>@S*%2KRV[E?[2__7\:Y[V![_Q^"]=&B.@ AJC:/SZ8OO)ACU M^!8^O@3;\,WWRH9@:WXL$2?*T09\7UND='HA!OU_A5S^%U!+ P04 " #R M@%=9-3<\4L4( $%@ &0 'AL+W=O_-2@C+GM9U8RY&*VLW9Y.)J59BS+UO4D#L-\LN:R&5V>N[%;?7FN6EO+1MQJ9MKU MFNOMM:C5X\4H&NT&OLCERM+ Y/)\PY?B3MC?-[<:OR:]E+EC MJ^CL.J7Y;L*_I7@T@W=&ELR4NJ#R(&U'7) AJ_-G) M'/5;TL+A^T[Z1V<[;)EQ(VY4_8>7.:GR56& #\)R69OSB85HFC"I.C'7 M7DS\BIB2_:(:NS+L7\U\T^LZ?E/@G=B,61(&+ [C] UY26]G MXN0EWV3G%U%S*^;L@S15K4RKA6'_N9H9JX&2_QXSWTM/CTNGS#DS&UZ)BQ%2 MPPC]($:7/_X0Y>%/;^B>]KJG;TG_]AC]#3'LAIM5P"K\9^+/5C[P6C36,-[, MD7-PB*S(4>Y[I9"+QC*U8'8EV$+52&G9+,\8HF7%>B9T'S+(K[J1R(TD[$0V M6*=: ]GFU&WLMGFQ]SL6I4603G-Z*Z9!7!106FG[W@J]?J%6628L"L(L8I]5 MLSP^!]M'4_9565Z[@6^TF#0I@[2,G29%D&0YNS+D@",6DX 75G<;';53-E7= M(EW86C5BBZS6]PC,HH5[: N^V6CU),$\HMZR=U&8C!-00%T[-H/ =]-B'.U& M E)^(QS)U=OQ=ZM)$;U1ZPUOMFS%7[KBB$+C\%"=Z'5MOD*Z$R/-4#(0 5 U M'4,_2KMBRY9KWEB!C$3)8970P&G#Y'H# +!Y:Z7PL5*+A02::P%.-F/VJ7F M4Y7>[F!J_B&<_H&J\EXV[V%[)0RA,TN#,BSQDH=!DA?LHVPD&'C.EDHA=&D4 M1%G*DC+(TA"SRCP(\X1>2JPKV*U&2=5VZZP@/&Q0Y&S &@3_#=U_-V+1UNRS M7(B_9=>T?3%[EA76); MQ3AKE!587 EPWJP6/L,Y.L#-II90AU0&L>TW=\+WZNZIB5B]RPI0R NYV!2_ M&[%45E*( V>%RR"I4;*0H?A08\Z&;QTX(0J$U=M(Q#1O!9MM.]NZ-,J\)-XT M[7"YZ=9/^_5(:;857#,".$GR2T"4T +M\@(6'$I?:+6F+7*"BVJ7Y$^*#V6 MI+#9%;<] 0XR#!Q8[\!JN5X*:_K@;[14 T76P@(MK0:#?#LP83(CMB7Y'0\] M502O7%""U M\/(VUK]V]OC=]U+>#@U9U#<6\+D/PC,=#&GV7>W!(0/<:O$@45GJ;? \)^(! MD_0YX?+S("D.,@%JTC3C-=AG0SQ%'U-5NA548:C:(Y2VZQ9JR6<(IGVCX/LS M'Z:+_CDVC("^H8$91$L33E-VL""==O,%_ M'=I<%-&6P/ T1DF)618&(;K)+QC5!H2"&2V"Q7'.I99K!A :E)T,4N-3]N,/ M11S%/[';G8-/,I3H E].RBB8QLDIV7*H6YJBZ!*E:K8D[=MZ@+O.?/>_L-H??5XVJU7*+ MS2I'C;WEU(+E:(CH62!X>_"K!3@)9L'^!?7&*?HGM#MHP_*]60V@*H0C^V=- M6:4H/]!+Y1&+T4I%_2+7C6.6KQ% 7AZ%#">=<#!%;7D-?*1A@I8W&9[%7/=] MX+0RF)8E_D?H#W<"_#T&>1FY(:$(] XS:C>119^:"M_ M$\#**9QQ#+\W?0K MD;IT.#_8*\K10@99.>UW4K-:+GT1(3CL-O;UT4.?S_^'4>_O. RRK*#^M$B^ M40C>JWNXQ'J4:;KU(4VFZ#U+:E M_$A(\1MJ-O:DY#_$_SF/WF M,(C,10N;HU?N\C<2!M[!O^[E33M*XYEIO;67 U\>-O= MT!'BO!T?Q (XG(,Z&[Q9=@M=V&^]4[MC^'.>[1B,VR.I] [,AQ-^28UX%,3P M!D8 HC(Z[?8\-(E,03%&O%QI[ IRY6/J3UJ4U(#<21[M>=;]&"AR),V=)E$< M/M.DR.+38S<]D\'-'""T=/>/Q"SH;/PE73_:7W%>^9N]_71_/XIRB?0V2+D% MEH;C:3;RZ-O]L&KC[OEFR@*O[G4E.!!($_!]H<#YW0_:H+_XO?P_4$L#!!0 M ( /* 5UFEQ>VR6PX +\L 9 >&PO=V]R:W-H965TKHR]JM;*N7%=9X5[MG!TOOR_.C( M)4N52S/RWE0ETJ_[G\8/'MJ*&2ZEP5 M3IM"6#5_=G Q.7]Q0NMYP;^T6KG.9T&2S(SY2E_>I,\.QL20RE3BB8+$OROU M4F49$0(;?T6:!\V1M+'[N:;^FF6'+#/IU$N3_:E3OWQV\.A I&HNJ\Q_-*M_ MJBC/*=%+3.;XKUB%M=.S Y%4SIL\;@8'N2["?WD=]=#9\&A\PX9IW#!EOL-! MS.4KZ>7SI]:LA*75H$8?6%3>#>9T04:Y]!:_:NSSSU^IF7]ZY$&)OA\E<=>+ ML&MZPZ['XITI_-*)WXI4I?W]1^"@86-:L_%BNI?@I2I'XG@\%-/Q]&0/O>-& MK&.F=[Q'+/%*NR0SKK)*_/MBYKR%"_QGE["!ULEN6A06YZZ4B7IV +]WREZI M@^>__C)Y.'ZRA].3AM.3?=1O-,#MNP3_^;14(I'6KG6Q$#(W5>&%F0N/QR]- M7LIB_>LOCZ:3LR=.9*98//#*YG!;[$P,0LMY5R^?FPPA"C+G N;P*I\IV]@$ MAR7QR82?'(M#76"?J9PL4C<0'ZPN$EW*#%&2R2)1Y^)-H;W& SXS,[(0%?S% M\FF_5X42TV.F-1&)5:GV0BZL4@AY+^Z)R?1T.!Z/.Y\^&0]BY>8YS>_U_[?* MN7/QN8 VK-=_JS3(F\(=6#V')V=G W%X>C89;*_2SE5,-3&DF\/)\.&C8ZR> M#L>G)P/Q'CBY0]T;JIU,I\-')V/^?WQV&CE**FM)MI(.!")M[V-339\T_]_V M?AZ*PA0/-JG<:TZ[UYQWP4;=8468:MN20S;(B@$,:I!7R@*/A9K/%6.FT 5X M4,X+*[T2A*4+&&I!7YCME71"EJ4UUQHXJ;*U.!L]OL^'G8T>WA\"O5T9:&7K MD7A56=(>'>J7,+C( Y@H I.;N&X9C6X-HHE9%&PYSYX1+2EKY?:M3D1V61@+ M[XU'4X!KEG&>P+KN@S[W8,&T^E#72(Y.]40J$*K_#Q*=;DK4/!@Q:'0,UK'G M7&HKKF16J1H6FN %X$N"3V M1W5ELBLZ_[5,=$:[;@+BEP&(+QH@_J-__*3OL8HC@?2$L)!;NX?"W.60H9BM MF5'X>XRB>$ X+:,XLD[,K3-D&G^BPG,0U"Z,>"&+ MKT/QGN,'6KEPSB2:OPW)@66*BDI38< P!]"+486J*H.W60K!!3/(_H6 N8+7 M@!&()853A<8'IP#)%+*D\Q M=R YF1(/D[-]/OON\^M_L.^)MSX=[7AR8!Y/\W,!/#R2NJ,\9VB$(IA#27&HB!B'ZSPR46F M_0XWVX&&.02=10>"W'-=,#9S682FDH-$EII28]&JG+5 M#+E'2ZN5NRUW[."5TB$49N4*8?2YT1RA#]CF B[:G ZD,H4?)B;/M6PE9 $= MM)%,)Z32XT$_N2QE\+K$![.$F/8]Y^I&=:=2J3T*N;3M*3AO4D?(&X-Q E/! M96]QOI)DX5*C99&Y^JNB6A!A$6H'.$-@XE9T+(PG"NJ:_)/INBHGSFA;6 +B MU$ 9_A6$"!!HQ>'U )AZ=KJ!\H?K@0#2WJC!T_!$VC59$YHF65SAA 4?ESZ8-"#$Z M#-9LR!2V#44!U!0^0U;8)ZO8E\S,1P_K+:UCJ ;?#AKC*SI2TKNE-D$+\SBF *6/] S@EGX9B"W@=0U?C;4HS!% RE3SU MVOB=""_1+Y+C1V_D.EFE#(9SQ)_C+=%_T'V,T0>2>P:XH&S%)%EML$CH-H,3 M_SW@"$B_5([\C46\_./UQ[ C50%5=C0#$D_4 VZ^VB8-,FJ4\LS'9#0F/N@\ MB4X@@62MAZ,C BIQ:D'/L-#<S->RZF13SS!@.U"CYWC.F M=,:(K>@ZR7 '^.M@]6S-UNX;^YNM2?5!(K.DRD+:F)DK-=C/Z3CH[W9U? ]Q M-LY(O*[G4+!TAF+)T&(2Q4MWT\3E:9*R$_);P,F8D#JN87V,? ML\T'D@+0_#OZ!WK,M M].JQ!S3E0JH=N@-= M3_2:@L0YY=N>A1Q2ESX,N%QE@\YK8J&0C3MQ#MS!K^/@ KSF11@8PN6Y@NNC M1LS>ZMJK6():I8LKQ2!.$A W@L9P>JY)F]Q8<@X=!C&H7G4N"(@\MX)]UCA7 MQ$Z#9KIN:;*Z4'1A+M-H(/:/SRETMZ:MR\B D9(38L*<_>YW>0,*CO1^&(0UKM&#]" M4V&.RKK:'*UT8HE4D22VBJUH5912IVU=%J'C!_C,47E0WT[^H-,@]DVY>K.'O+A5V<=J!+9LZ@Y^ J2L+0\>-85WP".K"*',P?*Q+ MU3N@K?S# >RGWS1RZ2(KA%@@+4F('<9*=1005"$B4Y/3L#[IC3G09BM/"J$9 MOH6U-8^I(DY0IO8D'E?M=W+PRPH&Z\C3;=VX4PXLXNAA: %C*0!^B2]/OW$9 MS?8.014A>,?4)G3F49QU3=R@VRHK2Z]>8M%_2:>0:!VP">UWJ#.=R#)F\ZYQR#AC+XW"SH)IK$;XDJ/M1N?N>B9J' 3MKJ\E9 MQZ>W!V<49E;S-*CG7"PV*S$,KBB%+<)YE8UO3A>D0)X[X =V_D4+X-2NRC@V M2)94U&,1EQ A,<9)"#^I]W28:6KFO3B;^0[:'38[1RIY3VR(.>[TNJF$:?=IUF(%1 M!X/GQVAKPNJ-? 89Z0;09@540T. MAOL<)FWYWE1HNSO$[=)^('1$AV:,-S/6LCBWM(AQK#=I*O261+?)X<@-A YW M%!??[QBUQAQA9:C+]P^;:X51:9]K>FJSSVYC/E2N/.!\67W.&5 M 95OJ4FJX-J(-U[E81OT;C\, MXS/N;)KA%+W4:=_A,R2'EB8PU)!(=]^!0!C$U$1!80K5=M5!EF)CILXO8-L[ M)111G;%EY0+PUF+0ZYFFF9)(TVNG7>Q3N#(-;[&^A#ZZ^L+NGG#(TP1XWV)_J4?ON84AR3DMG-RO[VJ@OJ4K MEX@T2H(X-K_T($!ZL:6Q+"A^%ZWL[K^Z<[!5L5ZJ_(\,-,W.P MVN%EUSW&H\ZE4GY+]I*K2C94N%_:/&UNYUZ$2ZGM\G"U]QV/5E'LJ3FVTH3T M( !0_<6;DJ^HSHQ'AN"/2R5A+5J W^?&^/H+'=#<67[^7U!+ P04 " #R M@%=9PK"]RO@. "B, &0 'AL+W=O$N4C10LLMD LB9QY\\[?.\B^VBC]U2R%*-G=*B_,ZX-E6:Y?G)V9="E6 MW/AJ+0JX,U=ZQ4OXJ1=G9JT%SVC3*C^+@F!\MN*R.'CSBJY=ZS>O5%7FLA#7 MFIEJM>+Z_E+D:O/Z(#RH+WR4BV6)%\[>O%KSA;@1Y:_K:PV_SAHJF5R)PDA5 M,"WFKP\NPA>7":ZG!9^EV)C.=X:2S)3ZBC]^REX?!,B0R$5:(@4.'[?BKY(=9)EQ(]ZJ_(O,RN7K@^D!R\2<5WGY46W^(9P\ M(Z27JMS07[:Q:Y/X@*65*=7*;08.5K*PG_S.Z:&S81KLV1"Y#1'Q;0\B+M_Q MDK]YI=6&:5P-U/ +B4J[@3E9H%%N2@UW)>PKW]R4*OUZ>@ER9>RM6H&M#4=U MO3HK@3JN.4L=I4M+*=I#Z9S]K(IR:=A5D8FLO_\,N&I8BVK6+J,'"=Z(M<_B MP&-1$"4/T(L;46.B%^^CM^1:.%&O^3UX5LDNM.;%0M#W?UW,3*G!3?X])+RE MG0S3QM!Y8=8\%:\/(#:,T+?BX,WWWX7CX.4#G"<-Y\E#U)]EI&^CQ*Y6ZUS= M"\'VKKC.>6'81 OFBC,50X@@=?6>-@+NA@%8<"N?J]D><]^*E*P%(0Q<>,Q;A@' MVX&_>4QIN]3=*;+.[IYP[+K2Z1)8I<+XBK$&<+RT@A%'> MUH]V3/)I2!7(<@;'SYTAB0XR8\D[[[6'>$P6:5Z1OQ:J. 7G+2O0]KUC$C2. MPGON)U\#"J32NKS&Q&!( :66*;)*JW:O@ @25ZZ%IG1K)89+Y G=JU9SUF7Q M?BGT"E9I@3;"R"HESW/@3JYDSAMO[ 1(*\]&EDMD95V;%I*[M6JCBUK5LB R MXM;=Y6PE] *T#BI$%X^"EQ!9 *BX,H5TH%5.U\.7&*N0+0&/'K"4QV95:1DR M5;ID"M;H6K@"H00@@S0-!Y04^,@Q(@P(2_LZ+BQ;XL0_$W>I($/Y[,(*M)<3 MR+$0D 50G0GXG@D\!PA*\!D(8 ->@%XO;J6J#*P2#F(,J@(]I+[ LB8P^WY. MX%5TF80:0VBP6VVMSG$./Q@L Y\#V94[D38V@CO2(!Z=M@^IBXHNPHHV GLQ MQV\YN,TL%Q0<\ZJLP+.V@K /51N0)AQY23CQQD'HZ/YM?"! $@MC+QF%WBB> M_MT<;+L/,K,-='Z;B-I<*JSN15K1F>[7%+X@*"GW8:D19YJ*. M6;[MVYA-,2+1ZT"ZF2PL,J&PW"S195OQD697!7Z7.7>2PMCS4&$Q MZ!MD=G0%B#Y2Z9KK4J82%%/B7< WA"J".)L\E,7+-%>&JAH >[$% XVY^V[7 M(X:PJSGISU&$!)/+E)BQ&P#:"'@]7,%9!E!"64AAQIW=[ZD5?! <0;5P/=(V MD#3,62T#.4B2*VNZ]V*F*RQ;=BM I^K 3Z!ER7.D/-="Y/>G* 9Q?=RI)5*A M2V@?FW1(^$ZET7PN<\BBPIP,UPK#RD._Z@5$ST<:Z'S ,^N2 $2+>WD7ODN5 M^4\K@PG?>9IJK/B C2*B:-=8$VF;> M63_>$$RRB@(D5RE(G?,-942^ /LC[\8?Q+I>CX#GR[(4>!0Z!L2"-"E\QYMH MOODCAWL%$@;6^7T\4Z"!*U*.0?H)F]_8PS!<204;E$ M2^$9\$'"XM$*K,)===A#A4P@?I ((%1K,RUR(M-4$)J:!4/MCFV1H#7ZM 2- M]EKN+8_\ -#QT'WR'G+P]MLQB0,5#:@*8F[KYUME*)P*40)/4 ."I0_9-(0_ MX22 OTD\AK_C: S]C0'G3:W.,UB;JS5).O$2..?2^V1Q+;<#WH%G;"BAQ0[L[SFB$:YN#17?SZT%17-S;Y?'%BGEXX,7_$ M?OST'2:_]UQJ]IGG%0EO=[!?.C,D7K)W(G4Z#3V+9B-O'$<8_F-_$EERP'#( M(N\\&0%Z^*#WS]9*QY&7C,,3%IW[2<+>HLM@3HO8<0CH,CD!"/&!UM:1 W8$ M["$P D+1B/VG\Q^0.L$Z$\H-K)^Q-KLC#\MQIC-I@+9.QH^.-9 #WGC':>T= MM,_6#'-4VVVC-B),A4@8^^/$!ZGWR\QT6O MGPQ5& :Y7$A7N%,8 )\TQRBH'!906]EB*U=8I0]45)WAA$:3FT7<(S3A1\O+JX!MO** M"@6N"^##=%0Z5%ZWXSK(Y00>R I.B%%W55X:"V"8:-T$HL.'J\CA#-@(UZNU MZ]J ?]F9HAF^$FPET!3-V J!UF?OW8HG9YDZ H 9=!Z/C8.CQEZ[5.R,!V!F M:TS9:L^RU; Z8!QD.(%3!J@\0>N/TK>Y9,4AS*H57L.N$T/$Z9;ZR0H'=HX4 M9O>1E1HIEEPO0)JV,[6*VI[+DB(ZR:A<@L-;BAY;J@TD2NU1)%!+.=_AMFL% MB9&_7J."2\"Y(])1& 1'7CTT!(?)[[UOX1&\DC(1A(.P^6ZC]I%]**@>&O-T M&R?G2=W12(=6[;5XNIS+-M9;AAS?;3M#^-*$-(T]ZIQ;E\B#,7MU?=-$'<7B ML,.XL2?/T2MP7R\BN^&*1V-LMJ/"E@][3,,EJ("W@ZTA<'M 8'!A:T%Q5])D M%1HEZ"71?SN*=K48*J? 7K# (3'DEYD[T0ZBVO()F2VHMTR5QEX%JP7"J]J# M\=ZMI#C?.<=_O&)Y(NBT-#PZ84GH3Y(GU"FQEP18&T4C_SSNU2E-K?)A>_Y5X[$T_20V M@&?61C3I<2[U9 .@O_E[']G16P,V*NR=7UQE_!B.?.B? M\83#*(0:L@^'-H&T510=W P*^D>[!T^6];J= 7Y,K8C+G*=?3V_2I<+D:%L4 MX@07K%0F#RC1SZ;9G%'I57[198";0 MP&0(5\H0F[ VZ^NNQ_(0'-M#FO$W>=3 MV@[RQKDGF?OP>UD7&:H&GG_EM\NLOMY.432MB)AHL%E L+=..?8)$L#%2R-AUN310? MS8GQ9$3313\Z;S(BY,GIE(70J8\:+B']Q>P/^^S?\GX!Y-\WS$#T$7B0-Y(/3A[&(OT"=HQB-:LA?7\>9>1!\CF..* M#J"/)GC1;MPNF>JB2?4-4==,V;/JC]C_IN2 U/MIH2NS1^0,/Y_\T6= M'VI;<=/MLEI'!ZG7N6T&H3U7+W% MH^G!<$IO1^T*BC&)S'22";5G[BG:D"YR, 0RV7D^W0$ ?(Y)D&B>^!3]ZM%D MMR?1]=]F>4;>^^'AC/>)7GVI\X8%@1V4$PWPT^0\L!5S,O&#=F[I'((F!\\H M^'?K[6=STWG.2WP%?M1<<%P]LPOI,_46'V="KRPD/MZGYQ8U"P,) 5@JQ**> M@7:0R&J&YA-/X.8;C@7!P_V:^%9.!FU4\CO FT+,H8Y,.WX_%A?%64]A7RYFKS OZ%?>^\76[? MWO^9ZP4^J<_%'+8&4'0=V/ZS_E&J-;V%/E-EJ5;T=2DX !0N@/MSI&PO=V]R:W-H M965T;)$$NE^_;G0_\F+KPVW<$"5U M7UD7+T>;E.HWTVDL-E3I./$U.3Q9^5#IA,NPGL8ZD"YE4V6GB]GLU;32QHVN M+N3>QW!UX9MDC:./0<6FJG1X>$O6;R]'\U%WXU>SWB2^,;VZJ/6:;BC]5G\, MN)KV5DI3D8O&.Q5H=3FZGK]Y>\;K9<'OAK9Q\%MQ)$OO;_GB0WDYFC$@LE0D MMJ#Q[X[>D;5L"# ^MS9'O4O>./S=6?^7Q(Y8ECK2.V__,&7:7(Y>CU1)*]W8 M]*O?_IO:>%ZRO<+;*'_5-J\]/1VIHHG)5^UF(*B,R__U?SJ*#\W;QK,$;JB?J=#96 MB]GB[!E[IWUXIV+O](OAJ?_:<]2^FX]G=A[$-3:I/&U)U\'=&#A7. MM#+Y<9+'=3 XFL8^X+Q9G7 G>5[_)\X0E6I%)05MQRHF/!PK[4JV@W8F MZI/'T4@44+&X!Z>?&QUP#I8(@V6Y,L5$FJC4YA@@_?%9+!3=T7V?X[?[6)8/G.)KDPT-O*N*QP+@# M#[Z)ZL\FF%@:Z2'R,+L:(D6'E*T3]0%MIBP-K\W!L-F,-RJ_4@6%A$:I(A@S M*U-HEQ1(:%P3!5FB"C&C0@,5'DO^ NH2=1O )4)JH;5A(';.$>FEL2;UEIY2&=4J^*IW@?2W/R=2.WUR$NS\Q?6!FSI& M3 _V:GL'%:6-+]FM+@K?N,1(GR:\0=\(;03HI10"(LZUR#3T-53NT@F.:A\P M0, ,X =R!58O*6V)@X1I@QD@H!'?=0&]AI(@/=L=$7 M#Y@ G^ M<]:1S_X>2(='I7$89* ["I'VJ>14AQ)(D"#;Z#RK+(8E8B!V"TH: M_#) ^X@B/!3^*R88"X#0&OB(?!(J'$R$=LN%DS8H!^=3&P6F-V>OE(*M]"T' M$AM)0>9;[RJX@UF@_ V2%1FS* N=5Y P 3A0/=]ZE.40@E-8$PM*1C(!:9C+0Y\8P6%QSCDT!'8 * MR#48\KHG= C+.F*R5XW-SS"38FX[+4XIIXEZ*P7?U-X-\_#C#Z\7\_.?I998 M\W E(Q_/9^%))G$:FUP_&\V;#@:*"ZXY.4/[NUX.+Q6FE*[ MOIL9!Q8R#_LM=RML#@/8'"00O<4S\UL3^R0-3V_;LGH0XC.E8):-].[AF2P] M90.H+S14-N-@%2Z6F"\KPP^&ADY6@>C8J,#JW81X>O)E, W:8N\"K+YX-3F' MZK.6,]/V[+1A7U767<2Z2T$UH>$LT4D[Z21T'S<[_SZSI]^,?SZ;O'SLR;$F M^';\.]T@AD^_RW ;P:XI[PV.QV?LZ7C,XNFY2GIQM_>]4 MA6SAJ??5<3]68&77Y"MSSX%#UYTPF$[$P-YZO_#&W-[0V[B5R$H6%>-6[OCB MMIVDV,Y%+8?^;R9E%AA]98ZQLVRFE%U _C2P&:6P[;0$9L18=P[.O([#0M4DL M*/( 003\[J$#3SI$Q\TS\'M\RL\+'V4>H+,3*XF(45^9_#"J=MI!\4)&=V)R MH)P/OVY\&+2)GJ\*;\_0H2Q-10R=9#%TPF+H1,006E[<>%OVLJ@3W4?+BS0!EN8((RCR+&RG-YQT]TO:F$ZP!4&.SC"!V7ZH$@HX4\Q1]?RRW)FU:W*QIO36E;.K?%42+YHDM;.DX'$.M M%IBH][L7@*_I[..#S?0X3+@,) UC^:!>S":+;MH=42I9ZH@..VX4Q.0S/'P# M1:7X.VK[,MTG-5^TP4S4=6.H\?^[#/!&H))XA?$SC,;OYT;_DTS&&; M_OWI+1455II],^*'>W,'Q*6C-9!'(@DEP];7S486PC'*6RM6 M?.TW%SF=_(&+RMY2?C%=$J]G )C_E,V@E_GC_D\] 5K.OBX6%%8RR=4"'!^ MY\S?&?N[_5?:Z_QQU0:265M@ZFYR_'*F0/YOFB^1K^52Y]"GY M2GYN2(, 7H#G*X]6T%ZP@_[;]=7_ %!+ P04 " #R@%=9"E WW @( !G M%0 &0 'AL+W=OY2P(D:?>"NW9%TNY^&(:!EFB+BTRJ)!4W__X^AY1DNW'2>W'1MJ@K MBN3A>7G.C39GLVB ?= MBVNY+AV]&)V?UGPM;H1[7[\U&(UZ*87<"&6E5LR(U=G@(GYQ.:'U?L$?4FSM MWC,C2Y9:W]+@U^)L,":%1"5R1Q(X_KL35Z*J2!#4^-#*'/1'TL;]YT[Z3]YV MV++D5ESIZM^R<.79(!NP0JQX4[EKO?U%M/9,25ZN*^M_V3:LG2\&+&^LTYMV M,S382!7^YQ];/^QMR,:/;$C:#8G7.QSDM7S)'3\_-7K+#*V&-'KPIOK=4$XJ M"LJ-,YB5V.?.K[3*A7*&>Q_I%;LRHI".74M[&[$;N59R)7.N'+ORR@AC&5<% M^UGHM>%U*7/VJPK8@(#3D8-.)'F4M^=?AO.31\Y?L-=:N=*R5ZH0Q>'^$6SI M#4HZ@RZ3)P7>B'K(TG'$DG$R>4)>VCLH]?+21^21(X+)[^$IXX!S)X5E?UXL M+=R6N[^.&1UD3H[+I$1[86N>B[,!,LD*/*4]*\0 MTJ]Y/GM*'/M)*JYRR2LF%<+1@"ZD5]@_B0R/O>$7G^I<\SW5# M R-R@9EE)88XL:JX$X;TM&PM%#U"FM(XB23@4 :3VXP79F^W';)W>TI7D*!VI:UERWM65SR7:NV7>36WTI6L!$5U*S\TO)+NGJT./"A= MXSTQ9!?P%=@7SK0-?%D(G$72-OR>+046X_A<6.\S[&S(@J#;H;XEM]Y,*"N, M%' W?$1V0%.D$4)*4GOQ3_EW^ AX]H]#F&Y%ZY_:Z*+)V[A0EDDH3,[:<-6L MD+I0VO@C.;&N8(:KM:"Q+QI&*T"Q$&';=V^ )A9_?V@=RDOUR6%+#4\7B&CN M*H\QH8J3_ #IKC2Z02A<*4UQ4G.#.!3 F9'+QFD#GWLA4"0 F2/&*%;"D),A M$2[=P_&WWV1)//_1LMTAK;()M+T6=T(U@G#'*ZM;\#G"F]$;9N':-H8.MD!I MX(*,0;3Y5CL(7%TA]?5'_2_*#S\)(:WT(G@H@M$0"#\S2Y! M25"+811\N%!U*'0'$G]78I=..40CI:%-/'[.D&AK=#!(2-JG!"6A]Y+U22AX M7G8G!2THO.!I&%Q$4-4(<5"V&(J.$YLEY%'E>0.5GIJGRD0_Z=[36V&(B'C MG],./MU3K$<[NV#)E#UG<4P_:?=$[EN!9/26LMX1;W0J Y&\0HH3]$ON?( > M.N$(;46^W2DH18\%;RDK,/_:)]0GKC]B[DN(#6_BZ)C%:T/,=42+G>67 #1, M3JZDI0+NZ<6!.2ASG)X1!WQ1O"_5/ ]\A%TVI@< M1 87>GC;UM?VQ9TXITVKF@G;P*KHHG M/5+&N\F7[ ?_U[_[^XD_6',M>A15E&8[?SWE)$JB7?+L1!\&C'TG"8M$"@_=*4HQN'$)E61HM M()\0F47SZ9P12B=Q-"4QTR F@S[T>"W06U&5TZ8",T//&?,I'B63L7^:1'$6 MWF71%-E 3^^\W<]8%D?Q.(&ZP2HRU.L3G%'+)&!.0],EQ7$F.:@HGR\H7X=2/E=??M&P MY5_T,UGX@%$8/+<0,JY097E'&SX&7&ZYBMCU[U<=D]#P0&CIPX,X1T5[L:;*+871P5UH* MU-"[OH=@=J_6JL9#K]7&WEM@D5IZ6H.C0=>'[:]4N3:UIDM7L/>!!59L)/B? MK(#7=GT\O(>+G,6= !Z@6YT&;^C&6>K>/?O!SD!C$7LMBP(A?L6M"V9?K P4 M[J\(].H-=9!@54$SJIL:LM_@C9,*\$)ZXIZRNU.V-T+?<.YZ7DBB>XK'0T1! MC0!FCR-#7X5.].JDL:(7A>R9-TWDT6\S8;.&;+K7FM?9-):T"WX2NE$@\"X-# MGDS))KMT?8D6X"VTS ^]G5DM/?Q"W%<^T]\-B1@ M^ [6O^V_(EZ$CV>[Y>$3Y&LD&.ZRB-T*6\?#^700 M@-G*[]IS1OX?4$L#!!0 ( /* 5UG:[T':U08 # 4 9 M >&PO=V]R:W-H965TZ5OS4((RQ[*HC+GO86UR]/!P&0+47+35TM1X);3>+?A-BGO3&3/R9*K4 M+?WXD)_W0B(D"I%90N#XNA/O1%$0$&C\W6#VUEN287?BP7,UX7]D;=_R0:?U+"RU1AW">[]VN3<8]EM;&J;(S!H)25_^8/ MC0X=@TFXQR!N#&+'VV_D6+[GEE^<:77/-*T&&@VZB?,>#HL1^D[T+EZ]B$;AVP/LDS7[Y!#ZMT?M.\"R M=M5TQ3YR?8O"\64AF.73 G-TRIGSN()E+@V?S[68G0--";.4/0_2M**>(":7 )] ^])Q2A#Z&G=&55CR?8@=VQ(9Q M$(]3&B1!$HTPF(R#*!UC$(U.@E$R8B^9FG7YLB3$7)SB8QC3!_V$0A45ESMI M5RR*@W$\8E$:A%@V3(-Q&+(H.@EB9_ (+J(MHH@^A@1,HP_53',D7)W96@L6 M#X,03)*3X&22$L-D"/@D#=+DY"E@/"%68_IP@",'F"-H6O*"D>,E"I4\;D2/ M@)Z"YRB(PH2EDR <33 Y#)+)< _=F-!C3CA @A4A' M8#()AJ,(HW0T#DZBL,T?X]/,\ )#N]"JGB_P+2!KN>35ZM6+21R-W[HD@A/3 MVBHD'\\R55>436A(D/FES-T@55%*O^ M]^2:Q W7\5ZN%27V_Z2*V<*=-JL,#268%-0,:X1MJ='6-=)6BTS-*_D/ M#/):RVK^]406'*=8"'36HE"9VW-SJ*E3YJQ>JLH!XG#/!;$P=;;83:6_*<,_ M2SZ5A;02S"\=^3TZO!=9,QL%C2A96[VS%JWHH-T+G"R^Q)X/$BT=PK&CL!^C MLQ:%NR10@8CZHW9B6^3 /0>P09CAWE(#1$N @"+/[WB5T2Q?E:[Z05L!.Q_^ M^X6$Y_#47:2PD*EI(5$8L8N!EG=075DO:(:L*@1VZ$9U'2>42\&!A3V?G32P MX&ASB)RLLJ+./1S!/)%KA1@6CB@W[5Y3,9=515F"B0T)941')W)2JMSX;4J2 MF6I0G]H$U'?F:.MWG_W241M'8]/.*#C76@+\ M,O\+LSYV9'@C4(@K/[XT1EB_V%UVN8ZJXD%/9I!S_5I?UR/!.7K&M]2R<;BHR3II]LY/X[ZXT-)SQ&T;LJ@ MMNG:'X%M7IOTV<33J$+FOD T<7075M-GN%G[B_G:0*[K9M!L2'+PDF:VL[93 M08DQ=" 5/H$)&R/>V%OOEUJ+YI)"Z#N4YIU<@.$4?A0<_T93'4#XH3=VAOSV2V#F-S'N$FPPP2P$/KG-5W5H'3> MG-<=^>B.WE$<;NJ;#WZG NZ,O<-[DL@-7)KT)X_AAM^22N(!_S2-\.=-N?!E MM=90<*L4_'=:L=<^"=ZXD@,&W(!:VV2-1!V=R8P#-Q<9/15=&GM3A@">)H>[ M&#SJ*-N2[%$/V(_,M@.S)XB!*ZLY6@(![/6FN:JH[53Q3:A=ES=":HJ1JOQ! MVZV":]MK*;RNB*'?#KITM]Y] Z.@/J]5.67ID'<;A.:5X;[2N%CXL.PJ#\^, MX_AEZ5/B(Z*/BYPI)MW)M MNHH[H9DOB,W=Q@=IHRUEWF[==MV\TLGZCU];.:+=E:/ON^Y3/Q\7DPWQKVD_ MSQ7;;MU@)%21NG0%2AFJ7'1+T\0$CF^JO&]G[7V0_B?W=[T#&'3>XL!N[MY5 MT:4 QOZ%SGIV_3KLTK\%VBSW[]+POQS99U@A9C -^^.TYQ.E_6'5TKT3FBH+ MDFZX$!PI0POP?*9009L?M,'Z)>'%OU!+ P04 " #R@%=97=@D7O4$ "] M"P &0 'AL+W=OFSM9N@:2W(5 ME"H]S$:CZ;"2JAXLKL/91[NX-JW7JJ:/5KBVJJ3=W9$VVYO!>+ _^*0VI>># MX>*ZD1NZ)_]'\]%B-^RMK%1%M5.F%I;6-X/;\=7=A.6#P)^*MNY@+3B2I3%? M>//KZF8P8D"DJ?!L0>+G@=Z2UFP(,/[M; YZEZQXN-Y;_SG$CEB6TM%;H_]2 M*U_>#&8#L:*U;+7_9+:_4!?/!=LKC';AO]A&V3&$B]9Y4W7*0%"I.O[*QXZ' M X79Z 6%K%/( N[H**!\)[U<7%NS%9:E88T7(=2@#7"JYJ3<>XNO"GI^\1LA M)'<]]+#%)\.BT[N+>MD+>G/QP=2^=.)]O:+54_TA,/1 LCV0N^RDP7MJ4I&/ M$I&-LLD)>WD?6![LY2<#$W_?+IVWR/T_S\4834R>-\']<.4:6=#- 7OR#[0 M8/'C#^/IZ*<3 "<]P,DIZR>8/ZGW/*HNVM\;LM*K>B..#C0?"&FMK#>$KO). M-%:A$97>B<*@RYP79HV_M2HHBCM!CXVRK*YJ\0!9TSJQ(VF=\*4U[:;D=,U3 M\;D$DKU2*1](&*LVJI9:>+*58\NR::QYA$M/<)D);\2L,R;KE7"F(@;B,4F$ M:;AG'Z!9%RC%8;M(W M9OVF93*<(Q^=1\M:R:72RBL$L2VI#O;>FJJ1]4XHAR$DG:GEDADC&X JCX;5 M&I]J3""6;]$05N]ZSETJ[@$A@E-5HU4!):):2J21AR 8@#"R &T)IK4&!BNU^B]P4]A0%LC8TEC4 M,@<04$)I+0OF9;=':B(U?8XC?9P')KF0NFAU+#L6"V5:>Q20;D/0Z]:W=I_. M1NY".:;B-I0)!H&G:DFVGP:!C7=4=*?C<)K'*+=A["( U)S%+2)6RA6FK3N& M<6NAEI[T %(+1B;I_'6P.TFGKQ-0Z!H*%X3>)3W[1\9!$3C_VDXAXA=]Y.GD MH+[S=!YW1]Y"V.R/ZQQ+DJB)>,3\$-INY4*/"8_2@.=9(B!@G%_.I^!Q".F(BSY+Q9 0DSEUQ-[8^1 <] MPOP[RY+Y:'K>?6YKF(SM@2ND=ES2J'QM'&+(SCL7QZQE\R3+L\Z(*XWU;T*A M'$N>S1'='/Y,O7E)YI48SY-)GA_-\L( ,=?9JPR%5F$*A6<.:@@'E_T!ER?G M#@.;J".9*PU1O=!JL;L.BS0]X?PRO7CJ?):.CIRC9[[?]_VW%+)S]WVVT=-H M$)ZE? ]9)74JGKO,AP=/JHKL)CP/#]H.TF)(\ MG-=0':67%X-X#^TWWC3A@;8T'L^]L"SQOB;+ OB^-L;O-^R@?[$O_@=02P,$ M% @ \H!76>/?6)+^ P ^PD !D !X;"]W;W)K&ULS599<]LV$/XK.VRFD\RH(G4X35U),S[2:1[2:.P>#YT^0,1*1(V# M 4 =_[Z[($7+CNT>3WV02 *[WW[[[>*8[9R_"Q5BA+W1-LRS*L;Z/,]#6:$1 M8>AJM#2S=MZ(2)]^DX?:HY#)R>A\7!1O8ORE7GKZRGL4J0S:H)P%C^MY=C$ZOYRR M?3+X5>$NG+P#9[)R[HX_/LAY5C AU%A&1A#TV.(5:LU 1.-SAYGU(=GQ]/V( M_D/*G7)9B8!73O^F9*SFV;L,)*Y%H^.-V_V(73YGC%;<#S]:$QB\IU>1-Y)3E MHMQ&3[.*_.+BO:FU.R#"#4;ED>2.L-3"AED>"9Z-\K*#NFRAQL] ?0CD/M2AQGM&"".BWF"V^_FKTMOC^!;;3GNWT M)?1_5YG_" 77I()%"5=4.:]635HI/ 4_5TBCIA;V )4((&!:C%[?O>&63R[E MJ8N_!Z[9^W4D]\Z!X=Z0^1:]LAL06@-JM5$KC8 =LS"$I?!1E8H"4EF,.,#6 MZ<9&X94^W =#X*4,I/QY02KB1D/&D3%8%R$ZP'V)1%'P2E&F,0_)=K9U MXT-#T=CAMMLD.LIN#9S !QO16Z%)MRW:A@61.'P@#47GF!X_-R2 9*Q[K@.: M\TD]%4^&Y8#-'BD$M,$"(W:Q:U++R0"ILXB')(6ZO5!8"9_(QO?EZ]KYM+Z? M5J2QX*3" \*\44?ZA;Z0J\[Y40W# )0M=2-3T8A/&YRG> 9*](S#O&GKL_!G MXU60*NE(Y;P(G DMX8AF152/ZWB0LK-TW#R.[WK& \I:F;;R'K6(K; NY?S8 MK>.Z(Y5?%<,I;9):$\:1P366'8%1(C#Y)P1:M-$I&FMX-*2B\TD@VU[DD['1 M D1=:]4R_:*_ 86W)"0)\Q-%;HNKRAZQ=(&Z?H<>X=7TC!BZ)G"9^4=9C8X\ M4I=F2YD83OJS2K*2. MUZY.W8![+CX&KCK'IDX.3BN9ZA(B/=@LJ4V7!2^Z#OC;1(OAN,^K2W3\1:*D MVO\[SZ>V^OSD0#;H-^G:$0B0]IWV;.Y'^YO-17N@WYNWUZ*/PF]XM6I-=J/Z.ITO*]JWH=H:>#6A^[5P\?G" _KZW^ M02P,$% M @ \H!76?IY7R]'$P ACT !D !X;"]W;W)K&UL[5MI;]RXEOTKA-]#PQ[(Y5KL..DL@.-TT.[)8L1YK]]@,!]8$JN*'958 M34HNU_SZ.?>2E%B;'2=IS'P8!(AMBF_%T7]>SEP=,#4:B) M;,KZDUG^J@(_9[1>;DK'_XNE'WLV/!!YXVHS#Y-!P5Q7_J>\"W)()CSM[YDP M#!.&3+??B*E\(VOYZH4U2V%I-%:C7YA5G@WB=$5*N:DMWFK,JU]=FOE5CNM5]NN&>Y9^(]%I@Y\4M5J&)]_@E( M:^D;1OI>#^]=\$8M>F+4S\2P/SR]9[U1R^^(UQM]"[_BC79Y:5QCE?C/B[&K M+8SFOW9)P6]RNGL3ZL.7OWTM\&3_O-[6#AM63B];_7' MJ^P[EA-7U2W>&+L2UXW-9[!_'O2QGBG+0TE$C2S%QW&IIY(\S8D+)\Q$0'6U MFH\Q+NHO$Y.F)N'"D/6\F8N%7/F-&YB+%;K=;)%N9G@SDVP@L89T8F)*@(K[ M>1>5*3V>VO3)9U.#9J))'([$G&WV2/Q=C+)^_Q0_S[/S_E/\'/2S\\&0!IZ) MP2@['3P3HV$V& W$Z5EV=M:G-T_$3W][.AP,GXO!L^STZ3#^P*OS]M4H>W(^ M"O_[S;=D@-V>9*?#$7YY,LR>/6,ZL-3@/#"02B#'?]K58F$UP%27*Y)XGNBC M7;9H% 0%'#:3>DF"*W4.4%6N)WXSNJHQ]2V)OQ"?8*H2XF.AOU&W0.P%K2'> M6C,7-;!8U(9_9@($0?WSA:Q6 D.4== >WD82'._Y1]A@XC>PZ09%LL'"FC\4 M3<(*X;FH53ZK3&FF*VPF:X#>2HP5-IC/E5-("19/7^),I"V9& MVUB5*^"^ZP0"PYGK4@%:*Q4MCR9UI).4YJKNB:O)&J/:8;D_&VVQ,;:U"FL* M698"K((&8SG0F$F@H2H<$7:KB??QBI]Z6UY(#&TWSY6M$3Z)@$*S>M?EBR!# M\G4-).=7Q6!>Z+@TU122LG-H58YUJ6G9WKT.2//Q\N^#LUZ?!%'Z\,I2*L2$ M5;U%Z$S>*DA?59X8RY(/8XB&XVT:/J]Q<(P=S+2"SAPOGPP5RYFJ6@UTT".= M,]!SC;V6NI[Q"!8YFTPGK(0X&)@IP49/O&FL)M%@3CVSRMM"!>@+S@ZC):UL MBX@'XI?1A@XTIIM:M&R ?YBB\@*C$4#Z6VT:5ZXZ&-"&ZA>>'6]O8A3!69P+O?&CP:/LD"1^_EW3O( M0%JV&5VQ<(G-]\I.0=S%%*+BS3%WCL1&+THEIM:PU1Q^,"!A=-03'[%K,T5V M0I 5UMZ@JE E#"IX2K>O)"D"@#)H7>=;O"P:8%R^S@9[OZ[%$HZ+N,!N1JHU M'1.[>2!-\N2-39:F*8L62V!L6$TB0;1C#0#@(6,%^/++WN"U7-!?5X1S%0\ MP%XDPR^QG65T=$I]$86<(Z$-:D]XM]K17NN/.4*0_!6>"H>!TW/)0!9=B;L0H,&?.+ M"*N;E!SM(Y$-DL+"FG4QWV-%(H#D85FUQ\5@2N?1DEJ]=:+3/N(!?!4'%(*/ M,L2U!HF:!'!03 6DUZ@M6@V <'67*]<*,YH,B6FB.(MH(7H/EVSN'_/:$$R< M[3'W"2(*_%U\8.NFW5+[:/'K$<;$YN Q;$T4P3QV^^VF;; ]MK%OCQ @\<(C M#2@)DLOHA?.ZR(VK Z#+-:80^=B+J@GDQQKHI80" =2M*@OE MJT#=*\MZM272F]KD7V:FI-#]#F+S*5GJYR2S$-,A<:+"3"8P"YO&JDK.R6)< M(%92G" +7!I1RJ5K:-H8_!#YJ#^QI1*22/!JTC;5E#0GJT6,05296Q MR$M$7!&$P X*!MJ4ZA^5)GW=8+ OE&JKD7!=FL;6[(FQZMWCL"JU,RD_I^+>0-HC*[@==&EC@9Q X!Z#FJB# M@,>(K*6,,?HF=!,&_<-Q"W^_W*'F0-XB+G(?=3XU *=!?WQ\1D:/0#J-QFX5 MYWS/>=CA\.&-AOU#N7,C5OD;Y&VC)Q M%(!-, *?Z%3(173!A%ZVV@<%;]78-@2J P]^IS&WVSDA,L-.3PLGYCV7!3!; MEJ&NFVM'1)'X'9E56X.>P)P,BE):>1ZCU(13\PTPG$DRX:*I5UPZA*0A([B M@JN8 H8LK@V#))7*.SZI'5-XV-P#T8XD*_6OX=.83'>BG@(_HJ 3AB4B4MP& MQ(%AR)W\K\5UFM I!9Z??\$R%-"*D.0XU&_K5IT"BM=%3A4OY4=ADY R,XI9 M]4=38"RST.6[@S4N$A("+H#=N<^1]RCZD.8==(/"\X,C3]+6"TJ8RZ8(^;^3 M5$VV3D7YL$ 0XX/#2"J_33";&D W" MGMN$R/O FXA,(F6[VCZ.?? E*$7!+;D_T897+PW2,1DC"H$Z\X&6*5!W"Z[1 M^0].R7SU8"FF3CK3\=97(&XZ37U_^.91WA-F/TN]YUC^GC%]YU;B@Y **"\LVAV0,A+.LL+Q'R M7QV'=C*U-_J<^NC3'XU^2/3Q)1#PT 3C=UT,<#\PVO@T[L&(DB7=MHZ.@# ; M .]V CS#K@PA1=MUG%U/P/9CK:\3]M0X;B:M"C:T2=GWNUN&; CV1=E0.W/# M ZG_4W/Q88B_/YJ*SQ6^WC,_AJI\,$P!.!%B3,RV0@<&:M?Q&^T'ST ]\?8# MW![@A6!2IXEMFF8,MCL)GMP(X\$1XC+O904I4F#/Q+MWEZ'![-]=LA2I_0R9 MYS(TOC J(]'69JI(X%D\M!,2-OW_P+1@2=Z8F.!A]%$#B:H2[B M!I#*?=LJ]"_'C0,14'PZJ;>;N%T$/'JEY2K;*.:ZU"VK*6_">OO;FP(".#OM7R1:D%C].5/T;T%<;N MLG%-(7&=2JF"485:&UUCF,#5CHUJZIK2D6?LCVZOTRVP@XWCSB8[B:[5[Z'X#*[-GF4I@X>9 M6H@0D-0!&P?PIII(H'[-KV!H%Z=?=D(RYD25"@P;+&^I5:<5^$,L&E@A]1 M1EBU88#2QW4 ;%71. X8":.@?%MCJ8 =QXKW?& R>!:#16L((=ODS*+34*'P MA_6RB*QQ^"O4O(+D^^QO#%P'/1IS0]699\NS^XFH[*++M0W&$0!SMXFG*_4+Q M[\-)5*6_>GE_"D%-*>YC\B8;/ Q'F\H*(3VH[ '*_E)MQ3[FX'1;89$^?VSF M:2;S6O-Z_[+D##-R_]U9!X+T;"/EZ+H.;6?CEZH&V@#%]^4,<4"VGI20H!>R M]DX^H0 ;S@>"$?+N'Q#J *98FTX8@MS7WO N:T]NE+WELPQ^Q:>F:TMU!4<8 MF:[^J'2&>\((X[OKF9ZXJ$/FR8>SG3ZH)T#'5I)1=Q4-V#?Y-LVV3>X>P07+ MG<=WXZ+X)V"!7)B =<8 M-*G8?==[U[OLL3!R4Y8Q$?&BC/+@&T(; CEL06'M\61;JD?[A+=K61(BM3%W MB8RZCE\IML-1.S0]NY);LL30TR/Q9X,<\SCNQ$Q01-4U'W&>- B3(%]5L."9 M5^GAV1'%[W$\C=!\)HKI.IQ6$/1@V).C]>XH^P0L>NG;^U0)'XY7FR(#X)4K ME.>'YT<1 ,!D0PU";K\^W5B5JGGQN@&B_83DZ+FXMF9"J1?0CV[O(%D9G _[ M?:&HUOS3PU8;NG>IP:I;.H^&].@$E>1FXLE.DBRO'7.A[O/N&(_6Z!1VK@KB MYI;OW,@[<5&66J+4%H?OS>7%T:X3,\]80/#NYDBXP7VZ M^/ &1I W\[$E)ES ?U^^/S+-0YA&:(DE9DS2VN32'V)1)F?KC8?)R58:;H:# MK\AD=F!$7#PU -\UYOQHV%;[@%'B#J(.?2]*8MA=,>6L(!?X.E3^334S7GX)\@T,/O\ZA1P\ZM(>4 M76Y[]FUNNU8X-^-POF#&?_B^6"N1(.1$1IOYGO>U)-?+LJ'DVX6JZP+PB$.R0)_WERJ&3]T+3W1=.2E2(!ZS=G^#!= M7,-^$(L_J5NZ#7Q(1 _[SX%:_-O@^=$/Z8_=)8FJ>RA395'3G,V4U3>5\08O MDOQQ>^A:7K6K.7:7Q6-CIQ:4-,7TSOW0##.Y ]%>^2%J0Z9]?Y;']S"2ZH6H M#412_\4#D;94UN8>\&CIM4X07Q)+:A5''135-=ECD($.NS+@P7#H=L;#-LYQ MF..=@G>0!8:-N"9;)0T9U%ME.+-#G&KX^A"WL.ZZ&T=F,N$[45*\Y3 8[F)& M+73+>TM;*_+71&RZU/59E@3O VQ?#.VKE'9DGD?=-$;MK MH/N6^;U1N^N_A%!]3U &1=U=JIU9=7J8_23"SB-"]%\4@N_'<3ZI+%2UVEBY MF[^MW?V:7!/((R-BUY]4@(3R6%?'5%4&6WA41'V 96ZXN;2;,]&,^Z[M/>SG M_7\S" 8L ;&]; M7-V(@ 1Y/#V\0HR!^*EXWD-=ULT"&=J;#>2E!%1+?$BON^>ZA,=Y/,K[/VK4%W+5/F MN6VX>6E%V76DNYL1U+MISS%T^^%"=U<)H0J@2!MUM]HR 8//U<[+://VC#Q> M$2%U&.4M,]RB[2X6<#^(LGS3U/P% C@FS00AX15_C5,HEUL])F&.@0%\2R!H M '*J^*SNUEA_DZ%;R9MF7"1\KH\K M3Y)O8_G.$7T!'-("_YEL^[3]R/C"?UO;#?=?*+^7=DIWT4LUP=1^[_SLP%\O MCW_49L%?V@+O:C/G7V<*MFMI -Y/C*GC'[1!^^GUJ_\!4$L#!!0 ( /* M5UG3J8O<+00 'L) 9 >&PO=V]R:W-H965T1CV0$E'$A>*5$G*CO?K]Y&R M%;ESLNW%%LESOO.=*[G8&/O@*F9/C[72;IE4WC>7X['+*JZ%.S$-:YP4QM;" M8VG+L6LLBSPJU6H\FTS.Q[60.EDMXMZM72U,ZY74?&O)M74M[/::E=DLDVFR MW[B39>7#QGBU:$3)]^Q_:6XM5N,>)9-)LO%,KF:7EZ?!ODH\*ODC1M\ M4_ D->8A++[/E\DD$&+%F0\( G]KOF&E A!H?-EA)KW)H#C\WJ-_BK[#EU0X MOC'J-YG[:IE<))1S(5KE[\SF.][Y09A=E.819Y=X8BRV^%%ZN%-1NR01IHX2.Z&K5!3NJ0E'MO<2JA MYU?WWF0/=,=-:[,*WKG%V ,V'(ZS'<1U!S%[!N(;^FRTKQQ]U#GGA_ICT.DY MS?:APBM<>D:D?$R0>T[MFM.5F]>3<\G'UX@>-H3/'T)_;\EX7]"T$^:/G%J M6[0:S>8QF-,1^8KIQM2-T-LWKRYFT_FKG'J(C^S9AL V4J3TZ:2644< MJN:)ZO2\R_L)_0PT49M6>Q(Z)R]1_F4P8P=>;M@R)DKZ)X@'2H+6PDI&NB%8 MB,X;J3/5YD%;2=1"CFH8D:L$5!LK,QZAH^P#)F!F- [AC1M%FXI+H6 /2I8Q MBC#_Z$IOZ2O[11M]**RI2:R%5")5',=1L)F)1GK !, HSD4!ME#PE35M65$8 ML7L*/?2(4A5BAI+53F0#5N"\%I[5EC27QDL1L09B7>PZ!P=):ZPIK:B1YIRT M\612)4LH#_,68EB+!T0>W\- 1_8"_\$U"*5,M1K+'"A-]O):F== /@"%3;S7Z]HG].ZK9EJC80)7NI9*H#PR[B/SV M1X/(S=^A(! 4L'6X!T8P: -2,*C1HHA1'(T=8PPVSW4*Q/UT.VC(/C$#U\-V MC(<+!1V\.VBH4'@V8OPS7&#FGS4IRM)R3/Y:* 0)X ? 3W#YP,@P$:+!ZE'6 M726^/CL[>9H%H5BTV1-'Z^!U$$9)WQMX31R,DZ\MH-!=MPZS)R84^D8?F1/' MYN]X<"'&'(9K/X0.1=+=C?UN_[*XZB[4)_'N6?)9V%)JAU%00'5R\OXL(=M= M]=W"FR9>KZGQN*SC9X77$=L@@//"H%!VBV"@?V^M_@902P,$% @ \H!7 M6:'=F97B @ 2 L !D !X;"]W;W)K&ULK99M M;YLP$,>_BL6J:9/6\DP>EB US>.D3E&S;J]=< (JV,PV2?OM9QO"DLZ)4)\.'_@&.T*?68(0!R]YAMG02#@O^J;)H@3ED-V0 F'Q9$UH#KF8THW) M"HI@K* \,QW+"LP9:313PT+!D0RE#$I0(4MRVZ0UDFA408OVM-HW$IPY/$&&[DCV M*XUY,C2Z!HC1&I89?R"[.:KS\:5>1#*FKF!7V?J^ :*2<9+7L(@@3W%UAR_U M>S@ [%. 4P/.6\ [ ;@UX+8%O!KPV@)^#?AM@: &@K9 IP8Z;=]2MP:Z;3WT M:J"GRJ':/[7Y8\AA.*!D!ZBT%FIRH"I(T6+/4RQK?<6I>)H*CH=+^ JV#"P1 M5=\-CA 8IRS*""LI M?@<34&GZX^@RN08O C(26#.&8#DPO?4L&,:C^CRH]S MPH\+[@GF"0,3'*-8P\_/\[TSO"ER;A)W]HF/G+."*U3< -?Z AS+\33QW)W' MOY7X+#X^C]]#*G#[)#YI'[RKP:?M@]?AL_;!Z_#Y_[WYQ;MS/RH$M_D"7*7G MON<+T!5Z)>?IY>39U&<%C-#0$('*LYHAO5DS$0D1+SZO_2K#9MWZWJ=MZLC^S^S-:L MST6;6'5U?^6K'E/\8CH^K0P( (H& 9 M>&PO=V]R:W-H965T%1IV-D:WD(,2SG6Q([ 56"!BDVA*PN1WA 1BS(*/Q MNV-Z_98V\7Q\HG]UM9M:#EC!@V"_*-%%['WP$($,UTSO1/,-NGIFEI<*IMP5 M-6WLY*.'TEII47;)QJ"DO+WCE^XJRC1SE]J7LM31/J!=>%0E\X ?)OOF_,>KWPI+<.!X%[J$9H$MRA, BG [Q)7^[$ M\297>)?*O$.'5[3AA!XIJ3&[5'4+G5Z&VN]FJ2J<0NR9#T.!/(*7O'\WG@>? M!I2GO?)TB)[L:@9H'!QF]^-S;;0BHM+_'W*K.PS,,%,P(#;KQ6:#G.^"W]\@ M-PQ]2V[>R\UO.K4GD.8KPE??]8<29.ZZH$*I MJ+EN6T6_VC?:5=M?_H:W7?H1RYQRA1AD)C48+:AL,AN:W[]OK,.7FX[R>P,L$ 0MR2R MCE?OONK);=.^LWMCNN1]5=;VZWO[KCM\^>"!S?:F2NUIV /K4ES>JDJ'UR%/L]AU^\>#IDT.Z,]>F>WMXW<*G!VZ4O*A,;8NF3EJS_?K>U?F7 MSRX>X0OTQ%\+]/<_KN1#=$" MLZ:T]/_D5IX]NY=DO>V:2EZ&%51%S?^F[P40=WGA0EZXH'7S1+3*%VF7/GW2 M-K=)BT_#:/@';97>AL45-9[*==?"KP6\USW]H=VE=?'WE$%4Y\DU'T_2;)/K M8E<7VR)+ZRZYRK*FK[NBWB6OF[+("F.3^_K7R9,'':P%1WR0R;S/>-Z+F7F_ M2+YOZFYODY=U;O+X_0>P![>1"]W(LXO% :_-X32Y/%LE%V<7#Q?&NW2 N:3Q M+N\ F%7RO*DM;#;W<'K=&FOJCK\ 8'U3U&F=%6F97,.7!A"WL\E_7VULUP+F M_<\4A'@!#Z<7@.3XI3VDF?GZW@'G:F_,O:=__-WY9V=?+6SOH=O>PZ71GSY+ M;6%QW=$^>&,%[.-0&OHYVOC4)GZ#:9(?]P;(-6NJ0UH?$>7Z.NWSHC-YDKD' MXOP2IO@^??\=K"YM5\FK.CNE113P4UZTP"'*(W]1 MNX^W^Z8LC^OFMH:9;+^Q15ZD+>(]/KA/;TRR,:9.X' .:6OP79JOS6%-!LBX MV^O\N(6#W^_.U*9-2YPRR\RAXW=QO6]KVB1A$"WZJC(M$. J:=KDVZNKUZL$ M&#$\W<'75;#_HF8&K="EV7'$H@8$[(D#VJ1K$F1ER?G9^B_TV%7;%5EIX N< M[(W9]26/<;W^SU.B^3:'Q9?'%0YV3/(FJ9O.@1CV@._Q//$"\L)F96-[.'9@ MWC_W!4)H.+\\^_LG.(-SZ 'A MR2Y%9,A_ZF6!*P$9(D*-<"H!*%G?MO@%($';IZ5-:I,9:Y'YPD$=F&"2;5JT M@"E3BYNAA4-C"^9:, 0()T(D$.,M00'6@B!MS1Y%ZPV>''PV*]A!D[T#G,]- M:V6*! ^N@\-'>&>IW2=;D.)P.DB@T>R;M"2L9TTBI2E?P':JC6F3RW/BRI?) M+?P P\.LL-ZVJ29W=7=*3SL8 /Z'CYS>F6DLGIW=-WT)VS$)JCB"0C_U-:L0 MCJH^8HT N=:4] "0#E #O-\:.& D ASK""PI,2@%)R FE.88Q!!85W4-J .4 M>VC:+H$E*GW_!RRG9)(+WO,[N$;T S01=O;R?;9/ZQT]6!76$OK( J]?/E_A MT']*82Y 3EG<0_= M BD,@:P8I]NM ;NFU0L]7F_U\C\>,,BN!/@I,1BE!8* MP'UDREF*VIMR&QV:CK]*CWA@YOT!&#>>@\RW!18$RU+X(DH, ?R0T68K!PQ/ M(U&:.B/])S,M$3(,",I='0N!@DXR*9LL>&O ,U-KC>! 6:2;HF2 \R:LF1X8 M(4#,CI&&D-S(#!WL4@X*J-GHCS'UY?0+RJ@":!K%1TE/\TDP29_":=V8NN<' M$72U-<08FIKQ=K2*6U)P\>\;8"4[$R\%Y6YBMELX@B3OB:_ARH#K%$U^FGP+ M(CQ$C4$@X\.O<)$]:XPD!6$CJ%XJPG&=9B0B(=2"G"]]%2<.'4&6 8V*N1)J!J HV M$,P(YBI]!_@6+0UHJZ\.HM<@&T@9^8@]5ZSUM<21_%E^C!I)(DS I?F>!P>%I)$BZ M'7+?K&BSOH)9D?H)"K( GCZ66'_Y!) M M4-AGCL(^6[90>@O?6(N0WZ#FB!@U13Z?,$QTHNGA4!8L_X%>FIO"TB.HY%\_ M3QZ?/5HETX.LU+(02X(L #R.# Z953U GE>=)YY0XL/!@JK9 !W_'00$DZF! M R!X[IHFORU U2:JD5/.1%LG%H+M^ P(%@2",)(B%Z[+O!MP 1]M0 A]< 4Z:4TZZ9UW=YK\ M;0_*4P3&'N4#0GT#V+?$BAH\JEZ S%0T-?7$M+,P!;#<&H8BVA: TC^$6Q6 M8*X:)'A$LBS=E""58GIGV88/U6C=]LK#:36@@/Q$S!.1!=@9\3"@1Y2U3(VK M4*K+@1%W9@F/\Q?97G6Q_H!#@81F[E^SW<+[.)AB_&GR]M#4RLM!Y%N17=/[0W:);+X$^P486"7$J2]X=!LN M%-Z;I!\"ET$D1NL+5+.BM=V*V3QH@T#).'D("3Q AI#)';L.Q5 @O")EY10 M;!F4YGU!<@- 0UX!V*33V+ @[2P@2XC^2'35GL'&LD^AM- M-N1SI"0K<\T\$98'7@$#O%*, &@JZ7!#T84%!^,1$%K(MFAYT5M1O<])W@61W8"K5(;'%=(9$"IP#.,GV MZ(X?5+AU2)Z.TV1>U$]S)]PPC&C>=T9<:JVY*!EJ> MM]NW3;\#H[R;(TQ8.I)$2PQG0UNQ_7:+?NFZB]Q2R)I1S;?(*]$*CX B>K^5 M98VVGR: 4KKN\$0#E6I,_K.LO@8>4(#MTJS(C!"F0C('1M8QZO!%T%(V*$I$ MO]9W@!)LQZPM?'>?YFS_*#;.RS, ROT"IO&ZNL,N794?%XP/\<=8L- WL!<' MG=/DVO-*88E3LHGM5#91P].R/5!3?-*LKK I :*KAE]8R+,R2I9>ZDP\M7B; MR#OS;W;::J1QQGXZ\DNF>2Z4ZB4S'J0^Q"_#-VOU)CG:0C=LX/88G/?&H"802E"G_0*PA!\6PO&% M\XZ1:0KED.U]JN;@X>PL+OP:C]X=*UEZGMAGE0=%XX^;AR>_G@) M. >@P?5/&82?.%1$-*K$6XJEE 4\%DR&?*FW? 6LF+%T"]6,'ZL>+ M\+G2T-P;DQE8#LB9*2!_]" 1> %G4/ZC#-PU2/X9R"40;EXQL>KCX%@[G02; M=(9<@B9%$2&_^<@+#W/;M,@JX,F8%<+9%%W3(G\M)?V ASVD1SY6TDK'TV(: M12=>R8#^43'-FW[3;?O2Q33UE$!0!WP5#4!RX)#**AYQ62YZ.=EOS$X!@9B^ M+S07>(W]"[1>"TRU!'-N7^SV25O8=^'JB0V+^JW.Z@S-+W&8^@!8Y,K2$0)0 MD>\(I;5CR:P]HH\8,)K9 :!LW50X@)OC-'D!?+\6RXFAI*YQ1O1;("%04M$< M!,X&'"=T,^XI."5Z6,Z"B#7M=S#LOFER]D@$RP0@5DVW2 Y?.'+X8A&37]7H MTVO:XQ01W/'5V-VD&,Q\-$.'B:I4@O*%>]$A0.C*2#>H=N>F(H(@["06$$+\ M&SD3>%L>+"(HNH$#K +C21PG/F33DRE*OZ ZI.N"P4B&.%T2* ).C<[!DIZ( MKAU0#+5M"L5_(7 M@F1#20VX@:G9-3+D);LU92DI )FS "E*A!H*X&G+OG=5RU;,T@.-]X $G'4T M"5NH! **H)/2Z*U2%.WH)T/WJMBXL9:6]YFXLOSYBR+CH$N<:0'"#!LTB-:; MXYH,(P8*N[^(\I 1-!M0!HS-C&@Q99J]X[ [8I*@(\:BENT WHDD=DXL.V>0(SP4%&8M78UP7G<6B%/T!%P+G M"V,7=H_\B?6MH;M&I3O,"I((!B;.)!X+=.^CH4QK D97"J66$J4.:: I<^][ M0(+:+O&<\S.?_'6VR#J^03/VKZIX^A2F5Y0U4LUI/K]\5,X@T&"#MP$SU9J& MJLN*?58%RS/X<>63>[PH"[X$44M'+W&$G;_P$I\7J4VL.+FO) MQ9X+\IXAW\+O0F?S!CAA;YT*;_= @6ODA$F=$FXYGX^F<>OCADB"+RKZ@C7F MDGR2?$9,V>3!9R("JZ@N$#GD)S%BE/LR68[(#;V4.IF&)24X[ MX(.W26>R?=V4S4Z3/6"'SB.U>+F95/?5@*YG@% MY%WO"!NNR'DWB92_9$ ?!BN&\2WR5HC1)NJ!"VP%+L;&^R>(ITW%LT"MF'+K MV(%GO*_SBLHK]W)DR$,5[<@+M0;,SUBKF3Y@ MRB9Z]?K-']/J\-6+U0!KHW!*QMA"-DE#CER.4! Z.X."\!DAL"\.\#TZ2(GE M=\CI0;BF)%4VH)' )"M5G%#^MY+G0!_KM$*=]+7;_1:=9&9=4A;;&!2_D(4 MT_AGVO@=MT,**ZN.Y+TR9'.+ZVX'XL.=\,2NMP-'HI_.>H1 SHDARM"W;IU+ M?MJEB8I:H"63V8CFO RU"D8/#@^TB1(^LB^0?/-CC/[H4UWB6SYE^WPYF?H5 MP*=H-7P2,9WOFGJW_HY0#Y:/B84Q>@CGEG*HE G!2*?AN4:&3C MQ!HH,,!MG ;C-=/1(,C%36X' ;X5AM\<;/S&R94BD4+TM<4HC\"RF*L9S['R M0^$I,,D7P,$_P(,&0(_S="[/F0HH,@\/PL&A?X==VIAMB>8?:!YE86XH9D+) ME^C-0C'D1R4G_="XQ+B?_80E,E[,(\2V06<8Y[.F\WB1HN5G[!1B2F+MEB8[1I% MT;IMCJ##'D6+8%55 HZ$D#^*6(5$2E&'_'+ -_41IG99'JAE1T<+^#IO> M\ Z;VUJWUV)"*E4X8*XV;*X$2."/!>#E"TY7B30,S^^%:P5Y+\+ ?';"+ ]C M;"F/,\3S<=BA,5(ZDHHV!'#AV9!+D*LAK<>"4-U;6$.Q8HKE8%"ZK*'HWM2( M&&UOTR!SK"J3%YQ! :?8M(HNDO*+6Q(IF7F0(7\R[%B=*(:9RATY8 499UZ4 M*&-XS8S;0]Z"Q2EMZ;G,#(;C*D=CA2>=HTJ+MHTN.SSZ59AM13FC@1@?Q.HU MC6"617):!+!)$5BWL-ITD-8#(\;\P4B MC0-G*U@"8 F+:8 6A2_P0/P@%R3@9_U!3G*:7'/5Q% X2";HW'H]WPK##[%Q MM,C!? X@?G0X%7"T);7+IV"?+V=&:Z;\&X;O7"'4W1:)04TC!$+%' 'O=5Z1>7 ,=[CF(9[/#D'!L7GT@B MA6VCU6I8(.8&@NN6DS@4:L).#TU!R3\)4)%A:L >MNX>C69U,[/BOP_2#C5 MC#N%CLSD";4V@YQ,XFH,JSAJI'DU< SI.Y)7=> W#V?Q6(&2P7)=&'H)8(B. M!UR)6HC?^PBG7;&2VIH-.HI8!/M!6@,LH(9'R+,LL (RWXE]9;AA=FL5E5V M#C,K[-!<0BOSP/"AQ$)TQ?JZ(V Q75N 2="T['O#XDJWO55,^I'9Z"*$#I6" MY$[W?A%1 [O37.D[,W'0K5F2I7+5NYO80;#U8 M#RVD/7JYZ=Z%74B[/P%X_ MVI QT.A21,!"5CBG"!-7=S3%8P*8\H"Z=UZH",H;(TZS.!TY#;-A:NH;(1(MY B2^88PTRI(S [& MN-,:-+ #F]XI^\>XZ"@H9O3*IV?%7R;WST]\1KBD\?'\DG_F)>[]B\&CDF/% MB8I!;KY/"*21X,W+DSC1.2K&)+T&'GIX0HE/SGDR>L9E>=YU7DHW?G02E$%% M/#@\08P&VRTYWF?&/TV>S^C'R:'L[1"MYY3BR7BS+MF.-1W2)6%"#/]SHKGF M>9%D&YT]AN98'XQR$C#G)DR 9CW0BA&@\_=4R=AD[Q+0,H79L>K(5<%&4S-F M..-PK7KHC@F/CUV3(H*T8]:$28%7NG4"6OR%D5DKSC7V045ZY:C#@/,Q;37A MAS$KJ$_(RK2HR"4;*%UV6%:M^ISHTZW7M3M$+C/T3.PA8J,9CYZEN68*\76""J\COVD7(N!M'8CEA_]!H(C)ILP,Y\# M:0?>3"HZ-IQ\A@DF.S-G,C#KH$G#Y5-)E4LQWQ)D5E)W9XOWHN*L)L5N8.R' M0RKYNRC(J-^(]B 8UU"PT1E:F;A?50BIAX.619*S$A5I3NY.XDXI25C++9XJ M11,:?M>B$PD@CWD1Z#0/.=C4JJ7;#J5\M>R-9#<^MJ/<>4JUYB-JUX&A\SA/<&)S/52D?Q\K8Q:J7-9T>W&M$%MW_!M M#=CX^G[?[R@XGLAIJSL(]!6GTX4%:80IEOA7Q=U6$/<#=8H\WG0,ZDPBE[4[ MQX&ICUXG&Q&69-D.6FM,IN1)3H.PF7"94]4E4=<3S,JDMP=K#TAR>2%#OUI8 M%??!R5<.CBC<0_8X&E;88T/HZMR*0Z85B:8F<+F1K!LT]9D0>6&/*#YTH/8> MBZZ X[0L@5PVM,@U8KQHY*0

\_G'1Y#27[+T #7)Y& M+90K,TXZ-5!4:93A9@@IMZA(IV./EBG+M>H0T_RL:.>P28OF%@XGUB+'X$<> M"0K?+X2-ZGD#:+!ZRN"(MTY2%:= <$,RA$!5]R'75C8(3MP M^,=]*GC)UI>FF(%,19"(O1(D@(0 "W*F[T"Q&N-U3@;80A?( *]%S;D1!F+. M]<,:<_5Y:XH,%6E&4*8'GSY,JJZ,1"7MT1#6318:;8:;$HUXCB<4_';7IE4( MPJ ME_;:;K2+PV//%H-UOIO+^7(? MEK^);C<9H;O;J]'V?:]&*GK,R37@%&UV1$,7_ER M]LD-?O0HT5ZYQ-(H6T!,L/)*:E6C=>EP6B,A7FZ))#DMHA9DR! MM0)S.2^:M61/8%TK%I:M0^44+?5FQ\5':"^MT4"E^IRJ DTC$SEOC[8SU1H3 M'3%&HQY8WWI.2J!AJ7OJ=7CKBO/Q+]*:BGK;IKXKAJ0XBT\T[Y%I2GD-*:)K M*1"1ABM2#O4#%ZEBJ1$#3D06]53)N8&+:['&738HL1K@AF4!5(@B'$,Z6,ST M^$2RO4D!GLYXCU(Z?+*$2". BW$UM)06DW$!+W;68LZE7\'.*"@)AE9_H )R M_(62>_> MVB)JG\.+?V^S8R"*?!?!ZHIT_("= M'="BF!IRYF&7,#(-2A%.DGXTE!GH)AKYWGC_7$X>0D#+2K%)DZ]/GH$$AP[K MH#&)ZRCB+:7K;:K@1H3YBQ1E#@MD@THGEOID5*V"6>A;YW]6=:+6YQNI;(N\H#M*/1JTR'() M-;B(81JV5.'Q5N-WII?(N.7Q76 Y\W"T.AH^K#&?\X@H'SFW2&4JAE8\7^5TQ1=]P_$DWA^HCZ63\PR:"[ MIA.5V@YG.^G:#>F3\XF1_]Z8T3"5P:4NQ^H(67PT(T:;7FN.GV&QY_HZVV,% M:-!BHFIR4W+:FR#8!'[%>$R\=1GY"07$T29/VKLA0^!!<0EE DP!M??,N$44 M05=KTKA)-_3D/Z1Z1V.!WMU;3B.EN+NQLY& (-=I<@]NU?$@08R$8@( IG5) MP78.D9#*KI4.VK%%;;:/ZN81D4^.BDNG62L>=!K\=B 4,;$H!7SU_/ER#?R; ML*KHA<_YG90"GS:4=%%SW8TF.NOP_OT;,RQL4$ M?QHU ".')85)&@D*1%8V:IN6_3D^W(@8^A.FS&&_M)ZR(F9G=74XOC0FW%#H MED56;5I4@M@_64OHA/WFZCBDW4]X&S@W?*$B$%?*BFKJ6FIP9J'O,2NI4#\! M(5NLH-<(L0N"J:'+N-C[LQ M:FK/#GC]CKIU\I0$ZP'&C NU,%KCSD./B6/7@GGX%U5Y;JJ?C]^>E# M_6(5%%N7QRB5YVZ)0_^W6[L\/1]L[?STY51GH'*"2E@K"H' N!5==$C2& M89JAJ#YA-8\&]!$Z-\,&"9J6$_1F&)- ;=*(+?DG[TD)(@O;-..(A#SD?=!!R2):E<[4X@=/ISUZ M/J<@(8>6-,*1^RN0Q='KU,6RQHM*)KJ).-5$'_9A$^W;'7HH70,D,0ZQZ97L MA00HIX=3ADG+@:SNUL!Y*J%S)5'ZW!;Y'16CW_8Z9-=VYQZ')DP/(+;>E TJS,%NAK&G''W3FAF M'"(&X&U@V\TM;9E:X&DR1E&A#PJSO:6A!V5=<0-/ M>MUE17,C5S1(D644^? 8JC0WTFD'7^=?G5ENQ2>?YKQP/$OJT_WP(KP+@ZZ1 M./^"&>BX>3H-ZCHV^JZ[1)H!>Z/&" +/H#=OKL1!Y32$JL&5)Y2?*IV-4[K+ MH(LT[3&485/$>>;,GYK"4J&MP ZP"8R=!\] X12-R;>9'>5$^E[[XDXB[0A3 M$A&@R-( /&1RLJ^]H&["6O1)8O=^>N*XF8.5UV_%-!DJ(V9K'1XY*1,RC;,3J;1D1Q NCX="E^X. ES-O8%B$ I;AQESP6$ MZ3O5$9N+ZK>[ 9VMI58KZC4:GE1/:6HDV[=@\S4^CU0;SH_%#]UV0=[BG_I< M'=YADN%*Z%_;.''HEAB5X.(DGG)6AB_9"[;6B9%+*OBPSB\)RRG7Y,%6=V7D MP]/^?-.U@GS%UG1-'S5%GS+JROG->%G.I$DE%C$LL5X9W?7I!L#7U'J(HG'Y M-@?NM:CY0IA#^69*KTID"PI M8[[CT<4'&A7)K9"(:ISU\4(B+,^X80ZFA1626A7T"Y]4W_X14\7[]/V2+I:; M';UBD^1'3 &;7/O=7X_;8FHHDS%=^[JBGDTUWLIJ?,&PE[>.*U#R;'PI13"2 M%B.1CU/?6;&B3T8%3>>[RWA7 '6816;(8<%!;L<@#]7=\**.J\;WX!ZVWFY= MO;W)F:H*+ Z)5Q1@O61V4A%(+1D7IW+=C?:_'0'0QXO=WFS\!.DB-/W116PX MC8!S.BCOS.62^WKK >@"-S#G>;T8@I:R*UT"FV^A9Z,>>CY0I5V!-ZF=KS.= M Z[D;\=M0'W].W4;=A=FX*J3D.8^5AI(6ZKAIRZ?1S8YL#1#$J()'D+HKJ2*NY&3?HZ5%RYRZ?/_ MTJF6RBX"1Y=NL&;/.F?86]EY=='0AJ&GGI$5N43=JM+-\G MN[+98$4F]:;6RRC%?-7.T!0U]YVMP[;4T@EZ>".#M Y%CZIUM4R*"(C9%V=? M32$!_73^E21164!L+OGC#I)XDY0O700M@ZZO2-^3'.R[?=-2;\NK#RTV1BN? MS;G5C(NPZ.C1V1\FYK;E;G,,)5<&F#HKRUC7)-B[TQ]R&BB^="=JJ /*T MG'A&?FFV)P5IY,(I1.U!#1M#AIMPNIXF$\2Z"MOPCDL>V/*T.>(G6OT&AFI9Y7WO"PC)B\'/[H9+W!& M\]U6G:DPZ;(]#A@VO\Y]4JE;3!2JY>)3UO7"OK_8#$>2DJ9XA O9#/>(>!TD M,U!+$$;8&R.-;W=<>FI0D7"WC[F&%XCW86]^]5:B0)V8;FIQ45^+-O!,3 >E M!C$IE:H2"_.-5OR2XD[%FBG)3D]J'>9NB[RX((OQ<]:#09]*GO M6^;R\?!7^HS6N8@S#GV\/;T^5=%'E )#/AZZ7G/*U0_O#>8.*>X::,(#0/EWTE/KNBA?+S1"?1[?+RDKN M?]?8Z6O"?ZW1XM7ZGFH7RTW/O@.+3:VQ370\%7O,: M-;<4XY:;;,)[J5W&G&]II-<4ZH#3EU5RNR;)REB\',??@B,MG.Y\38Z_*'%F M&>0HTFMS"#;8<(/, W1,$; 6[LI9(A??"^?B0UUL,B[R>X4]^D&-_#-(X?^" M?5^A+PTV<^4YU^NVJ1O$G-D^TK_99,A=OZ>(K+^1\INKZV=\M0"\>/T6!CNE M7]=GP-V?-[EW\[VJ2$'BD=9X!WN=NV9-;TP%O\$_3CB[$@Z*D5B^O=T]W_+S M6+/9]*B7AN]E^DYPS,YBHP4'6[R6@@$;K1;)%WL%]46N>C\.#-HN%FCKUU@- MBE$"^.J6=?J$0G0*"=Q.W@0MZ!$$0<48F)4L$=)^_$M<4S* MW%\O4'D \(]6KCH=AO>!T)4T'&9_F+IHF;%T_L'(A,#NZGBUPY!Q8C.#G*LG M<2#6 /S*B3EBO(3O2(V6H:L<&A^L1'BO]_*0TF=N4(_A&F7,5/]\X&)W <;$ MU3BG'X?XYZLXSW$M]:O1E_=_; Y%EGQ^_O@$'\A@MN0J-M]>>YHES7F1P(WO])>DI3R'X)H6DC#[R% M_1]"=+%/W#>X" $VA)?O#O>O0EC>'G 9)3.T=;D^^V*51/Y7):.'9TA&D8B! MQ?I'\;;+#(0YY1BO6(+P9#O(0IZ\]Q/1]KC@ 1<3!9'"Q MEFM2@SX8[(6U8G=%";@%8D.D@[Y#MWZB[8U9JZ0;%0R&HH;HM=M@^4,(J)9M>Q2XH(=)JT>.NK-UZPKQ MK?:$Y$N6,#3GBC$\N-D/=0QKZ=WHE'* -]_Y)%[5@)'2P^R&1W_PJ$YNJ4QO MK $+7"J>79L/VN%8&(D"Z:YR;S!=L>44B:C, MS2TM+/*Z[KE7AP,G-6LB?5#526FK):518PC_>FSFX;(V&/$47B0JP.P@T:># M2H)Y8"?H(MDU+45Y?*\1$25TSLZ%ZRMDE97\R[(9H2-9EMY>2N7D.^D@KUCW MV["5*;_. RIR?Y%VZ=,GE6EWYKDI2QP,A/+7]S#/PGV+8ACK*[Z\NKCW -[T MCS]]<@!U"*S)'2:#EF8+KYZ=?O[H'F=TZ(>N.>"0J$9U345_[DT*TO*?_"U!+ P04 " #R@%=9Q=]AW!D# @!P &0 'AL M+W=OV4[M_O;$/&M!9M+XE]OOONNSO?>;H3\E$5B!J> MZXJKF5=HW4R"0&4%UDSU18.<3C9"UDS35FX#U4ADN36JJR *PXN@9B7WYE,K M6\KY5+2Z*CDN):BVKIG\NP#L([LMMH8T@F$\;ML45ZL_-4M(NZ%#R MLD:N2L%!XF;F70TFB\3H6X4O)>[4T1I,)&LA'LWF)I]YH2&$%6;:(##Z/>$[ MK"H#1#1^[#&]SJ4Q/%X?T#_8V"F6-5/X3E1?RUP7,R_U(,<-:RM]+W8?<1_/ MT.!EHE+V"SNGFY!RUBHMZKTQ,:A+[O[L>9^'(X,T?,4@VAM$EK=S9%E>,\WF M4REV((TVH9F%#=5:$[F2FZ*LM*33DNST_([J?L,S42.GB";=&234^CSE6L8$!M8,%5FP'@.UV75:LSA[TA> MHG_:P4.!H$VM86VZ%&P,7"O0=$!WHVDULSU$#-8=@_S 8+F:P$,A$?^H.E#- M--9KHF4*=T<^3YV;PII/?+0Z+SE1$*TB=\H'?,[(!!JR4+9DK!8MT>S!75NC M9%K("9@+7=%%AK=P/AKZHW38,\MX[*?1V"X'ZY-&@^C2Y21-_'"40#KPHV0,:>S' M80QIZ,?CH:L6C9\.2HOL$?!'6SZQRJ9Z#_7J_[])'=P7_0?>E+@B.IA:5;VMGLZ*XJ*9N@'72;OQ?N:GW M6]V]';=,;DNNH,(-F8;]T= #Z>:QVVC1V!FX%IHFJET6](2A- ITOA%"'S;& M0?&PO=V]R:W-H M965T; MV#IH9?#&@:_+4KC= K7=3I-ALC_XK-9%X(-T-JG$&F\Q?*EN'.W2SDJN2C1> M60,.5]-D/APO1BP?!;XJW/J#-7 D2VOO>?-3/DT&# @URL 6!/UL\!JU9D,$ MXUMK,^EF_]0XR=8ED*C]=6_Z+R4$R3JP1R7(E:A\]V^R.V\;QA>])J M'__#MI4=)"!K'VS9*A."4IGF5SRT//P7A:Q5R"+NQE%$^5X$,9LXNP7'TF2- M%S'4J$W@E.&DW 9'MXKTPFQ1>SKQ'JYMN51&,%4>3N_$4J,_FZ2!?+!D*EM[ MB\9>]H*]M_#)FE!X^-[DF#_63PE;!S#; UQD1PW>8M6'\T$/LD$V.F+OO OX M/-H[_Q\!]V#N/37 7'ZKE5?-D3 Y?+3*!/B*)M0.H2D#KJ7?YDL?'%74[\\Q MU 8/0^ NVSL*R%QFE ;>70;3&:O7PTO!N^.A#?JPAL=LSZ[;9H+[ JZ2 _" M\CU8[@X/GL-_W,-=@;"RFKI9F34$+I2VI=5?Z"'PM5 .-D+7R#BJVLF"&@BDAE3 [^!5.%5T4MO:4 W\VAO?HI5-55)B7MJ:< M?'C>Q2/C8[@6OH 3>-N[RD9DWP2"3,E\@N%T> 99[V(P@#L;A'X*^ 2&66]$ M!OYX^A M7Y3"!R*K4+C!DHW7U&+LUBFBZF6O)&Z"AVVA9$%/QX[>4D]O%A#)=<7&3[+^ M!;TM6D>,!BJQ*Z-*3O'0/2-LDY3#LJVJUZ^NLN'E.P^>O/A5#$6B"S0'8$5] M9:0B*KF)*G3>&H,:[/)/C*^PYRK\6!N$X673V6TP[.IF3_]\[3!&VH>?<4?( MJII Q=K R';+JI&ZSK'CB$ ZCKG&WGX!&\N4:A5V$5*NO(QE1!1A'[ZP[R8; M'='4Z3S_@I)$'5)Y=IG[ 2TEADH#%M2<1@E#^6N1@ "G_/UW!FMZ'S2LG"B1 MY](CMTRCD/<=MU0*2L9&(JX499P,->EJJ)=U4Q(;2D=!V2NLSEM4;3WD(,+C MJ+@@2IZ>->]HJH3&&L.+8/"AHF20)J6;IC4$="57+PN]5$O]YUZH]&#ZE.C6 M<<:R>X+2#*+NM!OC\V9Z_2/>? -\$FZM:/YH7)'JH'_Y)B' <:XVFV"K.,N6 M-M!DC,N"/D70L0#=KZP-^PT[Z#YN9G\#4$L#!!0 ( /* 5UD7$M^Q. 0 M &4* 9 >&PO=V]R:W-H965T+/AHB8*MV+KR$90DANE MNG)\UYTZ-2F9M9B9LT>QF/%6526CCP)D6]=$[&]IQ7=SR[.&@V6Y+90^2[N3!&G0D:\Z_ZLTO M^=QRM4.THIG2" 2G;_2.5I4&0C?^Z3&MT:16/%P/Z#^9V#&6-9'TCE=_E+DJ MYE9B04XWI*W4DN]^IGT\QL&,5]*,L.MDP]2"K)6*U[TR>E"7K)O)L#;#M!_!S"%SYRI0L(]RVG^6M]! MYT8/_<'#6_\DX!-M+B%P;?!=/SR!%XP1!P8O^%\1$Y;#DE9$T7R(OJ02_KQ9 MHQ12YJ]C&>@,A,<-Z#*ZD@W)Z-S".I%4?*/6XN,';^I>GW _'-T/3Z$OGKKJ M ;Z!]R.YXU+)8YZ?Q#[N^:J@L.$55J^VHC0OP-PR)4'A)1E((WKKBIMS\X#,0>$U%88^7S#84_>:7GH(#E83XP-O)297GL-]W51\CV8D M;4AG&>@SOH\2W3V#U/;<%.>)%YSCY"=VZOJX2.QD&L #Q<=CS-$0Y#0.X>.' MQ/?\:PCLJ9] Z,.O&+< +[;=,$()O8I3]"L(-.S43E#L#*)0#ZX=^$%G/$C@ M!,&BD6#1CQ%LV3$"UGM8[1NJ!33/CM'LI(4?H!D!@5<7^ _:$9%KRYH9=[QN M"-N;],77\@V-JI*LRTKS$M6,/-,,J#L&T'<8< FK[ZC[@O2&MR3+1(O+D0.Z M!KGY>%DK!+H^ZI:O;BO.MA>*BOK5_3'"KPG638:,TR^\O'RAX-,+!>\'\QW% MQD>@IUC'IA57I'I+Z(F_H M,3"ZIWU'YIZY/4OOB"R@(?NN@">8\S!"U(D7ZS'U(AS1S02\_-[$YQCNPD2KZ/ZTBE8Q6Y+@01>*$=I#[XGNW[ M,:90XF,R?+V&BZYW> ]E8F"T ]KWQ(YC/7N1/?7P]&'\S/\)=#:^ H!'O&K#/F.>22:CH!E7=RQBK M6'1-3;=1O#&-Q)HK;$O,LL ^D HM@/<;SM6PT0;&SG+Q+U!+ P04 " #R M@%=9?/1@>P<& !%$ &0 'AL+W=O(X&D42X.]YR MOW2VHRUS;L2%JC[)TJ[.1MD(2K'@764_JO6O8F-/3/P*51GW"^O^;(H2B\Y8 M56^(<5[+IO_RKQL_[!!DW@,$P88@<'KW@IR6K[CETU.MUJ#I-'*C@3/54:-R MLJ&@7%N-NQ+I[/2-4N5:5A7PIH2WC>7-4LXK 3-CA#5P=,-Q9L:G$XO"B&12 M;!B?]XR#!QCG\%XU=F7@=5.*\C[]!)4<- VVFIX'!QE>B_880H]!X 71 7[A M8'GH^(5/L_R5-$6E3*<%_#F;&ZL1/W_MQ7\68E8*$JS%G9+,$2"L#M M-N@;BYO%"ATF#,BFGW*M[^@HKU776-)HN74PE@YWIA5:JI)(2EEP*\H3^("Z MW ,*8)BMJ.="#[&FGQ".G"#5&0R7&<.Y6,JF(8%S7O&F$/ <0C]C<9;1R$M8 M&N8P*[YTTDC*?\3R!V4%A&-X\2P+_. E^#Y+_93D/L@'1U&& MRFFET=9+V4@K?GF'=6D?!.=W\)[_C:\FLL822-P66M4P[PSJ80P6W!WG4Y(I9*ZA[31B MQPC#8+V2Q0HXIABB1EOY#_)7M\*A16H0QLJ:< *=$8NN M+ G.R#R"M1;%9\ MUN/EDZO'2/M&*U3F8HO/68_/65%T=5.'=MX@,VPN\/_P06W\'WG2RP ML2&A%<6J495:WD%Z["'D@I!E<8J#HX#Y:3"F)9\E64P#C_EA2'L^BT*?]A"@ MJ1>@_;?87]O[#)/C'/WALR#QD5OFL2A"]*//,C_;V4A"EH3Q&**4)4$"-YJ7 MV/CQ4N""9FD*#:\QUY/C /R(99Z'&D0LS)!=A!FTLQ:DR1ABC,B%ZUT8$2TJ MYQ:SDJV!&(WT@VQS/DA9[*&-J$J>[:XG+(S2,028?2%")/ M(?R/1GR/7ELOE_NYL^/:7X/.Z^_M@2,?S?YO$DLIZ476E.]2W!(RYJF3I6!F+G]J%$3V"2-5\4QC,1D-, M[)N5%@?;P>/;Q8.-X[OIA3*N6368LQJ3J.E(E7.DF7"[J;0IS[ MD"#@?8?, )."*@*".DSPF[,@)+SZ.:*VAP_T$9F6Y:681R[%R8M' \O*; M:VJE-*TRO#)#Q(_2)!_?S^VC/G*(P3YR8WB+C59JAQR\:V)/I,H>A"D=P0J? MC7^\G P%+ M8$H6'HI\-T<]^3O097':6;L2/+5D'Y3[AXKGHQ=^K6ZCU$RXM MW.[!QLD#W=KAYBB$VD%K[ I$G@>T'E/S2_RRW84KC#&+F MY3F6-X'OYH5%B3DB*(,;9;$0##'=%\K)SM,.N^G2/6 -UE94LW_E#:O#&WG6 M/PV_'>\?V.^Y1I0;J,0"2;WC%&^/NG^T]A.K6O=0G"N+K=L-5_C.%YH.X/Y" MX05Z,R$!PS\'TW\!4$L#!!0 ( /* 5UD(>H\2[0, L+ 9 >&PO M=V]R:W-H965TO>O7N\HVZZD^JS MSA$-?"T+H6=!;LQV$H8ZR;%D^E)N4=!.)E7)#$W5)M1;A2QU1F41QE$T#DO& M13"?NK6EFD]E90HN<*E 5V7)U/,""[F;!8.@67CDF]S8A7 ^W;(-KM#\LETJ MFH4M2LI+%)I+ 0JS67 [F"S&]KP[\(GC3A^,P4:REO*SG;Q+9T%D"6&!B;$( MC'Z>\ Z+P@(1C2\U9M"ZM(:'XP;]C8N=8EDSC7>R^)6G)I\%UP&DF+&J,(]R M]Q;K>*XL7B(+[?[#SI\=#P-(*FUD61L3@Y(+_\N^UCH<&%Q')PSBVB!VO+TC MQ_*>&3:?*KD#94\3FAVX4)TUD>/"7LK**-KE9&?F;[A@(N&L@'="&U61WD;# MQ4>V+E#WIJ$A'_9DF-1X"X\7G\"[@0FP?$K>68-P07,1G 5>X MO81AU(%3COS1%;.' M''5#VKJ9Z"U+>@('\M+-&2S7J-KK@WM, MZI6!6QG"!1=@(^^,H#T@LSF3 E%YQ*12BEC"@FG>*?Y9 M?]WB'XA8._-:,],EZH(5="]H=W^N2)D4EHHG1'3%-X)G/&&DX.'XOVB^E_KE MB^MX$+\^&OF],[2_O?@#UM]N_K]QV%0Y%<>_I-&X3:/Q]Z;1>WS" H:=U0JW M]J/$S7-7XISW8 O45YW-/O]-Y7]1Z(8V6 U+E=KZ[RS?"7P@W*,WNRO%NDKU MI,0+W' A+*MU?<=[T>/^S6A 47^IN']8Z%LSZ.TKNKF*N$]=!2S9L\^@9ODB M[K^*HAX!) J;=RFE9UQ6-A\(:3"\AGAT8T/Y)X/FI1C?1/!GUY\#(%TU/7TY MH]!(3.GT;&"8UI(DM+FYXR9W>Z@-+]U29O/_R>4_T4I.Z4.=E#,45OG2*X^G ME">MO?H[5 @I0=>46)JV+_-)5UU\V5[\YIO"Q#/\9G/E)R8JF[;.HW7-NH36 M]N4[Y?.RJWK"@P:E1+5Q;9@&A^9[E7:U[?1N?8.S/^[;Q >F*+TT%)B1:73Y MBMY7Y5LO/S%RZ]J=M334/+EA3MTJ*GN ]C-)N59/K(.V_YW_#5!+ P04 M" #R@%=9FDMTOA6JB]ZR;DA=ZNJUL>3I3'KP^E4%TN^ M8OJ%7/,:;^92K9C!HUI,]5IQ5KI)JVH:^'XR73%13TZ.7-^E.CF2C:E$S2\5 MTG*T9@M^S%L>3WP;$:]X8:P)AI\;?LZKREI" M'%\[HY/>IYVXW=Y8?^,6C\7,F.;GLOHL2K,\GF034O(Y:RIS)6]_Y=V"8FNO MD)5V_\EM.S;U)Z1HM)&K;C(B6(FZ_65W72*V)F2/30BZ"8&+NW7DHGS%##LY M4O*6*#L:UFS#+=7-1G"BMJA<&X6W O/,R1FK6%UPV>MO> 1>SEY)VNSU.1U7?)R=_X4L?4!!IL SX)1@]=\_8*$ MOD<"/XA&[(7]@D-G+WS2@J]XQ0POR2NABTKJ1G%-?C^=::- ES^&EM]:CX:M MVQHZU&M6\.,)BD1S=<,G)\]_H8G_$1ID7I8EM9:D7 M9!E0E,H<&*Y6/X25YR&AGA]3E139Z*ZMOZ!MZENA^"<]3* M,)R]O0U:^B?!]1D[Z8&H#]9*%EQ;D.+(R_T\;"R/:9_']*EYO%0XE2AS[V"TVK?&.<$,)774 MY'!2=XSSC7&/U-@N1M+\2?-Y4Y$+,>?_*N5O&E4+@PW(^9V+.^,VHQ@Y#+T\ MBMK?/";O6+'$.M1W 9+P(":9[R41)6GBI6& D?I+2W7@6#:MFCQ,B$D2> D* M#]@&0.U:SLTM0P H'\"91_8G"E)RP7'L6Y%/[4^6 MI.0T#%&YEG!)XD4A'2-SKA!(X,8(;I#I,7@LU$)DEF>4=IZ 5I1,Z73"U@DX%44,\- MHQ"/XA"BAI,H #(!B7W/AXQ>H5=IB#!&-'51,1SGK>S.@#+.F#2&U6"?//\E M"VCPDERR^Y98>S&8GN'-7DZ]- CW[5IV8XLB;!E!%V04CL&=]W#G3X5[@\;K M.WS\:#YXIAHU-@XR[\PZ;DM@J7#25\K6Y 9N@;<_=P?>. >QEK6LY.(>S@H; M!UEO$F\E)D'!V]\,67U@I9RC2@$VP)QSQ!9!'U#.D)FD'\5K<(ASY2BY*SJ% MM,2%5B24!) *VD]RFS!&-6X:*)%0GV#O];>&R'M6H0 B/\3N$VZ?#BJK3#M) MR[TTS_&?0O\V!MK/*)MED%8@$,3MQU9.0>^W=8%WQ+"[K5J+ DIB_)WW,U%3 M]I-@QQ=-()%>G*>])SFKQ,+)E"9&]HXUP%-=;;/R3_2V^0Y\+XXSJ[]9^$0C M:!=?D!+3BJ&R'YTVDA3:FEL!-LBC99)C3\E5.^Z@9]C:2BEZK/CZ^!\E ?G@ M.(B2@D0GV NZPJ*YI4*.TUDRNH-3_^%CT_\'-=8+?NO_7&)WX4O[Q7_#-[CL M74@-]L[NW6M9/[+/_XW?CSMZ:>S';7Q9(A<7;7ZE3&">WVMM15 MZDZ4HHNRVD19;*(\!'G<3#OLHV*UKEHH3K<(<-E=;]AR:9/PBL\1>PE!KM$R MY!*QD \]([I3[??JW>DB,P,Z\ QZB@-S;G=)Z@6 $CVH@)SN=SYWEV270F8< M9..H3J@V"G\NBI:0[3'(*A+J92^A#^KM'K8"&= H%PD-_.\BR>)@?XA=TZU; M#?!_X>YNK"PVM6DO./K>_G[HM+T5>1C>7BZ]P\8E4$X5GV.J_R+%MY-J[VO: M!R/7[HYD)@V*S367G*%\[ "\GTOLR-V#==#?FIW\!5!+ P04 " #R@%=9 M7KS$]@0# "O!@ &0 'AL+W=O8,W.B"I2T,UA&: M0B/+/"@781)%IV'.N S&0V^;Z/%0E59PB1,-ILQSIE\N4*C5*(B#C>&.+Y;6 M&<+QL& +G*)]*"::5F'-DO$%*@L;Y*#B/!Q<=Y^\=?G!-U5(*_RBEDV'FJU NV\B3>*X=('L^ IG%AKW M;";0-(>A)4JW$:9K^$4%3SZ ?X);)>W2P&>98?8:'Y*46D^RT7.1["6<8G$" M[:@%291T]O"UZ_S:GJ^]+[\K;E*A3*D1?IW/C-5T%W[O2K;BZNSFG>I>^O0R[]=TO$5*F M]0N7"V"Y*J5U$2R9+U5>,/ER=-!/XMZ9 :'DXMBBSNE:4]5214_/6+-QGRM! M3YAH!D"G9#&?H:Z/BB2G:TOL+6UH<$DX51HF,].$B>8RY043](H$DRD.X%IR MR\G@8PK%))1TC;2/]JV4"$G;<\60:LRX!;;0B-02+!Q"G'1;411MS>Z5);+B M;9QZ?S/>H#$#>)!4#6WY7\RJ?#.Z);X\C4ZOUX1&MQEC9.DU>]$?FSWNFM%::FURZUP :ECO-:'_[E4K MOV5ZP25=*)P3-#KI=0/057NL%E85OB7-E*4&YZ=+^J.@=@ZT/U?*;A8N0/V/ M&O\#4$L#!!0 ( /* 5UEJY=*VY08 $4 9 >&PO=V]R:W-H965T M9DLC#^3AS.-'96JIO>B6$@?NJ MK/7Y9&5,;!IV*Y,O1@>G'6\*6X$>:/YEKA MW71 R8M*U+J0-2BQ.)_,_=/+&W$KYC6[>Y^<3CPP2I<@, M(7#\N1-7HBP)",WXN\><#%O2PNWQ!OT7ZSOZXVLE:^Y89?G"FY!D6S$8T&UE6[&HTK:DK*C5'XML!UYN+&R.S;R27ZE<.5 MK##7FMMP'7WFMZ70QV=3@]O0Y&G60UYVD&P/Y Q^E[59:7A7YR)_NGZ*Y@TV MLHV-EVP4\$8T+@2> \QCX0A>,/@<6+Q@']Z**]'[?,T?D&(&YDKQ>BGL^#_S M6VT4\N7/7W=/8['+]%'PW:9_7@D+S^L'K,%,+NOBOT*#MKO?VMVS[=V+&@PN MR62M95GDW. $;?"'(JO)<-039>=J!SH V:W)1<.5L1DP$M:K(EO9YTJ4%D94 M32D?!#UHI#*XG&M8R!)U19_"YY7"5]O, ^0-[GLKE"7/!W1W[#V1BR[!UNC( MNB-;S>M<'S^_O9+:D$8X:4! [2-*C+*E.4F_%$76%>DNH5YV$7'<>CYYJ @;XC,4,#+$L3?+=TV):\U%/H):3ZT-OU43J0)&KY:%1?YR?P.8[X4 M\"O*@CE!:17P"R\4?.$E9ADIW*V CZU!>MY]@4]P8='S EC_QC8S U#N.)UAH=7#@R.?$QI-DO<%GFVB? #&DH'=H+MX M+'M[6RP89;/POL[;K-/):PPI6]WF]1^)U!V28J_XA%S UC=Z0LXJ$LXI>6Q;50MG5"LWNU?GVAC&_VPT)I MMDSH%/<'I?/O5PESXBB@*@G=(-VJ$M\)L6K\Q$W2H4HBE#H6NF'P6")'<1P= M0^B[2?B"\@B+8J MQ!UU3YO3\,4)6'.5C_$O&?B7O)1_[S:G9L>UZQ9/(33!EHIC$]4=W'.-+&KL MN;R+@N/[49?P6%7VF!].Z\Z_9K.O(NIHK$^D!0;!ECI6LZ9T4:PN2XZ=Q4VV MDB4!68N@P5C1A$KFHJ2LXDS<#:/8"-O6=_D!6]Z/6!V#+1$>O3M]12?P=:>* MP'X5.8B(J2=P$+M!! >)&\5TY_ON+(%/A?YVLJ VI4 N$05 $5+DAMXA3L-? M_Q!"-PJ[.X:_;[$B&[D M=9CA"OG0@7_JJ)A4^=DD<4[A1 MQ-V=Z0]EKR->QR#] G'[V,_\3MW>W6-Q%U0S2$/Q_?LKI!+]N]!BD_99J&H[ M!_/E4HDE9?D]3BKPG]FL5\=GS>0/)3)((MM8NFPV""3*)G9X/O8+T6 EJF$P M.X;$C=,M@:2V(G 1XB7R2-L=$&P00$K8!P/=>A&F$UEL>(?=^AV1>3<<$8P@7I%EQOM!7+/=8$UFTT@[BP6/C_F-P>]?)J(S3F?MVH3NYJ"5'5!$KN#%.P\M*=;GV4JH9;VXQ.V ML+*M3?>%9G@Z?-^:=Y]U'J=W'\=^YVJ)X@&E6.!2#PMYTIVDFQLC&_N1YU8: M(RL[7 F.+3)-P/<+*&ULO5=M;]LV$/XK!SK?@H^ KL]4&\N1. MJ4_4>5M>#'PRB->\L"2!X<\]G_"Z)D%HQN=.YJ!721NWVVOIKYWOZ,L=,WRB MZC]%::N+03Z DL_8LK93M7K#.W\2DE>HVK@OK+JU_@"*I;%JT6U&"Q9"MK_L M2X?#8S:$W8;0V=TJ;F[?XA.]9Z%:\^N MPH,";WAS"I'O0>B'\0%Y48]4Y.1%WY%'B+2^?T#(M,6$MX(;^.ORSB!^A?U[ MG].MS'B_3*JX,].P@E\,L*0,U_=\,'[Z)$C]%P\F[).4:"K5HM#"\A, _!J5ACBQA<0+52:07S>^Y M7")BF"[ 65'1A*TX-%P+51IP$$C+2P]N*\WY3D8 QM/RQ1W*HZ#^@98@ MTR?::EUS32 @USC-RK)ZV[ ^P^$2P@2.(0CH$ZU;MVCJ3-5(8T+.P5*BKTTV MR PU0X@-.L0L,,WW@,"*0BUIL>8%%_AT"B(MH4SZ9V3@\01](31_)8XIAVM3'3:@&OOF#L M)!JT.0N00;:.@DL,K]E'(X?UW>Y)_4))HVI18KJ4N_2!*N<;E9@L;%-$IA+- M"19+K8J6ZG9S"9X)*C2U-,CCYOE/2JW+!148'.]GF9\X:P2#(T@3+QQ%D%/J M'<$H]](X@RQRO6 4>4F20!:Z;AR,O#C+(:,D?K74>-?#S/-"/V]Y+XR]/$^[ MPAAY?A1WJ8Z+_ 07C;#S00J*T8W%4!F(O!'*IV+)O2S)@ HH#KR$Q"2MF!SM MH>:4&TN>X+VMQD,#[4S!L8\7QKYKQ5Z0MV.YEV"A4NO6^7T$>> %?HCFMGX& M4>(ED=_WPS3WHC3H^TF:>:-@/4\9UVA5+@NL.DJ:!CT@DI6EN!?E$C4XEM1T MPE.E<:T%5B!U];I>]Y/-;8OIV9)7/I!7LBQQ=!/EW@BEY%MD$:>AEVZQ09R/D VBMK\O=X9;3RH\ MZ.;NX6A:4FA?5_UH_S:];)]DF^7MP_8=TW,A*;]GN-4_S? PU.UCL>U8U;@' MVIVR>*JZ9H7O:ZYI <[/E++K#BGH7^SC?P%02P,$% @ \H!760\[-Z=' M P , < !D !X;"]W;W)K&ULE57?;^,V#/Y7 M".\VW %>;K;7YM$VB Z>^T[9>= X-UQ'D5TWV$M[I0=4=++1II>.MF8;V<&@ MK+U3WT4BCHNHEZT*%C.ONS.+F=ZYKE5X9\#N^EZ:ER5V>C\/DN!5<=]N&\>* M:#$;Y!97Z'X=[@SMHB-*W?:H;*L5&-S,@YOD>IFQO3?XK<6]/9&!,ZFT?N3- MEWH>Q$P(.UP[1I#T><);[#H&(AI_'3"#8TAV/)5?T7_RN5,NE;1XJ[O?V]HU M\Z ,H,:-W'7N7N]_QD,^.>.M=6?]"OO1MB#C]-YC(,_R1^GD8F;T'@Q;$QH+/E7O3>1:Q9>R"8M7PDMQ$7"%PQ6D<0@B%MD%O/18@-3CI?^G &_SAS]N*NOU M?YXKP(B?G4"OQJ)YPF#QW3=)$?]P@7UV9)]=0E^LQK<$>@-O M$OG\[- HV9W<8?4"=T;7.[Y>J6I8$95VC?9<2A>#GD_IH4%PW"50\4L'?Z(H M5MU:N=T:W$J'-2B:,V9DZBD1^T=2?6P5N$;O+#&SGZ[AH3&(;UJ'^ X.^XJN M@V__%^)TZ9R[@Y?T1%H:+>N*<_\ J0C%)&3?\+*$IF->'% M Q8>L*8.,"VU B?>T[!JOS\4/2'TG'@681)GD)=A7)2D3,.L3-^A*QA=<#*" M31ZT(^!3*ZIC0G""ZT@%R*E('XA)&:9%0E)>3,)I$L.YUH].IAAU[-;/:@MK MO5-N'&A'[?%W<#-.P7_,QW_)5VFVK;+0X89-QS@^)-<_ U02P,$% @ \H!761\ *\<: P LP8 M !D !X;"]W;W)K&UL?55M;]LV$/XK![488D"- M9$EQ+,\VD+0-.J!!@R;;/@S[0$MGB2A?-)*JV_WZ'BE9RU#'@" =>7?//7<\ MGM8';;[8%M'!-RF4W42M<]TJ26S5HF3V4G>H2+/71C)'2],DMC/(ZN D19*E MZ2*1C*MHNPY[#V:[UKT37.&# =M+R2[;IC#3ZB M^[U[,+1*)I2:2U26:P4&]YOH9KZZ+;Q],/B#X\$^D\%GLM/ZBU_\5F^BU!-" M@97S"(P^7_$M"N&!B,8_(V8TA?2.S^4C^EW(G7+9,8MOM?B3UZ[=1,L(:MRS M7KC/^O !QWRN/%ZEA0UO. RV11E!U5NGY>A,#"17PY=]&^OPS&&9ON"0C0Y9 MX#T$"BS?,<>V:Z,/8+PUH7DAI!J\B1Q7_E >G2$M)S^W_8B4DH6+)[83:&?K MQ!&H5R75"' [ &0O )1PKY5K+;Q7-=;_]T^(S,0H.S*ZS@\W36.P80[AKG>]0;CGBLM>P@/[3C?!67C7XRG^ M9R.0 (["DX_5@M<4JZ:[)9BJ$(99Q*RO!_6" M0[FC0,>&6,&G#@US7#5P[-V IGO+5&UGP0HN+:Z#BT(C;.XH\CZ_*!3R%E'ZJ1)[%\R(E)M:N M@,NN=R$[\D/KX"*+RW0Q&]6](DC!__4U,DQ9P<)<$MI2#MEL#/%SU;(RSO)L M!+&M-NX-XP[R,BSR'4YV;/!LD$DT3QJ6E<^J5&V;* MM#M-Y)MA$/UG/HSS>V8:KBPQV)-K>GE]%8$91N2P<+H+8VFG'0VY(+;T5T'C M#4B_U]H=%S[ ])_:_@!02P,$% @ \H!7672(6AGP @ :0@ !D !X M;"]W;W)K&UL[59+;]LP#/XKA#<4+6#4SSR;!$C2 M%>NA:-"TVV'80;'E6*AE>9+2K)*2?J7%2T1$DF)"<:EW+MJ4I2DEHC7GBA[W<]3ECI M3$9V;R$G(U'K@I5T(4'5G!/Y,J.%V(R=P-EMW+%UKLV&-QE59$V75#]4"XDK MKT5)&:>E8J($2;.Q,PV&LX[1MPI?&-VHO3F82%9"/)K%=3IV?$.(%C31!H'@ M\$3GM"@,$-+XL<5T6I?&<'^^0[^RL6,L*Z+H7!1?6:KSL=-W(*49J0M])S:? MZ38>2S 1A;)?V#2ZO="!I%9:\*TQ,N"L;$;RO,W#GD'??\<@W!J$EG?CR+*\ M))I,1E)L0!IM1#,3&ZJU1G*L-(>RU!*E#.WT9"XX9QJSK!60,H6Y*#4KU[1, M&%5P>D]6!55G(T^C+V/A)5O<68,;OH,[@!M$RA5\*E.:_FKO(<>6:+@C.@N/ M BYI=0Z1[T+HA_$1O*@-/+)XT1\%?LE44@A52PK?IBNE)5;/]T-9:)S$AYV8 M&S54%4GHV,$KHZA\HL[DY$/0]2^.A!"W(<3'T"?+YB*!R."JUH;K#2L9KSDL MR$L3V0-F7\)U^80K@:J+6B8Y%C'0N4$IQ%P6Y]G\!$BU_=C''MNS^_C&/AN+PB-8@>"R(V# 42A&T0!Q!VW MT_&-I LG'_IA$%Y ,'#C?K@;4-1K19';[47;;^/\30[06]>-PP@GW= =#"P/ MA IZ<*1".FV%=/Y.A;Q)UJ&B..KK?U'\LZ+P]IY_3N7:-CD%B:A+W72"=K?M MH].F?;RJ-TWXAL@UPZP4-$-3_[R'9RZ;QM8LM*AL,UD)C:W)3G/\%Z#2** \ M$T+O%L9!^W&ULQ5IM;]LV$/XKA%<,+1!8ENR\SC%06QI: M8&F#&MT^#,/ R+1-1!)5DHJ;HC]^)*5(9B?1D7M%OR22S'MX?(X\WB-QNF/\ M7FP)D>ASFF3B>K"5,K_R/!%O28K%D.4D4[^L&4^Q5+=\XXF<$[PR1FGB!:/1 MF9=BF@UF4_/LEL^FK) )S<@M1Z)(4\P?YR1AN^N!/WAZ\(%NME(_\&;3'&_( MDLB/^2U7=UZ-LJ(IR01E&>)D?3UX[5]%P:4V,"W^I&0G]JZ1'LH=8_?ZYNWJ M>C#2'I&$Q%)#8/7O@2Q(DF@DY<>G"G10]ZD-]Z^?T'\W@U>#N<."+%CR%UW) M[?7@8H!69(V+1'Y@NS>D&M"IQHM9(LQ?M*O:C@8H+H1D:66L/$AI5O['GRLB M]@R"H,,@J R"YQJ,*X/Q-P:3BPZ#264P>6X/IY6!&;I7CMT0%V*)9U/.=HCK MU@I-7QCVC;7BBV9ZHBPE5[]292=G[_D&9_0++J.6K="RG#&(K=&2;C*ZIC'. M)'H=QZS(),TVZ)8E-*9$H)7$O'0B MZ'!BC&Y8)K<"1=F*K%KL0[?]I4X34K 1/K,P#)^"2Y$,T'IV@8!1,T,=E MB%Z^>-7BU^+Y,&,'3'B$-TB0C5JP$MT50K47XE^SYJA\;.D@^FX_+1K']>0: M&]QQ!^X[E2?V)PYGF;J.B?9;(,;18HNS#=&3QVI&LYCF"4%__Z$ T5M)4O%/ MVZPJ>Y^T]ZY3[)7(<4RN!RJ'"L(?R&#VZR_^V>BWME!"@H608!$0F!7"21W" MB0M]=HL?S2R3A*=M(7!:]PT!)%CH'M=XA%;XL2U714!>6'2?UG2?.MU:2A;? M(\YDE9 3M9%CM6).3 #0RR)'DK6ED+D3MV\@(,%"]XC/4&IR=ULD@-RP(G%6 M1^+,Z5=($E7!J(VP:^8[S?L2#@D6N@?FHT>">1O=0$Y8=)_7=)^[)SY.5$41 MLS2EPA2A6 BB-@E.8J:JD"]D];0$5#N!I-HX6I>!LY>^48$$"]WC[XX*D!-6 M5"[JJ%PXO3*Z09>"G,B"9R>=B\$)TY=V2+#0/4!7]@%RPR+^LB;^TNG7NR*] M(UPSKR0AQZ8NJ@H^@;X^7;9%PHG;-Q*08&$)=FK M'Y]F/E3[V&?<:#N+,;] M4:.$1L_D_*FD1E5)K<7.UV<5VG-W'WWY!T4+*S17!* ZM$.P)T9]=[Y1F)C' M6Z-$5^2!)"PWY2?F7"L%?7VRMRDPC*$YO\1L'Z3G4U4YIU593OM&ZPN&]_N0&J0T'10E"T" K- M#D:C1?W)3WV?X(.J65"T$!0M@D*S ]FH7-\M^E3D5%*3CR" MYF6"+P19%PE*Z)JTALD-?FI*Z?:T!BILC_8C@O+#IK^1MKY; M[0C*9%:R'O MMNR]!$!U+2A:!(5FQZ#1N_[YS\UEH$H8%"T$18N@T.Q -A+9=TO([\QE;O"Q M(Y>!RN2C_8B@_+#I;X2R[U;*W[RB0$6V,D4Q01N2J<(YT6^2"JY?HJ*=D1$Z M5%WO,=R=]5XUH/KY !'=;Y"@W+ _I36Z.G#KZ@_D3@D5LRYR3E48%MR6O7D_UH\(R@^;^$:W!V[=?H,_ M=Y6X;LO>*054KH.B15!H=@P:N1[\7+D>@,IU4+00%"V"0K,#VY1XMPMV5OLH\6X5!^V&0W(CQP M:\^CRUPW[(6#>%!I?;0?$90?)?'>WD'>E/"-.4&MC\6HVJ@\=ED_K4]IOS9G MD[]Y/O>O%G[+\]"_BLHSV U\>23\!O,-S80*X%IU-1J>JSV/EZ>LRQO) ML 0 $$< 9 >&PO=V]R:W-H965T:P_4U'A\P>:9;A!CXE:4YG2A;QG:WJDI76Y1!>H-W*.=WUIADD/$FV:AT M1Q",*U"6JH:F.6H&DUR9CJN^!S(=XX*E28X>"*!%ED'R>X92?)@HNO+2\3W9 M;%G9H4['.[A!2\0>=P^$M]26)4XRE-,$YX"@]43YIM]&>@6H+/Y)T($>78,R ME">,G\M&%$\4K?0(I6C%2@K(__;H#J5IR<3]^-F0*NV8)?#X^H5]407/@WF" M%-WA]$<2L^U$\100HS4L4O8='T+4!&27?"N_APR.!T3? "DM.9LY46EH K-GWF2EV)?,L+O)AS' MIG_Q]RG*5SA#X/)/3.D5>$ $++>0(' -EO4K / :S"!-5@#F,9@G:<%0#'Q( M\B3?T"/$Y1PQF*2^\ MZ+3'*N/QE5ZJJR:661V+<286$]SCG&TI\/,8Q0)\V(\?]>!5/J_MY!HODSLS M>@F7:'<#3.T+,#3#$OASUP__H\A[X?-^^#TD'*Z?A?O#G3<%\,5PYT7P8+CS M(GCX_V8^^L^Q=X1@MF^96?&9Y]ZR(D,$,DQN1:JNL9886ZYVMW0'5VBB\.6, M(K)'RO3S)]W1OHHD)9-L+I/,ETFVD$D6R"0+99)%DL@ZHK5:T5I][-72D/(E M0239&NE4R+*>VD^O7=OU[+&Z/Q:CP,P<&8[3-9N+V Q3&W7-?"&;9YR8+01F MEFGK7:O@K=7(-LVN42B@TCW7=+2N723RS'(LMS7K/ "[?0!V;]:8HQSS)?]L MWK!EY@V99'.99+Y,LH5,LD F62B3+))$UI&MT\K6ZAL$ M>'69\7U-4_/Q'1=EO,#CI>/G3YZA&U^?JM+R,GDQN1*)O1[3/GK%/$MSK9.$ MT^O91U4LD\P7^*\;UFGNDCED(),L%/AOFMI)PHP$5IHYLL5YT&T%Y?8*JMIP M\"UQ*R2&5\\ _2R2/4Q1SNA[VG'?>'62P.]Z'?BH;F22^>_ZOI Y7""3+'S7 M]ZC/HJ,5K]6*)S?YQ,UN]AT)>8/23Z]O'Y613#)?X+\@_<@<,I!)%@K\%Z0? M@=7Y]#-J)37JW[PU=3#8(5)+1%B-C6168S+)YC+)?)ED"YED@4RR4"99)(FL MHUY=>_W"I_6FQ%E;7A4T?A6Q,,TU5-[Q3D:[.4D3=_T#?E2>4ME\<01O,IW4 M00.I;*$H!./&.-E<1VB#%-,[Y(<5(Y/-%T?P M5C$R!PVDLH6B$$2*$4=ZJACUZ#@A0V13G4517DD5.:N_>;:][7G7M^J4YZ1_ MIM\&NJ _+,_'JN.+5_KZ<.T>DDV24Y"B-1]*NW'Y6D[J\ZJZP?"N.LQXPHSA MK+K<(A@C4AKP^VN,V4NC'* ]-9S^"U!+ P04 " #R@%=9%L9DI\T" C M" &0 'AL+W=OY\YG MWQVCG50/.@!^ M& 0#OZ!,>,G(K2U4,I*5X4S 0A%=%055OV^ R]W8ZWO[A7NVR8U=\)-123>P M!/.U7"B<^:U*Q@H0FDE!%*S'WJ0_G,<6[P#?&.STP9C8DZRD?+"3VVSL!=8A MX) :JT#QLX4I<&Z%T(U?C:;7FK3$P_%>_:,[.YYE135,)?_.,I./O2N/9+"F M%3?W-+S>U+^$SOD3D3@J3:S(7&60=_-EI M_O4)OH]Q:8,3[H-S$YX47$+9(U'PCH1!&'?X,WTY/>HZSO]9G_^S]:-@1.U+ MB9Q>](S>G"K!Q$8?/) ?DY4V"G/]9]=EUW)QMYRM?T-=TA3&'A8X#6H+7O+V M37\0?.B*]&N*S5Y3;/Y*8D=W$K=W$I]23Z:R*# ?L4JD#P1^56Q+.0BC"3RF MO,(D(&LE"V)R("GE:<7K_)5KDC%>&=P7F/^LR7],WCJ-S[NNL_;DTGEBN\\V M&8S\[>$=U8A^< ")>]?'H%D':- +CT'S3J6K%E3'RC^H>@6HC6LWFJ2R$J9^ MUNUJV]$FKI _6;_I#Z?]CO49=L"Z8?V5K]OG'54;)C3AL$930>\]AD75+:F> M&%FZFKN2!BNX&^;8Q4%9 .ZOI33[B370_B](_@!02P,$% @ \H!760*J M/K)H! R1\ !D !X;"]W;W)K&ULK9EM;Z-& M%(7_RHA6U:[4AC<;VZEM*3$OFVI319MNJZKJAS&,[=$"P\Z,X^R_WQD@Q,AD MUI9N/L2 YSP7? X#7.8'QK^('2$2/1=Y*1;63LKJVK9%NB,%%E>L(J7Z9L-X M@:5:Y5M;5)S@K!85N>TY3F 7F);6^#+.=O+G);D@2.Q+PK,O]V2G!T6 MEFN];/A$MSNI-]C+>86WY)'(S]4#5VMV1\EH04I!68DXV2RL&_SQH*L6/X/S>1N84TME)$-WN?R$SM\(.T!C34O9;FH_Z-#,S:86"C= M"\F*5JSVH*!E\XF?VQ_B2* .=%C@M0+O7('?"OQS!:-6,#I7,&X%XW,%02L( MSA5,6L&D-JOY=6MK0BSQ-C6]-VK^@3\G??Z0L! 2%D'"8DA8 M @3K)<;O$N.;Z,L5*R4MMZ24*%53!&?84D&YP.C,1+ ]/ @AJF+[1/ M2R]P]-_\"WA0R89B9>:! D+(6$1)"R&A"5 L%Y@@BXP ?RU M/X!,#"0LA(1%D+ 8$I8 P7J)F72)F9BG&(Y+@9MGR)0)*8828D13DHN!._8&;F@2H:L_]:>?^] =W?D6%RV_HWR'7C=)+78>$A9"P"!(6 M0\(2(%@O&;,N&3/X*\D,,C&0L! 2%D'"8DA8 @3K)<9U7OM.CGDVP6+7?X(< M;"0Y)S/C;.J-3B;&E;G:I0D I46@M!B4ED#1^BDXZCZZX-V$%GG\-#C8 5B9 M:U^<"4A:!$J+06D)%*V?B=>6I&OL7RW_)!*QJ@Y"N44YQ6OU."LI&;S;;%F] M,#B#80!M-(+2(E!:#$I+H&C],+QV&UUSN]'48G)/6X&N.QTTWS])R?#(T+P[ M%QL+VC<$I250M+ZQKZU#U]P[C)XKDNIFE<3/*"/97CU6KG."<,'VZFK -@CK MFTFN1FQ-&0#M,[JGW;F3@$ 6C$!I,2@M@:(U ;&/WE'JE]SWF&]I*5!.-@KO M7$W4R+[\#4$L# M!!0 ( /* 5UFD=(\HF@( *,' 9 >&PO=V]R:W-H965TLFEJI"X0DM,L2I#95M4V:5#7MICTZ,H95W,OT[J8^KY*,LR)&H@" MN9E9"YD3;;IRXZM"(DD=*&=^& 21GQ/*O7CFQFYD/!.E9I3CC015YCF1^TMD M8C?WAM[SP"W=9-H.^/&L(!MDU2UI@N_W,?NV\ M&R\KHG AV ^:ZFSNG7N0XIJ43-^*W6>L_4PL7R*87$9JO@ RRK706QAJ;D(GDLJ:*NY!16^_8 M'%^A)I2I$P,V7 7A>_AIVO?+*S@^.H$CH!SN,E$JPE,U\[41;R7X22WTLA(: MOB'T*^$#&)Z=0AB$HP[XHA^^Q&( H\#!QR_AOHFLR2UL<@L=W^@-OFM")6P) M*]%&5)0RR>^2D5RBUZ\?MWPRCX MU.7Y/Y&]2)##J8X\71&5=!BM4Y%#V#-G&'\]MY-NV\%[J X6/&^'C?N&" M:\HWR/7+[>HR4S%-6F;"* C^,-.[W(%F)HV92:^9.Z$)^_W]%9(FV&5D\LK( M,!R_VI;>M0YT$C5.HH.V!8[+ K0XZ7(5O?K6.K;G+T656+]UA-KKZQN1&VI. M0H9K PL&9R8:65T)54>+PIVJ*Z'-&>V:F;E%4=H",[\60C]W[$'=W,OQ+U!+ M P04 " #R@%=9EWG)N4 & #F.0 &0 'AL+W=O_TEL63R.>(YU&N]DKA\3+/O^99S09[B*,DO1ULA M=A>6E6^V//;SM^F.)_*;NS2+?2$WLWLKWV7<#\I.<62YMCVU8C],1JMEN>]C MMEJF>Q&%"?^8D7P?QW[VXYI'Z>/ER!D][_@4WF]%L<-:+7?^/;_EXLON8R:W MK(82A#%/\C!-2,;O+D=7S@6CLZ)#V>+/D#_F!Y]),91O:?J]V+@)+D=V<40\ MXAM1('SY[X&O>105)'D<_]3041.SZ'CX^9G^KAR\',PW/^?K-/H:!F)[.9J/ M2,#O_'TD/J6/O_-Z0)."MTFCO/Q+'NNV]HAL]KE(X[JS/((X3*K__E.=B(,. MDM/=P:T[N,<=QBJL9>)\WSAKY99^DBRHK6D M%1_*[)>]9;["I)@HMR*3WX:RGUA]XKG(]ANQS\+DGEP590O%#_*&7 5!6)32 MC\A-4DW(HK O/2[\,,I?R29?;CWR\L4K\H*$"?F\3?>YGP3YTA+RN JZM:F/ MX;HZ!O?$,5#R(4W$-BD7+M&X"W?O274?DU< MVQUW',^Z?W?:-9S_%YW]='0M&;29(;3DT5XS9)WF@L@R$[F;9P^<_/5>MB\\#2O,M,04OR /*WU6D['>Q.MH8M-BMAVV M8NU6"X>J:-I8)\U8)\:QLG@7I3\X)SG?^5FE2?Q)_FSFW4,VTH9./R3,0\(8 M"*:59-J49'I.@9@B*X2$>4@8 \&T"LV:"LTP E%A)MH9:R^.]*'=Z(US=.I[ M[3;N?&&[1P+1;C6?3VFW0,R;LE; M<_(O^1 F8;R/.U-@Q ^=D5":!Z4Q%$TOE*L*Y9Y3.&HZJDY(F@>E,11-KY.R MAH[1UQS5J2A1\\,K:_:ZO#+?/&]V5HJVQ<"V[6-5@?J^7C$9*J:>667I'+.G MZR=5_M-)J3+B!Y\"2)H'I3$432^4\J/.Y*Q2!36H4)H'I3$43:^3,JF.T6$! MI&K:DHU)AU1!'6BOF P54\^L,I>.V5V>4JC.)!I1@Z<[DN9!:0Q%TXNB7+ S M/ZLL0=TQE.9!:0Q%T^ND'+)CM'<#[->B?4ME.F_K#]3G]@O*4$'UAS7*PKIF M"WM*@.05TCI-1.9O!/G,LSA,_%.Z9(XP=+Y#:1Z4QE TO5;*@KO..77)A3IP M*,V#TAB*IM=).7#7Z!S[ZU+-.90(9]:^+C*'&YSJ7D$9*JB>0^6.7;,[-NC2 MT,=8YDB#YSW43T-I#$73:Z9\MSL^JSY!;3>4YD%I#$73ZZ1LMVM^#MQ?GR9= MS[1:\@0USKUB,E1,/8/*$+MF0VQ0I][/T,PA!D]WJ'>&TAB*IA=+>6QW=E99 M@MIN*,V#TAB*IM=)V6[7_/2YORS-6\^W9FU5@OKFFC8QA62HD'K^E!UVS7:X MO.W=\UZ2&35X4D.-,Y3&4#3]_3_EKZE]3O&A4&\-I7E0&D/1]#HI;TW-C[=[ MBX^9,[@B4!==TPY5:DQI2Z=00?54*WM,S?;XE$[]A+4S1QI<#*C/AM(8BJ;7 M[. ]YO.^R(Q]DQG[*C/V7>9S6'"J+#@U/_KN+V-0LPVE>35-NT.U:-\Y1P75 M4ZU<-#6[:(.,_2&V/.O,.O2)-93F06D,1=.+HPPZ/>M[U13JS:$T#TIC*)I> M)^7-*>CM:C-G<$6@+KRF:6M#Z*2M5U![;1VL6XNY3%NQ8# GFW2?B&J!4K.W M691X52[%.]I_[5RLG8[]GG/!JB6'"E^M@/P@JQ0F.8GXG0QEOYW)&PO=V]R:W-H965T>SZTD I MON6P9T?72+IR2\A/>?,A75J.'!$4D'")P.+O#M90%)(DQO%O"[6Z/J7A\?4C M_9UR7CASBQFL2?%/GO)L:!.#(0'+V!UQIX0X/@%P9^:^ _M8>@-0B>VL.D-5"NVXWO M*G 1YGBUH&2/J%0+FKQ0T5?6(EYY)2?*#:?B:2[L^.H:&*>[A.]H7FW1A4Q; MSA_06]1_@*M4M!280XK6A'&&7D? <5ZP-T+[]29"KU^]0:]07J$O&=DQH6<+ MFXL!RF[LI!W,93,8[Q>#\=$G4O&,H;A*(=781^/V\Q%[6P2FBX[W&)U+;Q1X M _49\IV_D.=X@68\ZZ>;^SIW_E_O\6_WW@N&WTT57_'\)TT5.0O::<& W@'Z M_E'HT0<.)?NA2WT##_1P60_/68T36%JBX"FBM?KS#S=T_M;%W20L,@F+#<%Z M&0JZ# 5C]$&&D@S3+6A?PP83*HS\E-RMO'#FS1;VW7&03U63H"^)-!+'E[/M M6!6?JN:N?^BMY^ND\W4RZFM=25AD M$A8;@O5R,>]R,7_)RC WF2&3L,@D+#8$ZV7(=0X; <=,;6@YQV]K.!TL#-8: MD3,H#1J)'PX7(;%&%7CZRN >;7K<45\_\PRHUK=1N^=.-:.TR"@M-D7K9\ [ M9,![R8K0TDWER20M,DJ+3='Z>3KL^=S1#H_4$L#!!0 ( /* 5UF6EE,6/P< !=! 9 M>&PO=V]R:W-H965TGLSM1K)!EL MIXYG-@9-.]-M=Y+=]J'3!VPK,5W^N"#'FV]?@8FQ@ @4WWU)C,/]'=#!H'L, MF1^2]&NVY5R@;U$89]>#K1"[J]$H6V]YY&?ODQV/Y5_NDS3RA5Q,'T;9+N7^ MIBB*PA&Q+&<4^4$\6,R+]SZEBWFR%V$0\T\IRO91Y*=/-SQ,#M<#/'A^XS9X MV(K\C=%BOO,?^!T77W:?4KDT.E$V0<3C+$ABE/+[Z\$'?,7H)"\HUO@SX(?L M[#7*=V65)%_SA5\WUP,KWR(>\K7($;[\]\=1)FQ4]T*->U!FB] MST02E<5R"Z(@/O[VOY4#<58@.>T%I"P@]8+Q"P6T+*!]%<9EP;BO@ET6V'T+ MG++ *<;^.%C%2+N^\!?S-#F@-%];TO(7A5U%M1S@(,Z/K#N1RK\&LDXL;GDF MTOU:[-,@?D ?PYM]R%%RC]25Y!)/'SE:/:'/3[MBA662"?36 MY<(/PNR=K/YRYZ*W;]ZA-RB(T>=MLL_\>)/-1T)N;=W/O.&;EGI77S_3U(_D4)W&BSR/UPW1 N_X[CVBUD^(6&3O93EN*U?&DIZ./5KP:*]C[_FP^OLV"4,D3QL'/]W\TW;( M'*GC=FI^*K[*=OZ:7P_DN;9@#A8__H =Z^ MVP:IR(!@BFWVR39;:YOZ\5QO_?2!MY["[<:P$&=*INJX+)MKV6-U%?>XBGV^ MBD7S4XTRP$W0#-.:&M/NVBL'SCD-G*,=N*6?;='.?Y(3,-$Z8-IRTR,<$N8Z M#0>&%-MT5K, 4I,!P12K)B>K)EJK?D_BX3JWJSR\D9RF('_SKYQXO>B>EFCJ M'B3,G33=LZ=V[:/A04HR()ABWO1DWK3G=87'FXZ+RK0Q- 03,JF=H[1ZIF[T MDO0@)1D03'%C=G)CIG>#9]F5;%G25'YPT"Y)CYUCEO<'+3BJ6[R>C-K M'K[8=K!5,TF[&:8F]=/T(#79K'$!&RKS"&7XL55U@"1^& J>1J\:_!*N M7'P=7/^ Z#?!=/![:7J@F@R*IIITUFYCK4E>M N3)\YS5_S4+VSRONUXG+7/ MK?0XTZL-*,T%I7F@- 9%4VTFEIJQRZ 11DD[/R=/Z+3>@X%J,BB:ZEX53V!]/M&[T=5SC'T#S29*FC+= MG,XL4C<.-)Z HJG&50$%UB<4G8VVOM[8,$B:BYMIQY!:8[OA&*0J@Z*ICE7) M"-9'(Z_IM_5(8Q-!\Q+<#$QF3F,""QJ70-%4!ZO !.L3$Y.F&S<#"6=JU?LY MO:"Q(WTT/5!-!D53+:EB$-R1@US<>>-F5C%L". MD.2R'KV95C0L DU'N@4]4$$&15._VZTB%-(1H7 _X[)="WW!-VCY\DQ0SS&] M)H'27%":!TIC4#35WRI](?B[M.4$-(4!I;F@- ^4QJ!HJMU5"D.T;;]I6ZZG M&;L,&KZ4-.5B6>\40!49%$WUKHI4B#Y2Z=V4ZSG&KH&&*:09IE"G_LVX!ZK) MH&BJ;U680O1A2F=/KJ\W]@LT1"'-$&6()XW/&6B& D53_:HR%*+/4%[3D>N1 MQA:"QBJD+589X_H=#*"B#(JF>EBE*D2?JICTY*296%"[UD3HY8P=Z5;T0!49 M%$VUHXI(2$=$0A$X4YH'2&!1-M;N*6JC^1A?#WEM/,W89-&$I:6./Z5*5<[?R6M_JW9&XK:C*KWWG0@B*TMA+3 M[]YKA^_LN19]=M'9 ^OKC8]VV&=8FIG%<(;K,T%0309%4_VJ,@NJSRQ>TP/K MD<86@L88M"7&H&/+J7L(FF- T50/JQR#ZG,,DQZ8-C,"/*8S4C]K@083_40] M4%$&15--J8()VA%,7-P)TY8G4J:32>," YI8]!/U0$49%$VUJ@HM:$=H<5$W M7,*5I[N:=X_K-\'8I3Z:'J@F@Z(=31J=/;<=<7GER9^PS] ZV\1G]"G_\EP$?Y84NB#,4\GLI9;V?R(,]/3Z% M?UP0R:YX:GR5")%$Q0?[]/$O&\D N<_A?"XG]02P,$% @ M\H!767F\^D2D @ _08 !D !X;"]W;W)K&UL MK55=3]LP%/TK5H8FD#:2)FU:6!NI+?O@@0G1L3U,>W"3V\;"L8/M-NS?[]H) M6>E"X6$O\=<]Q^=;DQY[OLZS:&@^E26('!E)55! M#0[5VM>E IHY4,'], ABOZ!,>,G8S5VK9"PWAC,!UXKH35%0]7L&7%83K^<] M3MRP=6[LA)^,2[J&!9C;\EKAR&]9,E: T$P*HF U\::]\WELXUW =P:5WND3 MZV0IY9T=7&83+[""@$-J+ /%9@MSX-P2H8S[AM-KM[3 W?XC^R?G';TLJ8:Y MY#]89O*)-_)(!BNZX>9&5E^@\3.P?*GDVGU)U<0&'DDWVLBB :."@HFZI0]- M'G8 R-,-"!M N _H/P.(&D#DC-;*G*T+:F@R5K(BRD8CF^VXW#@TNF'"GN+" M*%QEB#/)9RFSBG%.J,C(I3!4K-F2 YEJ#4:3]V11'R^1*]+&'E^ H8SK$UR_ M75R0XZ,3^07%V"S]MA,QJ(>$S0L[(E10FU^2CR"![BO?1 M5.LL?'0V"P\2+J \)5'PCH1!V._0,W\]/#H@)VH3'3F^Z*5$_[R1^,5_L*(J M^]65J)JHWTUDK_6Y+FD*$P_OK0:U!2]Y^Z87!Q^Z7/XGLB>>^ZWG_B'V9 9K M)@03:[QIG(H4NMS6%+&CL#5GFT2]T6 T&OO;71\=84$\C,[:L"<*!ZW"P4&% MT_1^PS2S%463XZ_2 (E.NE36-(.=[8,]@?]&]'K#WK!;7]SJBP_JP\OP0OKB MUZ6O,ZP_B/?D^3N5I "U=@56DU1NA*FO7CO;UO"I*UU[\S.L[74I_DM3/PQ7 M5.%?H0F'%5(&IT-,F:J+;3TPLG3U:BD-5C_7S?%] F4#<'TE\9B:@=V@??&2 M/U!+ P04 " #R@%=9>$ >&O8" !W"@ &0 'AL+W=O\Y"J;SCNC)9 M0(;E.<^!Z9D9%QE6NBOFKLP%X-2",NH&GM=V,TR8$W?MV*V(NWRI*&%P*Y!< M9AD6?ZZ \G7/\9W-P!V9+Y09<.-NCN

,"2*S'MP[WT4;-Y30?L;[?@W4$L#!!0 ( /* M5UF7BKL

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 98 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 100 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 362 405 1 false 97 0 false 7 false false R1.htm 0000001 - Document - Cover Sheet http://www.maxlinear.com/role/Cover Cover Cover 1 false false R2.htm 9952151 - Statement - Consolidated Balance Sheets Sheet http://www.maxlinear.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 9952152 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.maxlinear.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 9952153 - Statement - Consolidated Statements of Operations Sheet http://www.maxlinear.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 4 false false R5.htm 9952154 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLoss Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 9952155 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical) Sheet http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical Consolidated Statements of Comprehensive Loss (Parenthetical) Statements 6 false false R7.htm 9952156 - Statement - Consolidated Statement of Stockholders' Equity Sheet http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity Consolidated Statement of Stockholders' Equity Statements 7 false false R8.htm 9952157 - Statement - Consolidated Statements of Cash Flows Sheet http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 9952158 - Disclosure - Organization and Summary of Significant Accounting Policies Sheet http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPolicies Organization and Summary of Significant Accounting Policies Notes 9 false false R10.htm 9952159 - Disclosure - Net Income (Loss) Per Share Sheet http://www.maxlinear.com/role/NetIncomeLossPerShare Net Income (Loss) Per Share Notes 10 false false R11.htm 9952160 - Disclosure - Business Combinations Sheet http://www.maxlinear.com/role/BusinessCombinations Business Combinations Notes 11 false false R12.htm 9952161 - Disclosure - Restructuring Activity Sheet http://www.maxlinear.com/role/RestructuringActivity Restructuring Activity Notes 12 false false R13.htm 9952162 - Disclosure - Goodwill and Intangible Assets Sheet http://www.maxlinear.com/role/GoodwillandIntangibleAssets Goodwill and Intangible Assets Notes 13 false false R14.htm 9952163 - Disclosure - Financial Instruments Sheet http://www.maxlinear.com/role/FinancialInstruments Financial Instruments Notes 14 false false R15.htm 9952164 - Disclosure - Balance Sheet Details Sheet http://www.maxlinear.com/role/BalanceSheetDetails Balance Sheet Details Notes 15 false false R16.htm 9952165 - Disclosure - Debt Sheet http://www.maxlinear.com/role/Debt Debt Notes 16 false false R17.htm 9952166 - Disclosure - Stock-Based Compensation Sheet http://www.maxlinear.com/role/StockBasedCompensation Stock-Based Compensation Notes 17 false false R18.htm 9952167 - Disclosure - Income Taxes Sheet http://www.maxlinear.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 9952168 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information Sheet http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformation Concentration of Credit Risk, Significant Customers and Geographic Information Notes 19 false false R20.htm 9952169 - Disclosure - Revenue from Contracts with Customers Sheet http://www.maxlinear.com/role/RevenuefromContractswithCustomers Revenue from Contracts with Customers Notes 20 false false R21.htm 9952170 - Disclosure - Leases Sheet http://www.maxlinear.com/role/Leases Leases Notes 21 false false R22.htm 9952171 - Disclosure - Employee Retirement Plans Sheet http://www.maxlinear.com/role/EmployeeRetirementPlans Employee Retirement Plans Notes 22 false false R23.htm 9952172 - Disclosure - Commitments and Contingencies Sheet http://www.maxlinear.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 23 false false R24.htm 9952173 - Disclosure - Stock Repurchases Sheet http://www.maxlinear.com/role/StockRepurchases Stock Repurchases Notes 24 false false R25.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 25 false false R26.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 26 false false R27.htm 9954471 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies) Sheet http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies Organization and Summary of Significant Accounting Policies (Policies) Policies http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPolicies 27 false false R28.htm 9954472 - Disclosure - Net Income (Loss) Per Share (Tables) Sheet http://www.maxlinear.com/role/NetIncomeLossPerShareTables Net Income (Loss) Per Share (Tables) Tables http://www.maxlinear.com/role/NetIncomeLossPerShare 28 false false R29.htm 9954473 - Disclosure - Business Combinations (Tables) Sheet http://www.maxlinear.com/role/BusinessCombinationsTables Business Combinations (Tables) Tables http://www.maxlinear.com/role/BusinessCombinations 29 false false R30.htm 9954474 - Disclosure - Restructuring Activity (Tables) Sheet http://www.maxlinear.com/role/RestructuringActivityTables Restructuring Activity (Tables) Tables http://www.maxlinear.com/role/RestructuringActivity 30 false false R31.htm 9954475 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.maxlinear.com/role/GoodwillandIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://www.maxlinear.com/role/GoodwillandIntangibleAssets 31 false false R32.htm 9954476 - Disclosure - Financial Instruments (Tables) Sheet http://www.maxlinear.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.maxlinear.com/role/FinancialInstruments 32 false false R33.htm 9954477 - Disclosure - Balance Sheet Details (Tables) Sheet http://www.maxlinear.com/role/BalanceSheetDetailsTables Balance Sheet Details (Tables) Tables http://www.maxlinear.com/role/BalanceSheetDetails 33 false false R34.htm 9954478 - Disclosure - Debt (Tables) Sheet http://www.maxlinear.com/role/DebtTables Debt (Tables) Tables http://www.maxlinear.com/role/Debt 34 false false R35.htm 9954479 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.maxlinear.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.maxlinear.com/role/StockBasedCompensation 35 false false R36.htm 9954480 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information (Tables) Sheet http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationTables Concentration of Credit Risk, Significant Customers and Geographic Information (Tables) Tables http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformation 36 false false R37.htm 9954481 - Disclosure - Revenue from Contracts with Customers (Tables) Sheet http://www.maxlinear.com/role/RevenuefromContractswithCustomersTables Revenue from Contracts with Customers (Tables) Tables http://www.maxlinear.com/role/RevenuefromContractswithCustomers 37 false false R38.htm 9954482 - Disclosure - Leases (Tables) Sheet http://www.maxlinear.com/role/LeasesTables Leases (Tables) Tables http://www.maxlinear.com/role/Leases 38 false false R39.htm 9954483 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.maxlinear.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://www.maxlinear.com/role/CommitmentsandContingencies 39 false false R40.htm 9954484 - Disclosure - Organization and Summary of Significant Accounting Policies (Details) Sheet http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails Organization and Summary of Significant Accounting Policies (Details) Details http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies 40 false false R41.htm 9954485 - Disclosure - Net Income (Loss) Per Share - Summary of Basic and Diluted Earnings Per Share (Details) Sheet http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails Net Income (Loss) Per Share - Summary of Basic and Diluted Earnings Per Share (Details) Details http://www.maxlinear.com/role/NetIncomeLossPerShareTables 41 false false R42.htm 9954486 - Disclosure - Net Income (Loss) Per Share - Additional Information (Details) Sheet http://www.maxlinear.com/role/NetIncomeLossPerShareAdditionalInformationDetails Net Income (Loss) Per Share - Additional Information (Details) Details http://www.maxlinear.com/role/NetIncomeLossPerShareTables 42 false false R43.htm 9954487 - Disclosure - Business Combinations - Additional Information (Details) Sheet http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails Business Combinations - Additional Information (Details) Details 43 false false R44.htm 9954488 - Disclosure - Business Combinations - Summary of Business Acquisitions, by Acquisition (Details) Sheet http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails Business Combinations - Summary of Business Acquisitions, by Acquisition (Details) Details 44 false false R45.htm 9954489 - Disclosure - Restructuring Activity - Additional Information (Details) Sheet http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails Restructuring Activity - Additional Information (Details) Details 45 false false R46.htm 9954490 - Disclosure - Restructuring Activity - Restructuring and Related Costs (Details) Sheet http://www.maxlinear.com/role/RestructuringActivityRestructuringandRelatedCostsDetails Restructuring Activity - Restructuring and Related Costs (Details) Details 46 false false R47.htm 9954491 - Disclosure - Restructuring Activity - Schedule of Restructuring Reserve by Type of Cost (Details) Sheet http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails Restructuring Activity - Schedule of Restructuring Reserve by Type of Cost (Details) Details 47 false false R48.htm 9954492 - Disclosure - Goodwill and Intangible Assets - Summary of Goodwill (Details) Sheet http://www.maxlinear.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails Goodwill and Intangible Assets - Summary of Goodwill (Details) Details 48 false false R49.htm 9954493 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details) Sheet http://www.maxlinear.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails Goodwill and Intangible Assets - Additional Information (Details) Details 49 false false R50.htm 9954494 - Disclosure - Goodwill and Intangible Assets - Schedule of Acquired Finite-Lived Intangible Assets by Major Class (Details) Sheet http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails Goodwill and Intangible Assets - Schedule of Acquired Finite-Lived Intangible Assets by Major Class (Details) Details 50 false false R51.htm 9954495 - Disclosure - Goodwill and Intangible Assets - Finite-lived Intangible Assets Amortization Expense (Details) Sheet http://www.maxlinear.com/role/GoodwillandIntangibleAssetsFinitelivedIntangibleAssetsAmortizationExpenseDetails Goodwill and Intangible Assets - Finite-lived Intangible Assets Amortization Expense (Details) Details 51 false false R52.htm 9954496 - Disclosure - Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) Sheet http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details) Details 52 false false R53.htm 9954497 - Disclosure - Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Sheet http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Details 53 false false R54.htm 9954498 - Disclosure - Financial Instruments - Composition of Financial Instruments (Details) Sheet http://www.maxlinear.com/role/FinancialInstrumentsCompositionofFinancialInstrumentsDetails Financial Instruments - Composition of Financial Instruments (Details) Details 54 false false R55.htm 9954499 - Disclosure - Financial Instruments - Additional Information (Details) Sheet http://www.maxlinear.com/role/FinancialInstrumentsAdditionalInformationDetails Financial Instruments - Additional Information (Details) Details 55 false false R56.htm 9954500 - Disclosure - Financial Instruments - Fair Value, Liabilities Measured on Recurring Basis (Details) Sheet http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails Financial Instruments - Fair Value, Liabilities Measured on Recurring Basis (Details) Details 56 false false R57.htm 9954501 - Disclosure - Financial Instruments - Summary of Level 3 Financial Instrument Activity (Details) Sheet http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails Financial Instruments - Summary of Level 3 Financial Instrument Activity (Details) Details 57 false false R58.htm 9954502 - Disclosure - Balance Sheet Details - Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails Balance Sheet Details - Cash, Cash Equivalents and Restricted Cash (Details) Details 58 false false R59.htm 9954503 - Disclosure - Balance Sheet Details - Inventory (Details) Sheet http://www.maxlinear.com/role/BalanceSheetDetailsInventoryDetails Balance Sheet Details - Inventory (Details) Details 59 false false R60.htm 9954504 - Disclosure - Balance Sheet Details - Property and Equipment, Net (Details) Sheet http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails Balance Sheet Details - Property and Equipment, Net (Details) Details 60 false false R61.htm 9954505 - Disclosure - Balance Sheet Details - Additional Information (Details) Sheet http://www.maxlinear.com/role/BalanceSheetDetailsAdditionalInformationDetails Balance Sheet Details - Additional Information (Details) Details 61 false false R62.htm 9954506 - Disclosure - Balance Sheet Details - Accrued Price Protection Liability (Details) Sheet http://www.maxlinear.com/role/BalanceSheetDetailsAccruedPriceProtectionLiabilityDetails Balance Sheet Details - Accrued Price Protection Liability (Details) Details 62 false false R63.htm 9954507 - Disclosure - Balance Sheet Details - Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails Balance Sheet Details - Accrued Expenses and Other Current Liabilities (Details) Details 63 false false R64.htm 9954508 - Disclosure - Balance Sheet Details - Schedule of Accumulated Other Comprehensive Income (Loss) by Component (Details) Sheet http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails Balance Sheet Details - Schedule of Accumulated Other Comprehensive Income (Loss) by Component (Details) Details 64 false false R65.htm 9954509 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.maxlinear.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 65 false false R66.htm 9954510 - Disclosure - Debt - Additional Information (Details) Sheet http://www.maxlinear.com/role/DebtAdditionalInformationDetails Debt - Additional Information (Details) Details 66 false false R67.htm 9954511 - Disclosure - Stock-Based Compensation - Additional Information (Details) Sheet http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional Information (Details) Details 67 false false R68.htm 9954512 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details) Sheet http://www.maxlinear.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails Stock-Based Compensation - Stock-Based Compensation Expense (Details) Details 68 false false R69.htm 9954513 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Unit and Performance-Based Restricted Stock Unit Activity (Details) Sheet http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails Stock-Based Compensation - Summary of Restricted Stock Unit and Performance-Based Restricted Stock Unit Activity (Details) Details 69 false false R70.htm 9954514 - Disclosure - Stock-Based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details) Sheet http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails Stock-Based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details) Details 70 false false R71.htm 9954515 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details) Sheet http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails Stock-Based Compensation - Summary of Stock Option Activity (Details) Details 71 false false R72.htm 9954516 - Disclosure - Stock-Based Compensation - Schedule of Stock Options, Valuation Assumptions (Details) Sheet http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails Stock-Based Compensation - Schedule of Stock Options, Valuation Assumptions (Details) Details 72 false false R73.htm 9954517 - Disclosure - Income Taxes (Details) Sheet http://www.maxlinear.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.maxlinear.com/role/IncomeTaxes 73 false false R74.htm 9954518 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information - Concentration of Risk, by Risk Factor (Details) Sheet http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails Concentration of Credit Risk, Significant Customers and Geographic Information - Concentration of Risk, by Risk Factor (Details) Details 74 false false R75.htm 9954519 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information - Revenue from External Customers by Geographic Areas (Details) Sheet http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails Concentration of Credit Risk, Significant Customers and Geographic Information - Revenue from External Customers by Geographic Areas (Details) Details 75 false false R76.htm 9954520 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information - Long-Lived Assets by Geographic Areas (Details) Sheet http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails Concentration of Credit Risk, Significant Customers and Geographic Information - Long-Lived Assets by Geographic Areas (Details) Details 76 false false R77.htm 9954521 - Disclosure - Revenue from Contracts with Customers - Revenues from External Customers by Products and Services (Details) Sheet http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails Revenue from Contracts with Customers - Revenues from External Customers by Products and Services (Details) Details 77 false false R78.htm 9954522 - Disclosure - Revenue from Contracts with Customers - Additional Information (Details) Sheet http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails Revenue from Contracts with Customers - Additional Information (Details) Details 78 false false R79.htm 9954523 - Disclosure - Leases - Additional Information (Details) Sheet http://www.maxlinear.com/role/LeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 79 false false R80.htm 9954524 - Disclosure - Leases - Aggregate Future Minimum Payments Due (Details) Sheet http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails Leases - Aggregate Future Minimum Payments Due (Details) Details 80 false false R81.htm 9954525 - Disclosure - Employee Retirement Plans (Details) Sheet http://www.maxlinear.com/role/EmployeeRetirementPlansDetails Employee Retirement Plans (Details) Details http://www.maxlinear.com/role/EmployeeRetirementPlans 81 false false R82.htm 9954526 - Disclosure - Commitments and Contingencies - Future Minimum Inventory Purchase and Other Obligations (Details) Sheet http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails Commitments and Contingencies - Future Minimum Inventory Purchase and Other Obligations (Details) Details 82 false false R83.htm 9954527 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 83 false false R84.htm 9954528 - Disclosure - Stock Repurchases (Details) Sheet http://www.maxlinear.com/role/StockRepurchasesDetails Stock Repurchases (Details) Details http://www.maxlinear.com/role/StockRepurchases 84 false false All Reports Book All Reports mxl-20240930.htm mxl-20240930.xsd mxl-20240930_cal.xml mxl-20240930_def.xml mxl-20240930_lab.xml mxl-20240930_pre.xml http://fasb.org/srt/2024 http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 true true JSON 103 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "mxl-20240930.htm": { "nsprefix": "mxl", "nsuri": "http://www.maxlinear.com/20240930", "dts": { "inline": { "local": [ "mxl-20240930.htm" ] }, "schema": { "local": [ "mxl-20240930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "calculationLink": { "local": [ "mxl-20240930_cal.xml" ] }, "definitionLink": { "local": [ "mxl-20240930_def.xml" ] }, "labelLink": { "local": [ "mxl-20240930_lab.xml" ] }, "presentationLink": { "local": [ "mxl-20240930_pre.xml" ] } }, "keyStandard": 355, "keyCustom": 50, "axisStandard": 25, "axisCustom": 2, "memberStandard": 58, "memberCustom": 38, "hidden": { "total": 9, "http://xbrl.sec.gov/dei/2024": 5, "http://fasb.org/us-gaap/2024": 1, "http://www.maxlinear.com/20240930": 3 }, "contextCount": 362, "entityCount": 1, "segmentCount": 97, "elementCount": 748, "unitCount": 7, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 1048, "http://xbrl.sec.gov/dei/2024": 29, "http://xbrl.sec.gov/ecd/2024": 4, "http://fasb.org/srt/2024": 1 }, "report": { "R1": { "role": "http://www.maxlinear.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.maxlinear.com/role/ConsolidatedBalanceSheets", "longName": "9952151 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R3": { "role": "http://www.maxlinear.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "9952152 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations", "longName": "9952153 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:CostOfRevenue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R5": { "role": "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLoss", "longName": "9952154 - Statement - Consolidated Statements of Comprehensive Loss", "shortName": "Consolidated Statements of Comprehensive Loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R6": { "role": "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical", "longName": "9952155 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)", "shortName": "Consolidated Statements of Comprehensive Loss (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity", "longName": "9952156 - Statement - Consolidated Statement of Stockholders' Equity", "shortName": "Consolidated Statement of Stockholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-40", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-45", "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R8": { "role": "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows", "longName": "9952157 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R9": { "role": "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPolicies", "longName": "9952158 - Disclosure - Organization and Summary of Significant Accounting Policies", "shortName": "Organization and Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.maxlinear.com/role/NetIncomeLossPerShare", "longName": "9952159 - Disclosure - Net Income (Loss) Per Share", "shortName": "Net Income (Loss) Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.maxlinear.com/role/BusinessCombinations", "longName": "9952160 - Disclosure - Business Combinations", "shortName": "Business Combinations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.maxlinear.com/role/RestructuringActivity", "longName": "9952161 - Disclosure - Restructuring Activity", "shortName": "Restructuring Activity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.maxlinear.com/role/GoodwillandIntangibleAssets", "longName": "9952162 - Disclosure - Goodwill and Intangible Assets", "shortName": "Goodwill and Intangible Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.maxlinear.com/role/FinancialInstruments", "longName": "9952163 - Disclosure - Financial Instruments", "shortName": "Financial Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.maxlinear.com/role/BalanceSheetDetails", "longName": "9952164 - Disclosure - Balance Sheet Details", "shortName": "Balance Sheet Details", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.maxlinear.com/role/Debt", "longName": "9952165 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.maxlinear.com/role/StockBasedCompensation", "longName": "9952166 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.maxlinear.com/role/IncomeTaxes", "longName": "9952167 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformation", "longName": "9952168 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information", "shortName": "Concentration of Credit Risk, Significant Customers and Geographic Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.maxlinear.com/role/RevenuefromContractswithCustomers", "longName": "9952169 - Disclosure - Revenue from Contracts with Customers", "shortName": "Revenue from Contracts with Customers", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.maxlinear.com/role/Leases", "longName": "9952170 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.maxlinear.com/role/EmployeeRetirementPlans", "longName": "9952171 - Disclosure - Employee Retirement Plans", "shortName": "Employee Retirement Plans", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.maxlinear.com/role/CommitmentsandContingencies", "longName": "9952172 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.maxlinear.com/role/StockRepurchases", "longName": "9952173 - Disclosure - Stock Repurchases", "shortName": "Stock Repurchases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R25": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": null }, "R26": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-5", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies", "longName": "9954471 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)", "shortName": "Organization and Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ConsolidationPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.maxlinear.com/role/NetIncomeLossPerShareTables", "longName": "9954472 - Disclosure - Net Income (Loss) Per Share (Tables)", "shortName": "Net Income (Loss) Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.maxlinear.com/role/BusinessCombinationsTables", "longName": "9954473 - Disclosure - Business Combinations (Tables)", "shortName": "Business Combinations (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.maxlinear.com/role/RestructuringActivityTables", "longName": "9954474 - Disclosure - Restructuring Activity (Tables)", "shortName": "Restructuring Activity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsTables", "longName": "9954475 - Disclosure - Goodwill and Intangible Assets (Tables)", "shortName": "Goodwill and Intangible Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.maxlinear.com/role/FinancialInstrumentsTables", "longName": "9954476 - Disclosure - Financial Instruments (Tables)", "shortName": "Financial Instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.maxlinear.com/role/BalanceSheetDetailsTables", "longName": "9954477 - Disclosure - Balance Sheet Details (Tables)", "shortName": "Balance Sheet Details (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.maxlinear.com/role/DebtTables", "longName": "9954478 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.maxlinear.com/role/StockBasedCompensationTables", "longName": "9954479 - Disclosure - Stock-Based Compensation (Tables)", "shortName": "Stock-Based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationTables", "longName": "9954480 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information (Tables)", "shortName": "Concentration of Credit Risk, Significant Customers and Geographic Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.maxlinear.com/role/RevenuefromContractswithCustomersTables", "longName": "9954481 - Disclosure - Revenue from Contracts with Customers (Tables)", "shortName": "Revenue from Contracts with Customers (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.maxlinear.com/role/LeasesTables", "longName": "9954482 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.maxlinear.com/role/CommitmentsandContingenciesTables", "longName": "9954483 - Disclosure - Commitments and Contingencies (Tables)", "shortName": "Commitments and Contingencies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails", "longName": "9954484 - Disclosure - Organization and Summary of Significant Accounting Policies (Details)", "shortName": "Organization and Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "mxl:ContractWithCustomerPaymentTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap:RevenueRecognitionPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "mxl:ContractWithCustomerPaymentTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap:RevenueRecognitionPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails", "longName": "9954485 - Disclosure - Net Income (Loss) Per Share - Summary of Basic and Diluted Earnings Per Share (Details)", "shortName": "Net Income (Loss) Per Share - Summary of Basic and Diluted Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R42": { "role": "http://www.maxlinear.com/role/NetIncomeLossPerShareAdditionalInformationDetails", "longName": "9954486 - Disclosure - Net Income (Loss) Per Share - Additional Information (Details)", "shortName": "Net Income (Loss) Per Share - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails", "longName": "9954487 - Disclosure - Business Combinations - Additional Information (Details)", "shortName": "Business Combinations - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-79", "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R44": { "role": "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails", "longName": "9954488 - Disclosure - Business Combinations - Summary of Business Acquisitions, by Acquisition (Details)", "shortName": "Business Combinations - Summary of Business Acquisitions, by Acquisition (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-80", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-80", "name": "us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R45": { "role": "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "longName": "9954489 - Disclosure - Restructuring Activity - Additional Information (Details)", "shortName": "Restructuring Activity - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RestructuringCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-84", "name": "us-gaap:RestructuringCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "us-gaap:RestructuringCharges", "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R46": { "role": "http://www.maxlinear.com/role/RestructuringActivityRestructuringandRelatedCostsDetails", "longName": "9954490 - Disclosure - Restructuring Activity - Restructuring and Related Costs (Details)", "shortName": "Restructuring Activity - Restructuring and Related Costs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RestructuringCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": null }, "R47": { "role": "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails", "longName": "9954491 - Disclosure - Restructuring Activity - Schedule of Restructuring Reserve by Type of Cost (Details)", "shortName": "Restructuring Activity - Schedule of Restructuring Reserve by Type of Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails", "longName": "9954492 - Disclosure - Goodwill and Intangible Assets - Summary of Goodwill (Details)", "shortName": "Goodwill and Intangible Assets - Summary of Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R49": { "role": "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "longName": "9954493 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details)", "shortName": "Goodwill and Intangible Assets - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-116", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-116", "name": "us-gaap:GoodwillImpairmentLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails", "longName": "9954494 - Disclosure - Goodwill and Intangible Assets - Schedule of Acquired Finite-Lived Intangible Assets by Major Class (Details)", "shortName": "Goodwill and Intangible Assets - Schedule of Acquired Finite-Lived Intangible Assets by Major Class (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsFinitelivedIntangibleAssetsAmortizationExpenseDetails", "longName": "9954495 - Disclosure - Goodwill and Intangible Assets - Finite-lived Intangible Assets Amortization Expense (Details)", "shortName": "Goodwill and Intangible Assets - Finite-lived Intangible Assets Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-127", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R52": { "role": "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails", "longName": "9954496 - Disclosure - Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)", "shortName": "Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FinitelivedIntangibleAssetsAcquired1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R53": { "role": "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails", "longName": "9954497 - Disclosure - Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)", "shortName": "Goodwill and Intangible Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R54": { "role": "http://www.maxlinear.com/role/FinancialInstrumentsCompositionofFinancialInstrumentsDetails", "longName": "9954498 - Disclosure - Financial Instruments - Composition of Financial Instruments (Details)", "shortName": "Financial Instruments - Composition of Financial Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": null }, "R55": { "role": "http://www.maxlinear.com/role/FinancialInstrumentsAdditionalInformationDetails", "longName": "9954499 - Disclosure - Financial Instruments - Additional Information (Details)", "shortName": "Financial Instruments - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails", "longName": "9954500 - Disclosure - Financial Instruments - Fair Value, Liabilities Measured on Recurring Basis (Details)", "shortName": "Financial Instruments - Fair Value, Liabilities Measured on Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-140", "name": "us-gaap:BusinessCombinationContingentConsiderationLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R57": { "role": "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails", "longName": "9954501 - Disclosure - Financial Instruments - Summary of Level 3 Financial Instrument Activity (Details)", "shortName": "Financial Instruments - Summary of Level 3 Financial Instrument Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-147", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-147", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails", "longName": "9954502 - Disclosure - Balance Sheet Details - Cash, Cash Equivalents and Restricted Cash (Details)", "shortName": "Balance Sheet Details - Cash, Cash Equivalents and Restricted Cash (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "mxl:CashCashEquivalentsAndRestrictedCash", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R59": { "role": "http://www.maxlinear.com/role/BalanceSheetDetailsInventoryDetails", "longName": "9954503 - Disclosure - Balance Sheet Details - Inventory (Details)", "shortName": "Balance Sheet Details - Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:InventoryWorkInProcess", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:InventoryWorkInProcess", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails", "longName": "9954504 - Disclosure - Balance Sheet Details - Property and Equipment, Net (Details)", "shortName": "Balance Sheet Details - Property and Equipment, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R61": { "role": "http://www.maxlinear.com/role/BalanceSheetDetailsAdditionalInformationDetails", "longName": "9954505 - Disclosure - Balance Sheet Details - Additional Information (Details)", "shortName": "Balance Sheet Details - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-169", "name": "mxl:ProceedsLoanedUnderNotesReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-169", "name": "mxl:ProceedsLoanedUnderNotesReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedPriceProtectionLiabilityDetails", "longName": "9954506 - Disclosure - Balance Sheet Details - Accrued Price Protection Liability (Details)", "shortName": "Balance Sheet Details - Accrued Price Protection Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-4", "name": "mxl:AccruedPriceProtectionLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "mxl:PriceProtectionLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "mxl:PriceProtectionRebateCharges", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "mxl:PriceProtectionLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R63": { "role": "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "longName": "9954507 - Disclosure - Balance Sheet Details - Accrued Expenses and Other Current Liabilities (Details)", "shortName": "Balance Sheet Details - Accrued Expenses and Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-3", "name": "mxl:AccruedTechnologyLicensePaymentsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "mxl:AccruedTechnologyLicensePaymentsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails", "longName": "9954508 - Disclosure - Balance Sheet Details - Schedule of Accumulated Other Comprehensive Income (Loss) by Component (Details)", "shortName": "Balance Sheet Details - Schedule of Accumulated Other Comprehensive Income (Loss) by Component (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R65": { "role": "http://www.maxlinear.com/role/DebtScheduleofDebtDetails", "longName": "9954509 - Disclosure - Debt - Schedule of Debt (Details)", "shortName": "Debt - Schedule of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-184", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R66": { "role": "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "longName": "9954510 - Disclosure - Debt - Additional Information (Details)", "shortName": "Debt - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R67": { "role": "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "longName": "9954511 - Disclosure - Stock-Based Compensation - Additional Information (Details)", "shortName": "Stock-Based Compensation - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-207", "name": "mxl:SharesIssuedUponSettlementOfExecutiveBonusPlan", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-207", "name": "mxl:SharesIssuedUponSettlementOfExecutiveBonusPlan", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R68": { "role": "http://www.maxlinear.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails", "longName": "9954512 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense (Details)", "shortName": "Stock-Based Compensation - Stock-Based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-5", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails", "longName": "9954513 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Unit and Performance-Based Restricted Stock Unit Activity (Details)", "shortName": "Stock-Based Compensation - Summary of Restricted Stock Unit and Performance-Based Restricted Stock Unit Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-214", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-214", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "longName": "9954514 - Disclosure - Stock-Based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details)", "shortName": "Stock-Based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-220", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-220", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R71": { "role": "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails", "longName": "9954515 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)", "shortName": "Stock-Based Compensation - Summary of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-4", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R72": { "role": "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails", "longName": "9954516 - Disclosure - Stock-Based Compensation - Schedule of Stock Options, Valuation Assumptions (Details)", "shortName": "Stock-Based Compensation - Schedule of Stock Options, Valuation Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-213", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-213", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "4", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.maxlinear.com/role/IncomeTaxesDetails", "longName": "9954517 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R74": { "role": "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails", "longName": "9954518 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information - Concentration of Risk, by Risk Factor (Details)", "shortName": "Concentration of Credit Risk, Significant Customers and Geographic Information - Concentration of Risk, by Risk Factor (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-238", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-238", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails", "longName": "9954519 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information - Revenue from External Customers by Geographic Areas (Details)", "shortName": "Concentration of Credit Risk, Significant Customers and Geographic Information - Revenue from External Customers by Geographic Areas (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-284", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R76": { "role": "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "longName": "9954520 - Disclosure - Concentration of Credit Risk, Significant Customers and Geographic Information - Long-Lived Assets by Geographic Areas (Details)", "shortName": "Concentration of Credit Risk, Significant Customers and Geographic Information - Long-Lived Assets by Geographic Areas (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-310", "name": "mxl:LongLivedAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-310", "name": "mxl:LongLivedAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails", "longName": "9954521 - Disclosure - Revenue from Contracts with Customers - Revenues from External Customers by Products and Services (Details)", "shortName": "Revenue from Contracts with Customers - Revenues from External Customers by Products and Services (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-5", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-314", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R78": { "role": "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails", "longName": "9954522 - Disclosure - Revenue from Contracts with Customers - Additional Information (Details)", "shortName": "Revenue from Contracts with Customers - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:ContractWithCustomerRightToRecoverProduct", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R79": { "role": "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails", "longName": "9954523 - Disclosure - Leases - Additional Information (Details)", "shortName": "Leases - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "us-gaap:LesseeLeasesPolicyTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R80": { "role": "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails", "longName": "9954524 - Disclosure - Leases - Aggregate Future Minimum Payments Due (Details)", "shortName": "Leases - Aggregate Future Minimum Payments Due (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R81": { "role": "http://www.maxlinear.com/role/EmployeeRetirementPlansDetails", "longName": "9954525 - Disclosure - Employee Retirement Plans (Details)", "shortName": "Employee Retirement Plans (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-4", "name": "us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "unique": true } }, "R82": { "role": "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails", "longName": "9954526 - Disclosure - Commitments and Contingencies - Future Minimum Inventory Purchase and Other Obligations (Details)", "shortName": "Commitments and Contingencies - Future Minimum Inventory Purchase and Other Obligations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCommitmentsTableTextBlock", "us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OtherCommitmentsTableTextBlock", "us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R83": { "role": "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails", "longName": "9954527 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "shortName": "Commitments and Contingencies - Additional Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c-3", "name": "mxl:ResearchAndDevelopmentArrangementContractForAJointlyFundedProjectCumulativeProceedsReceivedFromOtherPartyDeferredInLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "mxl:ResearchAndDevelopmentArrangementContractForAJointlyFundedProjectCumulativeProceedsReceivedFromOtherPartyDeferredInLiabilities", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } }, "R84": { "role": "http://www.maxlinear.com/role/StockRepurchasesDetails", "longName": "9954528 - Disclosure - Stock Repurchases (Details)", "shortName": "Stock Repurchases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c-360", "name": "srt:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-360", "name": "srt:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mxl-20240930.htm", "first": true, "unique": true } } }, "tag": { "mxl_A2023And2024WorkforceReductionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "A2023And2024WorkforceReductionsMember", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2023 And 2024 Workforce Reductions", "label": "2023 And 2024 Workforce Reductions [Member]", "documentation": "2023 And 2024 Workforce Reductions" } } }, "auth_ref": [] }, "mxl_A2023WorkforceReductionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "A2023WorkforceReductionMember", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2023 Workforce Reduction", "label": "2023 Workforce Reduction [Member]", "documentation": "2023 Workforce Reduction" } } }, "auth_ref": [] }, "mxl_A2024WorkforceReductionMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "A2024WorkforceReductionMember", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024 Workforce Reduction", "label": "2024 Workforce Reduction [Member]", "documentation": "2024 Workforce Reduction" } } }, "auth_ref": [] }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AOCIAttributableToParentNetOfTaxRollForward", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r82", "r896" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r830" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r1048" ] }, "us-gaap_AccruedBonusesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedBonusesCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued bonuses", "label": "Accrued Bonuses", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements." } } }, "auth_ref": [ "r153" ] }, "mxl_AccruedCustomerCredits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "AccruedCustomerCredits", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued customer credits", "label": "Accrued Customer Credits", "documentation": "Accrued Customer Credits" } } }, "auth_ref": [] }, "mxl_AccruedEngineeringAndProductionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "AccruedEngineeringAndProductionCosts", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued engineering and production costs", "label": "Accrued Engineering And Production Costs", "documentation": "Accrued Engineering And Production Costs" } } }, "auth_ref": [] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax liability", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r85", "r152" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 }, "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued expenses and other current liabilities", "totalLabel": "Total", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r85" ] }, "mxl_AccruedObligationsToCustomersForStockRotationRights": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "AccruedObligationsToCustomersForStockRotationRights", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued obligations to customers for stock rotation rights", "label": "Accrued Obligations To Customers For Stock Rotation Rights", "documentation": "Accrued Obligations To Customers For Stock Rotation Rights" } } }, "auth_ref": [] }, "mxl_AccruedPriceProtectionLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "AccruedPriceProtectionLiability", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedPriceProtectionLiabilityDetails", "http://www.maxlinear.com/role/ConsolidatedBalanceSheets", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued price protection liability", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Accrued Price Protection Liability", "documentation": "Accrued price protection liability." } } }, "auth_ref": [] }, "mxl_AccruedPriceProtectionRebateActivityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "AccruedPriceProtectionRebateActivityRollForward", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedPriceProtectionLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued Price Protection Rebate Activity [Roll Forward]", "label": "Accrued Price Protection Rebate Activity [Roll Forward]", "documentation": "Accrued price protection rebate activity" } } }, "auth_ref": [] }, "us-gaap_AccruedProfessionalFeesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedProfessionalFeesCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued professional fees", "label": "Accrued Professional Fees, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r85" ] }, "us-gaap_AccruedRoyaltiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedRoyaltiesCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued royalty", "label": "Accrued Royalties, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r85", "r849" ] }, "mxl_AccruedTechnologyLicensePaymentsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "AccruedTechnologyLicensePaymentsCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued technology license payments", "label": "Accrued Technology License Payments Current", "documentation": "Accrued technology license payments current." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and Other Defined Benefit Plan Obligation", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r17", "r29", "r105", "r238", "r239", "r1024" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: accumulated depreciation and amortization", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r52", "r219", "r717" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r237", "r238", "r628", "r629", "r630", "r631", "r632", "r634" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r28", "r29", "r106", "r226", "r713", "r744", "r748" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r237", "r238", "r628", "r629", "r630", "r631", "r632", "r634" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails", "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss)", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r3", "r17", "r29", "r576", "r579", "r658", "r739", "r740", "r1024", "r1025", "r1026", "r1037", "r1038", "r1039", "r1040" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cumulative Translation Adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r4", "r17", "r29", "r103", "r104", "r238", "r239", "r629", "r630", "r631", "r632", "r634", "r1024" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r960" ] }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalCommonStock", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital, Common Stock", "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital." } } }, "auth_ref": [ "r95" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r759", "r1037", "r1038", "r1039", "r1040", "r1138", "r1196" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r973" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r973" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r973" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r973" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r64", "r65", "r475" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to cash provided by operating activities:", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "mxl_AggregateCommitmentsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "AggregateCommitmentsPercentage", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate commitments percentage", "label": "Aggregate Commitments, Percentage", "documentation": "Aggregate Commitments, Percentage" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r1006" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r932", "r942", "r952", "r984" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r935", "r945", "r955", "r987" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r1007" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r973" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r980" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r936", "r946", "r956", "r980", "r988", "r992", "r1000" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r998" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r507", "r516" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "mxl_AmortizationOfDebtIssuanceCostAndAccretionOfDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "AmortizationOfDebtIssuanceCostAndAccretionOfDiscounts", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of debt issuance costs and accretion of discounts", "label": "Amortization Of Debt Issuance Cost And Accretion Of Discounts", "documentation": "Amortization of Debt Issuance Costs and Discount on Debt and Leases" } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of debt issuance costs and accretion of discount on debt and leases", "label": "Amortization of Debt Issuance Costs and Discounts", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r412", "r872", "r873", "r1031", "r1150" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsFinitelivedIntangibleAssetsAmortizationExpenseDetails", "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization", "negatedLabel": "Amortization", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r10", "r334", "r341", "r863" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.maxlinear.com/role/NetIncomeLossPerShareAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock equivalents excluded from the calculation of diluted net income (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r279" ] }, "srt_AsiaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "AsiaMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asia", "label": "Asia [Member]", "documentation": "Continent of Asia." } } }, "auth_ref": [ "r1013", "r1014", "r1015", "r1016", "r1198", "r1199", "r1200", "r1201" ] }, "us-gaap_AssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment losses", "label": "Asset Impairment Charges", "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill." } } }, "auth_ref": [ "r10", "r50" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r151", "r162", "r223", "r250", "r283", "r285", "r300", "r301", "r312", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r567", "r569", "r618", "r708", "r786", "r858", "r859", "r896", "r923", "r1098", "r1099", "r1155" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Assets", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r214", "r229", "r250", "r312", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r567", "r569", "r618", "r896", "r1098", "r1099", "r1155" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r995" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r996" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r991" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r991" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r991" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r991" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r991" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r991" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r478", "r479", "r480", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r502", "r503", "r504", "r505", "r506" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r994" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r993" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r992" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r992" ] }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetRelatedDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Related Disclosures [Abstract]", "label": "Balance Sheet Related Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BaseRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BaseRateMember", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Base rate", "label": "Base Rate [Member]", "documentation": "Minimum rate investor will accept." } } }, "auth_ref": [] }, "mxl_BroadbandMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "BroadbandMember", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Broadband", "label": "Broadband [Member]", "documentation": "Broadband" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails", "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails", "http://www.maxlinear.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition, Acquiree [Domain]", "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r335", "r336", "r337", "r338", "r339", "r554", "r882", "r883" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails", "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails", "http://www.maxlinear.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Axis]", "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r67", "r68", "r335", "r336", "r337", "r338", "r339", "r554", "r882", "r883" ] }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction costs", "label": "Business Acquisition, Transaction Costs", "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails", "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business Acquisition [Line Items]", "label": "Business Acquisition [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r554" ] }, "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected tax deductible amount of acquired goodwill", "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount", "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes." } } }, "auth_ref": [ "r74" ] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total purchase price", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r0", "r1", "r16" ] }, "us-gaap_BusinessCombinationConsiderationTransferredAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationConsiderationTransferredAbstract", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of purchase consideration:", "label": "Business Combination, Consideration Transferred [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Contingent consideration", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r0", "r1", "r71", "r560" ] }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails", "http://www.maxlinear.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration (up to)", "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High", "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid." } } }, "auth_ref": [ "r73" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails", "http://www.maxlinear.com/role/FinancialInstrumentsCompositionofFinancialInstrumentsDetails", "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration (up to)", "verboseLabel": "Contingent consideration (Note 3)", "netLabel": "Contingent consideration", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r72", "r146", "r561", "r597", "r598", "r599" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration - current portion", "label": "Business Combination, Contingent Consideration, Liability, Current", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r72", "r146" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinations" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combinations", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r140", "r555" ] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combinations", "label": "Business Combinations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r141", "r142", "r143", "r144" ] }, "country_CN": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "CN", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China", "label": "CHINA" } } }, "auth_ref": [] }, "mxl_CallPremiumPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "CallPremiumPercentage", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Call premium, percentage", "label": "Call Premium, Percentage", "documentation": "Call Premium, Percentage" } } }, "auth_ref": [] }, "mxl_CallPremiumPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "CallPremiumPeriod", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Call premium, period", "label": "Call Premium, Period", "documentation": "Call Premium, Period" } } }, "auth_ref": [] }, "us-gaap_CapitalizedContractCostLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CapitalizedContractCostLineItems", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized Contract Cost [Line Items]", "label": "Capitalized Contract Cost [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r326" ] }, "us-gaap_CapitalizedContractCostTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CapitalizedContractCostTable", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized Contract Cost [Table]", "label": "Capitalized Contract Cost [Table]", "documentation": "Disclosure of information about cost capitalized in obtaining or fulfilling contract with customer." } } }, "auth_ref": [ "r326" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "mxl_CashCashEquivalentsAndRestrictedCash", "weight": 1.0, "order": 1.0 }, "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails", "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r33", "r217", "r847" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and Cash Equivalents", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r34" ] }, "mxl_CashCashEquivalentsAndRestrictedCash": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "CashCashEquivalentsAndRestrictedCash", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents And Restricted Cash", "documentation": "Cash, Cash Equivalents And Restricted Cash" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r33", "r115", "r247" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Decrease in cash, cash equivalents and restricted cash", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r115" ] }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosures of non-cash activities:", "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r971" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r968" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r966" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r972" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r972" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r91", "r155", "r709", "r773" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r129", "r369", "r370", "r831", "r1081", "r1090" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r913", "r914", "r915", "r917", "r918", "r919", "r920", "r1037", "r1038", "r1040", "r1138", "r1195", "r1196" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in usd per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r94" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r94", "r774" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r94" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Balance at beginning of period (in shares)", "periodEndLabel": "Balance at end of period (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r18", "r94", "r774", "r792", "r1196", "r1197" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.0001 par value; 550,000 shares authorized; 84,362 shares issued and outstanding at September\u00a030, 2024 and 81,818 shares issued and outstanding December\u00a031, 2023", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r94", "r712", "r896" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r977" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r976" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r978" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r975" ] }, "mxl_CompanyYMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "CompanyYMember", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails", "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails", "http://www.maxlinear.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Company Y", "label": "Company Y [Member]", "documentation": "Company Y" } } }, "auth_ref": [] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive loss", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r30", "r233", "r235", "r240", "r704", "r722", "r723" ] }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Comprehensive Income (Loss)", "label": "Comprehensive Income, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for comprehensive income." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r41", "r43", "r78", "r79", "r306", "r830" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r41", "r43", "r78", "r79", "r306", "r750", "r830" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r41", "r43", "r78", "r79", "r306", "r830", "r1011" ] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformation" ], "lang": { "en-us": { "role": { "verboseLabel": "Concentration of Credit Risk, Significant Customers and Geographic Information", "label": "Concentration Risk Disclosure [Text Block]", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r119" ] }, "us-gaap_ConcentrationRiskLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskLineItems", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Line Items]", "label": "Concentration Risk [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r830" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk percentage", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r41", "r43", "r78", "r79", "r306" ] }, "us-gaap_ConcentrationRiskTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTable", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk [Table]", "label": "Concentration Risk [Table]", "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk." } } }, "auth_ref": [ "r40", "r41", "r43", "r44", "r78", "r149", "r830" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r41", "r43", "r78", "r79", "r306", "r830" ] }, "mxl_ConnectivityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ConnectivityMember", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Connectivity", "label": "Connectivity [Member]", "documentation": "Connectivity" } } }, "auth_ref": [] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and Principles of Consolidation", "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r75", "r850" ] }, "us-gaap_ConstructionInProgressMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConstructionInProgressMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Construction in progress", "label": "Construction in Progress [Member]", "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service." } } }, "auth_ref": [] }, "mxl_ContingentConsiderationLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ContingentConsiderationLiabilityMember", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent Consideration, Liability", "label": "Contingent Consideration, Liability [Member]", "documentation": "Contingent Consideration, Liability" } } }, "auth_ref": [] }, "us-gaap_ContractTerminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractTerminationMember", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract Termination", "label": "Contract Termination [Member]", "documentation": "Termination of a contract associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [ "r864", "r865", "r866", "r867" ] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiability", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer contract liabilities", "label": "Contract with Customer, Liability", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r434", "r435", "r446" ] }, "mxl_ContractWithCustomerPaymentTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ContractWithCustomerPaymentTerm", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment term", "label": "Contract with Customer, Payment Term", "documentation": "Contract with Customer, Payment Term" } } }, "auth_ref": [] }, "mxl_ContractWithCustomerRightOfReturnTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ContractWithCustomerRightOfReturnTerm", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right of return, term", "label": "Contract with Customer, Right of Return, Term", "documentation": "Contract with Customer, Right of Return, Term" } } }, "auth_ref": [] }, "mxl_ContractWithCustomerRightOfReturnUnderGeneralAssuranceWarrantyTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ContractWithCustomerRightOfReturnUnderGeneralAssuranceWarrantyTerm", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right of return under the general assurance warranty, term", "label": "Contract with Customer, Right of Return Under General Assurance Warranty, Term", "documentation": "Contract with Customer, Right of Return Under General Assurance Warranty, Term" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerRightToRecoverProduct": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerRightToRecoverProduct", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right of return assets", "label": "Contract with Customer, Right to Recover Product", "documentation": "Amount of right to recover product from customer on settling refund liability." } } }, "auth_ref": [ "r1104" ] }, "mxl_ContractWithCustomerStockRotationAllowanceTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ContractWithCustomerStockRotationAllowanceTerm", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock rotation allowance, term (up to)", "label": "Contract with Customer, Stock Rotation Allowance, Term", "documentation": "Contract with Customer, Stock Rotation Allowance, Term" } } }, "auth_ref": [] }, "us-gaap_ContractualObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractualObligation", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total minimum payments", "label": "Contractual Obligation", "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments." } } }, "auth_ref": [ "r1036" ] }, "us-gaap_ContractualObligationDueInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractualObligationDueInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails_1": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 3.0 }, "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2025", "label": "Contractual Obligation, to be Paid, Year One", "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInSecondYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractualObligationDueInSecondYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails_1": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 4.0 }, "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2026", "label": "Contractual Obligation, to be Paid, Year Two", "documentation": "Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationDueInThirdYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractualObligationDueInThirdYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails_1": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 1.0 }, "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2027", "label": "Contractual Obligation, to be Paid, Year Three", "documentation": "Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_ContractualObligationFiscalYearMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractualObligationFiscalYearMaturityAbstract", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total", "label": "Contractual Obligation, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails_1": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 2.0 }, "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "2024 (3 months)", "label": "Contractual Obligation, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of contractual obligation to be paid in remainder of current fiscal year." } } }, "auth_ref": [] }, "mxl_ContractwithCustomerRebateandPriceProtectionProgramTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ContractwithCustomerRebateandPriceProtectionProgramTerm", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rebate and price protection program, term", "label": "Contract with Customer, Rebate and Price Protection Program Term", "documentation": "Contract with Customer, Rebate and Price Protection Program Term" } } }, "auth_ref": [] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of net revenue", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r109", "r250", "r312", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r618", "r858", "r1098" ] }, "us-gaap_CostOfSalesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfSalesMember", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsFinitelivedIntangibleAssetsAmortizationExpenseDetails", "http://www.maxlinear.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of net revenue", "verboseLabel": "Cost of net revenue", "label": "Cost of Sales [Member]", "documentation": "Primary financial statement caption encompassing cost of sales." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover page.", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "mxl_CoxLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "CoxLitigationMember", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cox Litigation", "label": "Cox Litigation [Member]", "documentation": "Cox Litigation" } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityAxis", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r380", "r1096" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CreditFacilityDomain", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r380", "r1096", "r1097" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "mxl_CustomerAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "CustomerAMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer A", "label": "Customer A [Member]", "documentation": "Customer A" } } }, "auth_ref": [] }, "mxl_CustomerBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "CustomerBMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer B", "label": "Customer B [Member]", "documentation": "Customer B" } } }, "auth_ref": [] }, "mxl_CustomerCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "CustomerCMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer C", "label": "Customer C [Member]", "documentation": "Customer C [Member]" } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r120", "r306" ] }, "us-gaap_CustomerRefundLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerRefundLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued obligations to customers for price adjustments", "terseLabel": "Accrued obligations to customers for price adjustments", "label": "Customer Refund Liability, Current", "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment." } } }, "auth_ref": [] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Customer relationships", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r70", "r1066", "r1068", "r1069", "r1070", "r1072", "r1074", "r1077", "r1078" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.maxlinear.com/role/Debt" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r130", "r248", "r350", "r351", "r352", "r353", "r354", "r379", "r380", "r390", "r396", "r397", "r398", "r399", "r400", "r401", "r406", "r413", "r414", "r416", "r635" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, basis spread on variable rate", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "mxl_DebtInstrumentBasisSpreadOnVariableRateAdditionalApplicableMargin": { "xbrltype": "percentItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "DebtInstrumentBasisSpreadOnVariableRateAdditionalApplicableMargin", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, basis spread on variable rate, additional applicable margin", "label": "Debt Instrument, Basis Spread On Variable Rate, Additional Applicable Margin", "documentation": "Debt Instrument, Basis Spread On Variable Rate, Additional Applicable Margin" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/DebtScheduleofDebtDetails_1": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal amount of long-term debt", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r26", "r154", "r417" ] }, "mxl_DebtInstrumentCovenantLeverageRatioMaximum": { "xbrltype": "pureItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "DebtInstrumentCovenantLeverageRatioMaximum", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, covenant, leverage ratio, maximum", "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum", "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum" } } }, "auth_ref": [] }, "mxl_DebtInstrumentCovenantLeverageRatioMaximumPotentialTemporaryIncrease": { "xbrltype": "pureItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "DebtInstrumentCovenantLeverageRatioMaximumPotentialTemporaryIncrease", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, covenant, leverage ratio, maximum, potential temporary increase", "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum, Potential Temporary Increase", "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum, Potential Temporary Increase" } } }, "auth_ref": [] }, "mxl_DebtInstrumentInterestPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "DebtInstrumentInterestPeriod", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest period", "label": "Debt Instrument, Interest Period", "documentation": "Debt Instrument, Interest Period" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective interest rate", "label": "Debt Instrument, Interest Rate, Effective Percentage", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r87", "r419", "r635", "r636", "r894" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r252", "r391", "r392", "r393", "r394", "r395", "r397", "r402", "r403", "r404", "r405", "r407", "r408", "r409", "r410", "r411", "r412", "r415", "r869", "r870", "r871", "r872", "r873", "r894", "r1033", "r1149", "r1151" ] }, "mxl_DebtInstrumentQuarterlyAmortizationRate": { "xbrltype": "percentItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "DebtInstrumentQuarterlyAmortizationRate", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, quarterly amortization rate", "label": "Debt Instrument, Quarterly Amortization Rate", "documentation": "Debt Instrument, Quarterly Amortization Rate" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTable", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r26", "r56", "r57", "r80", "r132", "r133", "r252", "r391", "r392", "r393", "r394", "r395", "r397", "r402", "r403", "r404", "r405", "r407", "r408", "r409", "r410", "r411", "r412", "r415", "r869", "r870", "r871", "r872", "r873", "r894", "r1033", "r1149", "r1151" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/DebtScheduleofDebtDetails_1": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unamortized debt discount", "terseLabel": "Unamortized debt discount", "label": "Debt Instrument, Unamortized Discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r1101", "r1148", "r1149", "r1151" ] }, "us-gaap_DeferredFinanceCostsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFinanceCostsGross", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs", "label": "Debt Issuance Costs, Gross", "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r1149", "r1151" ] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/DebtScheduleofDebtDetails_1": { "parentTag": "us-gaap_LongTermDebt", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unamortized debt issuance costs", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r1101", "r1148", "r1149", "r1151" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r523", "r524" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r10", "r176", "r1035" ] }, "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/EmployeeRetirementPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined benefit obligation", "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position", "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans." } } }, "auth_ref": [ "r58", "r59" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/EmployeeRetirementPlansDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net periodic benefit cost", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r458", "r467", "r880", "r881" ] }, "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 21.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gain on settlement of pension", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement", "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from irrevocable action relieving primary responsibility for benefit obligation and eliminating risk related to obligation and assets used to effect settlement." } } }, "auth_ref": [ "r449", "r459", "r468" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation expense", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r10", "r51" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization and depreciation", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r10", "r283", "r290", "r301", "r858", "r859" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed technology", "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r145", "r1066", "r1068", "r1069", "r1070", "r1072", "r1074", "r1077", "r1078" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r473", "r477", "r508", "r509", "r511", "r885" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Share-based Payment Arrangement [Abstract]", "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "mxl_DishLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "DishLitigationMember", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dish Litigation", "label": "Dish Litigation [Member]", "documentation": "Dish Litigation" } } }, "auth_ref": [] }, "mxl_DistributorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "DistributorsMember", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Distributors", "label": "Distributors [Member]", "documentation": "Distributors" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r927" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r959" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r970" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations", "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in usd per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r241", "r261", "r262", "r263", "r264", "r265", "r266", "r272", "r274", "r276", "r277", "r278", "r282", "r552", "r566", "r592", "r593", "r705", "r724", "r853" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share:", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations", "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in usd per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r241", "r261", "r262", "r263", "r264", "r265", "r266", "r274", "r276", "r277", "r278", "r282", "r552", "r566", "r592", "r593", "r705", "r724", "r853" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.maxlinear.com/role/NetIncomeLossPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Net Income (Loss) Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r271", "r279", "r280", "r281" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r626" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r85" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation cost", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement." } } }, "auth_ref": [ "r510" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation costs, period for recognition", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r510" ] }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Excess tax (benefits) deficiencies on stock-based awards", "label": "Share-Based Payment Arrangement, Expense, Tax Benefit", "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement." } } }, "auth_ref": [ "r507" ] }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax benefit from stock options exercised", "label": "Share-Based Payment Arrangement, Exercise of Option, Tax Benefit", "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r174" ] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/RestructuringActivityRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee separation expenses", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockMember", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock", "label": "Employee Stock [Member]", "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Options", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "mxl_EmployeeStockPurchasePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "EmployeeStockPurchasePlanMember", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Purchase Plan", "label": "Employee Stock Purchase Plan [Member]", "documentation": "Employee stock purchase plan." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r925" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r925" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r925" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1009" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r925" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r925" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r925" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r925" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r964" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r1005" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r1005" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r1005" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails", "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r18", "r209", "r237", "r238", "r239", "r253", "r254", "r255", "r258", "r265", "r267", "r269", "r284", "r316", "r322", "r348", "r433", "r535", "r536", "r548", "r549", "r550", "r553", "r565", "r566", "r574", "r576", "r577", "r578", "r579", "r581", "r591", "r628", "r629", "r630", "r631", "r632", "r634", "r638", "r641", "r658", "r721", "r739", "r740", "r741", "r759", "r813" ] }, "mxl_EquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "EquityIncentivePlanMember", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Incentive Plan", "label": "Equity Incentive Plan [Member]", "documentation": "Equity incentive plan." } } }, "auth_ref": [] }, "us-gaap_EquitySecuritiesFvNiUnrealizedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesFvNiUnrealizedLoss", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment losses", "label": "Equity Securities, FV-NI, Unrealized Loss", "documentation": "Amount of unrealized loss on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI)." } } }, "auth_ref": [ "r311" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in privately held entities", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "documentation": "Amount of investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r310" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r974" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r932", "r942", "r952", "r984" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r929", "r939", "r949", "r981" ] }, "srt_EuropeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "EuropeMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe", "label": "Europe [Member]", "documentation": "Continent of Europe." } } }, "auth_ref": [ "r1013", "r1014", "r1015", "r1016", "r1198", "r1199", "r1200", "r1201" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r980" ] }, "us-gaap_FacilityClosingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FacilityClosingMember", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/RestructuringActivityRestructuringandRelatedCostsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease related charges", "label": "Facility Closing [Member]", "documentation": "Closing of a facility associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "mxl_FacilityClosingNettingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "FacilityClosingNettingMember", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lease Related Charges", "label": "Facility Closing, Netting [Member]", "documentation": "Facility Closing, Netting" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r595", "r596", "r609", "r887" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r595", "r596", "r609", "r887" ] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]", "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r76", "r77" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Composition of Financial Instruments", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r76" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r404", "r452", "r453", "r454", "r455", "r456", "r457", "r594", "r596", "r597", "r598", "r599", "r608", "r609", "r611", "r659", "r660", "r661", "r870", "r871", "r878", "r879", "r880", "r887", "r890" ] }, "us-gaap_FairValueByLiabilityClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByLiabilityClassAxis", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liability Class [Axis]", "label": "Liability Class [Axis]", "documentation": "Information by class of liability." } } }, "auth_ref": [ "r600", "r601", "r602", "r603", "r604", "r605", "r610" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Axis]", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r595", "r596", "r597", "r599", "r887", "r1142", "r1144" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.maxlinear.com/role/FinancialInstruments" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r604", "r606", "r607", "r608", "r611", "r612", "r613", "r614", "r615", "r702", "r887", "r891" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quoted\u00a0Prices in Active Markets for Identical\u00a0Assets (Level 1)", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r404", "r452", "r457", "r596", "r609", "r659", "r878", "r879", "r880", "r887" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Other Observable Inputs (Level 2)", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r404", "r452", "r457", "r596", "r597", "r609", "r660", "r870", "r871", "r878", "r879", "r880", "r887" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Unobservable Inputs (Level\u00a03)", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r404", "r452", "r453", "r454", "r455", "r456", "r457", "r596", "r597", "r598", "r599", "r609", "r661", "r870", "r871", "r878", "r879", "r880", "r887", "r890" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Fair Value, Liabilities Measured on Recurring Basis", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r1139", "r1140" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value by Liability Class [Domain]", "label": "Fair Value by Liability Class [Domain]", "documentation": "Represents classes of liabilities measured and disclosed at fair value." } } }, "auth_ref": [ "r600", "r601", "r602", "r603", "r604", "r605", "r610" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r600", "r601", "r602", "r603", "r604", "r605" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input." } } }, "auth_ref": [ "r600", "r601", "r602", "r603", "r604", "r605", "r610" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Level 3 Financial Instrument Activity", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r600", "r605", "r610" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Domain]", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [ "r595", "r596", "r597", "r599", "r887", "r1142", "r1144" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accretion of discount", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r601", "r610" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions (Note 3)", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r603", "r610" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r603", "r610" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsSummaryofLevel3FinancialInstrumentActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r600", "r610" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r404", "r452", "r453", "r454", "r455", "r456", "r457", "r594", "r596", "r597", "r598", "r599", "r608", "r609", "r611", "r659", "r660", "r661", "r870", "r871", "r878", "r879", "r880", "r887", "r890" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r887", "r1139", "r1140", "r1141", "r1142", "r1143", "r1144" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r13" ] }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FederalFundsEffectiveSwapRateMember", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal funds rate", "label": "Fed Funds Effective Rate Overnight Index Swap Rate [Member]", "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg." } } }, "auth_ref": [ "r1137" ] }, "mxl_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four", "documentation": "Finite-Lived Intangible Asset, Expected Amortization, After Year Four" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Useful Life (in\u00a0Years)", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Accumulated Amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r221", "r327", "r340", "r863" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r342", "r843", "r863" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024 (3 months)", "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [ "r1202" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Finite-lived Intangible Assets Amortization Expense", "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r342", "r843", "r863" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r342", "r843", "r863" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r342", "r843", "r863" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r333", "r335", "r336", "r337", "r339", "r340", "r343", "r344", "r667", "r671", "r843" ] }, "mxl_FiniteLivedIntangibleAssetsDisposals": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "FiniteLivedIntangibleAssetsDisposals", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other disposals", "label": "Finite-Lived Intangible Assets Disposals", "documentation": "Finite-Lived Intangible Assets Disposals" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross Carrying Amount", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r327", "r340", "r671", "r863" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsFinitelivedIntangibleAssetsAmortizationExpenseDetails", "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r333", "r340", "r343", "r344", "r346", "r667", "r843", "r863" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r333", "r335", "r336", "r337", "r339", "r340", "r343", "r344", "r843" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails", "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net Carrying Amount", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r667", "r1074" ] }, "us-gaap_FiniteLivedIntangibleAssetsRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FiniteLivedIntangibleAssetsRollForward", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-lived Intangible Assets [Roll Forward]", "label": "Finite-Lived Intangible Assets [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FinitelivedIntangibleAssetsAcquired1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinitelivedIntangibleAssetsAcquired1", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions", "label": "Finite-Lived Intangible Assets Acquired", "documentation": "Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition." } } }, "auth_ref": [ "r335" ] }, "mxl_FirstInitialRepaymentsOfNotesReceivableDueToTheCompanyAnnually": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "FirstInitialRepaymentsOfNotesReceivableDueToTheCompanyAnnually", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "First initial repayments of notes receivable due to the company annually", "label": "First Initial Repayments Of Notes Receivable Due To The Company Annually", "documentation": "First Initial Repayments Of Notes Receivable Due To The Company Annually" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Loss on foreign currency", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r619", "r621", "r623", "r625", "r810" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r936", "r946", "r956", "r988" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r936", "r946", "r956", "r988" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r936", "r946", "r956", "r988" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r936", "r946", "r956", "r988" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r936", "r946", "r956", "r988" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r969" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Furniture and fixtures", "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "mxl_GainLossOnExtinguishmentOfLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "GainLossOnExtinguishmentOfLeaseLiabilities", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Gain on extinguishment of lease liabilities", "label": "Gain (Loss) On Extinguishment Of Lease Liabilities", "documentation": "Gain (Loss) On Extinguishment Of Lease Liabilities" } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossOnSaleOfPropertyPlantEquipment", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on disposal of property and equipment", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property." } } }, "auth_ref": [ "r10" ] }, "us-gaap_GeographicConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeographicConcentrationRiskMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographic Concentration Risk", "label": "Geographic Concentration Risk [Member]", "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)." } } }, "auth_ref": [ "r42", "r830" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails", "http://www.maxlinear.com/role/ConsolidatedBalanceSheets", "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill", "terseLabel": "Goodwill", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r220", "r328", "r703", "r859", "r862", "r888", "r896", "r1055", "r1062" ] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions (Note 3)", "label": "Goodwill, Acquired During Period", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r330", "r862" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r1053", "r1065" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r1053", "r1065" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment", "label": "Goodwill, Impairment Loss", "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r10", "r329", "r331", "r332", "r862", "r888" ] }, "us-gaap_GoodwillRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GoodwillRollForward", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsSummaryofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Roll Forward]", "label": "Goodwill [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r107", "r109", "r161", "r250", "r312", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r618", "r855", "r858", "r1042", "r1044", "r1045", "r1046", "r1047", "r1098" ] }, "country_HK": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "HK", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hong Kong", "label": "HONG KONG" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 }, "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 18.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows", "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment losses", "verboseLabel": "Impairment of intangible assets", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value." } } }, "auth_ref": [ "r10", "r334", "r345" ] }, "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOfIntangibleAssetsFinitelived", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsAdditionalInformationDetails", "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment losses related to finite-lived intangible assets", "negatedTerseLabel": "Impairment losses", "label": "Impairment of Intangible Assets, Finite-Lived", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value." } } }, "auth_ref": [ "r334", "r1031", "r1079" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of Goodwill and Long-Lived Assets", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r108", "r157", "r161", "r706", "r719", "r855", "r858", "r1042", "r1044", "r1045", "r1046", "r1047" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsFinitelivedIntangibleAssetsAmortizationExpenseDetails", "http://www.maxlinear.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Axis]", "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r349", "r355", "r361", "r601", "r605", "r610", "r734", "r736", "r797", "r843", "r889", "r1166" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsFinitelivedIntangibleAssetsAmortizationExpenseDetails", "http://www.maxlinear.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location [Domain]", "label": "Statement of Income Location, Balance [Domain]", "documentation": "Location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r355", "r361", "r601", "r605", "r610", "r734", "r736", "r797", "r843", "r889", "r1166" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.maxlinear.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r251", "r520", "r526", "r527", "r528", "r529", "r530", "r533", "r540", "r542", "r543", "r544", "r758", "r886" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations", "http://www.maxlinear.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax provision (benefit)", "verboseLabel": "Income tax provision (benefit)", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r166", "r177", "r268", "r269", "r283", "r291", "r301", "r525", "r526", "r541", "r725", "r886" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r236", "r521", "r522", "r530", "r531", "r532", "r534", "r755" ] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for income taxes", "label": "Income Taxes Paid", "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r35", "r117", "r1032", "r1135", "r1136" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable, accrued expenses and other current liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation", "label": "Increase (Decrease) in Employee Related Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities", "label": "Increase (Decrease) in Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r1012", "r1030" ] }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term liabilities", "label": "Increase (Decrease) in Other Noncurrent Liabilities", "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r9" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "mxl_IncreaseDecreaseinAccruedPriceProtectionLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "IncreaseDecreaseinAccruedPriceProtectionLiability", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued price protection liability", "label": "Increase (Decrease) in Accrued Price Protection Liability", "documentation": "The increase (decrease) during the reporting period in accrued price protection liability." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r936", "r946", "r956", "r980", "r988", "r992", "r1000" ] }, "mxl_InducementPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "InducementPlanMember", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inducement Plan", "label": "Inducement Plan [Member]", "documentation": "Inducement Plan" } } }, "auth_ref": [] }, "mxl_IndustrialAndMultiMarketMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "IndustrialAndMultiMarketMember", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Industrial and multi-market", "label": "Industrial And multi-market [Member]", "documentation": "Industrial and multi-market [Member]" } } }, "auth_ref": [] }, "mxl_InfrastructureMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "InfrastructureMember", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Infrastructure", "label": "Infrastructure [Member]", "documentation": "Infrastructure [Member]" } } }, "auth_ref": [] }, "mxl_InitialTermLoanTLBJune2021Member": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "InitialTermLoanTLBJune2021Member", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial term loan under the June 23, 2021 credit agreement", "label": "Initial Term Loan - TLB June 2021 [Member]", "documentation": "Initial Term Loan - TLB June 2021" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r998" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r928", "r1004" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r928", "r1004" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r928", "r1004" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r333", "r1074", "r1076" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Interest expense", "label": "Interest Expense, Nonoperating", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r289", "r1028" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for interest", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r243", "r245", "r246" ] }, "us-gaap_InventoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoriesMember", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory Purchase Obligations", "label": "Inventories [Member]", "documentation": "Tangible personal property held for sale in the ordinary course of business, or in process of, or to be consumed in, production for sale." } } }, "auth_ref": [] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryFinishedGoods", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Gross", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r1021" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.maxlinear.com/role/BalanceSheetDetailsInventoryDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsInventoryDetails", "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory", "totalLabel": "Inventory", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r228", "r848", "r896" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r168", "r216", "r227", "r323", "r324", "r325", "r665", "r851" ] }, "us-gaap_InventoryWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryWorkInProcess", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsInventoryDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsInventoryDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Work-in-process", "label": "Inventory, Work in Process, Gross", "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r1022" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r283", "r288", "r301", "r858", "r1027" ] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold improvements", "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r125", "r651" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Leases [Abstract]", "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LegalCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LegalCostsPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation and Settlement Costs", "label": "Legal Costs, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights." } } }, "auth_ref": [ "r377" ] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Line Items]", "label": "Lessee, Lease, Description [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r645", "r652" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lessee, Lease, Description [Table]", "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r645", "r652" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r644" ] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Aggregate Future Minimum Payments Due", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1154" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total minimum payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r650" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r650" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r650" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r650" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r650" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024 (3 months)", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year." } } }, "auth_ref": [ "r1154" ] }, "mxl_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four", "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r650" ] }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseRenewalTerm", "presentation": [ "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease renewal term", "label": "Lessee, Operating Lease, Renewal Term", "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1153" ] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails", "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Operating lease, term (greater than)", "terseLabel": "Original operating lease terms", "label": "Lessee, Operating Lease, Term of Contract", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1153" ] }, "us-gaap_LesseeOperatingLeasesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LesseeOperatingLeasesTextBlock", "presentation": [ "http://www.maxlinear.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Operating Leases [Text Block]", "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability." } } }, "auth_ref": [ "r640" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r26", "r84", "r85", "r86", "r89", "r90", "r91", "r92", "r250", "r312", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r568", "r569", "r570", "r618", "r772", "r854", "r923", "r1098", "r1155", "r1156" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r99", "r156", "r715", "r896", "r1034", "r1052", "r1145" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and stockholders\u2019 equity", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r86", "r215", "r250", "r312", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r568", "r569", "r570", "r618", "r896", "r1098", "r1155", "r1156" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesFairValueDisclosureAbstract", "presentation": [ "http://www.maxlinear.com/role/FinancialInstrumentsFairValueLiabilitiesMeasuredonRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities", "label": "Liabilities, Fair Value Disclosure [Abstract]" } } }, "auth_ref": [] }, "mxl_LicensedTechnologyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "LicensedTechnologyMember", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Licensed technology", "label": "Licensed Technology [Member]", "documentation": "Licensed technology." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityAxis", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lender Name [Axis]", "label": "Lender Name [Axis]", "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit." } } }, "auth_ref": [ "r83", "r88", "r1033", "r1096", "r1097" ] }, "mxl_LineOfCreditFacilityIncrementalBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "LineOfCreditFacilityIncrementalBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit facility, incremental borrowing capacity", "label": "Line Of Credit Facility, Incremental Borrowing Capacity", "documentation": "Line Of Credit Facility, Incremental Borrowing Capacity" } } }, "auth_ref": [] }, "mxl_LineOfCreditFacilityIncrementalBorrowingCapacityPercentOfConsolidatedEBITDA": { "xbrltype": "percentItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "LineOfCreditFacilityIncrementalBorrowingCapacityPercentOfConsolidatedEBITDA", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit facility, incremental borrowing capacity, percent of consolidated EBITDA", "label": "Line Of Credit Facility, Incremental Borrowing Capacity, Percent Of Consolidated EBITDA", "documentation": "Line Of Credit Facility, Incremental Borrowing Capacity, Percent Of Consolidated EBITDA" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditFacilityLenderDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityLenderDomain", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility, Lender [Domain]", "label": "Line of Credit Facility, Lender [Domain]", "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility." } } }, "auth_ref": [ "r83", "r88", "r1033", "r1096" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit facility, maximum borrowing capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r83", "r88" ] }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commitment fee percentage", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility." } } }, "auth_ref": [] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LineOfCreditMember", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "srt_LitigationCaseAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "LitigationCaseAxis", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Axis]", "label": "Litigation Case [Axis]", "documentation": "Information by type of judicial proceeding, alternative dispute resolution or claim." } } }, "auth_ref": [] }, "srt_LitigationCaseTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "LitigationCaseTypeDomain", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Litigation Case [Domain]", "label": "Litigation Case [Domain]", "documentation": "Judicial proceeding, alternative dispute resolution or claim. For example, but not limited to, name of case, category of litigation, or other differentiating information." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "mxl_LongLivedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "LongLivedAssets", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long lived assets", "label": "Long Lived Assets", "documentation": "Long Lived Assets" } } }, "auth_ref": [] }, "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongLivedAssetsByGeographicAreasTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Long-lived Assets by Geographic Areas", "label": "Long-Lived Assets by Geographic Areas [Table Text Block]", "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets." } } }, "auth_ref": [ "r123" ] }, "mxl_LongLivedAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "LongLivedAssetsMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long lived assets", "label": "Long Lived Assets [Member]", "documentation": "Long lived assets [Member]" } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/DebtScheduleofDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.maxlinear.com/role/DebtScheduleofDebtDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net carrying amount of long-term debt", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r26", "r154", "r403", "r418", "r870", "r871", "r894", "r1163" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/DebtScheduleofDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: current portion of long-term debt", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r224" ] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of term loans outstanding", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [ "r1139", "r1141", "r1142", "r1143" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/DebtScheduleofDebtDetails": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 }, "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets", "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt", "verboseLabel": "Long-term debt, non-current portion", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r225" ] }, "us-gaap_LongTermPurchaseCommitmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermPurchaseCommitmentLineItems", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Purchase Commitment [Line Items]", "label": "Long-Term Purchase Commitment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongTermPurchaseCommitmentTable", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Purchase Commitment [Table]", "label": "Long-Term Purchase Commitment [Table]", "documentation": "Disclosure of information about long-term purchase arrangement. Includes, but is not limited to, term of arrangement with supplier, minimum quantity required, milestone, period covered by arrangement, and committed amount. Excludes short-term purchase arrangement and unconditional purchase obligation." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r26", "r1082", "r1083", "r1084" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r26", "r55", "r1082", "r1083", "r1084" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r372", "r373", "r374", "r378", "r517", "r868", "r1091", "r1092" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingenciesTable", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation." } } }, "auth_ref": [ "r372", "r373", "r374", "r378", "r517", "r868", "r1091", "r1092" ] }, "us-gaap_LossContingencyNewClaimsFiledNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyNewClaimsFiledNumber", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency, number of claims filed", "label": "Loss Contingency, New Claims Filed, Number", "documentation": "The total number of new claims filed pertaining to a loss contingency during the period." } } }, "auth_ref": [ "r1091", "r1092" ] }, "us-gaap_LossContingencyPendingClaimsNumber": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LossContingencyPendingClaimsNumber", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency, number of pending claims", "label": "Loss Contingency, Pending Claims, Number", "documentation": "Number of pending claims pertaining to a loss contingency." } } }, "auth_ref": [ "r1091", "r1092" ] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Machinery and equipment", "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MajorCustomersAxis", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r306", "r877", "r906", "r910", "r1103", "r1165", "r1167", "r1168", "r1170", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194" ] }, "mxl_MasksAndProductionEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "MasksAndProductionEquipmentMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Masks and production equipment", "label": "Masks And Production Equipment [Member]", "documentation": "Masks and production equipment." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails", "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails", "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails", "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "verboseLabel": "Maximum", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r179", "r181", "r183", "r184", "r186", "r205", "r206", "r373", "r374", "r375", "r376", "r472", "r517", "r599", "r664", "r733", "r735", "r749", "r764", "r765", "r818", "r820", "r822", "r823", "r825", "r841", "r842", "r861", "r874", "r884", "r890", "r891", "r892", "r893", "r907", "r1100", "r1157", "r1158", "r1159", "r1160", "r1161", "r1162" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r972" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r972" ] }, "us-gaap_MediumTermNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MediumTermNotesMember", "presentation": [ "http://www.maxlinear.com/role/DebtScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Debt", "label": "Medium-Term Note [Member]", "documentation": "Debt instruments with maturities ranging from five to ten years." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails", "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails", "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails", "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "verboseLabel": "Minimum", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r179", "r181", "r183", "r184", "r186", "r205", "r206", "r373", "r374", "r375", "r376", "r472", "r517", "r599", "r664", "r733", "r735", "r749", "r764", "r765", "r818", "r820", "r822", "r823", "r825", "r841", "r842", "r861", "r874", "r884", "r890", "r891", "r892", "r907", "r1100", "r1157", "r1158", "r1159", "r1160", "r1161", "r1162" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r991" ] }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MoneyMarketFundsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Money market funds", "label": "Money Market Funds, at Carrying Value", "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months." } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r999" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r306", "r877", "r906", "r910", "r1103", "r1165", "r1167", "r1168", "r1170", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r973" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r244" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Financing Activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r244" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Investing Activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r115", "r116", "r118" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 }, "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity", "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows", "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLoss", "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations", "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net loss", "verboseLabel": "Net income (loss)", "netLabel": "Net loss", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r110", "r118", "r158", "r213", "r231", "r234", "r239", "r250", "r257", "r261", "r262", "r263", "r264", "r265", "r268", "r269", "r275", "r312", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r552", "r566", "r593", "r618", "r720", "r794", "r811", "r812", "r921", "r1098" ] }, "us-gaap_NetIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAbstract", "presentation": [ "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Numerator:", "label": "Net Income (Loss) Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "mxl_NetOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "NetOperatingLiabilities", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating liabilities", "label": "Net Operating Liabilities", "documentation": "Net Operating Liabilities" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r207", "r208", "r209", "r210", "r211", "r212", "r256", "r257", "r258", "r259", "r260", "r263", "r270", "r282", "r307", "r308", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r347", "r348", "r356", "r535", "r536", "r537", "r538", "r539", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r556", "r557", "r558", "r562", "r563", "r564", "r565", "r566", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r616", "r617", "r637", "r638", "r639", "r653", "r654", "r655", "r656", "r657", "r658", "r668", "r669", "r670", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r753" ] }, "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Accounting Policies", "label": "Accounting Standards Update and Change in Accounting Principle [Table]", "documentation": "Disclosure of information about change in accounting principle or amendment to accounting standards or both. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards and other change in accounting principle." } } }, "auth_ref": [ "r39", "r207", "r208", "r209", "r210", "r211", "r212", "r256", "r257", "r258", "r259", "r260", "r263", "r270", "r282", "r307", "r308", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r347", "r348", "r356", "r535", "r536", "r537", "r538", "r539", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r556", "r557", "r558", "r562", "r563", "r564", "r565", "r566", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593", "r616", "r617", "r637", "r638", "r639", "r653", "r654", "r655", "r656", "r657", "r658", "r668", "r669", "r670", "r737", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r753" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Issued, Not Yet Adopted Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r972" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r936", "r946", "r956", "r980", "r988" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r963" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r962" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r980" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r999" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r999" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (expense), net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r112" ] }, "mxl_NoteReceivableWriteOff": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "NoteReceivableWriteOff", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Portion of note receivable written off", "label": "Note Receivable, Write-Off", "documentation": "Note Receivable, Write-Off" } } }, "auth_ref": [] }, "mxl_NumberOfBusinessActivities": { "xbrltype": "integerItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "NumberOfBusinessActivities", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of business activities", "label": "Number of Business Activities", "documentation": "Number of Business Activities" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r859", "r1043" ] }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive loss before reclassifications, net of tax", "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent", "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent." } } }, "auth_ref": [ "r25", "r29" ] }, "us-gaap_OneTimeTerminationBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OneTimeTerminationBenefitsMember", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Employee Separation Expenses", "label": "One-time Termination Benefits [Member]", "documentation": "A lump sum payment to an involuntarily terminated employee in conjunction with exit or disposal activities." } } }, "auth_ref": [ "r864", "r865", "r866", "r867" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Income (loss) from operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r161", "r855", "r1042", "r1044", "r1045", "r1046", "r1047" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease cost", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r646", "r895" ] }, "us-gaap_OperatingLeaseImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseImpairmentLoss", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 19.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of leased right-of-use assets", "label": "Operating Lease, Impairment Loss", "documentation": "Amount of loss from impairment of right-of-use asset from operating lease." } } }, "auth_ref": [ "r1152" ] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 }, "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total lease liabilities", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r643" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term lease liabilities", "negatedLabel": "Less: short-term lease liabilities", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r643" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets", "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term lease liabilities", "verboseLabel": "Long-term lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r643" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Leased right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r642" ] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease, weighted average discount rate, percent", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r649", "r895" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease, weighted average remaining lease term", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r648", "r895" ] }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeasesFutureMinimumPaymentsDueAbstract", "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Leases", "label": "Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Organization and Summary of Significant Accounting Policies", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r81", "r147", "r751", "r752" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r85" ] }, "us-gaap_OtherAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetImpairmentCharges", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 22.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of investments and other assets", "label": "Other Asset Impairment Charges", "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value." } } }, "auth_ref": [ "r1031", "r1080" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r222" ] }, "us-gaap_OtherCommitment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCommitment", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total minimum payments", "label": "Other Commitment", "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentDueInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCommitmentDueInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": "us-gaap_OtherCommitment", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Other Commitment, to be Paid, Year One", "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentDueInSecondYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCommitmentDueInSecondYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": "us-gaap_ContractualObligationDueInSecondYear", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Other Commitment, to be Paid, Year Two", "documentation": "Amount of commitment classified as other to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentDueInThirdYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCommitmentDueInThirdYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": "us-gaap_OtherCommitment", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Other Commitment, to be Paid, Year Three", "documentation": "Amount of commitment classified as other to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentFiscalYearMaturityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCommitmentFiscalYearMaturityAbstract", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Inventory Purchase Obligations", "label": "Other Commitment, Fiscal Year Maturity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCommitmentsAbstract", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Obligations", "label": "Other Commitments [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": "us-gaap_OtherCommitment", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024 (3 months)", "label": "Other Commitment, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of commitment classified as other to be paid in remainder of current fiscal year." } } }, "auth_ref": [] }, "us-gaap_OtherCommitmentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherCommitmentsTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Future Minimum Payments Under Other Obligations", "label": "Other Commitments [Table Text Block]", "documentation": "Tabular disclosure of information about obligations resulting from other commitments." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLoss" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign currency translation adjustments, net of tax benefit of $42 and $169 for the three and nine months ended September 30, 2024, respectively, and net of tax benefit of $64 and $229 for the three and nine months ended September 30, 2023, respectively", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r4", "r103", "r104", "r106", "r620", "r622", "r627" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign currency translation adjustment, tax benefit", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r4", "r5", "r624", "r633" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss) income", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r8", "r17", "r148", "r232", "r235", "r265" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reclassification adjustments of unrealized gain (loss) on pension and other defined benefit plans", "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax", "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan." } } }, "auth_ref": [ "r7", "r106", "r230", "r460" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r90" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense), net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r113" ] }, "mxl_OtherObligationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "OtherObligationsMember", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Obligations", "label": "Other Obligations [Member]", "documentation": "Other Obligations" } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r972" ] }, "us-gaap_OtherRestructuringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherRestructuringMember", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Restructuring [Member]", "documentation": "Restructuring and related activities classified as other." } } }, "auth_ref": [ "r864", "r865", "r866", "r867" ] }, "mxl_OtherRestructuringNettingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "OtherRestructuringNettingMember", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityRestructuringandRelatedCostsDetails", "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Restructuring, Netting [Member]", "documentation": "Other Restructuring, Netting" } } }, "auth_ref": [] }, "us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of shares for payment of bonuses", "label": "Other Significant Noncash Transaction, Value of Consideration Given", "documentation": "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r36", "r37", "r38" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r934", "r944", "r954", "r986" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r937", "r947", "r957", "r989" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r937", "r947", "r957", "r989" ] }, "us-gaap_PatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PatentsMember", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Patents", "label": "Patents [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law." } } }, "auth_ref": [ "r145", "r1066", "r1068", "r1069", "r1070", "r1072", "r1074", "r1077", "r1078" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r961" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash payments", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r360", "r1029" ] }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfDebtIssuanceCosts", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payment of debt commitment fees", "label": "Payments of Debt Issuance Costs", "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt." } } }, "auth_ref": [ "r32" ] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Minimum tax withholding paid on behalf of employees for restricted stock units", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r242" ] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails": { "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails", "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Cash consideration", "terseLabel": "Cash", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r31", "r559" ] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash used in acquisition, net of cash acquired", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r31" ] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of intangible assets", "label": "Payments to Acquire Intangible Assets", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r114" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r114" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r971" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r971" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.maxlinear.com/role/EmployeeRetirementPlans" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Retirement Plans", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r448", "r450", "r451", "r457", "r461", "r462", "r463", "r464", "r465", "r466", "r469", "r470", "r471", "r880" ] }, "us-gaap_PensionAndOtherPostretirementPlansPensionsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PensionAndOtherPostretirementPlansPensionsPolicy", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and Other Defined Benefit Retirement Obligations", "label": "Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for pension plans. This accounting policy may address (1) the types of plans sponsored by the entity (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived." } } }, "auth_ref": [ "r14", "r15", "r19", "r60" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r963" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r980" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r973" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r962" ] }, "mxl_PerformanceBasedCompensationSharesAwardedAsAPercentageOfGrantsPeerGroupBased": { "xbrltype": "percentItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "PerformanceBasedCompensationSharesAwardedAsAPercentageOfGrantsPeerGroupBased", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares awarded as a percentage of grants, peer group based", "label": "Performance Based Compensation, Shares Awarded As A Percentage Of Grants, Peer Group Based", "documentation": "Performance Based Compensation, Shares Awarded As A Percentage Of Grants, Peer Group Based" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PerformanceSharesMember", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Performance-based restricted stock units (PRSUs)", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameAxis", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Axis]", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1105", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1124", "r1125", "r1126", "r1127", "r1128", "r1129", "r1130" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameDomain", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name [Domain]", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1105", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1124", "r1125", "r1126", "r1127", "r1128", "r1129", "r1130" ] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Prior Service Cost", "label": "Pension Adjustments Prior Service Cost [Member]" } } }, "auth_ref": [ "r964" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Service Cost", "label": "Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r1008" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits Adjustments, Footnote", "label": "Pension Benefits Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r963" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in usd per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r93", "r421" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r93", "r774" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r93", "r421" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r93", "r774", "r792", "r1196", "r1197" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r93", "r711", "r896" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1023" ] }, "mxl_PriceProtectionLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "PriceProtectionLiabilityTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Price Protection Liability", "label": "Price Protection Liability [Table Text Block]", "documentation": "Tabular disclosure of price protection liability" } } }, "auth_ref": [] }, "mxl_PriceProtectionPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "PriceProtectionPayments", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedPriceProtectionLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments", "label": "Price Protection Payments", "documentation": "Price Protection Payments" } } }, "auth_ref": [] }, "mxl_PriceProtectionRebateCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "PriceProtectionRebateCharges", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedPriceProtectionLiabilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Charged as a reduction of revenue", "label": "Price Protection Rebate Charges", "documentation": "Price protection rebate charges as a reduction of revenue" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Net proceeds from issuance of common stock", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash received from exercise of stock options", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r6", "r22" ] }, "mxl_ProceedsLoanedUnderNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ProceedsLoanedUnderNotesReceivable", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds loaned under notes receivable", "label": "Proceeds Loaned Under Notes Receivable", "documentation": "Proceeds Loaned Under Notes Receivable" } } }, "auth_ref": [] }, "us-gaap_ProductConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductConcentrationRiskMember", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product Concentration Risk", "label": "Product Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [ "r121" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r188", "r189", "r190", "r191", "r192", "r193", "r204", "r303", "r666", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r845", "r875", "r905", "r907", "r908", "r911", "r912", "r1017", "r1093", "r1094", "r1103", "r1165", "r1167", "r1168", "r1169", "r1170", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194" ] }, "mxl_ProductionMasksMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ProductionMasksMember", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Production Masks", "label": "Production Masks [Member]", "documentation": "Production Masks" } } }, "auth_ref": [] }, "mxl_ProductionMasksPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ProductionMasksPolicyPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Production Masks", "label": "Production Masks, Policy [Policy Text Block]", "documentation": "Production Masks, Policy" } } }, "auth_ref": [] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r188", "r189", "r190", "r191", "r192", "r193", "r204", "r303", "r666", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r845", "r875", "r905", "r907", "r908", "r911", "r912", "r1017", "r1093", "r1094", "r1103", "r1165", "r1167", "r1168", "r1169", "r1170", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails", "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, Type [Axis]", "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r11", "r651" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r125", "r218", "r718" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment [Line Items]", "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r651" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 }, "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails", "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r11", "r651", "r707", "r718", "r896" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Property and Equipment", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r11", "r171", "r175", "r716" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Property and Equipment", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r11" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails", "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, Type [Domain]", "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r125", "r651" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails", "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Property, plant and equipment, useful life", "terseLabel": "Useful\u00a0Life (in Years)", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r961" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r961" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails", "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails", "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails", "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r179", "r181", "r183", "r184", "r186", "r205", "r206", "r373", "r374", "r375", "r376", "r450", "r472", "r503", "r504", "r505", "r517", "r599", "r662", "r663", "r664", "r733", "r735", "r749", "r764", "r765", "r818", "r820", "r822", "r823", "r825", "r841", "r842", "r861", "r874", "r884", "r890", "r891", "r892", "r893", "r907", "r915", "r1085", "r1100", "r1142", "r1158", "r1159", "r1160", "r1161", "r1162" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails", "http://www.maxlinear.com/role/DebtAdditionalInformationDetails", "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails", "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails", "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r179", "r181", "r183", "r184", "r186", "r205", "r206", "r373", "r374", "r375", "r376", "r450", "r472", "r503", "r504", "r505", "r517", "r599", "r662", "r663", "r664", "r733", "r735", "r749", "r764", "r765", "r818", "r820", "r822", "r823", "r825", "r841", "r842", "r861", "r874", "r884", "r890", "r891", "r892", "r893", "r907", "r915", "r1085", "r1100", "r1142", "r1158", "r1159", "r1160", "r1161", "r1162" ] }, "us-gaap_RecordedUnconditionalPurchaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RecordedUnconditionalPurchaseObligation", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": "us-gaap_ContractualObligation", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total minimum payments", "label": "Recorded Unconditional Purchase Obligation", "documentation": "Amount of the recorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts)." } } }, "auth_ref": [ "r371" ] }, "us-gaap_RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RecordedUnconditionalPurchaseObligationByCategoryOfItemPurchasedAxis", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]", "label": "Recorded Unconditional Purchase Obligation by Category of Item Purchased [Axis]", "documentation": "Information by category of product and service for recorded unconditional purchase arrangement to acquire product or service or both." } } }, "auth_ref": [ "r371" ] }, "us-gaap_RecordedUnconditionalPurchaseObligationCategoryDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RecordedUnconditionalPurchaseObligationCategoryDomain", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recorded Unconditional Purchase Obligation, Category [Domain]", "label": "Recorded Unconditional Purchase Obligation, Category [Domain]", "documentation": "Category of product or service for recorded unconditional purchase arrangement to acquire product or service." } } }, "auth_ref": [ "r371" ] }, "us-gaap_RecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": "us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2024 (3 months)", "label": "Recorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of recorded unconditional purchase obligation to be paid in remainder of current fiscal year." } } }, "auth_ref": [] }, "us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RecordedUnconditionalPurchaseObligationDueInSecondYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Two", "documentation": "Amount of recorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r371" ] }, "us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RecordedUnconditionalPurchaseObligationDueInThirdYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": "us-gaap_RecordedUnconditionalPurchaseObligation", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Three", "documentation": "Amount of recorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r371" ] }, "us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYear", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails": { "parentTag": "us-gaap_ContractualObligationDueInNextTwelveMonths", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesFutureMinimumInventoryPurchaseandOtherObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year One", "documentation": "Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r371" ] }, "us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RecordedUnconditionalPurchaseObligationsTextBlock", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Future Minimum Payments Under Inventory Purchase Obligations", "label": "Recorded Unconditional Purchase Obligations [Table Text Block]", "documentation": "Tabular disclosure of unconditional purchase obligation recognized as liability." } } }, "auth_ref": [ "r12", "r1089" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r929", "r939", "r949", "r981" ] }, "mxl_ReductionInTransactionPriceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ReductionInTransactionPriceMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued obligations to customers for price adjustments", "terseLabel": "Reduction in Transaction Price", "label": "Reduction In Transaction Price [Member]", "documentation": "Reduction in Transaction Price [Member]" } } }, "auth_ref": [] }, "mxl_RepaymentsOfNotesReceivableDueToTheCompanyAnnually": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "RepaymentsOfNotesReceivableDueToTheCompanyAnnually", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of notes receivable due to the company annually", "label": "Repayments Of Notes Receivable Due To The Company Annually", "documentation": "Repayments Of Notes Receivable Due To The Company Annually" } } }, "auth_ref": [] }, "mxl_ResearchAndDevelopmentArrangementContractForAJointlyFundedProjectCumulativeProceedsReceivedFromOtherPartyDeferredInLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ResearchAndDevelopmentArrangementContractForAJointlyFundedProjectCumulativeProceedsReceivedFromOtherPartyDeferredInLiabilities", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds received from other party, deferred in other long-term liabilities", "label": "Research And Development Arrangement, Contract For A Jointly Funded Project, Cumulative Proceeds Received From Other Party, Deferred In Liabilities", "documentation": "Research And Development Arrangement, Contract For A Jointly Funded Project, Cumulative Proceeds Received From Other Party, Deferred In Liabilities" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development arrangement, recognized income", "label": "Research and Development Arrangement, Contract to Perform for Others, Compensation Earned", "documentation": "The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others." } } }, "auth_ref": [ "r519" ] }, "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "label": "Research and Development Expense (Excluding Acquired in Process Cost)", "documentation": "Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r1132" ] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsFinitelivedIntangibleAssetsAmortizationExpenseDetails", "http://www.maxlinear.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Research and development", "verboseLabel": "Research and development", "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Research and Development", "label": "Research and Development Expense, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r518" ] }, "mxl_RestOfWorldMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "RestOfWorldMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rest of world", "verboseLabel": "Rest of world", "label": "Rest Of World [Member]", "documentation": "Rest of World [Member]" } } }, "auth_ref": [] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r930", "r940", "r950", "r982" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r931", "r941", "r951", "r983" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r938", "r948", "r958", "r990" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted Cash and Cash Equivalents", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r33", "r150", "r217", "r247", "r710" ] }, "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "mxl_CashCashEquivalentsAndRestrictedCash", "weight": 1.0, "order": 2.0 }, "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails", "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term restricted cash", "verboseLabel": "Short-term restricted cash", "label": "Restricted Cash and Cash Equivalents, Current", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r33", "r217", "r247" ] }, "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedCashAndCashEquivalentsNoncurrent", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "mxl_CashCashEquivalentsAndRestrictedCash", "weight": 1.0, "order": 3.0 }, "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsCashCashEquivalentsandRestrictedCashDetails", "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term restricted cash", "verboseLabel": "Long-term restricted cash", "label": "Restricted Cash and Cash Equivalents, Noncurrent", "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r33", "r167", "r247" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs)", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivity" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Activity", "label": "Restructuring and Related Activities Disclosure [Text Block]", "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled." } } }, "auth_ref": [ "r357", "r358", "r360", "r363", "r368" ] }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringAndRelatedCostExpectedCost1", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and related cost, expected cost", "label": "Restructuring and Related Cost, Expected Cost", "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost." } } }, "auth_ref": [ "r359", "r362", "r365", "r367" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCharges", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations", "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/RestructuringActivityRestructuringandRelatedCostsDetails", "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring charges", "verboseLabel": "Restructuring charges", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r10", "r364", "r365", "r1086" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/RestructuringActivityRestructuringandRelatedCostsDetails", "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r359", "r360", "r365", "r366" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/RestructuringActivityRestructuringandRelatedCostsDetails", "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r359", "r360", "r361", "r362", "r365", "r366", "r367" ] }, "us-gaap_RestructuringPlanAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringPlanAxis", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Axis]", "label": "Restructuring Plan [Axis]", "documentation": "Information by individual restructuring plan." } } }, "auth_ref": [] }, "us-gaap_RestructuringPlanDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringPlanDomain", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Plan [Domain]", "label": "Restructuring Plan [Domain]", "documentation": "Identification of the individual restructuring plans." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserve", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Liability beginning balance", "periodEndLabel": "Liability ending balance", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r360", "r366" ] }, "us-gaap_RestructuringReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserveCurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails": { "parentTag": "us-gaap_RestructuringReserve", "weight": 1.0, "order": 1.0 }, "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: current portion as of September 30, 2024", "terseLabel": "Accrued restructuring", "label": "Restructuring Reserve, Current", "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r1019", "r1087", "r1088" ] }, "mxl_RestructuringReserveNonCashChargesAndAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "RestructuringReserveNonCashChargesAndAdjustments", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash charges and adjustments", "label": "Restructuring Reserve, Non-Cash Charges and Adjustments", "documentation": "Restructuring Reserve, Non-Cash Charges and Adjustments" } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserveNoncurrent", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails": { "parentTag": "us-gaap_RestructuringReserve", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term portion as of September 30, 2024", "label": "Restructuring Reserve, Noncurrent", "documentation": "Carrying amount as of the balance sheet date of known and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid after one year or beyond the next operating cycle, if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r1020", "r1087", "r1088" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r96", "r134", "r714", "r743", "r748", "r757", "r775", "r896" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r209", "r253", "r254", "r255", "r258", "r265", "r267", "r269", "r316", "r322", "r348", "r535", "r536", "r548", "r549", "r550", "r553", "r565", "r566", "r574", "r577", "r578", "r581", "r591", "r638", "r641", "r739", "r741", "r759", "r1196" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "terseLabel": "Revenue from Contract with Customer [Abstract]", "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net revenue", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r159", "r160", "r283", "r286", "r287", "r299", "r301", "r303", "r304", "r306", "r444", "r445", "r666" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomers" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenue from Contracts with Customers", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r178", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r447" ] }, "mxl_RevenueFromDistributorsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "RevenueFromDistributorsMember", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue from Distributors", "label": "Revenue From Distributors [Member]", "documentation": "Revenue from Distributors [Member]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Revenue from External Customers by Geographic Areas", "label": "Revenue from External Customers by Geographic Areas [Table Text Block]", "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue." } } }, "auth_ref": [ "r122" ] }, "mxl_RevenuePerformanceObligationDeliveryTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "RevenuePerformanceObligationDeliveryTerm", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Delivery term", "label": "Revenue, Performance Obligation, Delivery Term", "documentation": "Revenue, Performance Obligation, Delivery Term" } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r795", "r844", "r852" ] }, "mxl_RevenueStreamAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "RevenueStreamAxis", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Stream [Axis]", "label": "Revenue Stream [Axis]", "documentation": "Revenue Stream" } } }, "auth_ref": [] }, "mxl_RevenueStreamDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "RevenueStreamDomain", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Stream [Domain]", "label": "Revenue Stream [Domain]", "documentation": "Revenue Stream [Domain]" } } }, "auth_ref": [] }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]", "label": "Revenues from External Customers and Long-Lived Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "mxl_ReversalOfUnclaimedRebates": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ReversalOfUnclaimedRebates", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedPriceProtectionLiabilityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Reversal of unclaimed rebates", "label": "Reversal Of Unclaimed Rebates", "documentation": "Reversal Of Unclaimed Rebates" } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/LeasesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use asset obtained in exchange for operating lease liability", "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability", "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability." } } }, "auth_ref": [ "r647", "r895" ] }, "us-gaap_RisksAndUncertaintiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RisksAndUncertaintiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Risks and Uncertainties [Abstract]", "label": "Risks and Uncertainties [Abstract]" } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r999" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r999" ] }, "country_SG": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "SG", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Singapore", "label": "SINGAPORE" } } }, "auth_ref": [] }, "mxl_SalesCommissionAssetsRecognizedTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "SalesCommissionAssetsRecognizedTerm", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales commission assets recognized, term (less than)", "label": "Sales Commission Assets Recognized, Term", "documentation": "Sales Commission Assets Recognized, Term" } } }, "auth_ref": [] }, "us-gaap_SalesReturnsAndAllowancesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesReturnsAndAllowancesMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsAccruedExpensesandOtherCurrentLiabilitiesDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued obligations to customers for stock rotation rights", "terseLabel": "Sales Returns and Allowances", "label": "Sales Returns and Allowances [Member]", "documentation": "A revision in the estimated reserve needed for product returns and price or other concessions granted to customers." } } }, "auth_ref": [] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Benchmark", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r306", "r1010" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Accrued Expenses", "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Accumulated Other Comprehensive Income (Loss) by Component", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r29", "r1146", "r1147" ] }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetsByMajorClassTextBlock", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Acquired Finite-Lived Intangible Assets by Major Class", "label": "Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]", "documentation": "Tabular disclosure of the characteristics, including initial carrying value, residual amount, weighted average useful life, of finite-lived intangible assets acquired during the period by major class. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company." } } }, "auth_ref": [ "r1067", "r1072" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails", "http://www.maxlinear.com/role/BusinessCombinationsSummaryofBusinessAcquisitionsbyAcquisitionDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability." } } }, "auth_ref": [ "r67", "r68", "r554" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Business Acquisitions, by Acquisition", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts." } } }, "auth_ref": [ "r67", "r68" ] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Cash and Cash Equivalents", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/NetIncomeLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Basic and Diluted Earnings Per Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1041" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Stock-Based Compensation Expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r63" ] }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Revenue from External Customers by Products and Services", "label": "Revenue from External Customers by Products and Services [Table Text Block]", "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information." } } }, "auth_ref": [ "r48" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsFinitelivedIntangibleAssetsAmortizationExpenseDetails", "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Intangible Asset, Finite-Lived [Table]", "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset." } } }, "auth_ref": [ "r333", "r340", "r343", "r344", "r346", "r667", "r843", "r863" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Finite-Lived Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r863", "r1073" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r862", "r1054", "r1055", "r1056", "r1057", "r1058", "r1059", "r1060", "r1061", "r1062", "r1063", "r1064" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Inventory", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r27", "r100", "r101", "r102" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Property, Plant and Equipment [Table]", "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r11", "r651" ] }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Restriction Cash", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage." } } }, "auth_ref": [ "r23", "r150", "r1164" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/RestructuringActivityRestructuringandRelatedCostsDetails", "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Restructuring Cost [Table]", "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve." } } }, "auth_ref": [ "r359", "r360", "r361", "r362", "r365", "r366", "r367" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Restructuring and Related Costs", "label": "Restructuring and Related Costs [Table Text Block]", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r53", "r126", "r127" ] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Restructuring Reserve by Type of Cost", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r54", "r128" ] }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "presentation": [ "http://www.maxlinear.com/role/RevenuefromContractswithCustomersAdditionalInformationDetails", "http://www.maxlinear.com/role/RevenuefromContractswithCustomersRevenuesfromExternalCustomersbyProductsandServicesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]", "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset." } } }, "auth_ref": [ "r49", "r107" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails", "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r474", "r476", "r478", "r479", "r480", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r502", "r503", "r504", "r505", "r506" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Stock Option Activity", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r20", "r21", "r135" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Employee Stock Purchase Plan, Valuation Assumptions", "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r139" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock Options, Valuation Assumptions", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r139" ] }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Restricted Stock Unit Activity", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Finite-Lived Intangible Assets, Future Amortization Expense", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r863", "r1075" ] }, "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Concentration of Risk, by Risk Factor", "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]", "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark." } } }, "auth_ref": [ "r40", "r41", "r43", "r44", "r78", "r149" ] }, "mxl_SecuredOvernightFinancingRateSOFRSubjectToFloorMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "SecuredOvernightFinancingRateSOFRSubjectToFloorMember", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SOFR subject to floor", "label": "Secured Overnight Financing Rate (SOFR) Subject To Floor [Member]", "documentation": "Secured Overnight Financing Rate (SOFR) Subject to Floor [Member]" } } }, "auth_ref": [] }, "us-gaap_SecuredOvernightFinancingRateSofrMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SecuredOvernightFinancingRateSofrMember", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SOFR", "label": "Secured Overnight Financing Rate (SOFR) [Member]", "documentation": "Interest rate at which bank can borrow U.S. dollar overnight while posting U.S. Treasury bond as collateral." } } }, "auth_ref": [ "r1137" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r924" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r926" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]", "documentation": "Geographical area." } } }, "auth_ref": [ "r180", "r182", "r185", "r187", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r304", "r305", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r761", "r762", "r763", "r819", "r821", "r824", "r826", "r829", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839", "r840", "r846", "r876", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r909", "r915", "r1103", "r1165", "r1167", "r1168", "r1170", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194" ] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r302", "r304", "r856", "r857", "r860" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r111" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsFinitelivedIntangibleAssetsAmortizationExpenseDetails", "http://www.maxlinear.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general and administrative", "verboseLabel": "Selling, general and administrative", "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r9" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Canceled (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r495" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Canceled (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r495" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r493" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r493" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares (in thousands)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding beginning balance (in usd per share)", "periodEndLabel": "Outstanding ending balance (in usd per share)", "terseLabel": "Weighted-average grant date fair value per share (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r490", "r491" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Grant-Date Fair Value per Share", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Vested (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r494" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r494" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend yield", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r504" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r503" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility, maximum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum", "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility, minimum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum", "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r505" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate, maximum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate, minimum", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationStockBasedCompensationExpenseDetails", "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r474", "r476", "r478", "r479", "r480", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r502", "r503", "r504", "r505", "r506" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding beginning balance (in shares)", "periodEndLabel": "Outstanding ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r136", "r137" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares available for grant (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r61" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r484" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercisable (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r484" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Intrinsic value of stock options exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value", "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares." } } }, "auth_ref": [ "r497" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Canceled (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r1111" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Granted (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r486" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Outstanding (in thousands)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding." } } }, "auth_ref": [ "r61" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding beginning balance (in shares)", "periodEndLabel": "Outstanding ending balance (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r482", "r483" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Options (in thousands)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding beginning balance (in usd per share)", "periodEndLabel": "Outstanding ending balance (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r482", "r483" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-Average Exercise Price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and expected to vest (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r499" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Vested and expected to vest (in thousands)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r498" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested and expected to vest (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r498" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Weighted average price of stock purchased under the ESPP (in usd per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Per Share Weighted Average Price of Shares Purchased", "documentation": "Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r61" ] }, "mxl_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerformancePeriod", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance period", "label": "Share-based Compensation Arrangement By Share-based Payment Award, Performance Period", "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Performance Period" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock purchased under the ESPP (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Purchased for Award", "documentation": "Number of shares purchased for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r1131" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails", "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationSummaryofRestrictedStockUnitandPerformanceBasedRestrictedStockUnitActivityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r478", "r479", "r480", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r496", "r497", "r498", "r499", "r502", "r503", "r504", "r505", "r506" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised (in usd per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r487" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Granted (in usd per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r486" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, tranche one", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationAwardTrancheThreeMember", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, tranche three", "label": "Share-Based Payment Arrangement, Tranche Three [Member]", "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, tranche two", "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r473", "r481", "r500", "r501", "r502", "r503", "r506", "r512", "r513", "r514", "r515" ] }, "us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Performance-Based Restricted Stock Unit Activity", "label": "Share-Based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block]", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares." } } }, "auth_ref": [ "r24" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationEmployeeStockPurchasePlanValuationAssumptionsDetails", "http://www.maxlinear.com/role/StockBasedCompensationScheduleofStockOptionsValuationAssumptionsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected life (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r502" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Exercisable (in thousands)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r61" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Contractual Term, Exercisable (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r61" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Canceled (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares", "documentation": "Number of non-vested options forfeited." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Contractual Term, Outstanding (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r138" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Contractual Term, Vested and expected to vest (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r498" ] }, "mxl_SharesIssuedUponSettlementOfExecutiveBonusPlan": { "xbrltype": "sharesItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "SharesIssuedUponSettlementOfExecutiveBonusPlan", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon settlement of employee bonus plan (in shares)", "label": "Shares Issued Upon Settlement Of Executive Bonus Plan", "documentation": "Shares issued upon settlement of executive bonus plan" } } }, "auth_ref": [] }, "mxl_SignificantSupplierAxis": { "xbrltype": "stringItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "SignificantSupplierAxis", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Supplier [Axis]", "label": "Significant Supplier [Axis]", "documentation": "Significant Supplier [Axis]" } } }, "auth_ref": [] }, "mxl_SignificantSupplierDomain": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "SignificantSupplierDomain", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Supplier [Domain]", "label": "Significant Supplier [Domain]", "documentation": "[Domain] for Significant Supplier [Axis]" } } }, "auth_ref": [] }, "mxl_SiliconMotionStockholderLitigationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "SiliconMotionStockholderLitigationMember", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Silicon Motion Stockholder Litigation", "label": "Silicon Motion Stockholder Litigation [Member]", "documentation": "Silicon Motion Stockholder Litigation" } } }, "auth_ref": [] }, "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SoftwareAndSoftwareDevelopmentCostsMember", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsPropertyandEquipmentNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Software", "label": "Software and Software Development Costs [Member]", "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "mxl_StandardProductWarrantyPeriod": { "xbrltype": "durationItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "StandardProductWarrantyPeriod", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product warranty, period", "label": "Standard Product Warranty, Period", "documentation": "Standard Product Warranty, Period" } } }, "auth_ref": [] }, "us-gaap_StandardProductWarrantyPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StandardProductWarrantyPolicy", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Warranty", "label": "Standard Product Warranty, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability." } } }, "auth_ref": [ "r1095" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails", "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r18", "r94", "r97", "r98", "r209", "r237", "r238", "r239", "r253", "r254", "r255", "r258", "r265", "r267", "r269", "r284", "r316", "r322", "r348", "r433", "r535", "r536", "r548", "r549", "r550", "r553", "r565", "r566", "r574", "r576", "r577", "r578", "r579", "r581", "r591", "r628", "r629", "r630", "r631", "r632", "r634", "r638", "r641", "r658", "r721", "r739", "r740", "r741", "r759", "r813" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]", "documentation": "Information by geographical components." } } }, "auth_ref": [ "r180", "r182", "r185", "r187", "r194", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r304", "r305", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693", "r694", "r695", "r696", "r697", "r698", "r699", "r700", "r701", "r761", "r762", "r763", "r819", "r821", "r824", "r826", "r829", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r839", "r840", "r846", "r876", "r897", "r898", "r899", "r900", "r901", "r902", "r903", "r904", "r909", "r915", "r1103", "r1165", "r1167", "r1168", "r1170", "r1171", "r1172", "r1173", "r1174", "r1175", "r1176", "r1177", "r1178", "r1179", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1186", "r1187", "r1188", "r1189", "r1190", "r1191", "r1192", "r1193", "r1194" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r253", "r254", "r255", "r284", "r641", "r666", "r754", "r760", "r766", "r767", "r768", "r769", "r770", "r771", "r774", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r787", "r788", "r789", "r790", "r791", "r793", "r795", "r796", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r813", "r916" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r253", "r254", "r255", "r284", "r309", "r641", "r666", "r754", "r760", "r766", "r767", "r768", "r769", "r770", "r771", "r774", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r787", "r788", "r789", "r790", "r791", "r793", "r795", "r796", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r813", "r916" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r933", "r943", "r953", "r985" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock purchase plan (in shares)", "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan", "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan." } } }, "auth_ref": [ "r18", "r66", "r93", "r94", "r134" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued pursuant to equity awards, net (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r18", "r93", "r94", "r134" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationSummaryofStockOptionActivityDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Exercised (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r18", "r93", "r94", "r134", "r487" ] }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock purchase plan", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan." } } }, "auth_ref": [ "r18", "r93", "r94", "r134" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issued pursuant to equity awards, net", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r62", "r93", "r94", "r134" ] }, "srt_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/StockRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase program, authorized amount", "label": "Share Repurchase Program, Authorized, Amount", "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [ "r1102" ] }, "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased", "presentation": [ "http://www.maxlinear.com/role/StockRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock available for purchase (in shares)", "label": "Share Repurchase Program, Remaining Authorized, Number of Shares", "documentation": "Number of shares remaining authorized to be purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://www.maxlinear.com/role/StockRepurchasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repurchase of common stock (in shares)", "label": "Stock Repurchased During Period, Shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r18", "r93", "r94", "r134", "r756", "r813", "r827" ] }, "us-gaap_StockRepurchasedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockRepurchasedDuringPeriodValue", "crdr": "debit", "presentation": [ "http://www.maxlinear.com/role/StockRepurchasesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock repurchased during period", "label": "Stock Repurchased During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r18", "r93", "r94", "r134", "r759", "r813", "r827", "r922" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetailsScheduleofAccumulatedOtherComprehensiveIncomeLossbyComponentDetails", "http://www.maxlinear.com/role/ConsolidatedBalanceSheets", "http://www.maxlinear.com/role/ConsolidatedStatementofStockholdersEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity", "periodStartLabel": "Balance at beginning of period", "periodEndLabel": "Balance at end of period", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r94", "r97", "r98", "r124", "r776", "r792", "r814", "r815", "r896", "r923", "r1034", "r1052", "r1145", "r1196" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders\u2019 equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.maxlinear.com/role/StockRepurchases" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Repurchases", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r131", "r249", "r420", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r429", "r430", "r431", "r432", "r433", "r582", "r816", "r817", "r828" ] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.maxlinear.com/role/BalanceSheetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Details", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r1018" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosures of cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Concentration Risk", "label": "Supplier Concentration Risk [Member]", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r120" ] }, "country_TH": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "TH", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Thailand", "label": "THAILAND" } } }, "auth_ref": [] }, "country_TW": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "TW", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Taiwan, ROC", "label": "TAIWAN" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r979" ] }, "mxl_TerminatedSiliconMotionMergerMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "TerminatedSiliconMotionMergerMember", "presentation": [ "http://www.maxlinear.com/role/BusinessCombinationsAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Terminated Silicon Motion Merger", "label": "Terminated Silicon Motion Merger [Member]", "documentation": "Terminated Silicon Motion Merger" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r971" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r978" ] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable", "label": "Accounts Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r163", "r164", "r165", "r1049", "r1050", "r1051" ] }, "us-gaap_TrademarksAndTradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TrademarksAndTradeNamesMember", "presentation": [ "http://www.maxlinear.com/role/GoodwillandIntangibleAssetsScheduleofAcquiredFiniteLivedIntangibleAssetsbyMajorClassDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Trademarks and trade names", "label": "Trademarks and Trade Names [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r69", "r1066", "r1068", "r1069", "r1070", "r1071", "r1072", "r1074", "r1076", "r1077", "r1078" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r998" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r1000" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.maxlinear.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r1001" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r1002" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration Date", "label": "Trading Arrangement Expiration Date" } } }, "auth_ref": [ "r1002" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r1000" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r1000" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r1003" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r1001" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.maxlinear.com/role/RestructuringActivityAdditionalInformationDetails", "http://www.maxlinear.com/role/RestructuringActivityRestructuringandRelatedCostsDetails", "http://www.maxlinear.com/role/RestructuringActivityScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r359", "r360", "r365", "r366" ] }, "country_US": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/country/2024", "localname": "US", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationLongLivedAssetsbyGeographicAreasDetails", "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationRevenuefromExternalCustomersbyGeographicAreasDetails" ], "lang": { "en-us": { "role": { "terseLabel": "United States", "verboseLabel": "United States", "label": "UNITED STATES" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r997" ] }, "us-gaap_UnrealizedGainLossOnInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrealizedGainLossOnInvestments", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unrealized holding loss on investments", "label": "Unrealized Gain (Loss) on Investments", "documentation": "Amount of unrealized gain (loss) on investment." } } }, "auth_ref": [ "r10" ] }, "mxl_UnrealizedGainLossOnTranslationToReportingCurrency": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "UnrealizedGainLossOnTranslationToReportingCurrency", "crdr": "credit", "calculation": { "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails_1": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maxlinear.com/role/LeasesAggregateFutureMinimumPaymentsDueDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: unrealized translation loss", "label": "Unrealized Gain (Loss) On Translation To Reporting Currency", "documentation": "Unrealized Gain (Loss) On Translation To Reporting Currency" } } }, "auth_ref": [] }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits, accrued penalties", "label": "Unrecognized Tax Benefits, Income Tax Penalties Accrued", "documentation": "Amount of statutory penalties accrued for a tax position claimed or expected to be claimed by the entity, in its tax return." } } }, "auth_ref": [ "r1133" ] }, "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued", "crdr": "credit", "presentation": [ "http://www.maxlinear.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits, accrued interest", "label": "Unrecognized Tax Benefits, Interest on Income Taxes Accrued", "documentation": "Amount of interest expense accrued for an underpayment of income taxes." } } }, "auth_ref": [ "r1133" ] }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "presentation": [ "http://www.maxlinear.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized tax benefits, period increase (decrease)", "label": "Unrecognized Tax Benefits, Period Increase (Decrease)", "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns." } } }, "auth_ref": [ "r1134" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UseOfEstimates", "presentation": [ "http://www.maxlinear.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates and Significant Risks and Uncertainties", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r45", "r46", "r47", "r169", "r170", "r172", "r173" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableRateAxis", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VariableRateDomain", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "mxl_VendorAMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "VendorAMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vendor A", "label": "Vendor A [Member]", "documentation": "Vendor A [Member]" } } }, "auth_ref": [] }, "mxl_VendorBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "VendorBMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vendor B", "label": "Vendor B [Member]", "documentation": "Vendor B [Member]" } } }, "auth_ref": [] }, "mxl_VendorCMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "VendorCMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vendor C", "label": "Vendor C [Member]", "documentation": "Vendor C [Member]" } } }, "auth_ref": [] }, "mxl_VendorDMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "VendorDMember", "presentation": [ "http://www.maxlinear.com/role/ConcentrationofCreditRiskSignificantCustomersandGeographicInformationConcentrationofRiskbyRiskFactorDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vendor D", "label": "Vendor D [Member]", "documentation": "Vendor D" } } }, "auth_ref": [] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VestingAxis", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Axis]", "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1105", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1124", "r1125", "r1126", "r1127", "r1128", "r1129", "r1130" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "VestingDomain", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting [Domain]", "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1105", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1124", "r1125", "r1126", "r1127", "r1128", "r1129", "r1130" ] }, "mxl_VestingPercentageRelativeToEPS": { "xbrltype": "percentItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "VestingPercentageRelativeToEPS", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting percentage relative to earnings per share", "label": "Vesting Percentage Relative To EPS", "documentation": "Vesting Percentage Relative To EPS" } } }, "auth_ref": [] }, "mxl_VestingPercentageRelativeToNetSales": { "xbrltype": "percentItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "VestingPercentageRelativeToNetSales", "presentation": [ "http://www.maxlinear.com/role/StockBasedCompensationAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting percentage relative to net sales", "label": "Vesting Percentage Relative To Net Sales", "documentation": "Vesting Percentage Relative To Net Sales" } } }, "auth_ref": [] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year", "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]" } } }, "auth_ref": [ "r967" ] }, "mxl_WaterIslandEventDrivenFundVMaxLinearIncMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "WaterIslandEventDrivenFundVMaxLinearIncMember", "presentation": [ "http://www.maxlinear.com/role/CommitmentsandContingenciesAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Water Island Event-Driven Fund v. MaxLinear, Inc.", "label": "Water Island Event-Driven Fund v. MaxLinear, Inc. [Member]", "documentation": "Water Island Event-Driven Fund v. MaxLinear, Inc." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "calculation": { "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive common stock equivalents (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r1041" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations", "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average common shares outstanding\u2014diluted (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r273", "r278" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations", "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Shares used to compute net loss per share:", "terseLabel": "Denominator:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maxlinear.com/role/ConsolidatedStatementsofOperations", "http://www.maxlinear.com/role/NetIncomeLossPerShareSummaryofBasicandDilutedEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Weighted average common shares outstanding\u2014basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r272", "r278" ] }, "mxl_WellsFargoBankNationalAssociationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maxlinear.com/20240930", "localname": "WellsFargoBankNationalAssociationMember", "presentation": [ "http://www.maxlinear.com/role/DebtAdditionalInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Wells Fargo Bank, National Association", "label": "Wells Fargo Bank, National Association [Member]", "documentation": "Wells Fargo Bank, National Association" } } }, "auth_ref": [] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2024", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested", "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r965" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-7" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479637/805-30-30-8" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-15" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481097/715-30-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "80", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Subparagraph": "(c)", "Paragraph": "2", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "70", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "40", "Section": "25", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480637/718-40-25-10" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-5" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479668/805-30-25-6" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/275/tableOfContent" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805/tableOfContent" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479613/805-30-35-1" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "210", "Topic": "954", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "270", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column C", "Footnote": "5", "Publisher": "SEC" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column C", "Footnote": "4", "Publisher": "SEC" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(a)", "Footnote": "4", "Publisher": "SEC" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(b)", "Footnote": "4", "Publisher": "SEC" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column C", "Footnote": "2", "Publisher": "SEC" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column F", "Footnote": "7", "Publisher": "SEC" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column A", "Publisher": "SEC" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column B", "Publisher": "SEC" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column C", "Publisher": "SEC" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column D", "Publisher": "SEC" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column E", "Publisher": "SEC" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column F", "Publisher": "SEC" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column B", "Publisher": "SEC" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column C", "Publisher": "SEC" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column D", "Publisher": "SEC" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column E", "Publisher": "SEC" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column F", "Publisher": "SEC" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column G", "Publisher": "SEC" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column H", "Publisher": "SEC" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "28", "Paragraph": "Column I", "Publisher": "SEC" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column A", "Footnote": "4", "Publisher": "SEC" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "L", "Publisher": "SEC" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 4", "Publisher": "SEC" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-7" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-17A" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-6" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "36", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476173/280-10-65-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-4" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/330/tableOfContent" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477123/405-50-65-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/420/tableOfContent" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-6" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/715/tableOfContent" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3A" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480126/715-20-S99-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480266/715-60-50-3" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-9" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479845/805-20-65-3" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482477/820-10-65-13" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-9" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-3" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-5" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-12" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-21" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-5" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/842-20/tableOfContent" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-1" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "330", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483194/926-20-65-2" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "280", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-3" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r844": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r845": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r846": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r847": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r848": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r849": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8" }, "r850": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r851": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r852": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r853": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r854": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r855": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r856": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r857": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r858": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r859": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r860": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r861": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r862": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r863": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r864": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r865": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r866": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r867": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r868": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27" }, "r869": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r870": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r871": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r872": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r873": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r874": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r875": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r876": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r877": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r878": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r879": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r880": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r881": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-18" }, "r882": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r883": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r884": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r885": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r886": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r887": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r888": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r889": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r890": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r891": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r892": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r893": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r894": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r895": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r896": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r897": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17" }, "r898": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21" }, "r899": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29" }, "r900": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3" }, "r901": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2" }, "r902": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4" }, "r903": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5" }, "r904": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6" }, "r905": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r906": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r907": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r908": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r909": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r910": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r911": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r912": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r913": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r914": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r915": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r916": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r917": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r918": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r919": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r920": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r921": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r922": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r923": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r924": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r925": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r926": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r927": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r928": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r929": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r930": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r931": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r932": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r933": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r934": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r935": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r936": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r937": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r938": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r939": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r940": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r941": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r942": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r943": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r944": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r945": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r946": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r947": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r948": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r949": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r950": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r951": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r952": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r953": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r954": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r955": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r956": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r957": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r958": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r959": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r960": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r961": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r962": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r963": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r964": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r965": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r966": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r967": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r968": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r969": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r970": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r971": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r972": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r973": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r974": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r975": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r976": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r977": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r978": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r979": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r980": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r981": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r982": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r983": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r984": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r985": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r986": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r987": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r988": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r989": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r990": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r991": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r992": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r993": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r994": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r995": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r996": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r997": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r998": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r999": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r1000": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r1001": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r1002": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r1003": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r1004": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r1005": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r1006": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r1007": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r1008": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r1009": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1010": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1011": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r1012": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r1013": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column A", "Subparagraph": "(ii)", "Footnote": "2", "Publisher": "SEC" }, "r1014": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r1015": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(b)", "Footnote": "1", "Publisher": "SEC" }, "r1016": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r1017": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r1018": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/210/tableOfContent" }, "r1019": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1020": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1021": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1022": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1023": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1024": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r1025": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r1026": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r1027": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1028": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1029": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r1030": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482047/420-10-45-3" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.b.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-6" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1093": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1094": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r1095": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8" }, "r1096": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1100": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1101": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r1102": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r1103": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r1104": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-27" }, "r1105": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1106": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1107": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1108": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1109": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1110": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1111": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1112": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1113": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1114": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1115": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1116": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1117": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1118": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1119": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1120": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1121": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1122": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1123": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1124": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1125": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1126": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1127": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1128": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1129": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1130": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1131": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1132": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r1133": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r1134": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A" }, "r1135": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r1136": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r1137": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480682/815-20-25-6A" }, "r1138": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1139": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1140": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1141": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1142": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1143": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1144": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r1145": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1146": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r1147": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r1148": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r1149": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r1150": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3" }, "r1151": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r1152": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479365/842-20-25-6" }, "r1153": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r1154": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r1155": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1156": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1157": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1158": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1159": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1160": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1161": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1162": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1163": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1164": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1165": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1166": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r1167": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1168": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1169": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1170": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1171": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1172": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1173": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1174": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1175": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1176": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1177": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1178": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1179": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1180": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1181": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1182": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1183": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1184": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1185": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1186": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1187": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1188": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1189": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1190": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1191": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1192": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1193": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1194": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1195": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1196": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1197": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1198": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r1199": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r1200": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r1201": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r1202": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" } } } ZIP 104 0001288469-24-000128-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001288469-24-000128-xbrl.zip M4$L#!!0 ( /* 5UE'SYVLIC< *U\ 0 > 83DS,#(P,C1E>#$P,7-E M<&%R871I;VYA9W(N:'1M[7UK=]K(ENCW^RMTTW-ZG%G8#?B=].FUB$T2NAWP M $Y./LTJI +4$1)'#SO,KY_]J"J5A+"=CM,&FUFS3L=(JL>N7?O]^'6:SH+? M?IU*X?WV_W[]_[N[SGGD9C,9IHX;2Y%*S\D2/YPXGSR9?'%V=]5;9]%\$?N3 M:>HTZ\T#YU,4?_&O!3]/_320O^EQ?OV%__[U%YKDUU'D+7[[U?.O'=_[YPO_ M>-248G3DBG']X, [JI_4Z_OBT#UMG#;')VY]]#^-%_ IO,[?).DBD/]\,?/# MW:G$^5\=-^?IZQO?2Z>O&O7Z/U[0>[_].H["%":+X6/^)X^Q-%(JOZ:[(O G MX2O:SPO^5#]VHR"*7_U4I_][C4]VQV+F!XM7_SGT9S)QNO+&Z4F&

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�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

CN$VIAA9\IW5=PHP(#EZ?%MM%(>K;@CX:V0:/; VY?'0FVP7IB;WC3?:?!)\U33EN9/% M!KZ'SW)1%PL-BLE6F,X;3VITSR3VEZD!&E-9*"G]<:I29X9@77B]D1H2_3JD MN18U.<2RQ*:EK2?.&9/ C<=CH4LLVGA(<,&:DQ)T$X]H@<9@/2LFUV5+VHYK M%&AAQ ^R#/JAHA!F93^05WF"@P[7'+(A>,="R'JND"HBW\,, MM*:OB4 C:D=@P#R[*X;X61H=_!ZTCG@1L%1/;JS@7+1D&(6]=+:[NG$#FRQ^ M+#MRRHPO"-B(V(T9Z8S;I K;G%AQ2Z+[BG"*&V$Y(/P5V+/3P; $NZHI;=B5 M5.(BCF-1 */RS=!]G(@=9"6'F0 _:CA6.=XBI)K="WF"="JB\U(1=FQJ=_PT M#9RU;.;E4%W)UPY,>=/?:J18)2?!UU4K2W=894W._QC&']$9;H+#B( 868!> MI_%$3HFUF,LFZY'JD]I9(0P,@1_3&T['HQK>T< :T#FBTV"/+N I[,"F*P,_ MF_681(_X=2:FPHU !_1[:_)#J%^:0KK+^U.TL7"X(E>ZS_=,P<4S%,+PLGDH M0_N.Y**"^(XP E1#PDC5S_;0_->!).9*'% $UO4 M.4;"4F1=EEA+,^/=)QO^Q-EVL%XF>3+=LSY+7HVABXI.%$(+]HKEYWU5:/OE M4#3DOM%P.?@BW\RU DO CG2%2MO*>6M2@$,F!D_])"!G&E3J/35+UZM](3Q, MJ,9.#YQ-?,Z<0Q$3ZVEE*+#HI><./)8+R2XH;_" )6Z5F2JEG1--/*W#^42A M_4_&3H;-%0Z1#>*]]6AX"O7+K.C@@&)2U' 9"F_7GKE,RV7K>!J7:4B]G-1@ MOK/!5B!'P5D6:]7RO(T\9G8;)()>>@7'@+GS\."FEY]KWCVD??#UZ M2)[ X-N>>.Z8,H;#OTZ&5D4/8NI-"I!B;ZPVD[*(OU,YKM$"D;8W8XBUH#3B M]*-\X\247)8^9C03-/*E+T_H#6K)'21C8_(L/=&#;NJ/1+YL(Z!#%=U7T1\? MJNB'*OK7KJ)O?1!LJST\1=.JX[$/1GV4YFRKYO%\T9_C74UP!:@O/T$&4+=V M-!\F]I1' /7D71QY=T,/F"VFSA0.J$>T)-(,%6($SX]I-'H:"!*;>HM1&D_> MHDKK$$P?FEBNWY!^#[U>ZI#/+F,:B:8IAK&C#>>)Z:@'WM!00: 8=EWGBO2 M(-9M:?RNI^[%H#.O,1L'3BN%>5R7Y$$K+-=$S;W*>FDTART'+QB9$>KUNJ_\ MEOOMQF^]?\4E;>+\EYH'/8DGH>-K(P"@9%;W" GG?;2WX?69IHJZY2Q0SKPZ MO3 GQU)V&TVCF3H_KJ$$8>"5=Y6G%I^:J+%,74YPL;RX!,ZL*7JPAX[2J:36 MM&@.;G]&"-1ZO"K@C_JQRO%;AX41P-$6&TX3K%ZU?T#$G)H4' M0J?9"@^=FT*=&CAOC0X\SIFFDR"@U?-&,W:\G5KZ7E!\B$^1)B=GIR]\(XXK M\R.%U\4GEQ_)>H:3QTA=)0_1J^!Y)#F(=S^E\.2HW3@4)-$/=(Y /U=.IQW3 MV6,'-F4EP0\>M,= MZ132F2//A!("FWHCV]?G)V>)4]FQWHJALHCT!F]I%K_ M@$A1_!1%>&< WLF7F11;,BR^3+W M@ _6;S$EBVU?!=& LL&['K-<")4NL:WWS2[^$"OU"2O�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end XML 105 mxl-20240930_htm.xml IDEA: XBRL DOCUMENT 0001288469 2024-01-01 2024-09-30 0001288469 2024-10-16 0001288469 2024-09-30 0001288469 2023-12-31 0001288469 2024-07-01 2024-09-30 0001288469 2023-07-01 2023-09-30 0001288469 2023-01-01 2023-09-30 0001288469 us-gaap:CommonStockMember 2023-12-31 0001288469 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001288469 us-gaap:RetainedEarningsMember 2023-12-31 0001288469 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001288469 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001288469 2024-01-01 2024-03-31 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001288469 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001288469 us-gaap:CommonStockMember 2024-03-31 0001288469 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001288469 us-gaap:RetainedEarningsMember 2024-03-31 0001288469 2024-03-31 0001288469 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001288469 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001288469 2024-04-01 2024-06-30 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001288469 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001288469 us-gaap:CommonStockMember 2024-06-30 0001288469 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001288469 us-gaap:RetainedEarningsMember 2024-06-30 0001288469 2024-06-30 0001288469 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001288469 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001288469 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001288469 us-gaap:CommonStockMember 2024-09-30 0001288469 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001288469 us-gaap:RetainedEarningsMember 2024-09-30 0001288469 us-gaap:CommonStockMember 2022-12-31 0001288469 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001288469 us-gaap:RetainedEarningsMember 2022-12-31 0001288469 2022-12-31 0001288469 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001288469 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001288469 2023-01-01 2023-03-31 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001288469 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001288469 us-gaap:CommonStockMember 2023-03-31 0001288469 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001288469 us-gaap:RetainedEarningsMember 2023-03-31 0001288469 2023-03-31 0001288469 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001288469 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001288469 2023-04-01 2023-06-30 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001288469 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001288469 us-gaap:CommonStockMember 2023-06-30 0001288469 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001288469 us-gaap:RetainedEarningsMember 2023-06-30 0001288469 2023-06-30 0001288469 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001288469 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001288469 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001288469 us-gaap:CommonStockMember 2023-09-30 0001288469 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001288469 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001288469 us-gaap:RetainedEarningsMember 2023-09-30 0001288469 2023-09-30 0001288469 srt:MinimumMember 2024-09-30 0001288469 srt:MaximumMember 2024-09-30 0001288469 mxl:ProductionMasksMember 2024-09-30 0001288469 srt:MinimumMember 2024-01-01 2024-09-30 0001288469 srt:MaximumMember 2024-01-01 2024-09-30 0001288469 mxl:TerminatedSiliconMotionMergerMember 2023-08-31 0001288469 mxl:CompanyYMember 2023-01-17 2023-01-17 0001288469 mxl:CompanyYMember 2023-01-17 0001288469 mxl:CompanyYMember 2024-09-30 0001288469 mxl:A2024WorkforceReductionMember 2024-01-01 2024-09-30 0001288469 mxl:A2024WorkforceReductionMember 2024-07-01 2024-09-30 0001288469 us-gaap:ContractTerminationMember mxl:A2024WorkforceReductionMember 2024-01-01 2024-09-30 0001288469 us-gaap:ContractTerminationMember mxl:A2024WorkforceReductionMember 2024-07-01 2024-09-30 0001288469 us-gaap:EmployeeSeveranceMember mxl:A2024WorkforceReductionMember 2024-07-01 2024-09-30 0001288469 us-gaap:EmployeeSeveranceMember mxl:A2024WorkforceReductionMember 2024-01-01 2024-09-30 0001288469 us-gaap:FacilityClosingMember mxl:A2024WorkforceReductionMember 2024-01-01 2024-09-30 0001288469 us-gaap:FacilityClosingMember mxl:A2024WorkforceReductionMember 2024-07-01 2024-09-30 0001288469 us-gaap:OtherRestructuringMember mxl:A2023WorkforceReductionMember 2024-01-01 2024-09-30 0001288469 us-gaap:EmployeeSeveranceMember mxl:A2023WorkforceReductionMember 2024-01-01 2024-09-30 0001288469 mxl:A2023WorkforceReductionMember 2024-01-01 2024-09-30 0001288469 srt:MinimumMember mxl:A2023And2024WorkforceReductionsMember 2024-09-30 0001288469 srt:MaximumMember mxl:A2023And2024WorkforceReductionsMember 2024-09-30 0001288469 us-gaap:EmployeeSeveranceMember 2024-07-01 2024-09-30 0001288469 us-gaap:EmployeeSeveranceMember 2023-07-01 2023-09-30 0001288469 us-gaap:EmployeeSeveranceMember 2024-01-01 2024-09-30 0001288469 us-gaap:EmployeeSeveranceMember 2023-01-01 2023-09-30 0001288469 us-gaap:FacilityClosingMember 2024-07-01 2024-09-30 0001288469 us-gaap:FacilityClosingMember 2023-07-01 2023-09-30 0001288469 us-gaap:FacilityClosingMember 2024-01-01 2024-09-30 0001288469 us-gaap:FacilityClosingMember 2023-01-01 2023-09-30 0001288469 mxl:OtherRestructuringNettingMember 2024-07-01 2024-09-30 0001288469 mxl:OtherRestructuringNettingMember 2023-07-01 2023-09-30 0001288469 mxl:OtherRestructuringNettingMember 2024-01-01 2024-09-30 0001288469 mxl:OtherRestructuringNettingMember 2023-01-01 2023-09-30 0001288469 us-gaap:OneTimeTerminationBenefitsMember 2023-12-31 0001288469 mxl:FacilityClosingNettingMember 2023-12-31 0001288469 mxl:OtherRestructuringNettingMember 2023-12-31 0001288469 us-gaap:OneTimeTerminationBenefitsMember 2024-01-01 2024-09-30 0001288469 mxl:FacilityClosingNettingMember 2024-01-01 2024-09-30 0001288469 us-gaap:OneTimeTerminationBenefitsMember 2024-09-30 0001288469 mxl:FacilityClosingNettingMember 2024-09-30 0001288469 mxl:OtherRestructuringNettingMember 2024-09-30 0001288469 2023-10-31 2023-10-31 0001288469 mxl:LicensedTechnologyMember 2024-09-30 0001288469 mxl:LicensedTechnologyMember 2023-12-31 0001288469 us-gaap:DevelopedTechnologyRightsMember 2024-09-30 0001288469 us-gaap:DevelopedTechnologyRightsMember 2023-12-31 0001288469 us-gaap:TrademarksAndTradeNamesMember 2024-09-30 0001288469 us-gaap:TrademarksAndTradeNamesMember 2023-12-31 0001288469 us-gaap:CustomerRelationshipsMember 2024-09-30 0001288469 us-gaap:CustomerRelationshipsMember 2023-12-31 0001288469 us-gaap:PatentsMember 2024-09-30 0001288469 us-gaap:PatentsMember 2023-12-31 0001288469 us-gaap:CostOfSalesMember 2024-07-01 2024-09-30 0001288469 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001288469 us-gaap:CostOfSalesMember 2024-01-01 2024-09-30 0001288469 us-gaap:CostOfSalesMember 2023-01-01 2023-09-30 0001288469 us-gaap:ResearchAndDevelopmentExpenseMember 2024-07-01 2024-09-30 0001288469 us-gaap:ResearchAndDevelopmentExpenseMember 2023-07-01 2023-09-30 0001288469 us-gaap:ResearchAndDevelopmentExpenseMember 2024-01-01 2024-09-30 0001288469 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-09-30 0001288469 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-07-01 2024-09-30 0001288469 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0001288469 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-01-01 2024-09-30 0001288469 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001288469 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001288469 us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001288469 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001288469 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001288469 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2024-09-30 0001288469 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001288469 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001288469 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001288469 mxl:ContingentConsiderationLiabilityMember 2023-12-31 0001288469 mxl:ContingentConsiderationLiabilityMember 2022-12-31 0001288469 mxl:ContingentConsiderationLiabilityMember 2024-01-01 2024-09-30 0001288469 mxl:ContingentConsiderationLiabilityMember 2023-01-01 2023-09-30 0001288469 mxl:ContingentConsiderationLiabilityMember 2024-09-30 0001288469 mxl:ContingentConsiderationLiabilityMember 2023-09-30 0001288469 us-gaap:FurnitureAndFixturesMember 2024-09-30 0001288469 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001288469 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2024-09-30 0001288469 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2024-09-30 0001288469 us-gaap:MachineryAndEquipmentMember 2024-09-30 0001288469 us-gaap:MachineryAndEquipmentMember 2023-12-31 0001288469 mxl:MasksAndProductionEquipmentMember 2024-09-30 0001288469 mxl:MasksAndProductionEquipmentMember 2023-12-31 0001288469 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2024-09-30 0001288469 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2023-12-31 0001288469 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2024-09-30 0001288469 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2024-09-30 0001288469 us-gaap:LeaseholdImprovementsMember 2024-09-30 0001288469 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001288469 us-gaap:ConstructionInProgressMember 2024-09-30 0001288469 us-gaap:ConstructionInProgressMember 2023-12-31 0001288469 2022-03-01 2022-03-31 0001288469 2023-09-01 2023-09-30 0001288469 2023-08-31 2023-08-31 0001288469 mxl:ReductionInTransactionPriceMember 2024-09-30 0001288469 mxl:ReductionInTransactionPriceMember 2023-12-31 0001288469 us-gaap:SalesReturnsAndAllowancesMember 2024-09-30 0001288469 us-gaap:SalesReturnsAndAllowancesMember 2023-12-31 0001288469 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0001288469 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2023-12-31 0001288469 us-gaap:AccumulatedTranslationAdjustmentMember 2024-01-01 2024-09-30 0001288469 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2024-01-01 2024-09-30 0001288469 us-gaap:AccumulatedTranslationAdjustmentMember 2024-09-30 0001288469 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2024-09-30 0001288469 mxl:InitialTermLoanTLBJune2021Member 2024-09-30 0001288469 mxl:InitialTermLoanTLBJune2021Member 2023-12-31 0001288469 us-gaap:MediumTermNotesMember 2024-09-30 0001288469 us-gaap:MediumTermNotesMember 2023-12-31 0001288469 mxl:WellsFargoBankNationalAssociationMember mxl:InitialTermLoanTLBJune2021Member 2021-06-23 0001288469 us-gaap:RevolvingCreditFacilityMember mxl:WellsFargoBankNationalAssociationMember us-gaap:LineOfCreditMember 2021-06-23 0001288469 mxl:InitialTermLoanTLBJune2021Member 2021-06-23 0001288469 mxl:InitialTermLoanTLBJune2021Member us-gaap:FederalFundsEffectiveSwapRateMember 2024-01-01 2024-09-30 0001288469 mxl:InitialTermLoanTLBJune2021Member us-gaap:SecuredOvernightFinancingRateSofrMember 2024-01-01 2024-09-30 0001288469 mxl:InitialTermLoanTLBJune2021Member 2024-01-01 2024-09-30 0001288469 mxl:InitialTermLoanTLBJune2021Member mxl:SecuredOvernightFinancingRateSOFRSubjectToFloorMember 2024-01-01 2024-09-30 0001288469 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2024-01-01 2024-09-30 0001288469 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2024-01-01 2024-09-30 0001288469 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2021-07-01 2024-09-30 0001288469 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:BaseRateMember 2021-07-01 2024-09-30 0001288469 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2021-07-01 2024-09-30 0001288469 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember us-gaap:SecuredOvernightFinancingRateSofrMember 2021-07-01 2024-09-30 0001288469 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-07-01 2024-09-30 0001288469 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2021-07-01 2024-09-30 0001288469 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2024-09-30 0001288469 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2024-01-01 2024-09-30 0001288469 mxl:InducementPlanMember 2024-05-22 0001288469 mxl:EquityIncentivePlanMember 2024-09-30 0001288469 mxl:EmployeeStockPurchasePlanMember 2024-09-30 0001288469 mxl:InducementPlanMember 2024-09-30 0001288469 2024-02-29 0001288469 us-gaap:RestrictedStockUnitsRSUMember 2024-09-30 0001288469 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-09-30 0001288469 us-gaap:PerformanceSharesMember 2024-09-30 0001288469 us-gaap:PerformanceSharesMember 2024-01-01 2024-09-30 0001288469 us-gaap:EmployeeStockOptionMember 2024-09-30 0001288469 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001288469 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001288469 us-gaap:RestrictedStockUnitsRSUMember mxl:InducementPlanMember 2024-01-01 2024-09-30 0001288469 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2024-01-01 2024-09-30 0001288469 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2024-01-01 2024-09-30 0001288469 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2024-01-01 2024-09-30 0001288469 us-gaap:PerformanceSharesMember 2023-12-31 0001288469 us-gaap:EmployeeStockMember 2024-01-01 2024-09-30 0001288469 us-gaap:EmployeeStockMember 2023-01-01 2023-09-30 0001288469 us-gaap:EmployeeStockMember 2024-09-30 0001288469 us-gaap:EmployeeStockMember 2023-09-30 0001288469 srt:MinimumMember us-gaap:EmployeeStockMember 2024-09-30 0001288469 srt:MaximumMember us-gaap:EmployeeStockMember 2024-09-30 0001288469 srt:MinimumMember us-gaap:EmployeeStockMember 2023-09-30 0001288469 srt:MaximumMember us-gaap:EmployeeStockMember 2023-09-30 0001288469 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2024-09-30 0001288469 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2024-09-30 0001288469 mxl:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 mxl:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 mxl:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 mxl:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 mxl:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 mxl:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001288469 mxl:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 mxl:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-12-31 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorAMember 2024-07-01 2024-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorAMember 2023-07-01 2023-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorAMember 2024-01-01 2024-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorAMember 2023-01-01 2023-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorBMember 2024-07-01 2024-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorBMember 2023-07-01 2023-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorBMember 2024-01-01 2024-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorBMember 2023-01-01 2023-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorCMember 2024-07-01 2024-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorCMember 2023-07-01 2023-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorCMember 2024-01-01 2024-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorCMember 2023-01-01 2023-09-30 0001288469 us-gaap:InventoriesMember us-gaap:SupplierConcentrationRiskMember mxl:VendorDMember 2023-01-01 2023-09-30 0001288469 srt:AsiaMember us-gaap:SalesRevenueNetMember 2024-07-01 2024-09-30 0001288469 srt:AsiaMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 srt:AsiaMember us-gaap:SalesRevenueNetMember 2023-07-01 2023-09-30 0001288469 srt:AsiaMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 srt:AsiaMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-09-30 0001288469 srt:AsiaMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 srt:AsiaMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-09-30 0001288469 srt:AsiaMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 srt:EuropeMember us-gaap:SalesRevenueNetMember 2024-07-01 2024-09-30 0001288469 srt:EuropeMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 srt:EuropeMember us-gaap:SalesRevenueNetMember 2023-07-01 2023-09-30 0001288469 srt:EuropeMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 srt:EuropeMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-09-30 0001288469 srt:EuropeMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 srt:EuropeMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-09-30 0001288469 srt:EuropeMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 country:US us-gaap:SalesRevenueNetMember 2024-07-01 2024-09-30 0001288469 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 country:US us-gaap:SalesRevenueNetMember 2023-07-01 2023-09-30 0001288469 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 country:US us-gaap:SalesRevenueNetMember 2024-01-01 2024-09-30 0001288469 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 country:US us-gaap:SalesRevenueNetMember 2023-01-01 2023-09-30 0001288469 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 mxl:RestOfWorldMember us-gaap:SalesRevenueNetMember 2024-07-01 2024-09-30 0001288469 mxl:RestOfWorldMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 mxl:RestOfWorldMember us-gaap:SalesRevenueNetMember 2023-07-01 2023-09-30 0001288469 mxl:RestOfWorldMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 mxl:RestOfWorldMember us-gaap:SalesRevenueNetMember 2024-01-01 2024-09-30 0001288469 mxl:RestOfWorldMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 mxl:RestOfWorldMember us-gaap:SalesRevenueNetMember 2023-01-01 2023-09-30 0001288469 mxl:RestOfWorldMember us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 us-gaap:SalesRevenueNetMember 2024-07-01 2024-09-30 0001288469 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 us-gaap:SalesRevenueNetMember 2023-07-01 2023-09-30 0001288469 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 us-gaap:SalesRevenueNetMember 2024-01-01 2024-09-30 0001288469 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 us-gaap:SalesRevenueNetMember 2023-01-01 2023-09-30 0001288469 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 country:HK us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 country:HK us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 country:HK us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 country:HK us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 country:CN us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 country:TW us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 country:TH us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 country:US mxl:LongLivedAssetsMember 2024-01-01 2024-09-30 0001288469 country:US mxl:LongLivedAssetsMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 country:US mxl:LongLivedAssetsMember 2023-01-01 2023-12-31 0001288469 country:US mxl:LongLivedAssetsMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-12-31 0001288469 country:SG mxl:LongLivedAssetsMember 2024-01-01 2024-09-30 0001288469 country:SG mxl:LongLivedAssetsMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 country:SG mxl:LongLivedAssetsMember 2023-01-01 2023-12-31 0001288469 country:SG mxl:LongLivedAssetsMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-12-31 0001288469 mxl:RestOfWorldMember mxl:LongLivedAssetsMember 2024-01-01 2024-09-30 0001288469 mxl:RestOfWorldMember mxl:LongLivedAssetsMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 mxl:RestOfWorldMember mxl:LongLivedAssetsMember 2023-01-01 2023-12-31 0001288469 mxl:RestOfWorldMember mxl:LongLivedAssetsMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-12-31 0001288469 mxl:LongLivedAssetsMember 2024-01-01 2024-09-30 0001288469 mxl:LongLivedAssetsMember us-gaap:GeographicConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 mxl:LongLivedAssetsMember 2023-01-01 2023-12-31 0001288469 mxl:LongLivedAssetsMember us-gaap:GeographicConcentrationRiskMember 2023-01-01 2023-12-31 0001288469 mxl:BroadbandMember 2024-07-01 2024-09-30 0001288469 mxl:BroadbandMember 2023-07-01 2023-09-30 0001288469 mxl:BroadbandMember 2024-01-01 2024-09-30 0001288469 mxl:BroadbandMember 2023-01-01 2023-09-30 0001288469 mxl:BroadbandMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 mxl:BroadbandMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 mxl:BroadbandMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 mxl:BroadbandMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 mxl:ConnectivityMember 2024-07-01 2024-09-30 0001288469 mxl:ConnectivityMember 2023-07-01 2023-09-30 0001288469 mxl:ConnectivityMember 2024-01-01 2024-09-30 0001288469 mxl:ConnectivityMember 2023-01-01 2023-09-30 0001288469 mxl:ConnectivityMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 mxl:ConnectivityMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 mxl:ConnectivityMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 mxl:ConnectivityMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 mxl:InfrastructureMember 2024-07-01 2024-09-30 0001288469 mxl:InfrastructureMember 2023-07-01 2023-09-30 0001288469 mxl:InfrastructureMember 2024-01-01 2024-09-30 0001288469 mxl:InfrastructureMember 2023-01-01 2023-09-30 0001288469 mxl:InfrastructureMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 mxl:InfrastructureMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 mxl:InfrastructureMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 mxl:InfrastructureMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 mxl:IndustrialAndMultiMarketMember 2024-07-01 2024-09-30 0001288469 mxl:IndustrialAndMultiMarketMember 2023-07-01 2023-09-30 0001288469 mxl:IndustrialAndMultiMarketMember 2024-01-01 2024-09-30 0001288469 mxl:IndustrialAndMultiMarketMember 2023-01-01 2023-09-30 0001288469 mxl:IndustrialAndMultiMarketMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-07-01 2024-09-30 0001288469 mxl:IndustrialAndMultiMarketMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-07-01 2023-09-30 0001288469 mxl:IndustrialAndMultiMarketMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2024-01-01 2024-09-30 0001288469 mxl:IndustrialAndMultiMarketMember us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2023-01-01 2023-09-30 0001288469 us-gaap:SalesRevenueNetMember mxl:RevenueFromDistributorsMember mxl:DistributorsMember 2024-07-01 2024-09-30 0001288469 us-gaap:SalesRevenueNetMember mxl:RevenueFromDistributorsMember mxl:DistributorsMember 2023-07-01 2023-09-30 0001288469 us-gaap:SalesRevenueNetMember mxl:RevenueFromDistributorsMember mxl:DistributorsMember 2024-01-01 2024-09-30 0001288469 us-gaap:SalesRevenueNetMember mxl:RevenueFromDistributorsMember mxl:DistributorsMember 2023-01-01 2023-09-30 0001288469 2023-01-01 2023-12-31 0001288469 us-gaap:InventoriesMember 2024-09-30 0001288469 mxl:OtherObligationsMember 2024-09-30 0001288469 mxl:SiliconMotionStockholderLitigationMember 2024-01-01 2024-09-30 0001288469 mxl:WaterIslandEventDrivenFundVMaxLinearIncMember 2023-08-31 0001288469 mxl:WaterIslandEventDrivenFundVMaxLinearIncMember 2024-09-18 0001288469 mxl:DishLitigationMember 2023-09-21 2023-09-21 0001288469 mxl:DishLitigationMember 2024-01-31 2024-01-31 0001288469 mxl:CoxLitigationMember 2023-02-10 2023-02-10 0001288469 mxl:CoxLitigationMember 2023-10-06 2023-10-06 0001288469 2021-02-23 0001288469 2021-02-23 2024-09-30 0001288469 2024-02-16 shares iso4217:USD iso4217:USD shares mxl:segment mxl:business_activity pure mxl:claim 0001288469 --12-31 2024 Q3 false P3Y P1Y P1Y P1Y 10-Q true 2024-09-30 false 001-34666 MaxLinear, Inc. DE 14-1896129 5966 La Place Court, Suite 100, Carlsbad CA 92008 760 692-0711 Common stock MXL NASDAQ Yes Yes Large Accelerated Filer false false false 84361778 148476000 187288000 993000 1051000 47930000 170619000 96063000 99908000 34798000 29159000 328260000 488025000 23000 17000 63493000 66431000 22549000 31264000 58031000 73630000 318588000 318588000 82552000 69493000 21807000 32809000 895303000 1080257000 30628000 21551000 44472000 71684000 71197000 98468000 22300000 30426000 168597000 222129000 19433000 26243000 122840000 122375000 27561000 23245000 338431000 393992000 0.0001 0.0001 25000000 25000000 0 0 0 0 0 0 0.0001 0.0001 550000000 550000000 84362000 84362000 81818000 81818000 8000 8000 866603000 808575000 -3852000 -3791000 -305887000 -118527000 556872000 686265000 895303000 1080257000 81102000 135530000 268361000 567910000 37022000 61586000 124827000 250786000 44080000 73944000 143534000 317124000 52604000 66306000 173911000 204254000 30154000 25402000 100242000 97772000 1237000 0 1237000 2438000 26828000 54000 50323000 9138000 110823000 91762000 325713000 313602000 -66743000 -17818000 -182179000 3522000 1653000 1736000 5346000 4272000 2655000 2715000 8072000 7793000 -14753000 -22721000 -12990000 -21180000 -15755000 -23700000 -15716000 -24701000 -82498000 -41518000 -197895000 -21179000 -6713000 -1689000 -10535000 13468000 -75785000 -39829000 -187360000 -34647000 -0.90 -0.49 -2.25 -0.43 -0.90 -0.49 -2.25 -0.43 84074000 81249000 83303000 80395000 84074000 81249000 83303000 80395000 -75785000 -39829000 -187360000 -34647000 -42000 -169000 -64000 -229000 2664000 -1855000 -61000 -3125000 0 3792000 0 3792000 -73121000 -45476000 -187421000 -41564000 81818000 8000 808575000 -3791000 -118527000 686265000 1249000 8777000 8777000 17032000 17032000 -1782000 -1782000 -72309000 -72309000 83067000 8000 834384000 -5573000 -190836000 637983000 655000 -545000 -545000 176000 2682000 2682000 17344000 17344000 -943000 -943000 -39266000 -39266000 83898000 8000 853865000 -6516000 -230102000 617255000 464000 -56000 -56000 12794000 12794000 2664000 2664000 -75785000 -75785000 84362000 8000 866603000 -3852000 -305887000 556872000 78745000 8000 722778000 -1021000 -45380000 676385000 1236000 31926000 31926000 16460000 16460000 -192000 -192000 9533000 9533000 79981000 8000 771164000 -1213000 -35847000 734112000 808000 -2752000 -2752000 141000 2989000 2989000 17127000 17127000 -1078000 -1078000 -4351000 -4351000 80930000 8000 788528000 -2291000 -40198000 746047000 631000 -3017000 -3017000 5123000 5123000 -5647000 -5647000 -39829000 -39829000 81561000 8000 790634000 -7938000 -80027000 702677000 -187360000 -34647000 42426000 54923000 1237000 2438000 14000000 0 1990000 1858000 47208000 38763000 -13058000 6502000 -1068000 -2057000 0 -3917000 3415000 0 554000 0 0 1008000 -973000 -140000 2988000 529000 -122689000 -13769000 -3845000 -45602000 8615000 10215000 -16041000 -17917000 3011000 8776000 -27212000 -45036000 -7806000 -8891000 4315000 -557000 -17457000 59945000 15487000 12180000 4961000 6198000 0 12384000 -20448000 -30762000 0 18325000 1579000 3168000 1714000 12370000 -135000 -27527000 -824000 -1861000 -38864000 -205000 188356000 188357000 149492000 188152000 7444000 6978000 9470000 25336000 10992000 38348000 Organization and Summary of Significant Accounting Policies<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MaxLinear, Inc. was incorporated in Delaware in September 2003. MaxLinear, Inc., together with its directly and indirectly wholly-owned subsidiaries, collectively referred to as MaxLinear, or the Company, is a provider of communications systems-on-chip, or SoC, solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. MaxLinear is a fabless integrated circuit design company whose products integrate all or substantial portions of a high-speed communication system, including radio frequency, or RF, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management. MaxLinear’s customers primarily include electronics distributors, module makers, original equipment manufacturers, or OEMs, and original design manufacturers, or ODMs, who incorporate the Company’s products in a wide range of electronic devices. Examples of such devices include broadband modems compliant with Data Over Cable Service Interface Specifications, or DOCSIS, Passive Optical Network, or PON, and DSL; Wi-Fi and wireline routers for home networking; radio transceivers and modems for 4G/5G base-station and backhaul infrastructure; optical transceivers targeting hyperscale data centers; as well as power management and interface products used in these and many other markets.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its directly and indirectly wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive income, stockholders’ equity, and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheet as of December 31, 2023 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on January 31, 2024, or the Annual Report. Interim results for the nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these foreign subsidiaries are translated at the current exchange rate at the balance sheet date and historical rates for equity. Revenue and expense components are translated at weighted average exchange rates in effect during the period. Gains and losses resulting from foreign currency translation are included as a component of stockholders’ equity. Foreign currency transaction gains and losses are included in the results of operations, and to date, have not been material.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates and Significant Risks and Uncertainties</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes of the consolidated financial statements. Actual results could differ from those estimates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of October 23, 2024, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of Significant Accounting Policies</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the provisions of ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in accounting for its acquisitions. It requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed, at the acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the acquisition date fair values of the net assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to exit or restructure certain activities of an acquired company or the Company’s internal operations are accounted for as termination and exit costs pursuant to ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and are accounted for separately from the business combination. A liability for costs associated with an exit or disposal activity is recognized and measured at its fair value in the consolidated statements of operations in the period in which the liability is incurred. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a given acquisition, the Company may identify certain pre-acquisition contingencies as of the acquisition date and may extend its review, evaluation, and adjustment of these pre-acquisition contingencies throughout the measurement period in order to obtain sufficient information to assess whether the Company includes these contingencies as a part of the fair value estimates of assets acquired and liabilities assumed and, if so, to determine their estimated amounts. A pre-acquisition contingency (non-income tax related) is only recognized as an asset or a liability if: (i) it is probable that an asset existed or a liability had been incurred at the acquisition date and (ii) the amount of the asset or liability can be reasonably estimated. Subsequent to the measurement period, changes in estimates of such contingencies will affect earnings and could have a material effect on the Company's results of operations and financial position.</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, uncertain tax positions and tax-related valuation allowances assumed, if any, in connection with a business combination are initially estimated as of the acquisition date. The Company re-evaluates these items quarterly based upon facts and circumstances that existed as of the acquisition date with any adjustments to the preliminary estimates being recorded to goodwill if identified within the measurement period. Subsequent to the end of the measurement period or final determination of the estimated value of the tax allowance or contingency, whichever comes first, changes to these uncertain tax positions and tax related valuation allowances will affect the income tax provision (benefit) in the consolidated statements of operations and could have a material impact on the results of operations and financial position.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Cash and Cash Equivalents</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all liquid investments with a maturity of three months or less when purchased to be cash equivalents. Cash equivalents are recorded at cost, which approximates market value.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Accounts Receivable</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs ongoing credit evaluations of its customers and assesses each customer’s credit worthiness. The Company monitors collections and payments from its customers and maintains an allowance for doubtful accounts, which is based upon applying an expected credit loss rate to receivables based on the historical loss rate from similar high risk customers adjusted for current conditions, including any specific customer collection issues identified, and forecasts of economic conditions. Delinquent account balances are written off after management has determined that the likelihood of collection is remote.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Inventory</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the recoverability of its inventory based on assumptions about demand and market conditions. Forecasted demand is determined based on historical sales and expected future sales. Inventory is stated at the lower of cost or </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net realizable value. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis and net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company reduces its inventory to the lower of its cost or net realizable value on a part-by-part basis to account for obsolescence or lack of marketability. Reductions are calculated as the difference between the cost of inventory and its net realizable value based upon assumptions about future demand, market conditions and costs. Once established, these adjustments are considered permanent and are not revised until the related inventory is sold or disposed of.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fair Value of Financial Instruments</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses and compensation are considered to be representative of their respective fair values because of the short-term nature of these accounts.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is carried at cost and depreciated over the estimated useful lives of the assets, ranging from <span style="-sec-ix-hidden:f-401">three</span> to five years, using the straight-line method. Leasehold improvements are stated at cost and amortized over the shorter of the estimated useful lives of the assets or the lease term. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Production Masks</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Production masks with alternative future uses or discernible future benefits are capitalized and amortized over their estimated useful lives of five years. To determine if a production mask has alternative future uses or benefits, the Company evaluates risks associated with developing new technologies and capabilities, and the related risks associated with entering new markets. Production masks that do not meet the criteria for capitalization are expensed as research and development costs.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations accounted for under the acquisition method. Intangible assets represent purchased intangible assets including developed technology, in-process research and development, or IPR&amp;D, technologies acquired or licensed from other companies, customer relationships, non-compete covenants, backlog, and trademarks and tradenames. Purchased finite-lived intangible assets are capitalized and amortized over their estimated useful lives. Technologies acquired or licensed from other companies, customer relationships, non-compete covenants, backlog, and trademarks and tradenames are capitalized and amortized over the lesser of the terms of the agreement, or estimated useful life. The Company capitalizes IPR&amp;D projects acquired as part of a business combination. On completion of each project, IPR&amp;D assets are reclassified to developed technology and amortized over their estimated useful lives.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Goodwill and Long-Lived Assets</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not amortized but is tested for impairment using either a qualitative assessment, and/or quantitative assessment, which is based on comparing the fair value of a reporting unit with its carrying amount. If the carrying amount of a reporting unit exceeds its fair value, a goodwill impairment loss is recorded. The Company tests by reporting unit, goodwill and other indefinite-lived intangible assets for impairment as of October 31 each year or more frequently if it believes indicators of impairment exist.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews indefinite-lived intangible assets for impairment using a qualitative assessment, followed by a quantitative assessment, as needed, each year as of October 31, the date of its annual goodwill impairment review, or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Recoverability of indefinite-lived intangible assets is measured by comparing the carrying amount of the asset to its fair value. In certain cases, the Company utilizes the relief-from-royalty method when appropriate, and a fair value will be obtained based on analysis over the costs saved by owning the right instead of leasing it. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During development, IPR&amp;D is not subject to amortization and is tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Once an IPR&amp;D project is complete, it becomes a finite-lived intangible asset and is evaluated for impairment both immediately prior to its change in classification and thereafter in accordance with the Company’s policy for long-lived assets.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the useful lives, to determine whether indicators of impairment may exist which warrant adjustments to carrying values or estimated useful lives. An impairment loss would be recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss would be measured based on the excess of the carrying amount of the asset over the asset’s fair value.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company’s revenue is generated from sales of the Company’s integrated circuits and intellectual property, typically under individual customer purchase orders, some of which have underlying master sales agreements that specify terms governing the product or intellectual property sales. The Company recognizes such revenue at the point in time when control of the products or intellectual property is transferred to the customer at the estimated net consideration for which collection is probable, taking into account the customer’s rights to price protection, other pricing credits, unit rebates, and rights to return unsold product. Transfer of control occurs either when products are shipped to or received by the distributor or direct customer, based on the terms of the specific agreement with the customer, if the Company has a present right to payment and transfer of legal title and the risks and rewards of ownership to the customer has occurred. For most of the Company’s product sales, transfer of control occurs upon shipment to the distributor or direct customer. Under certain intellectual property sale agreements, we are entitled to fixed upfront consideration upon sale and variable consideration in the form of a portion of revenue generated by the recipient from the intellectual property. Fixed consideration is recognized when control of the functional intellectual property transfers; variable consideration may be constrained but is continuously monitored and recognized as revenue when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur and the uncertainty associated with the variable consideration is resolved. The Company recognized a material amount of variable consideration during the nine months ended September 30, 2024 as uncertainties related to such consideration were resolved. During the three months ended September 30, 2024, there was no variable consideration recognized related to resolution of uncertainties related to such consideration.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing whether collection of consideration from a customer is probable, the Company considers the customer’s ability and intention to pay that amount of consideration when it is due. Payment of invoices is due as specified in the underlying customer agreement, typically 30 days from the invoice date, which occurs on the date of transfer of control of the products to the customer. Since payment terms are less than a year, the Company has elected the practical expedient and does not assess whether a customer contract has a significant financing component.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A five-step approach is applied in the recognition of revenue: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when the Company satisfies a performance obligation. Customer purchase orders plus the underlying master sales agreements are considered to be contracts with the customer for purposes of applying the five-step approach.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing adjustments and estimates of returns under contractual stock rotation rights are treated as variable consideration for purposes of determining the transaction price, and are estimated at the time control transfers using the expected value method based on the Company’s analysis of actual price adjustment claims by distributors and historical product return rates, and then reassessed at the end of each reporting period. The Company also considers whether any variable consideration is constrained, since such amounts for which it is probable that a significant reversal will occur when the contingency is subsequently resolved are required to be excluded from revenues. Price adjustments are finalized at the time the products are sold through to the end customer and the distributor or end customer submits a claim to reduce the sale price to a pre-approved net price. Stock rotation allowances are capped at a fixed percentage of the Company’s sales to a distributor for a period of time, up to six months, as specified in the individual distributor contract. If the Company’s current estimates of such credits and rights are materially inaccurate, it may result in adjustments that affect future revenues and gross profits. Returns under the Company’s general assurance warranty of products for a period of <span style="-sec-ix-hidden:f-410">one</span> to three years have not been material and warranty-related services are not considered a separate performance obligation under the customer contracts. Most of the Company’s customers resell the Company’s product as part of their product and thus are tax-exempt; however, to the extent the Company </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">collects and remits taxes on product sales from customers, it has elected to exclude from the measurement of transaction price such taxes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each distinct promise to transfer products is considered to be an identified performance obligation for which revenue is recognized upon transfer of control of the products to the customer. Although customers may place orders for products to be delivered on multiple dates that may be in different quarterly reporting periods, all of the orders are scheduled within one year from the order date. The Company has elected to record sales commissions when incurred, as the period over which the sales commission asset that would have been recognized is less than one year.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer contract liabilities consist primarily of obligations to deliver rebates to customers in the form of units of products which are included in accrued expenses and other current liabilities in the consolidated balance sheets. Other obligations to customers, which are included in accrued price protection liability in the consolidated balance sheets, consist of estimates of price protection rights offered to the Company’s end customer on products sold by the Company to the end customer’s contract manufacturer at a standard price that are later incorporated into the end customers’ product. The Company’s price adjustments included in accrued expenses and other current liabilities are discounts and rebates expected to be claimed by the Company’s distributors upon sell-through of the products to their customers, which are initially sold by the Company to the distributors at a standard price. Also included in accrued expenses and other current liabilities are amounts expected to be returned by distributors under stock rotation rights. The Company also records a right of return asset, consisting of amounts representing the products the Company expects to receive from customers in returns, which is included in inventory in the consolidated balance sheets, and is typically settled within six months of transfer of control to the customer, or the period over which stock rotation rights are based. Upon lapse of the time period for stock rotations, or the contractual end to price protection and rebate programs, which is approximately <span style="-sec-ix-hidden:f-415">one</span> to two years, and when the Company believes unclaimed amounts are no longer subject to payment and will not be paid, any remaining asset or liability is derecognized by an offsetting entry to cost of net revenue and net revenue. For additional disclosures regarding contract liabilities and other obligations to customers, see Note 12.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses customer accounts receivable and contract assets for impairment in accordance with ASC 310-10-35.</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranty</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally provides a warranty on its products for a period of <span style="-sec-ix-hidden:f-418">one</span> to three years. The Company makes estimates of product return rates and expected costs to replace the products under warranty at the time revenue is recognized based on historical warranty experience and any known product warranty issues. If actual return rates and/or replacement costs differ significantly from these estimates, adjustments to recognize additional warranty expenses in cost of net revenue may be required in future periods.</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates under one segment as it has developed, marketed and sold primarily only one class of similar products, radio-frequency, high-performance analog and mixed-signal communications system-on-chip solutions for the connected home, wired and wireless infrastructure markets and industrial and multi-market applications.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company’s Chief Executive Officer reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports under a single operating segment.</span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based Compensation </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the cost of employee services received in exchange for equity incentive awards, including restricted stock units, employee stock purchase rights and stock options based on the grant date fair value of the award. The Company calculates the fair value of restricted stock units and performance-based restricted stock units based on the fair market value of the Company’s common stock on the grant date. Stock-based compensation expense is then determined based on the number of restricted stock units that are expected to vest; for performance-based restricted stock units, this is the number of units that are expected to vest during the performance period if it is probable that the Company will achieve the performance metrics specified in the underlying award agreement. The Company uses the Black-Scholes valuation model to calculate the fair value of stock options and employee stock purchase rights granted to employees. Stock-based compensation expense is recognized over the period during which the employee is required to provide services in exchange for the award, which is usually the vesting period. The Company recognizes compensation expense over the vesting period using the straight-line method and classifies these amounts in the consolidated statements of operations based on the department to which the related employee reports.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in connection with the development of the Company’s technology and future products are charged to research and development expense as incurred. From time to time, the Company enters into contracts for jointly funded research and development projects to develop technology that may be commercialized into a product in the future. The Company also obtains research and development funding grants from governments in certain jurisdictions in which it operates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both of these types of income are reflected as a credit to research and development expense when such income has been earned and any contingencies associated with retaining such income have been resolved. In the three months ended September 30, 2024 and 2023, the Company recognized aggregate income from jointly funded R&amp;D projects and government grants of approximately $0.6 million and $1.4 million, respectively. During the nine months ended September 30, 2024 and 2023, the Company recognized aggregate income from jointly funded R&amp;D projects and government grants of approximately $3.1 million and $11.3 million, respectively. While the Company retains ownership and rights to the underlying technology developed under the joint development projects, the Company may be required to repay all or a portion of the funds provided by the other parties under certain conditions, and defers such funds as liabilities until the repayment conditions have been resolved (Note 15).</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s leases primarily consist of facility leases which are classified as operating leases. The Company assesses whether an arrangement contains a lease at inception. The Company recognizes a lease liability to make contractual payments under all leases with terms greater than twelve months and a corresponding right-of-use asset, representing its right to use the underlying asset for the lease term. The lease liability is initially measured at the present value of the lease payments over the lease term using the collateralized incremental borrowing rate when the implicit rate is unknown. Options to extend or terminate a lease are included in the lease term when it is reasonably certain that the Company will exercise such an option. The right-of-use asset is initially measured as the contractual lease liability plus any initial direct costs and prepaid lease payments made, less any lease incentives. Upon adoption of ASC 842 on January 1, 2019, the carrying value of lease-related restructuring liabilities for certain restructured leases existing at that date was offset against the related right-of-use assets. Lease expense is recognized on a straight-line basis over the lease term.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon adoption of ASC 842, the Company elected certain practical expedients and accordingly has (1) carried forward its prior assessments of (a) whether existing contracts on the January 1, 2019 adoption date contain leases, (b) classification of leases as operating or financing and (c) initial direct costs for existing leases and (2) considered hindsight in determining the lease term and assessing impairment of the right-of-use-asset. In addition, the Company used a portfolio approach for its facility leases when making judgments and estimates, such as the discount rate. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leased right-of-use assets are subject to impairment testing as a long-lived asset at the asset-group level. The Company monitors its long-lived assets for indicators of impairment. As the Company’s leased right-of-use assets primarily relate to facility leases, early abandonment of all or part of a facility as part of a restructuring plan is typically an indicator of impairment. If impairment indicators are present, the Company tests whether the carrying amount of the leased right-of-use </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">asset is recoverable including consideration of sublease income, and if not recoverable, measures impairment loss for the right-of-use asset or asset group. </span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension and Other Defined Benefit Retirement Obligations</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of pension and certain other defined benefit employee retirement benefits are required to be recognized based upon actuarial valuations. The related net retirement benefit obligation is recognized as the excess of the projected benefit obligation over the fair value of the plan assets. In measuring the retirement benefit obligation, the discount rate, expected long-term rate of return on plan assets, and long-term rate of salary increase are the most significant assumptions. Retirement benefit costs primarily represent the increase in the actuarial present value of the retirement benefit obligation. </span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides for income taxes utilizing the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are presented net as noncurrent. The provision for income taxes generally represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from the differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when a judgment is made that is considered more likely than not that a tax benefit will not be realized. A decision to record a valuation allowance results in an increase in income tax expense or a decrease in income tax benefit. If the valuation allowance is released in a future period, income tax expense will be reduced accordingly.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of tax liabilities involves dealing with uncertainties in the application of complex global tax regulations. The impact of an uncertain income tax position is recognized at the largest amount that is “more likely than not” to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. If the estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to expense would result.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company continually assesses the need for a valuation allowance on the deferred tax asset by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the consolidated statement of operations for the period that the adjustment is determined to be required.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the Tax Cuts and Jobs Act, or the Tax Act, was enacted into U.S. tax law. In 2018, the Company made an accounting policy election to treat Global Intangible Low Taxed Income in accordance with the Tax Act as a period cost.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss)</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) is defined as the change in equity (net assets) of a business entity during a period from transactions and other events and circumstances from non-owner sources. Other comprehensive income (loss) includes certain changes in equity that are excluded from net income (loss), net of tax, such as foreign currency translation gains and losses and changes in fair value of projected benefit obligations for defined benefit plans. </span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Settlement Costs</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal costs are expensed as incurred. The Company is involved in disputes, litigation and other legal actions in the ordinary course of business. The Company continually evaluates uncertainties associated with litigation and records a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the loss or range of loss can be reasonably estimated.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Recently Issued, Not Yet Adopted Accounting Pronouncements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the FASB issued ASU No. 2024-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements - Amendments to Remove References to the Concepts Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to remove various references to concepts statements from the FASB Accounting Standards Codification. This guidance is to clarify guidance, simplify wording or structure of guidance, and other minor improvements. These amendments are effective for the Company for annual periods in 2025, applied prospectively, with early adoption and retrospective application permitted. The Company intends to adopt the amendments in this update prospectively in 2025. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the FASB issued ASU No. 2024-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) - Scope Application of Profits Interest and Similar Awards, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to clarify whether profits interest and similar awards should be accounted for in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Topic 718, Compensation - Stock Compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guidance applies to all business entities that issue profits interest awards as compensation to employees or nonemployees in exchange for goods or services. These amendments are effective for the Company for annual and interim periods in 2025, applied prospectively, with early adoption and retrospective application permitted. As the Company does not issue profit interest awards, the impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) - Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to require enhanced income tax disclosures to provide information to assess how an entity’s operations and related tax risks, tax planning, and operational opportunities affect its tax rate and prospects for future cash flows. The amendments in this update provide that a business entity disclose (1) a tabular income tax rate reconciliation, using both percentages and amounts, (2) separate disclosure of any individual reconciling items that are equal to or greater than 5% of the amount computed by multiplying the income (loss) from continuing operations before income taxes by the applicable statutory income tax rate, and disaggregation of certain items that are significant and (3) amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign jurisdictions, including separate disclosure of any individual jurisdictions greater than 5% of total income taxes paid. These amendments are effective for the Company for annual periods in 2025, applied prospectively, with early adoption and retrospective application permitted. The Company intends to adopt the amendments in this update prospectively in 2025. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, since the amendments require only enhancement of existing income tax disclosures in the footnotes to the Company’s consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280) – Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to require enhanced disclosures that include reportable segment expenses. The amendments in this update provide that a business entity disclose significant segment expenses, segment profit or loss (after significant segment expenses), and allows reporting of additional measures of a segments profit or loss if used in assessing segment performance. Such disclosures apply to entities with a single reportable segment. These amendments are effective for the Company for annual periods in 2024 and interim periods in 2025, retrospectively to all prior periods using the significant segment expense categories identified and disclosed in the period of adoption. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, since the requirements impact only segment reporting disclosures in the footnotes to the Company’s consolidated financial statements.</span></div> <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited consolidated financial statements include the accounts of MaxLinear, Inc. and its directly and indirectly wholly-owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by GAAP for complete financial statements. All intercompany transactions and investments have been eliminated in consolidation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of management, the Company’s unaudited consolidated interim financial statements contain adjustments, including normal recurring accruals necessary to present fairly the Company’s consolidated financial position, results of operations, comprehensive income, stockholders’ equity, and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated balance sheet as of December 31, 2023 was derived from the Company’s audited consolidated financial statements at that date. The accompanying unaudited consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K filed by the Company with the Securities and Exchange Commission, or the SEC, on January 31, 2024, or the Annual Report. Interim results for the nine months ended September 30, 2024 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2024.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The functional currency of certain foreign subsidiaries is the local currency. Accordingly, assets and liabilities of these foreign subsidiaries are translated at the current exchange rate at the balance sheet date and historical rates for equity. Revenue and expense components are translated at weighted average exchange rates in effect during the period. Gains and losses resulting from foreign currency translation are included as a component of stockholders’ equity. Foreign currency transaction gains and losses are included in the results of operations, and to date, have not been material.</span></div> <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates and Significant Risks and Uncertainties</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the unaudited consolidated financial statements and accompanying notes of the consolidated financial statements. Actual results could differ from those estimates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not aware of any specific event or circumstance that would require an update to its estimates or adjustments to the carrying value of its assets and liabilities as of October 23, 2024, the issuance date of this Quarterly Report on Form 10-Q. Actual results could differ from those estimates.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the provisions of ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in accounting for its acquisitions. It requires the Company to recognize separately from goodwill the assets acquired and the liabilities assumed, at the acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the acquisition date fair values of the net assets acquired and the liabilities assumed. While the Company uses its best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date as well as contingent consideration, where applicable, its estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, the Company records adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs to exit or restructure certain activities of an acquired company or the Company’s internal operations are accounted for as termination and exit costs pursuant to ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and are accounted for separately from the business combination. A liability for costs associated with an exit or disposal activity is recognized and measured at its fair value in the consolidated statements of operations in the period in which the liability is incurred. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a given acquisition, the Company may identify certain pre-acquisition contingencies as of the acquisition date and may extend its review, evaluation, and adjustment of these pre-acquisition contingencies throughout the measurement period in order to obtain sufficient information to assess whether the Company includes these contingencies as a part of the fair value estimates of assets acquired and liabilities assumed and, if so, to determine their estimated amounts. A pre-acquisition contingency (non-income tax related) is only recognized as an asset or a liability if: (i) it is probable that an asset existed or a liability had been incurred at the acquisition date and (ii) the amount of the asset or liability can be reasonably estimated. Subsequent to the measurement period, changes in estimates of such contingencies will affect earnings and could have a material effect on the Company's results of operations and financial position.</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, uncertain tax positions and tax-related valuation allowances assumed, if any, in connection with a business combination are initially estimated as of the acquisition date. The Company re-evaluates these items quarterly based upon facts and circumstances that existed as of the acquisition date with any adjustments to the preliminary estimates being recorded to goodwill if identified within the measurement period. Subsequent to the end of the measurement period or final determination of the estimated value of the tax allowance or contingency, whichever comes first, changes to these uncertain tax positions and tax related valuation allowances will affect the income tax provision (benefit) in the consolidated statements of operations and could have a material impact on the results of operations and financial position.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Cash and Cash Equivalents</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all liquid investments with a maturity of three months or less when purchased to be cash equivalents. Cash equivalents are recorded at cost, which approximates market value.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Accounts Receivable</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs ongoing credit evaluations of its customers and assesses each customer’s credit worthiness. The Company monitors collections and payments from its customers and maintains an allowance for doubtful accounts, which is based upon applying an expected credit loss rate to receivables based on the historical loss rate from similar high risk customers adjusted for current conditions, including any specific customer collection issues identified, and forecasts of economic conditions. Delinquent account balances are written off after management has determined that the likelihood of collection is remote.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Inventory</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses the recoverability of its inventory based on assumptions about demand and market conditions. Forecasted demand is determined based on historical sales and expected future sales. Inventory is stated at the lower of cost or </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net realizable value. Cost is computed using standard cost, which approximates actual cost on a first-in, first-out basis and net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company reduces its inventory to the lower of its cost or net realizable value on a part-by-part basis to account for obsolescence or lack of marketability. Reductions are calculated as the difference between the cost of inventory and its net realizable value based upon assumptions about future demand, market conditions and costs. Once established, these adjustments are considered permanent and are not revised until the related inventory is sold or disposed of.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Fair Value of Financial Instruments</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued expenses and compensation are considered to be representative of their respective fair values because of the short-term nature of these accounts.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment</span></div>Property and equipment is carried at cost and depreciated over the estimated useful lives of the assets, ranging from <span style="-sec-ix-hidden:f-401">three</span> to five years, using the straight-line method. Leasehold improvements are stated at cost and amortized over the shorter of the estimated useful lives of the assets or the lease term. P5Y <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Production Masks</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Production masks with alternative future uses or discernible future benefits are capitalized and amortized over their estimated useful lives of five years. To determine if a production mask has alternative future uses or benefits, the Company evaluates risks associated with developing new technologies and capabilities, and the related risks associated with entering new markets. Production masks that do not meet the criteria for capitalization are expensed as research and development costs.</span></div> P5Y <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations accounted for under the acquisition method. Intangible assets represent purchased intangible assets including developed technology, in-process research and development, or IPR&amp;D, technologies acquired or licensed from other companies, customer relationships, non-compete covenants, backlog, and trademarks and tradenames. Purchased finite-lived intangible assets are capitalized and amortized over their estimated useful lives. Technologies acquired or licensed from other companies, customer relationships, non-compete covenants, backlog, and trademarks and tradenames are capitalized and amortized over the lesser of the terms of the agreement, or estimated useful life. The Company capitalizes IPR&amp;D projects acquired as part of a business combination. On completion of each project, IPR&amp;D assets are reclassified to developed technology and amortized over their estimated useful lives.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Goodwill and Long-Lived Assets</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is not amortized but is tested for impairment using either a qualitative assessment, and/or quantitative assessment, which is based on comparing the fair value of a reporting unit with its carrying amount. If the carrying amount of a reporting unit exceeds its fair value, a goodwill impairment loss is recorded. The Company tests by reporting unit, goodwill and other indefinite-lived intangible assets for impairment as of October 31 each year or more frequently if it believes indicators of impairment exist.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews indefinite-lived intangible assets for impairment using a qualitative assessment, followed by a quantitative assessment, as needed, each year as of October 31, the date of its annual goodwill impairment review, or whenever events or changes in circumstances indicate the carrying value may not be recoverable. Recoverability of indefinite-lived intangible assets is measured by comparing the carrying amount of the asset to its fair value. In certain cases, the Company utilizes the relief-from-royalty method when appropriate, and a fair value will be obtained based on analysis over the costs saved by owning the right instead of leasing it. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During development, IPR&amp;D is not subject to amortization and is tested for impairment annually or more frequently if events or changes in circumstances indicate that the asset might be impaired. Once an IPR&amp;D project is complete, it becomes a finite-lived intangible asset and is evaluated for impairment both immediately prior to its change in classification and thereafter in accordance with the Company’s policy for long-lived assets.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the useful lives, to determine whether indicators of impairment may exist which warrant adjustments to carrying values or estimated useful lives. An impairment loss would be recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss would be measured based on the excess of the carrying amount of the asset over the asset’s fair value.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company’s revenue is generated from sales of the Company’s integrated circuits and intellectual property, typically under individual customer purchase orders, some of which have underlying master sales agreements that specify terms governing the product or intellectual property sales. The Company recognizes such revenue at the point in time when control of the products or intellectual property is transferred to the customer at the estimated net consideration for which collection is probable, taking into account the customer’s rights to price protection, other pricing credits, unit rebates, and rights to return unsold product. Transfer of control occurs either when products are shipped to or received by the distributor or direct customer, based on the terms of the specific agreement with the customer, if the Company has a present right to payment and transfer of legal title and the risks and rewards of ownership to the customer has occurred. For most of the Company’s product sales, transfer of control occurs upon shipment to the distributor or direct customer. Under certain intellectual property sale agreements, we are entitled to fixed upfront consideration upon sale and variable consideration in the form of a portion of revenue generated by the recipient from the intellectual property. Fixed consideration is recognized when control of the functional intellectual property transfers; variable consideration may be constrained but is continuously monitored and recognized as revenue when it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur and the uncertainty associated with the variable consideration is resolved. The Company recognized a material amount of variable consideration during the nine months ended September 30, 2024 as uncertainties related to such consideration were resolved. During the three months ended September 30, 2024, there was no variable consideration recognized related to resolution of uncertainties related to such consideration.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing whether collection of consideration from a customer is probable, the Company considers the customer’s ability and intention to pay that amount of consideration when it is due. Payment of invoices is due as specified in the underlying customer agreement, typically 30 days from the invoice date, which occurs on the date of transfer of control of the products to the customer. Since payment terms are less than a year, the Company has elected the practical expedient and does not assess whether a customer contract has a significant financing component.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A five-step approach is applied in the recognition of revenue: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when the Company satisfies a performance obligation. Customer purchase orders plus the underlying master sales agreements are considered to be contracts with the customer for purposes of applying the five-step approach.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing adjustments and estimates of returns under contractual stock rotation rights are treated as variable consideration for purposes of determining the transaction price, and are estimated at the time control transfers using the expected value method based on the Company’s analysis of actual price adjustment claims by distributors and historical product return rates, and then reassessed at the end of each reporting period. The Company also considers whether any variable consideration is constrained, since such amounts for which it is probable that a significant reversal will occur when the contingency is subsequently resolved are required to be excluded from revenues. Price adjustments are finalized at the time the products are sold through to the end customer and the distributor or end customer submits a claim to reduce the sale price to a pre-approved net price. Stock rotation allowances are capped at a fixed percentage of the Company’s sales to a distributor for a period of time, up to six months, as specified in the individual distributor contract. If the Company’s current estimates of such credits and rights are materially inaccurate, it may result in adjustments that affect future revenues and gross profits. Returns under the Company’s general assurance warranty of products for a period of <span style="-sec-ix-hidden:f-410">one</span> to three years have not been material and warranty-related services are not considered a separate performance obligation under the customer contracts. Most of the Company’s customers resell the Company’s product as part of their product and thus are tax-exempt; however, to the extent the Company </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">collects and remits taxes on product sales from customers, it has elected to exclude from the measurement of transaction price such taxes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each distinct promise to transfer products is considered to be an identified performance obligation for which revenue is recognized upon transfer of control of the products to the customer. Although customers may place orders for products to be delivered on multiple dates that may be in different quarterly reporting periods, all of the orders are scheduled within one year from the order date. The Company has elected to record sales commissions when incurred, as the period over which the sales commission asset that would have been recognized is less than one year.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer contract liabilities consist primarily of obligations to deliver rebates to customers in the form of units of products which are included in accrued expenses and other current liabilities in the consolidated balance sheets. Other obligations to customers, which are included in accrued price protection liability in the consolidated balance sheets, consist of estimates of price protection rights offered to the Company’s end customer on products sold by the Company to the end customer’s contract manufacturer at a standard price that are later incorporated into the end customers’ product. The Company’s price adjustments included in accrued expenses and other current liabilities are discounts and rebates expected to be claimed by the Company’s distributors upon sell-through of the products to their customers, which are initially sold by the Company to the distributors at a standard price. Also included in accrued expenses and other current liabilities are amounts expected to be returned by distributors under stock rotation rights. The Company also records a right of return asset, consisting of amounts representing the products the Company expects to receive from customers in returns, which is included in inventory in the consolidated balance sheets, and is typically settled within six months of transfer of control to the customer, or the period over which stock rotation rights are based. Upon lapse of the time period for stock rotations, or the contractual end to price protection and rebate programs, which is approximately <span style="-sec-ix-hidden:f-415">one</span> to two years, and when the Company believes unclaimed amounts are no longer subject to payment and will not be paid, any remaining asset or liability is derecognized by an offsetting entry to cost of net revenue and net revenue. For additional disclosures regarding contract liabilities and other obligations to customers, see Note 12.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses customer accounts receivable and contract assets for impairment in accordance with ASC 310-10-35.</span></div> P30D P6M P3Y P1Y P1Y P6M P2Y <div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranty</span></div><div style="text-indent:27.35pt"><span><br/></span></div><div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally provides a warranty on its products for a period of <span style="-sec-ix-hidden:f-418">one</span> to three years. The Company makes estimates of product return rates and expected costs to replace the products under warranty at the time revenue is recognized based on historical warranty experience and any known product warranty issues. If actual return rates and/or replacement costs differ significantly from these estimates, adjustments to recognize additional warranty expenses in cost of net revenue may be required in future periods.</span></div> P3Y <div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Information</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates under one segment as it has developed, marketed and sold primarily only one class of similar products, radio-frequency, high-performance analog and mixed-signal communications system-on-chip solutions for the connected home, wired and wireless infrastructure markets and industrial and multi-market applications.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is its Chief Executive Officer. The Company’s Chief Executive Officer reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results and plans for products or components below the consolidated unit level. Accordingly, the Company reports under a single operating segment.</span></div> 1 1 <div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based Compensation </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the cost of employee services received in exchange for equity incentive awards, including restricted stock units, employee stock purchase rights and stock options based on the grant date fair value of the award. The Company calculates the fair value of restricted stock units and performance-based restricted stock units based on the fair market value of the Company’s common stock on the grant date. Stock-based compensation expense is then determined based on the number of restricted stock units that are expected to vest; for performance-based restricted stock units, this is the number of units that are expected to vest during the performance period if it is probable that the Company will achieve the performance metrics specified in the underlying award agreement. The Company uses the Black-Scholes valuation model to calculate the fair value of stock options and employee stock purchase rights granted to employees. Stock-based compensation expense is recognized over the period during which the employee is required to provide services in exchange for the award, which is usually the vesting period. The Company recognizes compensation expense over the vesting period using the straight-line method and classifies these amounts in the consolidated statements of operations based on the department to which the related employee reports.</span></div> <div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in connection with the development of the Company’s technology and future products are charged to research and development expense as incurred. From time to time, the Company enters into contracts for jointly funded research and development projects to develop technology that may be commercialized into a product in the future. The Company also obtains research and development funding grants from governments in certain jurisdictions in which it operates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both of these types of income are reflected as a credit to research and development expense when such income has been earned and any contingencies associated with retaining such income have been resolved. In the three months ended September 30, 2024 and 2023, the Company recognized aggregate income from jointly funded R&amp;D projects and government grants of approximately $0.6 million and $1.4 million, respectively. During the nine months ended September 30, 2024 and 2023, the Company recognized aggregate income from jointly funded R&amp;D projects and government grants of approximately $3.1 million and $11.3 million, respectively. While the Company retains ownership and rights to the underlying technology developed under the joint development projects, the Company may be required to repay all or a portion of the funds provided by the other parties under certain conditions, and defers such funds as liabilities until the repayment conditions have been resolved (Note 15).</span></div> 600000 1400000 3100000 11300000 <div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s leases primarily consist of facility leases which are classified as operating leases. The Company assesses whether an arrangement contains a lease at inception. The Company recognizes a lease liability to make contractual payments under all leases with terms greater than twelve months and a corresponding right-of-use asset, representing its right to use the underlying asset for the lease term. The lease liability is initially measured at the present value of the lease payments over the lease term using the collateralized incremental borrowing rate when the implicit rate is unknown. Options to extend or terminate a lease are included in the lease term when it is reasonably certain that the Company will exercise such an option. The right-of-use asset is initially measured as the contractual lease liability plus any initial direct costs and prepaid lease payments made, less any lease incentives. Upon adoption of ASC 842 on January 1, 2019, the carrying value of lease-related restructuring liabilities for certain restructured leases existing at that date was offset against the related right-of-use assets. Lease expense is recognized on a straight-line basis over the lease term.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon adoption of ASC 842, the Company elected certain practical expedients and accordingly has (1) carried forward its prior assessments of (a) whether existing contracts on the January 1, 2019 adoption date contain leases, (b) classification of leases as operating or financing and (c) initial direct costs for existing leases and (2) considered hindsight in determining the lease term and assessing impairment of the right-of-use-asset. In addition, the Company used a portfolio approach for its facility leases when making judgments and estimates, such as the discount rate. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leased right-of-use assets are subject to impairment testing as a long-lived asset at the asset-group level. The Company monitors its long-lived assets for indicators of impairment. As the Company’s leased right-of-use assets primarily relate to facility leases, early abandonment of all or part of a facility as part of a restructuring plan is typically an indicator of impairment. If impairment indicators are present, the Company tests whether the carrying amount of the leased right-of-use </span></div>asset is recoverable including consideration of sublease income, and if not recoverable, measures impairment loss for the right-of-use asset or asset group. P12M <div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pension and Other Defined Benefit Retirement Obligations</span></div>The costs of pension and certain other defined benefit employee retirement benefits are required to be recognized based upon actuarial valuations. The related net retirement benefit obligation is recognized as the excess of the projected benefit obligation over the fair value of the plan assets. In measuring the retirement benefit obligation, the discount rate, expected long-term rate of return on plan assets, and long-term rate of salary increase are the most significant assumptions. Retirement benefit costs primarily represent the increase in the actuarial present value of the retirement benefit obligation. <div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides for income taxes utilizing the asset and liability approach of accounting for income taxes. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. Deferred taxes are presented net as noncurrent. The provision for income taxes generally represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from the differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted. Valuation allowances are recorded to reduce deferred tax assets when a judgment is made that is considered more likely than not that a tax benefit will not be realized. A decision to record a valuation allowance results in an increase in income tax expense or a decrease in income tax benefit. If the valuation allowance is released in a future period, income tax expense will be reduced accordingly.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of tax liabilities involves dealing with uncertainties in the application of complex global tax regulations. The impact of an uncertain income tax position is recognized at the largest amount that is “more likely than not” to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. If the estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to expense would result.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company continually assesses the need for a valuation allowance on the deferred tax asset by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the consolidated statement of operations for the period that the adjustment is determined to be required.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, the Tax Cuts and Jobs Act, or the Tax Act, was enacted into U.S. tax law. In 2018, the Company made an accounting policy election to treat Global Intangible Low Taxed Income in accordance with the Tax Act as a period cost.</span></div> <div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Comprehensive Income (Loss)</span></div>Comprehensive income (loss) is defined as the change in equity (net assets) of a business entity during a period from transactions and other events and circumstances from non-owner sources. Other comprehensive income (loss) includes certain changes in equity that are excluded from net income (loss), net of tax, such as foreign currency translation gains and losses and changes in fair value of projected benefit obligations for defined benefit plans. <div style="text-indent:27.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Settlement Costs</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal costs are expensed as incurred. The Company is involved in disputes, litigation and other legal actions in the ordinary course of business. The Company continually evaluates uncertainties associated with litigation and records a charge equal to at least the minimum estimated liability for a loss contingency when both of the following conditions are met: (i) information available prior to issuance of the financial statements indicates that it is probable that an asset had been impaired or a liability had been incurred at the date of the financial statements and (ii) the loss or range of loss can be reasonably estimated.</span></div> <div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Recently Issued, Not Yet Adopted Accounting Pronouncements</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the FASB issued ASU No. 2024-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements - Amendments to Remove References to the Concepts Statements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to remove various references to concepts statements from the FASB Accounting Standards Codification. This guidance is to clarify guidance, simplify wording or structure of guidance, and other minor improvements. These amendments are effective for the Company for annual periods in 2025, applied prospectively, with early adoption and retrospective application permitted. The Company intends to adopt the amendments in this update prospectively in 2025. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the FASB issued ASU No. 2024-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) - Scope Application of Profits Interest and Similar Awards, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to clarify whether profits interest and similar awards should be accounted for in accordance with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Topic 718, Compensation - Stock Compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The guidance applies to all business entities that issue profits interest awards as compensation to employees or nonemployees in exchange for goods or services. These amendments are effective for the Company for annual and interim periods in 2025, applied prospectively, with early adoption and retrospective application permitted. As the Company does not issue profit interest awards, the impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) - Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to require enhanced income tax disclosures to provide information to assess how an entity’s operations and related tax risks, tax planning, and operational opportunities affect its tax rate and prospects for future cash flows. The amendments in this update provide that a business entity disclose (1) a tabular income tax rate reconciliation, using both percentages and amounts, (2) separate disclosure of any individual reconciling items that are equal to or greater than 5% of the amount computed by multiplying the income (loss) from continuing operations before income taxes by the applicable statutory income tax rate, and disaggregation of certain items that are significant and (3) amount of income taxes paid (net of refunds received) disaggregated by federal, state and foreign jurisdictions, including separate disclosure of any individual jurisdictions greater than 5% of total income taxes paid. These amendments are effective for the Company for annual periods in 2025, applied prospectively, with early adoption and retrospective application permitted. The Company intends to adopt the amendments in this update prospectively in 2025. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, since the amendments require only enhancement of existing income tax disclosures in the footnotes to the Company’s consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280) – Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to require enhanced disclosures that include reportable segment expenses. The amendments in this update provide that a business entity disclose significant segment expenses, segment profit or loss (after significant segment expenses), and allows reporting of additional measures of a segments profit or loss if used in assessing segment performance. Such disclosures apply to entities with a single reportable segment. These amendments are effective for the Company for annual periods in 2024 and interim periods in 2025, retrospectively to all prior periods using the significant segment expense categories identified and disclosed in the period of adoption. The impact of the adoption of the amendments in this update is not expected to be material to the Company’s consolidated financial position and results of operations, since the requirements impact only segment reporting disclosures in the footnotes to the Company’s consolidated financial statements.</span></div> Net Income (Loss) Per Share<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share, or EPS, is calculated by dividing net loss by the weighted-average number of common shares outstanding for the period, without consideration for common stock equivalents. Diluted EPS is computed by dividing net loss by the weighted-average number of common shares outstanding for the period and the weighted-average number of dilutive common stock equivalents outstanding for the period determined using the treasury-stock method. For purposes of this calculation, stock options and restricted stock units are considered to be common stock equivalents and are only included in the calculation of diluted EPS when their effect is dilutive. In periods in which the Company has a net loss, dilutive common stock equivalents are excluded from the calculation of diluted EPS.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted EPS:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:46.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share amounts)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,829)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding—basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,074 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding—diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,074 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,249 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.90)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.49)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.25)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September 30, 2024 and 2023, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 6.0 million and 4.9 million, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature. </span></div>For the nine months ended September 30, 2024 and 2023, the Company excluded common stock equivalents for outstanding stock-based awards, which represented potentially dilutive securities of 6.2 million and 4.8 million, respectively, from the calculation of diluted net loss per share due to their anti-dilutive nature. <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the computation of basic and diluted EPS:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.076%"><tr><td style="width:1.0%"></td><td style="width:46.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.550%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except per share amounts)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,829)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(187,360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding—basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,074 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,249 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,303 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,395 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive common stock equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding—diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,074 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,249 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,303 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.49)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.90)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.49)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.25)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -75785000 -39829000 -187360000 -34647000 84074000 81249000 83303000 80395000 0 0 0 0 84074000 81249000 83303000 80395000 -0.90 -0.49 -2.25 -0.43 -0.90 -0.49 -2.25 -0.43 6000000.0 4900000 6200000 4800000 Business Combinations<div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terminated Silicon Motion Merger</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 5, 2022, MaxLinear entered into an Agreement and Plan of Merger, or the Merger Agreement, with Silicon Motion Technology Corporation, or Silicon Motion, an exempted company with limited liability incorporated under the laws of the Cayman Islands, pursuant to which, among other things and subject to the terms and conditions thereof, MaxLinear agreed to acquire Silicon Motion pursuant to a statutory merger, under the laws of the Cayman Islands, of Shark Merger Sub, a wholly-owned subsidiary of MaxLinear, with and into Silicon Motion, with Silicon Motion surviving the merger as a wholly-owned subsidiary of MaxLinear. Silicon Motion is a provider of NAND flash controllers for solid state drives, or SSDs, and other solid state storage devices.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 26, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MaxLinear terminated the Merger Agreement and notified Silicon Motion that MaxLinear was relieved of its obligations to close because, among other reasons, (i) certain conditions to closing set forth in the Merger Agreement were not satisfied and were incapable of being satisfied, (ii) Silicon Motion had suffered a Material Adverse Effect that was continuing, (iii) Silicon Motion was in material breach of representations, warranties, covenants, and agreements in the Merger Agreement that gave rise to the right of the Company to terminate, and (iv) in any event, the First Extended Outside Date had passed and was not automatically extended because certain conditions in Article 6 of the Merger Agreement were not satisfied or waived as of May 5, 2023. For these same reasons, under the terms of the Merger Agreement, MaxLinear was not required to pay a break-up fee or other fee to Silicon Motion as a result of the termination of the Merger Agreement. Undefined capitalized terms in this paragraph have the same meaning as in the Merger Agreement. On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration to seek damages from MaxLinear arising from MaxLinear's alleged breaches of the Merger Agreement.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. See Note 15 for more information on legal matters related to the termination of the Merger Agreement.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The second amended and restated commitment letter dated October 24, 2022 with Wells Fargo Bank, N.A., or Wells Fargo Bank, and other lenders, and related financing commitments for the previously pending (now terminated) merger were also terminated upon termination of the Merger Agreement. As a result of the termination of the financing, in August 2023, the Company was required to pay to Wells Fargo Bank a ticking fee of $18.3 million.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisition of Company Y</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 17, 2023, the Company completed its acquisition of a business, or Company Y, pursuant to a Purchase and Sale Agreement, or the Purchase Agreement. The transaction consideration included $9.8 million in cash. In addition, Company Y stockholders are eligible to receive up to $2.6 million in consideration due to the acquired business satisfying certain personnel objectives by June 17, 2024.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company Y is headquartered in Bangalore, India and operates as a provider of engineering design services.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition Consideration</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of purchase price consideration to acquire Company Y (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.691%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of purchase consideration:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,424 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of contingent consideration is based on applying the Monte Carlo simulation method to forecast achievement under various contingent consideration events which may result in up to $2.6 million in payments due to the acquired business’s satisfying certain financial and personnel objectives by June 17, 2024 under the Purchase Agreement. Key inputs in the valuation include forecasted revenue, revenue volatility and discount rate. Underlying forecast mathematics were based on Geometric Brownian Motion in a risk-neutral framework and discounted back to the applicable period in which the accumulative thresholds were achieved at discount rates commensurate with the risk and expected payout term of the contingent consideration.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Purchase Price Allocation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final allocation of purchase price as of the January 17, 2023 acquisition closing date based upon an estimate of the fair value of the assets acquired and the liabilities assumed by the Company in the acquisition primarily includes $2.0 million in net operating liabilities, with $11.8 million in goodwill.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assumptions in the Allocations of Purchase Price</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management prepared the purchase price allocations for Company Y and in doing so considered or relied in part upon reports of a third party valuation expert to calculate the fair value of certain acquired assets, which primarily included an acquired workforce and contingent consideration. Certain stockholders that are employees of Company Y were not required to remain employed in order to receive the contingent consideration; accordingly, the fair value of the contingent consideration was accounted for as a portion of the purchase consideration.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimates of fair value require management to make significant estimates and assumptions. The goodwill recognized is attributable primarily to the acquired workforce. Certain liabilities included in the purchase price allocations are based on management’s best estimates of the amounts to be paid or settled and based on information available at the time the purchase price allocations were prepared. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Goodwill recorded in connection with Company Y was $11.8 million as of September 30, 2024. The Company does not expect to deduct any of the acquired goodwill for tax purposes.</span></div> 18300000 9800000 2600000 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of purchase price consideration to acquire Company Y (in thousands):</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.691%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of purchase consideration:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,824 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total purchase price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,424 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The fair value of contingent consideration is based on applying the Monte Carlo simulation method to forecast achievement under various contingent consideration events which may result in up to $2.6 million in payments due to the acquired business’s satisfying certain financial and personnel objectives by June 17, 2024 under the Purchase Agreement. Key inputs in the valuation include forecasted revenue, revenue volatility and discount rate. Underlying forecast mathematics were based on Geometric Brownian Motion in a risk-neutral framework and discounted back to the applicable period in which the accumulative thresholds were achieved at discount rates commensurate with the risk and expected payout term of the contingent consideration.</span></div> 9824000 2600000 12424000 2600000 2000000 11800000 11800000 0 Restructuring Activity<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company approves and implements restructuring plans as a result of internal resource alignment and cost saving measures. Such restructuring plans may include terminating employees, vacating certain leased facilities, and cancellation of contracts. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring costs in the nine months ended September 30, 2024 included costs pertaining to restructuring plans initiated in 2023 and 2024 as described below.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2024, the Company initiated a reduction of its workforce, or the 2024 Workforce Reduction. In the three and nine months ended September 30, 2024, the Company incurred $26.8 million in restructuring costs pertaining to the 2024 Workforce Reduction, which included $17.0 million in charges under contracts associated with cancelled projects and related impairment of assets, $9.1 million in severance costs and related expenses, and $0.7 million from exiting facilities. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, the Company entered into restructuring plans to reduce its workforce, or the 2023 Workforce Reductions. In the nine months ended September 30, 2024, the Company completed notification to remaining affected employees of the 2023 Workforce Reductions, and incurred $23.5 million in restructuring costs, including $19.8 million in severance and related costs, or a cumulative total of $43.3 million pertaining to the 2023 Workforce Reductions. Substantially all of the severance and related costs incurred in the nine months ended September 30, 2024 related to the 2023 Workforce Reductions pertained to statutory severance benefits in the jurisdictions in which the terminated employees were employed.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to incur additional restructuring costs associated with the 2023 Workforce Reductions and 2024 Workforce Reduction of approximately $3.0 million to $5.0 million, which is expected to pertain to severance due to statutory requirements in the jurisdictions in which the terminated employees were employed, as well as exiting facilities. The Company expects to complete notifications to employees regarding the 2024 Workforce Reduction and finalize its plans to exit facilities by the end of 2024. The estimate of costs that the Company expects to incur, and the timing thereof, are subject to a number of assumptions and actual results may differ. The Company may also incur other charges or cash expenditures not currently contemplated due to events that may occur as a result of, or associated with, the 2023 Workforce Reductions and 2024 Workforce Reduction. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All statements other than statements of historical facts contained in the paragraphs above are forward-looking statements including statements relating to the Company’s plans, expectations, forecasts and future events. Such forward-looking statements include, but are not limited to, the potential of, and expectations regarding the Company’s statements relating to the expected impacts, charges and costs associated with the 2023 Workforce Reductions and 2024 Workforce Reduction that the Company expects to incur.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the activity related to the restructuring plans, which is included in restructuring charges in the consolidated statements of operations:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee separation expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,863 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,045 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,793 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,828 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,323 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,138 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a roll-forward of the Company’s restructuring liability for the nine months ended September 30, 2024. The restructuring liability is included in accrued expenses and other current liabilities and other long-term liabilities in the consolidated balance sheets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Separation Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease Related Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability as of December 31, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,301 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,902 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,793 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,323 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(915)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,419)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,858)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,800 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,392 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,227 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion as of September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,775)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,610)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion as of September 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,617 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,617 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 26800000 26800000 17000000 17000000 9100000 9100000 700000 700000 23500000 19800000 43300000 3000000 5000000.0 <div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the activity related to the restructuring plans, which is included in restructuring charges in the consolidated statements of operations:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee separation expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,109 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,902 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,863 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,045 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,793 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,828 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,323 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,138 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 9109000 -13000 28902000 8863000 674000 0 3628000 42000 17045000 67000 17793000 233000 26828000 54000 50323000 9138000 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a roll-forward of the Company’s restructuring liability for the nine months ended September 30, 2024. The restructuring liability is included in accrued expenses and other current liabilities and other long-term liabilities in the consolidated balance sheets.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Employee Separation Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease Related Charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability as of December 31, 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,301 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,902 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,793 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,323 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,452)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(915)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash charges and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">967 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,419)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,858)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,800 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,392 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,227 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion as of September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,775)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,610)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion as of September 30, 2024</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,617 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,617 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 7383000 -2000 920000 8301000 28902000 3628000 17793000 50323000 30452000 172000 915000 31539000 967000 -3419000 -3406000 -5858000 6800000 35000 14392000 21227000 6800000 35000 8775000 15610000 0 0 5617000 5617000 Goodwill and Intangible Assets<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill arises from the acquisition method of accounting for business combinations and represents the excess of the purchase price over the fair value of the net assets and other identifiable intangible assets acquired. The fair values of net tangible assets and intangible assets acquired are based upon preliminary valuations and the Company’s estimates and assumptions are subject to change within the measurement period (potentially up to one year from the acquisition date). </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of goodwill for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (Note 3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,717 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,588 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,456 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs an annual goodwill impairment assessment on October 31st each year, using a quantitative assessment comparing the fair value of each reporting unit, which the Company has determined to be the entity itself, with its carrying amount, including goodwill. If the carrying amount of a reporting unit exceeds its fair value, an impairment loss is recorded. As a result of the Company’s impairment assessment, no goodwill impairment was recognized as of October 31, 2023.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to its annual review, the Company performs a test of impairment when indicators of impairment are present. During the nine months ended September 30, 2024 and 2023, there were no indications of impairment of the Company’s goodwill balances. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquired Intangibles</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finite-lived Intangible Assets</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which are amortized over their estimated useful lives:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Useful Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,857 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,685 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,702 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,818 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,626 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,383)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126,347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,780 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(967)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,780 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,498 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(425,467)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,031 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479,774 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406,144)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,630 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of net revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,581 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,774 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,336 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,234 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,323 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,664 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of finite-lived intangible assets in cost of net revenue in the consolidated statements of operations results primarily from acquired developed technology.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the activity related to finite-lived intangible assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,316 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,961 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,031 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,643 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly reviews the carrying amount of its long-lived assets subject to depreciation and amortization, as well as the related useful lives, to determine whether indicators of impairment may exist that warrant adjustments to carrying values or estimated useful lives. An impairment loss is recognized when the sum of the expected future undiscounted net cash flows is less than the carrying amount of the asset. Should impairment exist, the impairment loss is measured based on the excess of the carrying amount of the asset over the asset’s fair value. During each of the three and nine months ended September 30, 2024, impairment losses related to finite-lived intangible assets of $1.2 million were recognized. During the three and nine months ended September 30, 2023, impairment losses related to finite-lived intangible assets of $0 and $2.4 million were recognized, respectively. The impairment losses were attributable to abandonment of certain purchased licensed technology. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents future amortization of the Company’s finite-lived intangible assets at September 30, 2024:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.691%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (3 months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,992 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,619 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,968 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,031 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the carrying amount of goodwill for the periods indicated:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,588 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,739 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions (Note 3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,717 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,588 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,456 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 318588000 306739000 0 11717000 318588000 318456000 0 0 0 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company’s finite-lived intangible assets resulting from business acquisitions and other purchases, which are amortized over their estimated useful lives:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Useful Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licensed technology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,857 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,685 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,133 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,431)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,702 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,818 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,261 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(263,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,626 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trademarks and trade names</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,383)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,800 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,276)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">524 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,502)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,298 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,800 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126,347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,453 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,780 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(967)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,813 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,780 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,325 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,498 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(425,467)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,031 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479,774 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(406,144)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,630 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> P7Y 23857000 2172000 21685000 20133000 1431000 18702000 P6Y10M24D 311261000 280443000 30818000 311261000 263635000 47626000 P6Y2M12D 14800000 14383000 417000 14800000 14276000 524000 P5Y 128800000 127502000 1298000 128800000 126347000 2453000 P7Y 4780000 967000 3813000 4780000 455000 4325000 P6Y1M6D 483498000 425467000 58031000 479774000 406144000 73630000 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth amortization expense associated with finite-lived intangible assets, which is included in the consolidated statements of operations as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of net revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,745 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,581 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,372 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,774 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,336 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,234 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,323 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,664 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 3745000 8581000 17549000 27372000 0 0 0 2000 591000 653000 1774000 2290000 4336000 9234000 19323000 29664000 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the activity related to finite-lived intangible assets:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,630 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,316 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,961 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,198 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other disposals</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,664)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment losses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,031 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,643 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 73630000 109316000 4961000 6198000 0 769000 19323000 29664000 1237000 2438000 58031000 82643000 1200000 1200000 0 2400000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents future amortization of the Company’s finite-lived intangible assets at September 30, 2024:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.379%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.691%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (3 months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,992 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,619 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,916 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,437 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,099 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,968 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,031 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 3992000 14619000 13916000 10437000 5099000 9968000 58031000 Financial Instruments <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of financial instruments is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration (Note 3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company’s financial instruments is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants and is recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The levels are described below:</span></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.</span></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.</span></div><div style="margin-top:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs are used when little or no market data is available.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its financial instruments that are categorized within Level 1 or Level 2 of the fair value hierarchy on the basis of valuations using quoted market prices or alternate pricing sources and models utilizing market observable inputs, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration liability as of September 30, 2024 and December 31, 2023 is associated with the Company’s acquisition of Company Y in January 2023 (Note 3). The contingent consideration liability is classified as a Level 3 financial instrument. The contingent consideration as it relates to Company Y was subject to the acquired business’s satisfaction of certain personnel objectives by June 17, 2024. The fair value of contingent consideration is based on (1) applying the Monte Carlo simulation method, with underlying forecast mathematics based on Geometric Brownian motion in a risk-neutral framework, to forecast achievement of the acquired business’ financial objectives, if applicable, under various possible contingent consideration events and (2) a probability based methodology using management’s inputs and assumptions to forecast achievement of the acquired business’ personnel objectives which included an assumption of total payments up to $2.6 million to Company Y. Key inputs in the valuation include forecasted revenue, revenue volatility, discount rate and discount term as it relates to the financial objectives and probability of achievement, discount term and discount rate as it relates to the personnel objectives. </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at September 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at <br/>September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity in Level 3 financial instruments:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent consideration<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance<br/></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,941 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Note 3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,700)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance<br/></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,690 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These changes to the balance associated with the estimated fair value of contingent consideration for the nine months ended September 30, 2024 and 2023 were due to the addition of contingent consideration associated with the acquisition of Company Y in January 2023 and accretion of discounts on contingent consideration.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between Level 1, Level 2, or Level 3 fair value hierarchy categories of financial instruments. for the nine months ended September 30, 2024.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instruments Not Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company’s financial instruments are recorded at amounts that approximate fair value due to their liquid or short-term nature or by election on investments in privately-held entities as described below. Such financial assets and financial liabilities include: cash and cash equivalents, restricted cash, net receivables, investments in privately-held entities, certain other assets, accounts payable, accrued price protection liability, accrued expenses, accrued compensation costs, and other current liabilities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s long-term debt is not recorded at fair value on a recurring basis but is measured at fair value for disclosure purposes (Note 8). </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in other long-term assets as of December 31, 2023 were investments in a privately held entity of $11.8 million, which were impaired in the three months ended September 30, 2024. The Company does not have the ability to exercise significant influence or control over such entity and had accounted for the investments as financial instruments. Given that fair values for such investments were not readily determinable, the Company had elected to measure these investments at cost, less any impairment, and adjust the carrying value to fair value if any observable price changes for similar investments in the same entity are identified. The impairment loss of $11.8 million is included in other expense in the consolidated statement of operations for the three and nine months ended September 30, 2024.</span></div> <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of financial instruments is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.759%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration (Note 3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2600000 2462000 2600000 <div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at September 30, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at <br/>September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at December 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted Prices<br/>in Active<br/>Markets for<br/>Identical Assets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 2600000 0 0 2600000 2462000 0 0 2462000 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity in Level 3 financial instruments:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Contingent consideration<br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance<br/></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,941 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Note 3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,700)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accretion of discount</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance<br/></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,690 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These changes to the balance associated with the estimated fair value of contingent consideration for the nine months ended September 30, 2024 and 2023 were due to the addition of contingent consideration associated with the acquisition of Company Y in January 2023 and accretion of discounts on contingent consideration.</span></div> 2462000 2941000 0 2200000 0 2700000 138000 249000 2600000 2690000 11800000 11800000 11800000 Balance Sheet Details<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,476 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,288 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,492 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,356 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, cash and cash equivalents included money market funds of approximately $103.3 million and $78.1 million, respectively. As of September 30, 2024 and December 31, 2023, the Company had restricted cash of approximately $1.0 million and $1.1 million, respectively. The cash is restricted in connection with guarantees for certain import duties and office leases. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,909 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,154 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,063 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,908 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,944 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,641 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,732 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Masks and production equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,676 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,240 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,194 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,542 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,609 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,493 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,431 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the three months ended September 30, 2024 and 2023 was $5.8 million and $5.6 million, respectively. Depreciation expense for the nine months ended September 30, 2024 and 2023 was $17.0 million and $18.5 million, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the Company entered into a note receivable with a supplier for $10.0 million. In September 2023, the terms of this note receivable were renegotiated, and the first initial repayment of $1.5 million is due by March 31, 2025, and annual repayments of $1.7 million per year are due annually thereafter by March 31, from 2026 through 2030, provided that certain production utilization targets for the prior year are met. During the three months ended September 30, 2024, a portion of the note receivable, or $0.5 million, was written off to other expense in the consolidated statement of operations. The amount written off represents the portion of the payment associated with production utilization that is anticipated to be less than target. The balance of the note receivable has been classified as a long-term asset based on expected timing of receipt of repayment. The long-term portion of the note receivable is included in other long-term assets as of September 30, 2024 and December 31, 2023, respectively. Previously, repayments of $2.0 million per year were due annually by March 31, in years 2024 through 2027.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued price protection liability consists of the following activity:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,684 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,274 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged as a reduction of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,042 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversal of unclaimed rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,982)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,472 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,643 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in price protection liability from approximately $71.7 million as of December 31, 2023 to approximately $44.5 million as of September 30, 2024 was driven by payments of rebates as well as reversal of unclaimed rebates due to expiration of rebate pricing.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued technology license payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,627 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,843 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,736 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued engineering and production costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,461 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,861 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,610 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued royalty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued customer credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued obligations to customers for price adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued obligations to customers for stock rotation rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration - current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,197 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,468 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Defined Benefit Plan Obligation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,059)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,268 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,120)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,268 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,852)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,476 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,288 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,492 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,356 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,476 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,288 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,051 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term restricted cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149,492 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,356 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 148476000 187288000 993000 1051000 23000 17000 149492000 188356000 103300000 78100000 1000000.0 1100000 <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,909 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,368 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,154 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,540 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,063 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,908 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table> 54909000 60368000 41154000 39540000 96063000 99908000 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:49.998%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.714%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Useful Life<br/>(in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,944 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,995 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-5</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,641 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,732 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Masks and production equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,676 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,240 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,194 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,427 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-5</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">686 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,542 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,609 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(131,049)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(116,178)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,493 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,431 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> P5Y 3944000 3995000 P3Y P5Y 80641000 76732000 P5Y 62676000 54240000 P3Y 11194000 11427000 P1Y P5Y 35401000 35867000 686000 348000 194542000 182609000 131049000 116178000 63493000 66431000 5800000 5600000 17000000.0 18500000 10000000 1500000 1700000 500000 2000000 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued price protection liability consists of the following activity:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,684 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,274 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged as a reduction of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,042 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,092 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversal of unclaimed rebates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,272)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,982)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,723)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,472 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,643 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 71684000 113274000 42042000 50092000 15272000 0 53982000 91723000 44472000 71643000 71700000 44500000 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.735%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.737%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued technology license payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,627 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,843 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,196 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,736 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued engineering and production costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,461 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,861 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,610 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,301 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued royalty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,799 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,132 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued customer credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,705 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,984 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">521 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contract liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued obligations to customers for price adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,558 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,837 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued obligations to customers for stock rotation rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration - current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,462 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,486 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,197 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,468 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 3627000 3843000 4196000 3736000 5461000 2861000 15610000 8301000 403000 603000 9799000 9132000 3705000 3984000 421000 521000 164000 1597000 20558000 54837000 167000 349000 2600000 2462000 4486000 6242000 71197000 98468000 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Translation Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pension and Other Defined Benefit Plan Obligation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,059)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,268 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,791)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss before reclassifications, net of tax</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,120)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,268 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,852)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> -5059000 1268000 -3791000 -61000 0 -61000 -5120000 1268000 -3852000 Debt<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company’s long-term debt consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal balance:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Initial term loan under the June 23, 2021 credit agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(571)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Unamortized debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,683)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,840 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,375 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, non-current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,840 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,375 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, the weighted average effective interest rate on aggregate debt was approximately 7.9% and 7.6%, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September 30, 2024 and 2023, the Company recognized total amortization of debt discount and debt issuance costs of $0.2 million and $0.2 million, respectively, to interest expense. During the nine months ended September 30, 2024 and 2023, the Company recognized total amortization of debt discount and debt issuance costs of $0.5 million and $0.5 million.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The approximate aggregate fair value of the term loans outstanding as of September 30, 2024 and December 31, 2023</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was $115.7 million and $114.5 million, respectively, which was estimated on the basis of inputs that are observable in the market and which is considered a Level 2 measurement method in the fair value hierarchy (Note 6).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024, the outstanding principal balance of $125.0 million is due in full on June 23, 2028, upon maturity of the loan.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.409%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Term Loan and Revolving Facility under the June 23, 2021 Credit Agreement</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 23, 2021, the Company entered into a Credit Agreement, or the June 23, 2021 Credit Agreement, by and among the Company, the lenders from time to time party thereto, and Wells Fargo Bank, National Association, as administrative agent and collateral agent, that provides for a senior secured term B loan facility, or the “Initial Term Loan under the June 23, 2021 Credit Agreement,” in an aggregate principal amount of $350.0 million and a senior secured revolving credit facility, or the “Revolving Facility,” in an aggregate principal amount of up to $100.0 million. The proceeds of the Initial Term Loan under the June 23, 2021 Credit Agreement were used (i) to repay in full all outstanding indebtedness under that certain Credit Agreement dated May 12, 2017, by and among the Company, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MUFG Bank Ltd., as administrative agent and MUFG Union Bank, N.A., as collateral agent and the lenders from time to time party thereto (as amended by Amendment No. 1, dated July 31, 2020)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and (ii) to pay fees and expenses incurred in connection therewith. The remaining proceeds of the Initial Term Loan under the June 23, 2021 Credit Agreement are available for general corporate purposes and the proceeds of the Revolving Facility may be used to finance the working capital needs and other general corporate purposes of the Company and its subsidiaries. As of September 30, 2024, the Revolving Facility was undrawn. Under the terminated amended and restated commitment letter with Wells Fargo Bank and other lenders entered into in connection with the previously pending (now terminated) merger with Silicon Motion (Note 3), the Company had expected to repay the remaining outstanding term loans under this agreement upon closing of the merger.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The June 23, 2021 Credit Agreement permits the Company to request incremental loans in an aggregate principal amount not to exceed the sum of an amount equal to the greater of (x) $175.0 million and (y) 100% of consolidated EBITDA, plus the amount of certain voluntary prepayments, plus an unlimited amount that is subject to pro forma compliance with certain first lien net leverage ratio, secured net leverage ratio and total net leverage ratio tests. Incremental loans are subject to certain additional conditions, including obtaining additional commitments from the lenders then party to the June 23, 2021 Credit Agreement or new lenders.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the June 23, 2021 Credit Agreement, the Initial Term Loan bears interest, at the Company’s option, at a per annum rate equal to either (i) a base rate equal to the highest of (x) the federal funds rate, plus 0.50%, (y) the prime rate then in effect and (z) an adjusted Term SOFR rate determined on the basis of a one-month interest period plus 1.00%, in each case, plus an applicable margin of 1.25% or (ii) an adjusted Term SOFR rate, subject to a floor of 0.50%, plus an applicable margin of 2.25%. Loans under the Revolving Facility initially bear interest, at a per annum rate equal to either (i) a base rate (as calculated above) plus an applicable margin of 0.00%, or (ii) an adjusted Term SOFR rate (as calculated above) plus an applicable margin of 1.00%. Following delivery of financial statements for the Company’s fiscal quarter ending June 30, 2021, the applicable margin for loans under the Revolving Facility will range from 0.00% to 0.75% in the case of base rate loans and 1.00% to 1.75% in the case of Term SOFR rate loans, in each case, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. The Company is required to pay commitment fees ranging from 0.175% to 0.25% per annum on the daily undrawn commitments under the Revolving Facility, depending on the Company’s secured net leverage ratio as of the most recently ended fiscal quarter. Commencing on September 30, 2021, the Initial Term Loan under the June 23, 2021 Credit Agreement will amortize in equal quarterly installments equal to 0.25% of the original principal amount of the Initial Term Loan under the June 23, 2021 Credit Agreement, with the balance payable on the maturity date. The June 23, 2021 Credit Agreement was amended on June 29, 2023 to implement a benchmark replacement.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is required to make mandatory prepayments of the outstanding principal amount of term loans under the June 23, 2021 Credit Agreement with the net cash proceeds from the disposition of certain assets and the receipt of insurance </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proceeds upon certain casualty and condemnation events, in each case, to the extent not reinvested within a specified time period, from excess cash flow beyond stated threshold amounts, and from the incurrence of certain indebtedness. The Company has the right to prepay its term loans under the June 23, 2021 Credit Agreement, in whole or in part, at any time without premium or penalty, subject to certain limitations and a 1.0% soft call premium applicable during the first six months following the closing date of the June 23, 2021 Credit Agreement. The Initial Term Loan under the June 23, 2021 Credit Agreement will mature on June 23, 2028, at which time all outstanding principal and accrued and unpaid interest on the Initial Term Loan under the June 23, 2021 Credit Agreement must be repaid. The Revolving Facility will mature on June 23, 2026, at which time all outstanding principal and accrued and unpaid interest under the Revolving Facility must be repaid. The Company is also obligated to pay fees customary for a credit facility of this size and type.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s obligations under the June 23, 2021 Credit Agreement are required to be guaranteed by certain of its domestic subsidiaries meeting materiality thresholds set forth in the June 23, 2021 Credit Agreement. Such obligations, including the guaranties, are secured by substantially all of the assets of the Company and the subsidiary guarantors pursuant to a Security Agreement, dated as of June 23, 2021, by and among the Company, the subsidiary guarantors from time to time party thereto, and Wells Fargo Bank, National Association, as collateral agent. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The June 23, 2021 Credit Agreement contains customary affirmative and negative covenants, including covenants limiting the ability of the Company and its restricted subsidiaries to, among other things, incur debt, grant liens, undergo certain fundamental changes, make investments, make certain restricted payments, and sell assets, in each case, subject to limitations and exceptions set forth in the June 23, 2021 Credit Agreement. The Revolving Facility also prohibits the Company from having a secured net leverage ratio in excess of 3.50:1.00 (subject to a temporary increase to 3.75:1.00 following the consummation of certain material permitted acquisitions) as of the last day of any fiscal quarter of the Company (commencing with the fiscal quarter ending September 30, 2021) if the aggregate borrowings under the Revolving Facility exceed 1% of the aggregate commitments thereunder (subject to certain exceptions set forth in the June 23, 2021 Credit Agreement) as of such date. As of September 30, 2024, the Company was in compliance with such covenants. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 23, 2021 Credit Agreement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> also contains customary events of default that include, among other things, certain payment defaults, cross defaults to other indebtedness, covenant defaults, change in control defaults, judgment defaults, and bankruptcy and insolvency defaults. If an event of default exists, the lenders may require immediate payment of all obligations under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 23, 2021 Credit Agreement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and may exercise certain other rights and remedies provided for under the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> June 23, 2021 Credit Agreement</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the other loan documents and applicable law.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt is carried at its principal amount, net of unamortized debt discount and issuance costs, and is not adjusted to fair value each period. The issuance date fair value of the liability component of the debt in the amount of $350.2 million was determined using a discounted cash flow analysis, in which the projected interest and principal payments were discounted back to the issuance date of the term loan at a market interest rate for nonconvertible debt of 3.4%, which represents a Level 2 fair value measurement. The debt discount of $0.9 million and debt issuance costs of $2.9 million associated with the Initial Term Loan under the June 23, 2021 Credit Agreement are being amortized to interest expense using the effective interest method over its seven-year term. Debt issuance costs of $0.4 million associated with the Revolving Facility are being amortized to interest expense over its five-year term.</span></div> <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company’s long-term debt consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.692%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal balance:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Initial term loan under the June 23, 2021 credit agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal balance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Unamortized debt discount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(571)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     Unamortized debt issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,683)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying amount of long-term debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,840 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,375 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, non-current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,840 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,375 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div> 125000000 125000000 125000000 125000000 477000 571000 1683000 2054000 122840000 122375000 0 0 122840000 122375000 0.079 0.076 200000 200000 500000 500000 115700000 114500000 125000000.0 350000000.0 100000000 175000000 1 0.0050 P1M 0.0100 0.0125 0.0050 0.0225 0.0000 0.0100 0.0000 0.0075 0.0100 0.0175 0.00175 0.0025 0.0025 0.010 P6M 3.50 3.75 0.01 350200000 0.034 900000 2900000 P7Y 400000 P5Y Stock-Based Compensation<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock-Based Compensation Plans</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2024, the Company had stock-based compensation awards outstanding under the following plans: the 2010 Equity Incentive Plan, as amended, or 2010 Plan, and the 2010 Employee Stock Purchase Plan, or ESPP, and the 2024 Inducement Equity Incentive Plan, or the Inducement Plan. Refer to the Company’s Annual Report for a summary of the 2010 Plan and the ESPP.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 22, 2024, the Board of Directors adopted the Inducement Plan pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules, and, subject to the adjustment provisions of the Inducement Plan, reserved 4,000,000 shares of the Company's common stock for issuance under equity awards granted under the Inducement Plan. The Inducement Plan provides for the grant of equity-based awards, including non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares, and its terms are substantially similar to the 2010 Plan, including with respect to treatment of equity awards in the event of a merger or “change in control” as defined under the Inducement Plan, but with such other terms and conditions intended to comply with the Nasdaq inducement award exception. Awards under the Inducement Plan may only be made to individuals not previously employees or non-employee directors of the Company as an inducement material to the individuals’ entry into employment with the Company.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024, the number of shares of common stock available for future issuance under the 2010 Plan was 15,417,601 shares. As of September 30, 2024, the number of shares of common stock available for future issuance under the ESPP was 6,451,538 shares. As of September 30, 2024, the number of shares of common stock available for future issuance under the Inducement Plan was 4,000,000 shares.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Incentive Bonus</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s Executive Incentive Bonus Plan permits the settlement of awards under the plan in any combination of cash or shares of its common stock. The Company settles a majority of bonus awards for its employees, including executives, in shares of common stock under the 2010 Equity Incentive Plan. When bonus awards are settled in common stock issued under the 2010 Equity Incentive Plan, the number of shares issuable to plan participants is determined based on the closing price of the Company’s common stock as determined in trading on the applicable stock exchange, on a date approved by the Board of Directors. In connection with the Company’s bonus programs, in February 2024, the Company issued 0.4 million freely-tradable (subject to certain restrictions for affiliates) shares of the Company’s common stock in settlement of bonus awards to employees, including executives, for the 2023 performance period. At September 30, 2024, the Company has an accrual of $3.5 million for bonus awards for employees for year-to-date achievement in the 2024 performance period, which the Company intends to settle primarily in shares of its common stock, unless otherwise required to be settled in cash due to local laws or agreements. The Company’s compensation committee retains discretion to effect payment in cash, stock, or a combination of cash and stock.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation in the consolidated statements of operations, based on the department to which the related employee reports, as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of net revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,423 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,952 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,128 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,284 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,009 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,788 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,118 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,208 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,763 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total unrecognized compensation cost related to unvested restricted stock units as of September 30, 2024 was $112.0 million, and the weighted average period over which these equity awards are expected to vest is 2.39 years. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total unrecognized compensation cost related to unvested performance-based restricted stock units as of September 30, 2024 was $1.4 million, and the weighted average period over which these equity awards are expected to vest is 1.40 years. Actual levels of future performance for the unvested periods may differ from current estimates. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total unrecognized compensation cost related to unvested stock options as of September 30, 2024 was $28.0 million, and the weighted average period over which these equity awards are expected to vest is 3.39 years.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s restricted stock unit activity for all equity plans is as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.241%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant-Date Fair Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Canceled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,109 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes approximately 227 thousand shares granted under the Inducement Plan at a weighted-average grant-date fair value per share of $13.64.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes approximately 24 thousand shares canceled under the Inducement Plan at a weighted-average grant-date fair value per share of $12.46.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based Restricted Stock Units</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance-based restricted stock units are eligible to vest at the end of each year-long performance period, as defined in the underlying agreement, in a three-year performance period based on the Company’s annual growth rate in net sales and non-GAAP diluted earnings per share (subject to certain adjustments) over baseline results relative to the growth rates for a peer group of companies for the same metrics and periods. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the performance-based restricted stock units granted to date, 60% of each performance-based award is subject to the net sales metric for the performance period and 40% is subject to the non-GAAP diluted earnings per share metric for the performance period. The maximum percentage for a particular metric is 250% of the target number of units subject to the award related to that metric, however, vesting of the performance stock units is capped at 30% and 100%, respectively, of the target number of units subject to the award in years one and two, respectively, of the three-year performance period. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024, achievement to date under the performance metrics specified in the respective award agreements are based on its expected revenue and non-GAAP diluted EPS results over the performance periods and calculated growth rates relative to its peers’ expected results based on data available, as defined in the respective award agreements. To the extent any prior achievement levels are no longer probable, any compensation expense recorded is adjusted to the revised achievement levels.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s performance-based restricted stock unit activity is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant-Date Fair Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.38 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,402 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Number of shares granted is based on the maximum percentage achievable in the performance-based restricted stock unit award.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Rights and Stock Options</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Stock Purchase Rights</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2024 and 2023, there were 175,764 and 140,631 shares of common stock purchased under the ESPP at a weighted average price of $15.26 and $21.25, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.78 - $6.35</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.56 - $11.97</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40% - 5.41%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.54% - 5.24%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.76% - 70.46%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.73% - 59.78%</span></div></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free interest rate assumption was based on rates for United States (U.S.) Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The assumed dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. The expected term is the duration of the offering period for each grant date. In addition, the estimated volatility incorporates the historical volatility over the expected term based on the Company’s daily closing stock prices.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock options activity is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Contractual Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,023 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.45</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of stock options were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.84 - $11.24</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) No options were granted during the nine months ended September 30, 2023.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free interest rate assumption was based on the United States Treasury’s rates for U.S. Treasury zero-coupon bonds with maturities similar to those of the expected term of the award being valued. The assumed dividend yield was based on the Company’s expectation of not paying dividends in the foreseeable future. The expected term of the options was calculated using the simplified method as prescribed by guidance provided by the SEC. This decision was based on the lack of historical data due to the Company’s limited number of stock option exercises under the 2010 Equity Incentive Plan. Estimated volatility incorporates historical volatility of the Company over the expected term based on the Company's daily closing stock prices.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value of stock options exercised was $0 and $47.0 thousand in the three months ended September 30, 2024 and 2023, respectively. The intrinsic value of stock options exercised was $0.5 million and $0.2 million in the nine months ended September 30, 2024 and 2023, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash received from exercise of stock options was negligible during the three and nine months ended September 30, 2024. Cash received from exercise of stock options was $0.1 million and $0.2 million during the three and nine months ended September 30, 2023, respectively. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax benefit from stock options exercised was $0 and $0.1 million during the three months ended September 30, 2024 and 2023, respectively. The tax benefit from stock options exercised was $0.8 million and $0.4 million during the nine months ended September 30, 2024 and 2023, respectively.</span></div> 4000000 15417601 6451538 4000000 400000 3500000 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation in the consolidated statements of operations, based on the department to which the related employee reports, as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of net revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,423 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,436 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,952 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,128 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,284 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,820 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,009 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,788 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,118 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,208 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,763 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 81000 170000 436000 626000 7423000 9436000 27952000 33128000 5284000 -4488000 18820000 5009000 12788000 5118000 47208000 38763000 112000000.0 P2Y4M20D 1400000 P1Y4M24D 28000000.0 P3Y4M20D <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s restricted stock unit activity for all equity plans is as follows:</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.241%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant-Date Fair Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,945 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Canceled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,007)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,109 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________<br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes approximately 227 thousand shares granted under the Inducement Plan at a weighted-average grant-date fair value per share of $13.64.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes approximately 24 thousand shares canceled under the Inducement Plan at a weighted-average grant-date fair value per share of $12.46.</span></div> 5632000 36.72 2945000 18.24 2461000 29.44 1007000 38.32 5109000 29.25 227000 13.64 24000 12.46 P3Y 0.60 0.40 2.50 0.30 1 P3Y <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s performance-based restricted stock unit activity is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant-Date Fair Value per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,653 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.38 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.78 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.43 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,402 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Number of shares granted is based on the maximum percentage achievable in the performance-based restricted stock unit award.</span></div> 2653000 34.38 1472000 17.78 58000 24.43 665000 41.74 3402000 25.93 175764 140631 15.26 21.25 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of employee stock purchase rights were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.78 - $6.35</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.56 - $11.97</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40% - 5.41%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.54% - 5.24%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.76% - 70.46%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.73% - 59.78%</span></div></td></tr></table></div> 5.78 6.35 7.56 11.97 0.0540 0.0541 0.0454 0.0524 0 0 P0Y6M P0Y6M 0.4976 0.7046 0.5173 0.5978 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the Company’s stock options activity is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options<br/>(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Contractual Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.29 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.45 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.68 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.75 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,023 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.45</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest at September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,807 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.38</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.40 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 375000 17.29 2688000 19.45 39000 7.68 1000 23.75 3023000 19.33 P8Y5M12D 0 2807000 19.32 P8Y4M17D 0 335000 18.40 P0Y10M9D 0 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of stock options were estimated using the Black-Scholes option pricing model at their respective grant date using the following assumptions:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.297%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023(1)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average grant date fair value per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.84 - $11.24</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) No options were granted during the nine months ended September 30, 2023.</span></div> 10.84 11.24 0.0433 0 P6Y6M 0.5750 0 47000.0 500000 200000 100000 200000 0 100000 800000 400000 Income Taxes<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes primarily relates to projected federal, state, and foreign income taxes. To determine the quarterly provision for income taxes, the Company uses an estimated annual effective tax rate, which is generally based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates. In addition, the tax effects of certain significant or unusual items are recognized discretely in the quarter during which they occur and can be a source of variability in the effective tax rates from quarter to quarter.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company utilizes the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on temporary differences between the financial statement and tax basis of assets and liabilities using tax rates expected to be in effect during the years in which the temporary differences reverse. The Company records a valuation allowance to reduce its deferred taxes to the amount it believes is more likely than not to be realized. In making such determination, the Company considers all available positive and negative evidence quarterly, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies, and recent financial performance. Forming a conclusion that a valuation allowance is not required is difficult when there is negative evidence such as cumulative losses in recent years. Based upon the Company’s review of all positive and negative evidence, the Company continues to have a valuation allowance on its state deferred tax assets, certain of its federal deferred tax assets, and certain foreign deferred tax assets in jurisdictions where the Company has cumulative losses or otherwise is not expected to utilize certain tax attributes. The Company does not incur expense or benefit in certain tax-free jurisdictions in which it operates. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an income tax benefit of $6.7 million in the three months ended September 30, 2024 and an income tax benefit of $1.7 million in the three months ended September 30, 2023. The Company recorded an income tax benefit of $10.5 million in the nine months ended September 30, 2024 and an income tax provision of $13.5 million in the nine months ended September 30, 2023.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the Company’s effective tax rate and the 21.0% United States federal statutory rate for the nine months ended September 30, 2024 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items, and stock based compensation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the Company’s effective tax rate and the 21.0% U.S. federal statutory rate for the nine months ended September 30, 2023 primarily related to the mix of pre-tax income among jurisdictions, permanent tax items including the tax on global intangible low-taxed income, stock based compensation, excess tax benefits related to stock-based compensation, and the release of uncertain tax positions under ASC 740-10. The permanent tax item related to global intangible low-taxed income also reflected the then recent legislative changes requiring the capitalization of research and experimentation costs, as well as limitations on the creditability of certain foreign income taxes.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax positions must meet a more-likely-than-not threshold to be recognized. Income tax positions that previously failed to meet the more-likely-than-not threshold are recognized in the first subsequent financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not threshold are de-recognized in the first financial reporting period in which that threshold is no longer met. The Company records potential penalties and interest accrued related to unrecognized tax benefits within the consolidated statements of operations as income tax expense. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30, 2024, the Company’s unrecognized tax benefits increased by $0.2 million. The Company does not expect its unrecognized tax benefits to change significantly over the next 12 months. Accrued interest and penalties associated with uncertain tax positions as of September 30, 2024 were approximately $0.1 million and $4 thousand, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to federal and state income tax in the United States and is also subject to income tax in certain other foreign tax jurisdictions. At September 30, 2024, the statutes of limitations for the assessment of federal, state, and foreign income taxes are closed for the years before 2020, 2019, and 2017, respectively. </span></div>The Company’s subsidiary in Singapore operates under certain tax incentives in Singapore, which are generally effective through March 2027, and are conditional upon meeting certain employment and investment thresholds in Singapore. Under the incentives, qualifying income derived from certain sales of the Company’s integrated circuits is taxed at a concessionary rate over the incentive period, and there are reduced Singapore withholding taxes on certain intercompany royalties during the incentive period. The Company recorded a tax benefit in the nine months ended September 30, 2024 and 2023 at the incentive rate. -6700000 -1700000 -10500000 13500000 200000 100000 4000 Concentration of Credit Risk, Significant Customers and Geographic Information<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents and accounts receivable. Collateral is generally not required for customer receivables. The Company limits its exposure to credit loss by placing its cash with high credit quality financial institutions. At times, such deposits may be in excess of insured limits. The Company has not experienced any losses on its deposits of cash and cash equivalents.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Customers</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company markets its products and services to manufacturers of a wide range of electronic devices (Note 1). The Company sells its products both directly to end-customers and through third-party distributors, both of which are referred to as the Company’s customers (Note 12). Revenue is also generated from sales of intellectual property, and the recipients of such intellectual property are also referred to as the Company’s customers. The Company makes periodic evaluations of the credit worthiness of its customers. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One customer comprised 10% or greater of net revenues for each of the periods presented, </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total net revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents balances that are 10% or greater of accounts receivable, based on the Company’s billings to its customers.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of gross accounts receivable</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Suppliers</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Suppliers comprising greater than 10% or greater of total inventory purchases are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor A</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor B</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor C</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor D</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*    Represents less than 10% of total inventory purchases for the period presented.</span></div><div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Information</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s consolidated net revenues by geographic area based on ship-to location are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total net revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total net revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total net revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total net revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,293 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,647 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,555 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,478 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,886 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,034 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,058 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,955 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,847 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,527 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,530 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,361 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567,910 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products shipped to individual countries or territories representing greater than 10% of net revenue for each of the periods presented are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total net revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan, ROC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*    Represents less than 10% of total net revenue for the respective period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of which country a particular sale is allocated to is based on the destination of the product shipment. No other individual country accounted for more than 10% of net revenue during these periods. Although a large percentage of the Company’s products is shipped to Asia, and in particular, Hong Kong and Thailand, the Company believes that a significant number of the systems designed by customers and incorporating the Company’s semiconductor products are subsequently sold outside Asia to Europe, Middle East, and Africa markets and North American markets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, which consists of property and equipment, net, leased right-of-use assets, intangible assets, net, and goodwill by geographic area are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.483%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,442 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,696 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,444 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,969 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,661 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489,913 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One customer comprised 10% or greater of net revenues for each of the periods presented, </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total net revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents balances that are 10% or greater of accounts receivable, based on the Company’s billings to its customers.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of gross accounts receivable</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Suppliers</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Suppliers comprising greater than 10% or greater of total inventory purchases are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor A</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor B</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor C</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor D</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*    Represents less than 10% of total inventory purchases for the period presented.</span></div> 0.25 0.11 0.13 0.11 0.12 0.33 0.18 0.24 0.27 0.28 0.18 0.21 0.26 0.17 0.35 0.24 0.12 0.14 0.11 0.10 0.10 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s consolidated net revenues by geographic area based on ship-to location are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.681%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total net revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total net revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total net revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total net revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,293 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,647 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,555 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">419,478 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,208 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,886 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,034 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,058 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,955 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,757 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,586 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,847 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,186 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,527 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,530 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,361 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567,910 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products shipped to individual countries or territories representing greater than 10% of net revenue for each of the periods presented are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of total net revenue</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hong Kong</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taiwan, ROC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thailand</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*    Represents less than 10% of total net revenue for the respective period.</span></div> 65293000 0.80 98647000 0.73 193555000 0.72 419478000 0.74 10208000 0.13 24886000 0.18 29034000 0.11 110058000 0.19 3955000 0.05 8757000 0.06 41586000 0.15 29847000 0.05 1646000 0.02 3240000 0.02 4186000 0.02 8527000 0.02 81102000 1 135530000 1 268361000 1 567910000 1 0.49 0.41 0.37 0.34 0.12 0.10 0.11 <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets, which consists of property and equipment, net, leased right-of-use assets, intangible assets, net, and goodwill by geographic area are as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.476%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.483%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326,442 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337,696 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Singapore</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,444 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,248 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,775 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,969 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,661 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489,913 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div> 326442000 0.71 337696000 0.69 106444000 0.23 113248000 0.23 29775000 0.06 38969000 0.08 462661000 1 489913000 1 Revenue from Contracts with Customers<div style="margin-top:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Market</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents disaggregated net revenues by market (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadband</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,275 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,416 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connectivity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,726 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,700 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infrastructure</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,046 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,985 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,436 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial and multi-market</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,068 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,530 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,361 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567,910 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales through the Company’s distributors accounted for 35% and 46% of net revenue for the three months ended September 30, 2024 and 2023, respectively. Revenues from sales through the Company’s distributors accounted for 42% and 47% of net revenue for the nine months ended September 30, 2024 and 2023, respectively. Revenue related to the sales of intellectual property recognized during the nine months ended September 30, 2024 has been allocated by market based upon the usage of such intellectual property.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Liabilities</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, customer contract liabilities were approximately $0.2 million and $1.6 million, respectively, and consisted primarily of advanced payments received for which performance obligations have not been completed. Revenue recognized in each of the nine months ended September 30, 2024 and 2023 that was included in the contract liability balance as of the beginning of each of those respective periods was immaterial.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material changes in the contract liabilities balance during the nine months ended September 30, 2024 and 2023. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obligations to Customers for Price Adjustments and Returns and Assets for Right-of-Returns</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, obligations to customers consisting of estimates of price protection rights offered to the Company’s end customers totaled $44.5 million and $71.7 million, respectively, and are included in accrued price protection liability in the consolidated balance sheets. For activity in this account, including amounts included in net revenue, refer to Note 7. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other obligations to customers representing estimates of price adjustments to be claimed by distributors upon sell-through of their inventory to their end customer and estimates of stock rotation returns to be claimed by distributors on products sold as of September 30, 2024 were $20.6 million and $0.2 million, respectively, and as of December 31, 2023 were $54.8 million and $0.3 million, respectively, and are included in accrued expenses and other current liabilities in the consolidated balance sheets (Note 7). The reason for the significant decrease in accrued obligations to customers for price adjustments from approximately $54.8 million as of December 31, 2023 to approximately $20.6 million as of September 30, 2024, was due to a significant decrease in sales to distributors which decreased the corresponding accrued obligations to such customers. The increase or decrease in revenue for the three and nine months ended September 30, 2024 and 2023 from net changes in transaction prices for amounts included in obligations to customers for price adjustments and estimates of stock rotation returns to be claimed by distributors as of the beginning of those respective periods was not material. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, right of return assets under customer contracts representing the estimates of product inventory the Company expects to receive from customers in stock rotation returns were approximately $58 thousand and $0.1 million, respectively. Right of return assets are included in inventory in the consolidated balance sheets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024 and December 31, 2023, there were no impairment losses recorded on customer accounts receivable.</span></div> <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents disaggregated net revenues by market (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broadband</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,275 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,416 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,157 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,646 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connectivity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,726 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,700 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,232 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Infrastructure</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,046 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,985 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,436 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,549 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial and multi-market</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,055 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,104 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,068 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,483 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% of net revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,102 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,530 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,361 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567,910 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 32275000 34416000 87157000 169646000 0.40 0.25 0.32 0.30 12726000 15025000 35700000 119232000 0.16 0.11 0.13 0.21 23046000 49985000 87436000 145549000 0.28 0.37 0.33 0.26 13055000 36104000 58068000 133483000 0.16 0.27 0.22 0.23 81102000 135530000 268361000 567910000 0.35 0.46 0.42 0.47 200000 1600000 44500000 71700000 20600000 200000 54800000 300000 54800000 20600000 58000 100000 0 0 Leases<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease arrangements primarily consist of office leases expiring in various years through 2029. These leases have original terms of approximately 2 to 8 years and some contain options to extend the lease up to 5 years or terminate the lease, which are included in right-of-use assets and lease liabilities when the Company is reasonably certain it will renew the underlying leases. Since the implicit rate of such leases is unknown and the Company is not reasonably certain to renew its leases, the Company has elected to apply a collateralized incremental borrowing rate to facility leases on the original lease term in calculating the present value of future lease payments. As of September 30, 2024 and December 31, 2023, the weighted average discount rate for operating leases was 4.9% and 4.6%, respectively, and the weighted average remaining lease term for operating leases was 3.4 years and 3.9 years, respectively, as of the end of each of these periods.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents aggregate future minimum payments due under leases, reconciled to total lease liabilities included in the consolidated balance sheet as of September 30, 2024:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (3 months)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,864 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,791 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,031 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,140 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,906)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unrealized translation loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,232 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: short-term lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,799)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,433 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost was $2.4 million and $2.7 million for the three months ended September 30, 2024 and 2023, respectively. Operating lease cost was $7.5 million and $8.0 million for the nine months ended September 30, 2024 and 2023, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease costs for the nine months ended September 30, 2024 and 2023 were not material. </span></div>There were $0 and $0 of right-of-use assets obtained in exchange for new lease liabilities for the three months ended September 30, 2024 and 2023, respectively. There were $1.2 million and $12.2 million of right-of-use assets obtained in exchange for new lease liabilities for the nine months ended September 30, 2024 and 2023, respectively. P2Y P8Y P5Y 0.049 0.046 P3Y4M24D P3Y10M24D <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents aggregate future minimum payments due under leases, reconciled to total lease liabilities included in the consolidated balance sheet as of September 30, 2024:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.595%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (3 months)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,864 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,791 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,391 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,031 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,140 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,906)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unrealized translation loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,232 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: short-term lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,799)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,433 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 2864000 10791000 8391000 6031000 2467000 1596000 32140000 2906000 2000 29232000 9799000 19433000 2400000 2700000 7500000 8000000.0 0 0 1200000 12200000 Employee Retirement Plans<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plan</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a 401(k) defined contribution retirement plan (the 401(k) Plan) covering all eligible employees. Participants may voluntarily contribute on a pre-tax basis an amount not to exceed a maximum contribution amount pursuant to Section 401(k) of the Internal Revenue Code. The Company is not required to contribute, nor has it contributed, to the 401(k) Plan for any of the periods presented.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pension and Other Defined Benefit Retirement Obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains defined benefit retirement plans, including a pension plan, in certain foreign jurisdictions. As of September 30, 2024, the net defined benefit obligation, primarily related to other defined benefit plans, was $0.4 million. As of December 31, 2023, the net defined benefit obligation was $1.4 million. The benefit is based on a formula applied to eligible employee earnings. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net periodic benefit costs were $45 thousand and $0.1 million for the three months ended September 30, 2024 and 2023, respectively, and were recorded to research and development expenses in the consolidated statements of operations. Net periodic benefit costs were $0.2 million and $0.2 million for the nine months ended September 30, 2024 and 2023, respectively, and were recorded to research and development expenses in the consolidated statements of operations.</span></div> 400000 1400000 45000 100000 200000 200000 Commitments and Contingencies<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory Purchase and Other Contractual Obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024, future minimum payments under inventory purchase and other obligations are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.126%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inventory Purchase Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (3 months)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,708 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,712 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,419 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,423 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,994 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,417 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other obligations consist primarily of contractual payments due for software licenses. </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Jointly Funded Research and Development</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into contracts for jointly funded research and development projects to develop technology that may be commercialized into a product in the future and receives payments as milestones under the contracts are met. If the Company is required to repay all or a portion of the funds provided by the other parties under certain conditions, the Company defers such funds in other-long term liabilities. As of September 30, 2024, funds of $15.0 million received from the other parties have been deferred in other long-term liabilities. The Company de-recognizes the liabilities when the contingencies associated with the repayment conditions have been resolved. During the three and nine months ended September 30, 2024 and 2023, the Company did not recognize income from any previously deferred amounts from other parties upon resolution of such repayment conditions.</span></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispute with Silicon Motion</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As previously disclosed, on July 26, 2023, MaxLinear terminated the Merger Agreement on multiple grounds (Note 3). On August 16, 2023, Silicon Motion delivered to MaxLinear a notice, which Silicon Motion publicly disclosed, that it was purporting to terminate the Merger Agreement and that Silicon Motion would be commencing an arbitration before the Singapore International Arbitration Centre to seek damages from MaxLinear arising from MaxLinear’s alleged breaches of the Merger Agreement. Silicon Motion’s position is that MaxLinear’s Willful and Material Breaches (as such term is defined in the Merger Agreement) of the Merger Agreement prevented the Merger from being completed by August 7, 2023, and that MaxLinear is consequently liable for substantial monetary damages in excess of the termination fee as provided in the Merger Agreement.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On October 5, 2023, Silicon Motion filed a Notice of Arbitration with the Singapore International Arbitration Centre alleging that MaxLinear breached the Merger Agreement. Silicon Motion seeks payment of the termination fee, additional damages, fees, and costs. The arbitration will be confidential.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">MaxLinear believes that it properly terminated the Merger Agreement. MaxLinear remains confident in its decision and will vigorously defend its right to terminate the Silicon Motion transaction without penalty.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Silicon Motion Stockholder Litigation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">MaxLinear and certain of its officers have been named as defendants in two lawsuits brought by stockholders of Silicon Motion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On August 31, 2023, a Silicon Motion stockholder filed a putative class action complaint in the United States District Court for the Southern District of California captioned Water Island Event-Driven Fund v. MaxLinear, Inc., No. 23-cv-01607 (S.D. Cal.), against MaxLinear and certain of its current officers, alleging two claims: (1) an alleged violation of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder; and (2) an alleged violation of Section 20(a) of the Exchange Act. On December 20, 2023, the court appointed the lead plaintiffs, who filed the Consolidated Complaint on February 15, 2024. The Consolidated Complaint alleged that the defendants made false and misleading statements and/or omitted material facts that MaxLinear had a duty to disclose, concerning the Company’s intention to close the merger with Silicon Motion. On August 28, 2024, the court granted the defendants a motion to dismiss, holding that the plaintiffs lacked standing to sue MaxLinear and its officers. The case was dismissed without prejudice.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On September 18, 2024, the plaintiffs filed an Amended Consolidated Complaint (the "Amended Complaint"). The Amended Complaint includes the same two claims as alleged in the Consolidated Complaint and makes similar factual allegations against the MaxLinear defendants, but adds Silicon Motion and certain of its officers as additional defendants. The Amended Complaint seeks compensatory damages, including interest, costs and expenses and such other relief that the court deems appropriate. MaxLinear intends to continue to vigorously defend its position.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On June 13, 2024, HBK Master Fund L.P. and HBK Merger Strategies Master Fund L.P., stockholders of Silicon Motion, filed an additional complaint in the United States District Court for the Southern District of California captioned HBK Master Fund L.P. v. MaxLinear, Inc., No. 24-cv-01033 (S.D. Cal.), against MaxLinear and certain of its current officers, which also alleges violations of Section 10(b) of the Exchange Act and Rule 10b-5 promulgated thereunder, and Section 20(a) of the Exchange Act, and other violations. The complaint alleges that the defendants concealed their intention to terminate the merger with Silicon Motion from Silicon Motion’s shareholders. The complaint seeks compensatory damages, including interest, costs and expenses, punitive damages, and such other equitable or injunctive relief that the court deems appropriate. On July 12, 2024, the defendants filed a motion to dismiss this complaint, which is pending. MaxLinear intends to continue to vigorously defend its position.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Comcast Litigation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 1, 2023, MaxLinear filed claims against Comcast Management, LLC and Comcast Cable Communications, LLC, or together, Comcast, in the United States District Court for the Southern District of New York. MaxLinear alleges that in 2020, MaxLinear shared its proprietary design and know-how for a full-duplex, or FDX, amplifier with Comcast in the hope of securing future business with Comcast. MaxLinear shared its design and know-how on several occasions, all pursuant to a non-disclosure agreement between MaxLinear and Comcast, with the expectation that Comcast would keep the information confidential. MaxLinear alleges that Comcast needed this technology in order to effectively compete with fiber-optic internet providers. Instead of engaging MaxLinear to develop the FDX amplifier, Comcast allegedly shared MaxLinear’s proprietary designs with MaxLinear’s direct competitor. Comcast allegedly then worked with MaxLinear’s competitor to develop the FDX-amplifier technology. MaxLinear brought claims for trade secret misappropriation, unfair competition, and breach of the parties’ non-disclosure agreement, and it sought an unspecified amount of compensatory damages, punitive damages, pre-judgment and post-judgment interest, costs, expenses, and attorney fees as well as an injunction against Comcast’s use or disclosure of MaxLinear’s trade secrets.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 19, 2024, Comcast amended its claims for declaratory judgments, indemnification, and breach of the implied covenant of good faith and fair dealing, and on April 3, 2024, MaxLinear moved to dismiss all claims against it. On September 19, 2024, the court granted the motion to dismiss with respect to certain claims for declaratory judgment claim and denied the motion to dismiss with respect to the remaining claims. On September 23, 2024, Comcast filed amended claims for declaratory judgment, indemnification, and breach of the implied covenant of good faith and fair dealing, and on October 14, 2024, MaxLinear amended and refiled its trade secret and related claims. MaxLinear intends to continue to vigorously defend its position.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Dish Litigation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 10, 2023, Entropic Communications, LLC, or Entropic, filed claims for patent infringement against Dish Network Corporation, Dish Network LLC, Dish Network Service, LLC, and Dish Network California Service Corporation in the United States District Court for the Central District of California. At that time, MaxLinear was not a party to the action. On September 21, 2023, Dish Network California Service Corporation, or Dish California, filed four counterclaims against </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">MaxLinear. The four claims are declaratory judgment, breach of contract, fraud and negligent misrepresentation, and civil conspiracy.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 31, 2024, the Dish defendants, together with DISH Technologies L.L.C., or collectively, Dish, filed eight counterclaims (amended counterclaims for Dish California) against MaxLinear. The eight counterclaims are (1) breach of contract, (2) fraud and negligent misrepresentation, (3) fraud arising from a civil conspiracy, (4) quasi-contract for restitution/unjust enrichment, (5) combination in restraint of trade, (6) violation of the Cartwright Act (by Dish California only), (7) patent misuse, and (8) violation of Cal. Bus. &amp; Prof. Code § 17200 et seq. Dish’s eight counterclaims revolve around a core allegation that MaxLinear is a member of the Multimedia over Coax Alliance (MoCA) and that MaxLinear violated its obligation under MoCA’s Intellectual Property Rights Policy, or IPR Policy, by acting with Entropic to rid the asserted patents of the RAND encumbrances. Dish seeks an unspecified amount of compensatory damages, disgorgement, attorneys’ fees, experts’ fees, and costs. On February 21, 2024, MaxLinear moved to dismiss the Dish defendants’ counterclaim.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 22, 2024, a Special Master issued a report and recommendation, or the R&amp;R, which recommended granting the motion to dismiss with prejudice as to the following counterclaims: (1) quasi-contract for restitution/unjust enrichment, (2) combination in restraint of trade, (3) violation of the Cartwright Act, (4) patent misuse, and (5) violation of Cal. Bus. &amp; Prof. Code § 17200. MaxLinear submitted objections to the R&amp;R as to the remaining claims that were not dismissed. Dish submitted objections to the R&amp;R’s recommended dismissal of the quasi-contract for restitution/unjust enrichment counterclaim. The court has not yet issued any ruling regarding the R&amp;R or MaxLinear’s pending motion to dismiss.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 30, 2024, this case was stayed until September 17, 2024. There was a motion to stay this case pending resolution of Inter Partes Review (“IPR”). MaxLinear intends to continue to vigorously defend its position.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Cox Litigations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February 10, 2023, Entropic sued Cox Communications, Inc., CoxCom, LLC, and Cox Communications California, LLC, or together, Cox, in two separate actions in the United States District Court for the Central District of California. On October 6, 2023, Cox filed counterclaims against MaxLinear in each of the two actions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the first action, Cox alleges that when MaxLinear assigned certain patents to Entropic, MaxLinear violated its obligations under MoCA’s IPR Policy by assigning these patents and by allegedly failing to ensure that Cox would be offered a FRAND license for these patents. Cox amended its counterclaims on January 9, 2024 and is asserting claims of breach of contract, unjust enrichment, and declaratory judgment against MaxLinear. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 22, 2024, a Special Master issued the R&amp;R, which recommended granting the motion to dismiss with prejudice as to the unjust enrichment counterclaim but denying the motion as to the breach of contract and declaratory judgment counterclaims. MaxLinear submitted objections to the R&amp;R’s denial-in-part. Cox submitted objections to the R&amp;R as to the unjust enrichment counterclaim and as to certain findings related to the breach of contract counterclaim. The court has not yet issued any ruling regarding the R&amp;R or MaxLinear’s pending motion to dismiss.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the second action, in response to Entropic suing Cox for patent infringement, Cox filed counterclaims against MaxLinear. Cox alleges that MaxLinear granted CableLabs a non-exclusive, royalty-free license to all patents essential for compliance with DOCSIS specifications. It further alleges that MaxLinear breached this agreement when MaxLinear assigned certain patents to Entropic. Cox amended its counterclaims on January 9, 2024 and is asserting claims for breach of contract, unjust enrichment, and declaratory judgment. Cox seeks an unspecified amount of compensatory damages, equitable relief, attorneys’ fees, expenses, and costs. MaxLinear moved to dismiss Cox’s amended counterclaims on February 6, 2024.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On April 22, 2024, a Special Master issued the R&amp;R, which recommended dismissing all Cox counterclaims with prejudice. Cox submitted objections to the R&amp;R as to the unjust enrichment counterclaim. The court has not yet issued any ruling regarding the R&amp;R or MaxLinear’s pending motion to dismiss.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 30, 2024, these cases were stayed until September 17, 2024. There was a motion to stay pending resolution of IPR. MaxLinear intends to continue to vigorously defend its position.</span></div><div style="margin-top:9pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">*    *    *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. As of September 30, 2024, no material loss contingencies have been accrued for litigation and other legal claims in the consolidated financial statements, since the Company’s management currently does </span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">not believe that the ultimate outcome of any of the matters described above is probable. An unfavorable outcome of these matters may be reasonably possible in excess of recorded amounts; however, a reasonable estimate of the amount or range of such loss cannot be made at this time.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Matters</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is subject to threats of litigation or actual litigation in the ordinary course of business as described above and in “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Part II. — Other Information, Item 1. — Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,” some of which may be material. The results of any litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have a material adverse impact on the Company because of defense and settlement costs, diversion of management resources, and other factors.</span></div> <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024, future minimum payments under inventory purchase and other obligations are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.126%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inventory Purchase Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (3 months)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,708 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,712 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,419 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,423 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,994 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,417 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> <div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September 30, 2024, future minimum payments under inventory purchase and other obligations are as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:54.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.126%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inventory Purchase Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024 (3 months)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,004 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,708 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,712 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,419 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,131 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,482 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,673 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,423 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,994 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,417 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div> 3004000 7708000 10712000 13419000 32131000 45550000 0 19482000 19482000 0 3673000 3673000 16423000 62994000 79417000 15000000 2 2 2 4 4 8 8 8 2 2 Stock Repurchases<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 23, 2021, the Company’s board of directors authorized a plan to repurchase up to $100 million of the Company’s common stock over a period which ended February 16, 2024. The amount and timing of repurchases were subject to a variety of factors including liquidity, share price, market conditions, and legal requirements. Any purchases were funded from available working capital and were effected through open market purchases, block transactions, and privately negotiated transactions. The share repurchase program did not obligate the Company to make any repurchases and was able to be modified, suspended, or terminated by the Company at any time without prior notice. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The share repurchase program was suspended from July 2022 until its expiration due to the Company’s previously pending (now terminated) merger with Silicon Motion (Note 3). As a result, during the nine months ended September 30, 2024, the Company did not repurchase any shares of its common stock under the repurchase program. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2024, the aggregate value of common stock repurchased under the program was approximately $55.0 million and no shares remained available for repurchase under the program, as the plan expired on February 16, 2024.</span></div> 100000000 0 55000000.0 0 false false false false

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